data_1ix5_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ix5 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.652 ' CG1' ' N ' ' A' ' 6' ' ' ASP . 1.6 t . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.657 ' H ' HG21 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -151.51 172.82 15.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.52 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 31.6 mtpt -61.23 77.05 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.627 ' N ' ' HA3' ' A' ' 53' ' ' GLY . . . 145.21 18.05 0.17 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.657 HG21 ' H ' ' A' ' 6' ' ' ASP . 1.2 t -128.75 132.64 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.5 ' HA ' HG23 ' A' ' 51' ' ' VAL . 2.8 ttmt -92.5 152.45 19.65 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.58 ' CG2' ' CG2' ' A' ' 5' ' ' VAL . 1.3 pt -153.25 126.86 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.458 ' HG3' ' HB3' ' A' ' 49' ' ' GLU . 4.6 mtmt -83.48 87.51 7.0 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.531 ' CG1' HD13 ' A' ' 149' ' ' ILE . 0.8 OUTLIER -112.47 154.21 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.572 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 1.1 m-20 -118.37 96.46 5.31 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.611 ' CB ' ' HA ' ' A' ' 147' ' ' ILE . 4.7 p90 -90.36 154.5 19.64 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.602 ' CG2' ' HB ' ' A' ' 27' ' ' THR . 1.2 mt -121.3 71.84 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -55.1 128.38 43.67 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.602 ' HE3' ' O ' ' A' ' 16' ' ' ILE . 5.8 mtmt -120.21 -170.51 1.98 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.686 ' C ' ' H ' ' A' ' 21' ' ' SER . 6.0 mt -111.48 164.93 12.43 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -55.19 1.69 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.686 ' H ' ' C ' ' A' ' 19' ' ' LEU . 83.0 p -114.01 -4.61 13.19 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.44 25.72 32.41 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.441 ' O ' ' HA ' ' A' ' 18' ' ' LYS . 93.2 m-20 -96.31 119.25 34.46 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.52 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 86.1 t -69.06 112.81 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.453 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 1.7 p90 -100.77 -31.59 11.11 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.453 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 9.8 t0 -143.24 133.95 25.17 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.602 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 1.4 t -153.68 136.48 15.32 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.572 ' HB2' ' HA ' ' A' ' 14' ' ' ASP . 2.8 m -83.84 -26.04 29.83 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.54 ' CD1' ' HB2' ' A' ' 14' ' ' ASP . 3.0 mt -82.73 106.86 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.459 ' CA ' ' HB2' ' A' ' 45' ' ' TYR . 2.0 tt0 -50.44 -37.11 36.46 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -49.36 -66.26 0.43 Allowed 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.497 ' H ' HG23 ' A' ' 32' ' ' VAL . 5.0 t -47.59 -39.44 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.603 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . . . -46.42 -46.55 18.74 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.542 ' HG2' ' CB ' ' A' ' 39' ' ' TYR . 3.3 mtmt -68.35 -32.01 71.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.58 -12.41 60.75 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.42 ' CB ' ' HB ' ' A' ' 24' ' ' VAL . . . -116.95 -7.08 11.42 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.33 47.47 35.86 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.523 HG13 ' HA ' ' A' ' 33' ' ' ALA . 1.2 pt -140.13 8.61 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.603 ' HA ' ' CB ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -45.59 -16.37 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.502 ' O ' ' CZ ' ' A' ' 39' ' ' TYR . . . . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.459 ' HB2' ' CA ' ' A' ' 30' ' ' GLU . 56.5 m-85 . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.656 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -111.58 177.87 1.11 Allowed Pre-proline 0 N--CA 1.449 -0.506 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.656 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 84.2 Cg_endo -72.34 125.95 11.21 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 124.295 3.33 . . . . 0.0 109.632 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.24 112.66 23.76 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.458 ' HB3' ' HG3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -85.32 97.35 9.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.676 ' HB2' HE21 ' A' ' 56' ' ' GLN . 40.3 p90 -99.56 160.63 14.15 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 53' ' ' GLY . 41.0 t -123.37 112.78 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.52 ' C ' ' HA ' ' A' ' 7' ' ' LYS . 32.4 t -54.78 -11.64 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.627 ' HA3' ' N ' ' A' ' 8' ' ' GLY . . . -114.91 46.55 1.15 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.429 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 4.2 mt-10 -151.9 -8.6 0.21 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.85 12.11 64.2 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.676 HE21 ' HB2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -44.41 -78.56 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.573 HD23 ' CE1' ' A' ' 61' ' ' PHE . 5.8 mp -84.87 165.7 17.48 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.69 ' CD1' ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -56.45 136.88 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.509 ' HA ' ' HB2' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -41.79 -60.06 1.48 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.766 ' CA ' ' HE3' ' A' ' 82' ' ' LYS . . . -30.25 -68.87 0.09 OUTLIER Glycine 0 C--N 1.335 0.522 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.602 ' CE2' HG23 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -57.19 -44.32 83.48 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 59' ' ' GLN . 4.1 mt-10 -55.34 -23.68 25.19 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.467 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 12.0 mt-10 -87.97 -39.06 15.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.494 ' CB ' ' HD2' ' A' ' 74' ' ' LYS . . . -62.22 -13.42 27.67 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.597 HG22 ' N ' ' A' ' 66' ' ' LEU . 4.5 m -106.96 -26.55 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.597 ' N ' HG22 ' A' ' 65' ' ' VAL . 2.2 mt -47.55 -31.53 4.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -118.12 49.66 1.24 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.589 ' CE ' ' CD1' ' A' ' 149' ' ' ILE . 2.5 mtp -138.02 118.49 13.83 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -69.2 -173.44 0.53 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.599 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 3.1 t -80.92 106.27 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.665 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 118.01 -5.56 15.83 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.533 ' CB ' ' HG2' ' A' ' 68' ' ' MET . 0.6 OUTLIER -71.03 170.49 12.72 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.25 126.18 9.07 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.497 ' HB2' ' SD ' ' A' ' 68' ' ' MET . 19.1 ttmm -131.64 95.71 3.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.546 ' HG1' ' HA ' ' A' ' 146' ' ' THR . 91.6 m -88.76 77.81 7.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 3.6 t -111.77 164.97 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 2.5 ttpt -104.81 116.21 31.62 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.06 134.88 59.04 Favored Pre-proline 0 N--CA 1.449 -0.521 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.555 ' C ' ' H ' ' A' ' 81' ' ' GLU . 84.1 Cg_endo -72.44 138.77 30.48 Favored 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 124.28 3.32 . . . . 0.0 109.633 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.675 ' HB3' ' H ' ' A' ' 141' ' ' LYS . . . -49.59 -10.66 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.596 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 1.0 OUTLIER -80.23 -39.03 29.85 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.766 ' HE3' ' CA ' ' A' ' 60' ' ' GLY . 2.0 mtpp -86.78 -32.46 20.35 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.631 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . . . -72.46 -93.81 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.44 ' HD1' ' N ' ' A' ' 84' ' ' TYR . 1.7 m-85 -97.87 18.54 15.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.596 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 41.64 83.93 0.01 OUTLIER Glycine 0 C--N 1.336 0.537 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.655 ' ND2' ' N ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER 46.72 -164.84 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.517 ' HD2' ' CG ' ' A' ' 135' ' ' ASN . 0.9 OUTLIER -90.59 154.44 19.59 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.564 ' CB ' ' CD1' ' A' ' 91' ' ' LEU . 1.3 t30 -91.41 153.61 19.75 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -90.09 -25.77 20.58 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.74 1.58 16.78 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.816 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 19.9 mt -104.5 5.47 34.06 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.61 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 52.3 mt -82.96 107.94 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.795 HE22 ' HB2' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -100.13 165.56 11.45 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.63 ' CG ' ' HG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -147.0 99.26 3.15 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.517 HG22 ' CD1' ' A' ' 132' ' ' LEU . 20.7 pt -96.47 155.19 38.2 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.55 ' O ' ' N ' ' A' ' 99' ' ' ALA . 83.7 Cg_endo -72.34 137.68 28.76 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 124.311 3.341 . . . . 0.0 109.598 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.87 HH21 ' HD2' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -41.64 -34.81 0.65 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.606 ' HA ' ' CB ' ' A' ' 101' ' ' LYS . 6.3 t70 -63.17 -37.06 85.71 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -45.87 -16.39 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.534 ' CD1' ' HB3' ' A' ' 105' ' ' PHE . 2.1 m-85 -137.52 -24.09 1.07 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.606 ' CB ' ' HA ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -41.57 -41.07 2.05 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -90.99 43.77 1.16 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.574 ' C ' ' H ' ' A' ' 105' ' ' PHE . . . -174.94 127.89 0.29 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.497 ' C ' ' H ' ' A' ' 106' ' ' GLU . 2.7 p30 -49.01 -9.28 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.684 ' O ' ' C ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -47.04 -14.85 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.684 ' C ' ' O ' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -4.32 99.85 0.03 OUTLIER Pre-proline 0 N--CA 1.45 -0.452 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.87 ' HD2' HH21 ' A' ' 97' ' ' ARG . 84.1 Cg_endo -72.4 151.64 53.99 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 124.287 3.325 . . . . 0.0 109.602 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 110' ' ' GLY . 2.9 mt-10 -132.67 156.59 46.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.531 ' HB2' ' CG1' ' A' ' 125' ' ' VAL . 1.1 tt0 -65.81 66.98 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.8 10.02 0.08 OUTLIER Glycine 0 C--N 1.335 0.509 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.526 ' HB3' ' CD1' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -69.97 170.67 10.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.448 ' CG2' ' O ' ' A' ' 111' ' ' MET . 60.9 t -156.23 73.94 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.58 HD12 ' CE1' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -105.46 135.48 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.628 HD21 ' CD ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -105.04 161.55 14.12 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -108.51 5.23 24.99 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.44 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 0.9 OUTLIER 166.29 -11.09 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.72 -43.04 0.21 Allowed Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.434 ' HA ' ' HD2' ' A' ' 119' ' ' PRO . 3.6 mt -82.51 112.46 36.99 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.628 ' CD ' HD21 ' A' ' 114' ' ' LEU . 83.5 Cg_endo -72.31 165.59 32.21 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 124.322 3.348 . . . . 0.0 109.588 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.562 ' CB ' ' HB3' ' A' ' 132' ' ' LEU . . . -126.91 90.87 3.23 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 6.0 m -62.55 95.54 0.07 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.596 ' HA ' ' HA ' ' A' ' 132' ' ' LEU . 2.6 mp -68.98 89.98 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 30.7 p -80.1 -17.74 51.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.703 ' HB3' ' H ' ' A' ' 131' ' ' THR . 0.8 OUTLIER -119.99 130.85 54.94 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.531 ' CG1' ' HB2' ' A' ' 109' ' ' GLU . 7.9 p -124.26 52.92 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.716 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.2 OUTLIER -79.07 126.49 30.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.534 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.3 OUTLIER -52.12 0.06 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.716 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -111.7 -21.14 11.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.712 ' H ' ' HG1' ' A' ' 126' ' ' THR . 0.6 OUTLIER -178.84 167.02 1.69 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 19.7 m -132.62 141.16 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.703 ' H ' ' HB3' ' A' ' 124' ' ' GLU . 23.5 m -96.49 83.91 3.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.596 ' HA ' ' HA ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -78.93 97.08 5.89 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.844 ' CG ' HD22 ' A' ' 135' ' ' ASN . 25.5 t0 -71.17 97.52 1.53 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.795 ' HB2' HE22 ' A' ' 93' ' ' GLN . 2.1 m-30 -42.89 -56.91 3.05 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.844 HD22 ' CG ' ' A' ' 133' ' ' ASP . 13.1 m120 55.98 -118.04 1.18 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 1.092 ' ND1' ' H ' ' A' ' 138' ' ' LEU . 24.1 t-80 -175.19 174.16 2.46 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.603 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 4.8 tp10 -65.84 -43.9 87.12 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 1.092 ' H ' ' ND1' ' A' ' 136' ' ' HIS . 25.4 mt -97.46 10.79 38.82 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.584 ' HB1' ' N ' ' A' ' 136' ' ' HIS . . . -62.52 133.76 55.41 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 86' ' ' ASN . . . 41.73 36.56 1.73 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 110.234 -1.147 . . . . 0.0 110.234 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.812 ' HE2' ' CD2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -146.6 144.04 29.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.514 ' HB3' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -95.71 143.12 27.24 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.627 ' CD1' ' CZ ' ' A' ' 145' ' ' PHE . 0.4 OUTLIER -130.67 154.06 48.31 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.611 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 0.5 OUTLIER -73.71 168.46 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.627 ' CZ ' ' CD1' ' A' ' 143' ' ' LEU . 26.8 m-85 -154.97 90.24 1.28 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.546 ' HA ' ' HG1' ' A' ' 75' ' ' THR . 96.0 m -81.6 58.8 3.87 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.611 ' HA ' ' CB ' ' A' ' 15' ' ' TYR . 3.2 mt -53.31 175.09 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -177.59 96.64 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.665 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 1.4 mm -62.21 134.22 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.414 HG13 ' HA ' ' A' ' 13' ' ' VAL . 8.9 mt -122.12 -26.51 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.599 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 2.1 tt0 -162.74 -175.41 4.42 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.538 ' CG2' HG22 ' A' ' 11' ' ' ILE . 73.8 t -140.27 137.45 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.426 ' C ' ' HB3' ' A' ' 10' ' ' LYS . 2.3 t . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.599 HG11 ' H ' ' A' ' 6' ' ' ASP . 9.2 t . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 109.767 -0.456 . . . . 0.0 109.767 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.599 ' H ' HG11 ' A' ' 5' ' ' VAL . 19.4 m-20 -146.78 164.75 31.78 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.519 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 17.3 ptmt -63.44 70.18 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.661 ' N ' ' HA3' ' A' ' 53' ' ' GLY . . . 155.19 16.63 0.05 OUTLIER Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.45 HG21 ' HB2' ' A' ' 6' ' ' ASP . 2.5 t -126.65 136.33 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.517 ' HE2' ' HG2' ' A' ' 49' ' ' GLU . 2.7 tttt -88.27 158.27 18.52 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.6 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 1.8 pt -166.23 133.49 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.686 ' HE2' ' CG2' ' A' ' 153' ' ' VAL . 18.3 mtmt -87.18 85.12 7.18 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.614 ' CG1' ' HA ' ' A' ' 149' ' ' ILE . 0.9 OUTLIER -122.8 158.75 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.449 ' O ' ' CG2' ' A' ' 147' ' ' ILE . 10.9 m-20 -114.55 -160.18 0.72 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.605 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.5 p90 -179.44 155.87 0.7 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.594 ' CG2' ' HB ' ' A' ' 27' ' ' THR . 1.3 mt -127.39 73.21 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -54.68 134.02 47.01 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.568 ' HG2' ' N ' ' A' ' 24' ' ' VAL . 8.1 mttt -123.92 -162.75 1.08 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.68 ' C ' ' H ' ' A' ' 21' ' ' SER . 39.9 mt -118.28 165.65 13.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -55.02 0.97 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.68 ' H ' ' C ' ' A' ' 19' ' ' LEU . 53.5 p -114.85 1.38 14.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.9 28.53 50.12 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.221 -1.151 . . . . 0.0 110.221 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.451 ' C ' ' HG2' ' A' ' 18' ' ' LYS . 98.1 m-20 -99.85 121.97 42.11 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.568 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 76.0 t -66.18 134.71 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.52 ' CE1' ' HB2' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -128.07 -28.87 2.59 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.52 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 11.3 t0 -145.68 132.17 19.75 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.594 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -152.26 126.67 9.34 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.412 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 73.0 m -86.49 14.13 7.28 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.456 HG22 ' H ' ' A' ' 32' ' ' VAL . 68.9 mt -113.11 116.85 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -54.01 -41.6 68.15 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -52.54 -70.78 0.08 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.456 ' H ' HG22 ' A' ' 29' ' ' ILE . 67.5 t -48.48 -41.44 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.621 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . . . -50.05 -38.34 37.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.51 ' CG ' ' HB2' ' A' ' 39' ' ' TYR . 22.0 mtpt -79.54 -21.4 45.22 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -87.21 -10.88 51.43 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.4 -10.66 12.61 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.68 43.57 10.05 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.526 HG13 ' HA ' ' A' ' 33' ' ' ALA . 0.4 OUTLIER -141.85 16.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.621 ' HA ' ' CB ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -47.62 -13.25 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.523 ' H ' ' C ' ' A' ' 38' ' ' ILE . . . . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.497 ' CZ ' ' O ' ' A' ' 27' ' ' THR . 2.2 m-85 . . . . . 0 N--CA 1.449 -0.502 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.711 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -135.61 -180.0 1.22 Allowed Pre-proline 0 N--CA 1.448 -0.546 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.711 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 82.3 Cg_endo -72.45 127.83 12.96 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 124.293 3.329 . . . . 0.0 109.573 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.454 HD23 HD23 ' A' ' 57' ' ' LEU . 2.6 tp -82.68 94.71 7.63 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.517 ' HG2' ' HE2' ' A' ' 10' ' ' LYS . 43.1 tt0 -76.58 97.95 4.53 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.467 ' CG ' HD22 ' A' ' 57' ' ' LEU . 6.4 p90 -118.92 173.86 6.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.922 ' H ' ' NE2' ' A' ' 56' ' ' GLN . 57.8 t -130.7 109.69 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.519 ' C ' ' HA ' ' A' ' 7' ' ' LYS . 16.3 t -49.08 -10.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.661 ' HA3' ' N ' ' A' ' 8' ' ' GLY . . . -108.07 25.74 19.41 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 51' ' ' VAL . 4.0 mt-10 -123.25 -43.16 2.21 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.85 7.59 50.24 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.922 ' NE2' ' H ' ' A' ' 51' ' ' VAL . 1.2 mt-30 -46.0 -50.07 15.36 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.549 HD21 ' N ' ' A' ' 57' ' ' LEU . 1.2 mm? -96.48 175.24 6.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.775 ' H ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -75.99 150.88 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.481 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 10.6 mt-30 -40.11 -65.72 0.37 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.624 ' H ' ' HB3' ' A' ' 82' ' ' LYS . . . -33.46 -82.78 0.01 OUTLIER Glycine 0 C--N 1.335 0.506 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.594 ' CE2' HG12 ' A' ' 147' ' ' ILE . 2.3 t80 -40.88 -53.57 2.88 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.411 ' OE2' ' HA ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -45.28 -34.04 2.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 60' ' ' GLY . 5.9 mt-10 -80.73 -31.11 36.13 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . -64.43 -29.84 70.88 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.555 HG11 ' CE1' ' A' ' 61' ' ' PHE . 2.5 m -92.36 -21.46 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.513 ' N ' HG23 ' A' ' 65' ' ' VAL . 1.1 mt -50.14 -55.67 14.09 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -98.74 55.58 1.06 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.527 ' HE3' ' HA ' ' A' ' 73' ' ' GLU . 9.4 mtp -134.12 123.8 25.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -77.92 167.49 21.41 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.592 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 0.2 OUTLIER -68.62 96.63 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.867 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 118.87 17.76 4.95 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -95.99 -172.08 2.49 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.527 ' HA ' ' HE3' ' A' ' 68' ' ' MET . 2.2 tt0 -162.54 123.11 2.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.493 ' HB2' ' SD ' ' A' ' 68' ' ' MET . 5.2 ttmt -125.82 99.69 6.07 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.487 ' HG1' ' HG1' ' A' ' 146' ' ' THR . 84.8 m -93.82 76.32 4.23 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.45 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 3.9 t -106.04 156.83 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.629 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 5.4 ttpm? -95.1 113.12 24.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.569 ' CG2' ' CB ' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -79.19 130.83 67.95 Favored Pre-proline 0 N--CA 1.45 -0.438 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.52 ' CG ' ' HD3' ' A' ' 82' ' ' LYS . 84.0 Cg_endo -72.35 144.54 41.33 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 124.33 3.354 . . . . 0.0 109.595 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.643 ' O ' ' N ' ' A' ' 85' ' ' GLY . . . -50.99 -11.68 0.1 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.55 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 15.7 tt0 -86.1 -34.65 20.59 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.624 ' HB3' ' H ' ' A' ' 60' ' ' GLY . 1.0 OUTLIER -105.67 41.45 1.38 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.729 ' HA ' ' CB ' ' A' ' 58' ' ' ILE . . . -159.57 -34.27 0.06 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.681 ' CD2' ' CB ' ' A' ' 138' ' ' LEU . 74.2 m-85 -158.89 8.6 0.12 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.643 ' N ' ' O ' ' A' ' 80' ' ' ALA . . . 72.49 143.5 0.49 Allowed Glycine 0 C--N 1.336 0.557 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.884 ' H ' ' ND2' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -47.82 167.38 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.534 ' HG2' ' HA3' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -41.4 139.96 0.97 Allowed 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.564 ' CB ' ' CD1' ' A' ' 91' ' ' LEU . 1.9 t30 -93.13 153.23 18.78 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.549 ' C ' ' H ' ' A' ' 91' ' ' LEU . 48.7 mt-10 -86.49 -39.18 16.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.48 11.86 0.22 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.655 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 54.5 mt -118.57 5.73 11.67 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.598 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 51.1 mt -84.75 114.05 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.765 HE22 ' HB2' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -106.22 166.3 10.62 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.894 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.762 ' HG3' ' HG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -146.39 96.81 2.83 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.588 HD12 ' CD1' ' A' ' 100' ' ' PHE . 3.7 pt -96.06 157.69 35.34 Favored Pre-proline 0 N--CA 1.449 -0.505 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.555 ' O ' ' N ' ' A' ' 99' ' ' ALA . 83.4 Cg_endo -72.45 139.96 32.48 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 124.296 3.331 . . . . 0.0 109.576 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.832 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -43.81 -20.65 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.612 ' C ' ' H ' ' A' ' 100' ' ' PHE . 3.3 m-20 -78.17 -35.46 48.76 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.555 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -50.56 -6.99 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.612 ' H ' ' C ' ' A' ' 98' ' ' ASP . 2.3 m-85 -131.46 -26.54 2.05 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.486 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 0.9 OUTLIER -63.39 -15.15 56.7 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.29 6.14 49.59 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.512 ' HB2' ' CZ ' ' A' ' 105' ' ' PHE . . . -100.61 -137.51 0.32 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.72 18.15 1.47 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.512 ' CZ ' ' HB2' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -133.13 -144.07 0.23 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.492 ' HG2' ' HD2' ' A' ' 107' ' ' PRO . 0.4 OUTLIER -171.21 126.65 0.63 Allowed Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.832 ' CG ' HH21 ' A' ' 97' ' ' ARG . 82.3 Cg_endo -72.33 131.83 18.34 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 124.321 3.348 . . . . 0.0 109.579 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.502 ' HA ' HG23 ' A' ' 125' ' ' VAL . 2.1 mm-40 -118.83 157.62 27.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -67.19 66.1 0.07 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.89 12.25 0.07 OUTLIER Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.536 ' CB ' ' CD1' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -68.55 171.34 7.67 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' A' ' 111' ' ' MET . 96.4 t -155.57 65.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.421 HG23 ' H ' ' A' ' 113' ' ' ILE . 0.0 OUTLIER -101.34 136.76 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.641 HD21 ' HD3' ' A' ' 119' ' ' PRO . 0.1 OUTLIER -104.58 172.81 6.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -119.71 -1.62 10.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 172.46 3.17 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 152.65 -32.34 0.83 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 18.2 mm -94.4 116.03 65.94 Favored Pre-proline 0 N--CA 1.449 -0.485 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.641 ' HD3' HD21 ' A' ' 114' ' ' LEU . 81.9 Cg_endo -72.42 171.8 16.3 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 124.333 3.356 . . . . 0.0 109.582 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.565 ' CB ' ' HB3' ' A' ' 132' ' ' LEU . . . -132.13 75.5 1.64 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 3.7 m -49.13 97.83 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.621 ' HA ' ' HA ' ' A' ' 132' ' ' LEU . 1.8 mp -71.14 95.6 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.432 ' N ' ' O ' ' A' ' 131' ' ' THR . 0.9 OUTLIER -82.06 -18.94 41.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.714 ' HB3' ' H ' ' A' ' 131' ' ' THR . 1.7 tp10 -121.9 130.88 53.7 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.502 HG23 ' HA ' ' A' ' 108' ' ' GLU . 15.0 p -122.02 50.89 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.686 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -78.62 126.03 30.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.527 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.9 OUTLIER -53.17 0.18 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.686 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -111.28 -20.21 12.38 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -177.86 164.64 1.94 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 17.4 m -129.57 135.95 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.762 ' HG1' ' HG3' ' A' ' 94' ' ' LYS . 24.2 m -95.45 87.24 4.71 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.641 ' H ' HD11 ' A' ' 132' ' ' LEU . 0.2 OUTLIER -85.68 122.2 29.44 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.598 ' HA ' ' HA ' ' A' ' 92' ' ' ILE . 15.4 t0 -90.17 94.28 9.7 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.765 ' HB2' HE22 ' A' ' 93' ' ' GLN . 2.4 m-85 -38.33 -42.29 0.7 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.655 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 0.7 OUTLIER 42.04 -112.12 0.18 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 1.019 ' ND1' ' H ' ' A' ' 138' ' ' LEU . 15.8 t-80 -177.76 -170.4 0.26 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.95 ' H ' ' CG ' ' A' ' 136' ' ' HIS . 1.5 tp10 -73.55 -42.03 62.2 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 1.019 ' H ' ' ND1' ' A' ' 136' ' ' HIS . 2.6 mm? -98.97 -15.64 19.03 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.625 ' HB2' ' N ' ' A' ' 136' ' ' HIS . . . -58.7 115.69 3.23 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.534 ' HA3' ' HG2' ' A' ' 87' ' ' ARG . . . 71.17 15.57 74.63 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.709 ' HE2' ' CD1' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -134.7 131.94 38.26 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.551 ' C ' ' HD3' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -100.47 130.02 46.5 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.633 ' HB3' ' HE2' ' A' ' 141' ' ' LYS . 1.4 pt? -115.98 144.94 43.39 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.629 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 0.2 OUTLIER -68.02 173.96 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.545 ' CE2' ' HG ' ' A' ' 143' ' ' LEU . 25.5 m-85 -157.44 90.28 1.09 Allowed 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.513 ' HB ' ' HB ' ' A' ' 16' ' ' ILE . 85.4 m -81.88 64.35 6.53 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.617 HG21 ' H ' ' A' ' 148' ' ' LYS . 1.9 mt -60.3 178.51 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.617 ' H ' HG21 ' A' ' 147' ' ' ILE . 13.7 tttp -178.03 110.59 0.06 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.867 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 4.4 mm -70.84 139.0 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 47' ' ' PRO . 3.6 mt -118.39 -41.15 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.592 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 2.4 tt0 -158.86 -165.69 1.69 Allowed 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.6 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 97.0 t -136.95 151.7 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.686 ' CG2' ' HE2' ' A' ' 12' ' ' LYS . 1.8 t . . . . . 0 N--CA 1.449 -0.503 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.644 ' CG1' ' N ' ' A' ' 6' ' ' ASP . 1.5 t . . . . . 0 N--CA 1.448 -0.53 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.644 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 0.5 OUTLIER -138.04 175.83 9.23 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.537 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 16.1 ptmt -67.35 65.65 0.07 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 6' ' ' ASP . . . 165.35 15.32 0.02 OUTLIER Glycine 0 C--N 1.336 0.557 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.518 ' CG2' ' H ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -129.14 132.64 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.582 ' HE2' ' HB ' ' A' ' 153' ' ' VAL . 4.2 ttpm? -87.55 165.03 15.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.578 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 1.1 pt -169.19 134.42 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.701 ' HZ3' ' HB3' ' A' ' 151' ' ' GLU . 7.5 mtmt -94.3 91.98 6.98 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.573 ' CG1' ' HA ' ' A' ' 149' ' ' ILE . 0.8 OUTLIER -116.02 153.95 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.522 ' HB3' ' CD1' ' A' ' 29' ' ' ILE . 3.6 m-20 -111.41 106.12 14.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.608 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.9 p90 -101.99 159.46 15.35 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.599 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 3.5 mt -133.55 73.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -56.9 129.17 48.86 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.599 ' HE3' ' O ' ' A' ' 16' ' ' ILE . 5.9 mttt -116.98 -164.03 0.95 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.673 ' C ' ' H ' ' A' ' 21' ' ' SER . 85.3 mt -118.02 165.87 13.21 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -54.66 0.07 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.673 ' H ' ' C ' ' A' ' 19' ' ' LEU . 84.5 p -112.05 -3.88 14.63 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.62 25.11 43.61 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.457 ' C ' ' HG2' ' A' ' 18' ' ' LYS . 1.6 m-20 -96.6 122.13 39.18 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.514 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 55.8 t -68.49 113.66 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.589 ' CE1' ' HB2' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -104.41 -31.56 9.45 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.589 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 14.4 t0 -140.07 138.94 35.76 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.577 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -158.24 161.24 37.74 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.695 ' HG ' ' HB2' ' A' ' 48' ' ' LEU . 12.9 m -115.73 -11.92 11.58 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.747 HG22 ' H ' ' A' ' 32' ' ' VAL . 3.0 mt -92.77 116.23 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.424 ' N ' ' HB3' ' A' ' 45' ' ' TYR . 2.5 tt0 -51.51 -38.98 56.69 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -48.72 -67.86 0.23 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.747 ' H ' HG22 ' A' ' 29' ' ' ILE . 34.7 t -53.93 -38.32 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.619 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . . . -53.16 -43.05 66.74 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.543 ' HG2' ' CB ' ' A' ' 39' ' ' TYR . 3.9 mtmt -68.13 -30.91 70.16 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -80.99 -20.08 42.6 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.425 ' HB3' ' HB ' ' A' ' 24' ' ' VAL . . . -103.41 -11.42 17.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.01 45.75 19.22 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.502 HG13 ' HA ' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -143.12 16.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.619 ' HA ' ' CB ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -57.97 -14.6 6.69 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.481 ' O ' ' CZ ' ' A' ' 39' ' ' TYR . . . . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.462 ' CE2' ' HB1' ' A' ' 33' ' ' ALA . 1.9 m-85 . . . . . 0 N--CA 1.449 -0.519 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.655 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -82.58 177.48 3.0 Favored Pre-proline 0 N--CA 1.449 -0.502 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.655 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 84.4 Cg_endo -72.43 128.81 14.03 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 124.292 3.328 . . . . 0.0 109.598 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.695 ' HB2' ' HG ' ' A' ' 28' ' ' SER . 22.0 tp -69.41 104.63 2.33 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.514 ' CD ' ' CE ' ' A' ' 10' ' ' LYS . 13.3 tt0 -91.15 100.87 13.63 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.753 ' HA ' HE22 ' A' ' 56' ' ' GLN . 32.1 p90 -119.78 170.61 9.07 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.835 HG11 ' H ' ' A' ' 53' ' ' GLY . 69.5 t -131.31 113.07 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.537 ' C ' ' HA ' ' A' ' 7' ' ' LYS . 4.6 t -50.53 -8.7 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.835 ' H ' HG11 ' A' ' 51' ' ' VAL . . . -117.33 35.35 4.16 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.447 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 2.7 mm-40 -124.27 -31.97 3.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.11 5.65 59.4 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.753 HE22 ' HA ' ' A' ' 50' ' ' PHE . 7.9 mt-30 -57.95 -97.36 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.587 ' HB3' ' CD1' ' A' ' 61' ' ' PHE . 1.5 mm? -54.32 157.8 2.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.801 ' CD1' ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -60.96 149.18 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -44.6 -55.24 5.35 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 63' ' ' GLU . . . -39.65 -79.79 0.04 OUTLIER Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.587 ' CD1' ' HB3' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -43.45 -44.69 5.98 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.41 ' CD ' ' HA ' ' A' ' 52' ' ' VAL . 6.5 mt-10 -55.85 -32.81 63.95 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.523 ' HA ' ' HB2' ' A' ' 66' ' ' LEU . 7.3 mt-10 -77.86 -29.77 50.57 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.36 -42.37 98.88 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.414 HG21 ' CZ ' ' A' ' 50' ' ' PHE . 4.6 m -84.06 -15.29 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.597 ' CD2' ' HA ' ' A' ' 6' ' ' ASP . 3.8 mt -63.05 -48.4 78.87 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -102.85 54.83 0.77 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.502 ' HB3' ' H ' ' A' ' 69' ' ' GLU . 6.1 mtp -131.57 -144.8 0.25 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.502 ' H ' ' HB3' ' A' ' 68' ' ' MET . 0.0 OUTLIER -155.96 -178.56 7.39 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.605 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 0.5 OUTLIER -90.09 80.12 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.673 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 138.4 11.07 0.9 Allowed Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.47 ' CG ' ' HB2' ' A' ' 69' ' ' GLU . 2.8 m-20 -95.48 -178.39 4.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -153.72 130.47 10.83 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.478 ' HB2' ' SD ' ' A' ' 68' ' ' MET . 9.6 ttmt -131.69 96.68 4.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.818 ' HG1' ' HA ' ' A' ' 146' ' ' THR . 80.3 m -95.5 78.77 3.39 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.73 HG12 ' H ' ' A' ' 77' ' ' LYS . 4.0 t -111.38 171.25 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.73 ' H ' HG12 ' A' ' 76' ' ' VAL . 1.8 ttpt -103.35 114.79 29.36 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.554 HD11 ' CD2' ' A' ' 145' ' ' PHE . 0.3 OUTLIER -79.4 129.33 72.37 Favored Pre-proline 0 N--CA 1.448 -0.554 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.513 ' C ' ' H ' ' A' ' 81' ' ' GLU . 83.0 Cg_endo -72.29 141.9 36.44 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 124.346 3.364 . . . . 0.0 109.582 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' A' ' 85' ' ' GLY . . . -54.36 -8.39 0.21 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.622 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 8.3 pt-20 -81.38 -37.4 28.25 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.452 ' N ' ' HG3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -87.52 -30.0 20.91 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.64 ' HA ' ' CB ' ' A' ' 58' ' ' ILE . . . -71.52 -94.74 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.593 ' CD1' ' N ' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -106.71 21.64 17.17 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.622 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 46.58 87.67 0.01 OUTLIER Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.645 ' ND2' ' N ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER 39.9 -144.5 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.559 ' HD2' ' HA3' ' A' ' 140' ' ' GLY . 0.1 OUTLIER -91.3 145.1 24.93 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.558 ' CB ' ' CD1' ' A' ' 91' ' ' LEU . 7.0 t30 -83.79 132.47 34.82 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -66.63 -25.97 66.84 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.62 8.17 15.13 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.843 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 34.5 mt -110.19 5.23 21.72 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.617 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 24.6 mt -84.88 108.28 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.709 HE22 ' HB2' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -101.84 152.14 21.24 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.485 ' HG3' ' HA ' ' A' ' 131' ' ' THR . 0.0 OUTLIER -135.81 91.4 2.7 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.551 HD13 ' CD1' ' A' ' 100' ' ' PHE . 3.3 pt -86.23 159.04 54.48 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.571 ' HA ' ' HG3' ' A' ' 129' ' ' GLU . 80.7 Cg_endo -72.46 136.18 25.7 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 124.35 3.367 . . . . 0.0 109.551 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.839 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -42.24 -29.53 0.25 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.547 ' HA ' ' CB ' ' A' ' 101' ' ' LYS . 8.4 t70 -70.29 -36.08 74.14 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -51.01 -12.82 0.12 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.559 ' C ' ' H ' ' A' ' 102' ' ' GLU . 4.5 m-85 -133.63 -21.03 2.0 Allowed 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.547 ' CB ' ' HA ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -49.84 -9.9 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.559 ' H ' ' C ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -143.32 40.45 1.46 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.603 ' HB2' ' CE1' ' A' ' 105' ' ' PHE . . . -103.25 21.52 15.73 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 71.16 -14.84 0.44 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.603 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 0.9 OUTLIER -135.87 -148.76 0.31 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.514 ' HG2' ' HD2' ' A' ' 107' ' ' PRO . 1.4 tt0 -160.78 138.04 6.77 Favored Pre-proline 0 N--CA 1.448 -0.552 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.839 ' CG ' HH21 ' A' ' 97' ' ' ARG . 82.9 Cg_endo -72.41 141.02 34.38 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 124.311 3.341 . . . . 0.0 109.61 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.512 ' HA ' HG21 ' A' ' 125' ' ' VAL . 20.9 mt-10 -130.06 153.57 48.32 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -63.64 70.06 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.21 5.23 0.12 Allowed Glycine 0 C--N 1.336 0.571 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.456 ' CB ' HD12 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -65.34 165.89 11.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 111' ' ' MET . 52.4 t -156.27 70.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.66 134.93 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.642 HD22 ' CD ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -104.47 170.57 7.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.415 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -116.07 5.23 13.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.415 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 0.5 OUTLIER 167.01 -10.88 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.413 ' O ' ' HD3' ' A' ' 119' ' ' PRO . . . 169.81 -45.15 0.21 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.433 ' HA ' ' HD2' ' A' ' 119' ' ' PRO . 4.3 mt -80.46 110.97 18.93 Favored Pre-proline 0 N--CA 1.45 -0.465 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.642 ' CD ' HD22 ' A' ' 114' ' ' LEU . 82.7 Cg_endo -72.37 163.94 37.12 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 124.255 3.303 . . . . 0.0 109.628 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.536 ' CB ' ' HB3' ' A' ' 132' ' ' LEU . . . -124.73 94.3 4.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 21.3 m -66.4 97.02 0.39 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.581 ' CG1' ' CD2' ' A' ' 132' ' ' LEU . 5.9 mt -71.75 84.41 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.54 ' CG2' HG22 ' A' ' 131' ' ' THR . 0.0 OUTLIER -74.82 -16.94 60.68 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.804 ' HB3' ' H ' ' A' ' 131' ' ' THR . 0.3 OUTLIER -119.23 127.95 53.74 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.512 HG21 ' HA ' ' A' ' 108' ' ' GLU . 8.1 p -122.56 49.15 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.727 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -78.05 125.48 29.41 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.665 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.4 OUTLIER -52.82 1.7 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.727 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.1 OUTLIER -112.95 -20.94 11.37 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.571 ' HG3' ' HA ' ' A' ' 96' ' ' PRO . 2.3 mt-10 -174.75 165.67 3.68 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.444 ' HB ' HG21 ' A' ' 122' ' ' ILE . 16.7 m -135.23 130.76 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.804 ' H ' ' HB3' ' A' ' 124' ' ' GLU . 66.1 m -93.79 94.89 8.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.662 ' H ' HD11 ' A' ' 132' ' ' LEU . 0.3 OUTLIER -92.35 103.37 15.82 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.798 ' CG ' HD22 ' A' ' 135' ' ' ASN . 18.9 t0 -74.8 96.87 3.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.709 ' HB2' HE22 ' A' ' 93' ' ' GLN . 2.0 m-30 -41.32 -82.59 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.843 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 0.3 OUTLIER 77.74 -127.67 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.997 ' HD1' ' N ' ' A' ' 138' ' ' LEU . 14.1 t-80 -171.49 178.34 3.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.678 ' N ' ' CG ' ' A' ' 136' ' ' HIS . 10.2 tp10 -67.88 -16.47 64.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.997 ' N ' ' HD1' ' A' ' 136' ' ' HIS . 16.2 mt -118.14 -16.83 9.72 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.661 ' HB2' ' H ' ' A' ' 136' ' ' HIS . . . -57.57 110.17 0.83 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 86' ' ' ASN . . . 79.97 31.99 37.59 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.85 ' HE2' ' CD2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -155.26 146.15 22.44 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.535 ' C ' ' HD2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -95.31 135.44 36.91 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.585 ' HB3' ' HE2' ' A' ' 141' ' ' LYS . 0.4 OUTLIER -124.15 149.16 46.59 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.6 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 1.7 t -73.56 166.87 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.557 ' CZ ' HD11 ' A' ' 143' ' ' LEU . 25.3 m-85 -151.21 91.64 1.71 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.818 ' HA ' ' HG1' ' A' ' 75' ' ' THR . 83.9 m -84.48 61.92 6.94 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.608 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.7 mt -56.21 -179.47 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.468 ' C ' ' HB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -178.33 90.61 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.673 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 1.1 mm -60.51 130.7 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.519 ' CD1' ' HB3' ' A' ' 47' ' ' PRO . 4.8 mt -113.64 -45.37 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.701 ' HB3' ' HZ3' ' A' ' 12' ' ' LYS . 0.2 OUTLIER -153.98 -165.64 2.16 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.578 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 88.7 t -138.65 153.3 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.683 ' CG2' ' HE2' ' A' ' 12' ' ' LYS . 1.9 t . . . . . 0 N--CA 1.45 -0.472 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.574 HG12 ' H ' ' A' ' 6' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.574 ' H ' HG12 ' A' ' 5' ' ' VAL . 8.5 m-20 -154.87 165.77 35.61 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.6 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 4.9 ptpt -69.94 63.68 0.21 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.05 3.19 0.03 OUTLIER Glycine 0 C--N 1.335 0.508 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.425 ' HB ' HG12 ' A' ' 5' ' ' VAL . 2.5 t -119.98 140.3 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.429 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 10.8 tttt -96.68 149.38 21.86 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.678 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 10.8 pt -158.05 140.49 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.488 ' CE ' HG21 ' A' ' 153' ' ' VAL . 7.0 ttmt -94.11 99.07 11.42 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.574 ' CG1' ' HA ' ' A' ' 149' ' ' ILE . 1.1 m -124.13 152.37 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 147' ' ' ILE . 16.4 m-20 -95.07 -167.35 1.61 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.767 ' HH ' ' CG ' ' A' ' 26' ' ' ASP . 0.3 OUTLIER 177.52 148.75 0.15 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.538 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 4.5 mt -132.25 74.27 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -58.21 134.14 52.49 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.58 ' HG2' ' N ' ' A' ' 24' ' ' VAL . 7.8 mtmt -118.98 -152.99 0.52 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.635 ' C ' ' H ' ' A' ' 21' ' ' SER . 1.5 mt -128.49 166.08 19.47 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -52.67 -3.71 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.635 ' H ' ' C ' ' A' ' 19' ' ' LEU . 52.0 p -113.89 14.25 18.51 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 19' ' ' LEU . . . 65.33 32.03 82.35 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.446 ' O ' ' HA ' ' A' ' 18' ' ' LYS . 2.3 m-20 -101.6 123.98 46.5 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.58 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 76.7 t -68.98 130.22 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.573 ' CE1' ' HB2' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -124.59 -29.55 3.45 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.767 ' CG ' ' HH ' ' A' ' 15' ' ' TYR . 9.3 t0 -145.08 135.78 24.47 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.586 ' HG1' ' H ' ' A' ' 29' ' ' ILE . 1.7 t -153.47 144.87 23.16 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 2.5 m -96.96 -4.95 38.99 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.586 ' H ' ' HG1' ' A' ' 27' ' ' THR . 20.6 mt -100.87 103.62 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -46.72 -38.72 10.33 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -50.03 -66.12 0.45 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.472 ' CG1' HD12 ' A' ' 16' ' ' ILE . 3.0 t -47.86 -42.41 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.579 ' HA ' HG13 ' A' ' 38' ' ' ILE . . . -49.17 -41.8 37.78 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.584 ' HG2' ' CG ' ' A' ' 39' ' ' TYR . 8.8 mtpt -74.31 -24.86 59.28 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -86.84 -23.76 25.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . -93.83 -27.48 16.41 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.3 16.17 19.2 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.579 HG13 ' HA ' ' A' ' 33' ' ' ALA . 3.5 pt -118.17 31.01 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.584 ' CG ' ' HG2' ' A' ' 34' ' ' LYS . 13.0 t80 -64.69 68.84 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.648 ' HB1' ' HH ' ' A' ' 45' ' ' TYR . . . . . . . . 0 N--CA 1.45 -0.475 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.648 ' HH ' ' HB1' ' A' ' 40' ' ' ALA . 24.8 m-85 . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.696 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -123.85 179.83 0.98 Allowed Pre-proline 0 N--CA 1.449 -0.495 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.696 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 80.7 Cg_endo -72.44 129.84 15.34 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 124.273 3.316 . . . . 0.0 109.556 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.444 ' CD1' ' N ' ' A' ' 49' ' ' GLU . 5.3 tp -97.26 135.14 39.61 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.524 ' HB3' ' CG2' ' A' ' 153' ' ' VAL . 0.3 OUTLIER -105.08 107.77 18.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.911 ' HA ' HE22 ' A' ' 56' ' ' GLN . 8.1 p90 -125.49 162.21 25.38 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.721 ' C ' ' H ' ' A' ' 53' ' ' GLY . 41.1 t -105.79 123.52 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.6 ' C ' ' HA ' ' A' ' 7' ' ' LYS . 8.3 t -58.53 8.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.721 ' H ' ' C ' ' A' ' 51' ' ' VAL . . . -147.31 48.74 0.64 Allowed Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.51 ' OE1' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -126.61 -32.76 2.6 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.58 -12.57 54.08 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.911 HE22 ' HA ' ' A' ' 50' ' ' PHE . 27.8 mt-30 -42.06 -78.53 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.66 HD23 ' H ' ' A' ' 57' ' ' LEU . 1.2 mm? -71.5 164.92 24.92 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.673 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -65.09 157.71 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.519 HE21 ' HA ' ' A' ' 82' ' ' LYS . 22.1 mt-30 -49.84 -59.29 3.99 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.585 ' H ' ' HB3' ' A' ' 82' ' ' LYS . . . -39.05 -78.31 0.06 OUTLIER Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.661 ' CZ ' ' CZ ' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -41.08 -55.18 2.65 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.422 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 3.0 mt-10 -45.94 -37.05 6.0 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 60' ' ' GLY . 4.8 mt-10 -77.63 -25.45 49.73 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.667 ' HA ' ' HE2' ' A' ' 74' ' ' LYS . . . -67.32 -40.04 85.94 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.556 HG13 ' CE1' ' A' ' 61' ' ' PHE . 2.1 m -73.5 -32.77 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.532 ' HG ' ' CG1' ' A' ' 52' ' ' VAL . 2.5 mt -41.31 -51.66 3.59 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.36 52.29 0.84 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.558 ' SD ' ' CA ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -140.62 114.05 8.67 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -77.58 168.89 19.24 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.664 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 1.5 t -61.93 113.04 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.858 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 100.52 9.0 48.22 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.95 -176.54 5.22 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.558 ' CA ' ' SD ' ' A' ' 68' ' ' MET . 0.6 OUTLIER -157.44 141.81 16.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.667 ' HE2' ' HA ' ' A' ' 64' ' ' ALA . 12.1 tttp -138.95 95.8 3.01 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.609 ' CG2' ' HA ' ' A' ' 146' ' ' THR . 0.0 OUTLIER -92.4 93.23 8.49 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.618 HG12 ' H ' ' A' ' 77' ' ' LYS . 16.2 t -131.63 164.64 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.618 ' H ' HG12 ' A' ' 76' ' ' VAL . 5.6 ttpt -99.48 114.8 27.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.589 ' HB ' ' CE2' ' A' ' 145' ' ' PHE . 0.3 OUTLIER -78.68 129.95 72.34 Favored Pre-proline 0 N--CA 1.449 -0.492 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.579 ' HG3' ' HZ3' ' A' ' 82' ' ' LYS . 84.8 Cg_endo -72.39 138.22 29.61 Favored 'Trans proline' 0 N--CA 1.447 -1.218 0 C-N-CA 124.28 3.32 . . . . 0.0 109.664 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.534 ' CB ' ' N ' ' A' ' 141' ' ' LYS . . . -51.56 -10.62 0.1 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.593 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 20.6 pt-20 -79.0 -38.2 37.27 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.585 ' HB3' ' H ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -84.88 -33.1 22.87 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.656 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . . . -74.12 -100.07 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.598 ' CE1' ' HB2' ' A' ' 138' ' ' LEU . 38.9 m-85 -90.22 17.81 6.68 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.593 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 42.35 85.71 0.01 OUTLIER Glycine 0 C--N 1.335 0.508 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.658 ' ND2' ' N ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER 47.26 -164.85 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.587 ' HD2' ' HA3' ' A' ' 140' ' ' GLY . 0.4 OUTLIER -81.17 146.42 30.52 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.518 ' CB ' HD12 ' A' ' 91' ' ' LEU . 9.7 t30 -89.2 149.98 22.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -85.35 -35.02 21.67 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.3 -9.08 37.42 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.833 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 75.1 mt -94.03 6.04 49.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.617 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 69.1 mt -85.56 113.75 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.75 HE22 ' HB2' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -106.99 150.3 26.63 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.503 ' HG3' ' HA ' ' A' ' 131' ' ' THR . 0.0 OUTLIER -130.17 97.08 4.34 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.57 HD11 ' CD1' ' A' ' 100' ' ' PHE . 18.5 pt -93.11 156.7 40.03 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.534 ' O ' ' N ' ' A' ' 99' ' ' ALA . 82.0 Cg_endo -72.43 140.37 33.21 Favored 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 124.33 3.354 . . . . 0.0 109.609 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.81 HH21 ' CD ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -42.72 -32.93 0.65 Allowed 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.474 ' HA ' ' CB ' ' A' ' 101' ' ' LYS . 6.7 t70 -66.81 -36.71 83.0 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -43.92 -21.61 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.57 ' CD1' HD11 ' A' ' 95' ' ' ILE . 3.3 m-85 -122.94 -28.82 4.03 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.474 ' CB ' ' HA ' ' A' ' 98' ' ' ASP . 0.8 OUTLIER -56.45 -24.15 43.57 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -104.18 1.91 31.2 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.477 ' HB1' ' HA ' ' A' ' 100' ' ' PHE . . . -102.05 19.69 18.02 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 41.63 36.78 0.62 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.3 -150.2 0.44 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.425 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -179.96 102.2 0.18 Allowed Pre-proline 0 N--CA 1.45 -0.475 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.81 ' CD ' HH21 ' A' ' 97' ' ' ARG . 83.6 Cg_endo -72.32 138.52 30.36 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 124.313 3.342 . . . . 0.0 109.592 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 110' ' ' GLY . 16.8 mt-10 -128.9 156.53 43.56 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.71 68.97 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 151.8 10.23 0.09 OUTLIER Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.523 ' HB3' ' CD1' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -68.17 167.7 13.66 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.457 ' CG2' ' O ' ' A' ' 111' ' ' MET . 62.0 t -156.41 82.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.35 137.13 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.637 ' CD2' ' HD3' ' A' ' 119' ' ' PRO . 0.2 OUTLIER -101.36 156.72 17.28 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -109.65 0.49 19.04 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 176.47 -12.37 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 114' ' ' LEU . . . 166.93 -34.42 0.22 Allowed Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 3.3 mt -94.04 122.41 61.89 Favored Pre-proline 0 N--CA 1.449 -0.483 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.637 ' HD3' ' CD2' ' A' ' 114' ' ' LEU . 84.9 Cg_endo -72.31 170.22 19.71 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 124.311 3.341 . . . . 0.0 109.662 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.577 ' CB ' ' HB3' ' A' ' 132' ' ' LEU . . . -128.58 73.61 1.51 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 28.8 m -50.2 95.36 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.646 ' HA ' ' HA ' ' A' ' 132' ' ' LEU . 1.8 mp -69.74 100.1 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.19 -19.11 32.21 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.536 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 0.4 OUTLIER -121.77 131.77 54.25 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' ' 108' ' ' GLU . 7.9 p -122.33 52.99 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.7 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -79.21 126.83 31.27 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.673 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.3 OUTLIER -53.16 0.21 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.7 ' H ' ' C ' ' A' ' 126' ' ' THR . 1.1 p30 -111.58 -21.22 11.85 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -177.85 168.5 2.08 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.465 HG12 ' CG ' ' A' ' 107' ' ' PRO . 29.0 m -132.09 145.42 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.536 ' HB ' ' HB2' ' A' ' 124' ' ' GLU . 21.4 m -102.47 84.71 2.48 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.646 ' HA ' ' HA ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -82.36 119.76 24.56 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.824 ' CG ' HD22 ' A' ' 135' ' ' ASN . 13.8 t0 -90.21 97.89 11.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.75 ' HB2' HE22 ' A' ' 93' ' ' GLN . 2.0 m-30 -41.25 -52.97 3.31 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.833 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 9.3 m120 48.44 -122.39 1.58 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 1.113 ' HD1' ' N ' ' A' ' 138' ' ' LEU . 24.3 t-80 179.71 174.93 0.8 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.74 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 0.5 OUTLIER -76.05 -8.62 57.4 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 1.113 ' N ' ' HD1' ' A' ' 136' ' ' HIS . 52.5 mt -119.35 -1.48 10.77 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.499 ' CB ' ' HB3' ' A' ' 135' ' ' ASN . . . -67.71 141.66 56.56 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.587 ' HA3' ' HD2' ' A' ' 87' ' ' ARG . . . 41.95 27.16 0.36 Allowed Glycine 0 C--N 1.336 0.536 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.866 ' HE2' ' CD2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -138.49 146.11 41.62 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.48 ' C ' ' HD2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -99.19 137.39 37.78 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.53 ' CD2' HD21 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -124.7 152.07 44.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.615 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 2.1 t -73.86 165.72 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.589 ' CE2' ' HB ' ' A' ' 78' ' ' ILE . 30.9 m-85 -148.6 98.05 2.82 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.609 ' HA ' ' CG2' ' A' ' 75' ' ' THR . 24.0 m -89.8 57.78 4.0 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.807 HG21 ' H ' ' A' ' 148' ' ' LYS . 2.3 mt -57.54 -179.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.807 ' H ' HG21 ' A' ' 147' ' ' ILE . 12.4 tttt -179.39 110.68 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.858 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 4.8 mm -67.14 145.29 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.528 ' CD1' ' HB3' ' A' ' 47' ' ' PRO . 4.1 mt -126.6 -45.86 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.664 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -161.66 -159.89 0.66 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.678 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 42.4 t -128.44 135.59 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.524 ' CG2' ' HB3' ' A' ' 49' ' ' GLU . 61.9 t . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.411 HG23 HD11 ' A' ' 11' ' ' ILE . 23.2 t . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -132.2 168.06 18.7 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.568 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 10.2 ptpt -72.93 70.32 1.01 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 174.13 -2.9 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.12 122.64 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.565 ' HE2' ' C ' ' A' ' 49' ' ' GLU . 1.7 tttt -76.52 166.88 22.79 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 1.0 OUTLIER -168.65 132.07 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.716 ' HE2' ' CG2' ' A' ' 153' ' ' VAL . 17.4 mtmt -89.82 92.89 9.22 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.517 ' CG1' HD11 ' A' ' 149' ' ' ILE . 0.8 OUTLIER -112.66 152.99 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.586 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 4.4 m-20 -110.55 95.49 5.6 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.618 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.1 p90 -92.7 154.4 18.35 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.701 HG12 ' HG1' ' A' ' 27' ' ' THR . 6.5 mt -129.36 75.08 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -60.22 132.06 50.23 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.607 ' HE3' ' O ' ' A' ' 16' ' ' ILE . 4.5 mtmt -121.03 -160.77 0.86 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.679 ' C ' ' H ' ' A' ' 21' ' ' SER . 30.5 mt -119.38 166.15 13.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.44 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 9.8 mt-10 -56.32 2.6 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.679 ' H ' ' C ' ' A' ' 19' ' ' LEU . 52.8 p -117.24 0.3 12.24 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.24 28.0 42.26 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 18' ' ' LYS . 18.8 m-20 -96.15 119.2 34.21 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.542 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 63.9 t -69.06 114.26 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.541 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 1.6 p90 -103.08 -32.69 9.56 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.541 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 11.6 t0 -146.23 136.55 23.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.701 ' HG1' HG12 ' A' ' 16' ' ' ILE . 3.8 t -154.11 149.9 27.6 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.586 ' HB2' ' HA ' ' A' ' 14' ' ' ASP . 27.1 m -97.8 -17.41 19.37 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.843 HG23 ' H ' ' A' ' 32' ' ' VAL . 2.1 mt -85.01 95.15 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.412 ' HG3' ' HB2' ' A' ' 45' ' ' TYR . 4.9 tt0 -42.03 -29.59 0.23 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.401 ' H ' HG21 ' A' ' 29' ' ' ILE . 12.5 tt0 -59.62 -63.52 1.27 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.843 ' H ' HG23 ' A' ' 29' ' ' ILE . 59.8 t -51.28 -38.97 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.596 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . . . -48.03 -44.76 31.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.518 ' HG2' ' CB ' ' A' ' 39' ' ' TYR . 11.1 mtmt -71.52 -32.29 68.01 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -74.54 -15.53 60.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -110.23 -6.15 15.12 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.3 46.44 34.04 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.52 HG13 ' HA ' ' A' ' 33' ' ' ALA . 1.3 pt -143.3 11.98 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.596 ' HA ' ' CB ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -45.39 -18.25 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.487 ' O ' ' CZ ' ' A' ' 39' ' ' TYR . . . . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.464 ' CE2' ' HB2' ' A' ' 33' ' ' ALA . 30.1 m-85 . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.68 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.4 OUTLIER -83.44 178.49 2.39 Favored Pre-proline 0 N--CA 1.45 -0.449 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.68 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 83.2 Cg_endo -72.36 125.38 10.69 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 124.337 3.358 . . . . 0.0 109.586 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.0 83.12 0.11 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.565 ' C ' ' HE2' ' A' ' 10' ' ' LYS . 40.6 tt0 -77.41 97.19 4.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.633 ' CE2' ' CE1' ' A' ' 61' ' ' PHE . 5.6 p90 -118.64 167.83 11.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 1.002 ' H ' ' NE2' ' A' ' 56' ' ' GLN . 21.4 t -128.36 114.44 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.568 ' C ' ' HA ' ' A' ' 7' ' ' LYS . 9.1 t -46.99 -14.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.698 ' H ' HG13 ' A' ' 51' ' ' VAL . . . -115.88 39.76 2.63 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.44 ' HG3' ' HB ' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -131.58 -19.7 2.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.23 18.13 79.74 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 1.002 ' NE2' ' H ' ' A' ' 51' ' ' VAL . 4.9 mt-30 -60.81 -63.12 1.41 Allowed 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.667 ' CB ' ' CD1' ' A' ' 61' ' ' PHE . 2.0 mm? -87.41 171.23 10.72 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.905 ' CD1' ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -66.21 155.09 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.443 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 2.3 mt-30 -49.72 -57.09 7.94 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -39.58 -79.68 0.04 OUTLIER Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.667 ' CD1' ' CB ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -41.4 -52.21 3.6 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.487 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 1.7 mt-10 -46.47 -42.19 15.07 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.514 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 4.8 mt-10 -70.17 -32.92 71.09 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.55 -24.85 67.98 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.626 ' C ' ' H ' ' A' ' 67' ' ' ASP . 8.6 m -100.25 -8.58 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.527 ' HG ' ' CG1' ' A' ' 52' ' ' VAL . 0.5 OUTLIER -66.65 37.29 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.626 ' H ' ' C ' ' A' ' 65' ' ' VAL . 0.3 OUTLIER 166.94 27.77 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.49 ' SD ' ' HB2' ' A' ' 74' ' ' LYS . 44.0 mtp -109.56 96.02 6.0 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.468 ' N ' ' OD2' ' A' ' 72' ' ' ASP . 0.5 OUTLIER -55.95 -177.09 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.623 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 1.5 t -75.18 108.42 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.856 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 116.07 -12.22 17.2 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 1.0 OUTLIER -65.53 166.37 10.59 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.427 ' HB2' ' HD2' ' A' ' 148' ' ' LYS . 0.0 OUTLIER -151.16 135.85 17.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.49 ' HB2' ' SD ' ' A' ' 68' ' ' MET . 1.4 tttm -142.33 102.33 4.07 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 145' ' ' PHE . 52.1 m -101.9 79.81 1.94 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.661 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 3.5 t -112.49 171.12 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.661 ' N ' ' CG1' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -105.18 114.11 28.1 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.492 HD13 ' CD2' ' A' ' 145' ' ' PHE . 0.5 OUTLIER -79.0 129.8 71.98 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.477 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 83.4 Cg_endo -72.39 144.37 40.81 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 124.304 3.336 . . . . 0.0 109.607 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.528 ' CB ' ' N ' ' A' ' 141' ' ' LYS . . . -55.85 -9.39 0.56 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.613 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 14.8 pt-20 -81.41 -38.21 26.88 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.428 ' N ' ' HG3' ' A' ' 81' ' ' GLU . 9.3 mtmt -86.94 -31.62 20.57 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.649 ' HA ' ' CB ' ' A' ' 58' ' ' ILE . . . -71.88 -95.88 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.732 ' CE2' ' CE1' ' A' ' 136' ' ' HIS . 2.0 m-85 -98.41 16.91 20.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.613 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 42.36 84.82 0.01 OUTLIER Glycine 0 C--N 1.335 0.509 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.698 ' ND2' ' N ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER 49.01 -171.99 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.569 ' CD ' ' HA3' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -89.26 152.5 21.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.57 ' CB ' ' CD1' ' A' ' 91' ' ' LEU . 2.2 t30 -90.24 100.77 13.53 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.509 ' C ' ' H ' ' A' ' 91' ' ' LEU . 29.9 mt-10 -44.31 -25.36 0.23 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.19 16.68 0.3 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.726 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 17.5 mt -114.11 -4.08 13.18 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 20.6 mt -78.47 114.21 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.557 ' NE2' ' CD1' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -110.33 167.7 10.0 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.706 ' CG ' ' HG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -140.2 90.51 2.37 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.579 HD12 ' CD1' ' A' ' 100' ' ' PHE . 35.8 pt -85.41 154.66 59.71 Favored Pre-proline 0 N--CA 1.449 -0.478 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 99' ' ' ALA . 82.6 Cg_endo -72.36 140.83 34.24 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 124.309 3.34 . . . . 0.0 109.636 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.917 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -41.8 -33.89 0.57 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 100' ' ' PHE . 8.4 m-20 -66.53 -37.03 84.14 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -43.52 -21.58 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.593 ' C ' ' H ' ' A' ' 102' ' ' GLU . 2.8 m-85 -122.2 -23.24 5.37 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.453 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -70.96 21.9 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.593 ' H ' ' C ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -143.59 -13.09 0.68 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.98 22.31 3.26 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 43.4 33.86 0.67 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.491 ' HD1' ' H ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -123.74 -149.46 0.42 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.491 ' H ' ' HD1' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -173.6 113.03 0.33 Allowed Pre-proline 0 N--CA 1.448 -0.525 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.917 ' CG ' HH21 ' A' ' 97' ' ' ARG . 83.5 Cg_endo -72.38 147.26 46.61 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 124.275 3.316 . . . . 0.0 109.632 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.52 ' HA ' HG21 ' A' ' 125' ' ' VAL . 1.3 mm-40 -138.37 151.94 47.96 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.408 ' CG ' ' O ' ' A' ' 123' ' ' THR . 2.5 tm-20 -66.4 66.33 0.05 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 122' ' ' ILE . . . 153.76 9.27 0.08 OUTLIER Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.518 ' CB ' HD13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -62.87 170.09 2.86 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.496 HG12 ' CB ' ' A' ' 119' ' ' PRO . 61.1 t -155.63 65.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.92 137.31 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.624 HD23 ' CD ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -109.3 146.09 34.88 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.432 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -95.04 4.19 54.02 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.432 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 0.9 OUTLIER 166.64 -12.15 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.48 -37.73 0.2 Allowed Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.2 mt -85.93 111.72 40.06 Favored Pre-proline 0 N--CA 1.449 -0.484 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.624 ' CD ' HD23 ' A' ' 114' ' ' LEU . 82.7 Cg_endo -72.37 159.56 49.07 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 124.352 3.368 . . . . 0.0 109.579 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.426 ' CB ' ' HB3' ' A' ' 132' ' ' LEU . . . -121.51 84.05 2.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.56 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 3.5 m -53.34 97.52 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 132' ' ' LEU . 72.3 mt -76.58 91.1 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.44 ' CG2' ' O ' ' A' ' 131' ' ' THR . 0.2 OUTLIER -77.53 -27.24 51.62 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.839 ' HB3' ' H ' ' A' ' 131' ' ' THR . 0.5 OUTLIER -111.12 132.42 54.29 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.52 HG21 ' HA ' ' A' ' 108' ' ' GLU . 7.1 p -129.67 53.55 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.724 ' C ' ' H ' ' A' ' 128' ' ' ASN . 81.4 p -80.1 133.11 36.06 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.591 ' HA ' ' HD3' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -54.58 4.36 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.724 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -112.21 -24.73 9.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -177.22 -178.45 0.79 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.543 HG12 ' CG ' ' A' ' 107' ' ' PRO . 4.2 m -144.57 134.14 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.839 ' H ' ' HB3' ' A' ' 124' ' ' GLU . 17.4 m -95.82 95.26 8.16 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 122' ' ' ILE . 0.1 OUTLIER -87.66 166.62 14.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.659 ' CG ' HD22 ' A' ' 135' ' ' ASN . 15.4 t0 -137.39 97.95 3.59 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.557 ' CD1' ' NE2' ' A' ' 93' ' ' GLN . 3.3 m-30 -41.57 -41.48 2.17 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.726 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 7.1 m120 41.47 -121.94 0.51 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 1.001 ' ND1' ' H ' ' A' ' 138' ' ' LEU . 8.9 t-80 177.01 169.49 0.54 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.565 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 3.0 tp10 -58.55 -53.88 53.38 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 1.001 ' H ' ' ND1' ' A' ' 136' ' ' HIS . 2.2 mm? -97.83 20.02 12.78 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.566 ' HB1' ' N ' ' A' ' 136' ' ' HIS . . . -66.57 134.45 52.37 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 86' ' ' ASN . . . 38.85 30.54 0.11 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.82 ' HE2' ' CD1' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -138.42 144.42 40.16 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.498 ' N ' ' HD3' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -94.04 138.84 31.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.563 ' CD1' ' CZ ' ' A' ' 145' ' ' PHE . 0.5 OUTLIER -129.13 140.47 51.53 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.726 HG12 ' H ' ' A' ' 145' ' ' PHE . 7.8 t -66.45 168.25 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.726 ' H ' HG12 ' A' ' 144' ' ' VAL . 23.2 m-85 -152.79 93.92 1.81 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.521 ' HB ' ' HB ' ' A' ' 16' ' ' ILE . 54.9 m -87.97 62.66 6.97 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.4 mt -57.58 179.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.451 ' C ' ' HB ' ' A' ' 13' ' ' VAL . 6.5 tptt 179.3 100.42 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.856 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -63.23 139.24 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.489 ' CD1' ' OD1' ' A' ' 14' ' ' ASP . 12.6 mt -126.47 -31.5 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.623 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 1.5 mt-10 -166.8 -170.91 1.69 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.595 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 47.2 t -136.95 144.6 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.716 ' CG2' ' HE2' ' A' ' 12' ' ' LYS . 38.8 t . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.56 HG23 ' CD1' ' A' ' 11' ' ' ILE . 58.7 t . . . . . 0 N--CA 1.448 -0.542 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.593 ' HA ' ' CD2' ' A' ' 66' ' ' LEU . 1.1 m-20 -119.67 173.79 6.8 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.513 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 9.4 ptpt -68.83 68.46 0.16 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.402 ' H ' ' H ' ' A' ' 9' ' ' VAL . . . 168.93 7.03 0.03 OUTLIER Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.55 ' HB ' ' CG1' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -126.78 134.47 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.527 ' CA ' HG21 ' A' ' 51' ' ' VAL . 9.1 tttt -87.73 158.48 18.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.629 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 3.3 pt -162.09 139.46 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.735 ' HE2' ' CG2' ' A' ' 153' ' ' VAL . 20.0 mtmt -89.91 78.48 6.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.61 HG22 ' CE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -116.83 145.71 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.435 ' O ' ' CG2' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -98.29 -160.67 0.82 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 0.3 OUTLIER 178.4 156.72 0.44 Allowed 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.591 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 4.5 mt -136.68 77.7 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -61.73 133.22 47.08 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.591 ' HE3' ' O ' ' A' ' 16' ' ' ILE . 4.9 mttt -120.42 -157.89 0.73 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.637 ' C ' ' H ' ' A' ' 21' ' ' SER . 1.8 mt -123.05 165.62 16.48 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -53.79 -2.05 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.637 ' H ' ' C ' ' A' ' 19' ' ' LEU . 59.6 p -113.6 9.03 17.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 19' ' ' LEU . . . 70.91 29.73 68.84 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.458 ' C ' ' HG2' ' A' ' 18' ' ' LYS . 4.2 m-20 -98.43 122.75 42.01 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.545 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 35.5 t -67.89 118.34 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -110.87 -27.51 8.8 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -151.95 141.24 21.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.642 ' HG1' ' H ' ' A' ' 29' ' ' ILE . 2.5 t -152.89 153.76 33.69 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.578 ' HA ' ' HA ' ' A' ' 45' ' ' TYR . 0.6 OUTLIER -104.35 14.76 29.6 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.642 ' H ' ' HG1' ' A' ' 27' ' ' THR . 6.4 mt -124.97 99.17 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.678 ' CG ' ' CE2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -43.12 -35.8 1.46 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -53.71 -65.03 0.64 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 36' ' ' ALA . 87.9 t -47.83 -43.66 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.601 ' HA ' ' CG1' ' A' ' 38' ' ' ILE . . . -44.35 -51.75 8.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.533 ' CG ' ' HB2' ' A' ' 39' ' ' TYR . 13.9 mtpt -65.42 -28.07 68.98 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 32' ' ' VAL . 45.8 tt0 -86.08 -13.62 46.76 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . -106.59 -23.38 12.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 99.32 14.87 34.3 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.601 ' CG1' ' HA ' ' A' ' 33' ' ' ALA . 1.6 pt -114.87 31.55 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.582 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 3.6 t80 -64.49 70.02 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 38' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.678 ' CE2' ' CG ' ' A' ' 30' ' ' GLU . 25.9 m-85 . . . . . 0 N--CA 1.449 -0.505 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.662 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER 61.52 178.0 0.04 OUTLIER Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.662 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 83.5 Cg_endo -72.37 116.9 4.89 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 124.3 3.333 . . . . 0.0 109.585 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.1 tp -82.49 103.81 12.31 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.521 ' CG ' ' HG2' ' A' ' 10' ' ' LYS . 36.7 tt0 -83.61 100.52 10.87 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.624 ' CG ' ' CD2' ' A' ' 57' ' ' LEU . 2.1 p90 -122.9 170.76 9.78 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.999 ' H ' ' NE2' ' A' ' 56' ' ' GLN . 48.9 t -124.82 113.56 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.529 HG12 ' CD2' ' A' ' 66' ' ' LEU . 3.5 t -49.67 -8.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.592 ' H ' HG13 ' A' ' 51' ' ' VAL . . . -121.08 38.2 2.76 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.444 ' HG3' ' HB ' ' A' ' 51' ' ' VAL . 2.1 mt-10 -123.29 -19.65 5.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.36 18.19 62.92 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.999 ' NE2' ' H ' ' A' ' 51' ' ' VAL . 6.2 mt-30 -72.86 -76.83 0.11 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.704 ' H ' HD22 ' A' ' 57' ' ' LEU . 1.3 mm? -73.17 149.58 42.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.702 ' CD1' ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -55.68 163.27 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.625 HE21 ' HA ' ' A' ' 82' ' ' LYS . 16.1 mt-30 -53.53 -59.08 5.05 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.78 ' H ' ' HB3' ' A' ' 82' ' ' LYS . . . -41.54 -78.78 0.06 OUTLIER Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.279 -1.129 . . . . 0.0 110.279 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.609 ' CE2' HG12 ' A' ' 147' ' ' ILE . 1.0 OUTLIER -38.34 -52.37 1.52 Allowed 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -48.59 -51.77 26.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.588 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 6.8 mt-10 -58.33 -27.67 64.36 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.51 ' HB3' ' CD1' ' A' ' 147' ' ' ILE . . . -63.9 -55.28 23.88 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.443 ' HA ' ' HB2' ' A' ' 68' ' ' MET . 33.9 m -78.84 4.08 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.593 ' CD2' ' HA ' ' A' ' 6' ' ' ASP . 5.3 mt -84.77 -38.08 20.05 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.07 26.01 11.13 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.522 ' CE ' HD12 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -104.2 -155.11 0.52 Allowed 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.475 ' HB2' ' CG ' ' A' ' 72' ' ' ASP . 0.5 OUTLIER -144.35 -177.38 5.44 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.62 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 1.1 t -90.71 84.36 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.782 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 131.07 12.54 2.09 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.475 ' CG ' ' HB2' ' A' ' 69' ' ' GLU . 1.3 m-20 -100.54 -170.56 1.88 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.2 126.4 6.58 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.452 ' CB ' ' HE1' ' A' ' 68' ' ' MET . 2.3 ttmm -119.63 96.3 5.14 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 145' ' ' PHE . 62.8 m -96.87 83.05 3.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.548 HG13 ' N ' ' A' ' 77' ' ' LYS . 3.8 t -119.69 157.75 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 13.7 ttmt -89.87 114.48 26.25 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.486 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -79.11 130.18 70.36 Favored Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.499 ' C ' ' H ' ' A' ' 81' ' ' GLU . 84.6 Cg_endo -72.34 134.3 22.49 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 124.286 3.324 . . . . 0.0 109.634 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.622 ' HB1' ' H ' ' A' ' 141' ' ' LYS . . . -46.81 -14.56 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.6 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 3.2 tp10 -76.64 -39.3 52.74 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.78 ' HB3' ' H ' ' A' ' 60' ' ' GLY . 14.6 mttt -81.97 -34.13 29.89 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.618 ' HA ' ' CG2' ' A' ' 58' ' ' ILE . . . -73.31 -102.05 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.673 ' HH ' HD11 ' A' ' 138' ' ' LEU . 2.8 m-85 -90.7 20.29 4.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.6 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 47.38 89.24 0.01 OUTLIER Glycine 0 C--N 1.336 0.535 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.579 ' HA ' ' HA2' ' A' ' 140' ' ' GLY . 0.0 OUTLIER 40.99 -133.94 0.28 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.505 ' H ' ' HB2' ' A' ' 86' ' ' ASN . 0.3 OUTLIER -90.85 149.17 22.06 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.49 ' ND2' HD13 ' A' ' 91' ' ' LEU . 1.7 m120 -87.52 135.18 33.45 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -81.46 -26.55 35.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.96 -4.99 59.13 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.599 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 28.2 mt -102.83 13.31 34.7 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.62 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 26.5 mt -82.5 124.09 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.778 HE22 ' HB2' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -115.53 156.2 26.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.52 ' HG3' ' HA ' ' A' ' 131' ' ' THR . 0.0 OUTLIER -133.32 90.16 2.7 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.569 ' H ' HD11 ' A' ' 132' ' ' LEU . 34.4 pt -88.25 154.25 51.62 Favored Pre-proline 0 N--CA 1.449 -0.501 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.512 ' O ' ' N ' ' A' ' 99' ' ' ALA . 81.5 Cg_endo -72.44 141.49 35.14 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 124.275 3.316 . . . . 0.0 109.591 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.913 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -44.11 -30.59 0.78 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.504 ' HA ' ' HB2' ' A' ' 101' ' ' LYS . 5.1 t70 -68.93 -36.18 77.67 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -47.9 -27.76 2.31 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.61 ' CE2' ' HB3' ' A' ' 107' ' ' PRO . 0.6 OUTLIER -99.41 -33.03 10.86 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.504 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 1.1 tttm -58.22 -0.35 0.09 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.587 ' H ' ' C ' ' A' ' 100' ' ' PHE . 7.8 mm-40 -117.12 4.65 12.71 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.14 -133.94 0.07 Allowed 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.71 -8.96 1.87 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.404 ' HB2' ' H ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -137.76 -157.73 0.8 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.432 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 1.6 pm0 -125.88 137.78 30.75 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.913 ' CG ' HH21 ' A' ' 97' ' ' ARG . 83.5 Cg_endo -72.3 129.31 14.78 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 124.38 3.387 . . . . 0.0 109.584 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 110' ' ' GLY . 1.7 mm-40 -125.65 150.84 47.25 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.478 ' HA ' HG21 ' A' ' 122' ' ' ILE . 2.5 tm-20 -62.68 71.07 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 151.86 14.72 0.07 OUTLIER Glycine 0 C--N 1.335 0.513 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.545 ' HB3' ' CD1' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -74.41 173.53 10.16 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.472 ' CG2' ' O ' ' A' ' 111' ' ' MET . 61.1 t -156.84 82.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.436 ' C ' ' HA ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -115.31 127.67 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.568 ' CD2' ' HD3' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -102.32 163.25 12.34 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -112.61 6.97 18.62 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 169.93 -6.33 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 156.34 -21.91 0.49 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.503 ' C ' ' HB3' ' A' ' 114' ' ' LEU . 3.0 mt -102.7 103.15 30.82 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.568 ' HD3' ' CD2' ' A' ' 114' ' ' LEU . 82.7 Cg_endo -72.4 158.72 50.85 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 124.264 3.309 . . . . 0.0 109.572 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.452 ' HB1' HD22 ' A' ' 132' ' ' LEU . . . -115.83 87.05 2.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 32.5 m -55.57 97.98 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.639 ' HA ' ' HA ' ' A' ' 132' ' ' LEU . 1.8 mp -63.45 99.96 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.3 p -86.09 -21.19 27.8 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.737 ' HB3' ' H ' ' A' ' 131' ' ' THR . 1.6 tp10 -128.66 136.1 50.18 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.7 p -119.3 56.71 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.9 ' CG2' HD22 ' A' ' 128' ' ' ASN . 0.1 OUTLIER -78.44 123.97 27.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.499 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.2 OUTLIER -52.01 -2.54 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.9 HD22 ' CG2' ' A' ' 126' ' ' THR . 0.0 OUTLIER -111.69 -17.87 12.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.3 OUTLIER -179.33 163.33 1.25 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.46 HG11 ' CG ' ' A' ' 107' ' ' PRO . 0.6 OUTLIER -127.48 118.9 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.737 ' H ' ' HB3' ' A' ' 124' ' ' GLU . 20.7 m -82.03 84.95 6.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -79.7 169.66 17.65 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.62 ' HA ' ' HA ' ' A' ' 92' ' ' ILE . 11.6 t0 -132.29 95.3 3.62 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.778 ' HB2' HE22 ' A' ' 93' ' ' GLN . 2.1 m-30 -37.7 -38.96 0.31 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.599 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 0.8 OUTLIER 38.89 -118.32 0.23 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 1.148 ' HD1' ' N ' ' A' ' 138' ' ' LEU . 14.1 t-80 177.93 176.88 0.41 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.759 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -73.36 -8.39 55.68 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 1.148 ' N ' ' HD1' ' A' ' 136' ' ' HIS . 72.0 mt -122.08 -5.63 8.96 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.583 ' HB3' ' N ' ' A' ' 136' ' ' HIS . . . -68.1 133.66 49.32 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 86' ' ' ASN . . . 55.25 24.45 36.88 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.875 ' HE2' ' CD2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -142.07 145.94 34.89 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.489 ' C ' ' HD2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -98.91 137.61 37.23 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.516 HD13 ' CZ ' ' A' ' 145' ' ' PHE . 0.5 OUTLIER -127.15 152.76 46.92 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.584 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 2.0 t -74.36 165.69 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.516 ' CZ ' HD13 ' A' ' 143' ' ' LEU . 28.0 m-85 -153.27 94.65 1.85 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.482 ' HB ' ' HB ' ' A' ' 16' ' ' ILE . 42.0 m -88.54 67.37 8.49 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.641 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -60.72 -177.81 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.524 ' H ' HG23 ' A' ' 147' ' ' ILE . 10.6 tttt -175.45 108.34 0.1 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.782 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 1.5 mp -75.4 134.11 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.53 ' CD1' ' HB3' ' A' ' 47' ' ' PRO . 6.9 mt -113.47 -41.61 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.62 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -166.02 -156.31 0.25 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.629 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 18.6 t -131.63 155.1 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.735 ' CG2' ' HE2' ' A' ' 12' ' ' LYS . 2.6 t . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.507 HG22 HG23 ' A' ' 11' ' ' ILE . 48.8 t . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 8' ' ' GLY . 0.5 OUTLIER -154.49 177.48 11.13 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.867 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.546 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 15.7 ptmt -66.32 65.45 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 6' ' ' ASP . . . 156.05 23.78 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.17 125.63 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.537 ' CG ' ' HG2' ' A' ' 49' ' ' GLU . 2.8 ttpm? -85.22 150.21 24.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.597 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 1.2 pt -154.17 126.9 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.672 ' HE2' HG22 ' A' ' 153' ' ' VAL . 21.0 mtmt -86.77 86.14 7.31 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.599 ' CG1' ' HA ' ' A' ' 149' ' ' ILE . 0.7 OUTLIER -114.93 152.48 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.528 ' CG ' ' CD1' ' A' ' 29' ' ' ILE . 0.8 OUTLIER -117.49 108.32 15.37 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.637 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.2 p90 -94.32 160.94 14.45 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.605 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 5.1 mt -129.98 75.49 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -59.14 136.64 50.93 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.605 ' HE3' ' O ' ' A' ' 16' ' ' ILE . 6.6 mttt -122.87 -159.6 0.85 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.643 ' C ' ' H ' ' A' ' 21' ' ' SER . 57.8 mt -117.68 165.93 13.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -55.33 0.05 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.643 ' H ' ' C ' ' A' ' 19' ' ' LEU . 56.8 p -114.16 2.11 14.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.32 28.6 52.49 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.457 ' C ' ' HG2' ' A' ' 18' ' ' LYS . 4.1 m-20 -97.81 123.55 41.82 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.566 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 47.4 t -67.87 126.02 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.568 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 1.9 p90 -119.62 -38.85 2.93 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.568 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 8.3 t0 -138.13 135.7 35.99 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.585 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 3.9 t -152.58 148.75 27.72 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.61 ' HG ' ' HB2' ' A' ' 48' ' ' LEU . 0.6 OUTLIER -91.79 -18.78 23.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.528 ' CD1' ' CG ' ' A' ' 14' ' ' ASP . 4.6 mt -93.81 121.1 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.587 ' HG3' ' CD1' ' A' ' 45' ' ' TYR . 3.5 tt0 -63.62 -32.02 73.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.403 ' H ' HG21 ' A' ' 29' ' ' ILE . 22.7 tt0 -51.67 -63.41 1.14 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.516 ' CG2' HD12 ' A' ' 16' ' ' ILE . 52.0 t -50.58 -42.18 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.595 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . . . -46.11 -42.79 14.16 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.516 ' HG2' ' CB ' ' A' ' 39' ' ' TYR . 11.6 mtmt -71.62 -32.41 67.95 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -74.46 -17.61 60.75 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.5 -7.57 16.52 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.0 43.73 32.67 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.526 HG13 ' HA ' ' A' ' 33' ' ' ALA . 1.8 pt -139.65 11.16 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.595 ' HA ' ' CB ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -46.95 -21.39 0.21 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.493 ' O ' ' CZ ' ' A' ' 39' ' ' TYR . . . . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.587 ' CD1' ' HG3' ' A' ' 30' ' ' GLU . 2.9 m-85 . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.734 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -114.53 -179.15 0.58 Allowed Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.734 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 82.4 Cg_endo -72.38 122.53 8.4 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 124.283 3.322 . . . . 0.0 109.607 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.61 ' HB2' ' HG ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -75.43 96.0 3.36 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.56 ' HB2' ' CG ' ' A' ' 12' ' ' LYS . 48.0 tt0 -79.31 97.49 6.31 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.597 ' CZ ' ' CD1' ' A' ' 11' ' ' ILE . 39.7 p90 -110.81 170.39 8.13 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 1.019 ' H ' ' NE2' ' A' ' 56' ' ' GLN . 89.6 t -134.48 104.4 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.546 ' C ' ' HA ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -44.54 -17.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 51' ' ' VAL . . . -101.24 37.59 3.54 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 51' ' ' VAL . 5.5 mt-10 -141.78 -30.08 0.6 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.1 7.37 77.35 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 1.019 ' NE2' ' H ' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -42.3 -68.89 0.16 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.562 ' N ' HD23 ' A' ' 57' ' ' LEU . 2.3 mm? -79.74 160.37 26.25 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.664 ' HB ' ' HA ' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -60.48 160.35 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.825 HE21 ' HA ' ' A' ' 82' ' ' LYS . 6.1 mt-30 -48.85 -67.01 0.3 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.733 ' H ' ' HB3' ' A' ' 82' ' ' LYS . . . -29.86 -74.37 0.04 OUTLIER Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.609 ' N ' HD11 ' A' ' 78' ' ' ILE . 1.0 OUTLIER -45.98 -51.72 12.95 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 59' ' ' GLN . 2.9 mt-10 -50.49 -38.63 45.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 59' ' ' GLN . 18.9 mt-10 -74.63 -25.09 58.99 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.607 ' HA ' ' CD ' ' A' ' 74' ' ' LYS . . . -68.88 -51.7 37.49 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.565 HG22 ' CZ ' ' A' ' 50' ' ' PHE . 27.2 m -74.0 -12.71 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.536 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 2.5 mt -60.51 106.31 0.53 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 66' ' ' LEU . 1.8 m-20 84.34 33.06 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.514 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 4.8 mtp -123.43 106.29 10.52 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -70.53 -179.63 2.18 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.522 HG23 ' CG2' ' A' ' 152' ' ' VAL . 7.1 t -60.05 127.4 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 107.43 -32.3 7.29 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.514 ' HB3' ' HG2' ' A' ' 68' ' ' MET . 0.9 OUTLIER -54.07 160.47 1.52 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.52 145.83 21.82 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.607 ' CD ' ' HA ' ' A' ' 64' ' ' ALA . 2.2 tttt -143.78 98.72 3.28 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.47 HG22 ' HG1' ' A' ' 146' ' ' THR . 83.1 m -100.01 83.17 2.66 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.531 HG11 ' N ' ' A' ' 77' ' ' LYS . 2.9 t -121.62 156.13 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 19.8 ttpt -79.16 114.71 18.32 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.737 ' CG1' ' CD1' ' A' ' 145' ' ' PHE . 24.5 mm -78.51 123.24 85.65 Favored Pre-proline 0 N--CA 1.449 -0.489 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.686 ' HG3' ' HE3' ' A' ' 82' ' ' LYS . 85.0 Cg_endo -72.29 145.03 42.61 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 124.361 3.374 . . . . 0.0 109.587 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.544 ' HB3' ' N ' ' A' ' 141' ' ' LYS . . . -54.33 -23.74 16.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.559 ' HG3' ' H ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -69.87 -41.07 75.29 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.825 ' HA ' HE21 ' A' ' 59' ' ' GLN . 17.8 mttt -82.24 -28.79 31.67 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.664 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . . . -112.75 110.97 21.42 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.623 ' CD2' ' HB3' ' A' ' 138' ' ' LEU . 32.6 m-85 70.91 -9.78 0.81 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 80' ' ' ALA . . . 64.02 156.41 0.15 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.639 ' H ' ' ND2' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -41.36 155.4 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.419 ' HD2' ' OD1' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -39.41 131.1 1.68 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.45 ' CB ' HD12 ' A' ' 91' ' ' LEU . 7.7 t30 -81.08 147.73 29.98 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -85.12 -27.49 26.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.88 -0.56 18.9 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.723 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 71.7 mt -98.95 3.46 47.07 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.611 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 42.1 mt -85.77 113.32 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.642 HE22 ' HB2' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -108.2 145.73 33.82 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.519 ' HG3' ' HA ' ' A' ' 131' ' ' THR . 0.0 OUTLIER -128.3 97.2 4.67 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.675 ' CD1' ' CD1' ' A' ' 100' ' ' PHE . 25.2 pt -92.63 153.63 42.4 Favored Pre-proline 0 N--CA 1.45 -0.454 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.538 ' O ' ' N ' ' A' ' 99' ' ' ALA . 83.6 Cg_endo -72.44 139.65 31.98 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 124.272 3.314 . . . . 0.0 109.562 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.772 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -44.73 -26.89 0.43 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.552 ' HA ' ' HB2' ' A' ' 101' ' ' LYS . 10.0 t70 -73.73 -34.01 64.58 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -58.5 -22.28 54.56 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.675 ' CD1' ' CD1' ' A' ' 95' ' ' ILE . 1.8 m-85 -121.42 2.88 10.26 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 0.2 OUTLIER -53.06 -41.44 64.85 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.421 ' C ' ' H ' ' A' ' 104' ' ' ASP . 2.0 pt-20 -118.74 34.68 5.1 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.673 ' C ' ' H ' ' A' ' 105' ' ' PHE . . . -81.15 20.06 0.86 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER 59.34 -6.75 0.06 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.673 ' H ' ' C ' ' A' ' 103' ' ' ALA . 0.5 OUTLIER -150.63 147.52 27.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.447 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 0.6 OUTLIER -94.83 129.67 35.33 Favored Pre-proline 0 N--CA 1.449 -0.496 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.772 ' CG ' HH21 ' A' ' 97' ' ' ARG . 82.6 Cg_endo -72.36 135.02 23.77 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 124.367 3.378 . . . . 0.0 109.544 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.511 ' HA ' HG22 ' A' ' 125' ' ' VAL . 1.2 mt-10 -124.19 156.81 36.12 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.465 ' N ' ' HB ' ' A' ' 125' ' ' VAL . 2.8 tm-20 -65.7 67.55 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.65 14.04 0.06 OUTLIER Glycine 0 C--N 1.336 0.537 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.465 ' O ' ' CG2' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -69.97 171.27 9.72 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.465 ' CG2' ' O ' ' A' ' 111' ' ' MET . 64.0 t -156.7 70.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.19 135.49 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.635 ' CD2' ' HD3' ' A' ' 119' ' ' PRO . 0.3 OUTLIER -99.2 149.2 23.33 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -103.37 3.48 35.22 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 171.41 -11.09 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.415 ' O ' ' CD2' ' A' ' 114' ' ' LEU . . . 166.06 -34.88 0.24 Allowed Glycine 0 C--N 1.335 0.492 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 3.0 mt -93.3 121.32 65.51 Favored Pre-proline 0 N--CA 1.448 -0.53 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.635 ' HD3' ' CD2' ' A' ' 114' ' ' LEU . 83.9 Cg_endo -72.39 164.13 36.55 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 124.282 3.321 . . . . 0.0 109.631 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.565 ' CB ' ' HB3' ' A' ' 132' ' ' LEU . . . -123.55 82.94 2.07 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 2.4 m -54.13 94.82 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.627 ' HA ' ' HA ' ' A' ' 132' ' ' LEU . 12.8 mt -70.49 97.3 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 131' ' ' THR . 1.3 p -82.68 -24.73 33.56 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.551 ' HB3' ' N ' ' A' ' 131' ' ' THR . 1.2 tt0 -111.54 132.38 54.56 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.511 HG22 ' HA ' ' A' ' 108' ' ' GLU . 8.1 p -126.22 48.03 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.711 ' C ' ' H ' ' A' ' 128' ' ' ASN . 2.1 p -79.85 129.28 34.35 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.538 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.4 OUTLIER -53.87 2.41 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.711 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -110.79 -22.74 11.41 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.489 ' HG2' ' HG1' ' A' ' 126' ' ' THR . 5.2 pm0 -177.88 168.66 2.06 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 22.0 m -132.15 143.56 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.551 ' N ' ' HB3' ' A' ' 124' ' ' GLU . 16.3 m -99.75 85.37 3.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.627 ' HA ' ' HA ' ' A' ' 122' ' ' ILE . 0.1 OUTLIER -82.5 107.72 15.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.611 ' HA ' ' HA ' ' A' ' 92' ' ' ILE . 18.8 t0 -83.86 97.04 8.98 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.642 ' HB2' HE22 ' A' ' 93' ' ' GLN . 2.3 m-85 -42.53 -45.55 4.55 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.723 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 6.7 m120 42.17 -121.76 0.58 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 1.091 ' HD1' ' N ' ' A' ' 138' ' ' LEU . 21.6 t-80 -179.21 166.87 1.54 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.695 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 0.9 OUTLIER -70.99 -16.07 62.61 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 1.091 ' N ' ' HD1' ' A' ' 136' ' ' HIS . 3.4 mm? -111.26 -23.2 10.97 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 141' ' ' LYS . . . -48.66 144.66 4.18 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 42.45 22.12 0.12 Allowed Glycine 0 C--N 1.336 0.531 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.674 ' HE2' ' HB3' ' A' ' 143' ' ' LEU . 0.0 OUTLIER -133.09 133.03 42.42 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.567 ' C ' ' HD3' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -99.11 131.56 45.06 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.674 ' HB3' ' HE2' ' A' ' 141' ' ' LYS . 2.4 pt? -122.57 146.43 47.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.586 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 4.0 t -67.71 163.04 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.737 ' CD1' ' CG1' ' A' ' 78' ' ' ILE . 16.4 m-85 -146.43 85.87 1.66 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.47 ' HG1' HG22 ' A' ' 75' ' ' THR . 95.0 m -83.82 70.81 10.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.637 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 2.1 mt -64.4 179.54 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.439 ' C ' ' HB ' ' A' ' 13' ' ' VAL . 3.1 tmtt? -177.65 96.49 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.599 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 2.4 mm -60.06 135.01 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.521 HG13 ' HA ' ' A' ' 13' ' ' VAL . 2.3 mt -122.51 -24.62 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.509 ' HA ' HG11 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -163.11 176.39 10.09 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.551 ' HA ' HG21 ' A' ' 11' ' ' ILE . 85.7 t -137.69 136.84 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.672 HG22 ' HE2' ' A' ' 12' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.702 HG11 ' H ' ' A' ' 6' ' ' ASP . 16.6 t . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.784 ' H ' HG21 ' A' ' 9' ' ' VAL . 7.8 m-20 -143.4 168.83 18.89 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.521 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 11.7 ptmt -66.05 69.59 0.06 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 6' ' ' ASP . . . 162.59 11.3 0.03 OUTLIER Glycine 0 C--N 1.336 0.561 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.784 HG21 ' H ' ' A' ' 6' ' ' ASP . 1.4 t -119.05 133.96 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.535 ' HG3' ' CG2' ' A' ' 51' ' ' VAL . 3.6 tttt -86.64 133.39 33.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.601 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 9.6 pt -147.03 136.38 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 9.5 mtpt -95.03 91.94 6.6 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.61 ' CG1' ' HA ' ' A' ' 149' ' ' ILE . 1.1 m -118.35 145.79 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.416 ' OD1' ' HA ' ' A' ' 47' ' ' PRO . 41.3 m-20 -92.19 -166.69 1.6 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.609 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.0 OUTLIER -179.81 151.79 0.45 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.606 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 3.5 mt -133.22 81.65 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -65.74 138.62 37.91 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.672 ' HZ2' ' HG1' ' A' ' 146' ' ' THR . 10.4 mttt -125.44 -165.81 1.46 Allowed 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.663 ' C ' ' H ' ' A' ' 21' ' ' SER . 34.1 mt -112.98 166.52 11.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -54.84 0.77 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.663 ' H ' ' C ' ' A' ' 19' ' ' LEU . 54.2 p -112.4 2.54 16.47 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.04 30.51 57.26 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 18' ' ' LYS . 87.3 m-20 -100.87 124.29 46.33 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.589 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 82.2 t -71.06 122.83 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.475 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -115.48 -30.13 6.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.475 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 16.7 t0 -143.56 140.23 30.13 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.595 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 6.1 t -158.72 148.66 19.48 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.4 m -101.78 16.68 25.12 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 29.0 mt -127.91 108.47 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.581 ' HG3' ' CD1' ' A' ' 45' ' ' TYR . 2.8 tt0 -48.81 -35.42 14.45 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -47.4 -64.66 0.72 Allowed 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.527 ' CG2' HD11 ' A' ' 16' ' ' ILE . 49.5 t -53.81 -40.39 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.59 ' HA ' ' CG1' ' A' ' 38' ' ' ILE . . . -54.68 -38.09 66.55 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.519 ' CG ' ' HB2' ' A' ' 39' ' ' TYR . 7.7 mtpt -78.51 -17.93 55.51 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -96.01 -23.62 16.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . -95.14 -23.71 17.17 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.81 37.58 4.93 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.59 ' CG1' ' HA ' ' A' ' 33' ' ' ALA . 2.1 pt -135.38 17.17 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.519 ' HB2' ' CG ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -43.44 -20.47 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 38' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.581 ' CD1' ' HG3' ' A' ' 30' ' ' GLU . 80.3 m-85 . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.611 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -131.23 174.92 4.13 Favored Pre-proline 0 N--CA 1.449 -0.523 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.611 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 83.8 Cg_endo -72.41 130.84 16.71 Favored 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 124.319 3.346 . . . . 0.0 109.643 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.501 ' CD2' HD23 ' A' ' 57' ' ' LEU . 1.4 tp -88.63 96.66 10.74 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 12' ' ' LYS . 23.4 tt0 -79.08 89.73 4.82 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.757 ' CE2' ' CE1' ' A' ' 61' ' ' PHE . 0.7 OUTLIER -108.32 172.8 6.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.578 ' C ' ' H ' ' A' ' 53' ' ' GLY . 59.1 t -123.6 107.28 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.538 ' CG1' ' HG ' ' A' ' 66' ' ' LEU . 2.8 t -50.93 -8.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.578 ' H ' ' C ' ' A' ' 51' ' ' VAL . . . -96.98 -25.27 11.53 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.296 -1.121 . . . . 0.0 110.296 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 51' ' ' VAL . 14.6 mt-10 -74.28 -65.32 0.86 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.82 13.84 8.36 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.529 HE21 ' HB2' ' A' ' 56' ' ' GLN . 0.5 OUTLIER -43.47 -67.09 0.31 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.631 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 1.5 mm? -70.67 -171.97 0.57 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.837 ' CD1' ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -81.68 146.38 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.528 HE21 ' HA ' ' A' ' 82' ' ' LYS . 14.0 mt-30 -43.15 -54.69 4.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.534 ' H ' ' HB3' ' A' ' 82' ' ' LYS . . . -39.45 -81.51 0.02 OUTLIER Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.757 ' CE1' ' CE2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -42.53 -49.56 5.37 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.67 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 1.9 mt-10 -49.88 -35.08 22.17 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 60' ' ' GLY . 4.9 mt-10 -78.09 -32.0 50.4 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' A' ' 74' ' ' LYS . . . -64.47 -25.42 67.99 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.596 HG23 ' CZ ' ' A' ' 50' ' ' PHE . 33.5 m -95.02 -20.4 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.538 ' HG ' ' CG1' ' A' ' 52' ' ' VAL . 1.2 mt -51.07 -60.44 3.1 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -96.33 55.59 1.5 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.511 ' CE ' HD12 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -144.37 127.38 16.47 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.408 ' O ' HG13 ' A' ' 149' ' ' ILE . 0.8 OUTLIER -75.31 -161.77 0.16 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.687 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 0.2 OUTLIER -90.0 115.56 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.845 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 107.0 -6.57 37.26 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 0.9 OUTLIER -68.64 177.81 2.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -154.8 142.59 19.96 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 2.4 tttm -139.38 101.98 4.37 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.59 ' CG2' ' CG2' ' A' ' 146' ' ' THR . 0.2 OUTLIER -99.19 93.6 6.04 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.413 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 18.3 t -136.09 156.04 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.676 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 2.5 ttpm? -85.35 116.44 23.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.689 ' CG1' ' CD1' ' A' ' 145' ' ' PHE . 22.2 mm -78.37 126.65 82.82 Favored Pre-proline 0 N--CA 1.448 -0.568 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.509 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 84.4 Cg_endo -72.32 144.1 40.57 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 124.264 3.31 . . . . 0.0 109.656 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.604 ' HB2' ' N ' ' A' ' 141' ' ' LYS . . . -56.62 -8.57 0.58 Allowed 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.584 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 9.3 pt-20 -81.55 -39.25 24.9 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.534 ' HB3' ' H ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -86.85 -34.73 19.38 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.647 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . . . -67.75 -96.44 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.583 ' CE1' ' HB3' ' A' ' 138' ' ' LEU . 3.1 m-85 -99.29 17.56 19.76 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 42.53 84.56 0.01 OUTLIER Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.666 ' ND2' ' N ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER 47.65 -166.22 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.893 ' HE ' ' CB ' ' A' ' 139' ' ' ALA . 3.4 mmt85 -70.47 145.91 50.64 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.405 ' HB2' HD11 ' A' ' 91' ' ' LEU . 0.9 OUTLIER -83.27 143.83 30.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.469 ' HA ' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -90.09 -26.79 20.06 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -74.66 -23.3 58.64 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.594 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 85.4 mt -85.34 26.67 0.88 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 86.5 mt -93.16 116.41 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.828 HE22 ' HB2' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -109.19 154.23 22.67 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.836 ' HG3' ' HG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -134.96 99.09 4.19 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.542 HG12 ' CD1' ' A' ' 132' ' ' LEU . 21.4 pt -95.5 156.02 38.0 Favored Pre-proline 0 N--CA 1.449 -0.483 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 99' ' ' ALA . 83.0 Cg_endo -72.36 139.53 32.01 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 124.283 3.322 . . . . 0.0 109.577 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.837 HH21 ' HG2' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -42.16 -33.94 0.67 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.505 ' HA ' ' HB2' ' A' ' 101' ' ' LYS . 0.9 OUTLIER -65.85 -36.37 83.25 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -43.65 -19.85 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.488 ' N ' ' O ' ' A' ' 98' ' ' ASP . 0.6 OUTLIER -126.49 -30.61 2.83 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.505 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 1.2 tmtt? -53.42 -17.46 1.95 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.03 28.36 8.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.438 ' HB3' ' CE1' ' A' ' 105' ' ' PHE . . . -113.03 -139.16 0.38 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.99 -3.31 3.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.458 ' HB2' ' H ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -128.13 -148.43 0.38 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.458 ' H ' ' HB2' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -162.44 132.93 3.5 Favored Pre-proline 0 N--CA 1.45 -0.448 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.837 ' HG2' HH21 ' A' ' 97' ' ' ARG . 82.3 Cg_endo -72.38 137.39 28.14 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 124.27 3.313 . . . . 0.0 109.591 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.48 ' HA ' HG22 ' A' ' 125' ' ' VAL . 4.0 mt-10 -126.05 154.61 42.77 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.529 ' N ' ' HB ' ' A' ' 125' ' ' VAL . 1.2 tt0 -65.51 67.03 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.91 9.86 0.08 OUTLIER Glycine 0 C--N 1.336 0.539 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.523 ' HB3' ' CD1' ' A' ' 122' ' ' ILE . 1.4 mmt -66.64 171.38 5.19 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 111' ' ' MET . 60.7 t -156.11 73.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.413 ' H ' HG22 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -110.29 136.95 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.648 HD22 ' HD3' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -106.49 171.07 7.56 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -114.79 -4.29 12.7 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.411 ' H ' ' H ' ' A' ' 117' ' ' GLY . 1.0 OUTLIER 172.33 5.63 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.411 ' H ' ' H ' ' A' ' 116' ' ' GLU . . . 153.87 -38.86 0.69 Allowed Glycine 0 C--N 1.335 0.483 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 48.8 mm -87.47 114.65 59.74 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.648 ' HD3' HD22 ' A' ' 114' ' ' LEU . 84.9 Cg_endo -72.38 173.5 13.03 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 124.305 3.337 . . . . 0.0 109.604 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.547 ' CB ' ' HB3' ' A' ' 132' ' ' LEU . . . -134.64 73.14 1.47 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 77.3 m -49.85 96.86 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.638 ' HA ' ' HA ' ' A' ' 132' ' ' LEU . 2.9 mp -69.1 98.73 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.414 ' H ' HG23 ' A' ' 123' ' ' THR . 1.0 OUTLIER -83.76 -21.14 32.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.561 ' HB3' ' H ' ' A' ' 131' ' ' THR . 0.3 OUTLIER -120.16 133.41 55.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.529 ' HB ' ' N ' ' A' ' 109' ' ' GLU . 7.2 p -124.76 52.6 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.672 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -79.67 127.81 32.63 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.427 ' HA ' ' HD3' ' A' ' 97' ' ' ARG . 0.5 OUTLIER -53.25 0.63 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.672 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -111.62 -21.67 11.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -177.83 168.43 2.09 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.513 HG13 ' CG ' ' A' ' 107' ' ' PRO . 4.2 m -133.66 141.69 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.836 ' HG1' ' HG3' ' A' ' 94' ' ' LYS . 17.3 m -98.18 86.27 3.64 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.638 ' HA ' ' HA ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -82.65 113.32 20.26 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.829 ' CG ' HD22 ' A' ' 135' ' ' ASN . 10.0 t0 -81.96 95.12 7.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.828 ' HB2' HE22 ' A' ' 93' ' ' GLN . 1.6 m-85 -39.88 -50.61 2.46 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.829 HD22 ' CG ' ' A' ' 133' ' ' ASP . 8.6 m120 45.97 -132.89 0.99 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 1.021 ' HD1' ' N ' ' A' ' 138' ' ' LEU . 23.2 t-80 -167.84 174.21 7.7 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.779 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 8.7 pt-20 -86.06 10.11 15.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 1.021 ' N ' ' HD1' ' A' ' 136' ' ' HIS . 63.5 mt -135.01 5.32 3.31 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.893 ' CB ' ' HE ' ' A' ' 87' ' ' ARG . . . -60.58 -111.23 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.86 ' H ' ' NE ' ' A' ' 87' ' ' ARG . . . -65.59 38.65 0.13 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.855 ' HE2' ' CD2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -136.47 143.18 43.71 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.509 ' HB3' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -101.0 129.9 46.91 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.702 ' HB3' ' HE2' ' A' ' 141' ' ' LYS . 1.1 pt? -121.07 145.69 47.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.676 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 1.6 t -62.14 163.88 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.689 ' CD1' ' CG1' ' A' ' 78' ' ' ILE . 12.3 m-85 -148.28 102.58 3.36 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.672 ' HG1' ' HZ2' ' A' ' 18' ' ' LYS . 24.3 m -97.17 60.81 1.7 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.609 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.1 mt -59.67 177.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.514 ' H ' HG22 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -177.25 113.86 0.09 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.845 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 2.8 mm -69.49 139.98 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.533 HG13 ' HA ' ' A' ' 13' ' ' VAL . 6.7 mt -118.78 -48.12 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.687 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -158.11 -165.39 1.71 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.601 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 10.7 t -134.16 137.83 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.552 ' CG2' ' CG ' ' A' ' 12' ' ' LYS . 45.8 t . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.569 HG11 ' N ' ' A' ' 6' ' ' ASP . 23.0 t . . . . . 0 N--CA 1.448 -0.529 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.649 ' H ' HG23 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -137.76 171.08 14.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.536 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 16.9 ptmt -64.76 70.64 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 6' ' ' ASP . . . 161.61 11.24 0.03 OUTLIER Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.649 HG23 ' H ' ' A' ' 6' ' ' ASP . 1.7 t -125.17 132.97 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.581 ' HE2' ' O ' ' A' ' 49' ' ' GLU . 11.6 tttt -88.2 152.94 21.62 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.61 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 6.2 pt -160.72 137.96 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 7.7 ttmt -96.12 99.94 11.63 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 149' ' ' ILE . 1.2 m -119.65 152.62 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.583 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 0.5 OUTLIER -115.42 103.01 10.35 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.615 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 9.3 p90 -96.63 151.63 19.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.599 ' CG2' ' HB ' ' A' ' 27' ' ' THR . 1.1 mt -119.81 77.94 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -62.65 130.45 43.07 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.593 ' HE2' HG22 ' A' ' 24' ' ' VAL . 6.9 mtmt -125.56 144.43 50.57 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.2 mt -64.07 170.09 3.88 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.61 50.86 0.07 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.567 ' HG ' ' CG ' ' A' ' 23' ' ' ASP . 94.1 p -161.82 -1.01 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.29 22.34 48.43 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.567 ' CG ' ' HG ' ' A' ' 21' ' ' SER . 2.2 m-20 -96.71 116.34 28.96 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.593 HG22 ' HE2' ' A' ' 18' ' ' LYS . 54.6 t -68.44 115.07 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.497 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 3.3 p90 -103.84 -37.75 7.31 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.497 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 9.3 t0 -136.04 133.46 37.43 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.599 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -153.91 131.59 11.49 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.583 ' HB2' ' HA ' ' A' ' 14' ' ' ASP . 3.0 m -79.68 -23.2 42.62 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.68 HG23 ' H ' ' A' ' 32' ' ' VAL . 5.0 mt -84.67 114.93 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.582 ' O ' ' HE3' ' A' ' 34' ' ' LYS . 6.4 tt0 -60.89 -22.02 63.89 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -60.51 -62.46 1.84 Allowed 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.68 ' H ' HG23 ' A' ' 29' ' ' ILE . 89.3 t -54.54 -41.0 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.59 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . . . -48.22 -39.18 20.37 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.582 ' HE3' ' O ' ' A' ' 30' ' ' GLU . 18.0 mttt -77.56 -24.32 49.84 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 32' ' ' VAL . 35.7 tt0 -84.37 -12.98 53.52 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.82 -10.49 14.76 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.83 44.0 10.74 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.578 HG13 ' HA ' ' A' ' 33' ' ' ALA . 1.6 pt -140.06 16.28 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.53 ' HB2' ' CG ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -45.07 -17.51 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.487 ' N ' ' C ' ' A' ' 38' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.508 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.59 ' CD2' ' HB2' ' A' ' 33' ' ' ALA . 9.8 m-85 . . . . . 0 N--CA 1.449 -0.52 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.601 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -117.42 174.78 2.33 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.601 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 81.7 Cg_endo -72.36 124.07 9.63 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 124.312 3.341 . . . . 0.0 109.578 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.8 tp -86.66 125.15 33.66 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.581 ' O ' ' HE2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -91.95 98.69 11.73 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.684 ' HB2' HE21 ' A' ' 56' ' ' GLN . 10.5 p90 -99.76 170.96 8.19 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.665 HG13 ' H ' ' A' ' 53' ' ' GLY . 57.6 t -135.01 106.13 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.536 ' C ' ' HA ' ' A' ' 7' ' ' LYS . 93.3 t -48.88 -10.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.665 ' H ' HG13 ' A' ' 51' ' ' VAL . . . -117.27 62.3 0.41 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -167.22 -20.05 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.38 6.57 88.57 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.684 HE21 ' HB2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -42.05 -78.61 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.608 ' CB ' ' CE1' ' A' ' 61' ' ' PHE . 3.0 mm? -75.02 -174.2 2.18 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.901 ' CD1' ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -82.19 144.02 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.878 HE21 ' HA ' ' A' ' 82' ' ' LYS . 3.7 mt-30 -41.83 -51.91 4.14 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.583 ' H ' ' HB3' ' A' ' 82' ' ' LYS . . . -42.23 -78.48 0.07 OUTLIER Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.686 ' HB3' ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -47.68 -37.94 13.98 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.555 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 18.3 mt-10 -62.51 -22.78 66.55 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 60' ' ' GLY . 4.7 mt-10 -88.54 -34.8 17.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.437 ' HB3' HD13 ' A' ' 147' ' ' ILE . . . -64.54 -30.39 71.42 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.555 HG21 ' N ' ' A' ' 66' ' ' LEU . 29.9 m -86.14 -32.8 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.555 ' N ' HG21 ' A' ' 65' ' ' VAL . 2.9 mt -41.87 -43.25 2.97 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.36 50.4 0.81 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.515 ' SD ' ' N ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -145.07 119.3 9.51 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.443 ' N ' ' OD2' ' A' ' 72' ' ' ASP . 3.2 mp0 -73.74 -168.77 0.62 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.608 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 34.5 t -79.29 113.93 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.79 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 108.99 -3.45 31.72 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.507 ' HB3' ' HG2' ' A' ' 68' ' ' MET . 0.7 OUTLIER -73.13 169.9 16.05 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.515 ' N ' ' SD ' ' A' ' 68' ' ' MET . 1.5 tt0 -150.15 139.16 21.05 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.5 ttmm -147.22 97.99 2.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.769 HG21 ' HG1' ' A' ' 146' ' ' THR . 28.6 m -93.71 90.63 6.66 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.9 t -126.41 145.69 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.632 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 5.6 ttpm? -76.44 115.08 15.85 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.68 ' CG1' ' CD2' ' A' ' 145' ' ' PHE . 37.5 mm -78.31 131.46 68.84 Favored Pre-proline 0 N--CA 1.45 -0.449 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.522 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 84.2 Cg_endo -72.41 139.44 31.73 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 124.35 3.367 . . . . 0.0 109.567 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.649 ' CB ' ' N ' ' A' ' 141' ' ' LYS . . . -52.01 -14.52 0.41 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.565 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 7.5 tt0 -78.85 -37.22 40.98 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.878 ' HA ' HE21 ' A' ' 59' ' ' GLN . 14.1 mttm -85.04 -36.27 21.34 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.647 ' HA ' ' CG2' ' A' ' 58' ' ' ILE . . . -67.55 -92.43 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.618 ' CE2' ' CD2' ' A' ' 136' ' ' HIS . 0.5 OUTLIER -103.72 17.1 24.82 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 65.09 144.09 0.03 OUTLIER Glycine 0 C--N 1.335 0.523 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.651 ' H ' ' ND2' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -39.75 150.84 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.464 ' HG3' ' HA3' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -39.37 120.99 1.11 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.494 ' H ' HD11 ' A' ' 91' ' ' LEU . 7.7 t30 -80.11 147.23 31.48 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.442 ' HG2' HD13 ' A' ' 92' ' ' ILE . 1.8 tt0 -73.87 -33.72 64.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -17.51 62.42 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.709 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 13.0 mt -79.11 0.06 29.62 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 11.6 mt -94.31 118.94 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.611 HE22 ' C ' ' A' ' 91' ' ' LEU . 2.9 mp0 -109.08 171.61 7.33 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.432 ' HG3' ' HA ' ' A' ' 131' ' ' THR . 0.0 OUTLIER -143.2 81.76 1.73 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.578 ' H ' HD12 ' A' ' 132' ' ' LEU . 26.4 pt -79.8 155.87 75.35 Favored Pre-proline 0 N--CA 1.449 -0.485 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.578 ' HA ' ' HG3' ' A' ' 129' ' ' GLU . 83.1 Cg_endo -72.37 137.08 27.6 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 124.316 3.344 . . . . 0.0 109.624 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.814 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -42.61 -33.45 0.71 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 100' ' ' PHE . 2.5 m-20 -66.07 -36.88 84.4 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -44.3 -19.68 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.61 ' CD2' ' HD3' ' A' ' 107' ' ' PRO . 3.1 m-85 -124.47 -30.32 3.39 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.426 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 4.3 tttt -60.63 -19.8 59.02 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.59 18.08 22.91 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -103.85 -137.61 0.35 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.45 -0.57 4.46 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.486 ' HB2' ' H ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -134.89 -149.81 0.36 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.502 ' HG2' ' HD2' ' A' ' 107' ' ' PRO . 1.8 tt0 -161.78 136.31 5.23 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.814 ' CG ' HH21 ' A' ' 97' ' ' ARG . 83.1 Cg_endo -72.41 141.48 35.24 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 124.279 3.319 . . . . 0.0 109.624 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.521 ' HA ' HG23 ' A' ' 125' ' ' VAL . 1.0 OUTLIER -130.81 157.58 42.46 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.434 ' HB2' HG12 ' A' ' 125' ' ' VAL . 1.9 tt0 -65.74 66.16 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 152.27 11.64 0.08 OUTLIER Glycine 0 C--N 1.335 0.477 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.543 ' HB3' ' CD1' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -66.24 171.15 4.99 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.502 ' CG1' ' HB2' ' A' ' 119' ' ' PRO . 60.7 t -156.49 70.87 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.41 134.99 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.627 HD23 ' CD ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -103.29 144.75 30.94 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -96.02 0.49 51.7 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.409 ' H ' ' H ' ' A' ' 117' ' ' GLY . 0.6 OUTLIER 170.82 -7.16 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.409 ' H ' ' H ' ' A' ' 116' ' ' GLU . . . 164.69 -38.82 0.3 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.434 ' HA ' ' HD2' ' A' ' 119' ' ' PRO . 5.3 mt -87.42 114.71 59.99 Favored Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.627 ' CD ' HD23 ' A' ' 114' ' ' LEU . 82.8 Cg_endo -72.44 156.18 54.63 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 124.246 3.297 . . . . 0.0 109.575 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -116.37 94.06 4.48 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.511 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 1.3 m -64.84 98.4 0.27 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.725 ' HA ' ' HA ' ' A' ' 132' ' ' LEU . 2.9 mp -70.41 100.13 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.45 HG23 HG23 ' A' ' 121' ' ' THR . 2.5 p -83.28 -21.89 33.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.821 ' HB3' ' H ' ' A' ' 131' ' ' THR . 0.4 OUTLIER -121.84 131.52 54.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.521 HG23 ' HA ' ' A' ' 108' ' ' GLU . 11.3 p -122.29 51.59 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.7 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -78.72 126.26 30.49 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.667 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.3 OUTLIER -53.36 2.84 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.7 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.3 OUTLIER -113.51 -21.96 10.57 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.578 ' HG3' ' HA ' ' A' ' 96' ' ' PRO . 1.4 mt-10 -173.96 168.43 4.19 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.561 ' CG2' ' CG1' ' A' ' 95' ' ' ILE . 18.1 m -135.07 122.55 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.821 ' H ' ' HB3' ' A' ' 124' ' ' GLU . 9.4 m -88.12 88.28 7.59 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.725 ' HA ' ' HA ' ' A' ' 122' ' ' ILE . 0.1 OUTLIER -76.66 163.18 27.1 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.742 ' CG ' HD22 ' A' ' 135' ' ' ASN . 31.8 t0 -139.69 95.96 3.0 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.597 ' N ' ' O ' ' A' ' 91' ' ' LEU . 4.5 m-30 -37.5 -81.08 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.742 HD22 ' CG ' ' A' ' 133' ' ' ASP . 0.6 OUTLIER 58.04 100.87 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 1.062 ' HD1' ' N ' ' A' ' 138' ' ' LEU . 14.3 t-80 -43.11 158.47 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.706 ' HG2' ' CE1' ' A' ' 136' ' ' HIS . 0.7 OUTLIER -54.78 -13.9 1.21 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 1.062 ' N ' ' HD1' ' A' ' 136' ' ' HIS . 11.3 mt -114.09 -5.34 13.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.549 ' HB3' ' N ' ' A' ' 136' ' ' HIS . . . -55.25 133.26 49.25 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.464 ' HA3' ' HG3' ' A' ' 87' ' ' ARG . . . 48.5 17.94 0.85 Allowed Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.702 ' HE2' ' HB3' ' A' ' 143' ' ' LEU . 0.0 OUTLIER -124.95 129.57 50.61 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.549 ' C ' ' HD3' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -96.43 131.22 43.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.702 ' HB3' ' HE2' ' A' ' 141' ' ' LYS . 0.5 OUTLIER -123.31 152.21 41.65 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.632 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 2.2 t -65.78 160.36 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.68 ' CD2' ' CG1' ' A' ' 78' ' ' ILE . 14.3 m-85 -146.85 92.15 2.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.769 ' HG1' HG21 ' A' ' 75' ' ' THR . 89.8 m -86.18 63.35 7.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.615 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.7 mt -60.94 174.24 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.423 ' H ' HG23 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -178.65 103.29 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.79 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -60.57 140.97 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.549 HD12 ' N ' ' A' ' 14' ' ' ASP . 2.8 mt -122.75 -47.12 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.608 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 5.1 tt0 -151.52 -164.05 1.9 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.61 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 95.8 t -141.42 141.03 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.495 ' N ' HG12 ' A' ' 152' ' ' VAL . 24.1 t . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.817 HG11 ' H ' ' A' ' 6' ' ' ASP . 3.4 t . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.817 ' H ' HG11 ' A' ' 5' ' ' VAL . 52.5 m-20 -152.21 159.8 43.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.521 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 50.9 mtpt -66.93 79.63 0.12 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.565 ' HA2' ' HA3' ' A' ' 53' ' ' GLY . . . 157.78 -1.93 0.12 Allowed Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.478 ' HB ' ' CG1' ' A' ' 5' ' ' VAL . 1.3 t -106.33 130.25 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.665 ' HE3' ' HB2' ' A' ' 49' ' ' GLU . 8.7 tttp -84.33 148.88 26.41 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.6 HG13 ' CE1' ' A' ' 50' ' ' PHE . 4.2 pt -160.27 136.28 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 11.3 ttmt -96.35 105.69 17.79 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.503 HG13 ' HA ' ' A' ' 149' ' ' ILE . 0.8 OUTLIER -122.44 160.62 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.513 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 0.5 OUTLIER -114.72 98.55 6.92 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.768 ' HH ' ' HB3' ' A' ' 26' ' ' ASP . 1.2 p90 -94.8 161.33 14.21 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.608 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 7.0 mt -138.91 80.04 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -67.87 131.03 28.24 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 110.314 -1.115 . . . . 0.0 110.314 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.646 ' HE2' HG23 ' A' ' 24' ' ' VAL . 4.8 mtmt -119.5 -171.67 2.17 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.739 ' C ' ' H ' ' A' ' 21' ' ' SER . 50.2 mt -108.25 168.76 9.08 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -60.07 13.36 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.739 ' H ' ' C ' ' A' ' 19' ' ' LEU . 98.7 p -124.58 -6.63 7.49 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.31 23.97 32.81 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.43 ' C ' ' HG2' ' A' ' 18' ' ' LYS . 4.0 m-20 -94.34 117.71 30.52 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.646 HG23 ' HE2' ' A' ' 18' ' ' LYS . 76.1 t -70.81 112.93 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.562 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -100.02 -40.43 7.64 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.768 ' HB3' ' HH ' ' A' ' 15' ' ' TYR . 21.3 t0 -134.4 127.53 31.77 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.582 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 3.7 t -148.13 155.92 42.0 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.513 ' HB2' ' HA ' ' A' ' 14' ' ' ASP . 5.4 m -103.78 -21.39 13.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.753 HG22 ' H ' ' A' ' 32' ' ' VAL . 3.9 mt -83.78 96.71 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.433 ' CA ' ' HB2' ' A' ' 45' ' ' TYR . 3.2 tt0 -43.31 -24.17 0.08 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.443 ' HB3' ' CG2' ' A' ' 29' ' ' ILE . 20.3 tt0 -60.54 -61.39 2.63 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.753 ' H ' HG22 ' A' ' 29' ' ' ILE . 95.2 t -53.75 -41.09 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.543 ' HA ' HG13 ' A' ' 38' ' ' ILE . . . -48.29 -40.5 25.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.517 ' CG ' ' HB2' ' A' ' 39' ' ' TYR . 15.7 mtpt -76.54 -25.2 53.86 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -84.45 -13.38 52.23 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.97 -10.41 15.05 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.56 44.22 11.11 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.543 HG13 ' HA ' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -141.46 14.12 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.517 ' HB2' ' CG ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -44.31 -19.15 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.488 ' O ' ' CZ ' ' A' ' 39' ' ' TYR . . . . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.491 ' CD1' ' O ' ' A' ' 27' ' ' THR . 16.9 m-85 . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.646 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -101.27 177.3 1.55 Allowed Pre-proline 0 N--CA 1.45 -0.452 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.646 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 82.3 Cg_endo -72.4 130.77 16.63 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 124.27 3.313 . . . . 0.0 109.546 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 tp -97.96 118.74 35.22 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.665 ' HB2' ' HE3' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -89.5 98.29 11.69 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.791 ' HB2' HE21 ' A' ' 56' ' ' GLN . 7.9 p90 -96.63 169.81 9.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.522 HG22 ' CB ' ' A' ' 10' ' ' LYS . 54.4 t -131.62 102.92 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.521 ' HB ' ' HA ' ' A' ' 7' ' ' LYS . 2.9 t -44.54 -17.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.565 ' HA3' ' HA2' ' A' ' 8' ' ' GLY . . . -108.55 40.87 2.39 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.449 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 2.0 mt-10 -138.26 -23.72 1.0 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.33 8.46 85.15 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.791 HE21 ' HB2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -42.43 -83.64 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.593 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 3.8 mp -76.46 165.52 24.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.668 ' HB ' ' HA ' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -56.84 145.25 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.415 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 1.5 mt-30 -43.14 -42.76 4.24 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 63' ' ' GLU . . . -41.63 -83.85 0.01 OUTLIER Glycine 0 C--N 1.336 0.552 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.649 ' CD1' ' N ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -43.93 -46.37 8.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.649 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 3.4 mt-10 -51.22 -29.69 15.0 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.481 ' N ' ' O ' ' A' ' 60' ' ' GLY . 2.8 mt-10 -85.32 -33.88 21.99 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.441 ' CB ' ' HD2' ' A' ' 74' ' ' LYS . . . -67.45 -25.87 66.12 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.582 ' HA ' ' HB2' ' A' ' 68' ' ' MET . 5.8 m -88.63 -28.61 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.546 ' CD2' ' HA ' ' A' ' 6' ' ' ASP . 4.1 mt -48.42 -25.89 1.84 Allowed 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.5 47.9 2.13 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.605 ' SD ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -140.01 102.41 4.39 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.507 ' N ' ' CG ' ' A' ' 72' ' ' ASP . 1.7 mp0 -61.47 -178.38 0.13 Allowed 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.647 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 1.9 t -71.34 109.36 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.835 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 110.35 -5.04 29.88 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.507 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 0.9 OUTLIER -70.97 173.21 7.76 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.605 ' N ' ' SD ' ' A' ' 68' ' ' MET . 0.2 OUTLIER -150.29 143.04 24.66 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.441 ' HD2' ' CB ' ' A' ' 64' ' ' ALA . 7.0 ttmt -146.05 103.93 3.78 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.601 ' CG2' ' CG2' ' A' ' 146' ' ' THR . 0.2 OUTLIER -103.62 114.33 28.51 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 77' ' ' LYS . 54.8 t -157.91 159.25 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.6 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 4.6 ttpm? -86.14 116.73 24.52 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.707 ' CG1' ' CD2' ' A' ' 145' ' ' PHE . 34.9 mm -79.26 118.87 74.86 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.512 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 84.6 Cg_endo -72.33 138.43 30.17 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 124.381 3.387 . . . . 0.0 109.573 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.689 ' CB ' ' H ' ' A' ' 85' ' ' GLY . . . -44.32 -34.19 1.87 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.437 ' HG2' ' HG2' ' A' ' 79' ' ' PRO . 3.7 pt-20 -55.62 -32.28 62.99 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.411 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 14.7 mtmt -106.48 -0.34 24.1 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.668 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . . . -121.44 -82.31 0.65 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.578 ' CE2' ' HB2' ' A' ' 138' ' ' LEU . 3.9 m-85 -107.9 -48.07 3.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.689 ' H ' ' CB ' ' A' ' 80' ' ' ALA . . . 101.35 154.88 26.56 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.783 ' H ' ' ND2' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -36.61 137.03 0.32 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.591 ' CD ' ' HA3' ' A' ' 140' ' ' GLY . 0.3 OUTLIER -39.84 143.77 0.23 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -79.57 140.05 37.31 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -65.74 -27.46 68.33 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -14.65 61.63 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.834 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 52.6 mt -85.15 7.62 21.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.592 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 62.1 mt -87.93 120.25 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.535 HE22 ' HB2' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -116.57 146.65 42.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.39 118.73 31.93 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.527 ' CG2' HD12 ' A' ' 132' ' ' LEU . 36.3 pt -114.45 152.29 45.97 Favored Pre-proline 0 N--CA 1.449 -0.48 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.573 ' HA ' ' HG3' ' A' ' 129' ' ' GLU . 84.7 Cg_endo -72.34 129.97 15.63 Favored 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 124.292 3.328 . . . . 0.0 109.654 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.881 HH21 ' HG3' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -41.98 -28.98 0.19 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.501 ' HA ' ' HB2' ' A' ' 101' ' ' LYS . 28.7 t70 -65.08 -38.14 89.78 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -50.09 -28.41 7.15 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.545 ' C ' ' H ' ' A' ' 102' ' ' GLU . 1.2 m-85 -107.96 -26.82 10.52 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.501 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -60.45 -0.85 0.29 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.545 ' H ' ' C ' ' A' ' 100' ' ' PHE . 5.1 pt-20 -120.14 22.27 11.48 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -104.47 -137.93 0.36 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -140.85 -3.11 1.28 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.45 ' HB2' ' H ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -123.02 -149.48 0.43 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.45 ' H ' ' HB2' ' A' ' 105' ' ' PHE . 1.0 OUTLIER -158.77 125.0 2.43 Favored Pre-proline 0 N--CA 1.449 -0.511 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.881 ' HG3' HH21 ' A' ' 97' ' ' ARG . 83.7 Cg_endo -72.4 141.97 36.15 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 124.408 3.405 . . . . 0.0 109.559 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.52 ' HA ' HG23 ' A' ' 125' ' ' VAL . 0.7 OUTLIER -133.16 159.45 40.1 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.482 ' HB2' ' CG1' ' A' ' 125' ' ' VAL . 0.9 OUTLIER -64.73 67.71 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 156.44 8.07 0.06 OUTLIER Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.553 ' CB ' ' CD1' ' A' ' 122' ' ' ILE . 0.5 OUTLIER -63.43 172.62 1.92 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.522 HG11 ' CB ' ' A' ' 119' ' ' PRO . 76.3 t -156.86 65.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.68 136.87 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.638 ' CD2' ' HD3' ' A' ' 119' ' ' PRO . 0.3 OUTLIER -103.38 153.03 20.91 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -105.9 2.72 27.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 173.28 -13.65 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.401 ' O ' ' CD2' ' A' ' 114' ' ' LEU . . . 168.25 -33.65 0.19 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 3.0 mt -94.51 122.19 61.58 Favored Pre-proline 0 N--CA 1.448 -0.535 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.638 ' HD3' ' CD2' ' A' ' 114' ' ' LEU . 81.7 Cg_endo -72.36 169.71 20.99 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 124.313 3.342 . . . . 0.0 109.549 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -126.79 67.98 1.25 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.529 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 6.2 m -41.77 100.26 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.712 ' HA ' ' HA ' ' A' ' 132' ' ' LEU . 2.6 mp -71.42 94.8 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.671 ' HG1' HG23 ' A' ' 131' ' ' THR . 1.3 p -77.08 -25.43 52.33 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.509 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 0.6 OUTLIER -122.46 129.28 51.86 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.52 HG23 ' HA ' ' A' ' 108' ' ' GLU . 7.7 p -115.82 59.56 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.688 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.2 OUTLIER -79.71 119.84 23.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.421 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 0.3 OUTLIER -48.9 -3.66 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.688 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.2 OUTLIER -113.73 -25.07 8.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.843 ' HA ' HH11 ' A' ' 97' ' ' ARG . 1.4 mt-10 -167.76 167.16 13.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.673 ' CG2' ' NH2' ' A' ' 97' ' ' ARG . 16.6 m -132.56 146.57 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.671 HG23 ' HG1' ' A' ' 123' ' ' THR . 65.9 m -102.71 64.16 0.87 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.712 ' HA ' ' HA ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -58.91 151.06 22.6 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.82 ' CG ' HD22 ' A' ' 135' ' ' ASN . 12.5 t0 -124.38 97.15 5.19 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.546 ' N ' ' O ' ' A' ' 91' ' ' LEU . 1.6 m-30 -39.47 -78.84 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.834 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 0.5 OUTLIER 68.0 -131.93 0.11 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 1.184 ' HD1' ' N ' ' A' ' 138' ' ' LEU . 8.2 t-80 -172.12 176.51 3.45 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.749 -0.464 . . . . 0.0 109.749 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.742 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -70.56 -6.61 37.71 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 1.184 ' N ' ' HD1' ' A' ' 136' ' ' HIS . 56.9 mt -126.78 -12.02 6.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.562 ' HB2' ' H ' ' A' ' 136' ' ' HIS . . . -57.21 133.41 55.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.658 ' HA2' ' HA ' ' A' ' 86' ' ' ASN . . . 39.94 39.75 1.5 Allowed Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.839 ' HE2' ' CD2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -145.48 145.32 31.03 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.512 ' HB3' ' HA ' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -103.57 124.3 48.53 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.689 ' CD2' ' H ' ' A' ' 143' ' ' LEU . 1.6 pt? -107.61 143.64 35.79 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.6 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 2.1 t -60.69 164.9 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.707 ' CD2' ' CG1' ' A' ' 78' ' ' ILE . 9.9 m-85 -153.03 97.03 2.15 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.601 ' CG2' ' CG2' ' A' ' 75' ' ' THR . 30.7 m -94.71 70.28 3.49 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.661 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -69.0 172.07 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.413 ' H ' HG21 ' A' ' 147' ' ' ILE . 0.7 OUTLIER -175.1 103.38 0.09 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.835 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 3.7 mm -58.68 146.93 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.492 HG13 ' HA ' ' A' ' 13' ' ' VAL . 15.6 mt -131.4 -42.33 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.647 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 2.0 mt-10 -153.44 -163.89 1.78 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 61.4 t -143.87 140.19 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.455 ' HB ' ' HB3' ' A' ' 10' ' ' LYS . 32.9 t . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.924 ' H ' ' HA ' ' A' ' 69' ' ' GLU . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.652 ' CG1' ' N ' ' A' ' 6' ' ' ASP . 1.6 t -140.54 169.48 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.657 ' H ' HG21 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -151.51 172.82 15.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.52 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 31.6 mtpt -61.23 77.05 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.627 ' N ' ' HA3' ' A' ' 53' ' ' GLY . . . 145.21 18.05 0.17 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.657 HG21 ' H ' ' A' ' 6' ' ' ASP . 1.2 t -128.75 132.64 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.555 ' HB3' ' N ' ' A' ' 154' ' ' GLU . 2.8 ttmt -92.5 152.45 19.65 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.58 ' CG2' ' CG2' ' A' ' 5' ' ' VAL . 1.3 pt -153.25 126.86 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.458 ' HG3' ' HB3' ' A' ' 49' ' ' GLU . 4.6 mtmt -83.48 87.51 7.0 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.531 ' CG1' HD13 ' A' ' 149' ' ' ILE . 0.8 OUTLIER -112.47 154.21 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.572 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 1.1 m-20 -118.37 96.46 5.31 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.611 ' CB ' ' HA ' ' A' ' 147' ' ' ILE . 4.7 p90 -90.36 154.5 19.64 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.602 ' CG2' ' HB ' ' A' ' 27' ' ' THR . 1.2 mt -121.3 71.84 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -55.1 128.38 43.67 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.602 ' HE3' ' O ' ' A' ' 16' ' ' ILE . 5.8 mtmt -120.21 -170.51 1.98 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.686 ' C ' ' H ' ' A' ' 21' ' ' SER . 6.0 mt -111.48 164.93 12.43 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -55.19 1.69 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.686 ' H ' ' C ' ' A' ' 19' ' ' LEU . 83.0 p -114.01 -4.61 13.19 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.44 25.72 32.41 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.441 ' O ' ' HA ' ' A' ' 18' ' ' LYS . 93.2 m-20 -96.31 119.25 34.46 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.52 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 86.1 t -69.06 112.81 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.453 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 1.7 p90 -100.77 -31.59 11.11 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.453 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 9.8 t0 -143.24 133.95 25.17 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.602 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 1.4 t -153.68 136.48 15.32 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.572 ' HB2' ' HA ' ' A' ' 14' ' ' ASP . 2.8 m -83.84 -26.04 29.83 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.54 ' CD1' ' HB2' ' A' ' 14' ' ' ASP . 3.0 mt -82.73 106.86 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.459 ' CA ' ' HB2' ' A' ' 45' ' ' TYR . 2.0 tt0 -50.44 -37.11 36.46 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -49.36 -66.26 0.43 Allowed 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.497 ' H ' HG23 ' A' ' 32' ' ' VAL . 5.0 t -47.59 -39.44 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.603 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . . . -46.42 -46.55 18.74 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.542 ' HG2' ' CB ' ' A' ' 39' ' ' TYR . 3.3 mtmt -68.35 -32.01 71.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.58 -12.41 60.75 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.42 ' CB ' ' HB ' ' A' ' 24' ' ' VAL . . . -116.95 -7.08 11.42 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.33 47.47 35.86 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.523 HG13 ' HA ' ' A' ' 33' ' ' ALA . 1.2 pt -140.13 8.61 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.603 ' HA ' ' CB ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -45.59 -16.37 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.604 ' CB ' ' HD2' ' A' ' 41' ' ' PRO . . . 71.96 174.75 0.08 OUTLIER Pre-proline 0 N--CA 1.448 -0.536 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.742 ' HG2' ' H ' ' A' ' 42' ' ' ASP . 84.0 Cg_endo -72.38 -80.79 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 124.292 3.328 . . . . 0.0 109.571 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.742 ' H ' ' HG2' ' A' ' 41' ' ' PRO . 5.0 p-10 -108.64 -9.43 15.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.524 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -41.89 152.99 0.07 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -126.64 101.68 6.75 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.518 ' CE1' ' NE ' ' A' ' 43' ' ' ARG . 56.5 m-85 -77.92 102.99 7.58 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.656 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -111.58 177.87 1.11 Allowed Pre-proline 0 N--CA 1.449 -0.506 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.656 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 84.2 Cg_endo -72.34 125.95 11.21 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 124.295 3.33 . . . . 0.0 109.632 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.24 112.66 23.76 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.458 ' HB3' ' HG3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -85.32 97.35 9.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.676 ' HB2' HE21 ' A' ' 56' ' ' GLN . 40.3 p90 -99.56 160.63 14.15 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 53' ' ' GLY . 41.0 t -123.37 112.78 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.52 ' C ' ' HA ' ' A' ' 7' ' ' LYS . 32.4 t -54.78 -11.64 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.627 ' HA3' ' N ' ' A' ' 8' ' ' GLY . . . -114.91 46.55 1.15 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.429 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 4.2 mt-10 -151.9 -8.6 0.21 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.85 12.11 64.2 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.676 HE21 ' HB2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -44.41 -78.56 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.573 HD23 ' CE1' ' A' ' 61' ' ' PHE . 5.8 mp -84.87 165.7 17.48 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.69 ' CD1' ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -56.45 136.88 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.509 ' HA ' ' HB2' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -41.79 -60.06 1.48 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.766 ' CA ' ' HE3' ' A' ' 82' ' ' LYS . . . -30.25 -68.87 0.09 OUTLIER Glycine 0 C--N 1.335 0.522 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.602 ' CE2' HG23 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -57.19 -44.32 83.48 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 59' ' ' GLN . 4.1 mt-10 -55.34 -23.68 25.19 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.467 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 12.0 mt-10 -87.97 -39.06 15.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.494 ' CB ' ' HD2' ' A' ' 74' ' ' LYS . . . -62.22 -13.42 27.67 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.597 HG22 ' N ' ' A' ' 66' ' ' LEU . 4.5 m -106.96 -26.55 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.597 ' N ' HG22 ' A' ' 65' ' ' VAL . 2.2 mt -47.55 -31.53 4.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -118.12 49.66 1.24 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.589 ' CE ' ' CD1' ' A' ' 149' ' ' ILE . 2.5 mtp -138.02 118.49 13.83 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.924 ' HA ' ' H ' ' A' ' 4' ' ' MET . 2.3 mp0 -69.2 -173.44 0.53 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.599 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 3.1 t -80.92 106.27 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.665 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 118.01 -5.56 15.83 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.533 ' CB ' ' HG2' ' A' ' 68' ' ' MET . 0.6 OUTLIER -71.03 170.49 12.72 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.25 126.18 9.07 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.497 ' HB2' ' SD ' ' A' ' 68' ' ' MET . 19.1 ttmm -131.64 95.71 3.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.546 ' HG1' ' HA ' ' A' ' 146' ' ' THR . 91.6 m -88.76 77.81 7.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 3.6 t -111.77 164.97 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 2.5 ttpt -104.81 116.21 31.62 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.06 134.88 59.04 Favored Pre-proline 0 N--CA 1.449 -0.521 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.555 ' C ' ' H ' ' A' ' 81' ' ' GLU . 84.1 Cg_endo -72.44 138.77 30.48 Favored 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 124.28 3.32 . . . . 0.0 109.633 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.675 ' HB3' ' H ' ' A' ' 141' ' ' LYS . . . -49.59 -10.66 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.596 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 1.0 OUTLIER -80.23 -39.03 29.85 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.766 ' HE3' ' CA ' ' A' ' 60' ' ' GLY . 2.0 mtpp -86.78 -32.46 20.35 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.631 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . . . -72.46 -93.81 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.44 ' HD1' ' N ' ' A' ' 84' ' ' TYR . 1.7 m-85 -97.87 18.54 15.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.596 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 41.64 83.93 0.01 OUTLIER Glycine 0 C--N 1.336 0.537 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.655 ' ND2' ' N ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER 46.72 -164.84 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.517 ' HD2' ' CG ' ' A' ' 135' ' ' ASN . 0.9 OUTLIER -90.59 154.44 19.59 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.564 ' CB ' ' CD1' ' A' ' 91' ' ' LEU . 1.3 t30 -91.41 153.61 19.75 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -90.09 -25.77 20.58 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.74 1.58 16.78 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.816 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 19.9 mt -104.5 5.47 34.06 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.61 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 52.3 mt -82.96 107.94 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.795 HE22 ' HB2' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -100.13 165.56 11.45 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.63 ' CG ' ' HG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -147.0 99.26 3.15 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.517 HG22 ' CD1' ' A' ' 132' ' ' LEU . 20.7 pt -96.47 155.19 38.2 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.55 ' O ' ' N ' ' A' ' 99' ' ' ALA . 83.7 Cg_endo -72.34 137.68 28.76 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 124.311 3.341 . . . . 0.0 109.598 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.87 HH21 ' HD2' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -41.64 -34.81 0.65 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.606 ' HA ' ' CB ' ' A' ' 101' ' ' LYS . 6.3 t70 -63.17 -37.06 85.71 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -45.87 -16.39 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.534 ' CD1' ' HB3' ' A' ' 105' ' ' PHE . 2.1 m-85 -137.52 -24.09 1.07 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.606 ' CB ' ' HA ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -41.57 -41.07 2.05 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -90.99 43.77 1.16 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.574 ' C ' ' H ' ' A' ' 105' ' ' PHE . . . -174.94 127.89 0.29 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.497 ' C ' ' H ' ' A' ' 106' ' ' GLU . 2.7 p30 -49.01 -9.28 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.684 ' O ' ' C ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -47.04 -14.85 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.684 ' C ' ' O ' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -4.32 99.85 0.03 OUTLIER Pre-proline 0 N--CA 1.45 -0.452 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.87 ' HD2' HH21 ' A' ' 97' ' ' ARG . 84.1 Cg_endo -72.4 151.64 53.99 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 124.287 3.325 . . . . 0.0 109.602 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 110' ' ' GLY . 2.9 mt-10 -132.67 156.59 46.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.531 ' HB2' ' CG1' ' A' ' 125' ' ' VAL . 1.1 tt0 -65.81 66.98 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.8 10.02 0.08 OUTLIER Glycine 0 C--N 1.335 0.509 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.526 ' HB3' ' CD1' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -69.97 170.67 10.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.448 ' CG2' ' O ' ' A' ' 111' ' ' MET . 60.9 t -156.23 73.94 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.58 HD12 ' CE1' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -105.46 135.48 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.628 HD21 ' CD ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -105.04 161.55 14.12 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -108.51 5.23 24.99 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.44 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 0.9 OUTLIER 166.29 -11.09 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.72 -43.04 0.21 Allowed Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.434 ' HA ' ' HD2' ' A' ' 119' ' ' PRO . 3.6 mt -82.51 112.46 36.99 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.628 ' CD ' HD21 ' A' ' 114' ' ' LEU . 83.5 Cg_endo -72.31 165.59 32.21 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 124.322 3.348 . . . . 0.0 109.588 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.562 ' CB ' ' HB3' ' A' ' 132' ' ' LEU . . . -126.91 90.87 3.23 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 6.0 m -62.55 95.54 0.07 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.596 ' HA ' ' HA ' ' A' ' 132' ' ' LEU . 2.6 mp -68.98 89.98 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 30.7 p -80.1 -17.74 51.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.703 ' HB3' ' H ' ' A' ' 131' ' ' THR . 0.8 OUTLIER -119.99 130.85 54.94 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.531 ' CG1' ' HB2' ' A' ' 109' ' ' GLU . 7.9 p -124.26 52.92 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.716 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.2 OUTLIER -79.07 126.49 30.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.534 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.3 OUTLIER -52.12 0.06 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.716 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -111.7 -21.14 11.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.712 ' H ' ' HG1' ' A' ' 126' ' ' THR . 0.6 OUTLIER -178.84 167.02 1.69 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 19.7 m -132.62 141.16 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.703 ' H ' ' HB3' ' A' ' 124' ' ' GLU . 23.5 m -96.49 83.91 3.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.596 ' HA ' ' HA ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -78.93 97.08 5.89 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.844 ' CG ' HD22 ' A' ' 135' ' ' ASN . 25.5 t0 -71.17 97.52 1.53 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.795 ' HB2' HE22 ' A' ' 93' ' ' GLN . 2.1 m-30 -42.89 -56.91 3.05 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.844 HD22 ' CG ' ' A' ' 133' ' ' ASP . 13.1 m120 55.98 -118.04 1.18 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 1.092 ' ND1' ' H ' ' A' ' 138' ' ' LEU . 24.1 t-80 -175.19 174.16 2.46 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.603 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 4.8 tp10 -65.84 -43.9 87.12 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 1.092 ' H ' ' ND1' ' A' ' 136' ' ' HIS . 25.4 mt -97.46 10.79 38.82 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.584 ' HB1' ' N ' ' A' ' 136' ' ' HIS . . . -62.52 133.76 55.41 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 86' ' ' ASN . . . 41.73 36.56 1.73 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 110.234 -1.147 . . . . 0.0 110.234 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.812 ' HE2' ' CD2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -146.6 144.04 29.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.514 ' HB3' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -95.71 143.12 27.24 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.627 ' CD1' ' CZ ' ' A' ' 145' ' ' PHE . 0.4 OUTLIER -130.67 154.06 48.31 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.611 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 0.5 OUTLIER -73.71 168.46 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.627 ' CZ ' ' CD1' ' A' ' 143' ' ' LEU . 26.8 m-85 -154.97 90.24 1.28 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.546 ' HA ' ' HG1' ' A' ' 75' ' ' THR . 96.0 m -81.6 58.8 3.87 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.611 ' HA ' ' CB ' ' A' ' 15' ' ' TYR . 3.2 mt -53.31 175.09 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -177.59 96.64 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.665 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 1.4 mm -62.21 134.22 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.414 HG13 ' HA ' ' A' ' 13' ' ' VAL . 8.9 mt -122.12 -26.51 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.599 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 2.1 tt0 -162.74 -175.41 4.42 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.538 ' CG2' HG22 ' A' ' 11' ' ' ILE . 73.8 t -140.27 137.45 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.519 ' CG1' ' H ' ' A' ' 154' ' ' GLU . 2.3 t -142.28 -143.95 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.555 ' N ' ' HB3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.79 ' N ' ' HA ' ' A' ' 69' ' ' GLU . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.599 HG11 ' H ' ' A' ' 6' ' ' ASP . 9.2 t -119.67 167.71 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.767 -0.456 . . . . 0.0 109.767 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.599 ' H ' HG11 ' A' ' 5' ' ' VAL . 19.4 m-20 -146.78 164.75 31.78 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.519 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 17.3 ptmt -63.44 70.18 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.661 ' N ' ' HA3' ' A' ' 53' ' ' GLY . . . 155.19 16.63 0.05 OUTLIER Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.45 HG21 ' HB2' ' A' ' 6' ' ' ASP . 2.5 t -126.65 136.33 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.713 ' H ' ' HB2' ' A' ' 154' ' ' GLU . 2.7 tttt -88.27 158.27 18.52 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.6 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 1.8 pt -166.23 133.49 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.686 ' HE2' ' CG2' ' A' ' 153' ' ' VAL . 18.3 mtmt -87.18 85.12 7.18 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.614 ' CG1' ' HA ' ' A' ' 149' ' ' ILE . 0.9 OUTLIER -122.8 158.75 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.449 ' O ' ' CG2' ' A' ' 147' ' ' ILE . 10.9 m-20 -114.55 -160.18 0.72 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.605 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.5 p90 -179.44 155.87 0.7 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.594 ' CG2' ' HB ' ' A' ' 27' ' ' THR . 1.3 mt -127.39 73.21 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -54.68 134.02 47.01 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.568 ' HG2' ' N ' ' A' ' 24' ' ' VAL . 8.1 mttt -123.92 -162.75 1.08 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.68 ' C ' ' H ' ' A' ' 21' ' ' SER . 39.9 mt -118.28 165.65 13.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -55.02 0.97 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.68 ' H ' ' C ' ' A' ' 19' ' ' LEU . 53.5 p -114.85 1.38 14.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.9 28.53 50.12 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.221 -1.151 . . . . 0.0 110.221 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.451 ' C ' ' HG2' ' A' ' 18' ' ' LYS . 98.1 m-20 -99.85 121.97 42.11 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.568 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 76.0 t -66.18 134.71 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.52 ' CE1' ' HB2' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -128.07 -28.87 2.59 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.52 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 11.3 t0 -145.68 132.17 19.75 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.594 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -152.26 126.67 9.34 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.412 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 73.0 m -86.49 14.13 7.28 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.456 HG22 ' H ' ' A' ' 32' ' ' VAL . 68.9 mt -113.11 116.85 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -54.01 -41.6 68.15 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -52.54 -70.78 0.08 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.456 ' H ' HG22 ' A' ' 29' ' ' ILE . 67.5 t -48.48 -41.44 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.621 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . . . -50.05 -38.34 37.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.51 ' CG ' ' HB2' ' A' ' 39' ' ' TYR . 22.0 mtpt -79.54 -21.4 45.22 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -87.21 -10.88 51.43 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.4 -10.66 12.61 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.68 43.57 10.05 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.526 HG13 ' HA ' ' A' ' 33' ' ' ALA . 0.4 OUTLIER -141.85 16.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.621 ' HA ' ' CB ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -47.62 -13.25 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.523 ' H ' ' C ' ' A' ' 38' ' ' ILE . . . 71.27 151.55 0.14 Allowed Pre-proline 0 N--CA 1.448 -0.555 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.717 ' HG2' ' H ' ' A' ' 42' ' ' ASP . 82.0 Cg_endo -72.5 -82.6 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 124.343 3.362 . . . . 0.0 109.577 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.717 ' H ' ' HG2' ' A' ' 41' ' ' PRO . 4.9 p-10 -93.7 -14.12 26.7 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.581 ' HG3' ' N ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -76.29 145.71 39.42 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.581 ' N ' ' HG3' ' A' ' 43' ' ' ARG . 0.4 OUTLIER -117.76 -174.74 2.69 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.497 ' CZ ' ' O ' ' A' ' 27' ' ' THR . 2.2 m-85 -139.27 131.78 28.68 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.711 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -135.61 -180.0 1.22 Allowed Pre-proline 0 N--CA 1.448 -0.546 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.711 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 82.3 Cg_endo -72.45 127.83 12.96 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 124.293 3.329 . . . . 0.0 109.573 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.454 HD23 HD23 ' A' ' 57' ' ' LEU . 2.6 tp -82.68 94.71 7.63 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.517 ' HG2' ' HE2' ' A' ' 10' ' ' LYS . 43.1 tt0 -76.58 97.95 4.53 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.467 ' CG ' HD22 ' A' ' 57' ' ' LEU . 6.4 p90 -118.92 173.86 6.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.922 ' H ' ' NE2' ' A' ' 56' ' ' GLN . 57.8 t -130.7 109.69 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.519 ' C ' ' HA ' ' A' ' 7' ' ' LYS . 16.3 t -49.08 -10.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.661 ' HA3' ' N ' ' A' ' 8' ' ' GLY . . . -108.07 25.74 19.41 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 51' ' ' VAL . 4.0 mt-10 -123.25 -43.16 2.21 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.85 7.59 50.24 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.922 ' NE2' ' H ' ' A' ' 51' ' ' VAL . 1.2 mt-30 -46.0 -50.07 15.36 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.549 HD21 ' N ' ' A' ' 57' ' ' LEU . 1.2 mm? -96.48 175.24 6.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.775 ' H ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -75.99 150.88 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.481 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 10.6 mt-30 -40.11 -65.72 0.37 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.624 ' H ' ' HB3' ' A' ' 82' ' ' LYS . . . -33.46 -82.78 0.01 OUTLIER Glycine 0 C--N 1.335 0.506 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.594 ' CE2' HG12 ' A' ' 147' ' ' ILE . 2.3 t80 -40.88 -53.57 2.88 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.411 ' OE2' ' HA ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -45.28 -34.04 2.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 60' ' ' GLY . 5.9 mt-10 -80.73 -31.11 36.13 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . -64.43 -29.84 70.88 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.555 HG11 ' CE1' ' A' ' 61' ' ' PHE . 2.5 m -92.36 -21.46 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.513 ' N ' HG23 ' A' ' 65' ' ' VAL . 1.1 mt -50.14 -55.67 14.09 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -98.74 55.58 1.06 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.527 ' HE3' ' HA ' ' A' ' 73' ' ' GLU . 9.4 mtp -134.12 123.8 25.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.79 ' HA ' ' N ' ' A' ' 4' ' ' MET . 1.1 mp0 -77.92 167.49 21.41 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.592 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 0.2 OUTLIER -68.62 96.63 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.867 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 118.87 17.76 4.95 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -95.99 -172.08 2.49 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.527 ' HA ' ' HE3' ' A' ' 68' ' ' MET . 2.2 tt0 -162.54 123.11 2.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.493 ' HB2' ' SD ' ' A' ' 68' ' ' MET . 5.2 ttmt -125.82 99.69 6.07 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.487 ' HG1' ' HG1' ' A' ' 146' ' ' THR . 84.8 m -93.82 76.32 4.23 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.45 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 3.9 t -106.04 156.83 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.629 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 5.4 ttpm? -95.1 113.12 24.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.569 ' CG2' ' CB ' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -79.19 130.83 67.95 Favored Pre-proline 0 N--CA 1.45 -0.438 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.52 ' CG ' ' HD3' ' A' ' 82' ' ' LYS . 84.0 Cg_endo -72.35 144.54 41.33 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 124.33 3.354 . . . . 0.0 109.595 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.643 ' O ' ' N ' ' A' ' 85' ' ' GLY . . . -50.99 -11.68 0.1 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.55 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 15.7 tt0 -86.1 -34.65 20.59 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.624 ' HB3' ' H ' ' A' ' 60' ' ' GLY . 1.0 OUTLIER -105.67 41.45 1.38 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.729 ' HA ' ' CB ' ' A' ' 58' ' ' ILE . . . -159.57 -34.27 0.06 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.681 ' CD2' ' CB ' ' A' ' 138' ' ' LEU . 74.2 m-85 -158.89 8.6 0.12 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.643 ' N ' ' O ' ' A' ' 80' ' ' ALA . . . 72.49 143.5 0.49 Allowed Glycine 0 C--N 1.336 0.557 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.884 ' H ' ' ND2' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -47.82 167.38 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.534 ' HG2' ' HA3' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -41.4 139.96 0.97 Allowed 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.564 ' CB ' ' CD1' ' A' ' 91' ' ' LEU . 1.9 t30 -93.13 153.23 18.78 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.549 ' C ' ' H ' ' A' ' 91' ' ' LEU . 48.7 mt-10 -86.49 -39.18 16.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.48 11.86 0.22 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.655 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 54.5 mt -118.57 5.73 11.67 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.598 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 51.1 mt -84.75 114.05 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.765 HE22 ' HB2' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -106.22 166.3 10.62 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.894 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.762 ' HG3' ' HG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -146.39 96.81 2.83 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.588 HD12 ' CD1' ' A' ' 100' ' ' PHE . 3.7 pt -96.06 157.69 35.34 Favored Pre-proline 0 N--CA 1.449 -0.505 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.555 ' O ' ' N ' ' A' ' 99' ' ' ALA . 83.4 Cg_endo -72.45 139.96 32.48 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 124.296 3.331 . . . . 0.0 109.576 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.832 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -43.81 -20.65 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.612 ' C ' ' H ' ' A' ' 100' ' ' PHE . 3.3 m-20 -78.17 -35.46 48.76 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.555 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -50.56 -6.99 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.612 ' H ' ' C ' ' A' ' 98' ' ' ASP . 2.3 m-85 -131.46 -26.54 2.05 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.486 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 0.9 OUTLIER -63.39 -15.15 56.7 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.29 6.14 49.59 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.512 ' HB2' ' CZ ' ' A' ' 105' ' ' PHE . . . -100.61 -137.51 0.32 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.72 18.15 1.47 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.512 ' CZ ' ' HB2' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -133.13 -144.07 0.23 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.492 ' HG2' ' HD2' ' A' ' 107' ' ' PRO . 0.4 OUTLIER -171.21 126.65 0.63 Allowed Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.832 ' CG ' HH21 ' A' ' 97' ' ' ARG . 82.3 Cg_endo -72.33 131.83 18.34 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 124.321 3.348 . . . . 0.0 109.579 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.502 ' HA ' HG23 ' A' ' 125' ' ' VAL . 2.1 mm-40 -118.83 157.62 27.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -67.19 66.1 0.07 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.89 12.25 0.07 OUTLIER Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.536 ' CB ' ' CD1' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -68.55 171.34 7.67 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' A' ' 111' ' ' MET . 96.4 t -155.57 65.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.421 HG23 ' H ' ' A' ' 113' ' ' ILE . 0.0 OUTLIER -101.34 136.76 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.641 HD21 ' HD3' ' A' ' 119' ' ' PRO . 0.1 OUTLIER -104.58 172.81 6.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -119.71 -1.62 10.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 172.46 3.17 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 152.65 -32.34 0.83 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 18.2 mm -94.4 116.03 65.94 Favored Pre-proline 0 N--CA 1.449 -0.485 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.641 ' HD3' HD21 ' A' ' 114' ' ' LEU . 81.9 Cg_endo -72.42 171.8 16.3 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 124.333 3.356 . . . . 0.0 109.582 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.565 ' CB ' ' HB3' ' A' ' 132' ' ' LEU . . . -132.13 75.5 1.64 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 3.7 m -49.13 97.83 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.621 ' HA ' ' HA ' ' A' ' 132' ' ' LEU . 1.8 mp -71.14 95.6 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.432 ' N ' ' O ' ' A' ' 131' ' ' THR . 0.9 OUTLIER -82.06 -18.94 41.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.714 ' HB3' ' H ' ' A' ' 131' ' ' THR . 1.7 tp10 -121.9 130.88 53.7 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.502 HG23 ' HA ' ' A' ' 108' ' ' GLU . 15.0 p -122.02 50.89 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.686 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -78.62 126.03 30.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.527 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.9 OUTLIER -53.17 0.18 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.686 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -111.28 -20.21 12.38 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -177.86 164.64 1.94 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 17.4 m -129.57 135.95 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.762 ' HG1' ' HG3' ' A' ' 94' ' ' LYS . 24.2 m -95.45 87.24 4.71 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.641 ' H ' HD11 ' A' ' 132' ' ' LEU . 0.2 OUTLIER -85.68 122.2 29.44 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.598 ' HA ' ' HA ' ' A' ' 92' ' ' ILE . 15.4 t0 -90.17 94.28 9.7 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.765 ' HB2' HE22 ' A' ' 93' ' ' GLN . 2.4 m-85 -38.33 -42.29 0.7 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.655 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 0.7 OUTLIER 42.04 -112.12 0.18 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 1.019 ' ND1' ' H ' ' A' ' 138' ' ' LEU . 15.8 t-80 -177.76 -170.4 0.26 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.95 ' H ' ' CG ' ' A' ' 136' ' ' HIS . 1.5 tp10 -73.55 -42.03 62.2 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 1.019 ' H ' ' ND1' ' A' ' 136' ' ' HIS . 2.6 mm? -98.97 -15.64 19.03 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.625 ' HB2' ' N ' ' A' ' 136' ' ' HIS . . . -58.7 115.69 3.23 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.534 ' HA3' ' HG2' ' A' ' 87' ' ' ARG . . . 71.17 15.57 74.63 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.709 ' HE2' ' CD1' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -134.7 131.94 38.26 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.551 ' C ' ' HD3' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -100.47 130.02 46.5 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.633 ' HB3' ' HE2' ' A' ' 141' ' ' LYS . 1.4 pt? -115.98 144.94 43.39 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.629 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 0.2 OUTLIER -68.02 173.96 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.545 ' CE2' ' HG ' ' A' ' 143' ' ' LEU . 25.5 m-85 -157.44 90.28 1.09 Allowed 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.513 ' HB ' ' HB ' ' A' ' 16' ' ' ILE . 85.4 m -81.88 64.35 6.53 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.617 HG21 ' H ' ' A' ' 148' ' ' LYS . 1.9 mt -60.3 178.51 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.617 ' H ' HG21 ' A' ' 147' ' ' ILE . 13.7 tttp -178.03 110.59 0.06 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.867 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 4.4 mm -70.84 139.0 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 47' ' ' PRO . 3.6 mt -118.39 -41.15 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.592 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 2.4 tt0 -158.86 -165.69 1.69 Allowed 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.6 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 97.0 t -136.95 151.7 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.686 ' CG2' ' HE2' ' A' ' 12' ' ' LYS . 1.8 t -133.5 -133.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.713 ' HB2' ' H ' ' A' ' 10' ' ' LYS . 11.4 tp10 . . . . . 0 N--CA 1.45 -0.461 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.699 ' N ' ' HA ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.644 ' CG1' ' N ' ' A' ' 6' ' ' ASP . 1.5 t -164.11 169.67 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.644 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 0.5 OUTLIER -138.04 175.83 9.23 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.537 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 16.1 ptmt -67.35 65.65 0.07 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 6' ' ' ASP . . . 165.35 15.32 0.02 OUTLIER Glycine 0 C--N 1.336 0.557 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.518 ' CG2' ' H ' ' A' ' 6' ' ' ASP . 0.2 OUTLIER -129.14 132.64 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.582 ' HE2' ' HB ' ' A' ' 153' ' ' VAL . 4.2 ttpm? -87.55 165.03 15.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.578 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 1.1 pt -169.19 134.42 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.701 ' HZ3' ' HB3' ' A' ' 151' ' ' GLU . 7.5 mtmt -94.3 91.98 6.98 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.573 ' CG1' ' HA ' ' A' ' 149' ' ' ILE . 0.8 OUTLIER -116.02 153.95 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.522 ' HB3' ' CD1' ' A' ' 29' ' ' ILE . 3.6 m-20 -111.41 106.12 14.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.608 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.9 p90 -101.99 159.46 15.35 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.599 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 3.5 mt -133.55 73.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -56.9 129.17 48.86 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.599 ' HE3' ' O ' ' A' ' 16' ' ' ILE . 5.9 mttt -116.98 -164.03 0.95 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.673 ' C ' ' H ' ' A' ' 21' ' ' SER . 85.3 mt -118.02 165.87 13.21 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -54.66 0.07 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.673 ' H ' ' C ' ' A' ' 19' ' ' LEU . 84.5 p -112.05 -3.88 14.63 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.62 25.11 43.61 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.457 ' C ' ' HG2' ' A' ' 18' ' ' LYS . 1.6 m-20 -96.6 122.13 39.18 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.514 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 55.8 t -68.49 113.66 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.589 ' CE1' ' HB2' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -104.41 -31.56 9.45 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.589 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 14.4 t0 -140.07 138.94 35.76 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.577 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -158.24 161.24 37.74 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.695 ' HG ' ' HB2' ' A' ' 48' ' ' LEU . 12.9 m -115.73 -11.92 11.58 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.747 HG22 ' H ' ' A' ' 32' ' ' VAL . 3.0 mt -92.77 116.23 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.424 ' N ' ' HB3' ' A' ' 45' ' ' TYR . 2.5 tt0 -51.51 -38.98 56.69 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -48.72 -67.86 0.23 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.747 ' H ' HG22 ' A' ' 29' ' ' ILE . 34.7 t -53.93 -38.32 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.619 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . . . -53.16 -43.05 66.74 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.543 ' HG2' ' CB ' ' A' ' 39' ' ' TYR . 3.9 mtmt -68.13 -30.91 70.16 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -80.99 -20.08 42.6 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.425 ' HB3' ' HB ' ' A' ' 24' ' ' VAL . . . -103.41 -11.42 17.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.01 45.75 19.22 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.502 HG13 ' HA ' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -143.12 16.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.619 ' HA ' ' CB ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -57.97 -14.6 6.69 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.585 ' CB ' ' HD2' ' A' ' 41' ' ' PRO . . . 72.13 174.53 0.08 OUTLIER Pre-proline 0 N--CA 1.449 -0.477 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.585 ' HD2' ' CB ' ' A' ' 40' ' ' ALA . 82.9 Cg_endo -72.36 -90.45 0.01 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 124.341 3.361 . . . . 0.0 109.639 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.577 ' H ' ' HG2' ' A' ' 41' ' ' PRO . 11.0 p-10 -100.15 -8.56 23.5 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.512 ' CB ' ' HB1' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -41.52 153.63 0.05 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.436 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -115.92 100.12 7.76 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.462 ' CE2' ' HB1' ' A' ' 33' ' ' ALA . 1.9 m-85 -67.48 76.19 0.17 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.655 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -82.58 177.48 3.0 Favored Pre-proline 0 N--CA 1.449 -0.502 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.655 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 84.4 Cg_endo -72.43 128.81 14.03 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 124.292 3.328 . . . . 0.0 109.598 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.695 ' HB2' ' HG ' ' A' ' 28' ' ' SER . 22.0 tp -69.41 104.63 2.33 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.514 ' CD ' ' CE ' ' A' ' 10' ' ' LYS . 13.3 tt0 -91.15 100.87 13.63 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.753 ' HA ' HE22 ' A' ' 56' ' ' GLN . 32.1 p90 -119.78 170.61 9.07 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.835 HG11 ' H ' ' A' ' 53' ' ' GLY . 69.5 t -131.31 113.07 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.537 ' C ' ' HA ' ' A' ' 7' ' ' LYS . 4.6 t -50.53 -8.7 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.835 ' H ' HG11 ' A' ' 51' ' ' VAL . . . -117.33 35.35 4.16 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.447 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 2.7 mm-40 -124.27 -31.97 3.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.11 5.65 59.4 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.753 HE22 ' HA ' ' A' ' 50' ' ' PHE . 7.9 mt-30 -57.95 -97.36 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.587 ' HB3' ' CD1' ' A' ' 61' ' ' PHE . 1.5 mm? -54.32 157.8 2.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.801 ' CD1' ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -60.96 149.18 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -44.6 -55.24 5.35 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 63' ' ' GLU . . . -39.65 -79.79 0.04 OUTLIER Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.587 ' CD1' ' HB3' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -43.45 -44.69 5.98 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.41 ' CD ' ' HA ' ' A' ' 52' ' ' VAL . 6.5 mt-10 -55.85 -32.81 63.95 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.523 ' HA ' ' HB2' ' A' ' 66' ' ' LEU . 7.3 mt-10 -77.86 -29.77 50.57 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.36 -42.37 98.88 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.414 HG21 ' CZ ' ' A' ' 50' ' ' PHE . 4.6 m -84.06 -15.29 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.597 ' CD2' ' HA ' ' A' ' 6' ' ' ASP . 3.8 mt -63.05 -48.4 78.87 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -102.85 54.83 0.77 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.593 ' C ' ' N ' ' A' ' 4' ' ' MET . 6.1 mtp -131.57 -144.8 0.25 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.699 ' HA ' ' N ' ' A' ' 4' ' ' MET . 0.0 OUTLIER -155.96 -178.56 7.39 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.605 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 0.5 OUTLIER -90.09 80.12 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.673 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 138.4 11.07 0.9 Allowed Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.47 ' CG ' ' HB2' ' A' ' 69' ' ' GLU . 2.8 m-20 -95.48 -178.39 4.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -153.72 130.47 10.83 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.478 ' HB2' ' SD ' ' A' ' 68' ' ' MET . 9.6 ttmt -131.69 96.68 4.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.818 ' HG1' ' HA ' ' A' ' 146' ' ' THR . 80.3 m -95.5 78.77 3.39 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.73 HG12 ' H ' ' A' ' 77' ' ' LYS . 4.0 t -111.38 171.25 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.73 ' H ' HG12 ' A' ' 76' ' ' VAL . 1.8 ttpt -103.35 114.79 29.36 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.554 HD11 ' CD2' ' A' ' 145' ' ' PHE . 0.3 OUTLIER -79.4 129.33 72.37 Favored Pre-proline 0 N--CA 1.448 -0.554 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.513 ' C ' ' H ' ' A' ' 81' ' ' GLU . 83.0 Cg_endo -72.29 141.9 36.44 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 124.346 3.364 . . . . 0.0 109.582 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' A' ' 85' ' ' GLY . . . -54.36 -8.39 0.21 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.622 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 8.3 pt-20 -81.38 -37.4 28.25 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.452 ' N ' ' HG3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -87.52 -30.0 20.91 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.64 ' HA ' ' CB ' ' A' ' 58' ' ' ILE . . . -71.52 -94.74 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.593 ' CD1' ' N ' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -106.71 21.64 17.17 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.622 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 46.58 87.67 0.01 OUTLIER Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.645 ' ND2' ' N ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER 39.9 -144.5 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.559 ' HD2' ' HA3' ' A' ' 140' ' ' GLY . 0.1 OUTLIER -91.3 145.1 24.93 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.558 ' CB ' ' CD1' ' A' ' 91' ' ' LEU . 7.0 t30 -83.79 132.47 34.82 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -66.63 -25.97 66.84 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.62 8.17 15.13 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.843 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 34.5 mt -110.19 5.23 21.72 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.617 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 24.6 mt -84.88 108.28 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.709 HE22 ' HB2' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -101.84 152.14 21.24 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.485 ' HG3' ' HA ' ' A' ' 131' ' ' THR . 0.0 OUTLIER -135.81 91.4 2.7 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.551 HD13 ' CD1' ' A' ' 100' ' ' PHE . 3.3 pt -86.23 159.04 54.48 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.571 ' HA ' ' HG3' ' A' ' 129' ' ' GLU . 80.7 Cg_endo -72.46 136.18 25.7 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 124.35 3.367 . . . . 0.0 109.551 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.839 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -42.24 -29.53 0.25 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.547 ' HA ' ' CB ' ' A' ' 101' ' ' LYS . 8.4 t70 -70.29 -36.08 74.14 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -51.01 -12.82 0.12 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.559 ' C ' ' H ' ' A' ' 102' ' ' GLU . 4.5 m-85 -133.63 -21.03 2.0 Allowed 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.547 ' CB ' ' HA ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -49.84 -9.9 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.559 ' H ' ' C ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -143.32 40.45 1.46 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.603 ' HB2' ' CE1' ' A' ' 105' ' ' PHE . . . -103.25 21.52 15.73 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 71.16 -14.84 0.44 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.603 ' CE1' ' HB2' ' A' ' 103' ' ' ALA . 0.9 OUTLIER -135.87 -148.76 0.31 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.514 ' HG2' ' HD2' ' A' ' 107' ' ' PRO . 1.4 tt0 -160.78 138.04 6.77 Favored Pre-proline 0 N--CA 1.448 -0.552 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.839 ' CG ' HH21 ' A' ' 97' ' ' ARG . 82.9 Cg_endo -72.41 141.02 34.38 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 124.311 3.341 . . . . 0.0 109.61 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.512 ' HA ' HG21 ' A' ' 125' ' ' VAL . 20.9 mt-10 -130.06 153.57 48.32 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -63.64 70.06 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.21 5.23 0.12 Allowed Glycine 0 C--N 1.336 0.571 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.456 ' CB ' HD12 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -65.34 165.89 11.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 111' ' ' MET . 52.4 t -156.27 70.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.66 134.93 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.642 HD22 ' CD ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -104.47 170.57 7.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.415 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -116.07 5.23 13.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.415 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 0.5 OUTLIER 167.01 -10.88 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.413 ' O ' ' HD3' ' A' ' 119' ' ' PRO . . . 169.81 -45.15 0.21 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.433 ' HA ' ' HD2' ' A' ' 119' ' ' PRO . 4.3 mt -80.46 110.97 18.93 Favored Pre-proline 0 N--CA 1.45 -0.465 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.642 ' CD ' HD22 ' A' ' 114' ' ' LEU . 82.7 Cg_endo -72.37 163.94 37.12 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 124.255 3.303 . . . . 0.0 109.628 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.536 ' CB ' ' HB3' ' A' ' 132' ' ' LEU . . . -124.73 94.3 4.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 21.3 m -66.4 97.02 0.39 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.581 ' CG1' ' CD2' ' A' ' 132' ' ' LEU . 5.9 mt -71.75 84.41 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.54 ' CG2' HG22 ' A' ' 131' ' ' THR . 0.0 OUTLIER -74.82 -16.94 60.68 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.804 ' HB3' ' H ' ' A' ' 131' ' ' THR . 0.3 OUTLIER -119.23 127.95 53.74 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.512 HG21 ' HA ' ' A' ' 108' ' ' GLU . 8.1 p -122.56 49.15 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.727 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -78.05 125.48 29.41 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.665 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.4 OUTLIER -52.82 1.7 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.727 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.1 OUTLIER -112.95 -20.94 11.37 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.571 ' HG3' ' HA ' ' A' ' 96' ' ' PRO . 2.3 mt-10 -174.75 165.67 3.68 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.444 ' HB ' HG21 ' A' ' 122' ' ' ILE . 16.7 m -135.23 130.76 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.804 ' H ' ' HB3' ' A' ' 124' ' ' GLU . 66.1 m -93.79 94.89 8.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.662 ' H ' HD11 ' A' ' 132' ' ' LEU . 0.3 OUTLIER -92.35 103.37 15.82 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.798 ' CG ' HD22 ' A' ' 135' ' ' ASN . 18.9 t0 -74.8 96.87 3.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.709 ' HB2' HE22 ' A' ' 93' ' ' GLN . 2.0 m-30 -41.32 -82.59 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.843 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 0.3 OUTLIER 77.74 -127.67 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.997 ' HD1' ' N ' ' A' ' 138' ' ' LEU . 14.1 t-80 -171.49 178.34 3.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.678 ' N ' ' CG ' ' A' ' 136' ' ' HIS . 10.2 tp10 -67.88 -16.47 64.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.997 ' N ' ' HD1' ' A' ' 136' ' ' HIS . 16.2 mt -118.14 -16.83 9.72 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.661 ' HB2' ' H ' ' A' ' 136' ' ' HIS . . . -57.57 110.17 0.83 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 86' ' ' ASN . . . 79.97 31.99 37.59 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.85 ' HE2' ' CD2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -155.26 146.15 22.44 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.535 ' C ' ' HD2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -95.31 135.44 36.91 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.585 ' HB3' ' HE2' ' A' ' 141' ' ' LYS . 0.4 OUTLIER -124.15 149.16 46.59 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.6 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 1.7 t -73.56 166.87 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.557 ' CZ ' HD11 ' A' ' 143' ' ' LEU . 25.3 m-85 -151.21 91.64 1.71 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.818 ' HA ' ' HG1' ' A' ' 75' ' ' THR . 83.9 m -84.48 61.92 6.94 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.608 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.7 mt -56.21 -179.47 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.468 ' C ' ' HB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -178.33 90.61 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.673 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 1.1 mm -60.51 130.7 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.519 ' CD1' ' HB3' ' A' ' 47' ' ' PRO . 4.8 mt -113.64 -45.37 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.701 ' HB3' ' HZ3' ' A' ' 12' ' ' LYS . 0.2 OUTLIER -153.98 -165.64 2.16 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.578 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 88.7 t -138.65 153.3 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.683 ' CG2' ' HE2' ' A' ' 12' ' ' LYS . 1.9 t -129.99 -133.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.571 ' HB2' ' H ' ' A' ' 10' ' ' LYS . 2.7 tm-20 . . . . . 0 N--CA 1.45 -0.441 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.508 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.574 HG12 ' H ' ' A' ' 6' ' ' ASP . 0.8 OUTLIER -111.9 179.31 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.574 ' H ' HG12 ' A' ' 5' ' ' VAL . 8.5 m-20 -154.87 165.77 35.61 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.6 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 4.9 ptpt -69.94 63.68 0.21 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.05 3.19 0.03 OUTLIER Glycine 0 C--N 1.335 0.508 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.425 ' HB ' HG12 ' A' ' 5' ' ' VAL . 2.5 t -119.98 140.3 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.661 ' H ' ' HB3' ' A' ' 154' ' ' GLU . 10.8 tttt -96.68 149.38 21.86 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.678 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 10.8 pt -158.05 140.49 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.488 ' CE ' HG21 ' A' ' 153' ' ' VAL . 7.0 ttmt -94.11 99.07 11.42 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.574 ' CG1' ' HA ' ' A' ' 149' ' ' ILE . 1.1 m -124.13 152.37 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 147' ' ' ILE . 16.4 m-20 -95.07 -167.35 1.61 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.767 ' HH ' ' CG ' ' A' ' 26' ' ' ASP . 0.3 OUTLIER 177.52 148.75 0.15 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.538 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 4.5 mt -132.25 74.27 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -58.21 134.14 52.49 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.58 ' HG2' ' N ' ' A' ' 24' ' ' VAL . 7.8 mtmt -118.98 -152.99 0.52 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.635 ' C ' ' H ' ' A' ' 21' ' ' SER . 1.5 mt -128.49 166.08 19.47 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -52.67 -3.71 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.635 ' H ' ' C ' ' A' ' 19' ' ' LEU . 52.0 p -113.89 14.25 18.51 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 19' ' ' LEU . . . 65.33 32.03 82.35 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.446 ' O ' ' HA ' ' A' ' 18' ' ' LYS . 2.3 m-20 -101.6 123.98 46.5 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.58 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 76.7 t -68.98 130.22 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.573 ' CE1' ' HB2' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -124.59 -29.55 3.45 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.767 ' CG ' ' HH ' ' A' ' 15' ' ' TYR . 9.3 t0 -145.08 135.78 24.47 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.586 ' HG1' ' H ' ' A' ' 29' ' ' ILE . 1.7 t -153.47 144.87 23.16 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 2.5 m -96.96 -4.95 38.99 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.586 ' H ' ' HG1' ' A' ' 27' ' ' THR . 20.6 mt -100.87 103.62 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -46.72 -38.72 10.33 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -50.03 -66.12 0.45 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.472 ' CG1' HD12 ' A' ' 16' ' ' ILE . 3.0 t -47.86 -42.41 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.579 ' HA ' HG13 ' A' ' 38' ' ' ILE . . . -49.17 -41.8 37.78 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.584 ' HG2' ' CG ' ' A' ' 39' ' ' TYR . 8.8 mtpt -74.31 -24.86 59.28 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -86.84 -23.76 25.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . -93.83 -27.48 16.41 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.3 16.17 19.2 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.579 HG13 ' HA ' ' A' ' 33' ' ' ALA . 3.5 pt -118.17 31.01 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.584 ' CG ' ' HG2' ' A' ' 34' ' ' LYS . 13.0 t80 -64.69 68.84 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.648 ' HB1' ' HH ' ' A' ' 45' ' ' TYR . . . -48.36 136.16 12.25 Favored Pre-proline 0 N--CA 1.45 -0.475 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.493 ' HG2' ' H ' ' A' ' 42' ' ' ASP . 80.9 Cg_endo -72.4 -94.99 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 124.374 3.383 . . . . 0.0 109.564 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.497 ' CG ' ' N ' ' A' ' 43' ' ' ARG . 0.3 OUTLIER -42.7 -50.19 5.54 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.521 ' HB2' ' CB ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -41.27 149.94 0.1 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -126.71 98.44 5.38 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.648 ' HH ' ' HB1' ' A' ' 40' ' ' ALA . 24.8 m-85 -82.26 99.95 9.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.696 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -123.85 179.83 0.98 Allowed Pre-proline 0 N--CA 1.449 -0.495 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.696 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 80.7 Cg_endo -72.44 129.84 15.34 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 124.273 3.316 . . . . 0.0 109.556 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.444 ' CD1' ' N ' ' A' ' 49' ' ' GLU . 5.3 tp -97.26 135.14 39.61 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.524 ' HB3' ' CG2' ' A' ' 153' ' ' VAL . 0.3 OUTLIER -105.08 107.77 18.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.911 ' HA ' HE22 ' A' ' 56' ' ' GLN . 8.1 p90 -125.49 162.21 25.38 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.721 ' C ' ' H ' ' A' ' 53' ' ' GLY . 41.1 t -105.79 123.52 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.6 ' C ' ' HA ' ' A' ' 7' ' ' LYS . 8.3 t -58.53 8.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.721 ' H ' ' C ' ' A' ' 51' ' ' VAL . . . -147.31 48.74 0.64 Allowed Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.51 ' OE1' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -126.61 -32.76 2.6 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.58 -12.57 54.08 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.911 HE22 ' HA ' ' A' ' 50' ' ' PHE . 27.8 mt-30 -42.06 -78.53 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.66 HD23 ' H ' ' A' ' 57' ' ' LEU . 1.2 mm? -71.5 164.92 24.92 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.673 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -65.09 157.71 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.519 HE21 ' HA ' ' A' ' 82' ' ' LYS . 22.1 mt-30 -49.84 -59.29 3.99 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.585 ' H ' ' HB3' ' A' ' 82' ' ' LYS . . . -39.05 -78.31 0.06 OUTLIER Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.661 ' CZ ' ' CZ ' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -41.08 -55.18 2.65 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.422 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 3.0 mt-10 -45.94 -37.05 6.0 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 60' ' ' GLY . 4.8 mt-10 -77.63 -25.45 49.73 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.667 ' HA ' ' HE2' ' A' ' 74' ' ' LYS . . . -67.32 -40.04 85.94 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.556 HG13 ' CE1' ' A' ' 61' ' ' PHE . 2.1 m -73.5 -32.77 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.532 ' HG ' ' CG1' ' A' ' 52' ' ' VAL . 2.5 mt -41.31 -51.66 3.59 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.36 52.29 0.84 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.558 ' SD ' ' CA ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -140.62 114.05 8.67 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -77.58 168.89 19.24 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.664 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 1.5 t -61.93 113.04 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.858 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 100.52 9.0 48.22 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.95 -176.54 5.22 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.558 ' CA ' ' SD ' ' A' ' 68' ' ' MET . 0.6 OUTLIER -157.44 141.81 16.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.667 ' HE2' ' HA ' ' A' ' 64' ' ' ALA . 12.1 tttp -138.95 95.8 3.01 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.609 ' CG2' ' HA ' ' A' ' 146' ' ' THR . 0.0 OUTLIER -92.4 93.23 8.49 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.618 HG12 ' H ' ' A' ' 77' ' ' LYS . 16.2 t -131.63 164.64 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.618 ' H ' HG12 ' A' ' 76' ' ' VAL . 5.6 ttpt -99.48 114.8 27.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.589 ' HB ' ' CE2' ' A' ' 145' ' ' PHE . 0.3 OUTLIER -78.68 129.95 72.34 Favored Pre-proline 0 N--CA 1.449 -0.492 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.579 ' HG3' ' HZ3' ' A' ' 82' ' ' LYS . 84.8 Cg_endo -72.39 138.22 29.61 Favored 'Trans proline' 0 N--CA 1.447 -1.218 0 C-N-CA 124.28 3.32 . . . . 0.0 109.664 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.534 ' CB ' ' N ' ' A' ' 141' ' ' LYS . . . -51.56 -10.62 0.1 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.593 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 20.6 pt-20 -79.0 -38.2 37.27 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.585 ' HB3' ' H ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -84.88 -33.1 22.87 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.656 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . . . -74.12 -100.07 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.598 ' CE1' ' HB2' ' A' ' 138' ' ' LEU . 38.9 m-85 -90.22 17.81 6.68 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.593 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 42.35 85.71 0.01 OUTLIER Glycine 0 C--N 1.335 0.508 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.658 ' ND2' ' N ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER 47.26 -164.85 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.587 ' HD2' ' HA3' ' A' ' 140' ' ' GLY . 0.4 OUTLIER -81.17 146.42 30.52 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.518 ' CB ' HD12 ' A' ' 91' ' ' LEU . 9.7 t30 -89.2 149.98 22.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -85.35 -35.02 21.67 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.3 -9.08 37.42 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.833 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 75.1 mt -94.03 6.04 49.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.617 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 69.1 mt -85.56 113.75 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.75 HE22 ' HB2' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -106.99 150.3 26.63 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.503 ' HG3' ' HA ' ' A' ' 131' ' ' THR . 0.0 OUTLIER -130.17 97.08 4.34 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.57 HD11 ' CD1' ' A' ' 100' ' ' PHE . 18.5 pt -93.11 156.7 40.03 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.534 ' O ' ' N ' ' A' ' 99' ' ' ALA . 82.0 Cg_endo -72.43 140.37 33.21 Favored 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 124.33 3.354 . . . . 0.0 109.609 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.81 HH21 ' CD ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -42.72 -32.93 0.65 Allowed 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.474 ' HA ' ' CB ' ' A' ' 101' ' ' LYS . 6.7 t70 -66.81 -36.71 83.0 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -43.92 -21.61 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.57 ' CD1' HD11 ' A' ' 95' ' ' ILE . 3.3 m-85 -122.94 -28.82 4.03 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.474 ' CB ' ' HA ' ' A' ' 98' ' ' ASP . 0.8 OUTLIER -56.45 -24.15 43.57 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -104.18 1.91 31.2 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.477 ' HB1' ' HA ' ' A' ' 100' ' ' PHE . . . -102.05 19.69 18.02 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 41.63 36.78 0.62 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.3 -150.2 0.44 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.425 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -179.96 102.2 0.18 Allowed Pre-proline 0 N--CA 1.45 -0.475 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.81 ' CD ' HH21 ' A' ' 97' ' ' ARG . 83.6 Cg_endo -72.32 138.52 30.36 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 124.313 3.342 . . . . 0.0 109.592 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 110' ' ' GLY . 16.8 mt-10 -128.9 156.53 43.56 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.71 68.97 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 151.8 10.23 0.09 OUTLIER Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.523 ' HB3' ' CD1' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -68.17 167.7 13.66 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.457 ' CG2' ' O ' ' A' ' 111' ' ' MET . 62.0 t -156.41 82.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.35 137.13 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.637 ' CD2' ' HD3' ' A' ' 119' ' ' PRO . 0.2 OUTLIER -101.36 156.72 17.28 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -109.65 0.49 19.04 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 176.47 -12.37 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 114' ' ' LEU . . . 166.93 -34.42 0.22 Allowed Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 3.3 mt -94.04 122.41 61.89 Favored Pre-proline 0 N--CA 1.449 -0.483 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.637 ' HD3' ' CD2' ' A' ' 114' ' ' LEU . 84.9 Cg_endo -72.31 170.22 19.71 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 124.311 3.341 . . . . 0.0 109.662 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.577 ' CB ' ' HB3' ' A' ' 132' ' ' LEU . . . -128.58 73.61 1.51 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 28.8 m -50.2 95.36 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.646 ' HA ' ' HA ' ' A' ' 132' ' ' LEU . 1.8 mp -69.74 100.1 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.19 -19.11 32.21 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.536 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 0.4 OUTLIER -121.77 131.77 54.25 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' ' 108' ' ' GLU . 7.9 p -122.33 52.99 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.7 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -79.21 126.83 31.27 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.673 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.3 OUTLIER -53.16 0.21 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.7 ' H ' ' C ' ' A' ' 126' ' ' THR . 1.1 p30 -111.58 -21.22 11.85 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -177.85 168.5 2.08 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.465 HG12 ' CG ' ' A' ' 107' ' ' PRO . 29.0 m -132.09 145.42 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.536 ' HB ' ' HB2' ' A' ' 124' ' ' GLU . 21.4 m -102.47 84.71 2.48 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.646 ' HA ' ' HA ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -82.36 119.76 24.56 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.824 ' CG ' HD22 ' A' ' 135' ' ' ASN . 13.8 t0 -90.21 97.89 11.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.75 ' HB2' HE22 ' A' ' 93' ' ' GLN . 2.0 m-30 -41.25 -52.97 3.31 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.833 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 9.3 m120 48.44 -122.39 1.58 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 1.113 ' HD1' ' N ' ' A' ' 138' ' ' LEU . 24.3 t-80 179.71 174.93 0.8 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.74 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 0.5 OUTLIER -76.05 -8.62 57.4 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 1.113 ' N ' ' HD1' ' A' ' 136' ' ' HIS . 52.5 mt -119.35 -1.48 10.77 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.499 ' CB ' ' HB3' ' A' ' 135' ' ' ASN . . . -67.71 141.66 56.56 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.587 ' HA3' ' HD2' ' A' ' 87' ' ' ARG . . . 41.95 27.16 0.36 Allowed Glycine 0 C--N 1.336 0.536 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.866 ' HE2' ' CD2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -138.49 146.11 41.62 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.48 ' C ' ' HD2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -99.19 137.39 37.78 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.53 ' CD2' HD21 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -124.7 152.07 44.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.615 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 2.1 t -73.86 165.72 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.589 ' CE2' ' HB ' ' A' ' 78' ' ' ILE . 30.9 m-85 -148.6 98.05 2.82 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.609 ' HA ' ' CG2' ' A' ' 75' ' ' THR . 24.0 m -89.8 57.78 4.0 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.807 HG21 ' H ' ' A' ' 148' ' ' LYS . 2.3 mt -57.54 -179.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.807 ' H ' HG21 ' A' ' 147' ' ' ILE . 12.4 tttt -179.39 110.68 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.858 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 4.8 mm -67.14 145.29 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.528 ' CD1' ' HB3' ' A' ' 47' ' ' PRO . 4.1 mt -126.6 -45.86 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.664 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -161.66 -159.89 0.66 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.678 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 42.4 t -128.44 135.59 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.524 ' CG2' ' HB3' ' A' ' 49' ' ' GLU . 61.9 t -111.47 40.53 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.661 ' HB3' ' H ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.453 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.588 ' HG3' ' HA ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' A' ' 4' ' ' MET . 23.2 t -159.09 145.87 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -132.2 168.06 18.7 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.568 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 10.2 ptpt -72.93 70.32 1.01 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 174.13 -2.9 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.435 HG12 ' HB2' ' A' ' 154' ' ' GLU . 0.2 OUTLIER -117.12 122.64 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.738 ' H ' ' HA ' ' A' ' 154' ' ' GLU . 1.7 tttt -76.52 166.88 22.79 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 1.0 OUTLIER -168.65 132.07 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.716 ' HE2' ' CG2' ' A' ' 153' ' ' VAL . 17.4 mtmt -89.82 92.89 9.22 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.517 ' CG1' HD11 ' A' ' 149' ' ' ILE . 0.8 OUTLIER -112.66 152.99 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.586 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 4.4 m-20 -110.55 95.49 5.6 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.618 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.1 p90 -92.7 154.4 18.35 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.701 HG12 ' HG1' ' A' ' 27' ' ' THR . 6.5 mt -129.36 75.08 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -60.22 132.06 50.23 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.607 ' HE3' ' O ' ' A' ' 16' ' ' ILE . 4.5 mtmt -121.03 -160.77 0.86 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.679 ' C ' ' H ' ' A' ' 21' ' ' SER . 30.5 mt -119.38 166.15 13.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.44 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 9.8 mt-10 -56.32 2.6 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.679 ' H ' ' C ' ' A' ' 19' ' ' LEU . 52.8 p -117.24 0.3 12.24 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.24 28.0 42.26 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 18' ' ' LYS . 18.8 m-20 -96.15 119.2 34.21 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.542 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 63.9 t -69.06 114.26 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.541 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 1.6 p90 -103.08 -32.69 9.56 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.541 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 11.6 t0 -146.23 136.55 23.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.701 ' HG1' HG12 ' A' ' 16' ' ' ILE . 3.8 t -154.11 149.9 27.6 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.586 ' HB2' ' HA ' ' A' ' 14' ' ' ASP . 27.1 m -97.8 -17.41 19.37 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.843 HG23 ' H ' ' A' ' 32' ' ' VAL . 2.1 mt -85.01 95.15 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.412 ' HG3' ' HB2' ' A' ' 45' ' ' TYR . 4.9 tt0 -42.03 -29.59 0.23 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.401 ' H ' HG21 ' A' ' 29' ' ' ILE . 12.5 tt0 -59.62 -63.52 1.27 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.843 ' H ' HG23 ' A' ' 29' ' ' ILE . 59.8 t -51.28 -38.97 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.596 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . . . -48.03 -44.76 31.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.518 ' HG2' ' CB ' ' A' ' 39' ' ' TYR . 11.1 mtmt -71.52 -32.29 68.01 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -74.54 -15.53 60.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -110.23 -6.15 15.12 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.3 46.44 34.04 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.52 HG13 ' HA ' ' A' ' 33' ' ' ALA . 1.3 pt -143.3 11.98 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.596 ' HA ' ' CB ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -45.39 -18.25 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.514 ' CB ' ' HB3' ' A' ' 43' ' ' ARG . . . 75.28 159.4 0.16 Allowed Pre-proline 0 N--CA 1.45 -0.433 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.685 ' HG2' ' H ' ' A' ' 42' ' ' ASP . 82.3 Cg_endo -72.43 -83.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 124.34 3.36 . . . . 0.0 109.604 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.685 ' H ' ' HG2' ' A' ' 41' ' ' PRO . 11.9 p-10 -99.88 -9.9 22.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.514 ' HB3' ' CB ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -73.72 137.93 44.33 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.455 ' N ' ' HG3' ' A' ' 43' ' ' ARG . 54.5 mt-10 -104.38 -175.81 2.9 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.464 ' CE2' ' HB2' ' A' ' 33' ' ' ALA . 30.1 m-85 -138.53 90.49 2.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.68 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.4 OUTLIER -83.44 178.49 2.39 Favored Pre-proline 0 N--CA 1.45 -0.449 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.68 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 83.2 Cg_endo -72.36 125.38 10.69 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 124.337 3.358 . . . . 0.0 109.586 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.0 83.12 0.11 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.565 ' C ' ' HE2' ' A' ' 10' ' ' LYS . 40.6 tt0 -77.41 97.19 4.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.633 ' CE2' ' CE1' ' A' ' 61' ' ' PHE . 5.6 p90 -118.64 167.83 11.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 1.002 ' H ' ' NE2' ' A' ' 56' ' ' GLN . 21.4 t -128.36 114.44 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.568 ' C ' ' HA ' ' A' ' 7' ' ' LYS . 9.1 t -46.99 -14.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.698 ' H ' HG13 ' A' ' 51' ' ' VAL . . . -115.88 39.76 2.63 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.44 ' HG3' ' HB ' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -131.58 -19.7 2.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.23 18.13 79.74 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 1.002 ' NE2' ' H ' ' A' ' 51' ' ' VAL . 4.9 mt-30 -60.81 -63.12 1.41 Allowed 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.667 ' CB ' ' CD1' ' A' ' 61' ' ' PHE . 2.0 mm? -87.41 171.23 10.72 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.905 ' CD1' ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -66.21 155.09 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.443 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 2.3 mt-30 -49.72 -57.09 7.94 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -39.58 -79.68 0.04 OUTLIER Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.667 ' CD1' ' CB ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -41.4 -52.21 3.6 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.487 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 1.7 mt-10 -46.47 -42.19 15.07 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.514 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 4.8 mt-10 -70.17 -32.92 71.09 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.55 -24.85 67.98 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.626 ' C ' ' H ' ' A' ' 67' ' ' ASP . 8.6 m -100.25 -8.58 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.527 ' HG ' ' CG1' ' A' ' 52' ' ' VAL . 0.5 OUTLIER -66.65 37.29 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.626 ' H ' ' C ' ' A' ' 65' ' ' VAL . 0.3 OUTLIER 166.94 27.77 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.49 ' SD ' ' HB2' ' A' ' 74' ' ' LYS . 44.0 mtp -109.56 96.02 6.0 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.468 ' N ' ' OD2' ' A' ' 72' ' ' ASP . 0.5 OUTLIER -55.95 -177.09 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.623 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 1.5 t -75.18 108.42 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.856 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 116.07 -12.22 17.2 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 1.0 OUTLIER -65.53 166.37 10.59 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.427 ' HB2' ' HD2' ' A' ' 148' ' ' LYS . 0.0 OUTLIER -151.16 135.85 17.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.49 ' HB2' ' SD ' ' A' ' 68' ' ' MET . 1.4 tttm -142.33 102.33 4.07 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 145' ' ' PHE . 52.1 m -101.9 79.81 1.94 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.661 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 3.5 t -112.49 171.12 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.661 ' N ' ' CG1' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -105.18 114.11 28.1 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.492 HD13 ' CD2' ' A' ' 145' ' ' PHE . 0.5 OUTLIER -79.0 129.8 71.98 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.477 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 83.4 Cg_endo -72.39 144.37 40.81 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 124.304 3.336 . . . . 0.0 109.607 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.528 ' CB ' ' N ' ' A' ' 141' ' ' LYS . . . -55.85 -9.39 0.56 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.613 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 14.8 pt-20 -81.41 -38.21 26.88 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.428 ' N ' ' HG3' ' A' ' 81' ' ' GLU . 9.3 mtmt -86.94 -31.62 20.57 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.649 ' HA ' ' CB ' ' A' ' 58' ' ' ILE . . . -71.88 -95.88 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.732 ' CE2' ' CE1' ' A' ' 136' ' ' HIS . 2.0 m-85 -98.41 16.91 20.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.613 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 42.36 84.82 0.01 OUTLIER Glycine 0 C--N 1.335 0.509 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.698 ' ND2' ' N ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER 49.01 -171.99 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.569 ' CD ' ' HA3' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -89.26 152.5 21.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.57 ' CB ' ' CD1' ' A' ' 91' ' ' LEU . 2.2 t30 -90.24 100.77 13.53 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.509 ' C ' ' H ' ' A' ' 91' ' ' LEU . 29.9 mt-10 -44.31 -25.36 0.23 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.19 16.68 0.3 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.726 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 17.5 mt -114.11 -4.08 13.18 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 20.6 mt -78.47 114.21 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.557 ' NE2' ' CD1' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -110.33 167.7 10.0 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.706 ' CG ' ' HG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -140.2 90.51 2.37 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.579 HD12 ' CD1' ' A' ' 100' ' ' PHE . 35.8 pt -85.41 154.66 59.71 Favored Pre-proline 0 N--CA 1.449 -0.478 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 99' ' ' ALA . 82.6 Cg_endo -72.36 140.83 34.24 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 124.309 3.34 . . . . 0.0 109.636 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.917 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -41.8 -33.89 0.57 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 100' ' ' PHE . 8.4 m-20 -66.53 -37.03 84.14 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -43.52 -21.58 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.593 ' C ' ' H ' ' A' ' 102' ' ' GLU . 2.8 m-85 -122.2 -23.24 5.37 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.453 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -70.96 21.9 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.593 ' H ' ' C ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -143.59 -13.09 0.68 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.98 22.31 3.26 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 43.4 33.86 0.67 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.491 ' HD1' ' H ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -123.74 -149.46 0.42 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.491 ' H ' ' HD1' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -173.6 113.03 0.33 Allowed Pre-proline 0 N--CA 1.448 -0.525 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.917 ' CG ' HH21 ' A' ' 97' ' ' ARG . 83.5 Cg_endo -72.38 147.26 46.61 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 124.275 3.316 . . . . 0.0 109.632 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.52 ' HA ' HG21 ' A' ' 125' ' ' VAL . 1.3 mm-40 -138.37 151.94 47.96 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.408 ' CG ' ' O ' ' A' ' 123' ' ' THR . 2.5 tm-20 -66.4 66.33 0.05 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 122' ' ' ILE . . . 153.76 9.27 0.08 OUTLIER Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.518 ' CB ' HD13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -62.87 170.09 2.86 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.496 HG12 ' CB ' ' A' ' 119' ' ' PRO . 61.1 t -155.63 65.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.92 137.31 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.624 HD23 ' CD ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -109.3 146.09 34.88 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.432 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -95.04 4.19 54.02 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.432 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 0.9 OUTLIER 166.64 -12.15 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.48 -37.73 0.2 Allowed Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.2 mt -85.93 111.72 40.06 Favored Pre-proline 0 N--CA 1.449 -0.484 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.624 ' CD ' HD23 ' A' ' 114' ' ' LEU . 82.7 Cg_endo -72.37 159.56 49.07 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 124.352 3.368 . . . . 0.0 109.579 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.426 ' CB ' ' HB3' ' A' ' 132' ' ' LEU . . . -121.51 84.05 2.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.56 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 3.5 m -53.34 97.52 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 132' ' ' LEU . 72.3 mt -76.58 91.1 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.44 ' CG2' ' O ' ' A' ' 131' ' ' THR . 0.2 OUTLIER -77.53 -27.24 51.62 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.839 ' HB3' ' H ' ' A' ' 131' ' ' THR . 0.5 OUTLIER -111.12 132.42 54.29 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.52 HG21 ' HA ' ' A' ' 108' ' ' GLU . 7.1 p -129.67 53.55 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.724 ' C ' ' H ' ' A' ' 128' ' ' ASN . 81.4 p -80.1 133.11 36.06 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.591 ' HA ' ' HD3' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -54.58 4.36 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.724 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -112.21 -24.73 9.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -177.22 -178.45 0.79 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.543 HG12 ' CG ' ' A' ' 107' ' ' PRO . 4.2 m -144.57 134.14 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.839 ' H ' ' HB3' ' A' ' 124' ' ' GLU . 17.4 m -95.82 95.26 8.16 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 122' ' ' ILE . 0.1 OUTLIER -87.66 166.62 14.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.659 ' CG ' HD22 ' A' ' 135' ' ' ASN . 15.4 t0 -137.39 97.95 3.59 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.557 ' CD1' ' NE2' ' A' ' 93' ' ' GLN . 3.3 m-30 -41.57 -41.48 2.17 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.726 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 7.1 m120 41.47 -121.94 0.51 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 1.001 ' ND1' ' H ' ' A' ' 138' ' ' LEU . 8.9 t-80 177.01 169.49 0.54 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.565 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 3.0 tp10 -58.55 -53.88 53.38 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 1.001 ' H ' ' ND1' ' A' ' 136' ' ' HIS . 2.2 mm? -97.83 20.02 12.78 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.566 ' HB1' ' N ' ' A' ' 136' ' ' HIS . . . -66.57 134.45 52.37 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 86' ' ' ASN . . . 38.85 30.54 0.11 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.82 ' HE2' ' CD1' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -138.42 144.42 40.16 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.498 ' N ' ' HD3' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -94.04 138.84 31.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.563 ' CD1' ' CZ ' ' A' ' 145' ' ' PHE . 0.5 OUTLIER -129.13 140.47 51.53 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.726 HG12 ' H ' ' A' ' 145' ' ' PHE . 7.8 t -66.45 168.25 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.726 ' H ' HG12 ' A' ' 144' ' ' VAL . 23.2 m-85 -152.79 93.92 1.81 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.521 ' HB ' ' HB ' ' A' ' 16' ' ' ILE . 54.9 m -87.97 62.66 6.97 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.4 mt -57.58 179.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.451 ' C ' ' HB ' ' A' ' 13' ' ' VAL . 6.5 tptt 179.3 100.42 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.856 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -63.23 139.24 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.489 ' CD1' ' OD1' ' A' ' 14' ' ' ASP . 12.6 mt -126.47 -31.5 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.623 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 1.5 mt-10 -166.8 -170.91 1.69 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.595 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 47.2 t -136.95 144.6 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.716 ' CG2' ' HE2' ' A' ' 12' ' ' LYS . 38.8 t -145.05 47.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.738 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.799 ' N ' ' HA ' ' A' ' 69' ' ' GLU . 1.5 ttm . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.56 HG23 ' CD1' ' A' ' 11' ' ' ILE . 58.7 t -131.27 148.6 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.593 ' HA ' ' CD2' ' A' ' 66' ' ' LEU . 1.1 m-20 -119.67 173.79 6.8 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.513 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 9.4 ptpt -68.83 68.46 0.16 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.402 ' H ' ' H ' ' A' ' 9' ' ' VAL . . . 168.93 7.03 0.03 OUTLIER Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.55 ' HB ' ' CG1' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -126.78 134.47 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.85 ' H ' ' HB3' ' A' ' 154' ' ' GLU . 9.1 tttt -87.73 158.48 18.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.629 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 3.3 pt -162.09 139.46 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.735 ' HE2' ' CG2' ' A' ' 153' ' ' VAL . 20.0 mtmt -89.91 78.48 6.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.61 HG22 ' CE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -116.83 145.71 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.435 ' O ' ' CG2' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -98.29 -160.67 0.82 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 0.3 OUTLIER 178.4 156.72 0.44 Allowed 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.591 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 4.5 mt -136.68 77.7 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -61.73 133.22 47.08 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.591 ' HE3' ' O ' ' A' ' 16' ' ' ILE . 4.9 mttt -120.42 -157.89 0.73 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.637 ' C ' ' H ' ' A' ' 21' ' ' SER . 1.8 mt -123.05 165.62 16.48 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -53.79 -2.05 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.637 ' H ' ' C ' ' A' ' 19' ' ' LEU . 59.6 p -113.6 9.03 17.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 19' ' ' LEU . . . 70.91 29.73 68.84 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.458 ' C ' ' HG2' ' A' ' 18' ' ' LYS . 4.2 m-20 -98.43 122.75 42.01 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.545 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 35.5 t -67.89 118.34 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -110.87 -27.51 8.8 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.727 ' HA ' HH22 ' A' ' 43' ' ' ARG . 14.7 t0 -151.95 141.24 21.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.836 HG21 HH21 ' A' ' 43' ' ' ARG . 2.5 t -152.89 153.76 33.69 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.578 ' HA ' ' HA ' ' A' ' 45' ' ' TYR . 0.6 OUTLIER -104.35 14.76 29.6 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.642 ' H ' ' HG1' ' A' ' 27' ' ' THR . 6.4 mt -124.97 99.17 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.678 ' CG ' ' CE2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -43.12 -35.8 1.46 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -53.71 -65.03 0.64 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 36' ' ' ALA . 87.9 t -47.83 -43.66 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.601 ' HA ' ' CG1' ' A' ' 38' ' ' ILE . . . -44.35 -51.75 8.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.533 ' CG ' ' HB2' ' A' ' 39' ' ' TYR . 13.9 mtpt -65.42 -28.07 68.98 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 32' ' ' VAL . 45.8 tt0 -86.08 -13.62 46.76 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . -106.59 -23.38 12.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 99.32 14.87 34.3 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.601 ' CG1' ' HA ' ' A' ' 33' ' ' ALA . 1.6 pt -114.87 31.55 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.582 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 3.6 t80 -64.49 70.02 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 38' ' ' ILE . . . -57.19 146.66 60.59 Favored Pre-proline 0 N--CA 1.449 -0.494 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.35 -37.77 4.13 Favored 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 124.329 3.353 . . . . 0.0 109.62 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -134.67 57.19 1.82 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.86 ' HD2' ' H ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -78.85 -150.5 0.05 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.86 ' H ' ' HD2' ' A' ' 43' ' ' ARG . 0.2 OUTLIER -145.96 50.13 1.18 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.678 ' CE2' ' CG ' ' A' ' 30' ' ' GLU . 25.9 m-85 -66.72 -133.05 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.662 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER 61.52 178.0 0.04 OUTLIER Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.662 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 83.5 Cg_endo -72.37 116.9 4.89 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 124.3 3.333 . . . . 0.0 109.585 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.1 tp -82.49 103.81 12.31 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.521 ' CG ' ' HG2' ' A' ' 10' ' ' LYS . 36.7 tt0 -83.61 100.52 10.87 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.624 ' CG ' ' CD2' ' A' ' 57' ' ' LEU . 2.1 p90 -122.9 170.76 9.78 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.999 ' H ' ' NE2' ' A' ' 56' ' ' GLN . 48.9 t -124.82 113.56 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.529 HG12 ' CD2' ' A' ' 66' ' ' LEU . 3.5 t -49.67 -8.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.592 ' H ' HG13 ' A' ' 51' ' ' VAL . . . -121.08 38.2 2.76 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.444 ' HG3' ' HB ' ' A' ' 51' ' ' VAL . 2.1 mt-10 -123.29 -19.65 5.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.36 18.19 62.92 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.999 ' NE2' ' H ' ' A' ' 51' ' ' VAL . 6.2 mt-30 -72.86 -76.83 0.11 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.704 ' H ' HD22 ' A' ' 57' ' ' LEU . 1.3 mm? -73.17 149.58 42.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.702 ' CD1' ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -55.68 163.27 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.625 HE21 ' HA ' ' A' ' 82' ' ' LYS . 16.1 mt-30 -53.53 -59.08 5.05 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.78 ' H ' ' HB3' ' A' ' 82' ' ' LYS . . . -41.54 -78.78 0.06 OUTLIER Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.279 -1.129 . . . . 0.0 110.279 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.609 ' CE2' HG12 ' A' ' 147' ' ' ILE . 1.0 OUTLIER -38.34 -52.37 1.52 Allowed 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -48.59 -51.77 26.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.588 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 6.8 mt-10 -58.33 -27.67 64.36 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.51 ' HB3' ' CD1' ' A' ' 147' ' ' ILE . . . -63.9 -55.28 23.88 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.443 ' HA ' ' HB2' ' A' ' 68' ' ' MET . 33.9 m -78.84 4.08 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.593 ' CD2' ' HA ' ' A' ' 6' ' ' ASP . 5.3 mt -84.77 -38.08 20.05 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.07 26.01 11.13 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.522 ' CE ' HD12 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -104.2 -155.11 0.52 Allowed 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.799 ' HA ' ' N ' ' A' ' 4' ' ' MET . 0.5 OUTLIER -144.35 -177.38 5.44 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.62 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 1.1 t -90.71 84.36 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.782 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 131.07 12.54 2.09 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.475 ' CG ' ' HB2' ' A' ' 69' ' ' GLU . 1.3 m-20 -100.54 -170.56 1.88 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.2 126.4 6.58 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.452 ' CB ' ' HE1' ' A' ' 68' ' ' MET . 2.3 ttmm -119.63 96.3 5.14 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 145' ' ' PHE . 62.8 m -96.87 83.05 3.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.548 HG13 ' N ' ' A' ' 77' ' ' LYS . 3.8 t -119.69 157.75 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 13.7 ttmt -89.87 114.48 26.25 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.486 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -79.11 130.18 70.36 Favored Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.499 ' C ' ' H ' ' A' ' 81' ' ' GLU . 84.6 Cg_endo -72.34 134.3 22.49 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 124.286 3.324 . . . . 0.0 109.634 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.622 ' HB1' ' H ' ' A' ' 141' ' ' LYS . . . -46.81 -14.56 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.6 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 3.2 tp10 -76.64 -39.3 52.74 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.78 ' HB3' ' H ' ' A' ' 60' ' ' GLY . 14.6 mttt -81.97 -34.13 29.89 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.618 ' HA ' ' CG2' ' A' ' 58' ' ' ILE . . . -73.31 -102.05 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.673 ' HH ' HD11 ' A' ' 138' ' ' LEU . 2.8 m-85 -90.7 20.29 4.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.6 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 47.38 89.24 0.01 OUTLIER Glycine 0 C--N 1.336 0.535 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.579 ' HA ' ' HA2' ' A' ' 140' ' ' GLY . 0.0 OUTLIER 40.99 -133.94 0.28 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.505 ' H ' ' HB2' ' A' ' 86' ' ' ASN . 0.3 OUTLIER -90.85 149.17 22.06 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.49 ' ND2' HD13 ' A' ' 91' ' ' LEU . 1.7 m120 -87.52 135.18 33.45 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -81.46 -26.55 35.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.96 -4.99 59.13 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.599 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 28.2 mt -102.83 13.31 34.7 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.62 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 26.5 mt -82.5 124.09 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.778 HE22 ' HB2' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -115.53 156.2 26.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.52 ' HG3' ' HA ' ' A' ' 131' ' ' THR . 0.0 OUTLIER -133.32 90.16 2.7 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.569 ' H ' HD11 ' A' ' 132' ' ' LEU . 34.4 pt -88.25 154.25 51.62 Favored Pre-proline 0 N--CA 1.449 -0.501 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.512 ' O ' ' N ' ' A' ' 99' ' ' ALA . 81.5 Cg_endo -72.44 141.49 35.14 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 124.275 3.316 . . . . 0.0 109.591 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.913 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -44.11 -30.59 0.78 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.504 ' HA ' ' HB2' ' A' ' 101' ' ' LYS . 5.1 t70 -68.93 -36.18 77.67 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -47.9 -27.76 2.31 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.61 ' CE2' ' HB3' ' A' ' 107' ' ' PRO . 0.6 OUTLIER -99.41 -33.03 10.86 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.504 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 1.1 tttm -58.22 -0.35 0.09 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.587 ' H ' ' C ' ' A' ' 100' ' ' PHE . 7.8 mm-40 -117.12 4.65 12.71 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.14 -133.94 0.07 Allowed 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.71 -8.96 1.87 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.404 ' HB2' ' H ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -137.76 -157.73 0.8 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.432 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 1.6 pm0 -125.88 137.78 30.75 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.913 ' CG ' HH21 ' A' ' 97' ' ' ARG . 83.5 Cg_endo -72.3 129.31 14.78 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 124.38 3.387 . . . . 0.0 109.584 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 110' ' ' GLY . 1.7 mm-40 -125.65 150.84 47.25 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.478 ' HA ' HG21 ' A' ' 122' ' ' ILE . 2.5 tm-20 -62.68 71.07 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 151.86 14.72 0.07 OUTLIER Glycine 0 C--N 1.335 0.513 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.545 ' HB3' ' CD1' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -74.41 173.53 10.16 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.472 ' CG2' ' O ' ' A' ' 111' ' ' MET . 61.1 t -156.84 82.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.436 ' C ' ' HA ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -115.31 127.67 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.568 ' CD2' ' HD3' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -102.32 163.25 12.34 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -112.61 6.97 18.62 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 169.93 -6.33 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 156.34 -21.91 0.49 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.503 ' C ' ' HB3' ' A' ' 114' ' ' LEU . 3.0 mt -102.7 103.15 30.82 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.568 ' HD3' ' CD2' ' A' ' 114' ' ' LEU . 82.7 Cg_endo -72.4 158.72 50.85 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 124.264 3.309 . . . . 0.0 109.572 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.452 ' HB1' HD22 ' A' ' 132' ' ' LEU . . . -115.83 87.05 2.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 32.5 m -55.57 97.98 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.639 ' HA ' ' HA ' ' A' ' 132' ' ' LEU . 1.8 mp -63.45 99.96 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.3 p -86.09 -21.19 27.8 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.737 ' HB3' ' H ' ' A' ' 131' ' ' THR . 1.6 tp10 -128.66 136.1 50.18 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.7 p -119.3 56.71 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.9 ' CG2' HD22 ' A' ' 128' ' ' ASN . 0.1 OUTLIER -78.44 123.97 27.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.499 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.2 OUTLIER -52.01 -2.54 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.9 HD22 ' CG2' ' A' ' 126' ' ' THR . 0.0 OUTLIER -111.69 -17.87 12.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.3 OUTLIER -179.33 163.33 1.25 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.46 HG11 ' CG ' ' A' ' 107' ' ' PRO . 0.6 OUTLIER -127.48 118.9 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.737 ' H ' ' HB3' ' A' ' 124' ' ' GLU . 20.7 m -82.03 84.95 6.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -79.7 169.66 17.65 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.62 ' HA ' ' HA ' ' A' ' 92' ' ' ILE . 11.6 t0 -132.29 95.3 3.62 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.778 ' HB2' HE22 ' A' ' 93' ' ' GLN . 2.1 m-30 -37.7 -38.96 0.31 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.599 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 0.8 OUTLIER 38.89 -118.32 0.23 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 1.148 ' HD1' ' N ' ' A' ' 138' ' ' LEU . 14.1 t-80 177.93 176.88 0.41 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.759 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -73.36 -8.39 55.68 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 1.148 ' N ' ' HD1' ' A' ' 136' ' ' HIS . 72.0 mt -122.08 -5.63 8.96 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.583 ' HB3' ' N ' ' A' ' 136' ' ' HIS . . . -68.1 133.66 49.32 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 86' ' ' ASN . . . 55.25 24.45 36.88 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.875 ' HE2' ' CD2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -142.07 145.94 34.89 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.489 ' C ' ' HD2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -98.91 137.61 37.23 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.516 HD13 ' CZ ' ' A' ' 145' ' ' PHE . 0.5 OUTLIER -127.15 152.76 46.92 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.584 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 2.0 t -74.36 165.69 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.516 ' CZ ' HD13 ' A' ' 143' ' ' LEU . 28.0 m-85 -153.27 94.65 1.85 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.482 ' HB ' ' HB ' ' A' ' 16' ' ' ILE . 42.0 m -88.54 67.37 8.49 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.641 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -60.72 -177.81 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.524 ' H ' HG23 ' A' ' 147' ' ' ILE . 10.6 tttt -175.45 108.34 0.1 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.782 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 1.5 mp -75.4 134.11 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.53 ' CD1' ' HB3' ' A' ' 47' ' ' PRO . 6.9 mt -113.47 -41.61 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.62 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -166.02 -156.31 0.25 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.629 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 18.6 t -131.63 155.1 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.735 ' CG2' ' HE2' ' A' ' 12' ' ' LYS . 2.6 t -138.03 39.73 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.85 ' HB3' ' H ' ' A' ' 10' ' ' LYS . 9.8 tp10 . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.5 ' O ' ' HA ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.507 HG22 HG23 ' A' ' 11' ' ' ILE . 48.8 t 65.88 117.47 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 8' ' ' GLY . 0.5 OUTLIER -154.49 177.48 11.13 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.867 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.546 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 15.7 ptmt -66.32 65.45 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 6' ' ' ASP . . . 156.05 23.78 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.17 125.63 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.582 ' HB3' ' N ' ' A' ' 154' ' ' GLU . 2.8 ttpm? -85.22 150.21 24.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.597 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 1.2 pt -154.17 126.9 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.672 ' HE2' HG22 ' A' ' 153' ' ' VAL . 21.0 mtmt -86.77 86.14 7.31 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.599 ' CG1' ' HA ' ' A' ' 149' ' ' ILE . 0.7 OUTLIER -114.93 152.48 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.528 ' CG ' ' CD1' ' A' ' 29' ' ' ILE . 0.8 OUTLIER -117.49 108.32 15.37 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.637 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.2 p90 -94.32 160.94 14.45 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.605 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 5.1 mt -129.98 75.49 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -59.14 136.64 50.93 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.605 ' HE3' ' O ' ' A' ' 16' ' ' ILE . 6.6 mttt -122.87 -159.6 0.85 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.643 ' C ' ' H ' ' A' ' 21' ' ' SER . 57.8 mt -117.68 165.93 13.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -55.33 0.05 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.643 ' H ' ' C ' ' A' ' 19' ' ' LEU . 56.8 p -114.16 2.11 14.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.32 28.6 52.49 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.457 ' C ' ' HG2' ' A' ' 18' ' ' LYS . 4.1 m-20 -97.81 123.55 41.82 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.566 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 47.4 t -67.87 126.02 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.568 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 1.9 p90 -119.62 -38.85 2.93 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.568 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 8.3 t0 -138.13 135.7 35.99 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.585 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 3.9 t -152.58 148.75 27.72 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.61 ' HG ' ' HB2' ' A' ' 48' ' ' LEU . 0.6 OUTLIER -91.79 -18.78 23.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.528 ' CD1' ' CG ' ' A' ' 14' ' ' ASP . 4.6 mt -93.81 121.1 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.587 ' HG3' ' CD1' ' A' ' 45' ' ' TYR . 3.5 tt0 -63.62 -32.02 73.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.403 ' H ' HG21 ' A' ' 29' ' ' ILE . 22.7 tt0 -51.67 -63.41 1.14 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.516 ' CG2' HD12 ' A' ' 16' ' ' ILE . 52.0 t -50.58 -42.18 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.595 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . . . -46.11 -42.79 14.16 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.516 ' HG2' ' CB ' ' A' ' 39' ' ' TYR . 11.6 mtmt -71.62 -32.41 67.95 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -74.46 -17.61 60.75 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.5 -7.57 16.52 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.0 43.73 32.67 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.526 HG13 ' HA ' ' A' ' 33' ' ' ALA . 1.8 pt -139.65 11.16 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.595 ' HA ' ' CB ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -46.95 -21.39 0.21 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.622 ' CB ' ' HD2' ' A' ' 41' ' ' PRO . . . 67.99 175.55 0.07 OUTLIER Pre-proline 0 N--CA 1.45 -0.474 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.75 ' HG2' ' H ' ' A' ' 42' ' ' ASP . 83.2 Cg_endo -72.33 -69.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 124.299 3.333 . . . . 0.0 109.623 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.75 ' H ' ' HG2' ' A' ' 41' ' ' PRO . 9.0 p-10 -109.92 -68.21 0.94 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.735 ' H ' ' CG ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 41.73 -153.71 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.464 ' H ' ' HD2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER 179.15 81.13 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.587 ' CD1' ' HG3' ' A' ' 30' ' ' GLU . 2.9 m-85 -76.45 101.37 5.57 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.734 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -114.53 -179.15 0.58 Allowed Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.734 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 82.4 Cg_endo -72.38 122.53 8.4 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 124.283 3.322 . . . . 0.0 109.607 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.61 ' HB2' ' HG ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -75.43 96.0 3.36 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.56 ' HB2' ' CG ' ' A' ' 12' ' ' LYS . 48.0 tt0 -79.31 97.49 6.31 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.597 ' CZ ' ' CD1' ' A' ' 11' ' ' ILE . 39.7 p90 -110.81 170.39 8.13 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 1.019 ' H ' ' NE2' ' A' ' 56' ' ' GLN . 89.6 t -134.48 104.4 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.546 ' C ' ' HA ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -44.54 -17.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 51' ' ' VAL . . . -101.24 37.59 3.54 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 51' ' ' VAL . 5.5 mt-10 -141.78 -30.08 0.6 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.1 7.37 77.35 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 1.019 ' NE2' ' H ' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -42.3 -68.89 0.16 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.562 ' N ' HD23 ' A' ' 57' ' ' LEU . 2.3 mm? -79.74 160.37 26.25 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.664 ' HB ' ' HA ' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -60.48 160.35 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.825 HE21 ' HA ' ' A' ' 82' ' ' LYS . 6.1 mt-30 -48.85 -67.01 0.3 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.733 ' H ' ' HB3' ' A' ' 82' ' ' LYS . . . -29.86 -74.37 0.04 OUTLIER Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.609 ' N ' HD11 ' A' ' 78' ' ' ILE . 1.0 OUTLIER -45.98 -51.72 12.95 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 59' ' ' GLN . 2.9 mt-10 -50.49 -38.63 45.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 59' ' ' GLN . 18.9 mt-10 -74.63 -25.09 58.99 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.607 ' HA ' ' CD ' ' A' ' 74' ' ' LYS . . . -68.88 -51.7 37.49 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.565 HG22 ' CZ ' ' A' ' 50' ' ' PHE . 27.2 m -74.0 -12.71 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.536 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 2.5 mt -60.51 106.31 0.53 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 66' ' ' LEU . 1.8 m-20 84.34 33.06 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.514 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 4.8 mtp -123.43 106.29 10.52 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -70.53 -179.63 2.18 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.522 HG23 ' CG2' ' A' ' 152' ' ' VAL . 7.1 t -60.05 127.4 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 107.43 -32.3 7.29 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.514 ' HB3' ' HG2' ' A' ' 68' ' ' MET . 0.9 OUTLIER -54.07 160.47 1.52 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.52 145.83 21.82 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.607 ' CD ' ' HA ' ' A' ' 64' ' ' ALA . 2.2 tttt -143.78 98.72 3.28 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.47 HG22 ' HG1' ' A' ' 146' ' ' THR . 83.1 m -100.01 83.17 2.66 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.531 HG11 ' N ' ' A' ' 77' ' ' LYS . 2.9 t -121.62 156.13 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 19.8 ttpt -79.16 114.71 18.32 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.737 ' CG1' ' CD1' ' A' ' 145' ' ' PHE . 24.5 mm -78.51 123.24 85.65 Favored Pre-proline 0 N--CA 1.449 -0.489 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.686 ' HG3' ' HE3' ' A' ' 82' ' ' LYS . 85.0 Cg_endo -72.29 145.03 42.61 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 124.361 3.374 . . . . 0.0 109.587 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.544 ' HB3' ' N ' ' A' ' 141' ' ' LYS . . . -54.33 -23.74 16.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.559 ' HG3' ' H ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -69.87 -41.07 75.29 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.825 ' HA ' HE21 ' A' ' 59' ' ' GLN . 17.8 mttt -82.24 -28.79 31.67 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.664 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . . . -112.75 110.97 21.42 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.623 ' CD2' ' HB3' ' A' ' 138' ' ' LEU . 32.6 m-85 70.91 -9.78 0.81 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 80' ' ' ALA . . . 64.02 156.41 0.15 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.639 ' H ' ' ND2' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -41.36 155.4 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.419 ' HD2' ' OD1' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -39.41 131.1 1.68 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.45 ' CB ' HD12 ' A' ' 91' ' ' LEU . 7.7 t30 -81.08 147.73 29.98 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -85.12 -27.49 26.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.88 -0.56 18.9 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.723 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 71.7 mt -98.95 3.46 47.07 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.611 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 42.1 mt -85.77 113.32 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.642 HE22 ' HB2' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -108.2 145.73 33.82 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.519 ' HG3' ' HA ' ' A' ' 131' ' ' THR . 0.0 OUTLIER -128.3 97.2 4.67 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.675 ' CD1' ' CD1' ' A' ' 100' ' ' PHE . 25.2 pt -92.63 153.63 42.4 Favored Pre-proline 0 N--CA 1.45 -0.454 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.538 ' O ' ' N ' ' A' ' 99' ' ' ALA . 83.6 Cg_endo -72.44 139.65 31.98 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 124.272 3.314 . . . . 0.0 109.562 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.772 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -44.73 -26.89 0.43 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.552 ' HA ' ' HB2' ' A' ' 101' ' ' LYS . 10.0 t70 -73.73 -34.01 64.58 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -58.5 -22.28 54.56 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.675 ' CD1' ' CD1' ' A' ' 95' ' ' ILE . 1.8 m-85 -121.42 2.88 10.26 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 0.2 OUTLIER -53.06 -41.44 64.85 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.421 ' C ' ' H ' ' A' ' 104' ' ' ASP . 2.0 pt-20 -118.74 34.68 5.1 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.673 ' C ' ' H ' ' A' ' 105' ' ' PHE . . . -81.15 20.06 0.86 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' A' ' 102' ' ' GLU . 0.1 OUTLIER 59.34 -6.75 0.06 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.673 ' H ' ' C ' ' A' ' 103' ' ' ALA . 0.5 OUTLIER -150.63 147.52 27.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.447 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 0.6 OUTLIER -94.83 129.67 35.33 Favored Pre-proline 0 N--CA 1.449 -0.496 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.772 ' CG ' HH21 ' A' ' 97' ' ' ARG . 82.6 Cg_endo -72.36 135.02 23.77 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 124.367 3.378 . . . . 0.0 109.544 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.511 ' HA ' HG22 ' A' ' 125' ' ' VAL . 1.2 mt-10 -124.19 156.81 36.12 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.465 ' N ' ' HB ' ' A' ' 125' ' ' VAL . 2.8 tm-20 -65.7 67.55 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.65 14.04 0.06 OUTLIER Glycine 0 C--N 1.336 0.537 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.465 ' O ' ' CG2' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -69.97 171.27 9.72 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.465 ' CG2' ' O ' ' A' ' 111' ' ' MET . 64.0 t -156.7 70.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.19 135.49 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.635 ' CD2' ' HD3' ' A' ' 119' ' ' PRO . 0.3 OUTLIER -99.2 149.2 23.33 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -103.37 3.48 35.22 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 171.41 -11.09 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.415 ' O ' ' CD2' ' A' ' 114' ' ' LEU . . . 166.06 -34.88 0.24 Allowed Glycine 0 C--N 1.335 0.492 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 3.0 mt -93.3 121.32 65.51 Favored Pre-proline 0 N--CA 1.448 -0.53 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.635 ' HD3' ' CD2' ' A' ' 114' ' ' LEU . 83.9 Cg_endo -72.39 164.13 36.55 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 124.282 3.321 . . . . 0.0 109.631 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.565 ' CB ' ' HB3' ' A' ' 132' ' ' LEU . . . -123.55 82.94 2.07 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 2.4 m -54.13 94.82 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.627 ' HA ' ' HA ' ' A' ' 132' ' ' LEU . 12.8 mt -70.49 97.3 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 131' ' ' THR . 1.3 p -82.68 -24.73 33.56 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.551 ' HB3' ' N ' ' A' ' 131' ' ' THR . 1.2 tt0 -111.54 132.38 54.56 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.511 HG22 ' HA ' ' A' ' 108' ' ' GLU . 8.1 p -126.22 48.03 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.711 ' C ' ' H ' ' A' ' 128' ' ' ASN . 2.1 p -79.85 129.28 34.35 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.538 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.4 OUTLIER -53.87 2.41 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.711 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -110.79 -22.74 11.41 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.489 ' HG2' ' HG1' ' A' ' 126' ' ' THR . 5.2 pm0 -177.88 168.66 2.06 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 124' ' ' GLU . 22.0 m -132.15 143.56 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.551 ' N ' ' HB3' ' A' ' 124' ' ' GLU . 16.3 m -99.75 85.37 3.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.627 ' HA ' ' HA ' ' A' ' 122' ' ' ILE . 0.1 OUTLIER -82.5 107.72 15.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.611 ' HA ' ' HA ' ' A' ' 92' ' ' ILE . 18.8 t0 -83.86 97.04 8.98 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.642 ' HB2' HE22 ' A' ' 93' ' ' GLN . 2.3 m-85 -42.53 -45.55 4.55 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.723 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 6.7 m120 42.17 -121.76 0.58 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 1.091 ' HD1' ' N ' ' A' ' 138' ' ' LEU . 21.6 t-80 -179.21 166.87 1.54 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.695 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 0.9 OUTLIER -70.99 -16.07 62.61 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 1.091 ' N ' ' HD1' ' A' ' 136' ' ' HIS . 3.4 mm? -111.26 -23.2 10.97 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 141' ' ' LYS . . . -48.66 144.66 4.18 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 42.45 22.12 0.12 Allowed Glycine 0 C--N 1.336 0.531 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.674 ' HE2' ' HB3' ' A' ' 143' ' ' LEU . 0.0 OUTLIER -133.09 133.03 42.42 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.567 ' C ' ' HD3' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -99.11 131.56 45.06 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.674 ' HB3' ' HE2' ' A' ' 141' ' ' LYS . 2.4 pt? -122.57 146.43 47.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.586 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 4.0 t -67.71 163.04 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.737 ' CD1' ' CG1' ' A' ' 78' ' ' ILE . 16.4 m-85 -146.43 85.87 1.66 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.47 ' HG1' HG22 ' A' ' 75' ' ' THR . 95.0 m -83.82 70.81 10.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.637 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 2.1 mt -64.4 179.54 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.439 ' C ' ' HB ' ' A' ' 13' ' ' VAL . 3.1 tmtt? -177.65 96.49 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.599 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 2.4 mm -60.06 135.01 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.521 HG13 ' HA ' ' A' ' 13' ' ' VAL . 2.3 mt -122.51 -24.62 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.509 ' HA ' HG11 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -163.11 176.39 10.09 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.551 ' HA ' HG21 ' A' ' 11' ' ' ILE . 85.7 t -137.69 136.84 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.672 HG22 ' HE2' ' A' ' 12' ' ' LYS . 0.9 OUTLIER -142.99 -142.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.582 ' N ' ' HB3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.498 ' N ' ' OE1' ' A' ' 69' ' ' GLU . 22.7 ttt . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.702 HG11 ' H ' ' A' ' 6' ' ' ASP . 16.6 t -81.07 162.62 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.784 ' H ' HG21 ' A' ' 9' ' ' VAL . 7.8 m-20 -143.4 168.83 18.89 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.521 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 11.7 ptmt -66.05 69.59 0.06 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 6' ' ' ASP . . . 162.59 11.3 0.03 OUTLIER Glycine 0 C--N 1.336 0.561 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.784 HG21 ' H ' ' A' ' 6' ' ' ASP . 1.4 t -119.05 133.96 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.863 ' H ' ' HB3' ' A' ' 154' ' ' GLU . 3.6 tttt -86.64 133.39 33.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.601 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 9.6 pt -147.03 136.38 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 9.5 mtpt -95.03 91.94 6.6 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.61 ' CG1' ' HA ' ' A' ' 149' ' ' ILE . 1.1 m -118.35 145.79 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.416 ' OD1' ' HA ' ' A' ' 47' ' ' PRO . 41.3 m-20 -92.19 -166.69 1.6 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.609 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.0 OUTLIER -179.81 151.79 0.45 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.606 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 3.5 mt -133.22 81.65 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -65.74 138.62 37.91 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.672 ' HZ2' ' HG1' ' A' ' 146' ' ' THR . 10.4 mttt -125.44 -165.81 1.46 Allowed 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.663 ' C ' ' H ' ' A' ' 21' ' ' SER . 34.1 mt -112.98 166.52 11.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -54.84 0.77 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.663 ' H ' ' C ' ' A' ' 19' ' ' LEU . 54.2 p -112.4 2.54 16.47 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.04 30.51 57.26 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 18' ' ' LYS . 87.3 m-20 -100.87 124.29 46.33 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.589 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 82.2 t -71.06 122.83 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.475 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -115.48 -30.13 6.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.475 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 16.7 t0 -143.56 140.23 30.13 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.595 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 6.1 t -158.72 148.66 19.48 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.4 m -101.78 16.68 25.12 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 29.0 mt -127.91 108.47 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.581 ' HG3' ' CD1' ' A' ' 45' ' ' TYR . 2.8 tt0 -48.81 -35.42 14.45 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -47.4 -64.66 0.72 Allowed 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.527 ' CG2' HD11 ' A' ' 16' ' ' ILE . 49.5 t -53.81 -40.39 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.59 ' HA ' ' CG1' ' A' ' 38' ' ' ILE . . . -54.68 -38.09 66.55 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.519 ' CG ' ' HB2' ' A' ' 39' ' ' TYR . 7.7 mtpt -78.51 -17.93 55.51 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -96.01 -23.62 16.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . -95.14 -23.71 17.17 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.81 37.58 4.93 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.59 ' CG1' ' HA ' ' A' ' 33' ' ' ALA . 2.1 pt -135.38 17.17 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.519 ' HB2' ' CG ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -43.44 -20.47 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.604 ' CB ' ' HD2' ' A' ' 41' ' ' PRO . . . 57.27 174.93 0.04 OUTLIER Pre-proline 0 N--CA 1.449 -0.492 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.758 ' HG2' ' H ' ' A' ' 42' ' ' ASP . 82.6 Cg_endo -72.5 -74.2 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 124.296 3.33 . . . . 0.0 109.57 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.758 ' H ' ' HG2' ' A' ' 41' ' ' PRO . 4.6 p-10 -104.29 -53.36 2.74 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.896 ' HE ' ' HH ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER 46.1 -162.42 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -171.36 74.89 0.06 Allowed 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.896 ' HH ' ' HE ' ' A' ' 43' ' ' ARG . 80.3 m-85 -79.65 102.99 9.26 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.611 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -131.23 174.92 4.13 Favored Pre-proline 0 N--CA 1.449 -0.523 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.611 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 83.8 Cg_endo -72.41 130.84 16.71 Favored 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 124.319 3.346 . . . . 0.0 109.643 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.501 ' CD2' HD23 ' A' ' 57' ' ' LEU . 1.4 tp -88.63 96.66 10.74 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 12' ' ' LYS . 23.4 tt0 -79.08 89.73 4.82 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.757 ' CE2' ' CE1' ' A' ' 61' ' ' PHE . 0.7 OUTLIER -108.32 172.8 6.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.578 ' C ' ' H ' ' A' ' 53' ' ' GLY . 59.1 t -123.6 107.28 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.538 ' CG1' ' HG ' ' A' ' 66' ' ' LEU . 2.8 t -50.93 -8.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.578 ' H ' ' C ' ' A' ' 51' ' ' VAL . . . -96.98 -25.27 11.53 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.296 -1.121 . . . . 0.0 110.296 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 51' ' ' VAL . 14.6 mt-10 -74.28 -65.32 0.86 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.82 13.84 8.36 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.529 HE21 ' HB2' ' A' ' 56' ' ' GLN . 0.5 OUTLIER -43.47 -67.09 0.31 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.631 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 1.5 mm? -70.67 -171.97 0.57 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.837 ' CD1' ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -81.68 146.38 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.528 HE21 ' HA ' ' A' ' 82' ' ' LYS . 14.0 mt-30 -43.15 -54.69 4.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.534 ' H ' ' HB3' ' A' ' 82' ' ' LYS . . . -39.45 -81.51 0.02 OUTLIER Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.757 ' CE1' ' CE2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -42.53 -49.56 5.37 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.67 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 1.9 mt-10 -49.88 -35.08 22.17 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 60' ' ' GLY . 4.9 mt-10 -78.09 -32.0 50.4 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' A' ' 74' ' ' LYS . . . -64.47 -25.42 67.99 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.596 HG23 ' CZ ' ' A' ' 50' ' ' PHE . 33.5 m -95.02 -20.4 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.538 ' HG ' ' CG1' ' A' ' 52' ' ' VAL . 1.2 mt -51.07 -60.44 3.1 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -96.33 55.59 1.5 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.511 ' CE ' HD12 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -144.37 127.38 16.47 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' A' ' 4' ' ' MET . 0.8 OUTLIER -75.31 -161.77 0.16 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.687 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 0.2 OUTLIER -90.0 115.56 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.845 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 107.0 -6.57 37.26 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 0.9 OUTLIER -68.64 177.81 2.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -154.8 142.59 19.96 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 2.4 tttm -139.38 101.98 4.37 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.59 ' CG2' ' CG2' ' A' ' 146' ' ' THR . 0.2 OUTLIER -99.19 93.6 6.04 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.413 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 18.3 t -136.09 156.04 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.676 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 2.5 ttpm? -85.35 116.44 23.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.689 ' CG1' ' CD1' ' A' ' 145' ' ' PHE . 22.2 mm -78.37 126.65 82.82 Favored Pre-proline 0 N--CA 1.448 -0.568 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.509 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 84.4 Cg_endo -72.32 144.1 40.57 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 124.264 3.31 . . . . 0.0 109.656 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.604 ' HB2' ' N ' ' A' ' 141' ' ' LYS . . . -56.62 -8.57 0.58 Allowed 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.584 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 9.3 pt-20 -81.55 -39.25 24.9 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.534 ' HB3' ' H ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -86.85 -34.73 19.38 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.647 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . . . -67.75 -96.44 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.583 ' CE1' ' HB3' ' A' ' 138' ' ' LEU . 3.1 m-85 -99.29 17.56 19.76 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 42.53 84.56 0.01 OUTLIER Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.666 ' ND2' ' N ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER 47.65 -166.22 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.893 ' HE ' ' CB ' ' A' ' 139' ' ' ALA . 3.4 mmt85 -70.47 145.91 50.64 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.405 ' HB2' HD11 ' A' ' 91' ' ' LEU . 0.9 OUTLIER -83.27 143.83 30.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.469 ' HA ' HD12 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -90.09 -26.79 20.06 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -74.66 -23.3 58.64 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.594 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 85.4 mt -85.34 26.67 0.88 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 86.5 mt -93.16 116.41 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.828 HE22 ' HB2' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -109.19 154.23 22.67 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.836 ' HG3' ' HG1' ' A' ' 131' ' ' THR . 0.0 OUTLIER -134.96 99.09 4.19 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.542 HG12 ' CD1' ' A' ' 132' ' ' LEU . 21.4 pt -95.5 156.02 38.0 Favored Pre-proline 0 N--CA 1.449 -0.483 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 99' ' ' ALA . 83.0 Cg_endo -72.36 139.53 32.01 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 124.283 3.322 . . . . 0.0 109.577 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.837 HH21 ' HG2' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -42.16 -33.94 0.67 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.505 ' HA ' ' HB2' ' A' ' 101' ' ' LYS . 0.9 OUTLIER -65.85 -36.37 83.25 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -43.65 -19.85 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.488 ' N ' ' O ' ' A' ' 98' ' ' ASP . 0.6 OUTLIER -126.49 -30.61 2.83 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.505 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 1.2 tmtt? -53.42 -17.46 1.95 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.03 28.36 8.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.438 ' HB3' ' CE1' ' A' ' 105' ' ' PHE . . . -113.03 -139.16 0.38 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.99 -3.31 3.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.458 ' HB2' ' H ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -128.13 -148.43 0.38 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.458 ' H ' ' HB2' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -162.44 132.93 3.5 Favored Pre-proline 0 N--CA 1.45 -0.448 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.837 ' HG2' HH21 ' A' ' 97' ' ' ARG . 82.3 Cg_endo -72.38 137.39 28.14 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 124.27 3.313 . . . . 0.0 109.591 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.48 ' HA ' HG22 ' A' ' 125' ' ' VAL . 4.0 mt-10 -126.05 154.61 42.77 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.529 ' N ' ' HB ' ' A' ' 125' ' ' VAL . 1.2 tt0 -65.51 67.03 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.91 9.86 0.08 OUTLIER Glycine 0 C--N 1.336 0.539 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.523 ' HB3' ' CD1' ' A' ' 122' ' ' ILE . 1.4 mmt -66.64 171.38 5.19 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 111' ' ' MET . 60.7 t -156.11 73.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.413 ' H ' HG22 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -110.29 136.95 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.648 HD22 ' HD3' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -106.49 171.07 7.56 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -114.79 -4.29 12.7 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.411 ' H ' ' H ' ' A' ' 117' ' ' GLY . 1.0 OUTLIER 172.33 5.63 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.411 ' H ' ' H ' ' A' ' 116' ' ' GLU . . . 153.87 -38.86 0.69 Allowed Glycine 0 C--N 1.335 0.483 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 48.8 mm -87.47 114.65 59.74 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.648 ' HD3' HD22 ' A' ' 114' ' ' LEU . 84.9 Cg_endo -72.38 173.5 13.03 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 124.305 3.337 . . . . 0.0 109.604 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.547 ' CB ' ' HB3' ' A' ' 132' ' ' LEU . . . -134.64 73.14 1.47 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 77.3 m -49.85 96.86 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.638 ' HA ' ' HA ' ' A' ' 132' ' ' LEU . 2.9 mp -69.1 98.73 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.414 ' H ' HG23 ' A' ' 123' ' ' THR . 1.0 OUTLIER -83.76 -21.14 32.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.561 ' HB3' ' H ' ' A' ' 131' ' ' THR . 0.3 OUTLIER -120.16 133.41 55.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.529 ' HB ' ' N ' ' A' ' 109' ' ' GLU . 7.2 p -124.76 52.6 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.672 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -79.67 127.81 32.63 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.427 ' HA ' ' HD3' ' A' ' 97' ' ' ARG . 0.5 OUTLIER -53.25 0.63 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.672 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -111.62 -21.67 11.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -177.83 168.43 2.09 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.513 HG13 ' CG ' ' A' ' 107' ' ' PRO . 4.2 m -133.66 141.69 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.836 ' HG1' ' HG3' ' A' ' 94' ' ' LYS . 17.3 m -98.18 86.27 3.64 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.638 ' HA ' ' HA ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -82.65 113.32 20.26 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.829 ' CG ' HD22 ' A' ' 135' ' ' ASN . 10.0 t0 -81.96 95.12 7.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.828 ' HB2' HE22 ' A' ' 93' ' ' GLN . 1.6 m-85 -39.88 -50.61 2.46 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.829 HD22 ' CG ' ' A' ' 133' ' ' ASP . 8.6 m120 45.97 -132.89 0.99 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 1.021 ' HD1' ' N ' ' A' ' 138' ' ' LEU . 23.2 t-80 -167.84 174.21 7.7 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.779 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 8.7 pt-20 -86.06 10.11 15.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 1.021 ' N ' ' HD1' ' A' ' 136' ' ' HIS . 63.5 mt -135.01 5.32 3.31 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.893 ' CB ' ' HE ' ' A' ' 87' ' ' ARG . . . -60.58 -111.23 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.86 ' H ' ' NE ' ' A' ' 87' ' ' ARG . . . -65.59 38.65 0.13 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.855 ' HE2' ' CD2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -136.47 143.18 43.71 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.509 ' HB3' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -101.0 129.9 46.91 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.702 ' HB3' ' HE2' ' A' ' 141' ' ' LYS . 1.1 pt? -121.07 145.69 47.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.676 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 1.6 t -62.14 163.88 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.689 ' CD1' ' CG1' ' A' ' 78' ' ' ILE . 12.3 m-85 -148.28 102.58 3.36 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.672 ' HG1' ' HZ2' ' A' ' 18' ' ' LYS . 24.3 m -97.17 60.81 1.7 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.609 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.1 mt -59.67 177.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.514 ' H ' HG22 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -177.25 113.86 0.09 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.845 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 2.8 mm -69.49 139.98 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.533 HG13 ' HA ' ' A' ' 13' ' ' VAL . 6.7 mt -118.78 -48.12 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.687 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -158.11 -165.39 1.71 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.603 HG12 ' H ' ' A' ' 154' ' ' GLU . 10.7 t -134.16 137.83 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.552 ' CG2' ' CG ' ' A' ' 12' ' ' LYS . 45.8 t -117.78 43.6 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.863 ' HB3' ' H ' ' A' ' 10' ' ' LYS . 14.0 tp10 . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.716 ' N ' ' HA ' ' A' ' 69' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.569 HG11 ' N ' ' A' ' 6' ' ' ASP . 23.0 t -123.64 155.07 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.649 ' H ' HG23 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -137.76 171.08 14.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.536 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 16.9 ptmt -64.76 70.64 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 6' ' ' ASP . . . 161.61 11.24 0.03 OUTLIER Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.649 HG23 ' H ' ' A' ' 6' ' ' ASP . 1.7 t -125.17 132.97 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.775 ' H ' ' HB2' ' A' ' 154' ' ' GLU . 11.6 tttt -88.2 152.94 21.62 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.61 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 6.2 pt -160.72 137.96 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 7.7 ttmt -96.12 99.94 11.63 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 149' ' ' ILE . 1.2 m -119.65 152.62 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.583 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 0.5 OUTLIER -115.42 103.01 10.35 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.615 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 9.3 p90 -96.63 151.63 19.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.599 ' CG2' ' HB ' ' A' ' 27' ' ' THR . 1.1 mt -119.81 77.94 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -62.65 130.45 43.07 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.593 ' HE2' HG22 ' A' ' 24' ' ' VAL . 6.9 mtmt -125.56 144.43 50.57 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.2 mt -64.07 170.09 3.88 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.61 50.86 0.07 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.567 ' HG ' ' CG ' ' A' ' 23' ' ' ASP . 94.1 p -161.82 -1.01 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.29 22.34 48.43 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.567 ' CG ' ' HG ' ' A' ' 21' ' ' SER . 2.2 m-20 -96.71 116.34 28.96 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.593 HG22 ' HE2' ' A' ' 18' ' ' LYS . 54.6 t -68.44 115.07 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.497 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 3.3 p90 -103.84 -37.75 7.31 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.497 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 9.3 t0 -136.04 133.46 37.43 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.599 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -153.91 131.59 11.49 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.583 ' HB2' ' HA ' ' A' ' 14' ' ' ASP . 3.0 m -79.68 -23.2 42.62 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.68 HG23 ' H ' ' A' ' 32' ' ' VAL . 5.0 mt -84.67 114.93 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.582 ' O ' ' HE3' ' A' ' 34' ' ' LYS . 6.4 tt0 -60.89 -22.02 63.89 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -60.51 -62.46 1.84 Allowed 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.68 ' H ' HG23 ' A' ' 29' ' ' ILE . 89.3 t -54.54 -41.0 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.59 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . . . -48.22 -39.18 20.37 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.582 ' HE3' ' O ' ' A' ' 30' ' ' GLU . 18.0 mttt -77.56 -24.32 49.84 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 32' ' ' VAL . 35.7 tt0 -84.37 -12.98 53.52 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.82 -10.49 14.76 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.83 44.0 10.74 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.578 HG13 ' HA ' ' A' ' 33' ' ' ALA . 1.6 pt -140.06 16.28 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.53 ' HB2' ' CG ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -45.07 -17.51 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.487 ' N ' ' C ' ' A' ' 38' ' ' ILE . . . 70.44 155.55 0.15 Allowed Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.69 ' HG2' ' H ' ' A' ' 42' ' ' ASP . 82.5 Cg_endo -72.41 -84.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 124.326 3.351 . . . . 0.0 109.618 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.69 ' H ' ' HG2' ' A' ' 41' ' ' PRO . 4.3 p-10 -93.16 -14.41 27.22 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.492 ' HG3' ' N ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -77.53 140.53 39.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.492 ' N ' ' HG3' ' A' ' 43' ' ' ARG . 4.3 mt-10 -115.15 179.01 4.08 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.59 ' CD2' ' HB2' ' A' ' 33' ' ' ALA . 9.8 m-85 -133.93 109.91 9.35 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.601 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -117.42 174.78 2.33 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.601 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 81.7 Cg_endo -72.36 124.07 9.63 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 124.312 3.341 . . . . 0.0 109.578 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.8 tp -86.66 125.15 33.66 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.581 ' O ' ' HE2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -91.95 98.69 11.73 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.684 ' HB2' HE21 ' A' ' 56' ' ' GLN . 10.5 p90 -99.76 170.96 8.19 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.665 HG13 ' H ' ' A' ' 53' ' ' GLY . 57.6 t -135.01 106.13 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.536 ' C ' ' HA ' ' A' ' 7' ' ' LYS . 93.3 t -48.88 -10.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.665 ' H ' HG13 ' A' ' 51' ' ' VAL . . . -117.27 62.3 0.41 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -167.22 -20.05 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.38 6.57 88.57 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.684 HE21 ' HB2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -42.05 -78.61 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.608 ' CB ' ' CE1' ' A' ' 61' ' ' PHE . 3.0 mm? -75.02 -174.2 2.18 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.901 ' CD1' ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -82.19 144.02 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.878 HE21 ' HA ' ' A' ' 82' ' ' LYS . 3.7 mt-30 -41.83 -51.91 4.14 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.583 ' H ' ' HB3' ' A' ' 82' ' ' LYS . . . -42.23 -78.48 0.07 OUTLIER Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.686 ' HB3' ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -47.68 -37.94 13.98 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.555 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 18.3 mt-10 -62.51 -22.78 66.55 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 60' ' ' GLY . 4.7 mt-10 -88.54 -34.8 17.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.437 ' HB3' HD13 ' A' ' 147' ' ' ILE . . . -64.54 -30.39 71.42 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.555 HG21 ' N ' ' A' ' 66' ' ' LEU . 29.9 m -86.14 -32.8 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.555 ' N ' HG21 ' A' ' 65' ' ' VAL . 2.9 mt -41.87 -43.25 2.97 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.36 50.4 0.81 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.515 ' SD ' ' N ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -145.07 119.3 9.51 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.716 ' HA ' ' N ' ' A' ' 4' ' ' MET . 3.2 mp0 -73.74 -168.77 0.62 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.608 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 34.5 t -79.29 113.93 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.79 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 108.99 -3.45 31.72 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.507 ' HB3' ' HG2' ' A' ' 68' ' ' MET . 0.7 OUTLIER -73.13 169.9 16.05 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.515 ' N ' ' SD ' ' A' ' 68' ' ' MET . 1.5 tt0 -150.15 139.16 21.05 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.5 ttmm -147.22 97.99 2.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.769 HG21 ' HG1' ' A' ' 146' ' ' THR . 28.6 m -93.71 90.63 6.66 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.9 t -126.41 145.69 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.632 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 5.6 ttpm? -76.44 115.08 15.85 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.68 ' CG1' ' CD2' ' A' ' 145' ' ' PHE . 37.5 mm -78.31 131.46 68.84 Favored Pre-proline 0 N--CA 1.45 -0.449 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.522 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 84.2 Cg_endo -72.41 139.44 31.73 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 124.35 3.367 . . . . 0.0 109.567 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.649 ' CB ' ' N ' ' A' ' 141' ' ' LYS . . . -52.01 -14.52 0.41 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.565 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 7.5 tt0 -78.85 -37.22 40.98 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.878 ' HA ' HE21 ' A' ' 59' ' ' GLN . 14.1 mttm -85.04 -36.27 21.34 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.647 ' HA ' ' CG2' ' A' ' 58' ' ' ILE . . . -67.55 -92.43 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.618 ' CE2' ' CD2' ' A' ' 136' ' ' HIS . 0.5 OUTLIER -103.72 17.1 24.82 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 65.09 144.09 0.03 OUTLIER Glycine 0 C--N 1.335 0.523 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.651 ' H ' ' ND2' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -39.75 150.84 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.464 ' HG3' ' HA3' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -39.37 120.99 1.11 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.494 ' H ' HD11 ' A' ' 91' ' ' LEU . 7.7 t30 -80.11 147.23 31.48 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.442 ' HG2' HD13 ' A' ' 92' ' ' ILE . 1.8 tt0 -73.87 -33.72 64.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -17.51 62.42 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.709 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 13.0 mt -79.11 0.06 29.62 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 11.6 mt -94.31 118.94 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.611 HE22 ' C ' ' A' ' 91' ' ' LEU . 2.9 mp0 -109.08 171.61 7.33 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.432 ' HG3' ' HA ' ' A' ' 131' ' ' THR . 0.0 OUTLIER -143.2 81.76 1.73 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.578 ' H ' HD12 ' A' ' 132' ' ' LEU . 26.4 pt -79.8 155.87 75.35 Favored Pre-proline 0 N--CA 1.449 -0.485 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.578 ' HA ' ' HG3' ' A' ' 129' ' ' GLU . 83.1 Cg_endo -72.37 137.08 27.6 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 124.316 3.344 . . . . 0.0 109.624 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.814 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -42.61 -33.45 0.71 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 100' ' ' PHE . 2.5 m-20 -66.07 -36.88 84.4 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -44.3 -19.68 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.61 ' CD2' ' HD3' ' A' ' 107' ' ' PRO . 3.1 m-85 -124.47 -30.32 3.39 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.426 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 4.3 tttt -60.63 -19.8 59.02 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.59 18.08 22.91 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -103.85 -137.61 0.35 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.45 -0.57 4.46 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.486 ' HB2' ' H ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -134.89 -149.81 0.36 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.502 ' HG2' ' HD2' ' A' ' 107' ' ' PRO . 1.8 tt0 -161.78 136.31 5.23 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.814 ' CG ' HH21 ' A' ' 97' ' ' ARG . 83.1 Cg_endo -72.41 141.48 35.24 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 124.279 3.319 . . . . 0.0 109.624 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.521 ' HA ' HG23 ' A' ' 125' ' ' VAL . 1.0 OUTLIER -130.81 157.58 42.46 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.434 ' HB2' HG12 ' A' ' 125' ' ' VAL . 1.9 tt0 -65.74 66.16 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 152.27 11.64 0.08 OUTLIER Glycine 0 C--N 1.335 0.477 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.543 ' HB3' ' CD1' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -66.24 171.15 4.99 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.502 ' CG1' ' HB2' ' A' ' 119' ' ' PRO . 60.7 t -156.49 70.87 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.41 134.99 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.627 HD23 ' CD ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -103.29 144.75 30.94 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -96.02 0.49 51.7 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.409 ' H ' ' H ' ' A' ' 117' ' ' GLY . 0.6 OUTLIER 170.82 -7.16 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.409 ' H ' ' H ' ' A' ' 116' ' ' GLU . . . 164.69 -38.82 0.3 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.434 ' HA ' ' HD2' ' A' ' 119' ' ' PRO . 5.3 mt -87.42 114.71 59.99 Favored Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.627 ' CD ' HD23 ' A' ' 114' ' ' LEU . 82.8 Cg_endo -72.44 156.18 54.63 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 124.246 3.297 . . . . 0.0 109.575 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -116.37 94.06 4.48 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.511 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 1.3 m -64.84 98.4 0.27 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.725 ' HA ' ' HA ' ' A' ' 132' ' ' LEU . 2.9 mp -70.41 100.13 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.45 HG23 HG23 ' A' ' 121' ' ' THR . 2.5 p -83.28 -21.89 33.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.821 ' HB3' ' H ' ' A' ' 131' ' ' THR . 0.4 OUTLIER -121.84 131.52 54.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.521 HG23 ' HA ' ' A' ' 108' ' ' GLU . 11.3 p -122.29 51.59 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.7 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -78.72 126.26 30.49 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.667 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.3 OUTLIER -53.36 2.84 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.7 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.3 OUTLIER -113.51 -21.96 10.57 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.578 ' HG3' ' HA ' ' A' ' 96' ' ' PRO . 1.4 mt-10 -173.96 168.43 4.19 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.561 ' CG2' ' CG1' ' A' ' 95' ' ' ILE . 18.1 m -135.07 122.55 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.821 ' H ' ' HB3' ' A' ' 124' ' ' GLU . 9.4 m -88.12 88.28 7.59 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.725 ' HA ' ' HA ' ' A' ' 122' ' ' ILE . 0.1 OUTLIER -76.66 163.18 27.1 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.742 ' CG ' HD22 ' A' ' 135' ' ' ASN . 31.8 t0 -139.69 95.96 3.0 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.597 ' N ' ' O ' ' A' ' 91' ' ' LEU . 4.5 m-30 -37.5 -81.08 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.742 HD22 ' CG ' ' A' ' 133' ' ' ASP . 0.6 OUTLIER 58.04 100.87 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 1.062 ' HD1' ' N ' ' A' ' 138' ' ' LEU . 14.3 t-80 -43.11 158.47 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.706 ' HG2' ' CE1' ' A' ' 136' ' ' HIS . 0.7 OUTLIER -54.78 -13.9 1.21 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 1.062 ' N ' ' HD1' ' A' ' 136' ' ' HIS . 11.3 mt -114.09 -5.34 13.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.549 ' HB3' ' N ' ' A' ' 136' ' ' HIS . . . -55.25 133.26 49.25 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.464 ' HA3' ' HG3' ' A' ' 87' ' ' ARG . . . 48.5 17.94 0.85 Allowed Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.702 ' HE2' ' HB3' ' A' ' 143' ' ' LEU . 0.0 OUTLIER -124.95 129.57 50.61 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.549 ' C ' ' HD3' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -96.43 131.22 43.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.702 ' HB3' ' HE2' ' A' ' 141' ' ' LYS . 0.5 OUTLIER -123.31 152.21 41.65 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.632 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 2.2 t -65.78 160.36 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.68 ' CD2' ' CG1' ' A' ' 78' ' ' ILE . 14.3 m-85 -146.85 92.15 2.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.769 ' HG1' HG21 ' A' ' 75' ' ' THR . 89.8 m -86.18 63.35 7.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.615 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.7 mt -60.94 174.24 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.423 ' H ' HG23 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -178.65 103.29 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.79 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -60.57 140.97 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.549 HD12 ' N ' ' A' ' 14' ' ' ASP . 2.8 mt -122.75 -47.12 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.608 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 5.1 tt0 -151.52 -164.05 1.9 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.61 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 95.8 t -141.42 141.03 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.742 ' CG1' ' H ' ' A' ' 154' ' ' GLU . 24.1 t -120.96 -135.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.775 ' HB2' ' H ' ' A' ' 10' ' ' LYS . 1.8 tm-20 . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.629 ' CB ' ' HA ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.817 HG11 ' H ' ' A' ' 6' ' ' ASP . 3.4 t -103.12 -176.69 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.817 ' H ' HG11 ' A' ' 5' ' ' VAL . 52.5 m-20 -152.21 159.8 43.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.521 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 50.9 mtpt -66.93 79.63 0.12 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.565 ' HA2' ' HA3' ' A' ' 53' ' ' GLY . . . 157.78 -1.93 0.12 Allowed Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.478 ' HB ' ' CG1' ' A' ' 5' ' ' VAL . 1.3 t -106.33 130.25 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.782 ' H ' ' HB2' ' A' ' 154' ' ' GLU . 8.7 tttp -84.33 148.88 26.41 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.6 HG13 ' CE1' ' A' ' 50' ' ' PHE . 4.2 pt -160.27 136.28 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 11.3 ttmt -96.35 105.69 17.79 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.503 HG13 ' HA ' ' A' ' 149' ' ' ILE . 0.8 OUTLIER -122.44 160.62 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.513 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 0.5 OUTLIER -114.72 98.55 6.92 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.768 ' HH ' ' HB3' ' A' ' 26' ' ' ASP . 1.2 p90 -94.8 161.33 14.21 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.608 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 7.0 mt -138.91 80.04 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -67.87 131.03 28.24 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 110.314 -1.115 . . . . 0.0 110.314 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.646 ' HE2' HG23 ' A' ' 24' ' ' VAL . 4.8 mtmt -119.5 -171.67 2.17 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.739 ' C ' ' H ' ' A' ' 21' ' ' SER . 50.2 mt -108.25 168.76 9.08 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -60.07 13.36 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.739 ' H ' ' C ' ' A' ' 19' ' ' LEU . 98.7 p -124.58 -6.63 7.49 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.31 23.97 32.81 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.43 ' C ' ' HG2' ' A' ' 18' ' ' LYS . 4.0 m-20 -94.34 117.71 30.52 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.646 HG23 ' HE2' ' A' ' 18' ' ' LYS . 76.1 t -70.81 112.93 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.562 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -100.02 -40.43 7.64 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.768 ' HB3' ' HH ' ' A' ' 15' ' ' TYR . 21.3 t0 -134.4 127.53 31.77 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.582 ' HB ' ' CG2' ' A' ' 16' ' ' ILE . 3.7 t -148.13 155.92 42.0 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.513 ' HB2' ' HA ' ' A' ' 14' ' ' ASP . 5.4 m -103.78 -21.39 13.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.753 HG22 ' H ' ' A' ' 32' ' ' VAL . 3.9 mt -83.78 96.71 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.433 ' CA ' ' HB2' ' A' ' 45' ' ' TYR . 3.2 tt0 -43.31 -24.17 0.08 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.443 ' HB3' ' CG2' ' A' ' 29' ' ' ILE . 20.3 tt0 -60.54 -61.39 2.63 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.753 ' H ' HG22 ' A' ' 29' ' ' ILE . 95.2 t -53.75 -41.09 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.543 ' HA ' HG13 ' A' ' 38' ' ' ILE . . . -48.29 -40.5 25.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.517 ' CG ' ' HB2' ' A' ' 39' ' ' TYR . 15.7 mtpt -76.54 -25.2 53.86 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -84.45 -13.38 52.23 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.97 -10.41 15.05 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.56 44.22 11.11 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.543 HG13 ' HA ' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -141.46 14.12 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.517 ' HB2' ' CG ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -44.31 -19.15 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.497 ' HB1' ' CB ' ' A' ' 43' ' ' ARG . . . 73.71 169.33 0.12 Allowed Pre-proline 0 N--CA 1.45 -0.473 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.725 ' HG2' ' H ' ' A' ' 42' ' ' ASP . 82.2 Cg_endo -72.47 -82.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 124.274 3.316 . . . . 0.0 109.623 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.725 ' H ' ' HG2' ' A' ' 41' ' ' PRO . 10.4 p-10 -103.48 -15.1 15.97 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.497 ' CB ' ' HB1' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -42.91 151.68 0.12 Allowed 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.436 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 50.5 mt-10 -130.8 100.72 5.37 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.491 ' CD1' ' O ' ' A' ' 27' ' ' THR . 16.9 m-85 -68.37 91.91 0.41 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.646 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -101.27 177.3 1.55 Allowed Pre-proline 0 N--CA 1.45 -0.452 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.646 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 82.3 Cg_endo -72.4 130.77 16.63 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 124.27 3.313 . . . . 0.0 109.546 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 tp -97.96 118.74 35.22 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.665 ' HB2' ' HE3' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -89.5 98.29 11.69 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.791 ' HB2' HE21 ' A' ' 56' ' ' GLN . 7.9 p90 -96.63 169.81 9.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.522 HG22 ' CB ' ' A' ' 10' ' ' LYS . 54.4 t -131.62 102.92 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.521 ' HB ' ' HA ' ' A' ' 7' ' ' LYS . 2.9 t -44.54 -17.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.565 ' HA3' ' HA2' ' A' ' 8' ' ' GLY . . . -108.55 40.87 2.39 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.449 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 2.0 mt-10 -138.26 -23.72 1.0 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.33 8.46 85.15 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.791 HE21 ' HB2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -42.43 -83.64 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.593 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 3.8 mp -76.46 165.52 24.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.668 ' HB ' ' HA ' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -56.84 145.25 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.415 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 1.5 mt-30 -43.14 -42.76 4.24 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 63' ' ' GLU . . . -41.63 -83.85 0.01 OUTLIER Glycine 0 C--N 1.336 0.552 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.649 ' CD1' ' N ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -43.93 -46.37 8.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.649 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 3.4 mt-10 -51.22 -29.69 15.0 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.481 ' N ' ' O ' ' A' ' 60' ' ' GLY . 2.8 mt-10 -85.32 -33.88 21.99 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.441 ' CB ' ' HD2' ' A' ' 74' ' ' LYS . . . -67.45 -25.87 66.12 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.582 ' HA ' ' HB2' ' A' ' 68' ' ' MET . 5.8 m -88.63 -28.61 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.546 ' CD2' ' HA ' ' A' ' 6' ' ' ASP . 4.1 mt -48.42 -25.89 1.84 Allowed 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.629 ' HA ' ' CB ' ' A' ' 4' ' ' MET . 0.7 OUTLIER -125.5 47.9 2.13 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.605 ' SD ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -140.01 102.41 4.39 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.507 ' N ' ' CG ' ' A' ' 72' ' ' ASP . 1.7 mp0 -61.47 -178.38 0.13 Allowed 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.647 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 1.9 t -71.34 109.36 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.835 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 110.35 -5.04 29.88 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.507 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 0.9 OUTLIER -70.97 173.21 7.76 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.605 ' N ' ' SD ' ' A' ' 68' ' ' MET . 0.2 OUTLIER -150.29 143.04 24.66 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.441 ' HD2' ' CB ' ' A' ' 64' ' ' ALA . 7.0 ttmt -146.05 103.93 3.78 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.601 ' CG2' ' CG2' ' A' ' 146' ' ' THR . 0.2 OUTLIER -103.62 114.33 28.51 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 77' ' ' LYS . 54.8 t -157.91 159.25 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.6 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 4.6 ttpm? -86.14 116.73 24.52 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.707 ' CG1' ' CD2' ' A' ' 145' ' ' PHE . 34.9 mm -79.26 118.87 74.86 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.512 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 84.6 Cg_endo -72.33 138.43 30.17 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 124.381 3.387 . . . . 0.0 109.573 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.689 ' CB ' ' H ' ' A' ' 85' ' ' GLY . . . -44.32 -34.19 1.87 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.437 ' HG2' ' HG2' ' A' ' 79' ' ' PRO . 3.7 pt-20 -55.62 -32.28 62.99 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.411 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 14.7 mtmt -106.48 -0.34 24.1 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.668 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . . . -121.44 -82.31 0.65 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.578 ' CE2' ' HB2' ' A' ' 138' ' ' LEU . 3.9 m-85 -107.9 -48.07 3.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.689 ' H ' ' CB ' ' A' ' 80' ' ' ALA . . . 101.35 154.88 26.56 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.783 ' H ' ' ND2' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -36.61 137.03 0.32 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.591 ' CD ' ' HA3' ' A' ' 140' ' ' GLY . 0.3 OUTLIER -39.84 143.77 0.23 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -79.57 140.05 37.31 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -65.74 -27.46 68.33 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -14.65 61.63 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.834 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 52.6 mt -85.15 7.62 21.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.592 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 62.1 mt -87.93 120.25 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.535 HE22 ' HB2' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -116.57 146.65 42.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.39 118.73 31.93 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.527 ' CG2' HD12 ' A' ' 132' ' ' LEU . 36.3 pt -114.45 152.29 45.97 Favored Pre-proline 0 N--CA 1.449 -0.48 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.573 ' HA ' ' HG3' ' A' ' 129' ' ' GLU . 84.7 Cg_endo -72.34 129.97 15.63 Favored 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 124.292 3.328 . . . . 0.0 109.654 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.881 HH21 ' HG3' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -41.98 -28.98 0.19 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.501 ' HA ' ' HB2' ' A' ' 101' ' ' LYS . 28.7 t70 -65.08 -38.14 89.78 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -50.09 -28.41 7.15 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.545 ' C ' ' H ' ' A' ' 102' ' ' GLU . 1.2 m-85 -107.96 -26.82 10.52 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.501 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -60.45 -0.85 0.29 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.545 ' H ' ' C ' ' A' ' 100' ' ' PHE . 5.1 pt-20 -120.14 22.27 11.48 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -104.47 -137.93 0.36 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -140.85 -3.11 1.28 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.45 ' HB2' ' H ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -123.02 -149.48 0.43 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.45 ' H ' ' HB2' ' A' ' 105' ' ' PHE . 1.0 OUTLIER -158.77 125.0 2.43 Favored Pre-proline 0 N--CA 1.449 -0.511 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.881 ' HG3' HH21 ' A' ' 97' ' ' ARG . 83.7 Cg_endo -72.4 141.97 36.15 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 124.408 3.405 . . . . 0.0 109.559 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.52 ' HA ' HG23 ' A' ' 125' ' ' VAL . 0.7 OUTLIER -133.16 159.45 40.1 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.482 ' HB2' ' CG1' ' A' ' 125' ' ' VAL . 0.9 OUTLIER -64.73 67.71 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 156.44 8.07 0.06 OUTLIER Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.553 ' CB ' ' CD1' ' A' ' 122' ' ' ILE . 0.5 OUTLIER -63.43 172.62 1.92 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.522 HG11 ' CB ' ' A' ' 119' ' ' PRO . 76.3 t -156.86 65.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.68 136.87 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.638 ' CD2' ' HD3' ' A' ' 119' ' ' PRO . 0.3 OUTLIER -103.38 153.03 20.91 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -105.9 2.72 27.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 173.28 -13.65 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.401 ' O ' ' CD2' ' A' ' 114' ' ' LEU . . . 168.25 -33.65 0.19 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 3.0 mt -94.51 122.19 61.58 Favored Pre-proline 0 N--CA 1.448 -0.535 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.638 ' HD3' ' CD2' ' A' ' 114' ' ' LEU . 81.7 Cg_endo -72.36 169.71 20.99 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 124.313 3.342 . . . . 0.0 109.549 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -126.79 67.98 1.25 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.529 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 6.2 m -41.77 100.26 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.712 ' HA ' ' HA ' ' A' ' 132' ' ' LEU . 2.6 mp -71.42 94.8 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.671 ' HG1' HG23 ' A' ' 131' ' ' THR . 1.3 p -77.08 -25.43 52.33 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.509 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 0.6 OUTLIER -122.46 129.28 51.86 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.52 HG23 ' HA ' ' A' ' 108' ' ' GLU . 7.7 p -115.82 59.56 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.688 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.2 OUTLIER -79.71 119.84 23.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.421 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 0.3 OUTLIER -48.9 -3.66 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.688 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.2 OUTLIER -113.73 -25.07 8.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.843 ' HA ' HH11 ' A' ' 97' ' ' ARG . 1.4 mt-10 -167.76 167.16 13.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.673 ' CG2' ' NH2' ' A' ' 97' ' ' ARG . 16.6 m -132.56 146.57 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.671 HG23 ' HG1' ' A' ' 123' ' ' THR . 65.9 m -102.71 64.16 0.87 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.712 ' HA ' ' HA ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -58.91 151.06 22.6 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.82 ' CG ' HD22 ' A' ' 135' ' ' ASN . 12.5 t0 -124.38 97.15 5.19 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.546 ' N ' ' O ' ' A' ' 91' ' ' LEU . 1.6 m-30 -39.47 -78.84 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.834 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 0.5 OUTLIER 68.0 -131.93 0.11 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 1.184 ' HD1' ' N ' ' A' ' 138' ' ' LEU . 8.2 t-80 -172.12 176.51 3.45 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.749 -0.464 . . . . 0.0 109.749 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.742 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -70.56 -6.61 37.71 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 1.184 ' N ' ' HD1' ' A' ' 136' ' ' HIS . 56.9 mt -126.78 -12.02 6.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.562 ' HB2' ' H ' ' A' ' 136' ' ' HIS . . . -57.21 133.41 55.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.658 ' HA2' ' HA ' ' A' ' 86' ' ' ASN . . . 39.94 39.75 1.5 Allowed Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.839 ' HE2' ' CD2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -145.48 145.32 31.03 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.512 ' HB3' ' HA ' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -103.57 124.3 48.53 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.689 ' CD2' ' H ' ' A' ' 143' ' ' LEU . 1.6 pt? -107.61 143.64 35.79 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.6 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 2.1 t -60.69 164.9 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.707 ' CD2' ' CG1' ' A' ' 78' ' ' ILE . 9.9 m-85 -153.03 97.03 2.15 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.601 ' CG2' ' CG2' ' A' ' 75' ' ' THR . 30.7 m -94.71 70.28 3.49 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.661 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -69.0 172.07 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.413 ' H ' HG21 ' A' ' 147' ' ' ILE . 0.7 OUTLIER -175.1 103.38 0.09 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.835 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 3.7 mm -58.68 146.93 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.492 HG13 ' HA ' ' A' ' 13' ' ' VAL . 15.6 mt -131.4 -42.33 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.647 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 2.0 mt-10 -153.44 -163.89 1.78 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 61.4 t -143.87 140.19 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.781 HG12 ' H ' ' A' ' 154' ' ' GLU . 32.9 t -119.83 -133.95 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.782 ' HB2' ' H ' ' A' ' 10' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.652 ' CG1' ' N ' ' A' ' 6' ' ' ASP . 1.6 t . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.652 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 0.4 OUTLIER -151.51 172.82 15.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.578 ' HG3' HG12 ' A' ' 52' ' ' VAL . 31.6 mtpt -61.23 77.05 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.625 ' N ' ' HA3' ' A' ' 53' ' ' GLY . . . 145.21 18.05 0.17 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.481 ' HB ' HG13 ' A' ' 5' ' ' VAL . 1.2 t -128.75 132.64 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.617 ' HE2' HG23 ' A' ' 51' ' ' VAL . 2.8 ttmt -92.5 152.45 19.65 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.853 HG22 HG22 ' A' ' 152' ' ' VAL . 1.3 pt -153.25 126.86 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.441 ' HG3' ' HB3' ' A' ' 49' ' ' GLU . 4.6 mtmt -83.48 87.51 7.0 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.467 HG21 ' CG2' ' A' ' 147' ' ' ILE . 0.8 OUTLIER -112.47 154.21 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.684 ' HB2' HD11 ' A' ' 29' ' ' ILE . 1.1 m-20 -118.37 96.46 5.31 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.604 ' CB ' ' HA ' ' A' ' 147' ' ' ILE . 4.7 p90 -90.36 154.5 19.64 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 1.011 HG21 HG11 ' A' ' 32' ' ' VAL . 1.2 mt -121.3 71.84 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -55.1 128.38 43.67 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.603 ' HE3' ' O ' ' A' ' 16' ' ' ILE . 5.8 mtmt -120.21 -170.51 1.98 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.633 ' C ' ' H ' ' A' ' 21' ' ' SER . 6.0 mt -111.48 164.93 12.43 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -55.19 1.69 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.633 ' H ' ' C ' ' A' ' 19' ' ' LEU . 83.0 p -114.01 -4.61 13.19 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.44 25.72 32.41 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.564 ' HB2' HD12 ' A' ' 19' ' ' LEU . 93.2 m-20 -96.31 119.25 34.46 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.53 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 86.1 t -69.06 112.81 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.465 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 1.7 p90 -100.77 -31.59 11.11 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.465 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 9.8 t0 -143.24 133.95 25.17 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.872 ' HB ' HG23 ' A' ' 16' ' ' ILE . 1.4 t -153.68 136.48 15.32 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.598 ' HB2' ' HA ' ' A' ' 14' ' ' ASP . 2.8 m -83.84 -26.04 29.83 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.684 HD11 ' HB2' ' A' ' 14' ' ' ASP . 3.0 mt -82.73 106.86 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.728 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 2.0 tt0 -50.44 -37.11 36.46 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -49.36 -66.26 0.43 Allowed 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.011 HG11 HG21 ' A' ' 16' ' ' ILE . 5.0 t -47.59 -39.44 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.747 ' HB1' ' HA ' ' A' ' 39' ' ' TYR . . . -46.42 -46.55 18.74 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.55 ' HG2' ' CB ' ' A' ' 39' ' ' TYR . 3.3 mtmt -68.35 -32.01 71.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.58 -12.41 60.75 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.42 ' CB ' ' HB ' ' A' ' 24' ' ' VAL . . . -116.95 -7.08 11.42 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.33 47.47 35.86 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.536 HG13 ' HA ' ' A' ' 33' ' ' ALA . 1.2 pt -140.13 8.61 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.747 ' HA ' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -45.59 -16.37 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.468 ' HB2' ' CA ' ' A' ' 30' ' ' GLU . 56.5 m-85 . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.662 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -111.58 177.87 1.11 Allowed Pre-proline 0 N--CA 1.449 -0.506 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.662 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 84.2 Cg_endo -72.34 125.95 11.21 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 124.295 3.33 . . . . 0.0 109.632 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.481 ' CD2' HD21 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -89.24 112.66 23.76 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -85.32 97.35 9.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.874 ' CE2' HG21 ' A' ' 65' ' ' VAL . 40.3 p90 -99.56 160.63 14.15 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.731 HG12 ' H ' ' A' ' 53' ' ' GLY . 41.0 t -123.37 112.78 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.7 HG11 HD21 ' A' ' 66' ' ' LEU . 32.4 t -54.78 -11.64 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.731 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -114.91 46.55 1.15 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.427 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 4.2 mt-10 -151.9 -8.6 0.21 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.85 12.11 64.2 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.501 ' OE1' ' CB ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -44.41 -78.56 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.56 ' N ' ' CD1' ' A' ' 57' ' ' LEU . 5.8 mp -84.87 165.7 17.48 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.851 ' N ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -56.45 136.88 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.516 ' HA ' ' HB2' ' A' ' 62' ' ' GLU . 4.1 mt-30 -41.79 -60.06 1.48 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.759 ' CA ' ' HE3' ' A' ' 82' ' ' LYS . . . -30.25 -68.87 0.09 OUTLIER Glycine 0 C--N 1.335 0.522 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.663 ' HE2' HG23 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -57.19 -44.32 83.48 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 59' ' ' GLN . 4.1 mt-10 -55.34 -23.68 25.19 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.909 ' HA ' HD12 ' A' ' 66' ' ' LEU . 12.0 mt-10 -87.97 -39.06 15.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.816 ' HB1' ' HD2' ' A' ' 74' ' ' LYS . . . -62.22 -13.42 27.67 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.874 HG21 ' CE2' ' A' ' 50' ' ' PHE . 4.5 m -106.96 -26.55 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.909 HD12 ' HA ' ' A' ' 63' ' ' GLU . 2.2 mt -47.55 -31.53 4.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -118.12 49.66 1.24 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.963 ' HE2' HD11 ' A' ' 149' ' ' ILE . 2.5 mtp -138.02 118.49 13.83 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -69.2 -173.44 0.53 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.651 HG22 HG23 ' A' ' 152' ' ' VAL . 3.1 t -80.92 106.27 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.653 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 118.01 -5.56 15.83 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.525 ' HB3' ' HG2' ' A' ' 68' ' ' MET . 0.6 OUTLIER -71.03 170.49 12.72 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.25 126.18 9.07 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.816 ' HD2' ' HB1' ' A' ' 64' ' ' ALA . 19.1 ttmm -131.64 95.71 3.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.626 ' OG1' HG23 ' A' ' 146' ' ' THR . 91.6 m -88.76 77.81 7.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 3.6 t -111.77 164.97 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 2.5 ttpt -104.81 116.21 31.62 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.639 HD13 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -79.06 134.88 59.04 Favored Pre-proline 0 N--CA 1.449 -0.521 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.512 ' C ' ' H ' ' A' ' 81' ' ' GLU . 84.1 Cg_endo -72.44 138.77 30.48 Favored 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 124.28 3.32 . . . . 0.0 109.633 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.734 ' HB2' ' N ' ' A' ' 141' ' ' LYS . . . -49.59 -10.66 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.595 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 1.0 OUTLIER -80.23 -39.03 29.85 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.759 ' HE3' ' CA ' ' A' ' 60' ' ' GLY . 2.0 mtpp -86.78 -32.46 20.35 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.625 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . . . -72.46 -93.81 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.442 ' HD1' ' N ' ' A' ' 84' ' ' TYR . 1.7 m-85 -97.87 18.54 15.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.595 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 41.64 83.93 0.01 OUTLIER Glycine 0 C--N 1.336 0.537 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.545 ' HA ' ' HA2' ' A' ' 140' ' ' GLY . 0.0 OUTLIER 46.72 -164.84 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.558 ' HD2' ' ND2' ' A' ' 135' ' ' ASN . 0.9 OUTLIER -90.59 154.44 19.59 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.835 ' CB ' HD12 ' A' ' 91' ' ' LEU . 0.4 OUTLIER -91.41 153.61 19.75 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -90.09 -25.77 20.58 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.74 1.58 16.78 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.87 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 19.9 mt -104.5 5.47 34.06 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.606 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 52.3 mt -82.96 107.94 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 131' ' ' THR . 5.4 mp0 -100.13 165.56 11.45 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.912 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -147.0 99.26 3.15 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.007 HG12 HD11 ' A' ' 132' ' ' LEU . 20.7 pt -96.47 155.19 38.2 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.55 ' O ' ' N ' ' A' ' 99' ' ' ALA . 83.7 Cg_endo -72.34 137.68 28.76 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 124.311 3.341 . . . . 0.0 109.598 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.867 HH21 ' HD2' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -41.64 -34.81 0.65 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.602 ' HA ' ' CB ' ' A' ' 101' ' ' LYS . 6.3 t70 -63.17 -37.06 85.71 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -45.87 -16.39 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.545 ' CD1' ' HB3' ' A' ' 105' ' ' PHE . 2.1 m-85 -137.52 -24.09 1.07 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.602 ' CB ' ' HA ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -41.57 -41.07 2.05 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -90.99 43.77 1.16 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.541 ' C ' ' H ' ' A' ' 105' ' ' PHE . . . -174.94 127.89 0.29 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.487 ' C ' ' N ' ' A' ' 106' ' ' GLU . 2.7 p30 -49.01 -9.28 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.866 ' CE1' HD12 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -47.04 -14.85 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.684 ' C ' ' O ' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -4.32 99.85 0.03 OUTLIER Pre-proline 0 N--CA 1.45 -0.452 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.917 ' HG2' HG11 ' A' ' 130' ' ' VAL . 84.1 Cg_endo -72.4 151.64 53.99 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 124.287 3.325 . . . . 0.0 109.602 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 110' ' ' GLY . 2.9 mt-10 -132.67 156.59 46.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.555 ' HB2' HG12 ' A' ' 125' ' ' VAL . 1.1 tt0 -65.81 66.98 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.8 10.02 0.08 OUTLIER Glycine 0 C--N 1.335 0.509 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.828 ' CB ' HD13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -69.97 170.67 10.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.508 HG13 ' HB2' ' A' ' 119' ' ' PRO . 60.9 t -156.23 73.94 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.866 HD12 ' CE1' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -105.46 135.48 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.626 HD23 ' CD ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -105.04 161.55 14.12 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -108.51 5.23 24.99 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.44 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 0.9 OUTLIER 166.29 -11.09 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.72 -43.04 0.21 Allowed Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.451 ' HA ' ' HD2' ' A' ' 119' ' ' PRO . 3.6 mt -82.51 112.46 36.99 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.626 ' CD ' HD23 ' A' ' 114' ' ' LEU . 83.5 Cg_endo -72.31 165.59 32.21 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 124.322 3.348 . . . . 0.0 109.588 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.863 ' HB1' ' HB3' ' A' ' 132' ' ' LEU . . . -126.91 90.87 3.23 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 6.0 m -62.55 95.54 0.07 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.828 HD13 ' CB ' ' A' ' 111' ' ' MET . 2.6 mp -68.98 89.98 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 121' ' ' THR . 30.7 p -80.1 -17.74 51.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.712 ' HB3' ' H ' ' A' ' 131' ' ' THR . 0.8 OUTLIER -119.99 130.85 54.94 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.707 ' HA ' HG12 ' A' ' 130' ' ' VAL . 7.9 p -124.26 52.92 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.68 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.2 OUTLIER -79.07 126.49 30.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.539 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.3 OUTLIER -52.12 0.06 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.68 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -111.7 -21.14 11.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.6 OUTLIER -178.84 167.02 1.69 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.917 HG11 ' HG2' ' A' ' 107' ' ' PRO . 19.7 m -132.62 141.16 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.912 HG23 ' HD2' ' A' ' 94' ' ' LYS . 23.5 m -96.49 83.91 3.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 1.007 HD11 HG12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -78.93 97.08 5.89 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.606 ' HA ' ' HA ' ' A' ' 92' ' ' ILE . 25.5 t0 -71.17 97.52 1.53 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.498 ' N ' ' O ' ' A' ' 91' ' ' LEU . 2.1 m-30 -42.89 -56.91 3.05 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.87 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 71.1 m-20 55.98 -118.04 1.18 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.631 ' ND1' ' N ' ' A' ' 138' ' ' LEU . 24.1 t-80 -175.19 174.16 2.46 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.603 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 4.8 tp10 -65.84 -43.9 87.12 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.823 HD22 ' HE2' ' A' ' 141' ' ' LYS . 25.4 mt -97.46 10.79 38.82 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.596 ' HB2' ' HB3' ' A' ' 136' ' ' HIS . . . -62.52 133.76 55.41 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 86' ' ' ASN . . . 41.73 36.56 1.73 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 110.234 -1.147 . . . . 0.0 110.234 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.823 ' HE2' HD22 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -146.6 144.04 29.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.505 ' C ' ' HD2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -95.71 143.12 27.24 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.838 HD11 ' CZ ' ' A' ' 145' ' ' PHE . 0.4 OUTLIER -130.67 154.06 48.31 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.601 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 0.5 OUTLIER -73.71 168.46 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.838 ' CZ ' HD11 ' A' ' 143' ' ' LEU . 26.8 m-85 -154.97 90.24 1.28 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.626 HG23 ' OG1' ' A' ' 75' ' ' THR . 96.0 m -81.6 58.8 3.87 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.663 HG23 ' HE2' ' A' ' 61' ' ' PHE . 3.2 mt -53.31 175.09 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.584 ' H ' HG22 ' A' ' 147' ' ' ILE . 3.2 tmtt? -177.59 96.64 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.963 HD11 ' HE2' ' A' ' 68' ' ' MET . 1.4 mm -62.21 134.22 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.408 HG13 ' HA ' ' A' ' 13' ' ' VAL . 8.9 mt -122.12 -26.51 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.591 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 2.1 tt0 -162.74 -175.41 4.42 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.853 HG22 HG22 ' A' ' 11' ' ' ILE . 73.8 t -140.27 137.45 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.435 ' C ' ' HB3' ' A' ' 10' ' ' LYS . 2.3 t . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.902 ' CG2' HD13 ' A' ' 11' ' ' ILE . 9.2 t . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 109.767 -0.456 . . . . 0.0 109.767 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 8' ' ' GLY . 19.4 m-20 -146.78 164.75 31.78 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.524 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 17.3 ptmt -63.44 70.18 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.664 ' N ' ' HA3' ' A' ' 53' ' ' GLY . . . 155.19 16.63 0.05 OUTLIER Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.536 ' HB ' HG13 ' A' ' 5' ' ' VAL . 2.5 t -126.65 136.33 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.842 ' CA ' HG22 ' A' ' 51' ' ' VAL . 2.7 tttt -88.27 158.27 18.52 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.902 HD13 ' CG2' ' A' ' 5' ' ' VAL . 1.8 pt -166.23 133.49 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.744 ' HE2' HG22 ' A' ' 153' ' ' VAL . 18.3 mtmt -87.18 85.12 7.18 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.719 HG11 HD12 ' A' ' 149' ' ' ILE . 0.9 OUTLIER -122.8 158.75 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.449 ' O ' ' CG2' ' A' ' 147' ' ' ILE . 10.9 m-20 -114.55 -160.18 0.72 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.5 p90 -179.44 155.87 0.7 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.991 HG21 HG11 ' A' ' 32' ' ' VAL . 1.3 mt -127.39 73.21 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -54.68 134.02 47.01 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.579 ' HG2' ' N ' ' A' ' 24' ' ' VAL . 8.1 mttt -123.92 -162.75 1.08 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.63 ' C ' ' H ' ' A' ' 21' ' ' SER . 39.9 mt -118.28 165.65 13.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -55.02 0.97 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.63 ' H ' ' C ' ' A' ' 19' ' ' LEU . 53.5 p -114.85 1.38 14.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.9 28.53 50.12 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.221 -1.151 . . . . 0.0 110.221 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.453 ' C ' ' HG2' ' A' ' 18' ' ' LYS . 98.1 m-20 -99.85 121.97 42.11 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.579 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 76.0 t -66.18 134.71 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.532 ' CE1' ' HB2' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -128.07 -28.87 2.59 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.532 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 11.3 t0 -145.68 132.17 19.75 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.966 ' HB ' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -152.26 126.67 9.34 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 73.0 m -86.49 14.13 7.28 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.9 mt -113.11 116.85 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 1.1 tt0 -54.01 -41.6 68.15 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -52.54 -70.78 0.08 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.991 HG11 HG21 ' A' ' 16' ' ' ILE . 67.5 t -48.48 -41.44 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.734 ' HB1' ' HA ' ' A' ' 39' ' ' TYR . . . -50.05 -38.34 37.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.522 ' CG ' ' HB2' ' A' ' 39' ' ' TYR . 22.0 mtpt -79.54 -21.4 45.22 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -87.21 -10.88 51.43 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.4 -10.66 12.61 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.68 43.57 10.05 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.548 HG13 ' HA ' ' A' ' 33' ' ' ALA . 0.4 OUTLIER -141.85 16.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.734 ' HA ' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -47.62 -13.25 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.519 ' CD2' ' HB2' ' A' ' 33' ' ' ALA . 2.2 m-85 . . . . . 0 N--CA 1.449 -0.502 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.717 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -135.61 -180.0 1.22 Allowed Pre-proline 0 N--CA 1.448 -0.546 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.717 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 82.3 Cg_endo -72.45 127.83 12.96 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 124.293 3.329 . . . . 0.0 109.573 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.8 HD23 ' HD2' ' A' ' 50' ' ' PHE . 2.6 tp -82.68 94.71 7.63 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.711 ' CD ' HG21 ' A' ' 153' ' ' VAL . 43.1 tt0 -76.58 97.95 4.53 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.8 ' HD2' HD23 ' A' ' 48' ' ' LEU . 6.4 p90 -118.92 173.86 6.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.842 HG22 ' CA ' ' A' ' 10' ' ' LYS . 57.8 t -130.7 109.69 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.961 HG11 ' HG ' ' A' ' 66' ' ' LEU . 16.3 t -49.08 -10.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.766 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -108.07 25.74 19.41 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 51' ' ' VAL . 4.0 mt-10 -123.25 -43.16 2.21 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.85 7.59 50.24 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -46.0 -50.07 15.36 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.518 ' N ' HD22 ' A' ' 57' ' ' LEU . 1.2 mm? -96.48 175.24 6.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.89 ' H ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -75.99 150.88 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.472 ' O ' ' C ' ' A' ' 60' ' ' GLY . 10.6 mt-30 -40.11 -65.72 0.37 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.673 ' H ' ' HB3' ' A' ' 82' ' ' LYS . . . -33.46 -82.78 0.01 OUTLIER Glycine 0 C--N 1.335 0.506 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.693 ' CE1' HG11 ' A' ' 65' ' ' VAL . 2.3 t80 -40.88 -53.57 2.88 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.504 ' O ' HG22 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -45.28 -34.04 2.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.634 ' HA ' HD12 ' A' ' 66' ' ' LEU . 5.9 mt-10 -80.73 -31.11 36.13 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . -64.43 -29.84 70.88 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.728 HG21 ' CE1' ' A' ' 50' ' ' PHE . 2.5 m -92.36 -21.46 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.961 ' HG ' HG11 ' A' ' 52' ' ' VAL . 1.1 mt -50.14 -55.67 14.09 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -98.74 55.58 1.06 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.733 ' HE3' ' HA ' ' A' ' 73' ' ' GLU . 9.4 mtp -134.12 123.8 25.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -77.92 167.49 21.41 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.594 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 0.2 OUTLIER -68.62 96.63 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.837 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 118.87 17.76 4.95 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -95.99 -172.08 2.49 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.733 ' HA ' ' HE3' ' A' ' 68' ' ' MET . 2.2 tt0 -162.54 123.11 2.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.512 ' HB2' ' SD ' ' A' ' 68' ' ' MET . 5.2 ttmt -125.82 99.69 6.07 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.531 ' OG1' HG23 ' A' ' 146' ' ' THR . 84.8 m -93.82 76.32 4.23 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.45 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 3.9 t -106.04 156.83 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.616 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 5.4 ttpm? -95.1 113.12 24.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 1.107 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -79.19 130.83 67.95 Favored Pre-proline 0 N--CA 1.45 -0.438 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.504 ' CG ' ' HD3' ' A' ' 82' ' ' LYS . 84.0 Cg_endo -72.35 144.54 41.33 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 124.33 3.354 . . . . 0.0 109.595 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.643 ' O ' ' N ' ' A' ' 85' ' ' GLY . . . -50.99 -11.68 0.1 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.54 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 15.7 tt0 -86.1 -34.65 20.59 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.673 ' HB3' ' H ' ' A' ' 60' ' ' GLY . 1.0 OUTLIER -105.67 41.45 1.38 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.107 ' HB2' ' CG2' ' A' ' 78' ' ' ILE . . . -159.57 -34.27 0.06 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.681 ' CD2' ' CB ' ' A' ' 138' ' ' LEU . 74.2 m-85 -158.89 8.6 0.12 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.643 ' N ' ' O ' ' A' ' 80' ' ' ALA . . . 72.49 143.5 0.49 Allowed Glycine 0 C--N 1.336 0.557 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -47.82 167.38 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.554 ' HG2' ' HA3' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -41.4 139.96 0.97 Allowed 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.951 ' CB ' HD12 ' A' ' 91' ' ' LEU . 1.9 t30 -93.13 153.23 18.78 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.508 ' C ' ' H ' ' A' ' 91' ' ' LEU . 48.7 mt-10 -86.49 -39.18 16.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.48 11.86 0.22 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.951 HD12 ' CB ' ' A' ' 88' ' ' ASN . 54.5 mt -118.57 5.73 11.67 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 51.1 mt -84.75 114.05 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.515 ' OE1' ' CD1' ' A' ' 134' ' ' PHE . 5.5 mp0 -106.22 166.3 10.62 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.793 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -146.39 96.81 2.83 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.657 HD11 ' CD1' ' A' ' 100' ' ' PHE . 3.7 pt -96.06 157.69 35.34 Favored Pre-proline 0 N--CA 1.449 -0.505 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.555 ' O ' ' N ' ' A' ' 99' ' ' ALA . 83.4 Cg_endo -72.45 139.96 32.48 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 124.296 3.331 . . . . 0.0 109.576 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.841 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -43.81 -20.65 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.572 ' C ' ' H ' ' A' ' 100' ' ' PHE . 3.3 m-20 -78.17 -35.46 48.76 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.555 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -50.56 -6.99 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.657 ' CD1' HD11 ' A' ' 95' ' ' ILE . 2.3 m-85 -131.46 -26.54 2.05 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.498 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 0.9 OUTLIER -63.39 -15.15 56.7 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.29 6.14 49.59 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.552 ' HB1' ' CZ ' ' A' ' 105' ' ' PHE . . . -100.61 -137.51 0.32 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.72 18.15 1.47 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.552 ' CZ ' ' HB1' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -133.13 -144.07 0.23 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.506 ' H ' ' HB2' ' A' ' 105' ' ' PHE . 0.4 OUTLIER -171.21 126.65 0.63 Allowed Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.892 ' CG ' HG11 ' A' ' 130' ' ' VAL . 82.3 Cg_endo -72.33 131.83 18.34 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 124.321 3.348 . . . . 0.0 109.579 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 110' ' ' GLY . 2.1 mm-40 -118.83 157.62 27.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -67.19 66.1 0.07 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.89 12.25 0.07 OUTLIER Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.797 ' CB ' HD13 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -68.55 171.34 7.67 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 112' ' ' VAL . 96.4 t -155.57 65.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.34 136.76 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.863 HD23 ' CD ' ' A' ' 119' ' ' PRO . 0.1 OUTLIER -104.58 172.81 6.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -119.71 -1.62 10.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 172.46 3.17 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 152.65 -32.34 0.83 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 18.2 mm -94.4 116.03 65.94 Favored Pre-proline 0 N--CA 1.449 -0.485 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.863 ' CD ' HD23 ' A' ' 114' ' ' LEU . 81.9 Cg_endo -72.42 171.8 16.3 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 124.333 3.356 . . . . 0.0 109.582 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.862 ' HB1' ' HB3' ' A' ' 132' ' ' LEU . . . -132.13 75.5 1.64 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 3.7 m -49.13 97.83 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.797 HD13 ' CB ' ' A' ' 111' ' ' MET . 1.8 mp -71.14 95.6 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.498 HG22 HG22 ' A' ' 121' ' ' THR . 0.9 OUTLIER -82.06 -18.94 41.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.726 ' HB3' ' H ' ' A' ' 131' ' ' THR . 1.7 tp10 -121.9 130.88 53.7 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 125' ' ' VAL . 15.0 p -122.02 50.89 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.657 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -78.62 126.03 30.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.537 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.9 OUTLIER -53.17 0.18 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.657 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.4 OUTLIER -111.28 -20.21 12.38 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -177.86 164.64 1.94 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.892 HG11 ' CG ' ' A' ' 107' ' ' PRO . 17.4 m -129.57 135.95 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.793 HG23 ' HD2' ' A' ' 94' ' ' LYS . 24.2 m -95.45 87.24 4.71 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.862 ' HB3' ' HB1' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -85.68 122.2 29.44 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.589 ' HA ' ' HA ' ' A' ' 92' ' ' ILE . 15.4 t0 -90.17 94.28 9.7 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.515 ' CD1' ' OE1' ' A' ' 93' ' ' GLN . 2.4 m-85 -38.33 -42.29 0.7 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.675 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 0.7 OUTLIER 42.04 -112.12 0.18 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.908 ' CG ' ' H ' ' A' ' 137' ' ' GLU . 15.8 t-80 -177.76 -170.4 0.26 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.908 ' H ' ' CG ' ' A' ' 136' ' ' HIS . 1.5 tp10 -73.55 -42.03 62.2 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 1.013 HD12 HD22 ' A' ' 143' ' ' LEU . 2.6 mm? -98.97 -15.64 19.03 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.777 ' HB2' ' HB3' ' A' ' 136' ' ' HIS . . . -58.7 115.69 3.23 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.554 ' HA3' ' HG2' ' A' ' 87' ' ' ARG . . . 71.17 15.57 74.63 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.692 ' HE2' ' CD1' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -134.7 131.94 38.26 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.553 ' C ' ' HD3' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -100.47 130.02 46.5 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 1.026 ' H ' HD23 ' A' ' 143' ' ' LEU . 1.4 pt? -115.98 144.94 43.39 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.616 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 0.2 OUTLIER -68.02 173.96 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.635 ' CD2' HD13 ' A' ' 78' ' ' ILE . 25.5 m-85 -157.44 90.28 1.09 Allowed 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 146' ' ' THR . 85.4 m -81.88 64.35 6.53 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.9 mt -60.3 178.51 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.554 ' H ' HG22 ' A' ' 147' ' ' ILE . 13.7 tttp -178.03 110.59 0.06 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.837 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 4.4 mm -70.84 139.0 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.598 HD12 ' HB3' ' A' ' 47' ' ' PRO . 3.6 mt -118.39 -41.15 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.594 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 2.4 tt0 -158.86 -165.69 1.69 Allowed 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.894 HG22 HG22 ' A' ' 11' ' ' ILE . 97.0 t -136.95 151.7 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.744 HG22 ' HE2' ' A' ' 12' ' ' LYS . 1.8 t . . . . . 0 N--CA 1.449 -0.503 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.644 ' CG1' ' N ' ' A' ' 6' ' ' ASP . 1.5 t . . . . . 0 N--CA 1.448 -0.53 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.644 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 0.5 OUTLIER -138.04 175.83 9.23 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.542 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 16.1 ptmt -67.35 65.65 0.07 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 6' ' ' ASP . . . 165.35 15.32 0.02 OUTLIER Glycine 0 C--N 1.336 0.557 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.588 ' HB ' HG22 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -129.14 132.64 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.8 ' O ' HG23 ' A' ' 11' ' ' ILE . 4.2 ttpm? -87.55 165.03 15.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.033 HG22 HG22 ' A' ' 152' ' ' VAL . 1.1 pt -169.19 134.42 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.664 ' HE2' ' CG2' ' A' ' 153' ' ' VAL . 7.5 mtmt -94.3 91.98 6.98 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.575 HG12 ' HA ' ' A' ' 149' ' ' ILE . 0.8 OUTLIER -116.02 153.95 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.607 ' OD2' HD11 ' A' ' 150' ' ' ILE . 3.6 m-20 -111.41 106.12 14.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.597 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.9 p90 -101.99 159.46 15.35 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 1.107 HG21 HG11 ' A' ' 32' ' ' VAL . 3.5 mt -133.55 73.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -56.9 129.17 48.86 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.596 ' HE3' ' O ' ' A' ' 16' ' ' ILE . 5.9 mttt -116.98 -164.03 0.95 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.623 ' C ' ' H ' ' A' ' 21' ' ' SER . 85.3 mt -118.02 165.87 13.21 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -54.66 0.07 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.623 ' H ' ' C ' ' A' ' 19' ' ' LEU . 84.5 p -112.05 -3.88 14.63 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.62 25.11 43.61 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.458 ' C ' ' HG2' ' A' ' 18' ' ' LYS . 1.6 m-20 -96.6 122.13 39.18 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.528 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 55.8 t -68.49 113.66 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.595 ' CE1' ' HB2' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -104.41 -31.56 9.45 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.595 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 14.4 t0 -140.07 138.94 35.76 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.995 ' HB ' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -158.24 161.24 37.74 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.442 ' HB3' ' OD1' ' A' ' 14' ' ' ASP . 12.9 m -115.73 -11.92 11.58 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.62 HG22 ' H ' ' A' ' 32' ' ' VAL . 3.0 mt -92.77 116.23 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.505 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 2.5 tt0 -51.51 -38.98 56.69 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -48.72 -67.86 0.23 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.107 HG11 HG21 ' A' ' 16' ' ' ILE . 34.7 t -53.93 -38.32 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.743 ' HB1' ' HA ' ' A' ' 39' ' ' TYR . . . -53.16 -43.05 66.74 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.55 ' HG2' ' CB ' ' A' ' 39' ' ' TYR . 3.9 mtmt -68.13 -30.91 70.16 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -80.99 -20.08 42.6 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.41 -11.42 17.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.01 45.75 19.22 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.526 HG13 ' HA ' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -143.12 16.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.743 ' HA ' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -57.97 -14.6 6.69 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.873 ' HE2' HG23 ' A' ' 27' ' ' THR . 1.9 m-85 . . . . . 0 N--CA 1.449 -0.519 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.663 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -82.58 177.48 3.0 Favored Pre-proline 0 N--CA 1.449 -0.502 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.663 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 84.4 Cg_endo -72.43 128.81 14.03 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 124.292 3.328 . . . . 0.0 109.598 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.0 tp -69.41 104.63 2.33 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.514 ' CD ' ' CE ' ' A' ' 10' ' ' LYS . 13.3 tt0 -91.15 100.87 13.63 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.884 ' CZ ' HG21 ' A' ' 65' ' ' VAL . 32.1 p90 -119.78 170.61 9.07 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.841 HG12 ' H ' ' A' ' 53' ' ' GLY . 69.5 t -131.31 113.07 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.928 HG11 ' CG ' ' A' ' 66' ' ' LEU . 4.6 t -50.53 -8.7 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.841 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -117.33 35.35 4.16 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 2.7 mm-40 -124.27 -31.97 3.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.11 5.65 59.4 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -57.95 -97.36 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.793 ' H ' HD22 ' A' ' 57' ' ' LEU . 1.5 mm? -54.32 157.8 2.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.952 ' H ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -60.96 149.18 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.459 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 9.1 mt-30 -44.6 -55.24 5.35 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 63' ' ' GLU . . . -39.65 -79.79 0.04 OUTLIER Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.658 ' HE2' HG23 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -43.45 -44.69 5.98 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.413 ' CD ' ' HA ' ' A' ' 52' ' ' VAL . 6.5 mt-10 -55.85 -32.81 63.95 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.778 ' HA ' HD12 ' A' ' 66' ' ' LEU . 7.3 mt-10 -77.86 -29.77 50.57 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.59 ' HB1' ' HD2' ' A' ' 74' ' ' LYS . . . -63.36 -42.37 98.88 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.884 HG21 ' CZ ' ' A' ' 50' ' ' PHE . 4.6 m -84.06 -15.29 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.928 ' CG ' HG11 ' A' ' 52' ' ' VAL . 3.8 mt -63.05 -48.4 78.87 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -102.85 54.83 0.77 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.496 ' SD ' ' HB2' ' A' ' 74' ' ' LYS . 6.1 mtp -131.57 -144.8 0.25 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.479 ' HB2' ' CG ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -155.96 -178.56 7.39 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.606 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 0.5 OUTLIER -90.09 80.12 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.671 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 138.4 11.07 0.9 Allowed Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.479 ' CG ' ' HB2' ' A' ' 69' ' ' GLU . 2.8 m-20 -95.48 -178.39 4.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -153.72 130.47 10.83 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.59 ' HD2' ' HB1' ' A' ' 64' ' ' ALA . 9.6 ttmt -131.69 96.68 4.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.676 ' OG1' HG23 ' A' ' 146' ' ' THR . 80.3 m -95.5 78.77 3.39 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.668 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 4.0 t -111.38 171.25 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.668 ' N ' ' CG1' ' A' ' 76' ' ' VAL . 1.8 ttpt -103.35 114.79 29.36 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.754 HD13 ' CD2' ' A' ' 145' ' ' PHE . 0.3 OUTLIER -79.4 129.33 72.37 Favored Pre-proline 0 N--CA 1.448 -0.554 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.486 ' HG2' ' HG2' ' A' ' 81' ' ' GLU . 83.0 Cg_endo -72.29 141.9 36.44 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 124.346 3.364 . . . . 0.0 109.582 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.579 ' HB2' ' N ' ' A' ' 141' ' ' LYS . . . -54.36 -8.39 0.21 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.622 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 8.3 pt-20 -81.38 -37.4 28.25 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.48 ' HD3' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -87.52 -30.0 20.91 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.639 ' HA ' ' CB ' ' A' ' 58' ' ' ILE . . . -71.52 -94.74 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.593 ' CD1' ' N ' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -106.71 21.64 17.17 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.622 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 46.58 87.67 0.01 OUTLIER Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.578 ' HA ' ' HA2' ' A' ' 140' ' ' GLY . 0.0 OUTLIER 39.9 -144.5 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.567 ' HD2' ' HA3' ' A' ' 140' ' ' GLY . 0.1 OUTLIER -91.3 145.1 24.93 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.969 ' CB ' HD12 ' A' ' 91' ' ' LEU . 7.0 t30 -83.79 132.47 34.82 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -66.63 -25.97 66.84 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.62 8.17 15.13 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.983 HD13 ' HA ' ' A' ' 135' ' ' ASN . 34.5 mt -110.19 5.23 21.72 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.606 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 24.6 mt -84.88 108.28 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.459 ' OE1' ' CD1' ' A' ' 134' ' ' PHE . 6.2 mp0 -101.84 152.14 21.24 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.822 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -135.81 91.4 2.7 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.569 HG12 HG23 ' A' ' 130' ' ' VAL . 3.3 pt -86.23 159.04 54.48 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.61 ' HA ' ' HG3' ' A' ' 129' ' ' GLU . 80.7 Cg_endo -72.46 136.18 25.7 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 124.35 3.367 . . . . 0.0 109.551 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.848 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -42.24 -29.53 0.25 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.546 ' HA ' ' CB ' ' A' ' 101' ' ' LYS . 8.4 t70 -70.29 -36.08 74.14 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -51.01 -12.82 0.12 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.569 ' HB3' ' HD3' ' A' ' 107' ' ' PRO . 4.5 m-85 -133.63 -21.03 2.0 Allowed 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.546 ' CB ' ' HA ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -49.84 -9.9 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.512 ' H ' ' C ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -143.32 40.45 1.46 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.651 ' HB1' ' CE1' ' A' ' 105' ' ' PHE . . . -103.25 21.52 15.73 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 71.16 -14.84 0.44 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.651 ' CE1' ' HB1' ' A' ' 103' ' ' ALA . 0.9 OUTLIER -135.87 -148.76 0.31 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.516 ' HG2' ' HD2' ' A' ' 107' ' ' PRO . 1.4 tt0 -160.78 138.04 6.77 Favored Pre-proline 0 N--CA 1.448 -0.552 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.923 ' CG ' HG11 ' A' ' 130' ' ' VAL . 82.9 Cg_endo -72.41 141.02 34.38 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 124.311 3.341 . . . . 0.0 109.61 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 110' ' ' GLY . 20.9 mt-10 -130.06 153.57 48.32 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -63.64 70.06 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.21 5.23 0.12 Allowed Glycine 0 C--N 1.336 0.571 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.859 ' HB3' HD12 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -65.34 165.89 11.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.513 HG23 ' C ' ' A' ' 111' ' ' MET . 52.4 t -156.27 70.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.66 134.93 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.637 HD23 ' CD ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -104.47 170.57 7.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.415 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -116.07 5.23 13.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.415 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 0.5 OUTLIER 167.01 -10.88 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.419 ' O ' HD22 ' A' ' 114' ' ' LEU . . . 169.81 -45.15 0.21 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.446 ' HA ' ' HD2' ' A' ' 119' ' ' PRO . 4.3 mt -80.46 110.97 18.93 Favored Pre-proline 0 N--CA 1.45 -0.465 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.637 ' CD ' HD23 ' A' ' 114' ' ' LEU . 82.7 Cg_endo -72.37 163.94 37.12 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 124.255 3.303 . . . . 0.0 109.628 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.857 ' HB1' ' HB3' ' A' ' 132' ' ' LEU . . . -124.73 94.3 4.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 21.3 m -66.4 97.02 0.39 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.859 HD12 ' HB3' ' A' ' 111' ' ' MET . 5.9 mt -71.75 84.41 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 123' ' ' THR . 0.0 OUTLIER -74.82 -16.94 60.68 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.837 ' HB3' ' H ' ' A' ' 131' ' ' THR . 0.3 OUTLIER -119.23 127.95 53.74 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.606 HG13 ' O ' ' A' ' 125' ' ' VAL . 8.1 p -122.56 49.15 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.689 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -78.05 125.48 29.41 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.678 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.4 OUTLIER -52.82 1.7 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.689 ' H ' ' C ' ' A' ' 126' ' ' THR . 1.2 p-10 -112.95 -20.94 11.37 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.61 ' HG3' ' HA ' ' A' ' 96' ' ' PRO . 2.3 mt-10 -174.75 165.67 3.68 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.923 HG11 ' CG ' ' A' ' 107' ' ' PRO . 16.7 m -135.23 130.76 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.837 ' H ' ' HB3' ' A' ' 124' ' ' GLU . 66.1 m -93.79 94.89 8.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.857 ' HB3' ' HB1' ' A' ' 120' ' ' ALA . 0.3 OUTLIER -92.35 103.37 15.82 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.606 ' HA ' ' HA ' ' A' ' 92' ' ' ILE . 18.9 t0 -74.8 96.87 3.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 91' ' ' LEU . 2.0 m-30 -41.32 -82.59 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.983 ' HA ' HD13 ' A' ' 91' ' ' LEU . 0.6 OUTLIER 77.74 -127.67 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.689 ' ND1' ' N ' ' A' ' 138' ' ' LEU . 14.1 t-80 -171.49 178.34 3.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.678 ' N ' ' CG ' ' A' ' 136' ' ' HIS . 10.2 tp10 -67.88 -16.47 64.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.875 HD23 ' HE2' ' A' ' 141' ' ' LYS . 16.2 mt -118.14 -16.83 9.72 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.646 ' HB3' ' H ' ' A' ' 136' ' ' HIS . . . -57.57 110.17 0.83 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' A' ' 86' ' ' ASN . . . 79.97 31.99 37.59 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.875 ' HE2' HD23 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -155.26 146.15 22.44 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.549 ' C ' ' HD2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -95.31 135.44 36.91 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.777 HD23 ' N ' ' A' ' 143' ' ' LEU . 0.4 OUTLIER -124.15 149.16 46.59 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.589 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 1.7 t -73.56 166.87 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.754 ' CD2' HD13 ' A' ' 78' ' ' ILE . 25.3 m-85 -151.21 91.64 1.71 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.676 HG23 ' OG1' ' A' ' 75' ' ' THR . 83.9 m -84.48 61.92 6.94 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.658 HG23 ' HE2' ' A' ' 61' ' ' PHE . 1.7 mt -56.21 -179.47 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.6 ' H ' HG22 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -178.33 90.61 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.671 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 1.1 mm -60.51 130.7 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.607 HD11 ' OD2' ' A' ' 14' ' ' ASP . 4.8 mt -113.64 -45.37 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.606 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -153.98 -165.64 2.16 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 1.033 HG22 HG22 ' A' ' 11' ' ' ILE . 88.7 t -138.65 153.3 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.664 ' CG2' ' HE2' ' A' ' 12' ' ' LYS . 1.9 t . . . . . 0 N--CA 1.45 -0.472 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.667 HG21 HD13 ' A' ' 11' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.525 ' H ' HG12 ' A' ' 5' ' ' VAL . 8.5 m-20 -154.87 165.77 35.61 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.599 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 4.9 ptpt -69.94 63.68 0.21 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.43 ' H ' ' H ' ' A' ' 9' ' ' VAL . . . 175.05 3.19 0.03 OUTLIER Glycine 0 C--N 1.335 0.508 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.43 ' H ' ' H ' ' A' ' 8' ' ' GLY . 2.5 t -119.98 140.3 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.663 ' O ' HG13 ' A' ' 152' ' ' VAL . 10.8 tttt -96.68 149.38 21.86 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.682 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 10.8 pt -158.05 140.49 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.61 ' O ' HD12 ' A' ' 150' ' ' ILE . 7.0 ttmt -94.11 99.07 11.42 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.575 ' CG1' ' HA ' ' A' ' 149' ' ' ILE . 1.1 m -124.13 152.37 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 147' ' ' ILE . 16.4 m-20 -95.07 -167.35 1.61 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 0.3 OUTLIER 177.52 148.75 0.15 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.97 HG23 ' HB ' ' A' ' 27' ' ' THR . 4.5 mt -132.25 74.27 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -58.21 134.14 52.49 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.587 ' HG2' ' N ' ' A' ' 24' ' ' VAL . 7.8 mtmt -118.98 -152.99 0.52 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.592 ' C ' ' H ' ' A' ' 21' ' ' SER . 1.5 mt -128.49 166.08 19.47 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -52.67 -3.71 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.592 ' H ' ' C ' ' A' ' 19' ' ' LEU . 52.0 p -113.89 14.25 18.51 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 19' ' ' LEU . . . 65.33 32.03 82.35 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 18' ' ' LYS . 2.3 m-20 -101.6 123.98 46.5 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.587 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 76.7 t -68.98 130.22 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.577 ' CE1' ' HB2' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -124.59 -29.55 3.45 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.577 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 9.3 t0 -145.08 135.78 24.47 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.97 ' HB ' HG23 ' A' ' 16' ' ' ILE . 1.7 t -153.47 144.87 23.16 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 2.5 m -96.96 -4.95 38.99 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.44 ' CG2' HG23 ' A' ' 32' ' ' VAL . 20.6 mt -100.87 103.62 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.594 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 5.5 tt0 -46.72 -38.72 10.33 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -50.03 -66.12 0.45 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.89 HG11 HD13 ' A' ' 16' ' ' ILE . 3.0 t -47.86 -42.41 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.604 ' HA ' HG13 ' A' ' 38' ' ' ILE . . . -49.17 -41.8 37.78 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.601 ' HG2' ' CG ' ' A' ' 39' ' ' TYR . 8.8 mtpt -74.31 -24.86 59.28 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -86.84 -23.76 25.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . -93.83 -27.48 16.41 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.3 16.17 19.2 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.604 HG13 ' HA ' ' A' ' 33' ' ' ALA . 3.5 pt -118.17 31.01 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.601 ' CG ' ' HG2' ' A' ' 34' ' ' LYS . 13.0 t80 -64.69 68.84 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 38' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.475 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.703 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -123.85 179.83 0.98 Allowed Pre-proline 0 N--CA 1.449 -0.495 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.703 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 80.7 Cg_endo -72.44 129.84 15.34 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 124.273 3.316 . . . . 0.0 109.556 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.855 HD12 ' N ' ' A' ' 49' ' ' GLU . 5.3 tp -97.26 135.14 39.61 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.964 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -105.08 107.77 18.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.661 ' CZ ' ' CZ ' ' A' ' 61' ' ' PHE . 8.1 p90 -125.49 162.21 25.38 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.937 HG12 ' H ' ' A' ' 53' ' ' GLY . 41.1 t -105.79 123.52 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.692 HG11 ' HG ' ' A' ' 66' ' ' LEU . 8.3 t -58.53 8.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.937 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -147.31 48.74 0.64 Allowed Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.735 ' OE1' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -126.61 -32.76 2.6 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.58 -12.57 54.08 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.488 ' OE1' ' CB ' ' A' ' 50' ' ' PHE . 99.4 mt-30 -42.06 -78.53 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.676 ' H ' HD22 ' A' ' 57' ' ' LEU . 1.2 mm? -71.5 164.92 24.92 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.814 ' H ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -65.09 157.71 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.422 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 34.2 mt-30 -49.84 -59.29 3.99 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.629 ' H ' ' HB3' ' A' ' 82' ' ' LYS . . . -39.05 -78.31 0.06 OUTLIER Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.81 ' CE1' HD13 ' A' ' 147' ' ' ILE . 0.9 OUTLIER -41.08 -55.18 2.65 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.541 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.0 mt-10 -45.94 -37.05 6.0 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 60' ' ' GLY . 4.8 mt-10 -77.63 -25.45 49.73 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.655 ' HA ' ' HE2' ' A' ' 74' ' ' LYS . . . -67.32 -40.04 85.94 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.642 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 2.1 m -73.5 -32.77 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.692 ' HG ' HG11 ' A' ' 52' ' ' VAL . 2.5 mt -41.31 -51.66 3.59 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.36 52.29 0.84 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.597 ' HE3' HD11 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -140.62 114.05 8.67 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -77.58 168.89 19.24 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.662 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 1.5 t -61.93 113.04 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.842 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 100.52 9.0 48.22 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.95 -176.54 5.22 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.558 ' CA ' ' SD ' ' A' ' 68' ' ' MET . 0.6 OUTLIER -157.44 141.81 16.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.655 ' HE2' ' HA ' ' A' ' 64' ' ' ALA . 12.1 tttp -138.95 95.8 3.01 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.903 ' CG2' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -92.4 93.23 8.49 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.55 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 16.2 t -131.63 164.64 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.598 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 5.6 ttpt -99.48 114.8 27.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.731 HD13 ' CD2' ' A' ' 145' ' ' PHE . 0.3 OUTLIER -78.68 129.95 72.34 Favored Pre-proline 0 N--CA 1.449 -0.492 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.501 ' HG2' ' HG2' ' A' ' 81' ' ' GLU . 84.8 Cg_endo -72.39 138.22 29.61 Favored 'Trans proline' 0 N--CA 1.447 -1.218 0 C-N-CA 124.28 3.32 . . . . 0.0 109.664 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.681 ' HB2' ' C ' ' A' ' 141' ' ' LYS . . . -51.56 -10.62 0.1 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.594 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 20.6 pt-20 -79.0 -38.2 37.27 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.629 ' HB3' ' H ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -84.88 -33.1 22.87 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.649 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . . . -74.12 -100.07 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.616 ' CE1' ' HB2' ' A' ' 138' ' ' LEU . 38.9 m-85 -90.22 17.81 6.68 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.594 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 42.35 85.71 0.01 OUTLIER Glycine 0 C--N 1.335 0.508 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.507 ' OD1' ' N ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER 47.26 -164.85 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.591 ' HD2' ' HA3' ' A' ' 140' ' ' GLY . 0.4 OUTLIER -81.17 146.42 30.52 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.693 ' CB ' HD12 ' A' ' 91' ' ' LEU . 9.7 t30 -89.2 149.98 22.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -85.35 -35.02 21.67 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.3 -9.08 37.42 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.866 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 75.1 mt -94.03 6.04 49.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.61 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 69.1 mt -85.56 113.75 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.99 150.3 26.63 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.698 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -130.17 97.08 4.34 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.999 HG12 HD11 ' A' ' 132' ' ' LEU . 18.5 pt -93.11 156.7 40.03 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.534 ' O ' ' N ' ' A' ' 99' ' ' ALA . 82.0 Cg_endo -72.43 140.37 33.21 Favored 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 124.33 3.354 . . . . 0.0 109.609 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.818 HH21 ' CD ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -42.72 -32.93 0.65 Allowed 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.473 ' HA ' ' CB ' ' A' ' 101' ' ' LYS . 6.7 t70 -66.81 -36.71 83.0 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -43.92 -21.61 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.493 ' CD2' ' HD3' ' A' ' 107' ' ' PRO . 3.3 m-85 -122.94 -28.82 4.03 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.473 ' CB ' ' HA ' ' A' ' 98' ' ' ASP . 0.8 OUTLIER -56.45 -24.15 43.57 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -104.18 1.91 31.2 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -102.05 19.69 18.02 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 41.63 36.78 0.62 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.3 -150.2 0.44 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.441 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -179.96 102.2 0.18 Allowed Pre-proline 0 N--CA 1.45 -0.475 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.918 ' CG ' HG11 ' A' ' 130' ' ' VAL . 83.6 Cg_endo -72.32 138.52 30.36 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 124.313 3.342 . . . . 0.0 109.592 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 110' ' ' GLY . 16.8 mt-10 -128.9 156.53 43.56 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.71 68.97 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 151.8 10.23 0.09 OUTLIER Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.545 ' HB3' ' CD1' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -68.17 167.7 13.66 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.507 HG23 ' C ' ' A' ' 111' ' ' MET . 62.0 t -156.41 82.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.35 137.13 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.91 HD23 ' N ' ' A' ' 119' ' ' PRO . 0.2 OUTLIER -101.36 156.72 17.28 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -109.65 0.49 19.04 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 176.47 -12.37 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.646 ' O ' HD22 ' A' ' 114' ' ' LEU . . . 166.93 -34.42 0.22 Allowed Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 3.3 mt -94.04 122.41 61.89 Favored Pre-proline 0 N--CA 1.449 -0.483 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.91 ' N ' HD23 ' A' ' 114' ' ' LEU . 84.9 Cg_endo -72.31 170.22 19.71 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 124.311 3.341 . . . . 0.0 109.662 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.883 ' HB1' ' HB3' ' A' ' 132' ' ' LEU . . . -128.58 73.61 1.51 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 28.8 m -50.2 95.36 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.625 ' HA ' ' HA ' ' A' ' 132' ' ' LEU . 1.8 mp -69.74 100.1 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 131' ' ' THR . 0.6 OUTLIER -85.19 -19.11 32.21 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.554 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 0.4 OUTLIER -121.77 131.77 54.25 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.654 HG22 ' O ' ' A' ' 125' ' ' VAL . 7.9 p -122.33 52.99 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.647 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -79.21 126.83 31.27 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.686 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.3 OUTLIER -53.16 0.21 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.647 ' H ' ' C ' ' A' ' 126' ' ' THR . 3.3 p-10 -111.58 -21.22 11.85 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -177.85 168.5 2.08 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.918 HG11 ' CG ' ' A' ' 107' ' ' PRO . 29.0 m -132.09 145.42 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.698 HG23 ' HD2' ' A' ' 94' ' ' LYS . 21.4 m -102.47 84.71 2.48 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.999 HD11 HG12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -82.36 119.76 24.56 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.61 ' HA ' ' HA ' ' A' ' 92' ' ' ILE . 13.8 t0 -90.21 97.89 11.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.538 ' N ' ' O ' ' A' ' 91' ' ' LEU . 2.0 m-30 -41.25 -52.97 3.31 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.866 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 69.8 m-20 48.44 -122.39 1.58 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.74 ' ND1' ' N ' ' A' ' 137' ' ' GLU . 24.3 t-80 179.71 174.93 0.8 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.74 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 0.5 OUTLIER -76.05 -8.62 57.4 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.959 HD22 HD22 ' A' ' 143' ' ' LEU . 52.5 mt -119.35 -1.48 10.77 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.497 ' CB ' ' HB3' ' A' ' 135' ' ' ASN . . . -67.71 141.66 56.56 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.591 ' HA3' ' HD2' ' A' ' 87' ' ' ARG . . . 41.95 27.16 0.36 Allowed Glycine 0 C--N 1.336 0.536 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.858 ' HE2' ' CD2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -138.49 146.11 41.62 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.494 ' C ' ' HD2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -99.19 137.39 37.78 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.959 HD22 HD22 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -124.7 152.07 44.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.598 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 2.1 t -73.86 165.72 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.731 ' CD2' HD13 ' A' ' 78' ' ' ILE . 30.9 m-85 -148.6 98.05 2.82 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.903 HG23 ' CG2' ' A' ' 75' ' ' THR . 24.0 m -89.8 57.78 4.0 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.81 HD13 ' CE1' ' A' ' 61' ' ' PHE . 2.3 mt -57.54 -179.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.749 ' H ' HG22 ' A' ' 147' ' ' ILE . 12.4 tttt -179.39 110.68 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.842 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 4.8 mm -67.14 145.29 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.649 HD13 ' HB3' ' A' ' 47' ' ' PRO . 4.1 mt -126.6 -45.86 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.662 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -161.66 -159.89 0.66 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.682 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 42.4 t -128.44 135.59 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.964 HG21 ' HB3' ' A' ' 49' ' ' GLU . 61.9 t . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.595 HG12 HG21 ' A' ' 52' ' ' VAL . 23.2 t . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -132.2 168.06 18.7 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.575 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 10.2 ptpt -72.93 70.32 1.01 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 174.13 -2.9 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.12 122.64 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.832 ' CA ' HG22 ' A' ' 51' ' ' VAL . 1.7 tttt -76.52 166.88 22.79 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.917 HG22 HG22 ' A' ' 152' ' ' VAL . 1.0 OUTLIER -168.65 132.07 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.714 ' HE2' ' CG2' ' A' ' 153' ' ' VAL . 17.4 mtmt -89.82 92.89 9.22 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.675 HG21 ' CG2' ' A' ' 147' ' ' ILE . 0.8 OUTLIER -112.66 152.99 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.606 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 4.4 m-20 -110.55 95.49 5.6 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.1 p90 -92.7 154.4 18.35 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 1.018 HG23 ' HB ' ' A' ' 27' ' ' THR . 6.5 mt -129.36 75.08 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -60.22 132.06 50.23 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.608 ' HE3' ' O ' ' A' ' 16' ' ' ILE . 4.5 mtmt -121.03 -160.77 0.86 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.88 HD12 ' HB2' ' A' ' 23' ' ' ASP . 30.5 mt -119.38 166.15 13.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.426 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 9.8 mt-10 -56.32 2.6 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.627 ' H ' ' C ' ' A' ' 19' ' ' LEU . 52.8 p -117.24 0.3 12.24 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.24 28.0 42.26 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.88 ' HB2' HD12 ' A' ' 19' ' ' LEU . 18.8 m-20 -96.15 119.2 34.21 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.555 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 63.9 t -69.06 114.26 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.556 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 1.6 p90 -103.08 -32.69 9.56 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.556 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 11.6 t0 -146.23 136.55 23.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . 1.018 ' HB ' HG23 ' A' ' 16' ' ' ILE . 3.8 t -154.11 149.9 27.6 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.606 ' HB2' ' HA ' ' A' ' 14' ' ' ASP . 27.1 m -97.8 -17.41 19.37 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.821 HG22 ' H ' ' A' ' 32' ' ' VAL . 2.1 mt -85.01 95.15 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.49 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 4.9 tt0 -42.03 -29.59 0.23 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -59.62 -63.52 1.27 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.822 HG11 HG21 ' A' ' 16' ' ' ILE . 59.8 t -51.28 -38.97 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.714 ' HB1' ' HA ' ' A' ' 39' ' ' TYR . . . -48.03 -44.76 31.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.538 ' HG2' ' CB ' ' A' ' 39' ' ' TYR . 11.1 mtmt -71.52 -32.29 68.01 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -74.54 -15.53 60.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -110.23 -6.15 15.12 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.3 46.44 34.04 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.538 HG13 ' HA ' ' A' ' 33' ' ' ALA . 1.3 pt -143.3 11.98 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.714 ' HA ' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -45.39 -18.25 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.686 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.4 OUTLIER -83.44 178.49 2.39 Favored Pre-proline 0 N--CA 1.45 -0.449 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.686 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 83.2 Cg_endo -72.36 125.38 10.69 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 124.337 3.358 . . . . 0.0 109.586 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.0 83.12 0.11 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.58 ' OE2' HG21 ' A' ' 153' ' ' VAL . 40.6 tt0 -77.41 97.19 4.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.869 ' CD2' HD23 ' A' ' 57' ' ' LEU . 5.6 p90 -118.64 167.83 11.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.832 HG22 ' CA ' ' A' ' 10' ' ' LYS . 21.4 t -128.36 114.44 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.914 HG11 ' HG ' ' A' ' 66' ' ' LEU . 9.1 t -46.99 -14.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.816 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -115.88 39.76 2.63 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.428 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -131.58 -19.7 2.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.23 18.13 79.74 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.527 ' OE1' ' N ' ' A' ' 51' ' ' VAL . 36.3 mt-30 -60.81 -63.12 1.41 Allowed 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.869 HD23 ' CD2' ' A' ' 50' ' ' PHE . 2.0 mm? -87.41 171.23 10.72 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.057 ' H ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -66.21 155.09 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.522 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 5.9 mt-30 -49.72 -57.09 7.94 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.446 ' H ' ' HB3' ' A' ' 82' ' ' LYS . . . -39.58 -79.68 0.04 OUTLIER Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.667 ' CD1' ' CB ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -41.4 -52.21 3.6 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.727 ' O ' HG22 ' A' ' 65' ' ' VAL . 1.7 mt-10 -46.47 -42.19 15.07 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.875 ' HA ' HD12 ' A' ' 66' ' ' LEU . 4.8 mt-10 -70.17 -32.92 71.09 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.55 -24.85 67.98 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.753 HG21 ' CE2' ' A' ' 50' ' ' PHE . 8.6 m -100.25 -8.58 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.914 ' HG ' HG11 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -66.65 37.29 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.585 ' H ' ' C ' ' A' ' 65' ' ' VAL . 0.3 OUTLIER 166.94 27.77 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.895 ' HE1' HD11 ' A' ' 149' ' ' ILE . 44.0 mtp -109.56 96.02 6.0 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.468 ' N ' ' OD2' ' A' ' 72' ' ' ASP . 0.5 OUTLIER -55.95 -177.09 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.618 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 1.5 t -75.18 108.42 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.842 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 116.07 -12.22 17.2 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 1.0 OUTLIER -65.53 166.37 10.59 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.42 ' HB2' ' HD2' ' A' ' 148' ' ' LYS . 0.0 OUTLIER -151.16 135.85 17.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.51 ' HB2' ' SD ' ' A' ' 68' ' ' MET . 1.4 tttm -142.33 102.33 4.07 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.588 ' OG1' HG23 ' A' ' 146' ' ' THR . 52.1 m -101.9 79.81 1.94 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.661 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 3.5 t -112.49 171.12 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.661 ' N ' ' CG1' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -105.18 114.11 28.1 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.722 HD13 ' CD2' ' A' ' 145' ' ' PHE . 0.5 OUTLIER -79.0 129.8 71.98 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.476 ' HG2' ' HG2' ' A' ' 81' ' ' GLU . 83.4 Cg_endo -72.39 144.37 40.81 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 124.304 3.336 . . . . 0.0 109.607 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.64 ' HB2' ' N ' ' A' ' 141' ' ' LYS . . . -55.85 -9.39 0.56 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.618 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 14.8 pt-20 -81.41 -38.21 26.88 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.446 ' HB3' ' H ' ' A' ' 60' ' ' GLY . 9.3 mtmt -86.94 -31.62 20.57 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.652 ' HA ' ' CB ' ' A' ' 58' ' ' ILE . . . -71.88 -95.88 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.732 ' CE2' ' CE1' ' A' ' 136' ' ' HIS . 2.0 m-85 -98.41 16.91 20.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.618 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 42.36 84.82 0.01 OUTLIER Glycine 0 C--N 1.335 0.509 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.621 ' HA ' ' HA2' ' A' ' 140' ' ' GLY . 0.0 OUTLIER 49.01 -171.99 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.932 ' HG3' ' HB1' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -89.26 152.5 21.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.57 ' CB ' ' CD1' ' A' ' 91' ' ' LEU . 2.2 t30 -90.24 100.77 13.53 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.458 ' C ' ' H ' ' A' ' 91' ' ' LEU . 29.9 mt-10 -44.31 -25.36 0.23 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.19 16.68 0.3 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.734 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 17.5 mt -114.11 -4.08 13.18 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 20.6 mt -78.47 114.21 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 132' ' ' LEU . 2.2 mp0 -110.33 167.7 10.0 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.641 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -140.2 90.51 2.37 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.915 HG12 HD11 ' A' ' 132' ' ' LEU . 35.8 pt -85.41 154.66 59.71 Favored Pre-proline 0 N--CA 1.449 -0.478 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.56 ' HD2' ' HB2' ' A' ' 99' ' ' ALA . 82.6 Cg_endo -72.36 140.83 34.24 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 124.309 3.34 . . . . 0.0 109.636 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.927 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -41.8 -33.89 0.57 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.471 ' HA ' ' HB2' ' A' ' 101' ' ' LYS . 8.4 m-20 -66.53 -37.03 84.14 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.56 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . . . -43.52 -21.58 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.55 ' C ' ' H ' ' A' ' 102' ' ' GLU . 2.8 m-85 -122.2 -23.24 5.37 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.471 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -70.96 21.9 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.55 ' H ' ' C ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -143.59 -13.09 0.68 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.98 22.31 3.26 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 43.4 33.86 0.67 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.475 ' HD1' ' H ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -123.74 -149.46 0.42 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.475 ' H ' ' HD1' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -173.6 113.03 0.33 Allowed Pre-proline 0 N--CA 1.448 -0.525 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.927 ' CG ' HH21 ' A' ' 97' ' ' ARG . 83.5 Cg_endo -72.38 147.26 46.61 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 124.275 3.316 . . . . 0.0 109.632 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 110' ' ' GLY . 1.3 mm-40 -138.37 151.94 47.96 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.543 ' HB2' HG12 ' A' ' 125' ' ' VAL . 2.5 tm-20 -66.4 66.33 0.05 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.76 9.27 0.08 OUTLIER Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.509 ' CB ' HD12 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -62.87 170.09 2.86 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.678 HG13 ' HB2' ' A' ' 119' ' ' PRO . 61.1 t -155.63 65.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.92 137.31 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.61 HD23 ' CD ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -109.3 146.09 34.88 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.432 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -95.04 4.19 54.02 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.432 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 0.9 OUTLIER 166.64 -12.15 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.48 -37.73 0.2 Allowed Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 134' ' ' PHE . 1.2 mt -85.93 111.72 40.06 Favored Pre-proline 0 N--CA 1.449 -0.484 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.678 ' HB2' HG13 ' A' ' 112' ' ' VAL . 82.7 Cg_endo -72.37 159.56 49.07 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 124.352 3.368 . . . . 0.0 109.579 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.763 ' HB1' ' HB3' ' A' ' 132' ' ' LEU . . . -121.51 84.05 2.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.577 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 3.5 m -53.34 97.52 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.715 ' CG1' HD23 ' A' ' 132' ' ' LEU . 72.3 mt -76.58 91.1 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 131' ' ' THR . 0.2 OUTLIER -77.53 -27.24 51.62 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.861 ' HB3' ' H ' ' A' ' 131' ' ' THR . 0.5 OUTLIER -111.12 132.42 54.29 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.688 HG22 ' O ' ' A' ' 125' ' ' VAL . 7.1 p -129.67 53.55 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.697 ' C ' ' H ' ' A' ' 128' ' ' ASN . 81.4 p -80.1 133.11 36.06 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.583 ' HA ' ' HD3' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -54.58 4.36 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.697 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -112.21 -24.73 9.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -177.22 -178.45 0.79 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.537 HG11 ' CG ' ' A' ' 107' ' ' PRO . 4.2 m -144.57 134.14 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.861 ' H ' ' HB3' ' A' ' 124' ' ' GLU . 17.4 m -95.82 95.26 8.16 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.915 HD11 HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -87.66 166.62 14.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.587 ' HA ' ' HA ' ' A' ' 92' ' ' ILE . 15.4 t0 -137.39 97.95 3.59 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.48 ' N ' ' O ' ' A' ' 91' ' ' LEU . 3.3 m-30 -41.57 -41.48 2.17 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.734 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 91.9 m-20 41.47 -121.94 0.51 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.922 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 8.9 t-80 177.01 169.49 0.54 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.576 ' CG ' HD22 ' A' ' 138' ' ' LEU . 3.0 tp10 -58.55 -53.88 53.38 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.92 ' CG ' HD22 ' A' ' 143' ' ' LEU . 2.2 mm? -97.83 20.02 12.78 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.932 ' HB1' ' HG3' ' A' ' 87' ' ' ARG . . . -66.57 134.45 52.37 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.621 ' HA2' ' HA ' ' A' ' 86' ' ' ASN . . . 38.85 30.54 0.11 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.805 ' HE2' ' CD1' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -138.42 144.42 40.16 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.515 ' N ' ' HD3' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -94.04 138.84 31.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.92 HD22 ' CG ' ' A' ' 138' ' ' LEU . 0.5 OUTLIER -129.13 140.47 51.53 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.607 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 7.8 t -66.45 168.25 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.722 ' CD2' HD13 ' A' ' 78' ' ' ILE . 23.2 m-85 -152.79 93.92 1.81 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.656 HG22 ' O ' ' A' ' 146' ' ' THR . 54.9 m -87.97 62.66 6.97 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.675 ' CG2' HG21 ' A' ' 13' ' ' VAL . 1.4 mt -57.58 179.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.529 ' H ' HG22 ' A' ' 147' ' ' ILE . 6.5 tptt 179.3 100.42 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.895 HD11 ' HE1' ' A' ' 68' ' ' MET . 1.0 OUTLIER -63.23 139.24 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.531 HD11 ' OD1' ' A' ' 14' ' ' ASP . 12.6 mt -126.47 -31.5 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.618 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 1.5 mt-10 -166.8 -170.91 1.69 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.917 HG22 HG22 ' A' ' 11' ' ' ILE . 47.2 t -136.95 144.6 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.714 ' CG2' ' HE2' ' A' ' 12' ' ' LYS . 38.8 t . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.105 HG21 HG21 ' A' ' 11' ' ' ILE . 58.7 t . . . . . 0 N--CA 1.448 -0.542 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.593 ' HA ' ' CD2' ' A' ' 66' ' ' LEU . 1.1 m-20 -119.67 173.79 6.8 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.519 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 9.4 ptpt -68.83 68.46 0.16 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.403 ' H ' ' H ' ' A' ' 9' ' ' VAL . . . 168.93 7.03 0.03 OUTLIER Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.021 ' HB ' HG13 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -126.78 134.47 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.719 ' O ' HG23 ' A' ' 11' ' ' ILE . 9.1 tttt -87.73 158.48 18.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.105 HG21 HG21 ' A' ' 5' ' ' VAL . 3.3 pt -162.09 139.46 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.938 ' HE2' HG22 ' A' ' 153' ' ' VAL . 20.0 mtmt -89.91 78.48 6.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.625 HG22 ' CE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -116.83 145.71 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.707 ' OD2' HD11 ' A' ' 150' ' ' ILE . 0.0 OUTLIER -98.29 -160.67 0.82 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 0.3 OUTLIER 178.4 156.72 0.44 Allowed 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.985 HG23 ' HB ' ' A' ' 27' ' ' THR . 4.5 mt -136.68 77.7 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -61.73 133.22 47.08 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.588 ' HE3' ' O ' ' A' ' 16' ' ' ILE . 4.9 mttt -120.42 -157.89 0.73 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.593 ' C ' ' H ' ' A' ' 21' ' ' SER . 1.8 mt -123.05 165.62 16.48 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -53.79 -2.05 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.593 ' H ' ' C ' ' A' ' 19' ' ' LEU . 59.6 p -113.6 9.03 17.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 19' ' ' LEU . . . 70.91 29.73 68.84 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.46 ' C ' ' HG2' ' A' ' 18' ' ' LYS . 4.2 m-20 -98.43 122.75 42.01 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.557 HG13 HG22 ' A' ' 16' ' ' ILE . 35.5 t -67.89 118.34 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -110.87 -27.51 8.8 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -151.95 141.24 21.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.985 ' HB ' HG23 ' A' ' 16' ' ' ILE . 2.5 t -152.89 153.76 33.69 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.586 ' HA ' ' HA ' ' A' ' 45' ' ' TYR . 0.6 OUTLIER -104.35 14.76 29.6 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.518 HG22 ' H ' ' A' ' 32' ' ' VAL . 6.4 mt -124.97 99.17 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.678 ' CG ' ' CE2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -43.12 -35.8 1.46 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -53.71 -65.03 0.64 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.732 HG11 HG21 ' A' ' 16' ' ' ILE . 87.9 t -47.83 -43.66 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.708 ' HB2' ' CE1' ' A' ' 45' ' ' TYR . . . -44.35 -51.75 8.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.527 ' CG ' ' HB2' ' A' ' 39' ' ' TYR . 13.9 mtpt -65.42 -28.07 68.98 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 32' ' ' VAL . 45.8 tt0 -86.08 -13.62 46.76 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.536 ' HB1' ' HB ' ' A' ' 24' ' ' VAL . . . -106.59 -23.38 12.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 99.32 14.87 34.3 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.606 ' CG1' ' HA ' ' A' ' 33' ' ' ALA . 1.6 pt -114.87 31.55 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.582 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 3.6 t80 -64.49 70.02 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 38' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.708 ' CE1' ' HB2' ' A' ' 33' ' ' ALA . 25.9 m-85 . . . . . 0 N--CA 1.449 -0.505 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.668 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER 61.52 178.0 0.04 OUTLIER Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.881 ' HB3' HD12 ' A' ' 150' ' ' ILE . 83.5 Cg_endo -72.37 116.9 4.89 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 124.3 3.333 . . . . 0.0 109.585 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.1 tp -82.49 103.81 12.31 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.734 ' OE1' HG11 ' A' ' 153' ' ' VAL . 36.7 tt0 -83.61 100.52 10.87 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.69 ' CD2' HD21 ' A' ' 57' ' ' LEU . 2.1 p90 -122.9 170.76 9.78 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.838 HG12 ' H ' ' A' ' 53' ' ' GLY . 48.9 t -124.82 113.56 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.854 HG11 ' CG ' ' A' ' 66' ' ' LEU . 3.5 t -49.67 -8.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.838 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -121.08 38.2 2.76 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.424 ' HG3' ' HB ' ' A' ' 51' ' ' VAL . 2.1 mt-10 -123.29 -19.65 5.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.36 18.19 62.92 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -72.86 -76.83 0.11 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.69 HD21 ' CD2' ' A' ' 50' ' ' PHE . 1.3 mm? -73.17 149.58 42.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.886 ' H ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -55.68 163.27 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.481 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 23.9 mt-30 -53.53 -59.08 5.05 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.826 ' H ' ' HB3' ' A' ' 82' ' ' LYS . . . -41.54 -78.78 0.06 OUTLIER Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.279 -1.129 . . . . 0.0 110.279 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.651 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 1.0 OUTLIER -38.34 -52.37 1.52 Allowed 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -48.59 -51.77 26.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.806 ' HA ' HD12 ' A' ' 66' ' ' LEU . 6.8 mt-10 -58.33 -27.67 64.36 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.651 ' HB3' ' O ' ' A' ' 61' ' ' PHE . . . -63.9 -55.28 23.88 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.554 HG13 HD13 ' A' ' 147' ' ' ILE . 33.9 m -78.84 4.08 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.854 ' CG ' HG11 ' A' ' 52' ' ' VAL . 5.3 mt -84.77 -38.08 20.05 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.07 26.01 11.13 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.988 ' CE ' HD11 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -104.2 -155.11 0.52 Allowed 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.484 ' HB2' ' CG ' ' A' ' 72' ' ' ASP . 0.5 OUTLIER -144.35 -177.38 5.44 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.618 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 1.1 t -90.71 84.36 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.771 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 131.07 12.54 2.09 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.484 ' CG ' ' HB2' ' A' ' 69' ' ' GLU . 1.3 m-20 -100.54 -170.56 1.88 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.2 126.4 6.58 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.469 ' CB ' ' HE2' ' A' ' 68' ' ' MET . 2.3 ttmm -119.63 96.3 5.14 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.537 ' OG1' HG23 ' A' ' 146' ' ' THR . 62.8 m -96.87 83.05 3.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.452 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 3.8 t -119.69 157.75 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 13.7 ttmt -89.87 114.48 26.25 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.692 HD13 ' CD2' ' A' ' 145' ' ' PHE . 0.3 OUTLIER -79.11 130.18 70.36 Favored Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.479 ' O ' ' N ' ' A' ' 81' ' ' GLU . 84.6 Cg_endo -72.34 134.3 22.49 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 124.286 3.324 . . . . 0.0 109.634 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.727 ' HB2' ' N ' ' A' ' 141' ' ' LYS . . . -46.81 -14.56 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.601 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 3.2 tp10 -76.64 -39.3 52.74 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.826 ' HB3' ' H ' ' A' ' 60' ' ' GLY . 14.6 mttt -81.97 -34.13 29.89 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.627 ' HA ' ' CG2' ' A' ' 58' ' ' ILE . . . -73.31 -102.05 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.561 ' CE1' ' HB2' ' A' ' 138' ' ' LEU . 2.8 m-85 -90.7 20.29 4.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 47.38 89.24 0.01 OUTLIER Glycine 0 C--N 1.336 0.535 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.584 ' HA ' ' HA2' ' A' ' 140' ' ' GLY . 0.0 OUTLIER 40.99 -133.94 0.28 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.495 ' H ' ' HB2' ' A' ' 86' ' ' ASN . 0.3 OUTLIER -90.85 149.17 22.06 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.899 ' CB ' HD12 ' A' ' 91' ' ' LEU . 1.7 m120 -87.52 135.18 33.45 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -81.46 -26.55 35.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.96 -4.99 59.13 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.899 HD12 ' CB ' ' A' ' 88' ' ' ASN . 28.2 mt -102.83 13.31 34.7 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.617 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 26.5 mt -82.5 124.09 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.552 ' CD ' ' CD1' ' A' ' 134' ' ' PHE . 3.1 mp0 -115.53 156.2 26.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.724 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -133.32 90.16 2.7 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.65 HG23 HD11 ' A' ' 132' ' ' LEU . 34.4 pt -88.25 154.25 51.62 Favored Pre-proline 0 N--CA 1.449 -0.501 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.512 ' O ' ' N ' ' A' ' 99' ' ' ALA . 81.5 Cg_endo -72.44 141.49 35.14 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 124.275 3.316 . . . . 0.0 109.591 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.924 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -44.11 -30.59 0.78 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.829 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.522 ' HA ' ' HB2' ' A' ' 101' ' ' LYS . 5.1 t70 -68.93 -36.18 77.67 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -47.9 -27.76 2.31 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.623 ' CE2' ' HB3' ' A' ' 107' ' ' PRO . 0.6 OUTLIER -99.41 -33.03 10.86 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 1.1 tttm -58.22 -0.35 0.09 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.531 ' H ' ' C ' ' A' ' 100' ' ' PHE . 7.8 mm-40 -117.12 4.65 12.71 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.14 -133.94 0.07 Allowed 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.71 -8.96 1.87 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.422 ' HB2' ' H ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -137.76 -157.73 0.8 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.471 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 1.6 pm0 -125.88 137.78 30.75 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.924 ' CG ' HH21 ' A' ' 97' ' ' ARG . 83.5 Cg_endo -72.3 129.31 14.78 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 124.38 3.387 . . . . 0.0 109.584 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 110' ' ' GLY . 1.7 mm-40 -125.65 150.84 47.25 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.454 ' HA ' HG22 ' A' ' 122' ' ' ILE . 2.5 tm-20 -62.68 71.07 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 151.86 14.72 0.07 OUTLIER Glycine 0 C--N 1.335 0.513 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.907 ' CB ' HD13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -74.41 173.53 10.16 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.531 HG13 ' HB2' ' A' ' 119' ' ' PRO . 61.1 t -156.84 82.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.453 ' C ' ' HA ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -115.31 127.67 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.989 HD23 ' HD3' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -102.32 163.25 12.34 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -112.61 6.97 18.62 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 169.93 -6.33 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 156.34 -21.91 0.49 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.494 ' C ' ' HB3' ' A' ' 114' ' ' LEU . 3.0 mt -102.7 103.15 30.82 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.989 ' HD3' HD23 ' A' ' 114' ' ' LEU . 82.7 Cg_endo -72.4 158.72 50.85 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 124.264 3.309 . . . . 0.0 109.572 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.75 ' HB1' ' HB2' ' A' ' 132' ' ' LEU . . . -115.83 87.05 2.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 32.5 m -55.57 97.98 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.907 HD13 ' CB ' ' A' ' 111' ' ' MET . 1.8 mp -63.45 99.96 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.3 p -86.09 -21.19 27.8 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.779 ' HB3' ' H ' ' A' ' 131' ' ' THR . 1.6 tp10 -128.66 136.1 50.18 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.732 ' HA ' HG12 ' A' ' 130' ' ' VAL . 10.7 p -119.3 56.71 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.631 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.1 OUTLIER -78.44 123.97 27.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.512 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.2 OUTLIER -52.01 -2.54 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.631 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -111.69 -17.87 12.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.3 OUTLIER -179.33 163.33 1.25 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.916 HG11 ' HB2' ' A' ' 107' ' ' PRO . 0.6 OUTLIER -127.48 118.9 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.779 ' H ' ' HB3' ' A' ' 124' ' ' GLU . 20.7 m -82.03 84.95 6.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.75 ' HB2' ' HB1' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -79.7 169.66 17.65 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.617 ' HA ' ' HA ' ' A' ' 92' ' ' ILE . 11.6 t0 -132.29 95.3 3.62 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.567 ' N ' ' O ' ' A' ' 91' ' ' LEU . 2.1 m-30 -37.7 -38.96 0.31 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.752 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 0.8 OUTLIER 38.89 -118.32 0.23 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.759 ' ND1' ' N ' ' A' ' 137' ' ' GLU . 14.1 t-80 177.93 176.88 0.41 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.759 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -73.36 -8.39 55.68 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.931 HD22 HD22 ' A' ' 143' ' ' LEU . 72.0 mt -122.08 -5.63 8.96 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.752 ' HB3' ' HB3' ' A' ' 135' ' ' ASN . . . -68.1 133.66 49.32 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 86' ' ' ASN . . . 55.25 24.45 36.88 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.867 ' HE2' ' CD2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -142.07 145.94 34.89 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.503 ' C ' ' HD2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -98.91 137.61 37.23 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.931 HD22 HD22 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -127.15 152.76 46.92 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 2.0 t -74.36 165.69 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.692 ' CD2' HD13 ' A' ' 78' ' ' ILE . 28.0 m-85 -153.27 94.65 1.85 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.653 HG22 ' O ' ' A' ' 146' ' ' THR . 42.0 m -88.54 67.37 8.49 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.627 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -60.72 -177.81 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.496 ' H ' HG22 ' A' ' 147' ' ' ILE . 10.6 tttt -175.45 108.34 0.1 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 1.03 ' H ' HD12 ' A' ' 149' ' ' ILE . 1.5 mp -75.4 134.11 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.881 HD12 ' HB3' ' A' ' 47' ' ' PRO . 6.9 mt -113.47 -41.61 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.618 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -166.02 -156.31 0.25 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.634 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 18.6 t -131.63 155.1 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.938 HG22 ' HE2' ' A' ' 12' ' ' LYS . 2.6 t . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.63 HG22 HG21 ' A' ' 11' ' ' ILE . 48.8 t . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 8' ' ' GLY . 0.5 OUTLIER -154.49 177.48 11.13 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.867 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.547 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 15.7 ptmt -66.32 65.45 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 6' ' ' ASP . . . 156.05 23.78 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.17 125.63 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.564 ' CA ' HG22 ' A' ' 51' ' ' VAL . 2.8 ttpm? -85.22 150.21 24.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.866 HG22 HG22 ' A' ' 152' ' ' VAL . 1.2 pt -154.17 126.9 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.655 ' HE2' HG21 ' A' ' 153' ' ' VAL . 21.0 mtmt -86.77 86.14 7.31 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.596 ' CG1' ' HA ' ' A' ' 149' ' ' ILE . 0.7 OUTLIER -114.93 152.48 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.806 ' CG ' HD11 ' A' ' 150' ' ' ILE . 0.8 OUTLIER -117.49 108.32 15.37 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.631 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.2 p90 -94.32 160.94 14.45 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 1.037 HG23 ' HB ' ' A' ' 27' ' ' THR . 5.1 mt -129.98 75.49 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -59.14 136.64 50.93 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.602 ' HE3' ' O ' ' A' ' 16' ' ' ILE . 6.6 mttt -122.87 -159.6 0.85 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.589 ' C ' ' H ' ' A' ' 21' ' ' SER . 57.8 mt -117.68 165.93 13.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -55.33 0.05 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.589 ' H ' ' C ' ' A' ' 19' ' ' LEU . 56.8 p -114.16 2.11 14.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.32 28.6 52.49 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.456 ' C ' ' HG2' ' A' ' 18' ' ' LYS . 4.1 m-20 -97.81 123.55 41.82 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.577 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 47.4 t -67.87 126.02 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.579 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 1.9 p90 -119.62 -38.85 2.93 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.579 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 8.3 t0 -138.13 135.7 35.99 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . 1.037 ' HB ' HG23 ' A' ' 16' ' ' ILE . 3.9 t -152.58 148.75 27.72 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.46 ' HB3' ' HB3' ' A' ' 14' ' ' ASP . 0.6 OUTLIER -91.79 -18.78 23.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.744 HD11 ' CG ' ' A' ' 14' ' ' ASP . 4.6 mt -93.81 121.1 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.596 ' HG3' ' CD1' ' A' ' 45' ' ' TYR . 3.5 tt0 -63.62 -32.02 73.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -51.67 -63.41 1.14 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.913 HG11 HG21 ' A' ' 16' ' ' ILE . 52.0 t -50.58 -42.18 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.67 ' HB1' ' HA ' ' A' ' 39' ' ' TYR . . . -46.11 -42.79 14.16 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.534 ' HG2' ' CB ' ' A' ' 39' ' ' TYR . 11.6 mtmt -71.62 -32.41 67.95 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -74.46 -17.61 60.75 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.5 -7.57 16.52 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.0 43.73 32.67 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.54 HG13 ' HA ' ' A' ' 33' ' ' ALA . 1.8 pt -139.65 11.16 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.67 ' HA ' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -46.95 -21.39 0.21 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.493 ' O ' ' CZ ' ' A' ' 39' ' ' TYR . . . . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.596 ' CD1' ' HG3' ' A' ' 30' ' ' GLU . 2.9 m-85 . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.738 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -114.53 -179.15 0.58 Allowed Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.738 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 82.4 Cg_endo -72.38 122.53 8.4 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 124.283 3.322 . . . . 0.0 109.607 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.9 HD21 HD21 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -75.43 96.0 3.36 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.549 ' HG2' ' CG ' ' A' ' 10' ' ' LYS . 48.0 tt0 -79.31 97.49 6.31 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.831 ' CE2' HG21 ' A' ' 65' ' ' VAL . 39.7 p90 -110.81 170.39 8.13 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.628 HG12 ' H ' ' A' ' 53' ' ' GLY . 89.6 t -134.48 104.4 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.558 HG21 HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -44.54 -17.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.628 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -101.24 37.59 3.54 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 51' ' ' VAL . 5.5 mt-10 -141.78 -30.08 0.6 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.1 7.37 77.35 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.486 ' OE1' ' N ' ' A' ' 51' ' ' VAL . 5.5 mt-30 -42.3 -68.89 0.16 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.9 HD21 HD21 ' A' ' 48' ' ' LEU . 2.3 mm? -79.74 160.37 26.25 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.693 HG13 HG21 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -60.48 160.35 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.52 ' O ' ' C ' ' A' ' 60' ' ' GLY . 21.8 mt-30 -48.85 -67.01 0.3 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.952 ' HA3' HD12 ' A' ' 78' ' ' ILE . . . -29.86 -74.37 0.04 OUTLIER Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.61 ' CE2' HG23 ' A' ' 147' ' ' ILE . 1.0 OUTLIER -45.98 -51.72 12.95 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 59' ' ' GLN . 2.9 mt-10 -50.49 -38.63 45.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.602 ' HA ' HD12 ' A' ' 66' ' ' LEU . 18.9 mt-10 -74.63 -25.09 58.99 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.763 ' HB1' ' HB3' ' A' ' 74' ' ' LYS . . . -68.88 -51.7 37.49 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.831 HG21 ' CE2' ' A' ' 50' ' ' PHE . 27.2 m -74.0 -12.71 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.602 HD12 ' HA ' ' A' ' 63' ' ' GLU . 2.5 mt -60.51 106.31 0.53 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 66' ' ' LEU . 1.8 m-20 84.34 33.06 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.511 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 4.8 mtp -123.43 106.29 10.52 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -70.53 -179.63 2.18 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.887 HG22 HG23 ' A' ' 152' ' ' VAL . 7.1 t -60.05 127.4 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 107.43 -32.3 7.29 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.511 ' HB3' ' HG2' ' A' ' 68' ' ' MET . 0.9 OUTLIER -54.07 160.47 1.52 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.52 145.83 21.82 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.763 ' HB3' ' HB1' ' A' ' 64' ' ' ALA . 2.2 tttt -143.78 98.72 3.28 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.745 ' OG1' HG23 ' A' ' 146' ' ' THR . 83.1 m -100.01 83.17 2.66 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 2.9 t -121.62 156.13 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 19.8 ttpt -79.16 114.71 18.32 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.952 HD12 ' HA3' ' A' ' 60' ' ' GLY . 24.5 mm -78.51 123.24 85.65 Favored Pre-proline 0 N--CA 1.449 -0.489 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.656 ' HG3' ' HE3' ' A' ' 82' ' ' LYS . 85.0 Cg_endo -72.29 145.03 42.61 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 124.361 3.374 . . . . 0.0 109.587 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.538 ' O ' ' CA ' ' A' ' 85' ' ' GLY . . . -54.33 -23.74 16.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.527 ' CG ' ' HB2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -69.87 -41.07 75.29 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.776 ' HB3' ' H ' ' A' ' 60' ' ' GLY . 17.8 mttt -82.24 -28.79 31.67 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.771 ' HB2' HG21 ' A' ' 78' ' ' ILE . . . -112.75 110.97 21.42 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.639 ' CD2' ' HB3' ' A' ' 138' ' ' LEU . 32.6 m-85 70.91 -9.78 0.81 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 80' ' ' ALA . . . 64.02 156.41 0.15 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -41.36 155.4 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.59 ' HD2' ' ND2' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -39.41 131.1 1.68 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.566 ' CB ' HD12 ' A' ' 91' ' ' LEU . 7.7 t30 -81.08 147.73 29.98 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -85.12 -27.49 26.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.88 -0.56 18.9 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.766 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 71.7 mt -98.95 3.46 47.07 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.609 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 42.1 mt -85.77 113.32 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.4 ' O ' ' N ' ' A' ' 132' ' ' LEU . 6.8 mp0 -108.2 145.73 33.82 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.618 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -128.3 97.2 4.67 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.019 HG12 HD11 ' A' ' 132' ' ' LEU . 25.2 pt -92.63 153.63 42.4 Favored Pre-proline 0 N--CA 1.45 -0.454 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.559 ' HG2' ' HB2' ' A' ' 99' ' ' ALA . 83.6 Cg_endo -72.44 139.65 31.98 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 124.272 3.314 . . . . 0.0 109.562 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.782 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -44.73 -26.89 0.43 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.548 ' HA ' ' HB2' ' A' ' 101' ' ' LYS . 10.0 t70 -73.73 -34.01 64.58 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.559 ' HB2' ' HG2' ' A' ' 96' ' ' PRO . . . -58.5 -22.28 54.56 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.675 ' CD1' ' CD1' ' A' ' 95' ' ' ILE . 1.8 m-85 -121.42 2.88 10.26 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.548 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 0.2 OUTLIER -53.06 -41.44 64.85 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -118.74 34.68 5.1 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.672 ' HB2' ' HA ' ' A' ' 100' ' ' PHE . . . -81.15 20.06 0.86 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 59.34 -6.75 0.06 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.621 ' H ' ' C ' ' A' ' 103' ' ' ALA . 0.5 OUTLIER -150.63 147.52 27.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.496 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 0.6 OUTLIER -94.83 129.67 35.33 Favored Pre-proline 0 N--CA 1.449 -0.496 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.846 ' CG ' HG11 ' A' ' 130' ' ' VAL . 82.6 Cg_endo -72.36 135.02 23.77 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 124.367 3.378 . . . . 0.0 109.544 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 110' ' ' GLY . 1.2 mt-10 -124.19 156.81 36.12 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.481 ' HB2' HG12 ' A' ' 125' ' ' VAL . 2.8 tm-20 -65.7 67.55 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.65 14.04 0.06 OUTLIER Glycine 0 C--N 1.336 0.537 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.808 ' HB3' HD12 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -69.97 171.27 9.72 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.66 HG13 ' HB2' ' A' ' 119' ' ' PRO . 64.0 t -156.7 70.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.19 135.49 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.882 HD23 ' N ' ' A' ' 119' ' ' PRO . 0.3 OUTLIER -99.2 149.2 23.33 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -103.37 3.48 35.22 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 171.41 -11.09 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.652 ' O ' HD22 ' A' ' 114' ' ' LEU . . . 166.06 -34.88 0.24 Allowed Glycine 0 C--N 1.335 0.492 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 3.0 mt -93.3 121.32 65.51 Favored Pre-proline 0 N--CA 1.448 -0.53 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.882 ' N ' HD23 ' A' ' 114' ' ' LEU . 83.9 Cg_endo -72.39 164.13 36.55 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 124.282 3.321 . . . . 0.0 109.631 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.866 ' HB1' ' HB3' ' A' ' 132' ' ' LEU . . . -123.55 82.94 2.07 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 2.4 m -54.13 94.82 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.808 HD12 ' HB3' ' A' ' 111' ' ' MET . 12.8 mt -70.49 97.3 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.482 HG22 HG22 ' A' ' 121' ' ' THR . 1.3 p -82.68 -24.73 33.56 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.769 ' HG2' HG23 ' A' ' 126' ' ' THR . 1.2 tt0 -111.54 132.38 54.56 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.705 HG22 ' O ' ' A' ' 125' ' ' VAL . 8.1 p -126.22 48.03 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.769 HG23 ' HG2' ' A' ' 124' ' ' GLU . 2.1 p -79.85 129.28 34.35 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.552 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.4 OUTLIER -53.87 2.41 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.682 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.7 OUTLIER -110.79 -22.74 11.41 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -177.88 168.66 2.06 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.846 HG11 ' CG ' ' A' ' 107' ' ' PRO . 22.0 m -132.15 143.56 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.618 HG23 ' HD2' ' A' ' 94' ' ' LYS . 16.3 m -99.75 85.37 3.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 1.019 HD11 HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -82.5 107.72 15.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.609 ' HA ' ' HA ' ' A' ' 92' ' ' ILE . 18.8 t0 -83.86 97.04 8.98 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.513 ' N ' ' O ' ' A' ' 91' ' ' LEU . 2.3 m-85 -42.53 -45.55 4.55 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.766 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 91.2 m-20 42.17 -121.76 0.58 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.695 ' ND1' ' N ' ' A' ' 137' ' ' GLU . 21.6 t-80 -179.21 166.87 1.54 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.695 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 0.9 OUTLIER -70.99 -16.07 62.61 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 1.04 HD12 HD22 ' A' ' 143' ' ' LEU . 3.4 mm? -111.26 -23.2 10.97 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.528 ' HB2' ' HB3' ' A' ' 136' ' ' HIS . . . -48.66 144.66 4.18 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 42.45 22.12 0.12 Allowed Glycine 0 C--N 1.336 0.531 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.81 ' HD2' HD13 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -133.09 133.03 42.42 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.566 ' C ' ' HD3' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -99.11 131.56 45.06 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 1.04 HD22 HD12 ' A' ' 138' ' ' LEU . 2.4 pt? -122.57 146.43 47.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.578 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 4.0 t -67.71 163.04 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.737 ' CD1' ' CG1' ' A' ' 78' ' ' ILE . 16.4 m-85 -146.43 85.87 1.66 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.745 HG23 ' OG1' ' A' ' 75' ' ' THR . 95.0 m -83.82 70.81 10.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.631 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 2.1 mt -64.4 179.54 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.631 ' H ' HG22 ' A' ' 147' ' ' ILE . 3.1 tmtt? -177.65 96.49 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.596 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 2.4 mm -60.06 135.01 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.806 HD11 ' CG ' ' A' ' 14' ' ' ASP . 2.3 mt -122.51 -24.62 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -163.11 176.39 10.09 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.887 HG23 HG22 ' A' ' 70' ' ' VAL . 85.7 t -137.69 136.84 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.655 HG21 ' HE2' ' A' ' 12' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.906 HG21 HD13 ' A' ' 11' ' ' ILE . 16.6 t . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.464 ' N ' HG12 ' A' ' 5' ' ' VAL . 7.8 m-20 -143.4 168.83 18.89 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.527 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 11.7 ptmt -66.05 69.59 0.06 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 6' ' ' ASP . . . 162.59 11.3 0.03 OUTLIER Glycine 0 C--N 1.336 0.561 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.827 ' HB ' HG13 ' A' ' 5' ' ' VAL . 1.4 t -119.05 133.96 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.584 ' HG3' HG22 ' A' ' 51' ' ' VAL . 3.6 tttt -86.64 133.39 33.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.999 ' CG2' HG22 ' A' ' 152' ' ' VAL . 9.6 pt -147.03 136.38 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.615 ' CG ' HG23 ' A' ' 153' ' ' VAL . 9.5 mtpt -95.03 91.94 6.6 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.633 HG22 ' CE1' ' A' ' 50' ' ' PHE . 1.1 m -118.35 145.79 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 147' ' ' ILE . 41.3 m-20 -92.19 -166.69 1.6 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.0 OUTLIER -179.81 151.79 0.45 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 1.077 HD13 HG21 ' A' ' 32' ' ' VAL . 3.5 mt -133.22 81.65 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -65.74 138.62 37.91 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.643 ' HE2' HG22 ' A' ' 24' ' ' VAL . 10.4 mttt -125.44 -165.81 1.46 Allowed 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.636 ' C ' ' H ' ' A' ' 21' ' ' SER . 34.1 mt -112.98 166.52 11.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -54.84 0.77 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.636 ' H ' ' C ' ' A' ' 19' ' ' LEU . 54.2 p -112.4 2.54 16.47 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.04 30.51 57.26 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 18' ' ' LYS . 87.3 m-20 -100.87 124.29 46.33 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.643 HG22 ' HE2' ' A' ' 18' ' ' LYS . 82.2 t -71.06 122.83 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.484 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -115.48 -30.13 6.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.484 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 16.7 t0 -143.56 140.23 30.13 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . 1.015 ' HB ' HG23 ' A' ' 16' ' ' ILE . 6.1 t -158.72 148.66 19.48 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.4 m -101.78 16.68 25.12 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 29.0 mt -127.91 108.47 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.583 ' HG3' ' CD1' ' A' ' 45' ' ' TYR . 2.8 tt0 -48.81 -35.42 14.45 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -47.4 -64.66 0.72 Allowed 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.077 HG21 HD13 ' A' ' 16' ' ' ILE . 49.5 t -53.81 -40.39 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.596 ' HA ' ' CG1' ' A' ' 38' ' ' ILE . . . -54.68 -38.09 66.55 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.522 ' CG ' ' HB2' ' A' ' 39' ' ' TYR . 7.7 mtpt -78.51 -17.93 55.51 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -96.01 -23.62 16.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . -95.14 -23.71 17.17 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.81 37.58 4.93 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.596 ' CG1' ' HA ' ' A' ' 33' ' ' ALA . 2.1 pt -135.38 17.17 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.522 ' HB2' ' CG ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -43.44 -20.47 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 38' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.658 ' HE2' HG23 ' A' ' 27' ' ' THR . 80.3 m-85 . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.618 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -131.23 174.92 4.13 Favored Pre-proline 0 N--CA 1.449 -0.523 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.618 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 83.8 Cg_endo -72.41 130.84 16.71 Favored 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 124.319 3.346 . . . . 0.0 109.643 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.806 HD21 HD21 ' A' ' 57' ' ' LEU . 1.4 tp -88.63 96.66 10.74 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.611 ' CD ' HG11 ' A' ' 153' ' ' VAL . 23.4 tt0 -79.08 89.73 4.82 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.757 ' CE2' ' CE1' ' A' ' 61' ' ' PHE . 0.7 OUTLIER -108.32 172.8 6.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.676 HG12 ' H ' ' A' ' 53' ' ' GLY . 59.1 t -123.6 107.28 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.85 HG11 ' HG ' ' A' ' 66' ' ' LEU . 2.8 t -50.93 -8.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.676 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -96.98 -25.27 11.53 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.296 -1.121 . . . . 0.0 110.296 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 51' ' ' VAL . 14.6 mt-10 -74.28 -65.32 0.86 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.82 13.84 8.36 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -43.47 -67.09 0.31 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.806 HD21 HD21 ' A' ' 48' ' ' LEU . 1.5 mm? -70.67 -171.97 0.57 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.067 ' H ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -81.68 146.38 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.503 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 27.1 mt-30 -43.15 -54.69 4.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.581 ' HA3' HD12 ' A' ' 78' ' ' ILE . . . -39.45 -81.51 0.02 OUTLIER Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.757 ' CE1' ' CE2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -42.53 -49.56 5.37 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.67 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 1.9 mt-10 -49.88 -35.08 22.17 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 60' ' ' GLY . 4.9 mt-10 -78.09 -32.0 50.4 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.473 ' HB1' ' HB3' ' A' ' 74' ' ' LYS . . . -64.47 -25.42 67.99 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.678 HG21 ' CE2' ' A' ' 50' ' ' PHE . 33.5 m -95.02 -20.4 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.85 ' HG ' HG11 ' A' ' 52' ' ' VAL . 1.2 mt -51.07 -60.44 3.1 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -96.33 55.59 1.5 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.471 ' CE ' HD11 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -144.37 127.38 16.47 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.401 ' O ' HG13 ' A' ' 149' ' ' ILE . 0.8 OUTLIER -75.31 -161.77 0.16 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.686 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 0.2 OUTLIER -90.0 115.56 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.868 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 107.0 -6.57 37.26 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 0.9 OUTLIER -68.64 177.81 2.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -154.8 142.59 19.96 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.473 ' HB3' ' HB1' ' A' ' 64' ' ' ALA . 2.4 tttm -139.38 101.98 4.37 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 1.066 ' CG2' HG23 ' A' ' 146' ' ' THR . 0.2 OUTLIER -99.19 93.6 6.04 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.413 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 18.3 t -136.09 156.04 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.673 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 2.5 ttpm? -85.35 116.44 23.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.689 ' CG1' ' CD1' ' A' ' 145' ' ' PHE . 22.2 mm -78.37 126.65 82.82 Favored Pre-proline 0 N--CA 1.448 -0.568 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.502 ' HG2' ' HG2' ' A' ' 81' ' ' GLU . 84.4 Cg_endo -72.32 144.1 40.57 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 124.264 3.31 . . . . 0.0 109.656 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.709 ' HB1' ' O ' ' A' ' 139' ' ' ALA . . . -56.62 -8.57 0.58 Allowed 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.582 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 9.3 pt-20 -81.55 -39.25 24.9 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.574 ' HB3' ' H ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -86.85 -34.73 19.38 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.639 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . . . -67.75 -96.44 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.604 ' CE1' ' HB3' ' A' ' 138' ' ' LEU . 3.1 m-85 -99.29 17.56 19.76 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 42.53 84.56 0.01 OUTLIER Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER 47.65 -166.22 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 1.042 ' HE ' ' HB3' ' A' ' 139' ' ' ALA . 3.4 mmt85 -70.47 145.91 50.64 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.64 ' HB2' HD12 ' A' ' 91' ' ' LEU . 0.9 OUTLIER -83.27 143.83 30.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.09 -26.79 20.06 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -74.66 -23.3 58.64 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.64 HD12 ' HB2' ' A' ' 88' ' ' ASN . 85.4 mt -85.34 26.67 0.88 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.601 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 86.5 mt -93.16 116.41 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.626 ' NE2' ' CG ' ' A' ' 134' ' ' PHE . 12.3 mp0 -109.19 154.23 22.67 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.664 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -134.96 99.09 4.19 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.038 HG12 HD11 ' A' ' 132' ' ' LEU . 21.4 pt -95.5 156.02 38.0 Favored Pre-proline 0 N--CA 1.449 -0.483 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 99' ' ' ALA . 83.0 Cg_endo -72.36 139.53 32.01 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 124.283 3.322 . . . . 0.0 109.577 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.82 HH21 ' HG2' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -42.16 -33.94 0.67 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.522 ' HA ' ' HB2' ' A' ' 101' ' ' LYS . 0.9 OUTLIER -65.85 -36.37 83.25 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -43.65 -19.85 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.488 ' N ' ' O ' ' A' ' 98' ' ' ASP . 0.6 OUTLIER -126.49 -30.61 2.83 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 1.2 tmtt? -53.42 -17.46 1.95 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.03 28.36 8.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.469 ' HB1' ' CE1' ' A' ' 105' ' ' PHE . . . -113.03 -139.16 0.38 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.99 -3.31 3.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.469 ' CE1' ' HB1' ' A' ' 103' ' ' ALA . 0.1 OUTLIER -128.13 -148.43 0.38 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.436 ' CD ' HH22 ' A' ' 97' ' ' ARG . 0.0 OUTLIER -162.44 132.93 3.5 Favored Pre-proline 0 N--CA 1.45 -0.448 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.82 ' HG2' HH21 ' A' ' 97' ' ' ARG . 82.3 Cg_endo -72.38 137.39 28.14 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 124.27 3.313 . . . . 0.0 109.591 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.479 ' O ' ' N ' ' A' ' 110' ' ' GLY . 4.0 mt-10 -126.05 154.61 42.77 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.528 ' N ' ' HB ' ' A' ' 125' ' ' VAL . 1.2 tt0 -65.51 67.03 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.91 9.86 0.08 OUTLIER Glycine 0 C--N 1.336 0.539 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.917 ' CB ' HD13 ' A' ' 122' ' ' ILE . 1.4 mmt -66.64 171.38 5.19 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.508 HG23 ' C ' ' A' ' 111' ' ' MET . 60.7 t -156.11 73.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.473 HD13 ' HZ ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -110.29 136.95 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.767 HD23 ' CD ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -106.49 171.07 7.56 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -114.79 -4.29 12.7 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.417 ' H ' ' H ' ' A' ' 117' ' ' GLY . 1.0 OUTLIER 172.33 5.63 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.418 ' O ' HD22 ' A' ' 114' ' ' LEU . . . 153.87 -38.86 0.69 Allowed Glycine 0 C--N 1.335 0.483 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 48.8 mm -87.47 114.65 59.74 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.767 ' CD ' HD23 ' A' ' 114' ' ' LEU . 84.9 Cg_endo -72.38 173.5 13.03 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 124.305 3.337 . . . . 0.0 109.604 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.875 ' HB1' ' HB3' ' A' ' 132' ' ' LEU . . . -134.64 73.14 1.47 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 77.3 m -49.85 96.86 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.917 HD13 ' CB ' ' A' ' 111' ' ' MET . 2.9 mp -69.1 98.73 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.426 HG23 ' H ' ' A' ' 123' ' ' THR . 1.0 OUTLIER -83.76 -21.14 32.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.561 ' HB3' ' H ' ' A' ' 131' ' ' THR . 0.3 OUTLIER -120.16 133.41 55.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.796 ' HA ' HG12 ' A' ' 130' ' ' VAL . 7.2 p -124.76 52.6 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.639 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -79.67 127.81 32.63 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 97' ' ' ARG . 0.5 OUTLIER -53.25 0.63 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.639 ' H ' ' C ' ' A' ' 126' ' ' THR . 1.4 p-10 -111.62 -21.67 11.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -177.83 168.43 2.09 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.796 HG12 ' HA ' ' A' ' 125' ' ' VAL . 4.2 m -133.66 141.69 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.664 HG23 ' HD2' ' A' ' 94' ' ' LYS . 17.3 m -98.18 86.27 3.64 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 1.038 HD11 HG12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -82.65 113.32 20.26 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.601 ' HA ' ' HA ' ' A' ' 92' ' ' ILE . 10.0 t0 -81.96 95.12 7.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.626 ' CG ' ' NE2' ' A' ' 93' ' ' GLN . 1.6 m-85 -39.88 -50.61 2.46 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.624 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 64.7 m-20 45.97 -132.89 0.99 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.779 ' ND1' ' N ' ' A' ' 137' ' ' GLU . 23.2 t-80 -167.84 174.21 7.7 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.779 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 8.7 pt-20 -86.06 10.11 15.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.844 ' CD2' ' HE2' ' A' ' 141' ' ' LYS . 63.5 mt -135.01 5.32 3.31 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.042 ' HB3' ' HE ' ' A' ' 87' ' ' ARG . . . -60.58 -111.23 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.858 ' H ' ' NE ' ' A' ' 87' ' ' ARG . . . -65.59 38.65 0.13 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.844 ' HE2' ' CD2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -136.47 143.18 43.71 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.495 ' HB3' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -101.0 129.9 46.91 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.788 HD22 HD22 ' A' ' 138' ' ' LEU . 1.1 pt? -121.07 145.69 47.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.673 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 1.6 t -62.14 163.88 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.689 ' CD1' ' CG1' ' A' ' 78' ' ' ILE . 12.3 m-85 -148.28 102.58 3.36 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . 1.066 HG23 ' CG2' ' A' ' 75' ' ' THR . 24.3 m -97.17 60.81 1.7 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.691 HD13 ' CD2' ' A' ' 61' ' ' PHE . 1.1 mt -59.67 177.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.473 ' H ' HG22 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -177.25 113.86 0.09 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.868 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 2.8 mm -69.49 139.98 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.524 HG13 ' HA ' ' A' ' 13' ' ' VAL . 6.7 mt -118.78 -48.12 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.686 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -158.11 -165.39 1.71 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.999 HG22 ' CG2' ' A' ' 11' ' ' ILE . 10.7 t -134.16 137.83 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.629 HG12 ' O ' ' A' ' 153' ' ' VAL . 45.8 t . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.079 HG21 HD13 ' A' ' 11' ' ' ILE . 23.0 t . . . . . 0 N--CA 1.448 -0.529 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' A' ' 8' ' ' GLY . 0.8 OUTLIER -137.76 171.08 14.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.539 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 16.9 ptmt -64.76 70.64 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 6' ' ' ASP . . . 161.61 11.24 0.03 OUTLIER Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.838 ' HB ' HG13 ' A' ' 5' ' ' VAL . 1.7 t -125.17 132.97 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.702 ' O ' HG23 ' A' ' 11' ' ' ILE . 11.6 tttt -88.2 152.94 21.62 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 1.079 HD13 HG21 ' A' ' 5' ' ' VAL . 6.2 pt -160.72 137.96 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 7.7 ttmt -96.12 99.94 11.63 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.607 HG12 ' HA ' ' A' ' 149' ' ' ILE . 1.2 m -119.65 152.62 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.621 ' CG ' HD11 ' A' ' 150' ' ' ILE . 0.5 OUTLIER -115.42 103.01 10.35 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.605 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 9.3 p90 -96.63 151.63 19.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.941 HG21 HG11 ' A' ' 32' ' ' VAL . 1.1 mt -119.81 77.94 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -62.65 130.45 43.07 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.603 ' HE2' HG22 ' A' ' 24' ' ' VAL . 6.9 mtmt -125.56 144.43 50.57 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 21' ' ' SER . 80.2 mt -64.07 170.09 3.88 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.61 50.86 0.07 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 19' ' ' LEU . 94.1 p -161.82 -1.01 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.29 22.34 48.43 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 18' ' ' LYS . 2.2 m-20 -96.71 116.34 28.96 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.603 HG22 ' HE2' ' A' ' 18' ' ' LYS . 54.6 t -68.44 115.07 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.513 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 3.3 p90 -103.84 -37.75 7.31 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.513 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 9.3 t0 -136.04 133.46 37.43 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.9 ' HB ' HG23 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -153.91 131.59 11.49 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.605 ' HB2' ' HA ' ' A' ' 14' ' ' ASP . 3.0 m -79.68 -23.2 42.62 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.487 HG22 ' H ' ' A' ' 32' ' ' VAL . 5.0 mt -84.67 114.93 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.594 ' O ' ' HE3' ' A' ' 34' ' ' LYS . 6.4 tt0 -60.89 -22.02 63.89 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -60.51 -62.46 1.84 Allowed 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.941 HG11 HG21 ' A' ' 16' ' ' ILE . 89.3 t -54.54 -41.0 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.596 ' HA ' HG13 ' A' ' 38' ' ' ILE . . . -48.22 -39.18 20.37 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.594 ' HE3' ' O ' ' A' ' 30' ' ' GLU . 18.0 mttt -77.56 -24.32 49.84 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 32' ' ' VAL . 35.7 tt0 -84.37 -12.98 53.52 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.82 -10.49 14.76 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.83 44.0 10.74 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.596 HG13 ' HA ' ' A' ' 33' ' ' ALA . 1.6 pt -140.06 16.28 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.54 ' HB2' ' CG ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -45.07 -17.51 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . . . . . . 0 N--CA 1.449 -0.508 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.56 ' CD2' ' HB2' ' A' ' 33' ' ' ALA . 9.8 m-85 . . . . . 0 N--CA 1.449 -0.52 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.607 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -117.42 174.78 2.33 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.607 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 81.7 Cg_endo -72.36 124.07 9.63 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 124.312 3.341 . . . . 0.0 109.578 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.581 HD21 HD21 ' A' ' 57' ' ' LEU . 2.8 tp -86.66 125.15 33.66 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.581 ' O ' ' HE2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -91.95 98.69 11.73 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.795 ' CZ ' HG21 ' A' ' 65' ' ' VAL . 10.5 p90 -99.76 170.96 8.19 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.672 HG12 ' H ' ' A' ' 53' ' ' GLY . 57.6 t -135.01 106.13 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.539 ' C ' ' HA ' ' A' ' 7' ' ' LYS . 93.3 t -48.88 -10.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.672 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -117.27 62.3 0.41 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.43 ' H ' ' H ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -167.22 -20.05 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.43 ' H ' ' H ' ' A' ' 54' ' ' GLU . . . 82.38 6.57 88.57 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.402 ' OE1' ' CB ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -42.05 -78.61 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.673 HD23 ' CB ' ' A' ' 50' ' ' PHE . 3.0 mm? -75.02 -174.2 2.18 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.069 ' H ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -82.19 144.02 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.496 ' HG3' ' H ' ' A' ' 59' ' ' GLN . 5.4 mt-30 -41.83 -51.91 4.14 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.647 ' HA3' HD12 ' A' ' 78' ' ' ILE . . . -42.23 -78.48 0.07 OUTLIER Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.817 ' HB3' HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -47.68 -37.94 13.98 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.555 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 18.3 mt-10 -62.51 -22.78 66.55 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.763 ' HA ' HD12 ' A' ' 66' ' ' LEU . 4.7 mt-10 -88.54 -34.8 17.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.54 -30.39 71.42 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.795 HG21 ' CZ ' ' A' ' 50' ' ' PHE . 29.9 m -86.14 -32.8 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.763 HD12 ' HA ' ' A' ' 63' ' ' GLU . 2.9 mt -41.87 -43.25 2.97 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.36 50.4 0.81 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' MET . . . . . 1.072 ' HE3' HD11 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -145.07 119.3 9.51 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.443 ' N ' ' OD2' ' A' ' 72' ' ' ASP . 3.2 mp0 -73.74 -168.77 0.62 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.679 HG22 HG23 ' A' ' 152' ' ' VAL . 34.5 t -79.29 113.93 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.774 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 108.99 -3.45 31.72 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.514 ' HB3' ' HG2' ' A' ' 68' ' ' MET . 0.7 OUTLIER -73.13 169.9 16.05 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.515 ' N ' ' SD ' ' A' ' 68' ' ' MET . 1.5 tt0 -150.15 139.16 21.05 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.5 ttmm -147.22 97.99 2.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.631 HG23 ' OG1' ' A' ' 146' ' ' THR . 28.6 m -93.71 90.63 6.66 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.9 t -126.41 145.69 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.625 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 5.6 ttpm? -76.44 115.08 15.85 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.68 ' CG1' ' CD2' ' A' ' 145' ' ' PHE . 37.5 mm -78.31 131.46 68.84 Favored Pre-proline 0 N--CA 1.45 -0.449 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.505 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 84.2 Cg_endo -72.41 139.44 31.73 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 124.35 3.367 . . . . 0.0 109.567 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.736 ' HB2' ' N ' ' A' ' 141' ' ' LYS . . . -52.01 -14.52 0.41 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.558 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 7.5 tt0 -78.85 -37.22 40.98 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.631 ' HB3' ' H ' ' A' ' 60' ' ' GLY . 14.1 mttm -85.04 -36.27 21.34 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.656 ' HA ' ' CG2' ' A' ' 58' ' ' ILE . . . -67.55 -92.43 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 1.004 ' CE1' HD12 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -103.72 17.1 24.82 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 65.09 144.09 0.03 OUTLIER Glycine 0 C--N 1.335 0.523 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -39.75 150.84 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.484 ' HG3' ' HA3' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -39.37 120.99 1.11 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.662 ' CB ' HD12 ' A' ' 91' ' ' LEU . 7.7 t30 -80.11 147.23 31.48 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.413 ' HA ' ' CD1' ' A' ' 92' ' ' ILE . 1.8 tt0 -73.87 -33.72 64.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -17.51 62.42 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.711 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 13.0 mt -79.11 0.06 29.62 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.608 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 11.6 mt -94.31 118.94 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.667 ' NE2' ' CE2' ' A' ' 134' ' ' PHE . 0.8 OUTLIER -109.08 171.61 7.33 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.463 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -143.2 81.76 1.73 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.78 HG23 ' CD1' ' A' ' 132' ' ' LEU . 26.4 pt -79.8 155.87 75.35 Favored Pre-proline 0 N--CA 1.449 -0.485 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.625 ' HA ' ' HG3' ' A' ' 129' ' ' GLU . 83.1 Cg_endo -72.37 137.08 27.6 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 124.316 3.344 . . . . 0.0 109.624 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.823 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -42.61 -33.45 0.71 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 100' ' ' PHE . 2.5 m-20 -66.07 -36.88 84.4 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -44.3 -19.68 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.77 ' HZ ' HD13 ' A' ' 113' ' ' ILE . 3.1 m-85 -124.47 -30.32 3.39 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 4.3 tttt -60.63 -19.8 59.02 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.59 18.08 22.91 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -103.85 -137.61 0.35 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.45 -0.57 4.46 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.413 ' HB2' ' H ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -134.89 -149.81 0.36 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.505 ' HG2' ' HD2' ' A' ' 107' ' ' PRO . 1.8 tt0 -161.78 136.31 5.23 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.943 ' CG ' HG11 ' A' ' 130' ' ' VAL . 83.1 Cg_endo -72.41 141.48 35.24 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 124.279 3.319 . . . . 0.0 109.624 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 110' ' ' GLY . 1.0 OUTLIER -130.81 157.58 42.46 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -65.74 66.16 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 152.27 11.64 0.08 OUTLIER Glycine 0 C--N 1.335 0.477 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.905 ' CB ' HD13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -66.24 171.15 4.99 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.743 HG13 ' HB2' ' A' ' 119' ' ' PRO . 60.7 t -156.49 70.87 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.77 HD13 ' HZ ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -99.41 134.99 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.626 HD23 ' CD ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -103.29 144.75 30.94 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -96.02 0.49 51.7 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 170.82 -7.16 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 164.69 -38.82 0.3 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 5.3 mt -87.42 114.71 59.99 Favored Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.743 ' HB2' HG13 ' A' ' 112' ' ' VAL . 82.8 Cg_endo -72.44 156.18 54.63 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 124.246 3.297 . . . . 0.0 109.575 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.766 ' O ' HD12 ' A' ' 122' ' ' ILE . . . -116.37 94.06 4.48 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.56 HG22 ' O ' ' A' ' 121' ' ' THR . 1.3 m -64.84 98.4 0.27 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.905 HD13 ' CB ' ' A' ' 111' ' ' MET . 2.9 mp -70.41 100.13 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.5 p -83.28 -21.89 33.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.839 ' HB3' ' H ' ' A' ' 131' ' ' THR . 0.4 OUTLIER -121.84 131.52 54.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 125' ' ' VAL . 11.3 p -122.29 51.59 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.69 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -78.72 126.26 30.49 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.676 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.3 OUTLIER -53.36 2.84 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.69 ' H ' ' C ' ' A' ' 126' ' ' THR . 2.7 p-10 -113.51 -21.96 10.57 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.625 ' HG3' ' HA ' ' A' ' 96' ' ' PRO . 1.4 mt-10 -173.96 168.43 4.19 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.943 HG11 ' CG ' ' A' ' 107' ' ' PRO . 18.1 m -135.07 122.55 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.839 ' H ' ' HB3' ' A' ' 124' ' ' GLU . 9.4 m -88.12 88.28 7.59 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.78 ' CD1' HG23 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -76.66 163.18 27.1 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.777 ' CG ' HD22 ' A' ' 135' ' ' ASN . 31.8 t0 -139.69 95.96 3.0 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.667 ' CE2' ' NE2' ' A' ' 93' ' ' GLN . 4.5 m-30 -37.5 -81.08 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.777 HD22 ' CG ' ' A' ' 133' ' ' ASP . 1.0 OUTLIER 58.04 100.87 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.693 ' CE1' ' HG2' ' A' ' 137' ' ' GLU . 14.3 t-80 -43.11 158.47 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.693 ' HG2' ' CE1' ' A' ' 136' ' ' HIS . 0.7 OUTLIER -54.78 -13.9 1.21 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 1.004 HD12 ' CE1' ' A' ' 84' ' ' TYR . 11.3 mt -114.09 -5.34 13.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.54 ' HB2' ' N ' ' A' ' 136' ' ' HIS . . . -55.25 133.26 49.25 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.484 ' HA3' ' HG3' ' A' ' 87' ' ' ARG . . . 48.5 17.94 0.85 Allowed Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.736 ' N ' ' HB2' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -124.95 129.57 50.61 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.548 ' C ' ' HD3' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -96.43 131.22 43.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.87 ' CD2' HD13 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -123.31 152.21 41.65 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.625 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 2.2 t -65.78 160.36 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.68 ' CD2' ' CG1' ' A' ' 78' ' ' ILE . 14.3 m-85 -146.85 92.15 2.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.631 ' OG1' HG23 ' A' ' 75' ' ' THR . 89.8 m -86.18 63.35 7.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.7 mt -60.94 174.24 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.508 ' H ' HG22 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -178.65 103.29 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 1.072 HD11 ' HE3' ' A' ' 68' ' ' MET . 0.8 OUTLIER -60.57 140.97 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.621 HD11 ' CG ' ' A' ' 14' ' ' ASP . 2.8 mt -122.75 -47.12 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.605 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 5.1 tt0 -151.52 -164.05 1.9 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.941 HG22 HG22 ' A' ' 11' ' ' ILE . 95.8 t -141.42 141.03 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.447 ' HB ' ' HB3' ' A' ' 10' ' ' LYS . 24.1 t . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.859 HG12 ' H ' ' A' ' 6' ' ' ASP . 3.4 t . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.859 ' H ' HG12 ' A' ' 5' ' ' VAL . 52.5 m-20 -152.21 159.8 43.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.515 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 50.9 mtpt -66.93 79.63 0.12 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.55 ' HA2' ' HA3' ' A' ' 53' ' ' GLY . . . 157.78 -1.93 0.12 Allowed Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.478 ' HB ' ' CG1' ' A' ' 5' ' ' VAL . 1.3 t -106.33 130.25 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.672 ' O ' HG23 ' A' ' 11' ' ' ILE . 8.7 tttp -84.33 148.88 26.41 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.898 HG22 HG22 ' A' ' 152' ' ' VAL . 4.2 pt -160.27 136.28 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 11.3 ttmt -96.35 105.69 17.79 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.558 HG21 HG22 ' A' ' 147' ' ' ILE . 0.8 OUTLIER -122.44 160.62 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.544 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 0.5 OUTLIER -114.72 98.55 6.92 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.652 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.2 p90 -94.8 161.33 14.21 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 1.058 HD13 HG21 ' A' ' 32' ' ' VAL . 7.0 mt -138.91 80.04 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -67.87 131.03 28.24 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 110.314 -1.115 . . . . 0.0 110.314 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.624 ' HE2' HG22 ' A' ' 24' ' ' VAL . 4.8 mtmt -119.5 -171.67 2.17 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.689 ' C ' ' H ' ' A' ' 21' ' ' SER . 50.2 mt -108.25 168.76 9.08 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -60.07 13.36 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.689 ' H ' ' C ' ' A' ' 19' ' ' LEU . 98.7 p -124.58 -6.63 7.49 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.31 23.97 32.81 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.44 ' HB2' HD12 ' A' ' 19' ' ' LEU . 4.0 m-20 -94.34 117.71 30.52 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.624 HG22 ' HE2' ' A' ' 18' ' ' LYS . 76.1 t -70.81 112.93 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.573 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -100.02 -40.43 7.64 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.573 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 21.3 t0 -134.4 127.53 31.77 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . 1.056 ' HB ' HG23 ' A' ' 16' ' ' ILE . 3.7 t -148.13 155.92 42.0 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.544 ' HB2' ' HA ' ' A' ' 14' ' ' ASP . 5.4 m -103.78 -21.39 13.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.674 HG22 ' H ' ' A' ' 32' ' ' VAL . 3.9 mt -83.78 96.71 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.443 ' CA ' ' HB2' ' A' ' 45' ' ' TYR . 3.2 tt0 -43.31 -24.17 0.08 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.458 ' HB3' ' CG2' ' A' ' 29' ' ' ILE . 20.3 tt0 -60.54 -61.39 2.63 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.058 HG21 HD13 ' A' ' 16' ' ' ILE . 95.2 t -53.75 -41.09 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.567 ' HA ' HG13 ' A' ' 38' ' ' ILE . . . -48.29 -40.5 25.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.524 ' CG ' ' HB2' ' A' ' 39' ' ' TYR . 15.7 mtpt -76.54 -25.2 53.86 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -84.45 -13.38 52.23 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.97 -10.41 15.05 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.56 44.22 11.11 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.567 HG13 ' HA ' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -141.46 14.12 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.565 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -44.31 -19.15 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.495 ' CD2' ' HB2' ' A' ' 33' ' ' ALA . 16.9 m-85 . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.652 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -101.27 177.3 1.55 Allowed Pre-proline 0 N--CA 1.45 -0.452 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.652 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 82.3 Cg_endo -72.4 130.77 16.63 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 124.27 3.313 . . . . 0.0 109.546 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 tp -97.96 118.74 35.22 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.669 ' HB2' ' HE3' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -89.5 98.29 11.69 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.723 ' CE2' HG21 ' A' ' 65' ' ' VAL . 7.9 p90 -96.63 169.81 9.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.573 HG12 ' H ' ' A' ' 53' ' ' GLY . 54.4 t -131.62 102.92 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.678 HG11 ' HG ' ' A' ' 66' ' ' LEU . 2.9 t -44.54 -17.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.573 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -108.55 40.87 2.39 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 2.0 mt-10 -138.26 -23.72 1.0 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.33 8.46 85.15 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.525 ' OE1' ' CB ' ' A' ' 50' ' ' PHE . 0.8 OUTLIER -42.43 -83.64 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.69 HD22 ' CZ ' ' A' ' 61' ' ' PHE . 3.8 mp -76.46 165.52 24.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.705 HG13 HG21 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -56.84 145.25 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.476 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 1.5 mt-30 -43.14 -42.76 4.24 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.518 ' HA3' HD12 ' A' ' 78' ' ' ILE . . . -41.63 -83.85 0.01 OUTLIER Glycine 0 C--N 1.336 0.552 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.712 ' O ' HG22 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -43.93 -46.37 8.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.649 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 3.4 mt-10 -51.22 -29.69 15.0 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.69 ' HA ' HD12 ' A' ' 66' ' ' LEU . 2.8 mt-10 -85.32 -33.88 21.99 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.715 ' HB1' ' HD2' ' A' ' 74' ' ' LYS . . . -67.45 -25.87 66.12 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.723 HG21 ' CE2' ' A' ' 50' ' ' PHE . 5.8 m -88.63 -28.61 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.69 HD12 ' HA ' ' A' ' 63' ' ' GLU . 4.1 mt -48.42 -25.89 1.84 Allowed 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.5 47.9 2.13 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.773 ' HE3' HD11 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -140.01 102.41 4.39 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.507 ' N ' ' CG ' ' A' ' 72' ' ' ASP . 1.7 mp0 -61.47 -178.38 0.13 Allowed 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.643 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 1.9 t -71.34 109.36 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.853 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 110.35 -5.04 29.88 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.507 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 0.9 OUTLIER -70.97 173.21 7.76 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.605 ' N ' ' SD ' ' A' ' 68' ' ' MET . 0.2 OUTLIER -150.29 143.04 24.66 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.715 ' HD2' ' HB1' ' A' ' 64' ' ' ALA . 7.0 ttmt -146.05 103.93 3.78 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . 1.071 ' CG2' HG23 ' A' ' 146' ' ' THR . 0.2 OUTLIER -103.62 114.33 28.51 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 75' ' ' THR . 54.8 t -157.91 159.25 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.591 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 4.6 ttpm? -86.14 116.73 24.52 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.707 ' CG1' ' CD2' ' A' ' 145' ' ' PHE . 34.9 mm -79.26 118.87 74.86 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.504 ' HA ' ' CG ' ' A' ' 142' ' ' ASP . 84.6 Cg_endo -72.33 138.43 30.17 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 124.381 3.387 . . . . 0.0 109.573 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.915 ' HB1' ' H ' ' A' ' 85' ' ' GLY . . . -44.32 -34.19 1.87 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.43 ' HG2' ' HG2' ' A' ' 79' ' ' PRO . 3.7 pt-20 -55.62 -32.28 62.99 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.413 ' N ' ' HG2' ' A' ' 81' ' ' GLU . 14.7 mtmt -106.48 -0.34 24.1 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.668 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . . . -121.44 -82.31 0.65 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.674 ' CZ ' HD12 ' A' ' 138' ' ' LEU . 3.9 m-85 -107.9 -48.07 3.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.915 ' H ' ' HB1' ' A' ' 80' ' ' ALA . . . 101.35 154.88 26.56 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.674 ' HA ' ' HA2' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -36.61 137.03 0.32 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.613 ' HD3' ' H ' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -39.84 143.77 0.23 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.552 ' H ' HD12 ' A' ' 91' ' ' LEU . 22.6 t30 -79.57 140.05 37.31 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.432 ' HG2' HD12 ' A' ' 92' ' ' ILE . 2.3 tt0 -65.74 -27.46 68.33 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -14.65 61.63 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.046 HD13 ' HA ' ' A' ' 135' ' ' ASN . 52.6 mt -85.15 7.62 21.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.581 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 62.1 mt -87.93 120.25 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.811 ' O ' HD12 ' A' ' 132' ' ' LEU . 8.3 mp0 -116.57 146.65 42.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.39 118.73 31.93 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.989 HG12 HD11 ' A' ' 132' ' ' LEU . 36.3 pt -114.45 152.29 45.97 Favored Pre-proline 0 N--CA 1.449 -0.48 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.599 ' HA ' ' HG3' ' A' ' 129' ' ' GLU . 84.7 Cg_endo -72.34 129.97 15.63 Favored 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 124.292 3.328 . . . . 0.0 109.654 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.881 HH21 ' HG3' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -41.98 -28.98 0.19 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.515 ' HA ' ' HB2' ' A' ' 101' ' ' LYS . 28.7 t70 -65.08 -38.14 89.78 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -50.09 -28.41 7.15 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.54 ' CD2' HD11 ' A' ' 95' ' ' ILE . 1.2 m-85 -107.96 -26.82 10.52 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -60.45 -0.85 0.29 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.497 ' H ' ' C ' ' A' ' 100' ' ' PHE . 5.1 pt-20 -120.14 22.27 11.48 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.415 ' HB1' ' CE1' ' A' ' 105' ' ' PHE . . . -104.47 -137.93 0.36 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -140.85 -3.11 1.28 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.421 ' HB2' ' H ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -123.02 -149.48 0.43 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.421 ' H ' ' HB2' ' A' ' 105' ' ' PHE . 1.0 OUTLIER -158.77 125.0 2.43 Favored Pre-proline 0 N--CA 1.449 -0.511 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.881 ' HG3' HH21 ' A' ' 97' ' ' ARG . 83.7 Cg_endo -72.4 141.97 36.15 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 124.408 3.405 . . . . 0.0 109.559 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 110' ' ' GLY . 0.7 OUTLIER -133.16 159.45 40.1 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.622 ' HB2' HG12 ' A' ' 125' ' ' VAL . 0.9 OUTLIER -64.73 67.71 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 156.44 8.07 0.06 OUTLIER Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' MET . . . . . 1.036 ' CB ' HD13 ' A' ' 122' ' ' ILE . 0.5 OUTLIER -63.43 172.62 1.92 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.561 HG13 ' HB2' ' A' ' 119' ' ' PRO . 76.3 t -156.86 65.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.479 HD13 ' CZ ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -96.68 136.87 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.904 HD23 ' N ' ' A' ' 119' ' ' PRO . 0.3 OUTLIER -103.38 153.03 20.91 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -105.9 2.72 27.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 173.28 -13.65 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.654 ' O ' HD22 ' A' ' 114' ' ' LEU . . . 168.25 -33.65 0.19 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 3.0 mt -94.51 122.19 61.58 Favored Pre-proline 0 N--CA 1.448 -0.535 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.904 ' N ' HD23 ' A' ' 114' ' ' LEU . 81.7 Cg_endo -72.36 169.71 20.99 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 124.313 3.342 . . . . 0.0 109.549 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.682 ' HB1' ' HB3' ' A' ' 132' ' ' LEU . . . -126.79 67.98 1.25 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 6.2 m -41.77 100.26 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 1.036 HD13 ' CB ' ' A' ' 111' ' ' MET . 2.6 mp -71.42 94.8 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 131' ' ' THR . 1.3 p -77.08 -25.43 52.33 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.526 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 0.6 OUTLIER -122.46 129.28 51.86 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 125' ' ' VAL . 7.7 p -115.82 59.56 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.658 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.2 OUTLIER -79.71 119.84 23.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.407 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 0.3 OUTLIER -48.9 -3.66 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.658 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.2 OUTLIER -113.73 -25.07 8.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.849 ' HA ' HH11 ' A' ' 97' ' ' ARG . 1.4 mt-10 -167.76 167.16 13.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.876 HG13 ' CZ ' ' A' ' 97' ' ' ARG . 16.6 m -132.56 146.57 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.602 ' O ' HG22 ' A' ' 131' ' ' THR . 65.9 m -102.71 64.16 0.87 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.989 HD11 HG12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -58.91 151.06 22.6 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.748 ' HB3' HD22 ' A' ' 135' ' ' ASN . 12.5 t0 -124.38 97.15 5.19 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.546 ' N ' ' O ' ' A' ' 91' ' ' LEU . 1.6 m-30 -39.47 -78.84 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 1.046 ' HA ' HD13 ' A' ' 91' ' ' LEU . 0.9 OUTLIER 68.0 -131.93 0.11 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.747 ' ND1' ' N ' ' A' ' 138' ' ' LEU . 8.2 t-80 -172.12 176.51 3.45 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.749 -0.464 . . . . 0.0 109.749 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.742 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -70.56 -6.61 37.71 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.955 HD23 ' HE2' ' A' ' 141' ' ' LYS . 56.9 mt -126.78 -12.02 6.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.538 ' CB ' ' HB3' ' A' ' 135' ' ' ASN . . . -57.21 133.41 55.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.674 ' HA2' ' HA ' ' A' ' 86' ' ' ASN . . . 39.94 39.75 1.5 Allowed Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.955 ' HE2' HD23 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -145.48 145.32 31.03 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.504 ' CG ' ' HA ' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -103.57 124.3 48.53 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 1.091 ' H ' HD23 ' A' ' 143' ' ' LEU . 1.6 pt? -107.61 143.64 35.79 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 2.1 t -60.69 164.9 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.707 ' CD2' ' CG1' ' A' ' 78' ' ' ILE . 9.9 m-85 -153.03 97.03 2.15 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . 1.071 HG23 ' CG2' ' A' ' 75' ' ' THR . 30.7 m -94.71 70.28 3.49 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.652 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -69.0 172.07 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -175.1 103.38 0.09 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.853 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 3.7 mm -58.68 146.93 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.499 HD11 ' OD1' ' A' ' 14' ' ' ASP . 15.6 mt -131.4 -42.33 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.643 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 2.0 mt-10 -153.44 -163.89 1.78 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.898 HG22 HG22 ' A' ' 11' ' ' ILE . 61.4 t -143.87 140.19 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.447 ' HB ' ' HB3' ' A' ' 10' ' ' LYS . 32.9 t . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.733 ' N ' ' HA ' ' A' ' 69' ' ' GLU . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.652 ' CG1' ' N ' ' A' ' 6' ' ' ASP . 1.6 t -140.54 169.48 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.652 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 0.4 OUTLIER -151.51 172.82 15.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.578 ' HG3' HG12 ' A' ' 52' ' ' VAL . 31.6 mtpt -61.23 77.05 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.625 ' N ' ' HA3' ' A' ' 53' ' ' GLY . . . 145.21 18.05 0.17 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.481 ' HB ' HG13 ' A' ' 5' ' ' VAL . 1.2 t -128.75 132.64 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.617 ' HE2' HG23 ' A' ' 51' ' ' VAL . 2.8 ttmt -92.5 152.45 19.65 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.853 HG22 HG22 ' A' ' 152' ' ' VAL . 1.3 pt -153.25 126.86 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.441 ' HG3' ' HB3' ' A' ' 49' ' ' GLU . 4.6 mtmt -83.48 87.51 7.0 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.467 HG21 ' CG2' ' A' ' 147' ' ' ILE . 0.8 OUTLIER -112.47 154.21 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.684 ' HB2' HD11 ' A' ' 29' ' ' ILE . 1.1 m-20 -118.37 96.46 5.31 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.604 ' CB ' ' HA ' ' A' ' 147' ' ' ILE . 4.7 p90 -90.36 154.5 19.64 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 1.011 HG21 HG11 ' A' ' 32' ' ' VAL . 1.2 mt -121.3 71.84 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -55.1 128.38 43.67 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.603 ' HE3' ' O ' ' A' ' 16' ' ' ILE . 5.8 mtmt -120.21 -170.51 1.98 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.633 ' C ' ' H ' ' A' ' 21' ' ' SER . 6.0 mt -111.48 164.93 12.43 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -55.19 1.69 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.633 ' H ' ' C ' ' A' ' 19' ' ' LEU . 83.0 p -114.01 -4.61 13.19 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.44 25.72 32.41 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.564 ' HB2' HD12 ' A' ' 19' ' ' LEU . 93.2 m-20 -96.31 119.25 34.46 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.53 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 86.1 t -69.06 112.81 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.465 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 1.7 p90 -100.77 -31.59 11.11 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.465 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 9.8 t0 -143.24 133.95 25.17 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.872 ' HB ' HG23 ' A' ' 16' ' ' ILE . 1.4 t -153.68 136.48 15.32 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.598 ' HB2' ' HA ' ' A' ' 14' ' ' ASP . 2.8 m -83.84 -26.04 29.83 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.684 HD11 ' HB2' ' A' ' 14' ' ' ASP . 3.0 mt -82.73 106.86 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.728 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 2.0 tt0 -50.44 -37.11 36.46 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -49.36 -66.26 0.43 Allowed 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.011 HG11 HG21 ' A' ' 16' ' ' ILE . 5.0 t -47.59 -39.44 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.747 ' HB1' ' HA ' ' A' ' 39' ' ' TYR . . . -46.42 -46.55 18.74 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.55 ' HG2' ' CB ' ' A' ' 39' ' ' TYR . 3.3 mtmt -68.35 -32.01 71.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.58 -12.41 60.75 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.42 ' CB ' ' HB ' ' A' ' 24' ' ' VAL . . . -116.95 -7.08 11.42 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.33 47.47 35.86 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.536 HG13 ' HA ' ' A' ' 33' ' ' ALA . 1.2 pt -140.13 8.61 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.747 ' HA ' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -45.59 -16.37 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 1.0 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . 71.96 174.75 0.08 OUTLIER Pre-proline 0 N--CA 1.448 -0.536 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 1.0 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 84.0 Cg_endo -72.38 -80.79 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 124.292 3.328 . . . . 0.0 109.571 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.65 ' H ' ' HG2' ' A' ' 41' ' ' PRO . 5.0 p-10 -108.64 -9.43 15.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.538 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -41.89 152.99 0.07 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -126.64 101.68 6.75 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.518 ' CE1' ' NE ' ' A' ' 43' ' ' ARG . 56.5 m-85 -77.92 102.99 7.58 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.662 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -111.58 177.87 1.11 Allowed Pre-proline 0 N--CA 1.449 -0.506 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.662 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 84.2 Cg_endo -72.34 125.95 11.21 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 124.295 3.33 . . . . 0.0 109.632 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.481 ' CD2' HD21 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -89.24 112.66 23.76 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -85.32 97.35 9.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.874 ' CE2' HG21 ' A' ' 65' ' ' VAL . 40.3 p90 -99.56 160.63 14.15 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.731 HG12 ' H ' ' A' ' 53' ' ' GLY . 41.0 t -123.37 112.78 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.7 HG11 HD21 ' A' ' 66' ' ' LEU . 32.4 t -54.78 -11.64 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.731 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -114.91 46.55 1.15 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.427 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 4.2 mt-10 -151.9 -8.6 0.21 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.85 12.11 64.2 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.501 ' OE1' ' CB ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -44.41 -78.56 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.56 ' N ' ' CD1' ' A' ' 57' ' ' LEU . 5.8 mp -84.87 165.7 17.48 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.851 ' N ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -56.45 136.88 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.516 ' HA ' ' HB2' ' A' ' 62' ' ' GLU . 4.1 mt-30 -41.79 -60.06 1.48 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.759 ' CA ' ' HE3' ' A' ' 82' ' ' LYS . . . -30.25 -68.87 0.09 OUTLIER Glycine 0 C--N 1.335 0.522 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.663 ' HE2' HG23 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -57.19 -44.32 83.48 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 59' ' ' GLN . 4.1 mt-10 -55.34 -23.68 25.19 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.909 ' HA ' HD12 ' A' ' 66' ' ' LEU . 12.0 mt-10 -87.97 -39.06 15.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.816 ' HB1' ' HD2' ' A' ' 74' ' ' LYS . . . -62.22 -13.42 27.67 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.874 HG21 ' CE2' ' A' ' 50' ' ' PHE . 4.5 m -106.96 -26.55 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.909 HD12 ' HA ' ' A' ' 63' ' ' GLU . 2.2 mt -47.55 -31.53 4.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -118.12 49.66 1.24 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.963 ' HE2' HD11 ' A' ' 149' ' ' ILE . 2.5 mtp -138.02 118.49 13.83 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.733 ' HA ' ' N ' ' A' ' 4' ' ' MET . 2.3 mp0 -69.2 -173.44 0.53 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.651 HG22 HG23 ' A' ' 152' ' ' VAL . 3.1 t -80.92 106.27 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.653 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 118.01 -5.56 15.83 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.525 ' HB3' ' HG2' ' A' ' 68' ' ' MET . 0.6 OUTLIER -71.03 170.49 12.72 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.25 126.18 9.07 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.816 ' HD2' ' HB1' ' A' ' 64' ' ' ALA . 19.1 ttmm -131.64 95.71 3.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.626 ' OG1' HG23 ' A' ' 146' ' ' THR . 91.6 m -88.76 77.81 7.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 3.6 t -111.77 164.97 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 2.5 ttpt -104.81 116.21 31.62 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.639 HD13 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -79.06 134.88 59.04 Favored Pre-proline 0 N--CA 1.449 -0.521 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.512 ' C ' ' H ' ' A' ' 81' ' ' GLU . 84.1 Cg_endo -72.44 138.77 30.48 Favored 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 124.28 3.32 . . . . 0.0 109.633 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.734 ' HB2' ' N ' ' A' ' 141' ' ' LYS . . . -49.59 -10.66 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.595 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 1.0 OUTLIER -80.23 -39.03 29.85 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.759 ' HE3' ' CA ' ' A' ' 60' ' ' GLY . 2.0 mtpp -86.78 -32.46 20.35 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.625 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . . . -72.46 -93.81 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.442 ' HD1' ' N ' ' A' ' 84' ' ' TYR . 1.7 m-85 -97.87 18.54 15.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.595 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 41.64 83.93 0.01 OUTLIER Glycine 0 C--N 1.336 0.537 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.545 ' HA ' ' HA2' ' A' ' 140' ' ' GLY . 0.0 OUTLIER 46.72 -164.84 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.558 ' HD2' ' ND2' ' A' ' 135' ' ' ASN . 0.9 OUTLIER -90.59 154.44 19.59 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.835 ' CB ' HD12 ' A' ' 91' ' ' LEU . 0.4 OUTLIER -91.41 153.61 19.75 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -90.09 -25.77 20.58 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.74 1.58 16.78 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.87 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 19.9 mt -104.5 5.47 34.06 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.606 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 52.3 mt -82.96 107.94 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 131' ' ' THR . 5.4 mp0 -100.13 165.56 11.45 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.912 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -147.0 99.26 3.15 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.007 HG12 HD11 ' A' ' 132' ' ' LEU . 20.7 pt -96.47 155.19 38.2 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.55 ' O ' ' N ' ' A' ' 99' ' ' ALA . 83.7 Cg_endo -72.34 137.68 28.76 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 124.311 3.341 . . . . 0.0 109.598 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.867 HH21 ' HD2' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -41.64 -34.81 0.65 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.602 ' HA ' ' CB ' ' A' ' 101' ' ' LYS . 6.3 t70 -63.17 -37.06 85.71 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -45.87 -16.39 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.545 ' CD1' ' HB3' ' A' ' 105' ' ' PHE . 2.1 m-85 -137.52 -24.09 1.07 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.602 ' CB ' ' HA ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -41.57 -41.07 2.05 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -90.99 43.77 1.16 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.541 ' C ' ' H ' ' A' ' 105' ' ' PHE . . . -174.94 127.89 0.29 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.487 ' C ' ' N ' ' A' ' 106' ' ' GLU . 2.7 p30 -49.01 -9.28 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.866 ' CE1' HD12 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -47.04 -14.85 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.684 ' C ' ' O ' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -4.32 99.85 0.03 OUTLIER Pre-proline 0 N--CA 1.45 -0.452 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.917 ' HG2' HG11 ' A' ' 130' ' ' VAL . 84.1 Cg_endo -72.4 151.64 53.99 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 124.287 3.325 . . . . 0.0 109.602 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 110' ' ' GLY . 2.9 mt-10 -132.67 156.59 46.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.555 ' HB2' HG12 ' A' ' 125' ' ' VAL . 1.1 tt0 -65.81 66.98 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.8 10.02 0.08 OUTLIER Glycine 0 C--N 1.335 0.509 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.828 ' CB ' HD13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -69.97 170.67 10.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.508 HG13 ' HB2' ' A' ' 119' ' ' PRO . 60.9 t -156.23 73.94 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.866 HD12 ' CE1' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -105.46 135.48 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.626 HD23 ' CD ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -105.04 161.55 14.12 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -108.51 5.23 24.99 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.44 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 0.9 OUTLIER 166.29 -11.09 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.72 -43.04 0.21 Allowed Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.451 ' HA ' ' HD2' ' A' ' 119' ' ' PRO . 3.6 mt -82.51 112.46 36.99 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.626 ' CD ' HD23 ' A' ' 114' ' ' LEU . 83.5 Cg_endo -72.31 165.59 32.21 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 124.322 3.348 . . . . 0.0 109.588 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.863 ' HB1' ' HB3' ' A' ' 132' ' ' LEU . . . -126.91 90.87 3.23 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 6.0 m -62.55 95.54 0.07 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.828 HD13 ' CB ' ' A' ' 111' ' ' MET . 2.6 mp -68.98 89.98 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 121' ' ' THR . 30.7 p -80.1 -17.74 51.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.712 ' HB3' ' H ' ' A' ' 131' ' ' THR . 0.8 OUTLIER -119.99 130.85 54.94 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.707 ' HA ' HG12 ' A' ' 130' ' ' VAL . 7.9 p -124.26 52.92 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.68 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.2 OUTLIER -79.07 126.49 30.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.539 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.3 OUTLIER -52.12 0.06 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.68 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -111.7 -21.14 11.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.6 OUTLIER -178.84 167.02 1.69 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.917 HG11 ' HG2' ' A' ' 107' ' ' PRO . 19.7 m -132.62 141.16 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.912 HG23 ' HD2' ' A' ' 94' ' ' LYS . 23.5 m -96.49 83.91 3.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 1.007 HD11 HG12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -78.93 97.08 5.89 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.606 ' HA ' ' HA ' ' A' ' 92' ' ' ILE . 25.5 t0 -71.17 97.52 1.53 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.498 ' N ' ' O ' ' A' ' 91' ' ' LEU . 2.1 m-30 -42.89 -56.91 3.05 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.87 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 71.1 m-20 55.98 -118.04 1.18 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.631 ' ND1' ' N ' ' A' ' 138' ' ' LEU . 24.1 t-80 -175.19 174.16 2.46 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.603 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 4.8 tp10 -65.84 -43.9 87.12 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.823 HD22 ' HE2' ' A' ' 141' ' ' LYS . 25.4 mt -97.46 10.79 38.82 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.596 ' HB2' ' HB3' ' A' ' 136' ' ' HIS . . . -62.52 133.76 55.41 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 86' ' ' ASN . . . 41.73 36.56 1.73 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 110.234 -1.147 . . . . 0.0 110.234 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.823 ' HE2' HD22 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -146.6 144.04 29.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.505 ' C ' ' HD2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -95.71 143.12 27.24 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.838 HD11 ' CZ ' ' A' ' 145' ' ' PHE . 0.4 OUTLIER -130.67 154.06 48.31 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.601 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 0.5 OUTLIER -73.71 168.46 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.838 ' CZ ' HD11 ' A' ' 143' ' ' LEU . 26.8 m-85 -154.97 90.24 1.28 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.626 HG23 ' OG1' ' A' ' 75' ' ' THR . 96.0 m -81.6 58.8 3.87 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.663 HG23 ' HE2' ' A' ' 61' ' ' PHE . 3.2 mt -53.31 175.09 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.584 ' H ' HG22 ' A' ' 147' ' ' ILE . 3.2 tmtt? -177.59 96.64 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.963 HD11 ' HE2' ' A' ' 68' ' ' MET . 1.4 mm -62.21 134.22 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.408 HG13 ' HA ' ' A' ' 13' ' ' VAL . 8.9 mt -122.12 -26.51 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.591 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 2.1 tt0 -162.74 -175.41 4.42 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.853 HG22 HG22 ' A' ' 11' ' ' ILE . 73.8 t -140.27 137.45 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.69 HG12 ' H ' ' A' ' 154' ' ' GLU . 2.3 t -142.28 -143.95 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.69 ' H ' HG12 ' A' ' 153' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.786 ' N ' ' HA ' ' A' ' 69' ' ' GLU . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.902 ' CG2' HD13 ' A' ' 11' ' ' ILE . 9.2 t -119.67 167.71 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.767 -0.456 . . . . 0.0 109.767 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 8' ' ' GLY . 19.4 m-20 -146.78 164.75 31.78 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.524 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 17.3 ptmt -63.44 70.18 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.664 ' N ' ' HA3' ' A' ' 53' ' ' GLY . . . 155.19 16.63 0.05 OUTLIER Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.536 ' HB ' HG13 ' A' ' 5' ' ' VAL . 2.5 t -126.65 136.33 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.842 ' CA ' HG22 ' A' ' 51' ' ' VAL . 2.7 tttt -88.27 158.27 18.52 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.902 HD13 ' CG2' ' A' ' 5' ' ' VAL . 1.8 pt -166.23 133.49 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.744 ' HE2' HG22 ' A' ' 153' ' ' VAL . 18.3 mtmt -87.18 85.12 7.18 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.719 HG11 HD12 ' A' ' 149' ' ' ILE . 0.9 OUTLIER -122.8 158.75 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.449 ' O ' ' CG2' ' A' ' 147' ' ' ILE . 10.9 m-20 -114.55 -160.18 0.72 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.5 p90 -179.44 155.87 0.7 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.991 HG21 HG11 ' A' ' 32' ' ' VAL . 1.3 mt -127.39 73.21 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -54.68 134.02 47.01 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.579 ' HG2' ' N ' ' A' ' 24' ' ' VAL . 8.1 mttt -123.92 -162.75 1.08 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.63 ' C ' ' H ' ' A' ' 21' ' ' SER . 39.9 mt -118.28 165.65 13.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -55.02 0.97 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.63 ' H ' ' C ' ' A' ' 19' ' ' LEU . 53.5 p -114.85 1.38 14.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.9 28.53 50.12 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.221 -1.151 . . . . 0.0 110.221 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.453 ' C ' ' HG2' ' A' ' 18' ' ' LYS . 98.1 m-20 -99.85 121.97 42.11 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.579 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 76.0 t -66.18 134.71 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.532 ' CE1' ' HB2' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -128.07 -28.87 2.59 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.532 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 11.3 t0 -145.68 132.17 19.75 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.966 ' HB ' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -152.26 126.67 9.34 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 73.0 m -86.49 14.13 7.28 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.9 mt -113.11 116.85 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 1.1 tt0 -54.01 -41.6 68.15 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -52.54 -70.78 0.08 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.991 HG11 HG21 ' A' ' 16' ' ' ILE . 67.5 t -48.48 -41.44 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.734 ' HB1' ' HA ' ' A' ' 39' ' ' TYR . . . -50.05 -38.34 37.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.522 ' CG ' ' HB2' ' A' ' 39' ' ' TYR . 22.0 mtpt -79.54 -21.4 45.22 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -87.21 -10.88 51.43 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.4 -10.66 12.61 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.68 43.57 10.05 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.548 HG13 ' HA ' ' A' ' 33' ' ' ALA . 0.4 OUTLIER -141.85 16.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.734 ' HA ' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -47.62 -13.25 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.911 ' HB1' ' HB3' ' A' ' 43' ' ' ARG . . . 71.27 151.55 0.14 Allowed Pre-proline 0 N--CA 1.448 -0.555 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.623 ' HG2' ' H ' ' A' ' 42' ' ' ASP . 82.0 Cg_endo -72.5 -82.6 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 124.343 3.362 . . . . 0.0 109.577 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.623 ' H ' ' HG2' ' A' ' 41' ' ' PRO . 4.9 p-10 -93.7 -14.12 26.7 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.911 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -76.29 145.71 39.42 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.583 ' N ' ' HG3' ' A' ' 43' ' ' ARG . 0.4 OUTLIER -117.76 -174.74 2.69 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.519 ' CD2' ' HB2' ' A' ' 33' ' ' ALA . 2.2 m-85 -139.27 131.78 28.68 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.717 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -135.61 -180.0 1.22 Allowed Pre-proline 0 N--CA 1.448 -0.546 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.717 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 82.3 Cg_endo -72.45 127.83 12.96 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 124.293 3.329 . . . . 0.0 109.573 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.8 HD23 ' HD2' ' A' ' 50' ' ' PHE . 2.6 tp -82.68 94.71 7.63 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.711 ' CD ' HG21 ' A' ' 153' ' ' VAL . 43.1 tt0 -76.58 97.95 4.53 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.8 ' HD2' HD23 ' A' ' 48' ' ' LEU . 6.4 p90 -118.92 173.86 6.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.842 HG22 ' CA ' ' A' ' 10' ' ' LYS . 57.8 t -130.7 109.69 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.961 HG11 ' HG ' ' A' ' 66' ' ' LEU . 16.3 t -49.08 -10.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.766 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -108.07 25.74 19.41 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 51' ' ' VAL . 4.0 mt-10 -123.25 -43.16 2.21 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.85 7.59 50.24 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -46.0 -50.07 15.36 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.518 ' N ' HD22 ' A' ' 57' ' ' LEU . 1.2 mm? -96.48 175.24 6.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.89 ' H ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -75.99 150.88 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.472 ' O ' ' C ' ' A' ' 60' ' ' GLY . 10.6 mt-30 -40.11 -65.72 0.37 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.673 ' H ' ' HB3' ' A' ' 82' ' ' LYS . . . -33.46 -82.78 0.01 OUTLIER Glycine 0 C--N 1.335 0.506 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.693 ' CE1' HG11 ' A' ' 65' ' ' VAL . 2.3 t80 -40.88 -53.57 2.88 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.504 ' O ' HG22 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -45.28 -34.04 2.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.634 ' HA ' HD12 ' A' ' 66' ' ' LEU . 5.9 mt-10 -80.73 -31.11 36.13 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . -64.43 -29.84 70.88 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.728 HG21 ' CE1' ' A' ' 50' ' ' PHE . 2.5 m -92.36 -21.46 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.961 ' HG ' HG11 ' A' ' 52' ' ' VAL . 1.1 mt -50.14 -55.67 14.09 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -98.74 55.58 1.06 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.733 ' HE3' ' HA ' ' A' ' 73' ' ' GLU . 9.4 mtp -134.12 123.8 25.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.786 ' HA ' ' N ' ' A' ' 4' ' ' MET . 1.1 mp0 -77.92 167.49 21.41 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.594 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 0.2 OUTLIER -68.62 96.63 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.837 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 118.87 17.76 4.95 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -95.99 -172.08 2.49 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.733 ' HA ' ' HE3' ' A' ' 68' ' ' MET . 2.2 tt0 -162.54 123.11 2.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.512 ' HB2' ' SD ' ' A' ' 68' ' ' MET . 5.2 ttmt -125.82 99.69 6.07 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.531 ' OG1' HG23 ' A' ' 146' ' ' THR . 84.8 m -93.82 76.32 4.23 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.45 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 3.9 t -106.04 156.83 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.616 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 5.4 ttpm? -95.1 113.12 24.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 1.107 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -79.19 130.83 67.95 Favored Pre-proline 0 N--CA 1.45 -0.438 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.504 ' CG ' ' HD3' ' A' ' 82' ' ' LYS . 84.0 Cg_endo -72.35 144.54 41.33 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 124.33 3.354 . . . . 0.0 109.595 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.643 ' O ' ' N ' ' A' ' 85' ' ' GLY . . . -50.99 -11.68 0.1 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.54 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 15.7 tt0 -86.1 -34.65 20.59 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.673 ' HB3' ' H ' ' A' ' 60' ' ' GLY . 1.0 OUTLIER -105.67 41.45 1.38 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.107 ' HB2' ' CG2' ' A' ' 78' ' ' ILE . . . -159.57 -34.27 0.06 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.681 ' CD2' ' CB ' ' A' ' 138' ' ' LEU . 74.2 m-85 -158.89 8.6 0.12 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.643 ' N ' ' O ' ' A' ' 80' ' ' ALA . . . 72.49 143.5 0.49 Allowed Glycine 0 C--N 1.336 0.557 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -47.82 167.38 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.554 ' HG2' ' HA3' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -41.4 139.96 0.97 Allowed 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.951 ' CB ' HD12 ' A' ' 91' ' ' LEU . 1.9 t30 -93.13 153.23 18.78 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.508 ' C ' ' H ' ' A' ' 91' ' ' LEU . 48.7 mt-10 -86.49 -39.18 16.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.48 11.86 0.22 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.951 HD12 ' CB ' ' A' ' 88' ' ' ASN . 54.5 mt -118.57 5.73 11.67 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 51.1 mt -84.75 114.05 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.515 ' OE1' ' CD1' ' A' ' 134' ' ' PHE . 5.5 mp0 -106.22 166.3 10.62 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.793 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -146.39 96.81 2.83 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.657 HD11 ' CD1' ' A' ' 100' ' ' PHE . 3.7 pt -96.06 157.69 35.34 Favored Pre-proline 0 N--CA 1.449 -0.505 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.555 ' O ' ' N ' ' A' ' 99' ' ' ALA . 83.4 Cg_endo -72.45 139.96 32.48 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 124.296 3.331 . . . . 0.0 109.576 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.841 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -43.81 -20.65 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.572 ' C ' ' H ' ' A' ' 100' ' ' PHE . 3.3 m-20 -78.17 -35.46 48.76 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.555 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -50.56 -6.99 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.657 ' CD1' HD11 ' A' ' 95' ' ' ILE . 2.3 m-85 -131.46 -26.54 2.05 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.498 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 0.9 OUTLIER -63.39 -15.15 56.7 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.29 6.14 49.59 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.552 ' HB1' ' CZ ' ' A' ' 105' ' ' PHE . . . -100.61 -137.51 0.32 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.72 18.15 1.47 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.552 ' CZ ' ' HB1' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -133.13 -144.07 0.23 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.506 ' H ' ' HB2' ' A' ' 105' ' ' PHE . 0.4 OUTLIER -171.21 126.65 0.63 Allowed Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.892 ' CG ' HG11 ' A' ' 130' ' ' VAL . 82.3 Cg_endo -72.33 131.83 18.34 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 124.321 3.348 . . . . 0.0 109.579 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 110' ' ' GLY . 2.1 mm-40 -118.83 157.62 27.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -67.19 66.1 0.07 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.89 12.25 0.07 OUTLIER Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.797 ' CB ' HD13 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -68.55 171.34 7.67 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 112' ' ' VAL . 96.4 t -155.57 65.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.34 136.76 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.863 HD23 ' CD ' ' A' ' 119' ' ' PRO . 0.1 OUTLIER -104.58 172.81 6.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -119.71 -1.62 10.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 172.46 3.17 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 152.65 -32.34 0.83 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 18.2 mm -94.4 116.03 65.94 Favored Pre-proline 0 N--CA 1.449 -0.485 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.863 ' CD ' HD23 ' A' ' 114' ' ' LEU . 81.9 Cg_endo -72.42 171.8 16.3 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 124.333 3.356 . . . . 0.0 109.582 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.862 ' HB1' ' HB3' ' A' ' 132' ' ' LEU . . . -132.13 75.5 1.64 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 3.7 m -49.13 97.83 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.797 HD13 ' CB ' ' A' ' 111' ' ' MET . 1.8 mp -71.14 95.6 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.498 HG22 HG22 ' A' ' 121' ' ' THR . 0.9 OUTLIER -82.06 -18.94 41.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.726 ' HB3' ' H ' ' A' ' 131' ' ' THR . 1.7 tp10 -121.9 130.88 53.7 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 125' ' ' VAL . 15.0 p -122.02 50.89 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.657 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -78.62 126.03 30.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.537 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.9 OUTLIER -53.17 0.18 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.657 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.4 OUTLIER -111.28 -20.21 12.38 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -177.86 164.64 1.94 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.892 HG11 ' CG ' ' A' ' 107' ' ' PRO . 17.4 m -129.57 135.95 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.793 HG23 ' HD2' ' A' ' 94' ' ' LYS . 24.2 m -95.45 87.24 4.71 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.862 ' HB3' ' HB1' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -85.68 122.2 29.44 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.589 ' HA ' ' HA ' ' A' ' 92' ' ' ILE . 15.4 t0 -90.17 94.28 9.7 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.515 ' CD1' ' OE1' ' A' ' 93' ' ' GLN . 2.4 m-85 -38.33 -42.29 0.7 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.675 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 0.7 OUTLIER 42.04 -112.12 0.18 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.908 ' CG ' ' H ' ' A' ' 137' ' ' GLU . 15.8 t-80 -177.76 -170.4 0.26 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.908 ' H ' ' CG ' ' A' ' 136' ' ' HIS . 1.5 tp10 -73.55 -42.03 62.2 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 1.013 HD12 HD22 ' A' ' 143' ' ' LEU . 2.6 mm? -98.97 -15.64 19.03 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.777 ' HB2' ' HB3' ' A' ' 136' ' ' HIS . . . -58.7 115.69 3.23 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.554 ' HA3' ' HG2' ' A' ' 87' ' ' ARG . . . 71.17 15.57 74.63 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.692 ' HE2' ' CD1' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -134.7 131.94 38.26 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.553 ' C ' ' HD3' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -100.47 130.02 46.5 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 1.026 ' H ' HD23 ' A' ' 143' ' ' LEU . 1.4 pt? -115.98 144.94 43.39 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.616 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 0.2 OUTLIER -68.02 173.96 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.635 ' CD2' HD13 ' A' ' 78' ' ' ILE . 25.5 m-85 -157.44 90.28 1.09 Allowed 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 146' ' ' THR . 85.4 m -81.88 64.35 6.53 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.9 mt -60.3 178.51 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.554 ' H ' HG22 ' A' ' 147' ' ' ILE . 13.7 tttp -178.03 110.59 0.06 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.837 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 4.4 mm -70.84 139.0 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.598 HD12 ' HB3' ' A' ' 47' ' ' PRO . 3.6 mt -118.39 -41.15 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.594 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 2.4 tt0 -158.86 -165.69 1.69 Allowed 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.894 HG22 HG22 ' A' ' 11' ' ' ILE . 97.0 t -136.95 151.7 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.744 HG22 ' HE2' ' A' ' 12' ' ' LYS . 1.8 t -133.5 -133.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.748 ' HB2' ' H ' ' A' ' 10' ' ' LYS . 11.4 tp10 . . . . . 0 N--CA 1.45 -0.461 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.691 ' N ' ' HA ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.644 ' CG1' ' N ' ' A' ' 6' ' ' ASP . 1.5 t -164.11 169.67 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.644 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 0.5 OUTLIER -138.04 175.83 9.23 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.542 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 16.1 ptmt -67.35 65.65 0.07 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 6' ' ' ASP . . . 165.35 15.32 0.02 OUTLIER Glycine 0 C--N 1.336 0.557 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.588 ' HB ' HG22 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -129.14 132.64 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.8 ' O ' HG23 ' A' ' 11' ' ' ILE . 4.2 ttpm? -87.55 165.03 15.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.033 HG22 HG22 ' A' ' 152' ' ' VAL . 1.1 pt -169.19 134.42 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.664 ' HE2' ' CG2' ' A' ' 153' ' ' VAL . 7.5 mtmt -94.3 91.98 6.98 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.575 HG12 ' HA ' ' A' ' 149' ' ' ILE . 0.8 OUTLIER -116.02 153.95 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.607 ' OD2' HD11 ' A' ' 150' ' ' ILE . 3.6 m-20 -111.41 106.12 14.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.597 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.9 p90 -101.99 159.46 15.35 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 1.107 HG21 HG11 ' A' ' 32' ' ' VAL . 3.5 mt -133.55 73.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -56.9 129.17 48.86 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.596 ' HE3' ' O ' ' A' ' 16' ' ' ILE . 5.9 mttt -116.98 -164.03 0.95 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.623 ' C ' ' H ' ' A' ' 21' ' ' SER . 85.3 mt -118.02 165.87 13.21 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -54.66 0.07 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.623 ' H ' ' C ' ' A' ' 19' ' ' LEU . 84.5 p -112.05 -3.88 14.63 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.62 25.11 43.61 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.458 ' C ' ' HG2' ' A' ' 18' ' ' LYS . 1.6 m-20 -96.6 122.13 39.18 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.528 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 55.8 t -68.49 113.66 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.595 ' CE1' ' HB2' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -104.41 -31.56 9.45 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.595 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 14.4 t0 -140.07 138.94 35.76 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.995 ' HB ' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -158.24 161.24 37.74 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.442 ' HB3' ' OD1' ' A' ' 14' ' ' ASP . 12.9 m -115.73 -11.92 11.58 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.62 HG22 ' H ' ' A' ' 32' ' ' VAL . 3.0 mt -92.77 116.23 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.505 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 2.5 tt0 -51.51 -38.98 56.69 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -48.72 -67.86 0.23 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.107 HG11 HG21 ' A' ' 16' ' ' ILE . 34.7 t -53.93 -38.32 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.743 ' HB1' ' HA ' ' A' ' 39' ' ' TYR . . . -53.16 -43.05 66.74 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.55 ' HG2' ' CB ' ' A' ' 39' ' ' TYR . 3.9 mtmt -68.13 -30.91 70.16 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -80.99 -20.08 42.6 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.41 -11.42 17.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.01 45.75 19.22 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.526 HG13 ' HA ' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -143.12 16.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.743 ' HA ' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -57.97 -14.6 6.69 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.993 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . 72.13 174.53 0.08 OUTLIER Pre-proline 0 N--CA 1.449 -0.477 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.993 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 82.9 Cg_endo -72.36 -90.45 0.01 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 124.341 3.361 . . . . 0.0 109.639 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.494 ' H ' ' HG2' ' A' ' 41' ' ' PRO . 11.0 p-10 -100.15 -8.56 23.5 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.538 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -41.52 153.63 0.05 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.436 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -115.92 100.12 7.76 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.873 ' HE2' HG23 ' A' ' 27' ' ' THR . 1.9 m-85 -67.48 76.19 0.17 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.663 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -82.58 177.48 3.0 Favored Pre-proline 0 N--CA 1.449 -0.502 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.663 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 84.4 Cg_endo -72.43 128.81 14.03 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 124.292 3.328 . . . . 0.0 109.598 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.0 tp -69.41 104.63 2.33 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.514 ' CD ' ' CE ' ' A' ' 10' ' ' LYS . 13.3 tt0 -91.15 100.87 13.63 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.884 ' CZ ' HG21 ' A' ' 65' ' ' VAL . 32.1 p90 -119.78 170.61 9.07 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.841 HG12 ' H ' ' A' ' 53' ' ' GLY . 69.5 t -131.31 113.07 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.928 HG11 ' CG ' ' A' ' 66' ' ' LEU . 4.6 t -50.53 -8.7 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.841 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -117.33 35.35 4.16 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 2.7 mm-40 -124.27 -31.97 3.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.11 5.65 59.4 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -57.95 -97.36 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.793 ' H ' HD22 ' A' ' 57' ' ' LEU . 1.5 mm? -54.32 157.8 2.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.952 ' H ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -60.96 149.18 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.459 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 9.1 mt-30 -44.6 -55.24 5.35 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 63' ' ' GLU . . . -39.65 -79.79 0.04 OUTLIER Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.658 ' HE2' HG23 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -43.45 -44.69 5.98 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.413 ' CD ' ' HA ' ' A' ' 52' ' ' VAL . 6.5 mt-10 -55.85 -32.81 63.95 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.778 ' HA ' HD12 ' A' ' 66' ' ' LEU . 7.3 mt-10 -77.86 -29.77 50.57 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.59 ' HB1' ' HD2' ' A' ' 74' ' ' LYS . . . -63.36 -42.37 98.88 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.884 HG21 ' CZ ' ' A' ' 50' ' ' PHE . 4.6 m -84.06 -15.29 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.928 ' CG ' HG11 ' A' ' 52' ' ' VAL . 3.8 mt -63.05 -48.4 78.87 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -102.85 54.83 0.77 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.593 ' C ' ' N ' ' A' ' 4' ' ' MET . 6.1 mtp -131.57 -144.8 0.25 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.691 ' HA ' ' N ' ' A' ' 4' ' ' MET . 0.0 OUTLIER -155.96 -178.56 7.39 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.606 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 0.5 OUTLIER -90.09 80.12 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.671 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 138.4 11.07 0.9 Allowed Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.479 ' CG ' ' HB2' ' A' ' 69' ' ' GLU . 2.8 m-20 -95.48 -178.39 4.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -153.72 130.47 10.83 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.59 ' HD2' ' HB1' ' A' ' 64' ' ' ALA . 9.6 ttmt -131.69 96.68 4.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.676 ' OG1' HG23 ' A' ' 146' ' ' THR . 80.3 m -95.5 78.77 3.39 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.668 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 4.0 t -111.38 171.25 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.668 ' N ' ' CG1' ' A' ' 76' ' ' VAL . 1.8 ttpt -103.35 114.79 29.36 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.754 HD13 ' CD2' ' A' ' 145' ' ' PHE . 0.3 OUTLIER -79.4 129.33 72.37 Favored Pre-proline 0 N--CA 1.448 -0.554 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.486 ' HG2' ' HG2' ' A' ' 81' ' ' GLU . 83.0 Cg_endo -72.29 141.9 36.44 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 124.346 3.364 . . . . 0.0 109.582 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.579 ' HB2' ' N ' ' A' ' 141' ' ' LYS . . . -54.36 -8.39 0.21 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.622 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 8.3 pt-20 -81.38 -37.4 28.25 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.48 ' HD3' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -87.52 -30.0 20.91 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.639 ' HA ' ' CB ' ' A' ' 58' ' ' ILE . . . -71.52 -94.74 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.593 ' CD1' ' N ' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -106.71 21.64 17.17 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.622 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 46.58 87.67 0.01 OUTLIER Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.578 ' HA ' ' HA2' ' A' ' 140' ' ' GLY . 0.0 OUTLIER 39.9 -144.5 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.567 ' HD2' ' HA3' ' A' ' 140' ' ' GLY . 0.1 OUTLIER -91.3 145.1 24.93 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.969 ' CB ' HD12 ' A' ' 91' ' ' LEU . 7.0 t30 -83.79 132.47 34.82 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -66.63 -25.97 66.84 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.62 8.17 15.13 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.983 HD13 ' HA ' ' A' ' 135' ' ' ASN . 34.5 mt -110.19 5.23 21.72 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.606 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 24.6 mt -84.88 108.28 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.459 ' OE1' ' CD1' ' A' ' 134' ' ' PHE . 6.2 mp0 -101.84 152.14 21.24 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.822 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -135.81 91.4 2.7 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.569 HG12 HG23 ' A' ' 130' ' ' VAL . 3.3 pt -86.23 159.04 54.48 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.61 ' HA ' ' HG3' ' A' ' 129' ' ' GLU . 80.7 Cg_endo -72.46 136.18 25.7 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 124.35 3.367 . . . . 0.0 109.551 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.848 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -42.24 -29.53 0.25 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.546 ' HA ' ' CB ' ' A' ' 101' ' ' LYS . 8.4 t70 -70.29 -36.08 74.14 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -51.01 -12.82 0.12 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.569 ' HB3' ' HD3' ' A' ' 107' ' ' PRO . 4.5 m-85 -133.63 -21.03 2.0 Allowed 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.546 ' CB ' ' HA ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -49.84 -9.9 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.512 ' H ' ' C ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -143.32 40.45 1.46 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.651 ' HB1' ' CE1' ' A' ' 105' ' ' PHE . . . -103.25 21.52 15.73 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 71.16 -14.84 0.44 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.651 ' CE1' ' HB1' ' A' ' 103' ' ' ALA . 0.9 OUTLIER -135.87 -148.76 0.31 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.516 ' HG2' ' HD2' ' A' ' 107' ' ' PRO . 1.4 tt0 -160.78 138.04 6.77 Favored Pre-proline 0 N--CA 1.448 -0.552 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.923 ' CG ' HG11 ' A' ' 130' ' ' VAL . 82.9 Cg_endo -72.41 141.02 34.38 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 124.311 3.341 . . . . 0.0 109.61 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 110' ' ' GLY . 20.9 mt-10 -130.06 153.57 48.32 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -63.64 70.06 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.21 5.23 0.12 Allowed Glycine 0 C--N 1.336 0.571 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.859 ' HB3' HD12 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -65.34 165.89 11.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.513 HG23 ' C ' ' A' ' 111' ' ' MET . 52.4 t -156.27 70.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.66 134.93 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.637 HD23 ' CD ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -104.47 170.57 7.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.415 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -116.07 5.23 13.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.415 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 0.5 OUTLIER 167.01 -10.88 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.419 ' O ' HD22 ' A' ' 114' ' ' LEU . . . 169.81 -45.15 0.21 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.446 ' HA ' ' HD2' ' A' ' 119' ' ' PRO . 4.3 mt -80.46 110.97 18.93 Favored Pre-proline 0 N--CA 1.45 -0.465 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.637 ' CD ' HD23 ' A' ' 114' ' ' LEU . 82.7 Cg_endo -72.37 163.94 37.12 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 124.255 3.303 . . . . 0.0 109.628 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.857 ' HB1' ' HB3' ' A' ' 132' ' ' LEU . . . -124.73 94.3 4.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 21.3 m -66.4 97.02 0.39 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.859 HD12 ' HB3' ' A' ' 111' ' ' MET . 5.9 mt -71.75 84.41 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 123' ' ' THR . 0.0 OUTLIER -74.82 -16.94 60.68 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.837 ' HB3' ' H ' ' A' ' 131' ' ' THR . 0.3 OUTLIER -119.23 127.95 53.74 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.606 HG13 ' O ' ' A' ' 125' ' ' VAL . 8.1 p -122.56 49.15 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.689 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -78.05 125.48 29.41 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.678 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.4 OUTLIER -52.82 1.7 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.689 ' H ' ' C ' ' A' ' 126' ' ' THR . 1.2 p-10 -112.95 -20.94 11.37 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.61 ' HG3' ' HA ' ' A' ' 96' ' ' PRO . 2.3 mt-10 -174.75 165.67 3.68 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.923 HG11 ' CG ' ' A' ' 107' ' ' PRO . 16.7 m -135.23 130.76 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.837 ' H ' ' HB3' ' A' ' 124' ' ' GLU . 66.1 m -93.79 94.89 8.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.857 ' HB3' ' HB1' ' A' ' 120' ' ' ALA . 0.3 OUTLIER -92.35 103.37 15.82 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.606 ' HA ' ' HA ' ' A' ' 92' ' ' ILE . 18.9 t0 -74.8 96.87 3.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 91' ' ' LEU . 2.0 m-30 -41.32 -82.59 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.983 ' HA ' HD13 ' A' ' 91' ' ' LEU . 0.6 OUTLIER 77.74 -127.67 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.689 ' ND1' ' N ' ' A' ' 138' ' ' LEU . 14.1 t-80 -171.49 178.34 3.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.678 ' N ' ' CG ' ' A' ' 136' ' ' HIS . 10.2 tp10 -67.88 -16.47 64.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.875 HD23 ' HE2' ' A' ' 141' ' ' LYS . 16.2 mt -118.14 -16.83 9.72 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.646 ' HB3' ' H ' ' A' ' 136' ' ' HIS . . . -57.57 110.17 0.83 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' A' ' 86' ' ' ASN . . . 79.97 31.99 37.59 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.875 ' HE2' HD23 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -155.26 146.15 22.44 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.549 ' C ' ' HD2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -95.31 135.44 36.91 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.777 HD23 ' N ' ' A' ' 143' ' ' LEU . 0.4 OUTLIER -124.15 149.16 46.59 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.589 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 1.7 t -73.56 166.87 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.754 ' CD2' HD13 ' A' ' 78' ' ' ILE . 25.3 m-85 -151.21 91.64 1.71 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.676 HG23 ' OG1' ' A' ' 75' ' ' THR . 83.9 m -84.48 61.92 6.94 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.658 HG23 ' HE2' ' A' ' 61' ' ' PHE . 1.7 mt -56.21 -179.47 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.6 ' H ' HG22 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -178.33 90.61 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.671 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 1.1 mm -60.51 130.7 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.607 HD11 ' OD2' ' A' ' 14' ' ' ASP . 4.8 mt -113.64 -45.37 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.606 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -153.98 -165.64 2.16 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 1.033 HG22 HG22 ' A' ' 11' ' ' ILE . 88.7 t -138.65 153.3 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.664 ' CG2' ' HE2' ' A' ' 12' ' ' LYS . 1.9 t -129.99 -133.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.618 ' HB2' ' H ' ' A' ' 10' ' ' LYS . 2.7 tm-20 . . . . . 0 N--CA 1.45 -0.441 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.412 ' N ' ' HG3' ' A' ' 69' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.508 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.667 HG21 HD13 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -111.9 179.31 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.525 ' H ' HG12 ' A' ' 5' ' ' VAL . 8.5 m-20 -154.87 165.77 35.61 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.599 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 4.9 ptpt -69.94 63.68 0.21 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.43 ' H ' ' H ' ' A' ' 9' ' ' VAL . . . 175.05 3.19 0.03 OUTLIER Glycine 0 C--N 1.335 0.508 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.43 ' H ' ' H ' ' A' ' 8' ' ' GLY . 2.5 t -119.98 140.3 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.719 ' H ' ' HB3' ' A' ' 154' ' ' GLU . 10.8 tttt -96.68 149.38 21.86 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.682 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 10.8 pt -158.05 140.49 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.61 ' O ' HD12 ' A' ' 150' ' ' ILE . 7.0 ttmt -94.11 99.07 11.42 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.575 ' CG1' ' HA ' ' A' ' 149' ' ' ILE . 1.1 m -124.13 152.37 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 147' ' ' ILE . 16.4 m-20 -95.07 -167.35 1.61 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 0.3 OUTLIER 177.52 148.75 0.15 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.97 HG23 ' HB ' ' A' ' 27' ' ' THR . 4.5 mt -132.25 74.27 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -58.21 134.14 52.49 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.587 ' HG2' ' N ' ' A' ' 24' ' ' VAL . 7.8 mtmt -118.98 -152.99 0.52 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.592 ' C ' ' H ' ' A' ' 21' ' ' SER . 1.5 mt -128.49 166.08 19.47 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -52.67 -3.71 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.592 ' H ' ' C ' ' A' ' 19' ' ' LEU . 52.0 p -113.89 14.25 18.51 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 19' ' ' LEU . . . 65.33 32.03 82.35 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 18' ' ' LYS . 2.3 m-20 -101.6 123.98 46.5 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.587 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 76.7 t -68.98 130.22 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.577 ' CE1' ' HB2' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -124.59 -29.55 3.45 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.577 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 9.3 t0 -145.08 135.78 24.47 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.97 ' HB ' HG23 ' A' ' 16' ' ' ILE . 1.7 t -153.47 144.87 23.16 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 2.5 m -96.96 -4.95 38.99 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.44 ' CG2' HG23 ' A' ' 32' ' ' VAL . 20.6 mt -100.87 103.62 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.594 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 5.5 tt0 -46.72 -38.72 10.33 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -50.03 -66.12 0.45 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.89 HG11 HD13 ' A' ' 16' ' ' ILE . 3.0 t -47.86 -42.41 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.604 ' HA ' HG13 ' A' ' 38' ' ' ILE . . . -49.17 -41.8 37.78 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.601 ' HG2' ' CG ' ' A' ' 39' ' ' TYR . 8.8 mtpt -74.31 -24.86 59.28 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -86.84 -23.76 25.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . -93.83 -27.48 16.41 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.3 16.17 19.2 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.604 HG13 ' HA ' ' A' ' 33' ' ' ALA . 3.5 pt -118.17 31.01 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.601 ' CG ' ' HG2' ' A' ' 34' ' ' LYS . 13.0 t80 -64.69 68.84 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.814 ' HB1' ' HB2' ' A' ' 43' ' ' ARG . . . -48.36 136.16 12.25 Favored Pre-proline 0 N--CA 1.45 -0.475 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.42 ' HG2' ' H ' ' A' ' 42' ' ' ASP . 80.9 Cg_endo -72.4 -94.99 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 124.374 3.383 . . . . 0.0 109.564 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.497 ' CG ' ' N ' ' A' ' 43' ' ' ARG . 0.3 OUTLIER -42.7 -50.19 5.54 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.814 ' HB2' ' HB1' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -41.27 149.94 0.1 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -126.71 98.44 5.38 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -82.26 99.95 9.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.703 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -123.85 179.83 0.98 Allowed Pre-proline 0 N--CA 1.449 -0.495 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.703 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 80.7 Cg_endo -72.44 129.84 15.34 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 124.273 3.316 . . . . 0.0 109.556 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.855 HD12 ' N ' ' A' ' 49' ' ' GLU . 5.3 tp -97.26 135.14 39.61 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.964 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -105.08 107.77 18.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.661 ' CZ ' ' CZ ' ' A' ' 61' ' ' PHE . 8.1 p90 -125.49 162.21 25.38 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.937 HG12 ' H ' ' A' ' 53' ' ' GLY . 41.1 t -105.79 123.52 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.692 HG11 ' HG ' ' A' ' 66' ' ' LEU . 8.3 t -58.53 8.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.937 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -147.31 48.74 0.64 Allowed Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.735 ' OE1' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -126.61 -32.76 2.6 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.58 -12.57 54.08 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.488 ' OE1' ' CB ' ' A' ' 50' ' ' PHE . 99.4 mt-30 -42.06 -78.53 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.676 ' H ' HD22 ' A' ' 57' ' ' LEU . 1.2 mm? -71.5 164.92 24.92 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.814 ' H ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -65.09 157.71 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.422 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 34.2 mt-30 -49.84 -59.29 3.99 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.629 ' H ' ' HB3' ' A' ' 82' ' ' LYS . . . -39.05 -78.31 0.06 OUTLIER Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.81 ' CE1' HD13 ' A' ' 147' ' ' ILE . 0.9 OUTLIER -41.08 -55.18 2.65 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.541 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.0 mt-10 -45.94 -37.05 6.0 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 60' ' ' GLY . 4.8 mt-10 -77.63 -25.45 49.73 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.655 ' HA ' ' HE2' ' A' ' 74' ' ' LYS . . . -67.32 -40.04 85.94 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.642 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 2.1 m -73.5 -32.77 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.692 ' HG ' HG11 ' A' ' 52' ' ' VAL . 2.5 mt -41.31 -51.66 3.59 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.36 52.29 0.84 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.597 ' HE3' HD11 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -140.62 114.05 8.67 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 4' ' ' MET . 1.3 mt-10 -77.58 168.89 19.24 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.662 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 1.5 t -61.93 113.04 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.842 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 100.52 9.0 48.22 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.95 -176.54 5.22 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.558 ' CA ' ' SD ' ' A' ' 68' ' ' MET . 0.6 OUTLIER -157.44 141.81 16.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.655 ' HE2' ' HA ' ' A' ' 64' ' ' ALA . 12.1 tttp -138.95 95.8 3.01 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.903 ' CG2' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -92.4 93.23 8.49 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.55 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 16.2 t -131.63 164.64 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.598 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 5.6 ttpt -99.48 114.8 27.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.731 HD13 ' CD2' ' A' ' 145' ' ' PHE . 0.3 OUTLIER -78.68 129.95 72.34 Favored Pre-proline 0 N--CA 1.449 -0.492 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.501 ' HG2' ' HG2' ' A' ' 81' ' ' GLU . 84.8 Cg_endo -72.39 138.22 29.61 Favored 'Trans proline' 0 N--CA 1.447 -1.218 0 C-N-CA 124.28 3.32 . . . . 0.0 109.664 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.681 ' HB2' ' C ' ' A' ' 141' ' ' LYS . . . -51.56 -10.62 0.1 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.594 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 20.6 pt-20 -79.0 -38.2 37.27 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.629 ' HB3' ' H ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -84.88 -33.1 22.87 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.649 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . . . -74.12 -100.07 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.616 ' CE1' ' HB2' ' A' ' 138' ' ' LEU . 38.9 m-85 -90.22 17.81 6.68 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.594 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 42.35 85.71 0.01 OUTLIER Glycine 0 C--N 1.335 0.508 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.507 ' OD1' ' N ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER 47.26 -164.85 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.591 ' HD2' ' HA3' ' A' ' 140' ' ' GLY . 0.4 OUTLIER -81.17 146.42 30.52 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.693 ' CB ' HD12 ' A' ' 91' ' ' LEU . 9.7 t30 -89.2 149.98 22.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -85.35 -35.02 21.67 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.3 -9.08 37.42 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.866 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 75.1 mt -94.03 6.04 49.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.61 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 69.1 mt -85.56 113.75 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -106.99 150.3 26.63 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.698 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -130.17 97.08 4.34 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.999 HG12 HD11 ' A' ' 132' ' ' LEU . 18.5 pt -93.11 156.7 40.03 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.534 ' O ' ' N ' ' A' ' 99' ' ' ALA . 82.0 Cg_endo -72.43 140.37 33.21 Favored 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 124.33 3.354 . . . . 0.0 109.609 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.818 HH21 ' CD ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -42.72 -32.93 0.65 Allowed 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.473 ' HA ' ' CB ' ' A' ' 101' ' ' LYS . 6.7 t70 -66.81 -36.71 83.0 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -43.92 -21.61 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.493 ' CD2' ' HD3' ' A' ' 107' ' ' PRO . 3.3 m-85 -122.94 -28.82 4.03 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.473 ' CB ' ' HA ' ' A' ' 98' ' ' ASP . 0.8 OUTLIER -56.45 -24.15 43.57 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -104.18 1.91 31.2 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -102.05 19.69 18.02 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 41.63 36.78 0.62 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.3 -150.2 0.44 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.441 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -179.96 102.2 0.18 Allowed Pre-proline 0 N--CA 1.45 -0.475 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.918 ' CG ' HG11 ' A' ' 130' ' ' VAL . 83.6 Cg_endo -72.32 138.52 30.36 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 124.313 3.342 . . . . 0.0 109.592 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 110' ' ' GLY . 16.8 mt-10 -128.9 156.53 43.56 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.71 68.97 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 151.8 10.23 0.09 OUTLIER Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.545 ' HB3' ' CD1' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -68.17 167.7 13.66 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.507 HG23 ' C ' ' A' ' 111' ' ' MET . 62.0 t -156.41 82.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.35 137.13 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.91 HD23 ' N ' ' A' ' 119' ' ' PRO . 0.2 OUTLIER -101.36 156.72 17.28 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -109.65 0.49 19.04 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 176.47 -12.37 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.646 ' O ' HD22 ' A' ' 114' ' ' LEU . . . 166.93 -34.42 0.22 Allowed Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 3.3 mt -94.04 122.41 61.89 Favored Pre-proline 0 N--CA 1.449 -0.483 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.91 ' N ' HD23 ' A' ' 114' ' ' LEU . 84.9 Cg_endo -72.31 170.22 19.71 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 124.311 3.341 . . . . 0.0 109.662 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.883 ' HB1' ' HB3' ' A' ' 132' ' ' LEU . . . -128.58 73.61 1.51 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 28.8 m -50.2 95.36 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.625 ' HA ' ' HA ' ' A' ' 132' ' ' LEU . 1.8 mp -69.74 100.1 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 131' ' ' THR . 0.6 OUTLIER -85.19 -19.11 32.21 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.554 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 0.4 OUTLIER -121.77 131.77 54.25 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.654 HG22 ' O ' ' A' ' 125' ' ' VAL . 7.9 p -122.33 52.99 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.647 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -79.21 126.83 31.27 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.686 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.3 OUTLIER -53.16 0.21 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.647 ' H ' ' C ' ' A' ' 126' ' ' THR . 3.3 p-10 -111.58 -21.22 11.85 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -177.85 168.5 2.08 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.918 HG11 ' CG ' ' A' ' 107' ' ' PRO . 29.0 m -132.09 145.42 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.698 HG23 ' HD2' ' A' ' 94' ' ' LYS . 21.4 m -102.47 84.71 2.48 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.999 HD11 HG12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -82.36 119.76 24.56 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.61 ' HA ' ' HA ' ' A' ' 92' ' ' ILE . 13.8 t0 -90.21 97.89 11.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.538 ' N ' ' O ' ' A' ' 91' ' ' LEU . 2.0 m-30 -41.25 -52.97 3.31 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.866 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 69.8 m-20 48.44 -122.39 1.58 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.74 ' ND1' ' N ' ' A' ' 137' ' ' GLU . 24.3 t-80 179.71 174.93 0.8 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.74 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 0.5 OUTLIER -76.05 -8.62 57.4 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.959 HD22 HD22 ' A' ' 143' ' ' LEU . 52.5 mt -119.35 -1.48 10.77 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.497 ' CB ' ' HB3' ' A' ' 135' ' ' ASN . . . -67.71 141.66 56.56 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.591 ' HA3' ' HD2' ' A' ' 87' ' ' ARG . . . 41.95 27.16 0.36 Allowed Glycine 0 C--N 1.336 0.536 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.858 ' HE2' ' CD2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -138.49 146.11 41.62 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.494 ' C ' ' HD2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -99.19 137.39 37.78 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.959 HD22 HD22 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -124.7 152.07 44.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.598 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 2.1 t -73.86 165.72 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.731 ' CD2' HD13 ' A' ' 78' ' ' ILE . 30.9 m-85 -148.6 98.05 2.82 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.903 HG23 ' CG2' ' A' ' 75' ' ' THR . 24.0 m -89.8 57.78 4.0 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.81 HD13 ' CE1' ' A' ' 61' ' ' PHE . 2.3 mt -57.54 -179.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.749 ' H ' HG22 ' A' ' 147' ' ' ILE . 12.4 tttt -179.39 110.68 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.842 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 4.8 mm -67.14 145.29 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.649 HD13 ' HB3' ' A' ' 47' ' ' PRO . 4.1 mt -126.6 -45.86 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.662 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -161.66 -159.89 0.66 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.682 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 42.4 t -128.44 135.59 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.964 HG21 ' HB3' ' A' ' 49' ' ' GLU . 61.9 t -111.47 40.53 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.719 ' HB3' ' H ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.453 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.647 ' O ' HG23 ' A' ' 5' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 4' ' ' MET . 23.2 t -159.09 145.87 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -132.2 168.06 18.7 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.575 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 10.2 ptpt -72.93 70.32 1.01 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 174.13 -2.9 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.12 122.64 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.832 ' CA ' HG22 ' A' ' 51' ' ' VAL . 1.7 tttt -76.52 166.88 22.79 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.917 HG22 HG22 ' A' ' 152' ' ' VAL . 1.0 OUTLIER -168.65 132.07 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.714 ' HE2' ' CG2' ' A' ' 153' ' ' VAL . 17.4 mtmt -89.82 92.89 9.22 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.675 HG21 ' CG2' ' A' ' 147' ' ' ILE . 0.8 OUTLIER -112.66 152.99 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.606 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 4.4 m-20 -110.55 95.49 5.6 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.1 p90 -92.7 154.4 18.35 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 1.018 HG23 ' HB ' ' A' ' 27' ' ' THR . 6.5 mt -129.36 75.08 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -60.22 132.06 50.23 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.608 ' HE3' ' O ' ' A' ' 16' ' ' ILE . 4.5 mtmt -121.03 -160.77 0.86 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.88 HD12 ' HB2' ' A' ' 23' ' ' ASP . 30.5 mt -119.38 166.15 13.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.426 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 9.8 mt-10 -56.32 2.6 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.627 ' H ' ' C ' ' A' ' 19' ' ' LEU . 52.8 p -117.24 0.3 12.24 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.24 28.0 42.26 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.88 ' HB2' HD12 ' A' ' 19' ' ' LEU . 18.8 m-20 -96.15 119.2 34.21 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.555 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 63.9 t -69.06 114.26 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.556 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 1.6 p90 -103.08 -32.69 9.56 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.556 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 11.6 t0 -146.23 136.55 23.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 1.018 ' HB ' HG23 ' A' ' 16' ' ' ILE . 3.8 t -154.11 149.9 27.6 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.606 ' HB2' ' HA ' ' A' ' 14' ' ' ASP . 27.1 m -97.8 -17.41 19.37 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.821 HG22 ' H ' ' A' ' 32' ' ' VAL . 2.1 mt -85.01 95.15 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.49 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 4.9 tt0 -42.03 -29.59 0.23 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -59.62 -63.52 1.27 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.822 HG11 HG21 ' A' ' 16' ' ' ILE . 59.8 t -51.28 -38.97 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.714 ' HB1' ' HA ' ' A' ' 39' ' ' TYR . . . -48.03 -44.76 31.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.538 ' HG2' ' CB ' ' A' ' 39' ' ' TYR . 11.1 mtmt -71.52 -32.29 68.01 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -74.54 -15.53 60.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -110.23 -6.15 15.12 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.3 46.44 34.04 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.538 HG13 ' HA ' ' A' ' 33' ' ' ALA . 1.3 pt -143.3 11.98 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.714 ' HA ' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -45.39 -18.25 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.785 ' HB1' ' HB3' ' A' ' 43' ' ' ARG . . . 75.28 159.4 0.16 Allowed Pre-proline 0 N--CA 1.45 -0.433 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.597 ' HG2' ' H ' ' A' ' 42' ' ' ASP . 82.3 Cg_endo -72.43 -83.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 124.34 3.36 . . . . 0.0 109.604 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.597 ' H ' ' HG2' ' A' ' 41' ' ' PRO . 11.9 p-10 -99.88 -9.9 22.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.785 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -73.72 137.93 44.33 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.454 ' N ' ' HG3' ' A' ' 43' ' ' ARG . 54.5 mt-10 -104.38 -175.81 2.9 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -138.53 90.49 2.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.686 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.4 OUTLIER -83.44 178.49 2.39 Favored Pre-proline 0 N--CA 1.45 -0.449 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.686 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 83.2 Cg_endo -72.36 125.38 10.69 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 124.337 3.358 . . . . 0.0 109.586 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.0 83.12 0.11 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.58 ' OE2' HG21 ' A' ' 153' ' ' VAL . 40.6 tt0 -77.41 97.19 4.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.869 ' CD2' HD23 ' A' ' 57' ' ' LEU . 5.6 p90 -118.64 167.83 11.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.832 HG22 ' CA ' ' A' ' 10' ' ' LYS . 21.4 t -128.36 114.44 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.914 HG11 ' HG ' ' A' ' 66' ' ' LEU . 9.1 t -46.99 -14.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.816 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -115.88 39.76 2.63 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.428 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -131.58 -19.7 2.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.23 18.13 79.74 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.527 ' OE1' ' N ' ' A' ' 51' ' ' VAL . 36.3 mt-30 -60.81 -63.12 1.41 Allowed 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.869 HD23 ' CD2' ' A' ' 50' ' ' PHE . 2.0 mm? -87.41 171.23 10.72 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.057 ' H ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -66.21 155.09 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.522 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 5.9 mt-30 -49.72 -57.09 7.94 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.446 ' H ' ' HB3' ' A' ' 82' ' ' LYS . . . -39.58 -79.68 0.04 OUTLIER Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.667 ' CD1' ' CB ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -41.4 -52.21 3.6 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.727 ' O ' HG22 ' A' ' 65' ' ' VAL . 1.7 mt-10 -46.47 -42.19 15.07 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.875 ' HA ' HD12 ' A' ' 66' ' ' LEU . 4.8 mt-10 -70.17 -32.92 71.09 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.55 -24.85 67.98 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.753 HG21 ' CE2' ' A' ' 50' ' ' PHE . 8.6 m -100.25 -8.58 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.914 ' HG ' HG11 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -66.65 37.29 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.593 ' HA ' ' HG3' ' A' ' 4' ' ' MET . 0.3 OUTLIER 166.94 27.77 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.895 ' HE1' HD11 ' A' ' 149' ' ' ILE . 44.0 mtp -109.56 96.02 6.0 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.468 ' N ' ' OD2' ' A' ' 72' ' ' ASP . 0.5 OUTLIER -55.95 -177.09 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.618 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 1.5 t -75.18 108.42 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.842 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 116.07 -12.22 17.2 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 1.0 OUTLIER -65.53 166.37 10.59 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.42 ' HB2' ' HD2' ' A' ' 148' ' ' LYS . 0.0 OUTLIER -151.16 135.85 17.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.51 ' HB2' ' SD ' ' A' ' 68' ' ' MET . 1.4 tttm -142.33 102.33 4.07 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.588 ' OG1' HG23 ' A' ' 146' ' ' THR . 52.1 m -101.9 79.81 1.94 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.661 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 3.5 t -112.49 171.12 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.661 ' N ' ' CG1' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -105.18 114.11 28.1 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.722 HD13 ' CD2' ' A' ' 145' ' ' PHE . 0.5 OUTLIER -79.0 129.8 71.98 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.476 ' HG2' ' HG2' ' A' ' 81' ' ' GLU . 83.4 Cg_endo -72.39 144.37 40.81 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 124.304 3.336 . . . . 0.0 109.607 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.64 ' HB2' ' N ' ' A' ' 141' ' ' LYS . . . -55.85 -9.39 0.56 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.618 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 14.8 pt-20 -81.41 -38.21 26.88 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.446 ' HB3' ' H ' ' A' ' 60' ' ' GLY . 9.3 mtmt -86.94 -31.62 20.57 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.652 ' HA ' ' CB ' ' A' ' 58' ' ' ILE . . . -71.88 -95.88 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.732 ' CE2' ' CE1' ' A' ' 136' ' ' HIS . 2.0 m-85 -98.41 16.91 20.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.618 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 42.36 84.82 0.01 OUTLIER Glycine 0 C--N 1.335 0.509 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.621 ' HA ' ' HA2' ' A' ' 140' ' ' GLY . 0.0 OUTLIER 49.01 -171.99 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.932 ' HG3' ' HB1' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -89.26 152.5 21.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.57 ' CB ' ' CD1' ' A' ' 91' ' ' LEU . 2.2 t30 -90.24 100.77 13.53 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.458 ' C ' ' H ' ' A' ' 91' ' ' LEU . 29.9 mt-10 -44.31 -25.36 0.23 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.19 16.68 0.3 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.734 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 17.5 mt -114.11 -4.08 13.18 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 20.6 mt -78.47 114.21 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 132' ' ' LEU . 2.2 mp0 -110.33 167.7 10.0 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.641 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -140.2 90.51 2.37 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.915 HG12 HD11 ' A' ' 132' ' ' LEU . 35.8 pt -85.41 154.66 59.71 Favored Pre-proline 0 N--CA 1.449 -0.478 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.56 ' HD2' ' HB2' ' A' ' 99' ' ' ALA . 82.6 Cg_endo -72.36 140.83 34.24 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 124.309 3.34 . . . . 0.0 109.636 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.927 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -41.8 -33.89 0.57 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.471 ' HA ' ' HB2' ' A' ' 101' ' ' LYS . 8.4 m-20 -66.53 -37.03 84.14 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.56 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . . . -43.52 -21.58 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.55 ' C ' ' H ' ' A' ' 102' ' ' GLU . 2.8 m-85 -122.2 -23.24 5.37 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.471 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -70.96 21.9 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.55 ' H ' ' C ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -143.59 -13.09 0.68 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.98 22.31 3.26 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 43.4 33.86 0.67 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.475 ' HD1' ' H ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -123.74 -149.46 0.42 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.475 ' H ' ' HD1' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -173.6 113.03 0.33 Allowed Pre-proline 0 N--CA 1.448 -0.525 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.927 ' CG ' HH21 ' A' ' 97' ' ' ARG . 83.5 Cg_endo -72.38 147.26 46.61 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 124.275 3.316 . . . . 0.0 109.632 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 110' ' ' GLY . 1.3 mm-40 -138.37 151.94 47.96 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.543 ' HB2' HG12 ' A' ' 125' ' ' VAL . 2.5 tm-20 -66.4 66.33 0.05 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.76 9.27 0.08 OUTLIER Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.509 ' CB ' HD12 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -62.87 170.09 2.86 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.678 HG13 ' HB2' ' A' ' 119' ' ' PRO . 61.1 t -155.63 65.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.92 137.31 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.61 HD23 ' CD ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -109.3 146.09 34.88 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.432 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -95.04 4.19 54.02 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.432 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 0.9 OUTLIER 166.64 -12.15 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.48 -37.73 0.2 Allowed Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 134' ' ' PHE . 1.2 mt -85.93 111.72 40.06 Favored Pre-proline 0 N--CA 1.449 -0.484 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.678 ' HB2' HG13 ' A' ' 112' ' ' VAL . 82.7 Cg_endo -72.37 159.56 49.07 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 124.352 3.368 . . . . 0.0 109.579 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.763 ' HB1' ' HB3' ' A' ' 132' ' ' LEU . . . -121.51 84.05 2.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.577 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 3.5 m -53.34 97.52 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.715 ' CG1' HD23 ' A' ' 132' ' ' LEU . 72.3 mt -76.58 91.1 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 131' ' ' THR . 0.2 OUTLIER -77.53 -27.24 51.62 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.861 ' HB3' ' H ' ' A' ' 131' ' ' THR . 0.5 OUTLIER -111.12 132.42 54.29 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.688 HG22 ' O ' ' A' ' 125' ' ' VAL . 7.1 p -129.67 53.55 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.697 ' C ' ' H ' ' A' ' 128' ' ' ASN . 81.4 p -80.1 133.11 36.06 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.583 ' HA ' ' HD3' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -54.58 4.36 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.697 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -112.21 -24.73 9.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -177.22 -178.45 0.79 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.537 HG11 ' CG ' ' A' ' 107' ' ' PRO . 4.2 m -144.57 134.14 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.861 ' H ' ' HB3' ' A' ' 124' ' ' GLU . 17.4 m -95.82 95.26 8.16 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.915 HD11 HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -87.66 166.62 14.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.587 ' HA ' ' HA ' ' A' ' 92' ' ' ILE . 15.4 t0 -137.39 97.95 3.59 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.48 ' N ' ' O ' ' A' ' 91' ' ' LEU . 3.3 m-30 -41.57 -41.48 2.17 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.734 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 91.9 m-20 41.47 -121.94 0.51 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.922 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 8.9 t-80 177.01 169.49 0.54 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.576 ' CG ' HD22 ' A' ' 138' ' ' LEU . 3.0 tp10 -58.55 -53.88 53.38 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.92 ' CG ' HD22 ' A' ' 143' ' ' LEU . 2.2 mm? -97.83 20.02 12.78 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.932 ' HB1' ' HG3' ' A' ' 87' ' ' ARG . . . -66.57 134.45 52.37 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.621 ' HA2' ' HA ' ' A' ' 86' ' ' ASN . . . 38.85 30.54 0.11 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.805 ' HE2' ' CD1' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -138.42 144.42 40.16 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.515 ' N ' ' HD3' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -94.04 138.84 31.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.92 HD22 ' CG ' ' A' ' 138' ' ' LEU . 0.5 OUTLIER -129.13 140.47 51.53 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.607 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 7.8 t -66.45 168.25 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.722 ' CD2' HD13 ' A' ' 78' ' ' ILE . 23.2 m-85 -152.79 93.92 1.81 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.656 HG22 ' O ' ' A' ' 146' ' ' THR . 54.9 m -87.97 62.66 6.97 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.675 ' CG2' HG21 ' A' ' 13' ' ' VAL . 1.4 mt -57.58 179.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.529 ' H ' HG22 ' A' ' 147' ' ' ILE . 6.5 tptt 179.3 100.42 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.895 HD11 ' HE1' ' A' ' 68' ' ' MET . 1.0 OUTLIER -63.23 139.24 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.531 HD11 ' OD1' ' A' ' 14' ' ' ASP . 12.6 mt -126.47 -31.5 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.618 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 1.5 mt-10 -166.8 -170.91 1.69 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.917 HG22 HG22 ' A' ' 11' ' ' ILE . 47.2 t -136.95 144.6 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.714 ' CG2' ' HE2' ' A' ' 12' ' ' LYS . 38.8 t -145.05 47.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.763 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.795 ' N ' ' HA ' ' A' ' 69' ' ' GLU . 1.5 ttm . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.105 HG21 HG21 ' A' ' 11' ' ' ILE . 58.7 t -131.27 148.6 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.593 ' HA ' ' CD2' ' A' ' 66' ' ' LEU . 1.1 m-20 -119.67 173.79 6.8 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.519 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 9.4 ptpt -68.83 68.46 0.16 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.403 ' H ' ' H ' ' A' ' 9' ' ' VAL . . . 168.93 7.03 0.03 OUTLIER Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.021 ' HB ' HG13 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -126.78 134.47 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.895 ' H ' ' HB3' ' A' ' 154' ' ' GLU . 9.1 tttt -87.73 158.48 18.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.105 HG21 HG21 ' A' ' 5' ' ' VAL . 3.3 pt -162.09 139.46 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.938 ' HE2' HG22 ' A' ' 153' ' ' VAL . 20.0 mtmt -89.91 78.48 6.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.625 HG22 ' CE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -116.83 145.71 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.707 ' OD2' HD11 ' A' ' 150' ' ' ILE . 0.0 OUTLIER -98.29 -160.67 0.82 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 0.3 OUTLIER 178.4 156.72 0.44 Allowed 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.985 HG23 ' HB ' ' A' ' 27' ' ' THR . 4.5 mt -136.68 77.7 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -61.73 133.22 47.08 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.588 ' HE3' ' O ' ' A' ' 16' ' ' ILE . 4.9 mttt -120.42 -157.89 0.73 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.593 ' C ' ' H ' ' A' ' 21' ' ' SER . 1.8 mt -123.05 165.62 16.48 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -53.79 -2.05 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.593 ' H ' ' C ' ' A' ' 19' ' ' LEU . 59.6 p -113.6 9.03 17.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 19' ' ' LEU . . . 70.91 29.73 68.84 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.46 ' C ' ' HG2' ' A' ' 18' ' ' LYS . 4.2 m-20 -98.43 122.75 42.01 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.557 HG13 HG22 ' A' ' 16' ' ' ILE . 35.5 t -67.89 118.34 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -110.87 -27.51 8.8 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.734 ' HA ' HH22 ' A' ' 43' ' ' ARG . 14.7 t0 -151.95 141.24 21.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.985 ' HB ' HG23 ' A' ' 16' ' ' ILE . 2.5 t -152.89 153.76 33.69 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.586 ' HA ' ' HA ' ' A' ' 45' ' ' TYR . 0.6 OUTLIER -104.35 14.76 29.6 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.518 HG22 ' H ' ' A' ' 32' ' ' VAL . 6.4 mt -124.97 99.17 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.678 ' CG ' ' CE2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -43.12 -35.8 1.46 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -53.71 -65.03 0.64 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.732 HG11 HG21 ' A' ' 16' ' ' ILE . 87.9 t -47.83 -43.66 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.708 ' HB2' ' CE1' ' A' ' 45' ' ' TYR . . . -44.35 -51.75 8.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.527 ' CG ' ' HB2' ' A' ' 39' ' ' TYR . 13.9 mtpt -65.42 -28.07 68.98 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 32' ' ' VAL . 45.8 tt0 -86.08 -13.62 46.76 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.536 ' HB1' ' HB ' ' A' ' 24' ' ' VAL . . . -106.59 -23.38 12.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 99.32 14.87 34.3 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.606 ' CG1' ' HA ' ' A' ' 33' ' ' ALA . 1.6 pt -114.87 31.55 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.582 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 3.6 t80 -64.49 70.02 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.918 ' HB3' ' HB2' ' A' ' 43' ' ' ARG . . . -57.19 146.66 60.59 Favored Pre-proline 0 N--CA 1.449 -0.494 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.35 -37.77 4.13 Favored 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 124.329 3.353 . . . . 0.0 109.62 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -134.67 57.19 1.82 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.918 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -78.85 -150.5 0.05 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.885 ' H ' ' HD2' ' A' ' 43' ' ' ARG . 0.2 OUTLIER -145.96 50.13 1.18 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.708 ' CE1' ' HB2' ' A' ' 33' ' ' ALA . 25.9 m-85 -66.72 -133.05 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.668 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER 61.52 178.0 0.04 OUTLIER Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.881 ' HB3' HD12 ' A' ' 150' ' ' ILE . 83.5 Cg_endo -72.37 116.9 4.89 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 124.3 3.333 . . . . 0.0 109.585 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.1 tp -82.49 103.81 12.31 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.734 ' OE1' HG11 ' A' ' 153' ' ' VAL . 36.7 tt0 -83.61 100.52 10.87 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.69 ' CD2' HD21 ' A' ' 57' ' ' LEU . 2.1 p90 -122.9 170.76 9.78 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.838 HG12 ' H ' ' A' ' 53' ' ' GLY . 48.9 t -124.82 113.56 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.854 HG11 ' CG ' ' A' ' 66' ' ' LEU . 3.5 t -49.67 -8.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.838 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -121.08 38.2 2.76 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.424 ' HG3' ' HB ' ' A' ' 51' ' ' VAL . 2.1 mt-10 -123.29 -19.65 5.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.36 18.19 62.92 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -72.86 -76.83 0.11 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.69 HD21 ' CD2' ' A' ' 50' ' ' PHE . 1.3 mm? -73.17 149.58 42.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.886 ' H ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -55.68 163.27 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.481 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 23.9 mt-30 -53.53 -59.08 5.05 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.826 ' H ' ' HB3' ' A' ' 82' ' ' LYS . . . -41.54 -78.78 0.06 OUTLIER Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.279 -1.129 . . . . 0.0 110.279 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.651 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 1.0 OUTLIER -38.34 -52.37 1.52 Allowed 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -48.59 -51.77 26.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.806 ' HA ' HD12 ' A' ' 66' ' ' LEU . 6.8 mt-10 -58.33 -27.67 64.36 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.651 ' HB3' ' O ' ' A' ' 61' ' ' PHE . . . -63.9 -55.28 23.88 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.554 HG13 HD13 ' A' ' 147' ' ' ILE . 33.9 m -78.84 4.08 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.854 ' CG ' HG11 ' A' ' 52' ' ' VAL . 5.3 mt -84.77 -38.08 20.05 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.07 26.01 11.13 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.988 ' CE ' HD11 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -104.2 -155.11 0.52 Allowed 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.795 ' HA ' ' N ' ' A' ' 4' ' ' MET . 0.5 OUTLIER -144.35 -177.38 5.44 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.618 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 1.1 t -90.71 84.36 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.771 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 131.07 12.54 2.09 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.484 ' CG ' ' HB2' ' A' ' 69' ' ' GLU . 1.3 m-20 -100.54 -170.56 1.88 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.2 126.4 6.58 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.469 ' CB ' ' HE2' ' A' ' 68' ' ' MET . 2.3 ttmm -119.63 96.3 5.14 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.537 ' OG1' HG23 ' A' ' 146' ' ' THR . 62.8 m -96.87 83.05 3.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.452 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 3.8 t -119.69 157.75 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 13.7 ttmt -89.87 114.48 26.25 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.692 HD13 ' CD2' ' A' ' 145' ' ' PHE . 0.3 OUTLIER -79.11 130.18 70.36 Favored Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.479 ' O ' ' N ' ' A' ' 81' ' ' GLU . 84.6 Cg_endo -72.34 134.3 22.49 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 124.286 3.324 . . . . 0.0 109.634 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.727 ' HB2' ' N ' ' A' ' 141' ' ' LYS . . . -46.81 -14.56 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.601 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 3.2 tp10 -76.64 -39.3 52.74 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.826 ' HB3' ' H ' ' A' ' 60' ' ' GLY . 14.6 mttt -81.97 -34.13 29.89 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.627 ' HA ' ' CG2' ' A' ' 58' ' ' ILE . . . -73.31 -102.05 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.561 ' CE1' ' HB2' ' A' ' 138' ' ' LEU . 2.8 m-85 -90.7 20.29 4.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 47.38 89.24 0.01 OUTLIER Glycine 0 C--N 1.336 0.535 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.584 ' HA ' ' HA2' ' A' ' 140' ' ' GLY . 0.0 OUTLIER 40.99 -133.94 0.28 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.495 ' H ' ' HB2' ' A' ' 86' ' ' ASN . 0.3 OUTLIER -90.85 149.17 22.06 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.899 ' CB ' HD12 ' A' ' 91' ' ' LEU . 1.7 m120 -87.52 135.18 33.45 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -81.46 -26.55 35.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.96 -4.99 59.13 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.899 HD12 ' CB ' ' A' ' 88' ' ' ASN . 28.2 mt -102.83 13.31 34.7 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.617 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 26.5 mt -82.5 124.09 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.552 ' CD ' ' CD1' ' A' ' 134' ' ' PHE . 3.1 mp0 -115.53 156.2 26.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.724 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -133.32 90.16 2.7 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.65 HG23 HD11 ' A' ' 132' ' ' LEU . 34.4 pt -88.25 154.25 51.62 Favored Pre-proline 0 N--CA 1.449 -0.501 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.512 ' O ' ' N ' ' A' ' 99' ' ' ALA . 81.5 Cg_endo -72.44 141.49 35.14 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 124.275 3.316 . . . . 0.0 109.591 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.924 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -44.11 -30.59 0.78 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.829 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.522 ' HA ' ' HB2' ' A' ' 101' ' ' LYS . 5.1 t70 -68.93 -36.18 77.67 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -47.9 -27.76 2.31 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.623 ' CE2' ' HB3' ' A' ' 107' ' ' PRO . 0.6 OUTLIER -99.41 -33.03 10.86 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 1.1 tttm -58.22 -0.35 0.09 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.531 ' H ' ' C ' ' A' ' 100' ' ' PHE . 7.8 mm-40 -117.12 4.65 12.71 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.14 -133.94 0.07 Allowed 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.71 -8.96 1.87 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.422 ' HB2' ' H ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -137.76 -157.73 0.8 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.471 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 1.6 pm0 -125.88 137.78 30.75 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.924 ' CG ' HH21 ' A' ' 97' ' ' ARG . 83.5 Cg_endo -72.3 129.31 14.78 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 124.38 3.387 . . . . 0.0 109.584 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 110' ' ' GLY . 1.7 mm-40 -125.65 150.84 47.25 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.454 ' HA ' HG22 ' A' ' 122' ' ' ILE . 2.5 tm-20 -62.68 71.07 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 151.86 14.72 0.07 OUTLIER Glycine 0 C--N 1.335 0.513 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.907 ' CB ' HD13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -74.41 173.53 10.16 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.531 HG13 ' HB2' ' A' ' 119' ' ' PRO . 61.1 t -156.84 82.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.453 ' C ' ' HA ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -115.31 127.67 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.989 HD23 ' HD3' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -102.32 163.25 12.34 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -112.61 6.97 18.62 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 169.93 -6.33 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 156.34 -21.91 0.49 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.494 ' C ' ' HB3' ' A' ' 114' ' ' LEU . 3.0 mt -102.7 103.15 30.82 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.989 ' HD3' HD23 ' A' ' 114' ' ' LEU . 82.7 Cg_endo -72.4 158.72 50.85 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 124.264 3.309 . . . . 0.0 109.572 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.75 ' HB1' ' HB2' ' A' ' 132' ' ' LEU . . . -115.83 87.05 2.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 32.5 m -55.57 97.98 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.907 HD13 ' CB ' ' A' ' 111' ' ' MET . 1.8 mp -63.45 99.96 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.3 p -86.09 -21.19 27.8 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.779 ' HB3' ' H ' ' A' ' 131' ' ' THR . 1.6 tp10 -128.66 136.1 50.18 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.732 ' HA ' HG12 ' A' ' 130' ' ' VAL . 10.7 p -119.3 56.71 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.631 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.1 OUTLIER -78.44 123.97 27.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.512 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.2 OUTLIER -52.01 -2.54 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.631 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -111.69 -17.87 12.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.3 OUTLIER -179.33 163.33 1.25 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.916 HG11 ' HB2' ' A' ' 107' ' ' PRO . 0.6 OUTLIER -127.48 118.9 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.779 ' H ' ' HB3' ' A' ' 124' ' ' GLU . 20.7 m -82.03 84.95 6.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.75 ' HB2' ' HB1' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -79.7 169.66 17.65 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.617 ' HA ' ' HA ' ' A' ' 92' ' ' ILE . 11.6 t0 -132.29 95.3 3.62 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.567 ' N ' ' O ' ' A' ' 91' ' ' LEU . 2.1 m-30 -37.7 -38.96 0.31 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.752 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 0.8 OUTLIER 38.89 -118.32 0.23 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.759 ' ND1' ' N ' ' A' ' 137' ' ' GLU . 14.1 t-80 177.93 176.88 0.41 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.759 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -73.36 -8.39 55.68 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.931 HD22 HD22 ' A' ' 143' ' ' LEU . 72.0 mt -122.08 -5.63 8.96 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.752 ' HB3' ' HB3' ' A' ' 135' ' ' ASN . . . -68.1 133.66 49.32 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 86' ' ' ASN . . . 55.25 24.45 36.88 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.867 ' HE2' ' CD2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -142.07 145.94 34.89 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.503 ' C ' ' HD2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -98.91 137.61 37.23 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.931 HD22 HD22 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -127.15 152.76 46.92 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 2.0 t -74.36 165.69 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.692 ' CD2' HD13 ' A' ' 78' ' ' ILE . 28.0 m-85 -153.27 94.65 1.85 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.653 HG22 ' O ' ' A' ' 146' ' ' THR . 42.0 m -88.54 67.37 8.49 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.627 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -60.72 -177.81 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.496 ' H ' HG22 ' A' ' 147' ' ' ILE . 10.6 tttt -175.45 108.34 0.1 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 1.03 ' H ' HD12 ' A' ' 149' ' ' ILE . 1.5 mp -75.4 134.11 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.881 HD12 ' HB3' ' A' ' 47' ' ' PRO . 6.9 mt -113.47 -41.61 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.618 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -166.02 -156.31 0.25 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.634 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 18.6 t -131.63 155.1 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.938 HG22 ' HE2' ' A' ' 12' ' ' LYS . 2.6 t -138.03 39.73 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.895 ' HB3' ' H ' ' A' ' 10' ' ' LYS . 9.8 tp10 . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.63 HG22 HG21 ' A' ' 11' ' ' ILE . 48.8 t 65.88 117.47 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 8' ' ' GLY . 0.5 OUTLIER -154.49 177.48 11.13 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.867 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.547 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 15.7 ptmt -66.32 65.45 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 6' ' ' ASP . . . 156.05 23.78 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.17 125.63 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.6 ' HB3' ' N ' ' A' ' 154' ' ' GLU . 2.8 ttpm? -85.22 150.21 24.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.866 HG22 HG22 ' A' ' 152' ' ' VAL . 1.2 pt -154.17 126.9 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.655 ' HE2' HG21 ' A' ' 153' ' ' VAL . 21.0 mtmt -86.77 86.14 7.31 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.596 ' CG1' ' HA ' ' A' ' 149' ' ' ILE . 0.7 OUTLIER -114.93 152.48 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.806 ' CG ' HD11 ' A' ' 150' ' ' ILE . 0.8 OUTLIER -117.49 108.32 15.37 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.631 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.2 p90 -94.32 160.94 14.45 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 1.037 HG23 ' HB ' ' A' ' 27' ' ' THR . 5.1 mt -129.98 75.49 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -59.14 136.64 50.93 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.602 ' HE3' ' O ' ' A' ' 16' ' ' ILE . 6.6 mttt -122.87 -159.6 0.85 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.589 ' C ' ' H ' ' A' ' 21' ' ' SER . 57.8 mt -117.68 165.93 13.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -55.33 0.05 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.589 ' H ' ' C ' ' A' ' 19' ' ' LEU . 56.8 p -114.16 2.11 14.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.32 28.6 52.49 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.456 ' C ' ' HG2' ' A' ' 18' ' ' LYS . 4.1 m-20 -97.81 123.55 41.82 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.577 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 47.4 t -67.87 126.02 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.579 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 1.9 p90 -119.62 -38.85 2.93 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.579 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 8.3 t0 -138.13 135.7 35.99 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 1.037 ' HB ' HG23 ' A' ' 16' ' ' ILE . 3.9 t -152.58 148.75 27.72 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.46 ' HB3' ' HB3' ' A' ' 14' ' ' ASP . 0.6 OUTLIER -91.79 -18.78 23.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.744 HD11 ' CG ' ' A' ' 14' ' ' ASP . 4.6 mt -93.81 121.1 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.596 ' HG3' ' CD1' ' A' ' 45' ' ' TYR . 3.5 tt0 -63.62 -32.02 73.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -51.67 -63.41 1.14 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.913 HG11 HG21 ' A' ' 16' ' ' ILE . 52.0 t -50.58 -42.18 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.67 ' HB1' ' HA ' ' A' ' 39' ' ' TYR . . . -46.11 -42.79 14.16 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.534 ' HG2' ' CB ' ' A' ' 39' ' ' TYR . 11.6 mtmt -71.62 -32.41 67.95 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -74.46 -17.61 60.75 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.5 -7.57 16.52 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.0 43.73 32.67 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.54 HG13 ' HA ' ' A' ' 33' ' ' ALA . 1.8 pt -139.65 11.16 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.67 ' HA ' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -46.95 -21.39 0.21 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 1.001 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . 67.99 175.55 0.07 OUTLIER Pre-proline 0 N--CA 1.45 -0.474 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 1.001 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 83.2 Cg_endo -72.33 -69.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 124.299 3.333 . . . . 0.0 109.623 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.695 ' CG ' ' H ' ' A' ' 43' ' ' ARG . 9.0 p-10 -109.92 -68.21 0.94 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.695 ' H ' ' CG ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 41.73 -153.71 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.48 ' H ' ' HD2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER 179.15 81.13 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.596 ' CD1' ' HG3' ' A' ' 30' ' ' GLU . 2.9 m-85 -76.45 101.37 5.57 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.738 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -114.53 -179.15 0.58 Allowed Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.738 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 82.4 Cg_endo -72.38 122.53 8.4 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 124.283 3.322 . . . . 0.0 109.607 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.9 HD21 HD21 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -75.43 96.0 3.36 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.549 ' HG2' ' CG ' ' A' ' 10' ' ' LYS . 48.0 tt0 -79.31 97.49 6.31 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.831 ' CE2' HG21 ' A' ' 65' ' ' VAL . 39.7 p90 -110.81 170.39 8.13 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.628 HG12 ' H ' ' A' ' 53' ' ' GLY . 89.6 t -134.48 104.4 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.558 HG21 HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -44.54 -17.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.628 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -101.24 37.59 3.54 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 51' ' ' VAL . 5.5 mt-10 -141.78 -30.08 0.6 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.1 7.37 77.35 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.486 ' OE1' ' N ' ' A' ' 51' ' ' VAL . 5.5 mt-30 -42.3 -68.89 0.16 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.9 HD21 HD21 ' A' ' 48' ' ' LEU . 2.3 mm? -79.74 160.37 26.25 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.693 HG13 HG21 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -60.48 160.35 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.52 ' O ' ' C ' ' A' ' 60' ' ' GLY . 21.8 mt-30 -48.85 -67.01 0.3 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.952 ' HA3' HD12 ' A' ' 78' ' ' ILE . . . -29.86 -74.37 0.04 OUTLIER Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.61 ' CE2' HG23 ' A' ' 147' ' ' ILE . 1.0 OUTLIER -45.98 -51.72 12.95 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 59' ' ' GLN . 2.9 mt-10 -50.49 -38.63 45.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.602 ' HA ' HD12 ' A' ' 66' ' ' LEU . 18.9 mt-10 -74.63 -25.09 58.99 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.763 ' HB1' ' HB3' ' A' ' 74' ' ' LYS . . . -68.88 -51.7 37.49 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.831 HG21 ' CE2' ' A' ' 50' ' ' PHE . 27.2 m -74.0 -12.71 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.602 HD12 ' HA ' ' A' ' 63' ' ' GLU . 2.5 mt -60.51 106.31 0.53 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 66' ' ' LEU . 1.8 m-20 84.34 33.06 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.511 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 4.8 mtp -123.43 106.29 10.52 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -70.53 -179.63 2.18 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.887 HG22 HG23 ' A' ' 152' ' ' VAL . 7.1 t -60.05 127.4 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 107.43 -32.3 7.29 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.511 ' HB3' ' HG2' ' A' ' 68' ' ' MET . 0.9 OUTLIER -54.07 160.47 1.52 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.52 145.83 21.82 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.763 ' HB3' ' HB1' ' A' ' 64' ' ' ALA . 2.2 tttt -143.78 98.72 3.28 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.745 ' OG1' HG23 ' A' ' 146' ' ' THR . 83.1 m -100.01 83.17 2.66 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 2.9 t -121.62 156.13 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 19.8 ttpt -79.16 114.71 18.32 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.952 HD12 ' HA3' ' A' ' 60' ' ' GLY . 24.5 mm -78.51 123.24 85.65 Favored Pre-proline 0 N--CA 1.449 -0.489 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.656 ' HG3' ' HE3' ' A' ' 82' ' ' LYS . 85.0 Cg_endo -72.29 145.03 42.61 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 124.361 3.374 . . . . 0.0 109.587 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.538 ' O ' ' CA ' ' A' ' 85' ' ' GLY . . . -54.33 -23.74 16.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.527 ' CG ' ' HB2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -69.87 -41.07 75.29 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.776 ' HB3' ' H ' ' A' ' 60' ' ' GLY . 17.8 mttt -82.24 -28.79 31.67 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.771 ' HB2' HG21 ' A' ' 78' ' ' ILE . . . -112.75 110.97 21.42 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.639 ' CD2' ' HB3' ' A' ' 138' ' ' LEU . 32.6 m-85 70.91 -9.78 0.81 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 80' ' ' ALA . . . 64.02 156.41 0.15 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -41.36 155.4 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.59 ' HD2' ' ND2' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -39.41 131.1 1.68 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.566 ' CB ' HD12 ' A' ' 91' ' ' LEU . 7.7 t30 -81.08 147.73 29.98 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -85.12 -27.49 26.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.88 -0.56 18.9 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.766 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 71.7 mt -98.95 3.46 47.07 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.609 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 42.1 mt -85.77 113.32 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.4 ' O ' ' N ' ' A' ' 132' ' ' LEU . 6.8 mp0 -108.2 145.73 33.82 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.618 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -128.3 97.2 4.67 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.019 HG12 HD11 ' A' ' 132' ' ' LEU . 25.2 pt -92.63 153.63 42.4 Favored Pre-proline 0 N--CA 1.45 -0.454 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.559 ' HG2' ' HB2' ' A' ' 99' ' ' ALA . 83.6 Cg_endo -72.44 139.65 31.98 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 124.272 3.314 . . . . 0.0 109.562 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.782 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -44.73 -26.89 0.43 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.548 ' HA ' ' HB2' ' A' ' 101' ' ' LYS . 10.0 t70 -73.73 -34.01 64.58 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.559 ' HB2' ' HG2' ' A' ' 96' ' ' PRO . . . -58.5 -22.28 54.56 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.675 ' CD1' ' CD1' ' A' ' 95' ' ' ILE . 1.8 m-85 -121.42 2.88 10.26 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.548 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 0.2 OUTLIER -53.06 -41.44 64.85 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -118.74 34.68 5.1 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.672 ' HB2' ' HA ' ' A' ' 100' ' ' PHE . . . -81.15 20.06 0.86 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 59.34 -6.75 0.06 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.621 ' H ' ' C ' ' A' ' 103' ' ' ALA . 0.5 OUTLIER -150.63 147.52 27.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.496 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 0.6 OUTLIER -94.83 129.67 35.33 Favored Pre-proline 0 N--CA 1.449 -0.496 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.846 ' CG ' HG11 ' A' ' 130' ' ' VAL . 82.6 Cg_endo -72.36 135.02 23.77 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 124.367 3.378 . . . . 0.0 109.544 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 110' ' ' GLY . 1.2 mt-10 -124.19 156.81 36.12 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.481 ' HB2' HG12 ' A' ' 125' ' ' VAL . 2.8 tm-20 -65.7 67.55 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.65 14.04 0.06 OUTLIER Glycine 0 C--N 1.336 0.537 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.808 ' HB3' HD12 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -69.97 171.27 9.72 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.66 HG13 ' HB2' ' A' ' 119' ' ' PRO . 64.0 t -156.7 70.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.19 135.49 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.882 HD23 ' N ' ' A' ' 119' ' ' PRO . 0.3 OUTLIER -99.2 149.2 23.33 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -103.37 3.48 35.22 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 171.41 -11.09 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.652 ' O ' HD22 ' A' ' 114' ' ' LEU . . . 166.06 -34.88 0.24 Allowed Glycine 0 C--N 1.335 0.492 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 3.0 mt -93.3 121.32 65.51 Favored Pre-proline 0 N--CA 1.448 -0.53 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.882 ' N ' HD23 ' A' ' 114' ' ' LEU . 83.9 Cg_endo -72.39 164.13 36.55 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 124.282 3.321 . . . . 0.0 109.631 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.866 ' HB1' ' HB3' ' A' ' 132' ' ' LEU . . . -123.55 82.94 2.07 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 2.4 m -54.13 94.82 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.808 HD12 ' HB3' ' A' ' 111' ' ' MET . 12.8 mt -70.49 97.3 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.482 HG22 HG22 ' A' ' 121' ' ' THR . 1.3 p -82.68 -24.73 33.56 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.769 ' HG2' HG23 ' A' ' 126' ' ' THR . 1.2 tt0 -111.54 132.38 54.56 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.705 HG22 ' O ' ' A' ' 125' ' ' VAL . 8.1 p -126.22 48.03 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.769 HG23 ' HG2' ' A' ' 124' ' ' GLU . 2.1 p -79.85 129.28 34.35 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.552 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.4 OUTLIER -53.87 2.41 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.682 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.7 OUTLIER -110.79 -22.74 11.41 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -177.88 168.66 2.06 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.846 HG11 ' CG ' ' A' ' 107' ' ' PRO . 22.0 m -132.15 143.56 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.618 HG23 ' HD2' ' A' ' 94' ' ' LYS . 16.3 m -99.75 85.37 3.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 1.019 HD11 HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -82.5 107.72 15.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.609 ' HA ' ' HA ' ' A' ' 92' ' ' ILE . 18.8 t0 -83.86 97.04 8.98 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.513 ' N ' ' O ' ' A' ' 91' ' ' LEU . 2.3 m-85 -42.53 -45.55 4.55 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.766 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 91.2 m-20 42.17 -121.76 0.58 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.695 ' ND1' ' N ' ' A' ' 137' ' ' GLU . 21.6 t-80 -179.21 166.87 1.54 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.695 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 0.9 OUTLIER -70.99 -16.07 62.61 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 1.04 HD12 HD22 ' A' ' 143' ' ' LEU . 3.4 mm? -111.26 -23.2 10.97 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.528 ' HB2' ' HB3' ' A' ' 136' ' ' HIS . . . -48.66 144.66 4.18 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 42.45 22.12 0.12 Allowed Glycine 0 C--N 1.336 0.531 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.81 ' HD2' HD13 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -133.09 133.03 42.42 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.566 ' C ' ' HD3' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -99.11 131.56 45.06 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 1.04 HD22 HD12 ' A' ' 138' ' ' LEU . 2.4 pt? -122.57 146.43 47.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.578 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 4.0 t -67.71 163.04 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.737 ' CD1' ' CG1' ' A' ' 78' ' ' ILE . 16.4 m-85 -146.43 85.87 1.66 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.745 HG23 ' OG1' ' A' ' 75' ' ' THR . 95.0 m -83.82 70.81 10.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.631 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 2.1 mt -64.4 179.54 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.631 ' H ' HG22 ' A' ' 147' ' ' ILE . 3.1 tmtt? -177.65 96.49 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.596 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 2.4 mm -60.06 135.01 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.806 HD11 ' CG ' ' A' ' 14' ' ' ASP . 2.3 mt -122.51 -24.62 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -163.11 176.39 10.09 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.887 HG23 HG22 ' A' ' 70' ' ' VAL . 85.7 t -137.69 136.84 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.655 HG21 ' HE2' ' A' ' 12' ' ' LYS . 0.9 OUTLIER -142.99 -142.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.6 ' N ' ' HB3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.498 ' N ' ' OE1' ' A' ' 69' ' ' GLU . 22.7 ttt . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.906 HG21 HD13 ' A' ' 11' ' ' ILE . 16.6 t -81.07 162.62 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.464 ' N ' HG12 ' A' ' 5' ' ' VAL . 7.8 m-20 -143.4 168.83 18.89 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.527 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 11.7 ptmt -66.05 69.59 0.06 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 6' ' ' ASP . . . 162.59 11.3 0.03 OUTLIER Glycine 0 C--N 1.336 0.561 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.827 ' HB ' HG13 ' A' ' 5' ' ' VAL . 1.4 t -119.05 133.96 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.909 ' H ' ' HB3' ' A' ' 154' ' ' GLU . 3.6 tttt -86.64 133.39 33.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.999 ' CG2' HG22 ' A' ' 152' ' ' VAL . 9.6 pt -147.03 136.38 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.615 ' CG ' HG23 ' A' ' 153' ' ' VAL . 9.5 mtpt -95.03 91.94 6.6 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.633 HG22 ' CE1' ' A' ' 50' ' ' PHE . 1.1 m -118.35 145.79 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 147' ' ' ILE . 41.3 m-20 -92.19 -166.69 1.6 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.0 OUTLIER -179.81 151.79 0.45 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 1.077 HD13 HG21 ' A' ' 32' ' ' VAL . 3.5 mt -133.22 81.65 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -65.74 138.62 37.91 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.643 ' HE2' HG22 ' A' ' 24' ' ' VAL . 10.4 mttt -125.44 -165.81 1.46 Allowed 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.636 ' C ' ' H ' ' A' ' 21' ' ' SER . 34.1 mt -112.98 166.52 11.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -54.84 0.77 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.636 ' H ' ' C ' ' A' ' 19' ' ' LEU . 54.2 p -112.4 2.54 16.47 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.04 30.51 57.26 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 18' ' ' LYS . 87.3 m-20 -100.87 124.29 46.33 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.643 HG22 ' HE2' ' A' ' 18' ' ' LYS . 82.2 t -71.06 122.83 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.484 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -115.48 -30.13 6.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.484 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 16.7 t0 -143.56 140.23 30.13 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 1.015 ' HB ' HG23 ' A' ' 16' ' ' ILE . 6.1 t -158.72 148.66 19.48 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.4 m -101.78 16.68 25.12 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 29.0 mt -127.91 108.47 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.583 ' HG3' ' CD1' ' A' ' 45' ' ' TYR . 2.8 tt0 -48.81 -35.42 14.45 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -47.4 -64.66 0.72 Allowed 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.077 HG21 HD13 ' A' ' 16' ' ' ILE . 49.5 t -53.81 -40.39 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.596 ' HA ' ' CG1' ' A' ' 38' ' ' ILE . . . -54.68 -38.09 66.55 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.522 ' CG ' ' HB2' ' A' ' 39' ' ' TYR . 7.7 mtpt -78.51 -17.93 55.51 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -96.01 -23.62 16.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . -95.14 -23.71 17.17 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.81 37.58 4.93 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.596 ' CG1' ' HA ' ' A' ' 33' ' ' ALA . 2.1 pt -135.38 17.17 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.522 ' HB2' ' CG ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -43.44 -20.47 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.983 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . 57.27 174.93 0.04 OUTLIER Pre-proline 0 N--CA 1.449 -0.492 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.983 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 82.6 Cg_endo -72.5 -74.2 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 124.296 3.33 . . . . 0.0 109.57 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.671 ' H ' ' HG2' ' A' ' 41' ' ' PRO . 4.6 p-10 -104.29 -53.36 2.74 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.653 ' NE ' ' CZ ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER 46.1 -162.42 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -171.36 74.89 0.06 Allowed 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.658 ' HE2' HG23 ' A' ' 27' ' ' THR . 80.3 m-85 -79.65 102.99 9.26 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.618 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -131.23 174.92 4.13 Favored Pre-proline 0 N--CA 1.449 -0.523 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.618 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 83.8 Cg_endo -72.41 130.84 16.71 Favored 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 124.319 3.346 . . . . 0.0 109.643 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.806 HD21 HD21 ' A' ' 57' ' ' LEU . 1.4 tp -88.63 96.66 10.74 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.611 ' CD ' HG11 ' A' ' 153' ' ' VAL . 23.4 tt0 -79.08 89.73 4.82 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.757 ' CE2' ' CE1' ' A' ' 61' ' ' PHE . 0.7 OUTLIER -108.32 172.8 6.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.676 HG12 ' H ' ' A' ' 53' ' ' GLY . 59.1 t -123.6 107.28 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.85 HG11 ' HG ' ' A' ' 66' ' ' LEU . 2.8 t -50.93 -8.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.676 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -96.98 -25.27 11.53 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.296 -1.121 . . . . 0.0 110.296 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 51' ' ' VAL . 14.6 mt-10 -74.28 -65.32 0.86 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.82 13.84 8.36 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -43.47 -67.09 0.31 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.806 HD21 HD21 ' A' ' 48' ' ' LEU . 1.5 mm? -70.67 -171.97 0.57 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.067 ' H ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -81.68 146.38 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.503 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 27.1 mt-30 -43.15 -54.69 4.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.581 ' HA3' HD12 ' A' ' 78' ' ' ILE . . . -39.45 -81.51 0.02 OUTLIER Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.757 ' CE1' ' CE2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -42.53 -49.56 5.37 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.67 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 1.9 mt-10 -49.88 -35.08 22.17 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 60' ' ' GLY . 4.9 mt-10 -78.09 -32.0 50.4 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.473 ' HB1' ' HB3' ' A' ' 74' ' ' LYS . . . -64.47 -25.42 67.99 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.678 HG21 ' CE2' ' A' ' 50' ' ' PHE . 33.5 m -95.02 -20.4 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.85 ' HG ' HG11 ' A' ' 52' ' ' VAL . 1.2 mt -51.07 -60.44 3.1 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -96.33 55.59 1.5 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.471 ' CE ' HD11 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -144.37 127.38 16.47 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' A' ' 4' ' ' MET . 0.8 OUTLIER -75.31 -161.77 0.16 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.686 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 0.2 OUTLIER -90.0 115.56 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.868 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 107.0 -6.57 37.26 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 0.9 OUTLIER -68.64 177.81 2.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -154.8 142.59 19.96 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.473 ' HB3' ' HB1' ' A' ' 64' ' ' ALA . 2.4 tttm -139.38 101.98 4.37 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 1.066 ' CG2' HG23 ' A' ' 146' ' ' THR . 0.2 OUTLIER -99.19 93.6 6.04 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.413 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 18.3 t -136.09 156.04 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.673 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 2.5 ttpm? -85.35 116.44 23.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.689 ' CG1' ' CD1' ' A' ' 145' ' ' PHE . 22.2 mm -78.37 126.65 82.82 Favored Pre-proline 0 N--CA 1.448 -0.568 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.502 ' HG2' ' HG2' ' A' ' 81' ' ' GLU . 84.4 Cg_endo -72.32 144.1 40.57 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 124.264 3.31 . . . . 0.0 109.656 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.709 ' HB1' ' O ' ' A' ' 139' ' ' ALA . . . -56.62 -8.57 0.58 Allowed 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.582 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 9.3 pt-20 -81.55 -39.25 24.9 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.574 ' HB3' ' H ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -86.85 -34.73 19.38 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.639 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . . . -67.75 -96.44 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.604 ' CE1' ' HB3' ' A' ' 138' ' ' LEU . 3.1 m-85 -99.29 17.56 19.76 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 42.53 84.56 0.01 OUTLIER Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER 47.65 -166.22 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 1.042 ' HE ' ' HB3' ' A' ' 139' ' ' ALA . 3.4 mmt85 -70.47 145.91 50.64 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.64 ' HB2' HD12 ' A' ' 91' ' ' LEU . 0.9 OUTLIER -83.27 143.83 30.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.09 -26.79 20.06 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -74.66 -23.3 58.64 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.64 HD12 ' HB2' ' A' ' 88' ' ' ASN . 85.4 mt -85.34 26.67 0.88 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.601 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 86.5 mt -93.16 116.41 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.626 ' NE2' ' CG ' ' A' ' 134' ' ' PHE . 12.3 mp0 -109.19 154.23 22.67 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.664 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -134.96 99.09 4.19 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.038 HG12 HD11 ' A' ' 132' ' ' LEU . 21.4 pt -95.5 156.02 38.0 Favored Pre-proline 0 N--CA 1.449 -0.483 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 99' ' ' ALA . 83.0 Cg_endo -72.36 139.53 32.01 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 124.283 3.322 . . . . 0.0 109.577 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.82 HH21 ' HG2' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -42.16 -33.94 0.67 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.522 ' HA ' ' HB2' ' A' ' 101' ' ' LYS . 0.9 OUTLIER -65.85 -36.37 83.25 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -43.65 -19.85 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.488 ' N ' ' O ' ' A' ' 98' ' ' ASP . 0.6 OUTLIER -126.49 -30.61 2.83 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 1.2 tmtt? -53.42 -17.46 1.95 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.03 28.36 8.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.469 ' HB1' ' CE1' ' A' ' 105' ' ' PHE . . . -113.03 -139.16 0.38 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.99 -3.31 3.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.469 ' CE1' ' HB1' ' A' ' 103' ' ' ALA . 0.1 OUTLIER -128.13 -148.43 0.38 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.436 ' CD ' HH22 ' A' ' 97' ' ' ARG . 0.0 OUTLIER -162.44 132.93 3.5 Favored Pre-proline 0 N--CA 1.45 -0.448 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.82 ' HG2' HH21 ' A' ' 97' ' ' ARG . 82.3 Cg_endo -72.38 137.39 28.14 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 124.27 3.313 . . . . 0.0 109.591 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.479 ' O ' ' N ' ' A' ' 110' ' ' GLY . 4.0 mt-10 -126.05 154.61 42.77 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.528 ' N ' ' HB ' ' A' ' 125' ' ' VAL . 1.2 tt0 -65.51 67.03 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.91 9.86 0.08 OUTLIER Glycine 0 C--N 1.336 0.539 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.917 ' CB ' HD13 ' A' ' 122' ' ' ILE . 1.4 mmt -66.64 171.38 5.19 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.508 HG23 ' C ' ' A' ' 111' ' ' MET . 60.7 t -156.11 73.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.473 HD13 ' HZ ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -110.29 136.95 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.767 HD23 ' CD ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -106.49 171.07 7.56 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -114.79 -4.29 12.7 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.417 ' H ' ' H ' ' A' ' 117' ' ' GLY . 1.0 OUTLIER 172.33 5.63 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.418 ' O ' HD22 ' A' ' 114' ' ' LEU . . . 153.87 -38.86 0.69 Allowed Glycine 0 C--N 1.335 0.483 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 48.8 mm -87.47 114.65 59.74 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.767 ' CD ' HD23 ' A' ' 114' ' ' LEU . 84.9 Cg_endo -72.38 173.5 13.03 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 124.305 3.337 . . . . 0.0 109.604 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.875 ' HB1' ' HB3' ' A' ' 132' ' ' LEU . . . -134.64 73.14 1.47 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 77.3 m -49.85 96.86 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.917 HD13 ' CB ' ' A' ' 111' ' ' MET . 2.9 mp -69.1 98.73 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.426 HG23 ' H ' ' A' ' 123' ' ' THR . 1.0 OUTLIER -83.76 -21.14 32.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.561 ' HB3' ' H ' ' A' ' 131' ' ' THR . 0.3 OUTLIER -120.16 133.41 55.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.796 ' HA ' HG12 ' A' ' 130' ' ' VAL . 7.2 p -124.76 52.6 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.639 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -79.67 127.81 32.63 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 97' ' ' ARG . 0.5 OUTLIER -53.25 0.63 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.639 ' H ' ' C ' ' A' ' 126' ' ' THR . 1.4 p-10 -111.62 -21.67 11.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -177.83 168.43 2.09 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.796 HG12 ' HA ' ' A' ' 125' ' ' VAL . 4.2 m -133.66 141.69 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.664 HG23 ' HD2' ' A' ' 94' ' ' LYS . 17.3 m -98.18 86.27 3.64 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 1.038 HD11 HG12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -82.65 113.32 20.26 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.601 ' HA ' ' HA ' ' A' ' 92' ' ' ILE . 10.0 t0 -81.96 95.12 7.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.626 ' CG ' ' NE2' ' A' ' 93' ' ' GLN . 1.6 m-85 -39.88 -50.61 2.46 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.624 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 64.7 m-20 45.97 -132.89 0.99 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.779 ' ND1' ' N ' ' A' ' 137' ' ' GLU . 23.2 t-80 -167.84 174.21 7.7 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.779 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 8.7 pt-20 -86.06 10.11 15.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.844 ' CD2' ' HE2' ' A' ' 141' ' ' LYS . 63.5 mt -135.01 5.32 3.31 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.042 ' HB3' ' HE ' ' A' ' 87' ' ' ARG . . . -60.58 -111.23 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.858 ' H ' ' NE ' ' A' ' 87' ' ' ARG . . . -65.59 38.65 0.13 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.844 ' HE2' ' CD2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -136.47 143.18 43.71 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.495 ' HB3' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -101.0 129.9 46.91 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.788 HD22 HD22 ' A' ' 138' ' ' LEU . 1.1 pt? -121.07 145.69 47.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.673 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 1.6 t -62.14 163.88 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.689 ' CD1' ' CG1' ' A' ' 78' ' ' ILE . 12.3 m-85 -148.28 102.58 3.36 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . 1.066 HG23 ' CG2' ' A' ' 75' ' ' THR . 24.3 m -97.17 60.81 1.7 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.691 HD13 ' CD2' ' A' ' 61' ' ' PHE . 1.1 mt -59.67 177.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.473 ' H ' HG22 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -177.25 113.86 0.09 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.868 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 2.8 mm -69.49 139.98 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.524 HG13 ' HA ' ' A' ' 13' ' ' VAL . 6.7 mt -118.78 -48.12 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.686 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -158.11 -165.39 1.71 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.999 HG22 ' CG2' ' A' ' 11' ' ' ILE . 10.7 t -134.16 137.83 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.629 HG12 ' O ' ' A' ' 153' ' ' VAL . 45.8 t -117.78 43.6 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.909 ' HB3' ' H ' ' A' ' 10' ' ' LYS . 14.0 tp10 . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.71 ' N ' ' HA ' ' A' ' 69' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.079 HG21 HD13 ' A' ' 11' ' ' ILE . 23.0 t -123.64 155.07 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' A' ' 8' ' ' GLY . 0.8 OUTLIER -137.76 171.08 14.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.539 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 16.9 ptmt -64.76 70.64 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 6' ' ' ASP . . . 161.61 11.24 0.03 OUTLIER Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.838 ' HB ' HG13 ' A' ' 5' ' ' VAL . 1.7 t -125.17 132.97 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.839 ' H ' ' HB2' ' A' ' 154' ' ' GLU . 11.6 tttt -88.2 152.94 21.62 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.079 HD13 HG21 ' A' ' 5' ' ' VAL . 6.2 pt -160.72 137.96 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 7.7 ttmt -96.12 99.94 11.63 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.607 HG12 ' HA ' ' A' ' 149' ' ' ILE . 1.2 m -119.65 152.62 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.621 ' CG ' HD11 ' A' ' 150' ' ' ILE . 0.5 OUTLIER -115.42 103.01 10.35 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.605 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 9.3 p90 -96.63 151.63 19.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.941 HG21 HG11 ' A' ' 32' ' ' VAL . 1.1 mt -119.81 77.94 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -62.65 130.45 43.07 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.603 ' HE2' HG22 ' A' ' 24' ' ' VAL . 6.9 mtmt -125.56 144.43 50.57 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 21' ' ' SER . 80.2 mt -64.07 170.09 3.88 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.61 50.86 0.07 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 19' ' ' LEU . 94.1 p -161.82 -1.01 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.29 22.34 48.43 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 18' ' ' LYS . 2.2 m-20 -96.71 116.34 28.96 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.603 HG22 ' HE2' ' A' ' 18' ' ' LYS . 54.6 t -68.44 115.07 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.513 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 3.3 p90 -103.84 -37.75 7.31 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.513 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 9.3 t0 -136.04 133.46 37.43 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.9 ' HB ' HG23 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -153.91 131.59 11.49 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.605 ' HB2' ' HA ' ' A' ' 14' ' ' ASP . 3.0 m -79.68 -23.2 42.62 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.487 HG22 ' H ' ' A' ' 32' ' ' VAL . 5.0 mt -84.67 114.93 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.594 ' O ' ' HE3' ' A' ' 34' ' ' LYS . 6.4 tt0 -60.89 -22.02 63.89 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -60.51 -62.46 1.84 Allowed 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.941 HG11 HG21 ' A' ' 16' ' ' ILE . 89.3 t -54.54 -41.0 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.596 ' HA ' HG13 ' A' ' 38' ' ' ILE . . . -48.22 -39.18 20.37 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.594 ' HE3' ' O ' ' A' ' 30' ' ' GLU . 18.0 mttt -77.56 -24.32 49.84 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 32' ' ' VAL . 35.7 tt0 -84.37 -12.98 53.52 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.82 -10.49 14.76 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.83 44.0 10.74 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.596 HG13 ' HA ' ' A' ' 33' ' ' ALA . 1.6 pt -140.06 16.28 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.54 ' HB2' ' CG ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -45.07 -17.51 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.774 ' HB1' ' HB3' ' A' ' 43' ' ' ARG . . . 70.44 155.55 0.15 Allowed Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.597 ' HG2' ' H ' ' A' ' 42' ' ' ASP . 82.5 Cg_endo -72.41 -84.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 124.326 3.351 . . . . 0.0 109.618 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.597 ' H ' ' HG2' ' A' ' 41' ' ' PRO . 4.3 p-10 -93.16 -14.41 27.22 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.774 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -77.53 140.53 39.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.494 ' N ' ' HG3' ' A' ' 43' ' ' ARG . 4.3 mt-10 -115.15 179.01 4.08 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.56 ' CD2' ' HB2' ' A' ' 33' ' ' ALA . 9.8 m-85 -133.93 109.91 9.35 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.607 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -117.42 174.78 2.33 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.607 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 81.7 Cg_endo -72.36 124.07 9.63 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 124.312 3.341 . . . . 0.0 109.578 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.581 HD21 HD21 ' A' ' 57' ' ' LEU . 2.8 tp -86.66 125.15 33.66 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.581 ' O ' ' HE2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -91.95 98.69 11.73 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.795 ' CZ ' HG21 ' A' ' 65' ' ' VAL . 10.5 p90 -99.76 170.96 8.19 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.672 HG12 ' H ' ' A' ' 53' ' ' GLY . 57.6 t -135.01 106.13 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.539 ' C ' ' HA ' ' A' ' 7' ' ' LYS . 93.3 t -48.88 -10.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.672 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -117.27 62.3 0.41 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.43 ' H ' ' H ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -167.22 -20.05 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.43 ' H ' ' H ' ' A' ' 54' ' ' GLU . . . 82.38 6.57 88.57 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.402 ' OE1' ' CB ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -42.05 -78.61 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.673 HD23 ' CB ' ' A' ' 50' ' ' PHE . 3.0 mm? -75.02 -174.2 2.18 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.069 ' H ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -82.19 144.02 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.496 ' HG3' ' H ' ' A' ' 59' ' ' GLN . 5.4 mt-30 -41.83 -51.91 4.14 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.647 ' HA3' HD12 ' A' ' 78' ' ' ILE . . . -42.23 -78.48 0.07 OUTLIER Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.817 ' HB3' HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -47.68 -37.94 13.98 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.555 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 18.3 mt-10 -62.51 -22.78 66.55 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.763 ' HA ' HD12 ' A' ' 66' ' ' LEU . 4.7 mt-10 -88.54 -34.8 17.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.54 -30.39 71.42 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.795 HG21 ' CZ ' ' A' ' 50' ' ' PHE . 29.9 m -86.14 -32.8 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.763 HD12 ' HA ' ' A' ' 63' ' ' GLU . 2.9 mt -41.87 -43.25 2.97 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.36 50.4 0.81 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' MET . . . . . 1.072 ' HE3' HD11 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -145.07 119.3 9.51 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.71 ' HA ' ' N ' ' A' ' 4' ' ' MET . 3.2 mp0 -73.74 -168.77 0.62 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.679 HG22 HG23 ' A' ' 152' ' ' VAL . 34.5 t -79.29 113.93 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.774 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 108.99 -3.45 31.72 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.514 ' HB3' ' HG2' ' A' ' 68' ' ' MET . 0.7 OUTLIER -73.13 169.9 16.05 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.515 ' N ' ' SD ' ' A' ' 68' ' ' MET . 1.5 tt0 -150.15 139.16 21.05 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.5 ttmm -147.22 97.99 2.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.631 HG23 ' OG1' ' A' ' 146' ' ' THR . 28.6 m -93.71 90.63 6.66 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.9 t -126.41 145.69 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.625 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 5.6 ttpm? -76.44 115.08 15.85 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.68 ' CG1' ' CD2' ' A' ' 145' ' ' PHE . 37.5 mm -78.31 131.46 68.84 Favored Pre-proline 0 N--CA 1.45 -0.449 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.505 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 84.2 Cg_endo -72.41 139.44 31.73 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 124.35 3.367 . . . . 0.0 109.567 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.736 ' HB2' ' N ' ' A' ' 141' ' ' LYS . . . -52.01 -14.52 0.41 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.558 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 7.5 tt0 -78.85 -37.22 40.98 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.631 ' HB3' ' H ' ' A' ' 60' ' ' GLY . 14.1 mttm -85.04 -36.27 21.34 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.656 ' HA ' ' CG2' ' A' ' 58' ' ' ILE . . . -67.55 -92.43 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 1.004 ' CE1' HD12 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -103.72 17.1 24.82 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 65.09 144.09 0.03 OUTLIER Glycine 0 C--N 1.335 0.523 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -39.75 150.84 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.484 ' HG3' ' HA3' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -39.37 120.99 1.11 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.662 ' CB ' HD12 ' A' ' 91' ' ' LEU . 7.7 t30 -80.11 147.23 31.48 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.413 ' HA ' ' CD1' ' A' ' 92' ' ' ILE . 1.8 tt0 -73.87 -33.72 64.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -17.51 62.42 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.711 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 13.0 mt -79.11 0.06 29.62 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.608 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 11.6 mt -94.31 118.94 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.667 ' NE2' ' CE2' ' A' ' 134' ' ' PHE . 0.8 OUTLIER -109.08 171.61 7.33 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.463 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -143.2 81.76 1.73 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.78 HG23 ' CD1' ' A' ' 132' ' ' LEU . 26.4 pt -79.8 155.87 75.35 Favored Pre-proline 0 N--CA 1.449 -0.485 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.625 ' HA ' ' HG3' ' A' ' 129' ' ' GLU . 83.1 Cg_endo -72.37 137.08 27.6 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 124.316 3.344 . . . . 0.0 109.624 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.823 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -42.61 -33.45 0.71 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 100' ' ' PHE . 2.5 m-20 -66.07 -36.88 84.4 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -44.3 -19.68 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.77 ' HZ ' HD13 ' A' ' 113' ' ' ILE . 3.1 m-85 -124.47 -30.32 3.39 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 4.3 tttt -60.63 -19.8 59.02 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.59 18.08 22.91 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -103.85 -137.61 0.35 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.45 -0.57 4.46 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.413 ' HB2' ' H ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -134.89 -149.81 0.36 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.505 ' HG2' ' HD2' ' A' ' 107' ' ' PRO . 1.8 tt0 -161.78 136.31 5.23 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.943 ' CG ' HG11 ' A' ' 130' ' ' VAL . 83.1 Cg_endo -72.41 141.48 35.24 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 124.279 3.319 . . . . 0.0 109.624 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 110' ' ' GLY . 1.0 OUTLIER -130.81 157.58 42.46 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -65.74 66.16 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 152.27 11.64 0.08 OUTLIER Glycine 0 C--N 1.335 0.477 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.905 ' CB ' HD13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -66.24 171.15 4.99 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.743 HG13 ' HB2' ' A' ' 119' ' ' PRO . 60.7 t -156.49 70.87 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.77 HD13 ' HZ ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -99.41 134.99 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.626 HD23 ' CD ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -103.29 144.75 30.94 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -96.02 0.49 51.7 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 170.82 -7.16 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 164.69 -38.82 0.3 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 5.3 mt -87.42 114.71 59.99 Favored Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.743 ' HB2' HG13 ' A' ' 112' ' ' VAL . 82.8 Cg_endo -72.44 156.18 54.63 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 124.246 3.297 . . . . 0.0 109.575 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.766 ' O ' HD12 ' A' ' 122' ' ' ILE . . . -116.37 94.06 4.48 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.56 HG22 ' O ' ' A' ' 121' ' ' THR . 1.3 m -64.84 98.4 0.27 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.905 HD13 ' CB ' ' A' ' 111' ' ' MET . 2.9 mp -70.41 100.13 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.5 p -83.28 -21.89 33.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.839 ' HB3' ' H ' ' A' ' 131' ' ' THR . 0.4 OUTLIER -121.84 131.52 54.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 125' ' ' VAL . 11.3 p -122.29 51.59 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.69 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -78.72 126.26 30.49 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.676 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.3 OUTLIER -53.36 2.84 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.69 ' H ' ' C ' ' A' ' 126' ' ' THR . 2.7 p-10 -113.51 -21.96 10.57 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.625 ' HG3' ' HA ' ' A' ' 96' ' ' PRO . 1.4 mt-10 -173.96 168.43 4.19 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.943 HG11 ' CG ' ' A' ' 107' ' ' PRO . 18.1 m -135.07 122.55 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.839 ' H ' ' HB3' ' A' ' 124' ' ' GLU . 9.4 m -88.12 88.28 7.59 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.78 ' CD1' HG23 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -76.66 163.18 27.1 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.777 ' CG ' HD22 ' A' ' 135' ' ' ASN . 31.8 t0 -139.69 95.96 3.0 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.667 ' CE2' ' NE2' ' A' ' 93' ' ' GLN . 4.5 m-30 -37.5 -81.08 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.777 HD22 ' CG ' ' A' ' 133' ' ' ASP . 1.0 OUTLIER 58.04 100.87 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.693 ' CE1' ' HG2' ' A' ' 137' ' ' GLU . 14.3 t-80 -43.11 158.47 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.693 ' HG2' ' CE1' ' A' ' 136' ' ' HIS . 0.7 OUTLIER -54.78 -13.9 1.21 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 1.004 HD12 ' CE1' ' A' ' 84' ' ' TYR . 11.3 mt -114.09 -5.34 13.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.54 ' HB2' ' N ' ' A' ' 136' ' ' HIS . . . -55.25 133.26 49.25 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.484 ' HA3' ' HG3' ' A' ' 87' ' ' ARG . . . 48.5 17.94 0.85 Allowed Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.736 ' N ' ' HB2' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -124.95 129.57 50.61 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.548 ' C ' ' HD3' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -96.43 131.22 43.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.87 ' CD2' HD13 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -123.31 152.21 41.65 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.625 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 2.2 t -65.78 160.36 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.68 ' CD2' ' CG1' ' A' ' 78' ' ' ILE . 14.3 m-85 -146.85 92.15 2.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.631 ' OG1' HG23 ' A' ' 75' ' ' THR . 89.8 m -86.18 63.35 7.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.7 mt -60.94 174.24 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.508 ' H ' HG22 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -178.65 103.29 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 1.072 HD11 ' HE3' ' A' ' 68' ' ' MET . 0.8 OUTLIER -60.57 140.97 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.621 HD11 ' CG ' ' A' ' 14' ' ' ASP . 2.8 mt -122.75 -47.12 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.605 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 5.1 tt0 -151.52 -164.05 1.9 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.941 HG22 HG22 ' A' ' 11' ' ' ILE . 95.8 t -141.42 141.03 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 1.0 HG12 ' H ' ' A' ' 154' ' ' GLU . 24.1 t -120.96 -135.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.0 ' H ' HG12 ' A' ' 153' ' ' VAL . 1.8 tm-20 . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.627 ' CB ' ' HA ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.859 HG12 ' H ' ' A' ' 6' ' ' ASP . 3.4 t -103.12 -176.69 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.859 ' H ' HG12 ' A' ' 5' ' ' VAL . 52.5 m-20 -152.21 159.8 43.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.515 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 50.9 mtpt -66.93 79.63 0.12 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.55 ' HA2' ' HA3' ' A' ' 53' ' ' GLY . . . 157.78 -1.93 0.12 Allowed Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.478 ' HB ' ' CG1' ' A' ' 5' ' ' VAL . 1.3 t -106.33 130.25 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.835 ' H ' ' HB2' ' A' ' 154' ' ' GLU . 8.7 tttp -84.33 148.88 26.41 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.898 HG22 HG22 ' A' ' 152' ' ' VAL . 4.2 pt -160.27 136.28 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 11.3 ttmt -96.35 105.69 17.79 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.558 HG21 HG22 ' A' ' 147' ' ' ILE . 0.8 OUTLIER -122.44 160.62 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.544 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 0.5 OUTLIER -114.72 98.55 6.92 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.652 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.2 p90 -94.8 161.33 14.21 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 1.058 HD13 HG21 ' A' ' 32' ' ' VAL . 7.0 mt -138.91 80.04 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -67.87 131.03 28.24 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 110.314 -1.115 . . . . 0.0 110.314 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.624 ' HE2' HG22 ' A' ' 24' ' ' VAL . 4.8 mtmt -119.5 -171.67 2.17 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.689 ' C ' ' H ' ' A' ' 21' ' ' SER . 50.2 mt -108.25 168.76 9.08 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -60.07 13.36 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.689 ' H ' ' C ' ' A' ' 19' ' ' LEU . 98.7 p -124.58 -6.63 7.49 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.31 23.97 32.81 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.44 ' HB2' HD12 ' A' ' 19' ' ' LEU . 4.0 m-20 -94.34 117.71 30.52 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.624 HG22 ' HE2' ' A' ' 18' ' ' LYS . 76.1 t -70.81 112.93 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.573 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -100.02 -40.43 7.64 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.573 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 21.3 t0 -134.4 127.53 31.77 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 1.056 ' HB ' HG23 ' A' ' 16' ' ' ILE . 3.7 t -148.13 155.92 42.0 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.544 ' HB2' ' HA ' ' A' ' 14' ' ' ASP . 5.4 m -103.78 -21.39 13.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.674 HG22 ' H ' ' A' ' 32' ' ' VAL . 3.9 mt -83.78 96.71 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.443 ' CA ' ' HB2' ' A' ' 45' ' ' TYR . 3.2 tt0 -43.31 -24.17 0.08 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.458 ' HB3' ' CG2' ' A' ' 29' ' ' ILE . 20.3 tt0 -60.54 -61.39 2.63 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.058 HG21 HD13 ' A' ' 16' ' ' ILE . 95.2 t -53.75 -41.09 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.567 ' HA ' HG13 ' A' ' 38' ' ' ILE . . . -48.29 -40.5 25.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.524 ' CG ' ' HB2' ' A' ' 39' ' ' TYR . 15.7 mtpt -76.54 -25.2 53.86 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -84.45 -13.38 52.23 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.97 -10.41 15.05 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.56 44.22 11.11 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.567 HG13 ' HA ' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -141.46 14.12 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.565 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -44.31 -19.15 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.824 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . 73.71 169.33 0.12 Allowed Pre-proline 0 N--CA 1.45 -0.473 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.824 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 82.2 Cg_endo -72.47 -82.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 124.274 3.316 . . . . 0.0 109.623 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.638 ' H ' ' HG2' ' A' ' 41' ' ' PRO . 10.4 p-10 -103.48 -15.1 15.97 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.501 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -42.91 151.68 0.12 Allowed 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.436 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 50.5 mt-10 -130.8 100.72 5.37 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.495 ' CD2' ' HB2' ' A' ' 33' ' ' ALA . 16.9 m-85 -68.37 91.91 0.41 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.652 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -101.27 177.3 1.55 Allowed Pre-proline 0 N--CA 1.45 -0.452 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.652 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 82.3 Cg_endo -72.4 130.77 16.63 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 124.27 3.313 . . . . 0.0 109.546 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 tp -97.96 118.74 35.22 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.669 ' HB2' ' HE3' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -89.5 98.29 11.69 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.723 ' CE2' HG21 ' A' ' 65' ' ' VAL . 7.9 p90 -96.63 169.81 9.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.573 HG12 ' H ' ' A' ' 53' ' ' GLY . 54.4 t -131.62 102.92 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.678 HG11 ' HG ' ' A' ' 66' ' ' LEU . 2.9 t -44.54 -17.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.573 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -108.55 40.87 2.39 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 2.0 mt-10 -138.26 -23.72 1.0 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.33 8.46 85.15 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.525 ' OE1' ' CB ' ' A' ' 50' ' ' PHE . 0.8 OUTLIER -42.43 -83.64 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.69 HD22 ' CZ ' ' A' ' 61' ' ' PHE . 3.8 mp -76.46 165.52 24.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.705 HG13 HG21 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -56.84 145.25 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.476 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 1.5 mt-30 -43.14 -42.76 4.24 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.518 ' HA3' HD12 ' A' ' 78' ' ' ILE . . . -41.63 -83.85 0.01 OUTLIER Glycine 0 C--N 1.336 0.552 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.712 ' O ' HG22 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -43.93 -46.37 8.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.649 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 3.4 mt-10 -51.22 -29.69 15.0 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.69 ' HA ' HD12 ' A' ' 66' ' ' LEU . 2.8 mt-10 -85.32 -33.88 21.99 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.715 ' HB1' ' HD2' ' A' ' 74' ' ' LYS . . . -67.45 -25.87 66.12 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.723 HG21 ' CE2' ' A' ' 50' ' ' PHE . 5.8 m -88.63 -28.61 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.69 HD12 ' HA ' ' A' ' 63' ' ' GLU . 4.1 mt -48.42 -25.89 1.84 Allowed 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.627 ' HA ' ' CB ' ' A' ' 4' ' ' MET . 0.7 OUTLIER -125.5 47.9 2.13 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.773 ' HE3' HD11 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -140.01 102.41 4.39 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.507 ' N ' ' CG ' ' A' ' 72' ' ' ASP . 1.7 mp0 -61.47 -178.38 0.13 Allowed 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.643 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 1.9 t -71.34 109.36 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.853 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 110.35 -5.04 29.88 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.507 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 0.9 OUTLIER -70.97 173.21 7.76 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.605 ' N ' ' SD ' ' A' ' 68' ' ' MET . 0.2 OUTLIER -150.29 143.04 24.66 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.715 ' HD2' ' HB1' ' A' ' 64' ' ' ALA . 7.0 ttmt -146.05 103.93 3.78 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 1.071 ' CG2' HG23 ' A' ' 146' ' ' THR . 0.2 OUTLIER -103.62 114.33 28.51 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 75' ' ' THR . 54.8 t -157.91 159.25 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.591 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 4.6 ttpm? -86.14 116.73 24.52 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.707 ' CG1' ' CD2' ' A' ' 145' ' ' PHE . 34.9 mm -79.26 118.87 74.86 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.504 ' HA ' ' CG ' ' A' ' 142' ' ' ASP . 84.6 Cg_endo -72.33 138.43 30.17 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 124.381 3.387 . . . . 0.0 109.573 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.915 ' HB1' ' H ' ' A' ' 85' ' ' GLY . . . -44.32 -34.19 1.87 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.43 ' HG2' ' HG2' ' A' ' 79' ' ' PRO . 3.7 pt-20 -55.62 -32.28 62.99 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.413 ' N ' ' HG2' ' A' ' 81' ' ' GLU . 14.7 mtmt -106.48 -0.34 24.1 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.668 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . . . -121.44 -82.31 0.65 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.674 ' CZ ' HD12 ' A' ' 138' ' ' LEU . 3.9 m-85 -107.9 -48.07 3.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.915 ' H ' ' HB1' ' A' ' 80' ' ' ALA . . . 101.35 154.88 26.56 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.674 ' HA ' ' HA2' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -36.61 137.03 0.32 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.613 ' HD3' ' H ' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -39.84 143.77 0.23 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.552 ' H ' HD12 ' A' ' 91' ' ' LEU . 22.6 t30 -79.57 140.05 37.31 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.432 ' HG2' HD12 ' A' ' 92' ' ' ILE . 2.3 tt0 -65.74 -27.46 68.33 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -14.65 61.63 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.046 HD13 ' HA ' ' A' ' 135' ' ' ASN . 52.6 mt -85.15 7.62 21.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.581 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 62.1 mt -87.93 120.25 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.811 ' O ' HD12 ' A' ' 132' ' ' LEU . 8.3 mp0 -116.57 146.65 42.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.39 118.73 31.93 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.989 HG12 HD11 ' A' ' 132' ' ' LEU . 36.3 pt -114.45 152.29 45.97 Favored Pre-proline 0 N--CA 1.449 -0.48 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.599 ' HA ' ' HG3' ' A' ' 129' ' ' GLU . 84.7 Cg_endo -72.34 129.97 15.63 Favored 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 124.292 3.328 . . . . 0.0 109.654 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.881 HH21 ' HG3' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -41.98 -28.98 0.19 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.515 ' HA ' ' HB2' ' A' ' 101' ' ' LYS . 28.7 t70 -65.08 -38.14 89.78 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -50.09 -28.41 7.15 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.54 ' CD2' HD11 ' A' ' 95' ' ' ILE . 1.2 m-85 -107.96 -26.82 10.52 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -60.45 -0.85 0.29 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.497 ' H ' ' C ' ' A' ' 100' ' ' PHE . 5.1 pt-20 -120.14 22.27 11.48 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.415 ' HB1' ' CE1' ' A' ' 105' ' ' PHE . . . -104.47 -137.93 0.36 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -140.85 -3.11 1.28 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.421 ' HB2' ' H ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -123.02 -149.48 0.43 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.421 ' H ' ' HB2' ' A' ' 105' ' ' PHE . 1.0 OUTLIER -158.77 125.0 2.43 Favored Pre-proline 0 N--CA 1.449 -0.511 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.881 ' HG3' HH21 ' A' ' 97' ' ' ARG . 83.7 Cg_endo -72.4 141.97 36.15 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 124.408 3.405 . . . . 0.0 109.559 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 110' ' ' GLY . 0.7 OUTLIER -133.16 159.45 40.1 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.622 ' HB2' HG12 ' A' ' 125' ' ' VAL . 0.9 OUTLIER -64.73 67.71 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 156.44 8.07 0.06 OUTLIER Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' MET . . . . . 1.036 ' CB ' HD13 ' A' ' 122' ' ' ILE . 0.5 OUTLIER -63.43 172.62 1.92 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.561 HG13 ' HB2' ' A' ' 119' ' ' PRO . 76.3 t -156.86 65.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.479 HD13 ' CZ ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -96.68 136.87 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.904 HD23 ' N ' ' A' ' 119' ' ' PRO . 0.3 OUTLIER -103.38 153.03 20.91 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -105.9 2.72 27.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 173.28 -13.65 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.654 ' O ' HD22 ' A' ' 114' ' ' LEU . . . 168.25 -33.65 0.19 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 3.0 mt -94.51 122.19 61.58 Favored Pre-proline 0 N--CA 1.448 -0.535 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.904 ' N ' HD23 ' A' ' 114' ' ' LEU . 81.7 Cg_endo -72.36 169.71 20.99 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 124.313 3.342 . . . . 0.0 109.549 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.682 ' HB1' ' HB3' ' A' ' 132' ' ' LEU . . . -126.79 67.98 1.25 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 6.2 m -41.77 100.26 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 1.036 HD13 ' CB ' ' A' ' 111' ' ' MET . 2.6 mp -71.42 94.8 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 131' ' ' THR . 1.3 p -77.08 -25.43 52.33 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.526 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 0.6 OUTLIER -122.46 129.28 51.86 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 125' ' ' VAL . 7.7 p -115.82 59.56 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.658 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.2 OUTLIER -79.71 119.84 23.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.407 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 0.3 OUTLIER -48.9 -3.66 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.658 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.2 OUTLIER -113.73 -25.07 8.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.849 ' HA ' HH11 ' A' ' 97' ' ' ARG . 1.4 mt-10 -167.76 167.16 13.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.876 HG13 ' CZ ' ' A' ' 97' ' ' ARG . 16.6 m -132.56 146.57 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.602 ' O ' HG22 ' A' ' 131' ' ' THR . 65.9 m -102.71 64.16 0.87 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.989 HD11 HG12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -58.91 151.06 22.6 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.748 ' HB3' HD22 ' A' ' 135' ' ' ASN . 12.5 t0 -124.38 97.15 5.19 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.546 ' N ' ' O ' ' A' ' 91' ' ' LEU . 1.6 m-30 -39.47 -78.84 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 1.046 ' HA ' HD13 ' A' ' 91' ' ' LEU . 0.9 OUTLIER 68.0 -131.93 0.11 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.747 ' ND1' ' N ' ' A' ' 138' ' ' LEU . 8.2 t-80 -172.12 176.51 3.45 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.749 -0.464 . . . . 0.0 109.749 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.742 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -70.56 -6.61 37.71 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.955 HD23 ' HE2' ' A' ' 141' ' ' LYS . 56.9 mt -126.78 -12.02 6.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.538 ' CB ' ' HB3' ' A' ' 135' ' ' ASN . . . -57.21 133.41 55.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.674 ' HA2' ' HA ' ' A' ' 86' ' ' ASN . . . 39.94 39.75 1.5 Allowed Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.955 ' HE2' HD23 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -145.48 145.32 31.03 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.504 ' CG ' ' HA ' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -103.57 124.3 48.53 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 1.091 ' H ' HD23 ' A' ' 143' ' ' LEU . 1.6 pt? -107.61 143.64 35.79 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 2.1 t -60.69 164.9 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.707 ' CD2' ' CG1' ' A' ' 78' ' ' ILE . 9.9 m-85 -153.03 97.03 2.15 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . 1.071 HG23 ' CG2' ' A' ' 75' ' ' THR . 30.7 m -94.71 70.28 3.49 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.652 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -69.0 172.07 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -175.1 103.38 0.09 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.853 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 3.7 mm -58.68 146.93 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.499 HD11 ' OD1' ' A' ' 14' ' ' ASP . 15.6 mt -131.4 -42.33 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.643 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 2.0 mt-10 -153.44 -163.89 1.78 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.898 HG22 HG22 ' A' ' 11' ' ' ILE . 61.4 t -143.87 140.19 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 1.015 HG12 ' H ' ' A' ' 154' ' ' GLU . 32.9 t -119.83 -133.95 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.015 ' H ' HG12 ' A' ' 153' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.652 ' CG1' ' N ' ' A' ' 6' ' ' ASP . 1.6 t . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.652 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 0.4 OUTLIER -151.51 172.82 15.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.578 ' HG3' HG12 ' A' ' 52' ' ' VAL . 31.6 mtpt -61.23 77.05 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.625 ' N ' ' HA3' ' A' ' 53' ' ' GLY . . . 145.21 18.05 0.17 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.481 ' HB ' HG13 ' A' ' 5' ' ' VAL . 1.2 t -128.75 132.64 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.617 ' HE2' HG23 ' A' ' 51' ' ' VAL . 2.8 ttmt -92.5 152.45 19.65 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.853 HG22 HG22 ' A' ' 152' ' ' VAL . 1.3 pt -153.25 126.86 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.441 ' HG3' ' HB3' ' A' ' 49' ' ' GLU . 4.6 mtmt -83.48 87.51 7.0 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.467 HG21 ' CG2' ' A' ' 147' ' ' ILE . 0.8 OUTLIER -112.47 154.21 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.684 ' HB2' HD11 ' A' ' 29' ' ' ILE . 1.1 m-20 -118.37 96.46 5.31 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.604 ' CB ' ' HA ' ' A' ' 147' ' ' ILE . 4.7 p90 -90.36 154.5 19.64 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 1.011 HG21 HG11 ' A' ' 32' ' ' VAL . 1.2 mt -121.3 71.84 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -55.1 128.38 43.67 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.603 ' HE3' ' O ' ' A' ' 16' ' ' ILE . 5.8 mtmt -120.21 -170.51 1.98 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.633 ' C ' ' H ' ' A' ' 21' ' ' SER . 6.0 mt -111.48 164.93 12.43 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -55.19 1.69 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.633 ' H ' ' C ' ' A' ' 19' ' ' LEU . 83.0 p -114.01 -4.61 13.19 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.44 25.72 32.41 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.564 ' HB2' HD12 ' A' ' 19' ' ' LEU . 93.2 m-20 -96.31 119.25 34.46 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.53 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 86.1 t -69.06 112.81 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.465 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 1.7 p90 -100.77 -31.59 11.11 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.465 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 9.8 t0 -143.24 133.95 25.17 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.872 ' HB ' HG23 ' A' ' 16' ' ' ILE . 1.4 t -153.68 136.48 15.32 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.598 ' HB2' ' HA ' ' A' ' 14' ' ' ASP . 2.8 m -83.84 -26.04 29.83 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.684 HD11 ' HB2' ' A' ' 14' ' ' ASP . 3.0 mt -82.73 106.86 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.728 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 2.0 tt0 -50.44 -37.11 36.46 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -49.36 -66.26 0.43 Allowed 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.011 HG11 HG21 ' A' ' 16' ' ' ILE . 5.0 t -47.59 -39.44 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.747 ' HB1' ' HA ' ' A' ' 39' ' ' TYR . . . -46.42 -46.55 18.74 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.55 ' HG2' ' CB ' ' A' ' 39' ' ' TYR . 3.3 mtmt -68.35 -32.01 71.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.58 -12.41 60.75 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.42 ' CB ' ' HB ' ' A' ' 24' ' ' VAL . . . -116.95 -7.08 11.42 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.33 47.47 35.86 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.536 HG13 ' HA ' ' A' ' 33' ' ' ALA . 1.2 pt -140.13 8.61 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.747 ' HA ' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -45.59 -16.37 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.468 ' HB2' ' CA ' ' A' ' 30' ' ' GLU . 56.5 m-85 . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.662 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -111.58 177.87 1.11 Allowed Pre-proline 0 N--CA 1.449 -0.506 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.662 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 84.2 Cg_endo -72.34 125.95 11.21 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 124.295 3.33 . . . . 0.0 109.632 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.481 ' CD2' HD21 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -89.24 112.66 23.76 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -85.32 97.35 9.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.874 ' CE2' HG21 ' A' ' 65' ' ' VAL . 40.3 p90 -99.56 160.63 14.15 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.731 HG12 ' H ' ' A' ' 53' ' ' GLY . 41.0 t -123.37 112.78 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.7 HG11 HD21 ' A' ' 66' ' ' LEU . 32.4 t -54.78 -11.64 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.731 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -114.91 46.55 1.15 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.427 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 4.2 mt-10 -151.9 -8.6 0.21 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.85 12.11 64.2 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.691 HE21 ' HB2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -44.41 -78.56 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.56 ' CD1' ' N ' ' A' ' 57' ' ' LEU . 5.8 mp -84.87 165.7 17.48 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.851 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -56.45 136.88 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.516 ' HA ' ' HB2' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -41.79 -60.06 1.48 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.759 ' CA ' ' HE3' ' A' ' 82' ' ' LYS . . . -30.25 -68.87 0.09 OUTLIER Glycine 0 C--N 1.335 0.522 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.663 ' HE2' HG23 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -57.19 -44.32 83.48 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 59' ' ' GLN . 4.1 mt-10 -55.34 -23.68 25.19 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.909 ' HA ' HD12 ' A' ' 66' ' ' LEU . 12.0 mt-10 -87.97 -39.06 15.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.816 ' HB1' ' HD2' ' A' ' 74' ' ' LYS . . . -62.22 -13.42 27.67 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.874 HG21 ' CE2' ' A' ' 50' ' ' PHE . 4.5 m -106.96 -26.55 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.909 HD12 ' HA ' ' A' ' 63' ' ' GLU . 2.2 mt -47.55 -31.53 4.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -118.12 49.66 1.24 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.963 ' HE2' HD11 ' A' ' 149' ' ' ILE . 2.5 mtp -138.02 118.49 13.83 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -69.2 -173.44 0.53 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.651 HG22 HG23 ' A' ' 152' ' ' VAL . 3.1 t -80.92 106.27 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.653 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 118.01 -5.56 15.83 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.525 ' CB ' ' HG2' ' A' ' 68' ' ' MET . 0.6 OUTLIER -71.03 170.49 12.72 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.25 126.18 9.07 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.816 ' HD2' ' HB1' ' A' ' 64' ' ' ALA . 19.1 ttmm -131.64 95.71 3.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.626 ' OG1' HG23 ' A' ' 146' ' ' THR . 91.6 m -88.76 77.81 7.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 3.6 t -111.77 164.97 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 2.5 ttpt -104.81 116.21 31.62 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.639 HD13 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -79.06 134.88 59.04 Favored Pre-proline 0 N--CA 1.449 -0.521 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.512 ' C ' ' H ' ' A' ' 81' ' ' GLU . 84.1 Cg_endo -72.44 138.77 30.48 Favored 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 124.28 3.32 . . . . 0.0 109.633 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.734 ' HB2' ' N ' ' A' ' 141' ' ' LYS . . . -49.59 -10.66 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.595 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 1.0 OUTLIER -80.23 -39.03 29.85 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.759 ' HE3' ' CA ' ' A' ' 60' ' ' GLY . 2.0 mtpp -86.78 -32.46 20.35 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.625 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . . . -72.46 -93.81 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.442 ' N ' ' HD1' ' A' ' 84' ' ' TYR . 1.7 m-85 -97.87 18.54 15.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.595 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 41.64 83.93 0.01 OUTLIER Glycine 0 C--N 1.336 0.537 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.655 ' N ' ' ND2' ' A' ' 86' ' ' ASN . 0.0 OUTLIER 46.72 -164.84 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.531 ' HD2' ' CG ' ' A' ' 135' ' ' ASN . 0.9 OUTLIER -90.59 154.44 19.59 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.835 ' CB ' HD12 ' A' ' 91' ' ' LEU . 1.3 t30 -91.41 153.61 19.75 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -90.09 -25.77 20.58 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.74 1.58 16.78 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.87 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 19.9 mt -104.5 5.47 34.06 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.606 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 52.3 mt -82.96 107.94 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.789 HE22 ' HB2' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -100.13 165.56 11.45 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.912 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -147.0 99.26 3.15 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.007 HG12 HD11 ' A' ' 132' ' ' LEU . 20.7 pt -96.47 155.19 38.2 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.55 ' O ' ' N ' ' A' ' 99' ' ' ALA . 83.7 Cg_endo -72.34 137.68 28.76 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 124.311 3.341 . . . . 0.0 109.598 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.867 HH21 ' HD2' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -41.64 -34.81 0.65 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.602 ' HA ' ' CB ' ' A' ' 101' ' ' LYS . 6.3 t70 -63.17 -37.06 85.71 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -45.87 -16.39 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.545 ' CD1' ' HB3' ' A' ' 105' ' ' PHE . 2.1 m-85 -137.52 -24.09 1.07 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.602 ' CB ' ' HA ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -41.57 -41.07 2.05 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -90.99 43.77 1.16 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.541 ' C ' ' H ' ' A' ' 105' ' ' PHE . . . -174.94 127.89 0.29 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.487 ' C ' ' N ' ' A' ' 106' ' ' GLU . 2.7 p30 -49.01 -9.28 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.866 ' CE1' HD12 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -47.04 -14.85 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.684 ' C ' ' O ' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -4.32 99.85 0.03 OUTLIER Pre-proline 0 N--CA 1.45 -0.452 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.917 ' HG2' HG11 ' A' ' 130' ' ' VAL . 84.1 Cg_endo -72.4 151.64 53.99 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 124.287 3.325 . . . . 0.0 109.602 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 110' ' ' GLY . 2.9 mt-10 -132.67 156.59 46.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.555 ' HB2' HG12 ' A' ' 125' ' ' VAL . 1.1 tt0 -65.81 66.98 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.8 10.02 0.08 OUTLIER Glycine 0 C--N 1.335 0.509 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.828 ' CB ' HD13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -69.97 170.67 10.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.508 HG13 ' HB2' ' A' ' 119' ' ' PRO . 60.9 t -156.23 73.94 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.866 HD12 ' CE1' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -105.46 135.48 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.626 HD23 ' CD ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -105.04 161.55 14.12 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -108.51 5.23 24.99 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.44 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 0.9 OUTLIER 166.29 -11.09 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.72 -43.04 0.21 Allowed Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.451 ' HA ' ' HD2' ' A' ' 119' ' ' PRO . 3.6 mt -82.51 112.46 36.99 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.626 ' CD ' HD23 ' A' ' 114' ' ' LEU . 83.5 Cg_endo -72.31 165.59 32.21 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 124.322 3.348 . . . . 0.0 109.588 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.863 ' HB1' ' HB3' ' A' ' 132' ' ' LEU . . . -126.91 90.87 3.23 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 6.0 m -62.55 95.54 0.07 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.828 HD13 ' CB ' ' A' ' 111' ' ' MET . 2.6 mp -68.98 89.98 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 121' ' ' THR . 30.7 p -80.1 -17.74 51.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.712 ' HB3' ' H ' ' A' ' 131' ' ' THR . 0.8 OUTLIER -119.99 130.85 54.94 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.707 ' HA ' HG12 ' A' ' 130' ' ' VAL . 7.9 p -124.26 52.92 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.68 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.2 OUTLIER -79.07 126.49 30.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.539 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.3 OUTLIER -52.12 0.06 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.68 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -111.7 -21.14 11.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.6 OUTLIER -178.84 167.02 1.69 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.917 HG11 ' HG2' ' A' ' 107' ' ' PRO . 19.7 m -132.62 141.16 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.912 HG23 ' HD2' ' A' ' 94' ' ' LYS . 23.5 m -96.49 83.91 3.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 1.007 HD11 HG12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -78.93 97.08 5.89 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.848 ' CG ' HD21 ' A' ' 135' ' ' ASN . 25.5 t0 -71.17 97.52 1.53 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.789 ' HB2' HE22 ' A' ' 93' ' ' GLN . 2.1 m-30 -42.89 -56.91 3.05 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.87 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 13.1 m120 55.98 -118.04 1.18 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.631 ' ND1' ' N ' ' A' ' 138' ' ' LEU . 24.1 t-80 -175.19 174.16 2.46 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.603 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 4.8 tp10 -65.84 -43.9 87.12 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.823 HD22 ' HE2' ' A' ' 141' ' ' LYS . 25.4 mt -97.46 10.79 38.82 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.596 ' HB2' ' HB3' ' A' ' 136' ' ' HIS . . . -62.52 133.76 55.41 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 86' ' ' ASN . . . 41.73 36.56 1.73 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 110.234 -1.147 . . . . 0.0 110.234 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.823 ' HE2' HD22 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -146.6 144.04 29.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.505 ' C ' ' HD2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -95.71 143.12 27.24 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.838 HD11 ' CZ ' ' A' ' 145' ' ' PHE . 0.4 OUTLIER -130.67 154.06 48.31 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.601 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 0.5 OUTLIER -73.71 168.46 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.838 ' CZ ' HD11 ' A' ' 143' ' ' LEU . 26.8 m-85 -154.97 90.24 1.28 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.626 HG23 ' OG1' ' A' ' 75' ' ' THR . 96.0 m -81.6 58.8 3.87 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.663 HG23 ' HE2' ' A' ' 61' ' ' PHE . 3.2 mt -53.31 175.09 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.584 ' H ' HG22 ' A' ' 147' ' ' ILE . 3.2 tmtt? -177.59 96.64 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.963 HD11 ' HE2' ' A' ' 68' ' ' MET . 1.4 mm -62.21 134.22 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.408 HG13 ' HA ' ' A' ' 13' ' ' VAL . 8.9 mt -122.12 -26.51 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.591 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 2.1 tt0 -162.74 -175.41 4.42 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.853 HG22 HG22 ' A' ' 11' ' ' ILE . 73.8 t -140.27 137.45 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.435 ' C ' ' HB3' ' A' ' 10' ' ' LYS . 2.3 t . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.902 ' CG2' HD13 ' A' ' 11' ' ' ILE . 9.2 t . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 109.767 -0.456 . . . . 0.0 109.767 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 8' ' ' GLY . 19.4 m-20 -146.78 164.75 31.78 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.524 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 17.3 ptmt -63.44 70.18 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.664 ' N ' ' HA3' ' A' ' 53' ' ' GLY . . . 155.19 16.63 0.05 OUTLIER Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.536 ' HB ' HG13 ' A' ' 5' ' ' VAL . 2.5 t -126.65 136.33 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.842 ' CA ' HG22 ' A' ' 51' ' ' VAL . 2.7 tttt -88.27 158.27 18.52 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.902 HD13 ' CG2' ' A' ' 5' ' ' VAL . 1.8 pt -166.23 133.49 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.744 ' HE2' HG22 ' A' ' 153' ' ' VAL . 18.3 mtmt -87.18 85.12 7.18 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.719 HG11 HD12 ' A' ' 149' ' ' ILE . 0.9 OUTLIER -122.8 158.75 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.449 ' O ' ' CG2' ' A' ' 147' ' ' ILE . 10.9 m-20 -114.55 -160.18 0.72 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.5 p90 -179.44 155.87 0.7 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.991 HG21 HG11 ' A' ' 32' ' ' VAL . 1.3 mt -127.39 73.21 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -54.68 134.02 47.01 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.579 ' HG2' ' N ' ' A' ' 24' ' ' VAL . 8.1 mttt -123.92 -162.75 1.08 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.63 ' C ' ' H ' ' A' ' 21' ' ' SER . 39.9 mt -118.28 165.65 13.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -55.02 0.97 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.63 ' H ' ' C ' ' A' ' 19' ' ' LEU . 53.5 p -114.85 1.38 14.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.9 28.53 50.12 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.221 -1.151 . . . . 0.0 110.221 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.453 ' C ' ' HG2' ' A' ' 18' ' ' LYS . 98.1 m-20 -99.85 121.97 42.11 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.579 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 76.0 t -66.18 134.71 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.532 ' CE1' ' HB2' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -128.07 -28.87 2.59 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.532 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 11.3 t0 -145.68 132.17 19.75 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.966 ' HB ' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -152.26 126.67 9.34 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 73.0 m -86.49 14.13 7.28 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.9 mt -113.11 116.85 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 1.1 tt0 -54.01 -41.6 68.15 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -52.54 -70.78 0.08 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.991 HG11 HG21 ' A' ' 16' ' ' ILE . 67.5 t -48.48 -41.44 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.734 ' HB1' ' HA ' ' A' ' 39' ' ' TYR . . . -50.05 -38.34 37.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.522 ' CG ' ' HB2' ' A' ' 39' ' ' TYR . 22.0 mtpt -79.54 -21.4 45.22 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -87.21 -10.88 51.43 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.4 -10.66 12.61 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.68 43.57 10.05 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.548 HG13 ' HA ' ' A' ' 33' ' ' ALA . 0.4 OUTLIER -141.85 16.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.734 ' HA ' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -47.62 -13.25 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.519 ' CD2' ' HB2' ' A' ' 33' ' ' ALA . 2.2 m-85 . . . . . 0 N--CA 1.449 -0.502 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.717 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -135.61 -180.0 1.22 Allowed Pre-proline 0 N--CA 1.448 -0.546 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.717 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 82.3 Cg_endo -72.45 127.83 12.96 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 124.293 3.329 . . . . 0.0 109.573 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.8 HD23 ' HD2' ' A' ' 50' ' ' PHE . 2.6 tp -82.68 94.71 7.63 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.711 ' CD ' HG21 ' A' ' 153' ' ' VAL . 43.1 tt0 -76.58 97.95 4.53 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.8 ' HD2' HD23 ' A' ' 48' ' ' LEU . 6.4 p90 -118.92 173.86 6.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.905 ' H ' ' NE2' ' A' ' 56' ' ' GLN . 57.8 t -130.7 109.69 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.961 HG11 ' HG ' ' A' ' 66' ' ' LEU . 16.3 t -49.08 -10.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.766 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -108.07 25.74 19.41 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 51' ' ' VAL . 4.0 mt-10 -123.25 -43.16 2.21 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.85 7.59 50.24 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.905 ' NE2' ' H ' ' A' ' 51' ' ' VAL . 1.2 mt-30 -46.0 -50.07 15.36 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.518 HD22 ' N ' ' A' ' 57' ' ' LEU . 1.2 mm? -96.48 175.24 6.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.89 HD13 ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -75.99 150.88 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.472 ' O ' ' C ' ' A' ' 60' ' ' GLY . 10.6 mt-30 -40.11 -65.72 0.37 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.673 ' H ' ' HB3' ' A' ' 82' ' ' LYS . . . -33.46 -82.78 0.01 OUTLIER Glycine 0 C--N 1.335 0.506 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.693 ' CE1' HG11 ' A' ' 65' ' ' VAL . 2.3 t80 -40.88 -53.57 2.88 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.504 ' O ' HG22 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -45.28 -34.04 2.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.634 ' HA ' HD12 ' A' ' 66' ' ' LEU . 5.9 mt-10 -80.73 -31.11 36.13 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . -64.43 -29.84 70.88 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.728 HG21 ' CE1' ' A' ' 50' ' ' PHE . 2.5 m -92.36 -21.46 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.961 ' HG ' HG11 ' A' ' 52' ' ' VAL . 1.1 mt -50.14 -55.67 14.09 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -98.74 55.58 1.06 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.733 ' HE3' ' HA ' ' A' ' 73' ' ' GLU . 9.4 mtp -134.12 123.8 25.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -77.92 167.49 21.41 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.594 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 0.2 OUTLIER -68.62 96.63 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.837 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 118.87 17.76 4.95 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -95.99 -172.08 2.49 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.733 ' HA ' ' HE3' ' A' ' 68' ' ' MET . 2.2 tt0 -162.54 123.11 2.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.512 ' HB2' ' SD ' ' A' ' 68' ' ' MET . 5.2 ttmt -125.82 99.69 6.07 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.531 ' OG1' HG23 ' A' ' 146' ' ' THR . 84.8 m -93.82 76.32 4.23 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.45 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 3.9 t -106.04 156.83 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.616 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 5.4 ttpm? -95.1 113.12 24.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 1.107 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -79.19 130.83 67.95 Favored Pre-proline 0 N--CA 1.45 -0.438 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.504 ' CG ' ' HD3' ' A' ' 82' ' ' LYS . 84.0 Cg_endo -72.35 144.54 41.33 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 124.33 3.354 . . . . 0.0 109.595 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.643 ' O ' ' N ' ' A' ' 85' ' ' GLY . . . -50.99 -11.68 0.1 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.54 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 15.7 tt0 -86.1 -34.65 20.59 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.673 ' HB3' ' H ' ' A' ' 60' ' ' GLY . 1.0 OUTLIER -105.67 41.45 1.38 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.107 ' HB2' ' CG2' ' A' ' 78' ' ' ILE . . . -159.57 -34.27 0.06 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.681 ' CD2' ' CB ' ' A' ' 138' ' ' LEU . 74.2 m-85 -158.89 8.6 0.12 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.643 ' N ' ' O ' ' A' ' 80' ' ' ALA . . . 72.49 143.5 0.49 Allowed Glycine 0 C--N 1.336 0.557 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.903 ' ND2' ' H ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -47.82 167.38 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.554 ' HG2' ' HA3' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -41.4 139.96 0.97 Allowed 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.951 ' CB ' HD12 ' A' ' 91' ' ' LEU . 1.9 t30 -93.13 153.23 18.78 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.508 ' C ' ' H ' ' A' ' 91' ' ' LEU . 48.7 mt-10 -86.49 -39.18 16.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.48 11.86 0.22 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.951 HD12 ' CB ' ' A' ' 88' ' ' ASN . 54.5 mt -118.57 5.73 11.67 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 51.1 mt -84.75 114.05 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.758 HE22 ' HB2' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -106.22 166.3 10.62 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.793 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -146.39 96.81 2.83 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.657 HD11 ' CD1' ' A' ' 100' ' ' PHE . 3.7 pt -96.06 157.69 35.34 Favored Pre-proline 0 N--CA 1.449 -0.505 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.555 ' O ' ' N ' ' A' ' 99' ' ' ALA . 83.4 Cg_endo -72.45 139.96 32.48 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 124.296 3.331 . . . . 0.0 109.576 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.841 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -43.81 -20.65 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.572 ' C ' ' H ' ' A' ' 100' ' ' PHE . 3.3 m-20 -78.17 -35.46 48.76 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.555 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -50.56 -6.99 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.657 ' CD1' HD11 ' A' ' 95' ' ' ILE . 2.3 m-85 -131.46 -26.54 2.05 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.498 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 0.9 OUTLIER -63.39 -15.15 56.7 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.29 6.14 49.59 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.552 ' HB1' ' CZ ' ' A' ' 105' ' ' PHE . . . -100.61 -137.51 0.32 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.72 18.15 1.47 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.552 ' CZ ' ' HB1' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -133.13 -144.07 0.23 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.506 ' H ' ' HB2' ' A' ' 105' ' ' PHE . 0.4 OUTLIER -171.21 126.65 0.63 Allowed Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.892 ' CG ' HG11 ' A' ' 130' ' ' VAL . 82.3 Cg_endo -72.33 131.83 18.34 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 124.321 3.348 . . . . 0.0 109.579 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 110' ' ' GLY . 2.1 mm-40 -118.83 157.62 27.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -67.19 66.1 0.07 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.89 12.25 0.07 OUTLIER Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.797 ' CB ' HD13 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -68.55 171.34 7.67 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.543 ' O ' HG12 ' A' ' 112' ' ' VAL . 96.4 t -155.57 65.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.34 136.76 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.863 HD23 ' CD ' ' A' ' 119' ' ' PRO . 0.1 OUTLIER -104.58 172.81 6.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -119.71 -1.62 10.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 172.46 3.17 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 152.65 -32.34 0.83 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 18.2 mm -94.4 116.03 65.94 Favored Pre-proline 0 N--CA 1.449 -0.485 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.863 ' CD ' HD23 ' A' ' 114' ' ' LEU . 81.9 Cg_endo -72.42 171.8 16.3 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 124.333 3.356 . . . . 0.0 109.582 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.862 ' HB1' ' HB3' ' A' ' 132' ' ' LEU . . . -132.13 75.5 1.64 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 3.7 m -49.13 97.83 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.797 HD13 ' CB ' ' A' ' 111' ' ' MET . 1.8 mp -71.14 95.6 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.498 HG22 HG22 ' A' ' 121' ' ' THR . 0.9 OUTLIER -82.06 -18.94 41.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.726 ' HB3' ' H ' ' A' ' 131' ' ' THR . 1.7 tp10 -121.9 130.88 53.7 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 125' ' ' VAL . 15.0 p -122.02 50.89 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.657 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -78.62 126.03 30.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.537 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.9 OUTLIER -53.17 0.18 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.657 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -111.28 -20.21 12.38 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -177.86 164.64 1.94 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.892 HG11 ' CG ' ' A' ' 107' ' ' PRO . 17.4 m -129.57 135.95 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.793 HG23 ' HD2' ' A' ' 94' ' ' LYS . 24.2 m -95.45 87.24 4.71 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.862 ' HB3' ' HB1' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -85.68 122.2 29.44 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.589 ' HA ' ' HA ' ' A' ' 92' ' ' ILE . 15.4 t0 -90.17 94.28 9.7 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.758 ' HB2' HE22 ' A' ' 93' ' ' GLN . 2.4 m-85 -38.33 -42.29 0.7 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.675 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 0.7 OUTLIER 42.04 -112.12 0.18 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.908 ' CG ' ' H ' ' A' ' 137' ' ' GLU . 15.8 t-80 -177.76 -170.4 0.26 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.908 ' H ' ' CG ' ' A' ' 136' ' ' HIS . 1.5 tp10 -73.55 -42.03 62.2 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 1.013 HD12 HD22 ' A' ' 143' ' ' LEU . 2.6 mm? -98.97 -15.64 19.03 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.777 ' HB2' ' HB3' ' A' ' 136' ' ' HIS . . . -58.7 115.69 3.23 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.554 ' HA3' ' HG2' ' A' ' 87' ' ' ARG . . . 71.17 15.57 74.63 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.692 ' HE2' ' CD1' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -134.7 131.94 38.26 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.553 ' C ' ' HD3' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -100.47 130.02 46.5 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 1.026 HD23 ' H ' ' A' ' 143' ' ' LEU . 1.4 pt? -115.98 144.94 43.39 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.616 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 0.2 OUTLIER -68.02 173.96 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.635 ' CD2' HD13 ' A' ' 78' ' ' ILE . 25.5 m-85 -157.44 90.28 1.09 Allowed 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 146' ' ' THR . 85.4 m -81.88 64.35 6.53 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.9 mt -60.3 178.51 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.554 ' H ' HG22 ' A' ' 147' ' ' ILE . 13.7 tttp -178.03 110.59 0.06 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.837 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 4.4 mm -70.84 139.0 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.598 HD12 ' HB3' ' A' ' 47' ' ' PRO . 3.6 mt -118.39 -41.15 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.594 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 2.4 tt0 -158.86 -165.69 1.69 Allowed 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.894 HG22 HG22 ' A' ' 11' ' ' ILE . 97.0 t -136.95 151.7 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.744 HG22 ' HE2' ' A' ' 12' ' ' LYS . 1.8 t . . . . . 0 N--CA 1.449 -0.503 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.644 ' CG1' ' N ' ' A' ' 6' ' ' ASP . 1.5 t . . . . . 0 N--CA 1.448 -0.53 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.644 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 0.5 OUTLIER -138.04 175.83 9.23 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.542 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 16.1 ptmt -67.35 65.65 0.07 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 6' ' ' ASP . . . 165.35 15.32 0.02 OUTLIER Glycine 0 C--N 1.336 0.557 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.588 ' HB ' HG22 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -129.14 132.64 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.8 ' O ' HG23 ' A' ' 11' ' ' ILE . 4.2 ttpm? -87.55 165.03 15.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.033 HG22 HG22 ' A' ' 152' ' ' VAL . 1.1 pt -169.19 134.42 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.664 ' HE2' ' CG2' ' A' ' 153' ' ' VAL . 7.5 mtmt -94.3 91.98 6.98 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.575 HG12 ' HA ' ' A' ' 149' ' ' ILE . 0.8 OUTLIER -116.02 153.95 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.607 ' OD2' HD11 ' A' ' 150' ' ' ILE . 3.6 m-20 -111.41 106.12 14.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.597 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.9 p90 -101.99 159.46 15.35 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 1.107 HG21 HG11 ' A' ' 32' ' ' VAL . 3.5 mt -133.55 73.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -56.9 129.17 48.86 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.596 ' HE3' ' O ' ' A' ' 16' ' ' ILE . 5.9 mttt -116.98 -164.03 0.95 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.623 ' C ' ' H ' ' A' ' 21' ' ' SER . 85.3 mt -118.02 165.87 13.21 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -54.66 0.07 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.623 ' H ' ' C ' ' A' ' 19' ' ' LEU . 84.5 p -112.05 -3.88 14.63 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.62 25.11 43.61 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.458 ' C ' ' HG2' ' A' ' 18' ' ' LYS . 1.6 m-20 -96.6 122.13 39.18 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.528 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 55.8 t -68.49 113.66 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.595 ' CE1' ' HB2' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -104.41 -31.56 9.45 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.595 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 14.4 t0 -140.07 138.94 35.76 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.995 ' HB ' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -158.24 161.24 37.74 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.442 ' HB3' ' OD1' ' A' ' 14' ' ' ASP . 12.9 m -115.73 -11.92 11.58 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.62 HG22 ' H ' ' A' ' 32' ' ' VAL . 3.0 mt -92.77 116.23 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.505 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 2.5 tt0 -51.51 -38.98 56.69 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -48.72 -67.86 0.23 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.107 HG11 HG21 ' A' ' 16' ' ' ILE . 34.7 t -53.93 -38.32 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.743 ' HB1' ' HA ' ' A' ' 39' ' ' TYR . . . -53.16 -43.05 66.74 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.55 ' HG2' ' CB ' ' A' ' 39' ' ' TYR . 3.9 mtmt -68.13 -30.91 70.16 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -80.99 -20.08 42.6 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.41 -11.42 17.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.01 45.75 19.22 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.526 HG13 ' HA ' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -143.12 16.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.743 ' HA ' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -57.97 -14.6 6.69 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.873 ' HE2' HG23 ' A' ' 27' ' ' THR . 1.9 m-85 . . . . . 0 N--CA 1.449 -0.519 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.663 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -82.58 177.48 3.0 Favored Pre-proline 0 N--CA 1.449 -0.502 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.663 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 84.4 Cg_endo -72.43 128.81 14.03 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 124.292 3.328 . . . . 0.0 109.598 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.0 tp -69.41 104.63 2.33 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.514 ' CD ' ' CE ' ' A' ' 10' ' ' LYS . 13.3 tt0 -91.15 100.87 13.63 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.884 ' CZ ' HG21 ' A' ' 65' ' ' VAL . 32.1 p90 -119.78 170.61 9.07 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.841 HG12 ' H ' ' A' ' 53' ' ' GLY . 69.5 t -131.31 113.07 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.928 HG11 ' CG ' ' A' ' 66' ' ' LEU . 4.6 t -50.53 -8.7 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.841 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -117.33 35.35 4.16 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 2.7 mm-40 -124.27 -31.97 3.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.11 5.65 59.4 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.769 HE22 ' HA ' ' A' ' 50' ' ' PHE . 7.9 mt-30 -57.95 -97.36 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.793 HD22 ' H ' ' A' ' 57' ' ' LEU . 1.5 mm? -54.32 157.8 2.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.952 HD13 ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -60.96 149.18 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.459 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 2.1 mt-30 -44.6 -55.24 5.35 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 63' ' ' GLU . . . -39.65 -79.79 0.04 OUTLIER Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.658 ' HE2' HG23 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -43.45 -44.69 5.98 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.413 ' CD ' ' HA ' ' A' ' 52' ' ' VAL . 6.5 mt-10 -55.85 -32.81 63.95 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.778 ' HA ' HD12 ' A' ' 66' ' ' LEU . 7.3 mt-10 -77.86 -29.77 50.57 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.59 ' HB1' ' HD2' ' A' ' 74' ' ' LYS . . . -63.36 -42.37 98.88 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.884 HG21 ' CZ ' ' A' ' 50' ' ' PHE . 4.6 m -84.06 -15.29 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.928 ' CG ' HG11 ' A' ' 52' ' ' VAL . 3.8 mt -63.05 -48.4 78.87 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -102.85 54.83 0.77 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.496 ' SD ' ' HB2' ' A' ' 74' ' ' LYS . 6.1 mtp -131.57 -144.8 0.25 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.479 ' HB2' ' CG ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -155.96 -178.56 7.39 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.606 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 0.5 OUTLIER -90.09 80.12 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.671 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 138.4 11.07 0.9 Allowed Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.479 ' CG ' ' HB2' ' A' ' 69' ' ' GLU . 2.8 m-20 -95.48 -178.39 4.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -153.72 130.47 10.83 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.59 ' HD2' ' HB1' ' A' ' 64' ' ' ALA . 9.6 ttmt -131.69 96.68 4.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.676 ' OG1' HG23 ' A' ' 146' ' ' THR . 80.3 m -95.5 78.77 3.39 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.668 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 4.0 t -111.38 171.25 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.668 ' N ' ' CG1' ' A' ' 76' ' ' VAL . 1.8 ttpt -103.35 114.79 29.36 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.754 HD13 ' CD2' ' A' ' 145' ' ' PHE . 0.3 OUTLIER -79.4 129.33 72.37 Favored Pre-proline 0 N--CA 1.448 -0.554 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.486 ' HG2' ' HG2' ' A' ' 81' ' ' GLU . 83.0 Cg_endo -72.29 141.9 36.44 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 124.346 3.364 . . . . 0.0 109.582 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.579 ' HB2' ' N ' ' A' ' 141' ' ' LYS . . . -54.36 -8.39 0.21 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.622 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 8.3 pt-20 -81.38 -37.4 28.25 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.48 ' HD3' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -87.52 -30.0 20.91 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.639 ' HA ' ' CB ' ' A' ' 58' ' ' ILE . . . -71.52 -94.74 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.593 ' CD1' ' N ' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -106.71 21.64 17.17 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.622 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 46.58 87.67 0.01 OUTLIER Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.645 ' N ' ' ND2' ' A' ' 86' ' ' ASN . 0.0 OUTLIER 39.9 -144.5 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.567 ' HD2' ' HA3' ' A' ' 140' ' ' GLY . 0.1 OUTLIER -91.3 145.1 24.93 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.969 ' CB ' HD12 ' A' ' 91' ' ' LEU . 7.0 t30 -83.79 132.47 34.82 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -66.63 -25.97 66.84 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.62 8.17 15.13 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.983 HD13 ' HA ' ' A' ' 135' ' ' ASN . 34.5 mt -110.19 5.23 21.72 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.606 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 24.6 mt -84.88 108.28 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.703 HE22 ' HB2' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -101.84 152.14 21.24 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.822 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -135.81 91.4 2.7 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.569 HG12 HG23 ' A' ' 130' ' ' VAL . 3.3 pt -86.23 159.04 54.48 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.61 ' HA ' ' HG3' ' A' ' 129' ' ' GLU . 80.7 Cg_endo -72.46 136.18 25.7 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 124.35 3.367 . . . . 0.0 109.551 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.848 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -42.24 -29.53 0.25 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.546 ' HA ' ' CB ' ' A' ' 101' ' ' LYS . 8.4 t70 -70.29 -36.08 74.14 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -51.01 -12.82 0.12 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.569 ' HB3' ' HD3' ' A' ' 107' ' ' PRO . 4.5 m-85 -133.63 -21.03 2.0 Allowed 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.546 ' CB ' ' HA ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -49.84 -9.9 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.512 ' H ' ' C ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -143.32 40.45 1.46 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.651 ' HB1' ' CE1' ' A' ' 105' ' ' PHE . . . -103.25 21.52 15.73 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 71.16 -14.84 0.44 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.651 ' CE1' ' HB1' ' A' ' 103' ' ' ALA . 0.9 OUTLIER -135.87 -148.76 0.31 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.516 ' HG2' ' HD2' ' A' ' 107' ' ' PRO . 1.4 tt0 -160.78 138.04 6.77 Favored Pre-proline 0 N--CA 1.448 -0.552 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.923 ' CG ' HG11 ' A' ' 130' ' ' VAL . 82.9 Cg_endo -72.41 141.02 34.38 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 124.311 3.341 . . . . 0.0 109.61 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 110' ' ' GLY . 20.9 mt-10 -130.06 153.57 48.32 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -63.64 70.06 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.21 5.23 0.12 Allowed Glycine 0 C--N 1.336 0.571 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.859 ' HB3' HD12 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -65.34 165.89 11.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.513 HG23 ' C ' ' A' ' 111' ' ' MET . 52.4 t -156.27 70.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.66 134.93 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.637 HD23 ' CD ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -104.47 170.57 7.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.415 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -116.07 5.23 13.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.415 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 0.5 OUTLIER 167.01 -10.88 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.419 ' O ' HD22 ' A' ' 114' ' ' LEU . . . 169.81 -45.15 0.21 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.446 ' HA ' ' HD2' ' A' ' 119' ' ' PRO . 4.3 mt -80.46 110.97 18.93 Favored Pre-proline 0 N--CA 1.45 -0.465 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.637 ' CD ' HD23 ' A' ' 114' ' ' LEU . 82.7 Cg_endo -72.37 163.94 37.12 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 124.255 3.303 . . . . 0.0 109.628 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.857 ' HB1' ' HB3' ' A' ' 132' ' ' LEU . . . -124.73 94.3 4.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 21.3 m -66.4 97.02 0.39 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.859 HD12 ' HB3' ' A' ' 111' ' ' MET . 5.9 mt -71.75 84.41 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 123' ' ' THR . 0.0 OUTLIER -74.82 -16.94 60.68 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.837 ' HB3' ' H ' ' A' ' 131' ' ' THR . 0.3 OUTLIER -119.23 127.95 53.74 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.606 HG13 ' O ' ' A' ' 125' ' ' VAL . 8.1 p -122.56 49.15 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.689 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -78.05 125.48 29.41 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.678 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.4 OUTLIER -52.82 1.7 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.689 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.1 OUTLIER -112.95 -20.94 11.37 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.61 ' HG3' ' HA ' ' A' ' 96' ' ' PRO . 2.3 mt-10 -174.75 165.67 3.68 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.923 HG11 ' CG ' ' A' ' 107' ' ' PRO . 16.7 m -135.23 130.76 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.837 ' H ' ' HB3' ' A' ' 124' ' ' GLU . 66.1 m -93.79 94.89 8.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.857 ' HB3' ' HB1' ' A' ' 120' ' ' ALA . 0.3 OUTLIER -92.35 103.37 15.82 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.809 ' CG ' HD21 ' A' ' 135' ' ' ASN . 18.9 t0 -74.8 96.87 3.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.703 ' HB2' HE22 ' A' ' 93' ' ' GLN . 2.0 m-30 -41.32 -82.59 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.983 ' HA ' HD13 ' A' ' 91' ' ' LEU . 0.3 OUTLIER 77.74 -127.67 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.689 ' ND1' ' N ' ' A' ' 138' ' ' LEU . 14.1 t-80 -171.49 178.34 3.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.678 ' N ' ' CG ' ' A' ' 136' ' ' HIS . 10.2 tp10 -67.88 -16.47 64.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.875 HD23 ' HE2' ' A' ' 141' ' ' LYS . 16.2 mt -118.14 -16.83 9.72 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.646 ' HB3' ' H ' ' A' ' 136' ' ' HIS . . . -57.57 110.17 0.83 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' A' ' 86' ' ' ASN . . . 79.97 31.99 37.59 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.875 ' HE2' HD23 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -155.26 146.15 22.44 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.549 ' C ' ' HD2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -95.31 135.44 36.91 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.777 HD23 ' N ' ' A' ' 143' ' ' LEU . 0.4 OUTLIER -124.15 149.16 46.59 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.589 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 1.7 t -73.56 166.87 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.754 ' CD2' HD13 ' A' ' 78' ' ' ILE . 25.3 m-85 -151.21 91.64 1.71 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.676 HG23 ' OG1' ' A' ' 75' ' ' THR . 83.9 m -84.48 61.92 6.94 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.658 HG23 ' HE2' ' A' ' 61' ' ' PHE . 1.7 mt -56.21 -179.47 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.6 ' H ' HG22 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -178.33 90.61 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.671 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 1.1 mm -60.51 130.7 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.607 HD11 ' OD2' ' A' ' 14' ' ' ASP . 4.8 mt -113.64 -45.37 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.606 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -153.98 -165.64 2.16 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 1.033 HG22 HG22 ' A' ' 11' ' ' ILE . 88.7 t -138.65 153.3 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.664 ' CG2' ' HE2' ' A' ' 12' ' ' LYS . 1.9 t . . . . . 0 N--CA 1.45 -0.472 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.667 HG21 HD13 ' A' ' 11' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.525 ' H ' HG12 ' A' ' 5' ' ' VAL . 8.5 m-20 -154.87 165.77 35.61 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.599 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 4.9 ptpt -69.94 63.68 0.21 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.43 ' H ' ' H ' ' A' ' 9' ' ' VAL . . . 175.05 3.19 0.03 OUTLIER Glycine 0 C--N 1.335 0.508 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.43 ' H ' ' H ' ' A' ' 8' ' ' GLY . 2.5 t -119.98 140.3 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.663 ' O ' HG13 ' A' ' 152' ' ' VAL . 10.8 tttt -96.68 149.38 21.86 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.682 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 10.8 pt -158.05 140.49 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.61 ' O ' HD12 ' A' ' 150' ' ' ILE . 7.0 ttmt -94.11 99.07 11.42 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.575 ' CG1' ' HA ' ' A' ' 149' ' ' ILE . 1.1 m -124.13 152.37 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 147' ' ' ILE . 16.4 m-20 -95.07 -167.35 1.61 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 0.3 OUTLIER 177.52 148.75 0.15 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.97 HG23 ' HB ' ' A' ' 27' ' ' THR . 4.5 mt -132.25 74.27 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -58.21 134.14 52.49 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.587 ' HG2' ' N ' ' A' ' 24' ' ' VAL . 7.8 mtmt -118.98 -152.99 0.52 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.592 ' C ' ' H ' ' A' ' 21' ' ' SER . 1.5 mt -128.49 166.08 19.47 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -52.67 -3.71 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.592 ' H ' ' C ' ' A' ' 19' ' ' LEU . 52.0 p -113.89 14.25 18.51 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 19' ' ' LEU . . . 65.33 32.03 82.35 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 18' ' ' LYS . 2.3 m-20 -101.6 123.98 46.5 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.587 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 76.7 t -68.98 130.22 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.577 ' CE1' ' HB2' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -124.59 -29.55 3.45 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.577 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 9.3 t0 -145.08 135.78 24.47 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.97 ' HB ' HG23 ' A' ' 16' ' ' ILE . 1.7 t -153.47 144.87 23.16 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 2.5 m -96.96 -4.95 38.99 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.44 ' CG2' HG23 ' A' ' 32' ' ' VAL . 20.6 mt -100.87 103.62 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.594 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 5.5 tt0 -46.72 -38.72 10.33 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -50.03 -66.12 0.45 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.89 HG11 HD13 ' A' ' 16' ' ' ILE . 3.0 t -47.86 -42.41 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.604 ' HA ' HG13 ' A' ' 38' ' ' ILE . . . -49.17 -41.8 37.78 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.601 ' HG2' ' CG ' ' A' ' 39' ' ' TYR . 8.8 mtpt -74.31 -24.86 59.28 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -86.84 -23.76 25.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . -93.83 -27.48 16.41 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.3 16.17 19.2 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.604 HG13 ' HA ' ' A' ' 33' ' ' ALA . 3.5 pt -118.17 31.01 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.601 ' CG ' ' HG2' ' A' ' 34' ' ' LYS . 13.0 t80 -64.69 68.84 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 38' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.475 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.703 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -123.85 179.83 0.98 Allowed Pre-proline 0 N--CA 1.449 -0.495 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.703 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 80.7 Cg_endo -72.44 129.84 15.34 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 124.273 3.316 . . . . 0.0 109.556 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.855 HD12 ' N ' ' A' ' 49' ' ' GLU . 5.3 tp -97.26 135.14 39.61 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.964 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -105.08 107.77 18.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.926 ' HA ' HE22 ' A' ' 56' ' ' GLN . 8.1 p90 -125.49 162.21 25.38 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.937 HG12 ' H ' ' A' ' 53' ' ' GLY . 41.1 t -105.79 123.52 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.692 HG11 ' HG ' ' A' ' 66' ' ' LEU . 8.3 t -58.53 8.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.937 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -147.31 48.74 0.64 Allowed Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.735 ' OE1' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -126.61 -32.76 2.6 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.58 -12.57 54.08 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.926 HE22 ' HA ' ' A' ' 50' ' ' PHE . 27.8 mt-30 -42.06 -78.53 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.676 HD22 ' H ' ' A' ' 57' ' ' LEU . 1.2 mm? -71.5 164.92 24.92 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.814 HD13 ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -65.09 157.71 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.531 HE21 ' HA ' ' A' ' 82' ' ' LYS . 22.1 mt-30 -49.84 -59.29 3.99 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.629 ' H ' ' HB3' ' A' ' 82' ' ' LYS . . . -39.05 -78.31 0.06 OUTLIER Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.81 ' CE1' HD13 ' A' ' 147' ' ' ILE . 0.9 OUTLIER -41.08 -55.18 2.65 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.541 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.0 mt-10 -45.94 -37.05 6.0 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 60' ' ' GLY . 4.8 mt-10 -77.63 -25.45 49.73 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.655 ' HA ' ' HE2' ' A' ' 74' ' ' LYS . . . -67.32 -40.04 85.94 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.642 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 2.1 m -73.5 -32.77 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.692 ' HG ' HG11 ' A' ' 52' ' ' VAL . 2.5 mt -41.31 -51.66 3.59 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.36 52.29 0.84 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.597 ' HE3' HD11 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -140.62 114.05 8.67 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -77.58 168.89 19.24 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.662 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 1.5 t -61.93 113.04 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.842 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 100.52 9.0 48.22 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.95 -176.54 5.22 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.558 ' CA ' ' SD ' ' A' ' 68' ' ' MET . 0.6 OUTLIER -157.44 141.81 16.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.655 ' HE2' ' HA ' ' A' ' 64' ' ' ALA . 12.1 tttp -138.95 95.8 3.01 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.903 ' CG2' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -92.4 93.23 8.49 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.55 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 16.2 t -131.63 164.64 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.598 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 5.6 ttpt -99.48 114.8 27.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.731 HD13 ' CD2' ' A' ' 145' ' ' PHE . 0.3 OUTLIER -78.68 129.95 72.34 Favored Pre-proline 0 N--CA 1.449 -0.492 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.501 ' HG2' ' HG2' ' A' ' 81' ' ' GLU . 84.8 Cg_endo -72.39 138.22 29.61 Favored 'Trans proline' 0 N--CA 1.447 -1.218 0 C-N-CA 124.28 3.32 . . . . 0.0 109.664 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.681 ' HB2' ' C ' ' A' ' 141' ' ' LYS . . . -51.56 -10.62 0.1 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.594 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 20.6 pt-20 -79.0 -38.2 37.27 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.629 ' HB3' ' H ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -84.88 -33.1 22.87 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.649 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . . . -74.12 -100.07 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.616 ' CE1' ' HB2' ' A' ' 138' ' ' LEU . 38.9 m-85 -90.22 17.81 6.68 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.594 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 42.35 85.71 0.01 OUTLIER Glycine 0 C--N 1.335 0.508 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.658 ' N ' ' ND2' ' A' ' 86' ' ' ASN . 0.0 OUTLIER 47.26 -164.85 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.591 ' HD2' ' HA3' ' A' ' 140' ' ' GLY . 0.4 OUTLIER -81.17 146.42 30.52 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.693 ' CB ' HD12 ' A' ' 91' ' ' LEU . 9.7 t30 -89.2 149.98 22.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -85.35 -35.02 21.67 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.3 -9.08 37.42 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.866 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 75.1 mt -94.03 6.04 49.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.61 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 69.1 mt -85.56 113.75 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.749 HE22 ' HB2' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -106.99 150.3 26.63 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.698 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -130.17 97.08 4.34 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.999 HG12 HD11 ' A' ' 132' ' ' LEU . 18.5 pt -93.11 156.7 40.03 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.534 ' O ' ' N ' ' A' ' 99' ' ' ALA . 82.0 Cg_endo -72.43 140.37 33.21 Favored 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 124.33 3.354 . . . . 0.0 109.609 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.818 HH21 ' CD ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -42.72 -32.93 0.65 Allowed 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.473 ' HA ' ' CB ' ' A' ' 101' ' ' LYS . 6.7 t70 -66.81 -36.71 83.0 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -43.92 -21.61 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.493 ' CD2' ' HD3' ' A' ' 107' ' ' PRO . 3.3 m-85 -122.94 -28.82 4.03 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.473 ' CB ' ' HA ' ' A' ' 98' ' ' ASP . 0.8 OUTLIER -56.45 -24.15 43.57 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -104.18 1.91 31.2 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -102.05 19.69 18.02 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 41.63 36.78 0.62 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.3 -150.2 0.44 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.441 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -179.96 102.2 0.18 Allowed Pre-proline 0 N--CA 1.45 -0.475 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.918 ' CG ' HG11 ' A' ' 130' ' ' VAL . 83.6 Cg_endo -72.32 138.52 30.36 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 124.313 3.342 . . . . 0.0 109.592 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 110' ' ' GLY . 16.8 mt-10 -128.9 156.53 43.56 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.71 68.97 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 151.8 10.23 0.09 OUTLIER Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.545 ' HB3' ' CD1' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -68.17 167.7 13.66 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.507 HG23 ' C ' ' A' ' 111' ' ' MET . 62.0 t -156.41 82.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.35 137.13 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.91 HD23 ' N ' ' A' ' 119' ' ' PRO . 0.2 OUTLIER -101.36 156.72 17.28 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -109.65 0.49 19.04 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 176.47 -12.37 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.646 ' O ' HD22 ' A' ' 114' ' ' LEU . . . 166.93 -34.42 0.22 Allowed Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 3.3 mt -94.04 122.41 61.89 Favored Pre-proline 0 N--CA 1.449 -0.483 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.91 ' N ' HD23 ' A' ' 114' ' ' LEU . 84.9 Cg_endo -72.31 170.22 19.71 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 124.311 3.341 . . . . 0.0 109.662 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.883 ' HB1' ' HB3' ' A' ' 132' ' ' LEU . . . -128.58 73.61 1.51 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 28.8 m -50.2 95.36 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.625 ' HA ' ' HA ' ' A' ' 132' ' ' LEU . 1.8 mp -69.74 100.1 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 131' ' ' THR . 0.6 OUTLIER -85.19 -19.11 32.21 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.554 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 0.4 OUTLIER -121.77 131.77 54.25 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.654 HG22 ' O ' ' A' ' 125' ' ' VAL . 7.9 p -122.33 52.99 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.647 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -79.21 126.83 31.27 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.686 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.3 OUTLIER -53.16 0.21 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.647 ' H ' ' C ' ' A' ' 126' ' ' THR . 1.1 p30 -111.58 -21.22 11.85 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -177.85 168.5 2.08 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.918 HG11 ' CG ' ' A' ' 107' ' ' PRO . 29.0 m -132.09 145.42 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.698 HG23 ' HD2' ' A' ' 94' ' ' LYS . 21.4 m -102.47 84.71 2.48 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.999 HD11 HG12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -82.36 119.76 24.56 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.831 ' CG ' HD21 ' A' ' 135' ' ' ASN . 13.8 t0 -90.21 97.89 11.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.749 ' HB2' HE22 ' A' ' 93' ' ' GLN . 2.0 m-30 -41.25 -52.97 3.31 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.866 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 9.3 m120 48.44 -122.39 1.58 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.74 ' ND1' ' N ' ' A' ' 137' ' ' GLU . 24.3 t-80 179.71 174.93 0.8 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.74 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 0.5 OUTLIER -76.05 -8.62 57.4 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.959 HD22 HD22 ' A' ' 143' ' ' LEU . 52.5 mt -119.35 -1.48 10.77 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.497 ' CB ' ' HB3' ' A' ' 135' ' ' ASN . . . -67.71 141.66 56.56 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.591 ' HA3' ' HD2' ' A' ' 87' ' ' ARG . . . 41.95 27.16 0.36 Allowed Glycine 0 C--N 1.336 0.536 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.858 ' HE2' ' CD2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -138.49 146.11 41.62 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.494 ' C ' ' HD2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -99.19 137.39 37.78 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.959 HD22 HD22 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -124.7 152.07 44.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.598 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 2.1 t -73.86 165.72 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.731 ' CD2' HD13 ' A' ' 78' ' ' ILE . 30.9 m-85 -148.6 98.05 2.82 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.903 HG23 ' CG2' ' A' ' 75' ' ' THR . 24.0 m -89.8 57.78 4.0 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.81 HD13 ' CE1' ' A' ' 61' ' ' PHE . 2.3 mt -57.54 -179.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.749 ' H ' HG22 ' A' ' 147' ' ' ILE . 12.4 tttt -179.39 110.68 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.842 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 4.8 mm -67.14 145.29 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.649 HD13 ' HB3' ' A' ' 47' ' ' PRO . 4.1 mt -126.6 -45.86 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.662 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -161.66 -159.89 0.66 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.682 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 42.4 t -128.44 135.59 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.964 HG21 ' HB3' ' A' ' 49' ' ' GLU . 61.9 t . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.595 HG12 HG21 ' A' ' 52' ' ' VAL . 23.2 t . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -132.2 168.06 18.7 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.575 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 10.2 ptpt -72.93 70.32 1.01 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 174.13 -2.9 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.12 122.64 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.832 ' CA ' HG22 ' A' ' 51' ' ' VAL . 1.7 tttt -76.52 166.88 22.79 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.917 HG22 HG22 ' A' ' 152' ' ' VAL . 1.0 OUTLIER -168.65 132.07 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.714 ' HE2' ' CG2' ' A' ' 153' ' ' VAL . 17.4 mtmt -89.82 92.89 9.22 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.675 HG21 ' CG2' ' A' ' 147' ' ' ILE . 0.8 OUTLIER -112.66 152.99 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.606 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 4.4 m-20 -110.55 95.49 5.6 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.1 p90 -92.7 154.4 18.35 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 1.018 HG23 ' HB ' ' A' ' 27' ' ' THR . 6.5 mt -129.36 75.08 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -60.22 132.06 50.23 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.608 ' HE3' ' O ' ' A' ' 16' ' ' ILE . 4.5 mtmt -121.03 -160.77 0.86 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.88 HD12 ' HB2' ' A' ' 23' ' ' ASP . 30.5 mt -119.38 166.15 13.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.426 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 9.8 mt-10 -56.32 2.6 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.627 ' H ' ' C ' ' A' ' 19' ' ' LEU . 52.8 p -117.24 0.3 12.24 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.24 28.0 42.26 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.88 ' HB2' HD12 ' A' ' 19' ' ' LEU . 18.8 m-20 -96.15 119.2 34.21 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.555 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 63.9 t -69.06 114.26 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.556 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 1.6 p90 -103.08 -32.69 9.56 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.556 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 11.6 t0 -146.23 136.55 23.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 1.018 ' HB ' HG23 ' A' ' 16' ' ' ILE . 3.8 t -154.11 149.9 27.6 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.606 ' HB2' ' HA ' ' A' ' 14' ' ' ASP . 27.1 m -97.8 -17.41 19.37 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.821 HG22 ' H ' ' A' ' 32' ' ' VAL . 2.1 mt -85.01 95.15 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.49 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 4.9 tt0 -42.03 -29.59 0.23 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -59.62 -63.52 1.27 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.822 HG11 HG21 ' A' ' 16' ' ' ILE . 59.8 t -51.28 -38.97 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.714 ' HB1' ' HA ' ' A' ' 39' ' ' TYR . . . -48.03 -44.76 31.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.538 ' HG2' ' CB ' ' A' ' 39' ' ' TYR . 11.1 mtmt -71.52 -32.29 68.01 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -74.54 -15.53 60.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -110.23 -6.15 15.12 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.3 46.44 34.04 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.538 HG13 ' HA ' ' A' ' 33' ' ' ALA . 1.3 pt -143.3 11.98 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.714 ' HA ' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -45.39 -18.25 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.686 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.4 OUTLIER -83.44 178.49 2.39 Favored Pre-proline 0 N--CA 1.45 -0.449 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.686 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 83.2 Cg_endo -72.36 125.38 10.69 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 124.337 3.358 . . . . 0.0 109.586 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.0 83.12 0.11 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.58 ' OE2' HG21 ' A' ' 153' ' ' VAL . 40.6 tt0 -77.41 97.19 4.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.869 ' CD2' HD23 ' A' ' 57' ' ' LEU . 5.6 p90 -118.64 167.83 11.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.969 ' H ' ' NE2' ' A' ' 56' ' ' GLN . 21.4 t -128.36 114.44 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.914 HG11 ' HG ' ' A' ' 66' ' ' LEU . 9.1 t -46.99 -14.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.816 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -115.88 39.76 2.63 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.428 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -131.58 -19.7 2.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.23 18.13 79.74 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.969 ' NE2' ' H ' ' A' ' 51' ' ' VAL . 4.9 mt-30 -60.81 -63.12 1.41 Allowed 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.869 HD23 ' CD2' ' A' ' 50' ' ' PHE . 2.0 mm? -87.41 171.23 10.72 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.057 HD13 ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -66.21 155.09 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.522 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 2.3 mt-30 -49.72 -57.09 7.94 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.446 ' H ' ' HB3' ' A' ' 82' ' ' LYS . . . -39.58 -79.68 0.04 OUTLIER Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.667 ' CD1' ' CB ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -41.4 -52.21 3.6 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.727 ' O ' HG22 ' A' ' 65' ' ' VAL . 1.7 mt-10 -46.47 -42.19 15.07 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.875 ' HA ' HD12 ' A' ' 66' ' ' LEU . 4.8 mt-10 -70.17 -32.92 71.09 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.55 -24.85 67.98 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.753 HG21 ' CE2' ' A' ' 50' ' ' PHE . 8.6 m -100.25 -8.58 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.914 ' HG ' HG11 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -66.65 37.29 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.585 ' H ' ' C ' ' A' ' 65' ' ' VAL . 0.3 OUTLIER 166.94 27.77 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.895 ' HE1' HD11 ' A' ' 149' ' ' ILE . 44.0 mtp -109.56 96.02 6.0 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.468 ' N ' ' OD2' ' A' ' 72' ' ' ASP . 0.5 OUTLIER -55.95 -177.09 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.618 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 1.5 t -75.18 108.42 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.842 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 116.07 -12.22 17.2 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 1.0 OUTLIER -65.53 166.37 10.59 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.42 ' HB2' ' HD2' ' A' ' 148' ' ' LYS . 0.0 OUTLIER -151.16 135.85 17.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.51 ' HB2' ' SD ' ' A' ' 68' ' ' MET . 1.4 tttm -142.33 102.33 4.07 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.588 ' OG1' HG23 ' A' ' 146' ' ' THR . 52.1 m -101.9 79.81 1.94 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.661 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 3.5 t -112.49 171.12 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.661 ' N ' ' CG1' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -105.18 114.11 28.1 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.722 HD13 ' CD2' ' A' ' 145' ' ' PHE . 0.5 OUTLIER -79.0 129.8 71.98 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.476 ' HG2' ' HG2' ' A' ' 81' ' ' GLU . 83.4 Cg_endo -72.39 144.37 40.81 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 124.304 3.336 . . . . 0.0 109.607 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.64 ' HB2' ' N ' ' A' ' 141' ' ' LYS . . . -55.85 -9.39 0.56 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.618 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 14.8 pt-20 -81.41 -38.21 26.88 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.446 ' HB3' ' H ' ' A' ' 60' ' ' GLY . 9.3 mtmt -86.94 -31.62 20.57 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.652 ' HA ' ' CB ' ' A' ' 58' ' ' ILE . . . -71.88 -95.88 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.732 ' CE2' ' CE1' ' A' ' 136' ' ' HIS . 2.0 m-85 -98.41 16.91 20.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.618 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 42.36 84.82 0.01 OUTLIER Glycine 0 C--N 1.335 0.509 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.698 ' N ' ' ND2' ' A' ' 86' ' ' ASN . 0.0 OUTLIER 49.01 -171.99 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.932 ' HG3' ' HB1' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -89.26 152.5 21.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.57 ' CB ' ' CD1' ' A' ' 91' ' ' LEU . 2.2 t30 -90.24 100.77 13.53 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.458 ' C ' ' H ' ' A' ' 91' ' ' LEU . 29.9 mt-10 -44.31 -25.36 0.23 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.19 16.68 0.3 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.734 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 17.5 mt -114.11 -4.08 13.18 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 20.6 mt -78.47 114.21 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.557 ' NE2' ' CD1' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -110.33 167.7 10.0 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.641 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -140.2 90.51 2.37 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.915 HG12 HD11 ' A' ' 132' ' ' LEU . 35.8 pt -85.41 154.66 59.71 Favored Pre-proline 0 N--CA 1.449 -0.478 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.56 ' HD2' ' HB2' ' A' ' 99' ' ' ALA . 82.6 Cg_endo -72.36 140.83 34.24 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 124.309 3.34 . . . . 0.0 109.636 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.927 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -41.8 -33.89 0.57 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.471 ' HA ' ' HB2' ' A' ' 101' ' ' LYS . 8.4 m-20 -66.53 -37.03 84.14 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.56 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . . . -43.52 -21.58 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.55 ' C ' ' H ' ' A' ' 102' ' ' GLU . 2.8 m-85 -122.2 -23.24 5.37 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.471 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -70.96 21.9 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.55 ' H ' ' C ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -143.59 -13.09 0.68 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.98 22.31 3.26 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 43.4 33.86 0.67 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.475 ' HD1' ' H ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -123.74 -149.46 0.42 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.475 ' H ' ' HD1' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -173.6 113.03 0.33 Allowed Pre-proline 0 N--CA 1.448 -0.525 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.927 ' CG ' HH21 ' A' ' 97' ' ' ARG . 83.5 Cg_endo -72.38 147.26 46.61 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 124.275 3.316 . . . . 0.0 109.632 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 110' ' ' GLY . 1.3 mm-40 -138.37 151.94 47.96 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.543 ' HB2' HG12 ' A' ' 125' ' ' VAL . 2.5 tm-20 -66.4 66.33 0.05 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.76 9.27 0.08 OUTLIER Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.509 ' CB ' HD12 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -62.87 170.09 2.86 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.678 HG13 ' HB2' ' A' ' 119' ' ' PRO . 61.1 t -155.63 65.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.92 137.31 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.61 HD23 ' CD ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -109.3 146.09 34.88 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.432 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -95.04 4.19 54.02 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.432 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 0.9 OUTLIER 166.64 -12.15 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.48 -37.73 0.2 Allowed Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 134' ' ' PHE . 1.2 mt -85.93 111.72 40.06 Favored Pre-proline 0 N--CA 1.449 -0.484 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.678 ' HB2' HG13 ' A' ' 112' ' ' VAL . 82.7 Cg_endo -72.37 159.56 49.07 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 124.352 3.368 . . . . 0.0 109.579 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.763 ' HB1' ' HB3' ' A' ' 132' ' ' LEU . . . -121.51 84.05 2.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.577 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 3.5 m -53.34 97.52 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.715 ' CG1' HD23 ' A' ' 132' ' ' LEU . 72.3 mt -76.58 91.1 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 131' ' ' THR . 0.2 OUTLIER -77.53 -27.24 51.62 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.861 ' HB3' ' H ' ' A' ' 131' ' ' THR . 0.5 OUTLIER -111.12 132.42 54.29 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.688 HG22 ' O ' ' A' ' 125' ' ' VAL . 7.1 p -129.67 53.55 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.697 ' C ' ' H ' ' A' ' 128' ' ' ASN . 81.4 p -80.1 133.11 36.06 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.583 ' HA ' ' HD3' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -54.58 4.36 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.697 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -112.21 -24.73 9.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -177.22 -178.45 0.79 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.537 HG11 ' CG ' ' A' ' 107' ' ' PRO . 4.2 m -144.57 134.14 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.861 ' H ' ' HB3' ' A' ' 124' ' ' GLU . 17.4 m -95.82 95.26 8.16 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.915 HD11 HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -87.66 166.62 14.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.663 ' CG ' HD21 ' A' ' 135' ' ' ASN . 15.4 t0 -137.39 97.95 3.59 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.557 ' CD1' ' NE2' ' A' ' 93' ' ' GLN . 3.3 m-30 -41.57 -41.48 2.17 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.734 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 7.1 m120 41.47 -121.94 0.51 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.922 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 8.9 t-80 177.01 169.49 0.54 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.576 ' CG ' HD22 ' A' ' 138' ' ' LEU . 3.0 tp10 -58.55 -53.88 53.38 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.92 ' CG ' HD22 ' A' ' 143' ' ' LEU . 2.2 mm? -97.83 20.02 12.78 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.932 ' HB1' ' HG3' ' A' ' 87' ' ' ARG . . . -66.57 134.45 52.37 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.621 ' HA2' ' HA ' ' A' ' 86' ' ' ASN . . . 38.85 30.54 0.11 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.805 ' HE2' ' CD1' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -138.42 144.42 40.16 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.515 ' N ' ' HD3' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -94.04 138.84 31.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.92 HD22 ' CG ' ' A' ' 138' ' ' LEU . 0.5 OUTLIER -129.13 140.47 51.53 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.607 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 7.8 t -66.45 168.25 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.722 ' CD2' HD13 ' A' ' 78' ' ' ILE . 23.2 m-85 -152.79 93.92 1.81 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.656 HG22 ' O ' ' A' ' 146' ' ' THR . 54.9 m -87.97 62.66 6.97 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.675 ' CG2' HG21 ' A' ' 13' ' ' VAL . 1.4 mt -57.58 179.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.529 ' H ' HG22 ' A' ' 147' ' ' ILE . 6.5 tptt 179.3 100.42 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.895 HD11 ' HE1' ' A' ' 68' ' ' MET . 1.0 OUTLIER -63.23 139.24 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.531 HD11 ' OD1' ' A' ' 14' ' ' ASP . 12.6 mt -126.47 -31.5 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.618 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 1.5 mt-10 -166.8 -170.91 1.69 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.917 HG22 HG22 ' A' ' 11' ' ' ILE . 47.2 t -136.95 144.6 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.714 ' CG2' ' HE2' ' A' ' 12' ' ' LYS . 38.8 t . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.105 HG21 HG21 ' A' ' 11' ' ' ILE . 58.7 t . . . . . 0 N--CA 1.448 -0.542 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.593 ' HA ' ' CD2' ' A' ' 66' ' ' LEU . 1.1 m-20 -119.67 173.79 6.8 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.519 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 9.4 ptpt -68.83 68.46 0.16 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.403 ' H ' ' H ' ' A' ' 9' ' ' VAL . . . 168.93 7.03 0.03 OUTLIER Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.021 ' HB ' HG13 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -126.78 134.47 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.719 ' O ' HG23 ' A' ' 11' ' ' ILE . 9.1 tttt -87.73 158.48 18.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.105 HG21 HG21 ' A' ' 5' ' ' VAL . 3.3 pt -162.09 139.46 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.938 ' HE2' HG22 ' A' ' 153' ' ' VAL . 20.0 mtmt -89.91 78.48 6.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.625 HG22 ' CE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -116.83 145.71 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.707 ' OD2' HD11 ' A' ' 150' ' ' ILE . 0.0 OUTLIER -98.29 -160.67 0.82 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 0.3 OUTLIER 178.4 156.72 0.44 Allowed 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.985 HG23 ' HB ' ' A' ' 27' ' ' THR . 4.5 mt -136.68 77.7 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -61.73 133.22 47.08 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.588 ' HE3' ' O ' ' A' ' 16' ' ' ILE . 4.9 mttt -120.42 -157.89 0.73 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.593 ' C ' ' H ' ' A' ' 21' ' ' SER . 1.8 mt -123.05 165.62 16.48 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -53.79 -2.05 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.593 ' H ' ' C ' ' A' ' 19' ' ' LEU . 59.6 p -113.6 9.03 17.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 19' ' ' LEU . . . 70.91 29.73 68.84 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.46 ' C ' ' HG2' ' A' ' 18' ' ' LYS . 4.2 m-20 -98.43 122.75 42.01 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.557 HG13 HG22 ' A' ' 16' ' ' ILE . 35.5 t -67.89 118.34 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -110.87 -27.51 8.8 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -151.95 141.24 21.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.985 ' HB ' HG23 ' A' ' 16' ' ' ILE . 2.5 t -152.89 153.76 33.69 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.586 ' HA ' ' HA ' ' A' ' 45' ' ' TYR . 0.6 OUTLIER -104.35 14.76 29.6 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.518 HG22 ' H ' ' A' ' 32' ' ' VAL . 6.4 mt -124.97 99.17 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.678 ' CG ' ' CE2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -43.12 -35.8 1.46 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -53.71 -65.03 0.64 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.732 HG11 HG21 ' A' ' 16' ' ' ILE . 87.9 t -47.83 -43.66 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.708 ' HB2' ' CE1' ' A' ' 45' ' ' TYR . . . -44.35 -51.75 8.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.527 ' CG ' ' HB2' ' A' ' 39' ' ' TYR . 13.9 mtpt -65.42 -28.07 68.98 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 32' ' ' VAL . 45.8 tt0 -86.08 -13.62 46.76 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.536 ' HB1' ' HB ' ' A' ' 24' ' ' VAL . . . -106.59 -23.38 12.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 99.32 14.87 34.3 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.606 ' CG1' ' HA ' ' A' ' 33' ' ' ALA . 1.6 pt -114.87 31.55 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.582 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 3.6 t80 -64.49 70.02 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 38' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.708 ' CE1' ' HB2' ' A' ' 33' ' ' ALA . 25.9 m-85 . . . . . 0 N--CA 1.449 -0.505 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.668 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER 61.52 178.0 0.04 OUTLIER Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.881 ' HB3' HD12 ' A' ' 150' ' ' ILE . 83.5 Cg_endo -72.37 116.9 4.89 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 124.3 3.333 . . . . 0.0 109.585 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.1 tp -82.49 103.81 12.31 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.734 ' OE1' HG11 ' A' ' 153' ' ' VAL . 36.7 tt0 -83.61 100.52 10.87 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.69 ' CD2' HD21 ' A' ' 57' ' ' LEU . 2.1 p90 -122.9 170.76 9.78 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.974 ' H ' ' NE2' ' A' ' 56' ' ' GLN . 48.9 t -124.82 113.56 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.854 HG11 ' CG ' ' A' ' 66' ' ' LEU . 3.5 t -49.67 -8.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.838 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -121.08 38.2 2.76 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.424 ' HG3' ' HB ' ' A' ' 51' ' ' VAL . 2.1 mt-10 -123.29 -19.65 5.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.36 18.19 62.92 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.974 ' NE2' ' H ' ' A' ' 51' ' ' VAL . 6.2 mt-30 -72.86 -76.83 0.11 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.69 HD21 ' CD2' ' A' ' 50' ' ' PHE . 1.3 mm? -73.17 149.58 42.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.886 HD13 ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -55.68 163.27 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.64 HE21 ' HA ' ' A' ' 82' ' ' LYS . 16.1 mt-30 -53.53 -59.08 5.05 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.826 ' H ' ' HB3' ' A' ' 82' ' ' LYS . . . -41.54 -78.78 0.06 OUTLIER Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.279 -1.129 . . . . 0.0 110.279 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.651 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 1.0 OUTLIER -38.34 -52.37 1.52 Allowed 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -48.59 -51.77 26.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.806 ' HA ' HD12 ' A' ' 66' ' ' LEU . 6.8 mt-10 -58.33 -27.67 64.36 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.651 ' HB3' ' O ' ' A' ' 61' ' ' PHE . . . -63.9 -55.28 23.88 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.554 HG13 HD13 ' A' ' 147' ' ' ILE . 33.9 m -78.84 4.08 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.854 ' CG ' HG11 ' A' ' 52' ' ' VAL . 5.3 mt -84.77 -38.08 20.05 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.07 26.01 11.13 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.988 ' CE ' HD11 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -104.2 -155.11 0.52 Allowed 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.484 ' HB2' ' CG ' ' A' ' 72' ' ' ASP . 0.5 OUTLIER -144.35 -177.38 5.44 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.618 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 1.1 t -90.71 84.36 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.771 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 131.07 12.54 2.09 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.484 ' CG ' ' HB2' ' A' ' 69' ' ' GLU . 1.3 m-20 -100.54 -170.56 1.88 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.2 126.4 6.58 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.469 ' CB ' ' HE2' ' A' ' 68' ' ' MET . 2.3 ttmm -119.63 96.3 5.14 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.537 ' OG1' HG23 ' A' ' 146' ' ' THR . 62.8 m -96.87 83.05 3.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.452 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 3.8 t -119.69 157.75 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 13.7 ttmt -89.87 114.48 26.25 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.692 HD13 ' CD2' ' A' ' 145' ' ' PHE . 0.3 OUTLIER -79.11 130.18 70.36 Favored Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.479 ' O ' ' N ' ' A' ' 81' ' ' GLU . 84.6 Cg_endo -72.34 134.3 22.49 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 124.286 3.324 . . . . 0.0 109.634 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.727 ' HB2' ' N ' ' A' ' 141' ' ' LYS . . . -46.81 -14.56 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.601 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 3.2 tp10 -76.64 -39.3 52.74 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.826 ' HB3' ' H ' ' A' ' 60' ' ' GLY . 14.6 mttt -81.97 -34.13 29.89 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.627 ' HA ' ' CG2' ' A' ' 58' ' ' ILE . . . -73.31 -102.05 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.561 ' CE1' ' HB2' ' A' ' 138' ' ' LEU . 2.8 m-85 -90.7 20.29 4.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 47.38 89.24 0.01 OUTLIER Glycine 0 C--N 1.336 0.535 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.584 ' HA ' ' HA2' ' A' ' 140' ' ' GLY . 0.0 OUTLIER 40.99 -133.94 0.28 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.495 ' H ' ' HB2' ' A' ' 86' ' ' ASN . 0.3 OUTLIER -90.85 149.17 22.06 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.899 ' CB ' HD12 ' A' ' 91' ' ' LEU . 1.7 m120 -87.52 135.18 33.45 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -81.46 -26.55 35.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.96 -4.99 59.13 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.899 HD12 ' CB ' ' A' ' 88' ' ' ASN . 28.2 mt -102.83 13.31 34.7 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.617 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 26.5 mt -82.5 124.09 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.773 HE22 ' HB2' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -115.53 156.2 26.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.724 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -133.32 90.16 2.7 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.65 HG23 HD11 ' A' ' 132' ' ' LEU . 34.4 pt -88.25 154.25 51.62 Favored Pre-proline 0 N--CA 1.449 -0.501 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.512 ' O ' ' N ' ' A' ' 99' ' ' ALA . 81.5 Cg_endo -72.44 141.49 35.14 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 124.275 3.316 . . . . 0.0 109.591 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.924 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -44.11 -30.59 0.78 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.522 ' HA ' ' HB2' ' A' ' 101' ' ' LYS . 5.1 t70 -68.93 -36.18 77.67 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -47.9 -27.76 2.31 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.623 ' CE2' ' HB3' ' A' ' 107' ' ' PRO . 0.6 OUTLIER -99.41 -33.03 10.86 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 1.1 tttm -58.22 -0.35 0.09 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.531 ' H ' ' C ' ' A' ' 100' ' ' PHE . 7.8 mm-40 -117.12 4.65 12.71 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.14 -133.94 0.07 Allowed 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.71 -8.96 1.87 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.422 ' HB2' ' H ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -137.76 -157.73 0.8 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.471 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 1.6 pm0 -125.88 137.78 30.75 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.924 ' CG ' HH21 ' A' ' 97' ' ' ARG . 83.5 Cg_endo -72.3 129.31 14.78 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 124.38 3.387 . . . . 0.0 109.584 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 110' ' ' GLY . 1.7 mm-40 -125.65 150.84 47.25 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.454 ' HA ' HG22 ' A' ' 122' ' ' ILE . 2.5 tm-20 -62.68 71.07 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 151.86 14.72 0.07 OUTLIER Glycine 0 C--N 1.335 0.513 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.907 ' CB ' HD13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -74.41 173.53 10.16 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.531 HG13 ' HB2' ' A' ' 119' ' ' PRO . 61.1 t -156.84 82.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.453 ' C ' ' HA ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -115.31 127.67 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.989 HD23 ' HD3' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -102.32 163.25 12.34 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -112.61 6.97 18.62 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 169.93 -6.33 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 156.34 -21.91 0.49 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.494 ' C ' ' HB3' ' A' ' 114' ' ' LEU . 3.0 mt -102.7 103.15 30.82 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.989 ' HD3' HD23 ' A' ' 114' ' ' LEU . 82.7 Cg_endo -72.4 158.72 50.85 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 124.264 3.309 . . . . 0.0 109.572 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.75 ' HB1' ' HB2' ' A' ' 132' ' ' LEU . . . -115.83 87.05 2.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 32.5 m -55.57 97.98 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.907 HD13 ' CB ' ' A' ' 111' ' ' MET . 1.8 mp -63.45 99.96 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.3 p -86.09 -21.19 27.8 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.779 ' HB3' ' H ' ' A' ' 131' ' ' THR . 1.6 tp10 -128.66 136.1 50.18 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.732 ' HA ' HG12 ' A' ' 130' ' ' VAL . 10.7 p -119.3 56.71 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.915 HG22 HD21 ' A' ' 128' ' ' ASN . 0.1 OUTLIER -78.44 123.97 27.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.512 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.2 OUTLIER -52.01 -2.54 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.915 HD21 HG22 ' A' ' 126' ' ' THR . 0.0 OUTLIER -111.69 -17.87 12.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.3 OUTLIER -179.33 163.33 1.25 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.916 HG11 ' HB2' ' A' ' 107' ' ' PRO . 0.6 OUTLIER -127.48 118.9 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.779 ' H ' ' HB3' ' A' ' 124' ' ' GLU . 20.7 m -82.03 84.95 6.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.75 ' HB2' ' HB1' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -79.7 169.66 17.65 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.617 ' HA ' ' HA ' ' A' ' 92' ' ' ILE . 11.6 t0 -132.29 95.3 3.62 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.773 ' HB2' HE22 ' A' ' 93' ' ' GLN . 2.1 m-30 -37.7 -38.96 0.31 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.752 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 0.8 OUTLIER 38.89 -118.32 0.23 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.759 ' ND1' ' N ' ' A' ' 137' ' ' GLU . 14.1 t-80 177.93 176.88 0.41 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.759 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -73.36 -8.39 55.68 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.931 HD22 HD22 ' A' ' 143' ' ' LEU . 72.0 mt -122.08 -5.63 8.96 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.752 ' HB3' ' HB3' ' A' ' 135' ' ' ASN . . . -68.1 133.66 49.32 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 86' ' ' ASN . . . 55.25 24.45 36.88 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.867 ' HE2' ' CD2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -142.07 145.94 34.89 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.503 ' C ' ' HD2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -98.91 137.61 37.23 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.931 HD22 HD22 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -127.15 152.76 46.92 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 2.0 t -74.36 165.69 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.692 ' CD2' HD13 ' A' ' 78' ' ' ILE . 28.0 m-85 -153.27 94.65 1.85 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.653 HG22 ' O ' ' A' ' 146' ' ' THR . 42.0 m -88.54 67.37 8.49 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.627 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -60.72 -177.81 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.496 ' H ' HG22 ' A' ' 147' ' ' ILE . 10.6 tttt -175.45 108.34 0.1 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 1.03 HD12 ' H ' ' A' ' 149' ' ' ILE . 1.5 mp -75.4 134.11 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.881 HD12 ' HB3' ' A' ' 47' ' ' PRO . 6.9 mt -113.47 -41.61 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.618 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -166.02 -156.31 0.25 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.634 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 18.6 t -131.63 155.1 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.938 HG22 ' HE2' ' A' ' 12' ' ' LYS . 2.6 t . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.63 HG22 HG21 ' A' ' 11' ' ' ILE . 48.8 t . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 8' ' ' GLY . 0.5 OUTLIER -154.49 177.48 11.13 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.547 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 15.7 ptmt -66.32 65.45 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 6' ' ' ASP . . . 156.05 23.78 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.17 125.63 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.564 ' CA ' HG22 ' A' ' 51' ' ' VAL . 2.8 ttpm? -85.22 150.21 24.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.866 HG22 HG22 ' A' ' 152' ' ' VAL . 1.2 pt -154.17 126.9 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.655 ' HE2' HG21 ' A' ' 153' ' ' VAL . 21.0 mtmt -86.77 86.14 7.31 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.596 ' CG1' ' HA ' ' A' ' 149' ' ' ILE . 0.7 OUTLIER -114.93 152.48 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.806 ' CG ' HD11 ' A' ' 150' ' ' ILE . 0.8 OUTLIER -117.49 108.32 15.37 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.631 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.2 p90 -94.32 160.94 14.45 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 1.037 HG23 ' HB ' ' A' ' 27' ' ' THR . 5.1 mt -129.98 75.49 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -59.14 136.64 50.93 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.602 ' HE3' ' O ' ' A' ' 16' ' ' ILE . 6.6 mttt -122.87 -159.6 0.85 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.589 ' C ' ' H ' ' A' ' 21' ' ' SER . 57.8 mt -117.68 165.93 13.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -55.33 0.05 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.589 ' H ' ' C ' ' A' ' 19' ' ' LEU . 56.8 p -114.16 2.11 14.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.32 28.6 52.49 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.456 ' C ' ' HG2' ' A' ' 18' ' ' LYS . 4.1 m-20 -97.81 123.55 41.82 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.577 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 47.4 t -67.87 126.02 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.579 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 1.9 p90 -119.62 -38.85 2.93 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.579 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 8.3 t0 -138.13 135.7 35.99 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 1.037 ' HB ' HG23 ' A' ' 16' ' ' ILE . 3.9 t -152.58 148.75 27.72 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.46 ' HB3' ' HB3' ' A' ' 14' ' ' ASP . 0.6 OUTLIER -91.79 -18.78 23.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.744 HD11 ' CG ' ' A' ' 14' ' ' ASP . 4.6 mt -93.81 121.1 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.596 ' HG3' ' CD1' ' A' ' 45' ' ' TYR . 3.5 tt0 -63.62 -32.02 73.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -51.67 -63.41 1.14 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.913 HG11 HG21 ' A' ' 16' ' ' ILE . 52.0 t -50.58 -42.18 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.67 ' HB1' ' HA ' ' A' ' 39' ' ' TYR . . . -46.11 -42.79 14.16 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.534 ' HG2' ' CB ' ' A' ' 39' ' ' TYR . 11.6 mtmt -71.62 -32.41 67.95 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -74.46 -17.61 60.75 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.5 -7.57 16.52 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.0 43.73 32.67 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.54 HG13 ' HA ' ' A' ' 33' ' ' ALA . 1.8 pt -139.65 11.16 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.67 ' HA ' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -46.95 -21.39 0.21 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.493 ' O ' ' CZ ' ' A' ' 39' ' ' TYR . . . . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.596 ' CD1' ' HG3' ' A' ' 30' ' ' GLU . 2.9 m-85 . . . . . 0 N--CA 1.449 -0.501 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.738 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -114.53 -179.15 0.58 Allowed Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.738 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 82.4 Cg_endo -72.38 122.53 8.4 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 124.283 3.322 . . . . 0.0 109.607 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.9 HD21 HD21 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -75.43 96.0 3.36 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.549 ' HG2' ' CG ' ' A' ' 10' ' ' LYS . 48.0 tt0 -79.31 97.49 6.31 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.831 ' CE2' HG21 ' A' ' 65' ' ' VAL . 39.7 p90 -110.81 170.39 8.13 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.02 ' H ' ' NE2' ' A' ' 56' ' ' GLN . 89.6 t -134.48 104.4 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.558 HG21 HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -44.54 -17.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.628 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -101.24 37.59 3.54 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 51' ' ' VAL . 5.5 mt-10 -141.78 -30.08 0.6 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.1 7.37 77.35 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 1.02 ' NE2' ' H ' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -42.3 -68.89 0.16 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.9 HD21 HD21 ' A' ' 48' ' ' LEU . 2.3 mm? -79.74 160.37 26.25 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.693 HG13 HG21 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -60.48 160.35 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.837 HE21 ' HA ' ' A' ' 82' ' ' LYS . 6.1 mt-30 -48.85 -67.01 0.3 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.952 ' HA3' HD12 ' A' ' 78' ' ' ILE . . . -29.86 -74.37 0.04 OUTLIER Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.61 ' CE2' HG23 ' A' ' 147' ' ' ILE . 1.0 OUTLIER -45.98 -51.72 12.95 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 59' ' ' GLN . 2.9 mt-10 -50.49 -38.63 45.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.602 ' HA ' HD12 ' A' ' 66' ' ' LEU . 18.9 mt-10 -74.63 -25.09 58.99 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.763 ' HB1' ' HB3' ' A' ' 74' ' ' LYS . . . -68.88 -51.7 37.49 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.831 HG21 ' CE2' ' A' ' 50' ' ' PHE . 27.2 m -74.0 -12.71 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.602 HD12 ' HA ' ' A' ' 63' ' ' GLU . 2.5 mt -60.51 106.31 0.53 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 66' ' ' LEU . 1.8 m-20 84.34 33.06 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.511 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 4.8 mtp -123.43 106.29 10.52 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -70.53 -179.63 2.18 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.887 HG22 HG23 ' A' ' 152' ' ' VAL . 7.1 t -60.05 127.4 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 107.43 -32.3 7.29 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.511 ' HB3' ' HG2' ' A' ' 68' ' ' MET . 0.9 OUTLIER -54.07 160.47 1.52 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.52 145.83 21.82 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.763 ' HB3' ' HB1' ' A' ' 64' ' ' ALA . 2.2 tttt -143.78 98.72 3.28 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.745 ' OG1' HG23 ' A' ' 146' ' ' THR . 83.1 m -100.01 83.17 2.66 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 2.9 t -121.62 156.13 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 19.8 ttpt -79.16 114.71 18.32 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.952 HD12 ' HA3' ' A' ' 60' ' ' GLY . 24.5 mm -78.51 123.24 85.65 Favored Pre-proline 0 N--CA 1.449 -0.489 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.656 ' HG3' ' HE3' ' A' ' 82' ' ' LYS . 85.0 Cg_endo -72.29 145.03 42.61 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 124.361 3.374 . . . . 0.0 109.587 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.538 ' O ' ' CA ' ' A' ' 85' ' ' GLY . . . -54.33 -23.74 16.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.527 ' CG ' ' HB2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -69.87 -41.07 75.29 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.837 ' HA ' HE21 ' A' ' 59' ' ' GLN . 17.8 mttt -82.24 -28.79 31.67 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.771 ' HB2' HG21 ' A' ' 78' ' ' ILE . . . -112.75 110.97 21.42 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.639 ' CD2' ' HB3' ' A' ' 138' ' ' LEU . 32.6 m-85 70.91 -9.78 0.81 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 80' ' ' ALA . . . 64.02 156.41 0.15 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.702 ' ND2' ' H ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -41.36 155.4 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.435 ' HD2' ' OD1' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -39.41 131.1 1.68 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.566 ' CB ' HD12 ' A' ' 91' ' ' LEU . 7.7 t30 -81.08 147.73 29.98 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -85.12 -27.49 26.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.88 -0.56 18.9 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.766 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 71.7 mt -98.95 3.46 47.07 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.609 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 42.1 mt -85.77 113.32 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.641 HE22 ' HB2' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -108.2 145.73 33.82 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.618 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -128.3 97.2 4.67 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.019 HG12 HD11 ' A' ' 132' ' ' LEU . 25.2 pt -92.63 153.63 42.4 Favored Pre-proline 0 N--CA 1.45 -0.454 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.559 ' HG2' ' HB2' ' A' ' 99' ' ' ALA . 83.6 Cg_endo -72.44 139.65 31.98 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 124.272 3.314 . . . . 0.0 109.562 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.782 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -44.73 -26.89 0.43 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.548 ' HA ' ' HB2' ' A' ' 101' ' ' LYS . 10.0 t70 -73.73 -34.01 64.58 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.559 ' HB2' ' HG2' ' A' ' 96' ' ' PRO . . . -58.5 -22.28 54.56 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.675 ' CD1' ' CD1' ' A' ' 95' ' ' ILE . 1.8 m-85 -121.42 2.88 10.26 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.548 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 0.2 OUTLIER -53.06 -41.44 64.85 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -118.74 34.68 5.1 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.672 ' HB2' ' HA ' ' A' ' 100' ' ' PHE . . . -81.15 20.06 0.86 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 59.34 -6.75 0.06 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.621 ' H ' ' C ' ' A' ' 103' ' ' ALA . 0.5 OUTLIER -150.63 147.52 27.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.496 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 0.6 OUTLIER -94.83 129.67 35.33 Favored Pre-proline 0 N--CA 1.449 -0.496 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.846 ' CG ' HG11 ' A' ' 130' ' ' VAL . 82.6 Cg_endo -72.36 135.02 23.77 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 124.367 3.378 . . . . 0.0 109.544 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 110' ' ' GLY . 1.2 mt-10 -124.19 156.81 36.12 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.481 ' HB2' HG12 ' A' ' 125' ' ' VAL . 2.8 tm-20 -65.7 67.55 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.65 14.04 0.06 OUTLIER Glycine 0 C--N 1.336 0.537 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.808 ' HB3' HD12 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -69.97 171.27 9.72 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.66 HG13 ' HB2' ' A' ' 119' ' ' PRO . 64.0 t -156.7 70.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.19 135.49 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.882 HD23 ' N ' ' A' ' 119' ' ' PRO . 0.3 OUTLIER -99.2 149.2 23.33 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -103.37 3.48 35.22 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 171.41 -11.09 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.652 ' O ' HD22 ' A' ' 114' ' ' LEU . . . 166.06 -34.88 0.24 Allowed Glycine 0 C--N 1.335 0.492 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 3.0 mt -93.3 121.32 65.51 Favored Pre-proline 0 N--CA 1.448 -0.53 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.882 ' N ' HD23 ' A' ' 114' ' ' LEU . 83.9 Cg_endo -72.39 164.13 36.55 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 124.282 3.321 . . . . 0.0 109.631 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.866 ' HB1' ' HB3' ' A' ' 132' ' ' LEU . . . -123.55 82.94 2.07 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 2.4 m -54.13 94.82 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.808 HD12 ' HB3' ' A' ' 111' ' ' MET . 12.8 mt -70.49 97.3 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.482 HG22 HG22 ' A' ' 121' ' ' THR . 1.3 p -82.68 -24.73 33.56 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.769 ' HG2' HG23 ' A' ' 126' ' ' THR . 1.2 tt0 -111.54 132.38 54.56 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.705 HG22 ' O ' ' A' ' 125' ' ' VAL . 8.1 p -126.22 48.03 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.769 HG23 ' HG2' ' A' ' 124' ' ' GLU . 2.1 p -79.85 129.28 34.35 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.552 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.4 OUTLIER -53.87 2.41 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.682 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -110.79 -22.74 11.41 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -177.88 168.66 2.06 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.846 HG11 ' CG ' ' A' ' 107' ' ' PRO . 22.0 m -132.15 143.56 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.618 HG23 ' HD2' ' A' ' 94' ' ' LYS . 16.3 m -99.75 85.37 3.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 1.019 HD11 HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -82.5 107.72 15.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.609 ' HA ' ' HA ' ' A' ' 92' ' ' ILE . 18.8 t0 -83.86 97.04 8.98 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.641 ' HB2' HE22 ' A' ' 93' ' ' GLN . 2.3 m-85 -42.53 -45.55 4.55 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.766 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 6.7 m120 42.17 -121.76 0.58 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.695 ' ND1' ' N ' ' A' ' 137' ' ' GLU . 21.6 t-80 -179.21 166.87 1.54 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.695 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 0.9 OUTLIER -70.99 -16.07 62.61 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 1.04 HD12 HD22 ' A' ' 143' ' ' LEU . 3.4 mm? -111.26 -23.2 10.97 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.528 ' HB2' ' HB3' ' A' ' 136' ' ' HIS . . . -48.66 144.66 4.18 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 42.45 22.12 0.12 Allowed Glycine 0 C--N 1.336 0.531 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.81 ' HD2' HD13 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -133.09 133.03 42.42 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.566 ' C ' ' HD3' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -99.11 131.56 45.06 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 1.04 HD22 HD12 ' A' ' 138' ' ' LEU . 2.4 pt? -122.57 146.43 47.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.578 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 4.0 t -67.71 163.04 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.737 ' CD1' ' CG1' ' A' ' 78' ' ' ILE . 16.4 m-85 -146.43 85.87 1.66 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.745 HG23 ' OG1' ' A' ' 75' ' ' THR . 95.0 m -83.82 70.81 10.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.631 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 2.1 mt -64.4 179.54 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.631 ' H ' HG22 ' A' ' 147' ' ' ILE . 3.1 tmtt? -177.65 96.49 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.596 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 2.4 mm -60.06 135.01 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.806 HD11 ' CG ' ' A' ' 14' ' ' ASP . 2.3 mt -122.51 -24.62 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -163.11 176.39 10.09 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.887 HG23 HG22 ' A' ' 70' ' ' VAL . 85.7 t -137.69 136.84 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.655 HG21 ' HE2' ' A' ' 12' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.906 HG21 HD13 ' A' ' 11' ' ' ILE . 16.6 t . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.464 ' N ' HG12 ' A' ' 5' ' ' VAL . 7.8 m-20 -143.4 168.83 18.89 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.527 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 11.7 ptmt -66.05 69.59 0.06 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 6' ' ' ASP . . . 162.59 11.3 0.03 OUTLIER Glycine 0 C--N 1.336 0.561 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.827 ' HB ' HG13 ' A' ' 5' ' ' VAL . 1.4 t -119.05 133.96 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.584 ' HG3' HG22 ' A' ' 51' ' ' VAL . 3.6 tttt -86.64 133.39 33.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.999 ' CG2' HG22 ' A' ' 152' ' ' VAL . 9.6 pt -147.03 136.38 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.615 ' CG ' HG23 ' A' ' 153' ' ' VAL . 9.5 mtpt -95.03 91.94 6.6 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.633 HG22 ' CE1' ' A' ' 50' ' ' PHE . 1.1 m -118.35 145.79 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 147' ' ' ILE . 41.3 m-20 -92.19 -166.69 1.6 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.0 OUTLIER -179.81 151.79 0.45 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 1.077 HD13 HG21 ' A' ' 32' ' ' VAL . 3.5 mt -133.22 81.65 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -65.74 138.62 37.91 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.643 ' HE2' HG22 ' A' ' 24' ' ' VAL . 10.4 mttt -125.44 -165.81 1.46 Allowed 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.636 ' C ' ' H ' ' A' ' 21' ' ' SER . 34.1 mt -112.98 166.52 11.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -54.84 0.77 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.636 ' H ' ' C ' ' A' ' 19' ' ' LEU . 54.2 p -112.4 2.54 16.47 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.04 30.51 57.26 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 18' ' ' LYS . 87.3 m-20 -100.87 124.29 46.33 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.643 HG22 ' HE2' ' A' ' 18' ' ' LYS . 82.2 t -71.06 122.83 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.484 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -115.48 -30.13 6.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.484 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 16.7 t0 -143.56 140.23 30.13 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 1.015 ' HB ' HG23 ' A' ' 16' ' ' ILE . 6.1 t -158.72 148.66 19.48 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.4 m -101.78 16.68 25.12 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 29.0 mt -127.91 108.47 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.583 ' HG3' ' CD1' ' A' ' 45' ' ' TYR . 2.8 tt0 -48.81 -35.42 14.45 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -47.4 -64.66 0.72 Allowed 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.077 HG21 HD13 ' A' ' 16' ' ' ILE . 49.5 t -53.81 -40.39 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.596 ' HA ' ' CG1' ' A' ' 38' ' ' ILE . . . -54.68 -38.09 66.55 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.522 ' CG ' ' HB2' ' A' ' 39' ' ' TYR . 7.7 mtpt -78.51 -17.93 55.51 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -96.01 -23.62 16.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . -95.14 -23.71 17.17 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.81 37.58 4.93 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.596 ' CG1' ' HA ' ' A' ' 33' ' ' ALA . 2.1 pt -135.38 17.17 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.522 ' HB2' ' CG ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -43.44 -20.47 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 38' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.658 ' HE2' HG23 ' A' ' 27' ' ' THR . 80.3 m-85 . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.618 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -131.23 174.92 4.13 Favored Pre-proline 0 N--CA 1.449 -0.523 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.618 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 83.8 Cg_endo -72.41 130.84 16.71 Favored 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 124.319 3.346 . . . . 0.0 109.643 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.806 HD21 HD21 ' A' ' 57' ' ' LEU . 1.4 tp -88.63 96.66 10.74 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.611 ' CD ' HG11 ' A' ' 153' ' ' VAL . 23.4 tt0 -79.08 89.73 4.82 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.757 ' CE2' ' CE1' ' A' ' 61' ' ' PHE . 0.7 OUTLIER -108.32 172.8 6.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.676 HG12 ' H ' ' A' ' 53' ' ' GLY . 59.1 t -123.6 107.28 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.85 HG11 ' HG ' ' A' ' 66' ' ' LEU . 2.8 t -50.93 -8.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.676 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -96.98 -25.27 11.53 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.296 -1.121 . . . . 0.0 110.296 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 51' ' ' VAL . 14.6 mt-10 -74.28 -65.32 0.86 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.82 13.84 8.36 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.53 HE21 ' HB2' ' A' ' 56' ' ' GLN . 0.5 OUTLIER -43.47 -67.09 0.31 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.806 HD21 HD21 ' A' ' 48' ' ' LEU . 1.5 mm? -70.67 -171.97 0.57 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.067 HD13 ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -81.68 146.38 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.543 HE21 ' HA ' ' A' ' 82' ' ' LYS . 14.0 mt-30 -43.15 -54.69 4.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.581 ' HA3' HD12 ' A' ' 78' ' ' ILE . . . -39.45 -81.51 0.02 OUTLIER Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.757 ' CE1' ' CE2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -42.53 -49.56 5.37 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.67 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 1.9 mt-10 -49.88 -35.08 22.17 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 60' ' ' GLY . 4.9 mt-10 -78.09 -32.0 50.4 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.473 ' HB1' ' HB3' ' A' ' 74' ' ' LYS . . . -64.47 -25.42 67.99 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.678 HG21 ' CE2' ' A' ' 50' ' ' PHE . 33.5 m -95.02 -20.4 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.85 ' HG ' HG11 ' A' ' 52' ' ' VAL . 1.2 mt -51.07 -60.44 3.1 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -96.33 55.59 1.5 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.471 ' CE ' HD11 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -144.37 127.38 16.47 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.401 ' O ' HG13 ' A' ' 149' ' ' ILE . 0.8 OUTLIER -75.31 -161.77 0.16 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.686 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 0.2 OUTLIER -90.0 115.56 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.868 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 107.0 -6.57 37.26 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 0.9 OUTLIER -68.64 177.81 2.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -154.8 142.59 19.96 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.473 ' HB3' ' HB1' ' A' ' 64' ' ' ALA . 2.4 tttm -139.38 101.98 4.37 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 1.066 ' CG2' HG23 ' A' ' 146' ' ' THR . 0.2 OUTLIER -99.19 93.6 6.04 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.413 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 18.3 t -136.09 156.04 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.673 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 2.5 ttpm? -85.35 116.44 23.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.689 ' CG1' ' CD1' ' A' ' 145' ' ' PHE . 22.2 mm -78.37 126.65 82.82 Favored Pre-proline 0 N--CA 1.448 -0.568 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.502 ' HG2' ' HG2' ' A' ' 81' ' ' GLU . 84.4 Cg_endo -72.32 144.1 40.57 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 124.264 3.31 . . . . 0.0 109.656 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.709 ' HB1' ' O ' ' A' ' 139' ' ' ALA . . . -56.62 -8.57 0.58 Allowed 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.582 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 9.3 pt-20 -81.55 -39.25 24.9 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.574 ' HB3' ' H ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -86.85 -34.73 19.38 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.639 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . . . -67.75 -96.44 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.604 ' CE1' ' HB3' ' A' ' 138' ' ' LEU . 3.1 m-85 -99.29 17.56 19.76 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 42.53 84.56 0.01 OUTLIER Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.666 ' N ' ' ND2' ' A' ' 86' ' ' ASN . 0.0 OUTLIER 47.65 -166.22 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 1.042 ' HE ' ' HB3' ' A' ' 139' ' ' ALA . 3.4 mmt85 -70.47 145.91 50.64 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.64 ' HB2' HD12 ' A' ' 91' ' ' LEU . 0.9 OUTLIER -83.27 143.83 30.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.09 -26.79 20.06 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -74.66 -23.3 58.64 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.64 HD12 ' HB2' ' A' ' 88' ' ' ASN . 85.4 mt -85.34 26.67 0.88 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.601 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 86.5 mt -93.16 116.41 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.825 HE22 ' HB2' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -109.19 154.23 22.67 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.664 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -134.96 99.09 4.19 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.038 HG12 HD11 ' A' ' 132' ' ' LEU . 21.4 pt -95.5 156.02 38.0 Favored Pre-proline 0 N--CA 1.449 -0.483 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 99' ' ' ALA . 83.0 Cg_endo -72.36 139.53 32.01 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 124.283 3.322 . . . . 0.0 109.577 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.82 HH21 ' HG2' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -42.16 -33.94 0.67 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.522 ' HA ' ' HB2' ' A' ' 101' ' ' LYS . 0.9 OUTLIER -65.85 -36.37 83.25 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -43.65 -19.85 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.488 ' N ' ' O ' ' A' ' 98' ' ' ASP . 0.6 OUTLIER -126.49 -30.61 2.83 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 1.2 tmtt? -53.42 -17.46 1.95 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.03 28.36 8.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.469 ' HB1' ' CE1' ' A' ' 105' ' ' PHE . . . -113.03 -139.16 0.38 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.99 -3.31 3.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.469 ' CE1' ' HB1' ' A' ' 103' ' ' ALA . 0.1 OUTLIER -128.13 -148.43 0.38 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.436 ' CD ' HH22 ' A' ' 97' ' ' ARG . 0.0 OUTLIER -162.44 132.93 3.5 Favored Pre-proline 0 N--CA 1.45 -0.448 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.82 ' HG2' HH21 ' A' ' 97' ' ' ARG . 82.3 Cg_endo -72.38 137.39 28.14 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 124.27 3.313 . . . . 0.0 109.591 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.479 ' O ' ' N ' ' A' ' 110' ' ' GLY . 4.0 mt-10 -126.05 154.61 42.77 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.528 ' N ' ' HB ' ' A' ' 125' ' ' VAL . 1.2 tt0 -65.51 67.03 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.91 9.86 0.08 OUTLIER Glycine 0 C--N 1.336 0.539 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.917 ' CB ' HD13 ' A' ' 122' ' ' ILE . 1.4 mmt -66.64 171.38 5.19 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.508 HG23 ' C ' ' A' ' 111' ' ' MET . 60.7 t -156.11 73.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.473 HD13 ' HZ ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -110.29 136.95 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.767 HD23 ' CD ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -106.49 171.07 7.56 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -114.79 -4.29 12.7 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.417 ' H ' ' H ' ' A' ' 117' ' ' GLY . 1.0 OUTLIER 172.33 5.63 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.418 ' O ' HD22 ' A' ' 114' ' ' LEU . . . 153.87 -38.86 0.69 Allowed Glycine 0 C--N 1.335 0.483 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 48.8 mm -87.47 114.65 59.74 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.767 ' CD ' HD23 ' A' ' 114' ' ' LEU . 84.9 Cg_endo -72.38 173.5 13.03 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 124.305 3.337 . . . . 0.0 109.604 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.875 ' HB1' ' HB3' ' A' ' 132' ' ' LEU . . . -134.64 73.14 1.47 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 77.3 m -49.85 96.86 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.917 HD13 ' CB ' ' A' ' 111' ' ' MET . 2.9 mp -69.1 98.73 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.426 HG23 ' H ' ' A' ' 123' ' ' THR . 1.0 OUTLIER -83.76 -21.14 32.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.561 ' HB3' ' H ' ' A' ' 131' ' ' THR . 0.3 OUTLIER -120.16 133.41 55.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.796 ' HA ' HG12 ' A' ' 130' ' ' VAL . 7.2 p -124.76 52.6 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.639 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -79.67 127.81 32.63 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 97' ' ' ARG . 0.5 OUTLIER -53.25 0.63 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.639 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -111.62 -21.67 11.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -177.83 168.43 2.09 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.796 HG12 ' HA ' ' A' ' 125' ' ' VAL . 4.2 m -133.66 141.69 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.664 HG23 ' HD2' ' A' ' 94' ' ' LYS . 17.3 m -98.18 86.27 3.64 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 1.038 HD11 HG12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -82.65 113.32 20.26 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.833 ' CG ' HD21 ' A' ' 135' ' ' ASN . 10.0 t0 -81.96 95.12 7.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.825 ' HB2' HE22 ' A' ' 93' ' ' GLN . 1.6 m-85 -39.88 -50.61 2.46 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.833 HD21 ' CG ' ' A' ' 133' ' ' ASP . 8.6 m120 45.97 -132.89 0.99 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.779 ' ND1' ' N ' ' A' ' 137' ' ' GLU . 23.2 t-80 -167.84 174.21 7.7 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.779 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 8.7 pt-20 -86.06 10.11 15.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.844 ' CD2' ' HE2' ' A' ' 141' ' ' LYS . 63.5 mt -135.01 5.32 3.31 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.042 ' HB3' ' HE ' ' A' ' 87' ' ' ARG . . . -60.58 -111.23 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.858 ' H ' ' NE ' ' A' ' 87' ' ' ARG . . . -65.59 38.65 0.13 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.844 ' HE2' ' CD2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -136.47 143.18 43.71 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.495 ' HB3' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -101.0 129.9 46.91 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.788 HD22 HD22 ' A' ' 138' ' ' LEU . 1.1 pt? -121.07 145.69 47.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.673 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 1.6 t -62.14 163.88 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.689 ' CD1' ' CG1' ' A' ' 78' ' ' ILE . 12.3 m-85 -148.28 102.58 3.36 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 1.066 HG23 ' CG2' ' A' ' 75' ' ' THR . 24.3 m -97.17 60.81 1.7 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.691 HD13 ' CD2' ' A' ' 61' ' ' PHE . 1.1 mt -59.67 177.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.473 ' H ' HG22 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -177.25 113.86 0.09 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.868 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 2.8 mm -69.49 139.98 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.524 HG13 ' HA ' ' A' ' 13' ' ' VAL . 6.7 mt -118.78 -48.12 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.686 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -158.11 -165.39 1.71 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.999 HG22 ' CG2' ' A' ' 11' ' ' ILE . 10.7 t -134.16 137.83 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.629 ' O ' HG12 ' A' ' 153' ' ' VAL . 45.8 t . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.079 HG21 HD13 ' A' ' 11' ' ' ILE . 23.0 t . . . . . 0 N--CA 1.448 -0.529 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' A' ' 8' ' ' GLY . 0.8 OUTLIER -137.76 171.08 14.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.539 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 16.9 ptmt -64.76 70.64 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 6' ' ' ASP . . . 161.61 11.24 0.03 OUTLIER Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.838 ' HB ' HG13 ' A' ' 5' ' ' VAL . 1.7 t -125.17 132.97 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.702 ' O ' HG23 ' A' ' 11' ' ' ILE . 11.6 tttt -88.2 152.94 21.62 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 1.079 HD13 HG21 ' A' ' 5' ' ' VAL . 6.2 pt -160.72 137.96 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 7.7 ttmt -96.12 99.94 11.63 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.607 HG12 ' HA ' ' A' ' 149' ' ' ILE . 1.2 m -119.65 152.62 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.621 ' CG ' HD11 ' A' ' 150' ' ' ILE . 0.5 OUTLIER -115.42 103.01 10.35 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.605 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 9.3 p90 -96.63 151.63 19.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.941 HG21 HG11 ' A' ' 32' ' ' VAL . 1.1 mt -119.81 77.94 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -62.65 130.45 43.07 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.603 ' HE2' HG22 ' A' ' 24' ' ' VAL . 6.9 mtmt -125.56 144.43 50.57 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 21' ' ' SER . 80.2 mt -64.07 170.09 3.88 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.61 50.86 0.07 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 19' ' ' LEU . 94.1 p -161.82 -1.01 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.29 22.34 48.43 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 18' ' ' LYS . 2.2 m-20 -96.71 116.34 28.96 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.603 HG22 ' HE2' ' A' ' 18' ' ' LYS . 54.6 t -68.44 115.07 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.513 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 3.3 p90 -103.84 -37.75 7.31 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.513 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 9.3 t0 -136.04 133.46 37.43 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.9 ' HB ' HG23 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -153.91 131.59 11.49 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.605 ' HB2' ' HA ' ' A' ' 14' ' ' ASP . 3.0 m -79.68 -23.2 42.62 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.487 HG22 ' H ' ' A' ' 32' ' ' VAL . 5.0 mt -84.67 114.93 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.594 ' O ' ' HE3' ' A' ' 34' ' ' LYS . 6.4 tt0 -60.89 -22.02 63.89 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -60.51 -62.46 1.84 Allowed 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.941 HG11 HG21 ' A' ' 16' ' ' ILE . 89.3 t -54.54 -41.0 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.596 ' HA ' HG13 ' A' ' 38' ' ' ILE . . . -48.22 -39.18 20.37 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.594 ' HE3' ' O ' ' A' ' 30' ' ' GLU . 18.0 mttt -77.56 -24.32 49.84 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 32' ' ' VAL . 35.7 tt0 -84.37 -12.98 53.52 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.82 -10.49 14.76 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.83 44.0 10.74 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.596 HG13 ' HA ' ' A' ' 33' ' ' ALA . 1.6 pt -140.06 16.28 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.54 ' HB2' ' CG ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -45.07 -17.51 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . . . . . . 0 N--CA 1.449 -0.508 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.56 ' CD2' ' HB2' ' A' ' 33' ' ' ALA . 9.8 m-85 . . . . . 0 N--CA 1.449 -0.52 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.607 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -117.42 174.78 2.33 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.607 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 81.7 Cg_endo -72.36 124.07 9.63 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 124.312 3.341 . . . . 0.0 109.578 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.581 HD21 HD21 ' A' ' 57' ' ' LEU . 2.8 tp -86.66 125.15 33.66 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.581 ' O ' ' HE2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -91.95 98.69 11.73 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.795 ' CZ ' HG21 ' A' ' 65' ' ' VAL . 10.5 p90 -99.76 170.96 8.19 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.672 HG12 ' H ' ' A' ' 53' ' ' GLY . 57.6 t -135.01 106.13 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.539 ' C ' ' HA ' ' A' ' 7' ' ' LYS . 93.3 t -48.88 -10.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.672 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -117.27 62.3 0.41 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.43 ' H ' ' H ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -167.22 -20.05 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.43 ' H ' ' H ' ' A' ' 54' ' ' GLU . . . 82.38 6.57 88.57 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.701 HE21 ' HB2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -42.05 -78.61 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.673 HD23 ' CB ' ' A' ' 50' ' ' PHE . 3.0 mm? -75.02 -174.2 2.18 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.069 HD13 ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -82.19 144.02 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.895 HE21 ' HA ' ' A' ' 82' ' ' LYS . 3.7 mt-30 -41.83 -51.91 4.14 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.647 ' HA3' HD12 ' A' ' 78' ' ' ILE . . . -42.23 -78.48 0.07 OUTLIER Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.817 ' HB3' HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -47.68 -37.94 13.98 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.555 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 18.3 mt-10 -62.51 -22.78 66.55 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.763 ' HA ' HD12 ' A' ' 66' ' ' LEU . 4.7 mt-10 -88.54 -34.8 17.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.54 -30.39 71.42 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.795 HG21 ' CZ ' ' A' ' 50' ' ' PHE . 29.9 m -86.14 -32.8 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.763 HD12 ' HA ' ' A' ' 63' ' ' GLU . 2.9 mt -41.87 -43.25 2.97 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.36 50.4 0.81 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 1.072 ' HE3' HD11 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -145.07 119.3 9.51 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.443 ' N ' ' OD2' ' A' ' 72' ' ' ASP . 3.2 mp0 -73.74 -168.77 0.62 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.679 HG22 HG23 ' A' ' 152' ' ' VAL . 34.5 t -79.29 113.93 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.774 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 108.99 -3.45 31.72 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.514 ' HB3' ' HG2' ' A' ' 68' ' ' MET . 0.7 OUTLIER -73.13 169.9 16.05 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.515 ' N ' ' SD ' ' A' ' 68' ' ' MET . 1.5 tt0 -150.15 139.16 21.05 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.5 ttmm -147.22 97.99 2.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.631 HG23 ' OG1' ' A' ' 146' ' ' THR . 28.6 m -93.71 90.63 6.66 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.9 t -126.41 145.69 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.625 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 5.6 ttpm? -76.44 115.08 15.85 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.68 ' CG1' ' CD2' ' A' ' 145' ' ' PHE . 37.5 mm -78.31 131.46 68.84 Favored Pre-proline 0 N--CA 1.45 -0.449 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.505 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 84.2 Cg_endo -72.41 139.44 31.73 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 124.35 3.367 . . . . 0.0 109.567 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.736 ' HB2' ' N ' ' A' ' 141' ' ' LYS . . . -52.01 -14.52 0.41 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.558 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 7.5 tt0 -78.85 -37.22 40.98 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.895 ' HA ' HE21 ' A' ' 59' ' ' GLN . 14.1 mttm -85.04 -36.27 21.34 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.656 ' HA ' ' CG2' ' A' ' 58' ' ' ILE . . . -67.55 -92.43 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 1.004 ' CE1' HD12 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -103.72 17.1 24.82 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 65.09 144.09 0.03 OUTLIER Glycine 0 C--N 1.335 0.523 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.7 ' ND2' ' H ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -39.75 150.84 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.484 ' HG3' ' HA3' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -39.37 120.99 1.11 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.662 ' CB ' HD12 ' A' ' 91' ' ' LEU . 7.7 t30 -80.11 147.23 31.48 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.413 ' HA ' ' CD1' ' A' ' 92' ' ' ILE . 1.8 tt0 -73.87 -33.72 64.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -17.51 62.42 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.711 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 13.0 mt -79.11 0.06 29.62 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.608 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 11.6 mt -94.31 118.94 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.615 HE22 ' C ' ' A' ' 91' ' ' LEU . 2.9 mp0 -109.08 171.61 7.33 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.463 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -143.2 81.76 1.73 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.78 HG23 ' CD1' ' A' ' 132' ' ' LEU . 26.4 pt -79.8 155.87 75.35 Favored Pre-proline 0 N--CA 1.449 -0.485 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.625 ' HA ' ' HG3' ' A' ' 129' ' ' GLU . 83.1 Cg_endo -72.37 137.08 27.6 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 124.316 3.344 . . . . 0.0 109.624 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.823 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -42.61 -33.45 0.71 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 100' ' ' PHE . 2.5 m-20 -66.07 -36.88 84.4 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -44.3 -19.68 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.77 ' HZ ' HD13 ' A' ' 113' ' ' ILE . 3.1 m-85 -124.47 -30.32 3.39 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 4.3 tttt -60.63 -19.8 59.02 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.59 18.08 22.91 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -103.85 -137.61 0.35 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.45 -0.57 4.46 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.413 ' HB2' ' H ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -134.89 -149.81 0.36 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.505 ' HG2' ' HD2' ' A' ' 107' ' ' PRO . 1.8 tt0 -161.78 136.31 5.23 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.943 ' CG ' HG11 ' A' ' 130' ' ' VAL . 83.1 Cg_endo -72.41 141.48 35.24 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 124.279 3.319 . . . . 0.0 109.624 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 110' ' ' GLY . 1.0 OUTLIER -130.81 157.58 42.46 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -65.74 66.16 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 152.27 11.64 0.08 OUTLIER Glycine 0 C--N 1.335 0.477 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.905 ' CB ' HD13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -66.24 171.15 4.99 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.743 HG13 ' HB2' ' A' ' 119' ' ' PRO . 60.7 t -156.49 70.87 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.77 HD13 ' HZ ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -99.41 134.99 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.626 HD23 ' CD ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -103.29 144.75 30.94 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -96.02 0.49 51.7 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 170.82 -7.16 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 164.69 -38.82 0.3 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 5.3 mt -87.42 114.71 59.99 Favored Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.743 ' HB2' HG13 ' A' ' 112' ' ' VAL . 82.8 Cg_endo -72.44 156.18 54.63 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 124.246 3.297 . . . . 0.0 109.575 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.766 ' O ' HD12 ' A' ' 122' ' ' ILE . . . -116.37 94.06 4.48 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.56 HG22 ' O ' ' A' ' 121' ' ' THR . 1.3 m -64.84 98.4 0.27 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.905 HD13 ' CB ' ' A' ' 111' ' ' MET . 2.9 mp -70.41 100.13 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.5 p -83.28 -21.89 33.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.839 ' HB3' ' H ' ' A' ' 131' ' ' THR . 0.4 OUTLIER -121.84 131.52 54.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 125' ' ' VAL . 11.3 p -122.29 51.59 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.69 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -78.72 126.26 30.49 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.676 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.3 OUTLIER -53.36 2.84 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.69 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.3 OUTLIER -113.51 -21.96 10.57 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.625 ' HG3' ' HA ' ' A' ' 96' ' ' PRO . 1.4 mt-10 -173.96 168.43 4.19 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.943 HG11 ' CG ' ' A' ' 107' ' ' PRO . 18.1 m -135.07 122.55 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.839 ' H ' ' HB3' ' A' ' 124' ' ' GLU . 9.4 m -88.12 88.28 7.59 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.78 ' CD1' HG23 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -76.66 163.18 27.1 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.748 ' CG ' HD21 ' A' ' 135' ' ' ASN . 31.8 t0 -139.69 95.96 3.0 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.597 ' N ' ' O ' ' A' ' 91' ' ' LEU . 4.5 m-30 -37.5 -81.08 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.748 HD21 ' CG ' ' A' ' 133' ' ' ASP . 0.6 OUTLIER 58.04 100.87 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.693 ' CE1' ' HG2' ' A' ' 137' ' ' GLU . 14.3 t-80 -43.11 158.47 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.693 ' HG2' ' CE1' ' A' ' 136' ' ' HIS . 0.7 OUTLIER -54.78 -13.9 1.21 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 1.004 HD12 ' CE1' ' A' ' 84' ' ' TYR . 11.3 mt -114.09 -5.34 13.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.54 ' HB2' ' N ' ' A' ' 136' ' ' HIS . . . -55.25 133.26 49.25 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.484 ' HA3' ' HG3' ' A' ' 87' ' ' ARG . . . 48.5 17.94 0.85 Allowed Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.736 ' N ' ' HB2' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -124.95 129.57 50.61 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.548 ' C ' ' HD3' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -96.43 131.22 43.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.87 ' CD2' HD13 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -123.31 152.21 41.65 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.625 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 2.2 t -65.78 160.36 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.68 ' CD2' ' CG1' ' A' ' 78' ' ' ILE . 14.3 m-85 -146.85 92.15 2.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.631 ' OG1' HG23 ' A' ' 75' ' ' THR . 89.8 m -86.18 63.35 7.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.7 mt -60.94 174.24 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.508 ' H ' HG22 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -178.65 103.29 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 1.072 HD11 ' HE3' ' A' ' 68' ' ' MET . 0.8 OUTLIER -60.57 140.97 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.621 HD11 ' CG ' ' A' ' 14' ' ' ASP . 2.8 mt -122.75 -47.12 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.605 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 5.1 tt0 -151.52 -164.05 1.9 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.941 HG22 HG22 ' A' ' 11' ' ' ILE . 95.8 t -141.42 141.03 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.447 ' HB ' ' HB3' ' A' ' 10' ' ' LYS . 24.1 t . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.859 HG12 ' H ' ' A' ' 6' ' ' ASP . 3.4 t . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.859 ' H ' HG12 ' A' ' 5' ' ' VAL . 52.5 m-20 -152.21 159.8 43.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.515 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 50.9 mtpt -66.93 79.63 0.12 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.55 ' HA2' ' HA3' ' A' ' 53' ' ' GLY . . . 157.78 -1.93 0.12 Allowed Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.478 ' HB ' ' CG1' ' A' ' 5' ' ' VAL . 1.3 t -106.33 130.25 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.672 ' O ' HG23 ' A' ' 11' ' ' ILE . 8.7 tttp -84.33 148.88 26.41 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.898 HG22 HG22 ' A' ' 152' ' ' VAL . 4.2 pt -160.27 136.28 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 11.3 ttmt -96.35 105.69 17.79 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.558 HG21 HG22 ' A' ' 147' ' ' ILE . 0.8 OUTLIER -122.44 160.62 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.544 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 0.5 OUTLIER -114.72 98.55 6.92 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.652 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.2 p90 -94.8 161.33 14.21 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 1.058 HD13 HG21 ' A' ' 32' ' ' VAL . 7.0 mt -138.91 80.04 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -67.87 131.03 28.24 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 110.314 -1.115 . . . . 0.0 110.314 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.624 ' HE2' HG22 ' A' ' 24' ' ' VAL . 4.8 mtmt -119.5 -171.67 2.17 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.689 ' C ' ' H ' ' A' ' 21' ' ' SER . 50.2 mt -108.25 168.76 9.08 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -60.07 13.36 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.689 ' H ' ' C ' ' A' ' 19' ' ' LEU . 98.7 p -124.58 -6.63 7.49 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.31 23.97 32.81 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.44 ' HB2' HD12 ' A' ' 19' ' ' LEU . 4.0 m-20 -94.34 117.71 30.52 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.624 HG22 ' HE2' ' A' ' 18' ' ' LYS . 76.1 t -70.81 112.93 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.573 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -100.02 -40.43 7.64 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.573 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 21.3 t0 -134.4 127.53 31.77 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 1.056 ' HB ' HG23 ' A' ' 16' ' ' ILE . 3.7 t -148.13 155.92 42.0 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.544 ' HB2' ' HA ' ' A' ' 14' ' ' ASP . 5.4 m -103.78 -21.39 13.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.674 HG22 ' H ' ' A' ' 32' ' ' VAL . 3.9 mt -83.78 96.71 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.443 ' CA ' ' HB2' ' A' ' 45' ' ' TYR . 3.2 tt0 -43.31 -24.17 0.08 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.458 ' HB3' ' CG2' ' A' ' 29' ' ' ILE . 20.3 tt0 -60.54 -61.39 2.63 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.058 HG21 HD13 ' A' ' 16' ' ' ILE . 95.2 t -53.75 -41.09 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.567 ' HA ' HG13 ' A' ' 38' ' ' ILE . . . -48.29 -40.5 25.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.524 ' CG ' ' HB2' ' A' ' 39' ' ' TYR . 15.7 mtpt -76.54 -25.2 53.86 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -84.45 -13.38 52.23 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.97 -10.41 15.05 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.56 44.22 11.11 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.567 HG13 ' HA ' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -141.46 14.12 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.565 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -44.31 -19.15 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 39' ' ' TYR . . . . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.495 ' CD2' ' HB2' ' A' ' 33' ' ' ALA . 16.9 m-85 . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.652 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -101.27 177.3 1.55 Allowed Pre-proline 0 N--CA 1.45 -0.452 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.652 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 82.3 Cg_endo -72.4 130.77 16.63 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 124.27 3.313 . . . . 0.0 109.546 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 tp -97.96 118.74 35.22 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.669 ' HB2' ' HE3' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -89.5 98.29 11.69 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.806 ' HB2' HE21 ' A' ' 56' ' ' GLN . 7.9 p90 -96.63 169.81 9.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.573 HG12 ' H ' ' A' ' 53' ' ' GLY . 54.4 t -131.62 102.92 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.678 HG11 ' HG ' ' A' ' 66' ' ' LEU . 2.9 t -44.54 -17.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.573 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -108.55 40.87 2.39 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 2.0 mt-10 -138.26 -23.72 1.0 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.33 8.46 85.15 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.806 HE21 ' HB2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -42.43 -83.64 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.69 HD22 ' CZ ' ' A' ' 61' ' ' PHE . 3.8 mp -76.46 165.52 24.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.705 HG13 HG21 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -56.84 145.25 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.476 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 1.5 mt-30 -43.14 -42.76 4.24 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.518 ' HA3' HD12 ' A' ' 78' ' ' ILE . . . -41.63 -83.85 0.01 OUTLIER Glycine 0 C--N 1.336 0.552 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.712 ' O ' HG22 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -43.93 -46.37 8.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.649 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 3.4 mt-10 -51.22 -29.69 15.0 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.69 ' HA ' HD12 ' A' ' 66' ' ' LEU . 2.8 mt-10 -85.32 -33.88 21.99 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.715 ' HB1' ' HD2' ' A' ' 74' ' ' LYS . . . -67.45 -25.87 66.12 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.723 HG21 ' CE2' ' A' ' 50' ' ' PHE . 5.8 m -88.63 -28.61 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.69 HD12 ' HA ' ' A' ' 63' ' ' GLU . 4.1 mt -48.42 -25.89 1.84 Allowed 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.5 47.9 2.13 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.773 ' HE3' HD11 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -140.01 102.41 4.39 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.507 ' N ' ' CG ' ' A' ' 72' ' ' ASP . 1.7 mp0 -61.47 -178.38 0.13 Allowed 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.643 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 1.9 t -71.34 109.36 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.853 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 110.35 -5.04 29.88 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.507 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 0.9 OUTLIER -70.97 173.21 7.76 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.605 ' N ' ' SD ' ' A' ' 68' ' ' MET . 0.2 OUTLIER -150.29 143.04 24.66 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.715 ' HD2' ' HB1' ' A' ' 64' ' ' ALA . 7.0 ttmt -146.05 103.93 3.78 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 1.071 ' CG2' HG23 ' A' ' 146' ' ' THR . 0.2 OUTLIER -103.62 114.33 28.51 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 75' ' ' THR . 54.8 t -157.91 159.25 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.591 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 4.6 ttpm? -86.14 116.73 24.52 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.707 ' CG1' ' CD2' ' A' ' 145' ' ' PHE . 34.9 mm -79.26 118.87 74.86 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.504 ' HA ' ' CG ' ' A' ' 142' ' ' ASP . 84.6 Cg_endo -72.33 138.43 30.17 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 124.381 3.387 . . . . 0.0 109.573 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.915 ' HB1' ' H ' ' A' ' 85' ' ' GLY . . . -44.32 -34.19 1.87 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.43 ' HG2' ' HG2' ' A' ' 79' ' ' PRO . 3.7 pt-20 -55.62 -32.28 62.99 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.413 ' N ' ' HG2' ' A' ' 81' ' ' GLU . 14.7 mtmt -106.48 -0.34 24.1 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.668 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . . . -121.44 -82.31 0.65 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.674 ' CZ ' HD12 ' A' ' 138' ' ' LEU . 3.9 m-85 -107.9 -48.07 3.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.915 ' H ' ' HB1' ' A' ' 80' ' ' ALA . . . 101.35 154.88 26.56 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.81 ' ND2' ' H ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -36.61 137.03 0.32 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.613 ' HD3' ' H ' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -39.84 143.77 0.23 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.552 ' H ' HD12 ' A' ' 91' ' ' LEU . 22.6 t30 -79.57 140.05 37.31 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.432 ' HG2' HD12 ' A' ' 92' ' ' ILE . 2.3 tt0 -65.74 -27.46 68.33 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -14.65 61.63 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.046 HD13 ' HA ' ' A' ' 135' ' ' ASN . 52.6 mt -85.15 7.62 21.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.581 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 62.1 mt -87.93 120.25 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.811 ' O ' HD12 ' A' ' 132' ' ' LEU . 0.0 OUTLIER -116.57 146.65 42.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.39 118.73 31.93 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.989 HG12 HD11 ' A' ' 132' ' ' LEU . 36.3 pt -114.45 152.29 45.97 Favored Pre-proline 0 N--CA 1.449 -0.48 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.599 ' HA ' ' HG3' ' A' ' 129' ' ' GLU . 84.7 Cg_endo -72.34 129.97 15.63 Favored 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 124.292 3.328 . . . . 0.0 109.654 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.881 HH21 ' HG3' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -41.98 -28.98 0.19 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.515 ' HA ' ' HB2' ' A' ' 101' ' ' LYS . 28.7 t70 -65.08 -38.14 89.78 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -50.09 -28.41 7.15 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.54 ' CD2' HD11 ' A' ' 95' ' ' ILE . 1.2 m-85 -107.96 -26.82 10.52 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -60.45 -0.85 0.29 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.497 ' H ' ' C ' ' A' ' 100' ' ' PHE . 5.1 pt-20 -120.14 22.27 11.48 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.415 ' HB1' ' CE1' ' A' ' 105' ' ' PHE . . . -104.47 -137.93 0.36 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -140.85 -3.11 1.28 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.421 ' HB2' ' H ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -123.02 -149.48 0.43 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.421 ' H ' ' HB2' ' A' ' 105' ' ' PHE . 1.0 OUTLIER -158.77 125.0 2.43 Favored Pre-proline 0 N--CA 1.449 -0.511 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.881 ' HG3' HH21 ' A' ' 97' ' ' ARG . 83.7 Cg_endo -72.4 141.97 36.15 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 124.408 3.405 . . . . 0.0 109.559 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 110' ' ' GLY . 0.7 OUTLIER -133.16 159.45 40.1 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.622 ' HB2' HG12 ' A' ' 125' ' ' VAL . 0.9 OUTLIER -64.73 67.71 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 156.44 8.07 0.06 OUTLIER Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 1.036 ' CB ' HD13 ' A' ' 122' ' ' ILE . 0.5 OUTLIER -63.43 172.62 1.92 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.561 HG13 ' HB2' ' A' ' 119' ' ' PRO . 76.3 t -156.86 65.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.479 HD13 ' CZ ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -96.68 136.87 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.904 HD23 ' N ' ' A' ' 119' ' ' PRO . 0.3 OUTLIER -103.38 153.03 20.91 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -105.9 2.72 27.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 173.28 -13.65 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.654 ' O ' HD22 ' A' ' 114' ' ' LEU . . . 168.25 -33.65 0.19 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 3.0 mt -94.51 122.19 61.58 Favored Pre-proline 0 N--CA 1.448 -0.535 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.904 ' N ' HD23 ' A' ' 114' ' ' LEU . 81.7 Cg_endo -72.36 169.71 20.99 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 124.313 3.342 . . . . 0.0 109.549 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.682 ' HB1' ' HB3' ' A' ' 132' ' ' LEU . . . -126.79 67.98 1.25 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 6.2 m -41.77 100.26 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 1.036 HD13 ' CB ' ' A' ' 111' ' ' MET . 2.6 mp -71.42 94.8 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 131' ' ' THR . 1.3 p -77.08 -25.43 52.33 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.526 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 0.6 OUTLIER -122.46 129.28 51.86 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 125' ' ' VAL . 7.7 p -115.82 59.56 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.658 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.2 OUTLIER -79.71 119.84 23.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.407 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 0.3 OUTLIER -48.9 -3.66 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.658 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.2 OUTLIER -113.73 -25.07 8.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.849 ' HA ' HH11 ' A' ' 97' ' ' ARG . 1.4 mt-10 -167.76 167.16 13.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.876 HG13 ' CZ ' ' A' ' 97' ' ' ARG . 16.6 m -132.56 146.57 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 131' ' ' THR . 65.9 m -102.71 64.16 0.87 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.989 HD11 HG12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -58.91 151.06 22.6 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.828 ' CG ' HD21 ' A' ' 135' ' ' ASN . 12.5 t0 -124.38 97.15 5.19 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.546 ' N ' ' O ' ' A' ' 91' ' ' LEU . 1.6 m-30 -39.47 -78.84 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 1.046 ' HA ' HD13 ' A' ' 91' ' ' LEU . 0.5 OUTLIER 68.0 -131.93 0.11 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.747 ' ND1' ' N ' ' A' ' 138' ' ' LEU . 8.2 t-80 -172.12 176.51 3.45 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.749 -0.464 . . . . 0.0 109.749 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.742 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -70.56 -6.61 37.71 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.955 HD23 ' HE2' ' A' ' 141' ' ' LYS . 56.9 mt -126.78 -12.02 6.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.538 ' CB ' ' HB3' ' A' ' 135' ' ' ASN . . . -57.21 133.41 55.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.674 ' HA2' ' HA ' ' A' ' 86' ' ' ASN . . . 39.94 39.75 1.5 Allowed Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.955 ' HE2' HD23 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -145.48 145.32 31.03 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.504 ' CG ' ' HA ' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -103.57 124.3 48.53 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 1.091 HD23 ' H ' ' A' ' 143' ' ' LEU . 1.6 pt? -107.61 143.64 35.79 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 2.1 t -60.69 164.9 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.707 ' CD2' ' CG1' ' A' ' 78' ' ' ILE . 9.9 m-85 -153.03 97.03 2.15 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 1.071 HG23 ' CG2' ' A' ' 75' ' ' THR . 30.7 m -94.71 70.28 3.49 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.652 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -69.0 172.07 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -175.1 103.38 0.09 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.853 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 3.7 mm -58.68 146.93 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.499 HD11 ' OD1' ' A' ' 14' ' ' ASP . 15.6 mt -131.4 -42.33 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.643 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 2.0 mt-10 -153.44 -163.89 1.78 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.898 HG22 HG22 ' A' ' 11' ' ' ILE . 61.4 t -143.87 140.19 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.447 ' HB ' ' HB3' ' A' ' 10' ' ' LYS . 32.9 t . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.733 ' N ' ' HA ' ' A' ' 69' ' ' GLU . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.652 ' CG1' ' N ' ' A' ' 6' ' ' ASP . 1.6 t -140.54 169.48 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.652 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 0.4 OUTLIER -151.51 172.82 15.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.578 ' HG3' HG12 ' A' ' 52' ' ' VAL . 31.6 mtpt -61.23 77.05 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.625 ' N ' ' HA3' ' A' ' 53' ' ' GLY . . . 145.21 18.05 0.17 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.481 ' HB ' HG13 ' A' ' 5' ' ' VAL . 1.2 t -128.75 132.64 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.617 ' HE2' HG23 ' A' ' 51' ' ' VAL . 2.8 ttmt -92.5 152.45 19.65 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.853 HG22 HG22 ' A' ' 152' ' ' VAL . 1.3 pt -153.25 126.86 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.441 ' HG3' ' HB3' ' A' ' 49' ' ' GLU . 4.6 mtmt -83.48 87.51 7.0 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.467 HG21 ' CG2' ' A' ' 147' ' ' ILE . 0.8 OUTLIER -112.47 154.21 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.684 ' HB2' HD11 ' A' ' 29' ' ' ILE . 1.1 m-20 -118.37 96.46 5.31 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.604 ' CB ' ' HA ' ' A' ' 147' ' ' ILE . 4.7 p90 -90.36 154.5 19.64 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 1.011 HG21 HG11 ' A' ' 32' ' ' VAL . 1.2 mt -121.3 71.84 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -55.1 128.38 43.67 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.603 ' HE3' ' O ' ' A' ' 16' ' ' ILE . 5.8 mtmt -120.21 -170.51 1.98 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.633 ' C ' ' H ' ' A' ' 21' ' ' SER . 6.0 mt -111.48 164.93 12.43 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -55.19 1.69 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.633 ' H ' ' C ' ' A' ' 19' ' ' LEU . 83.0 p -114.01 -4.61 13.19 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.44 25.72 32.41 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.564 ' HB2' HD12 ' A' ' 19' ' ' LEU . 93.2 m-20 -96.31 119.25 34.46 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.53 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 86.1 t -69.06 112.81 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.465 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 1.7 p90 -100.77 -31.59 11.11 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.465 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 9.8 t0 -143.24 133.95 25.17 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.872 ' HB ' HG23 ' A' ' 16' ' ' ILE . 1.4 t -153.68 136.48 15.32 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.598 ' HB2' ' HA ' ' A' ' 14' ' ' ASP . 2.8 m -83.84 -26.04 29.83 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.684 HD11 ' HB2' ' A' ' 14' ' ' ASP . 3.0 mt -82.73 106.86 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.728 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 2.0 tt0 -50.44 -37.11 36.46 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -49.36 -66.26 0.43 Allowed 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.011 HG11 HG21 ' A' ' 16' ' ' ILE . 5.0 t -47.59 -39.44 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.747 ' HB1' ' HA ' ' A' ' 39' ' ' TYR . . . -46.42 -46.55 18.74 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.55 ' HG2' ' CB ' ' A' ' 39' ' ' TYR . 3.3 mtmt -68.35 -32.01 71.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.58 -12.41 60.75 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.42 ' CB ' ' HB ' ' A' ' 24' ' ' VAL . . . -116.95 -7.08 11.42 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.33 47.47 35.86 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.536 HG13 ' HA ' ' A' ' 33' ' ' ALA . 1.2 pt -140.13 8.61 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.747 ' HA ' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -45.59 -16.37 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 1.0 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . 71.96 174.75 0.08 OUTLIER Pre-proline 0 N--CA 1.448 -0.536 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 1.0 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 84.0 Cg_endo -72.38 -80.79 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 124.292 3.328 . . . . 0.0 109.571 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.65 ' H ' ' HG2' ' A' ' 41' ' ' PRO . 5.0 p-10 -108.64 -9.43 15.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.538 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -41.89 152.99 0.07 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -126.64 101.68 6.75 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.518 ' CE1' ' NE ' ' A' ' 43' ' ' ARG . 56.5 m-85 -77.92 102.99 7.58 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.662 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -111.58 177.87 1.11 Allowed Pre-proline 0 N--CA 1.449 -0.506 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.662 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 84.2 Cg_endo -72.34 125.95 11.21 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 124.295 3.33 . . . . 0.0 109.632 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.481 ' CD2' HD21 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -89.24 112.66 23.76 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -85.32 97.35 9.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.874 ' CE2' HG21 ' A' ' 65' ' ' VAL . 40.3 p90 -99.56 160.63 14.15 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.731 HG12 ' H ' ' A' ' 53' ' ' GLY . 41.0 t -123.37 112.78 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.7 HG11 HD21 ' A' ' 66' ' ' LEU . 32.4 t -54.78 -11.64 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.731 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -114.91 46.55 1.15 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.427 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 4.2 mt-10 -151.9 -8.6 0.21 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.85 12.11 64.2 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.691 HE21 ' HB2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -44.41 -78.56 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.56 ' CD1' ' N ' ' A' ' 57' ' ' LEU . 5.8 mp -84.87 165.7 17.48 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.851 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -56.45 136.88 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.516 ' HA ' ' HB2' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -41.79 -60.06 1.48 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.759 ' CA ' ' HE3' ' A' ' 82' ' ' LYS . . . -30.25 -68.87 0.09 OUTLIER Glycine 0 C--N 1.335 0.522 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.663 ' HE2' HG23 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -57.19 -44.32 83.48 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 59' ' ' GLN . 4.1 mt-10 -55.34 -23.68 25.19 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.909 ' HA ' HD12 ' A' ' 66' ' ' LEU . 12.0 mt-10 -87.97 -39.06 15.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.816 ' HB1' ' HD2' ' A' ' 74' ' ' LYS . . . -62.22 -13.42 27.67 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.874 HG21 ' CE2' ' A' ' 50' ' ' PHE . 4.5 m -106.96 -26.55 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.909 HD12 ' HA ' ' A' ' 63' ' ' GLU . 2.2 mt -47.55 -31.53 4.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -118.12 49.66 1.24 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.963 ' HE2' HD11 ' A' ' 149' ' ' ILE . 2.5 mtp -138.02 118.49 13.83 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.733 ' HA ' ' N ' ' A' ' 4' ' ' MET . 2.3 mp0 -69.2 -173.44 0.53 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.651 HG22 HG23 ' A' ' 152' ' ' VAL . 3.1 t -80.92 106.27 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.653 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 118.01 -5.56 15.83 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.525 ' CB ' ' HG2' ' A' ' 68' ' ' MET . 0.6 OUTLIER -71.03 170.49 12.72 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.25 126.18 9.07 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.816 ' HD2' ' HB1' ' A' ' 64' ' ' ALA . 19.1 ttmm -131.64 95.71 3.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.626 ' OG1' HG23 ' A' ' 146' ' ' THR . 91.6 m -88.76 77.81 7.78 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 3.6 t -111.77 164.97 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 2.5 ttpt -104.81 116.21 31.62 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.639 HD13 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -79.06 134.88 59.04 Favored Pre-proline 0 N--CA 1.449 -0.521 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.512 ' C ' ' H ' ' A' ' 81' ' ' GLU . 84.1 Cg_endo -72.44 138.77 30.48 Favored 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 124.28 3.32 . . . . 0.0 109.633 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.734 ' HB2' ' N ' ' A' ' 141' ' ' LYS . . . -49.59 -10.66 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.595 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 1.0 OUTLIER -80.23 -39.03 29.85 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.759 ' HE3' ' CA ' ' A' ' 60' ' ' GLY . 2.0 mtpp -86.78 -32.46 20.35 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.625 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . . . -72.46 -93.81 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.442 ' N ' ' HD1' ' A' ' 84' ' ' TYR . 1.7 m-85 -97.87 18.54 15.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.595 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 41.64 83.93 0.01 OUTLIER Glycine 0 C--N 1.336 0.537 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.655 ' N ' ' ND2' ' A' ' 86' ' ' ASN . 0.0 OUTLIER 46.72 -164.84 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.531 ' HD2' ' CG ' ' A' ' 135' ' ' ASN . 0.9 OUTLIER -90.59 154.44 19.59 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.835 ' CB ' HD12 ' A' ' 91' ' ' LEU . 1.3 t30 -91.41 153.61 19.75 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -90.09 -25.77 20.58 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.74 1.58 16.78 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.87 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 19.9 mt -104.5 5.47 34.06 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.606 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 52.3 mt -82.96 107.94 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.789 HE22 ' HB2' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -100.13 165.56 11.45 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.912 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -147.0 99.26 3.15 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.007 HG12 HD11 ' A' ' 132' ' ' LEU . 20.7 pt -96.47 155.19 38.2 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.55 ' O ' ' N ' ' A' ' 99' ' ' ALA . 83.7 Cg_endo -72.34 137.68 28.76 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 124.311 3.341 . . . . 0.0 109.598 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.867 HH21 ' HD2' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -41.64 -34.81 0.65 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.602 ' HA ' ' CB ' ' A' ' 101' ' ' LYS . 6.3 t70 -63.17 -37.06 85.71 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -45.87 -16.39 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.545 ' CD1' ' HB3' ' A' ' 105' ' ' PHE . 2.1 m-85 -137.52 -24.09 1.07 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.602 ' CB ' ' HA ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -41.57 -41.07 2.05 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -90.99 43.77 1.16 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.541 ' C ' ' H ' ' A' ' 105' ' ' PHE . . . -174.94 127.89 0.29 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.487 ' C ' ' N ' ' A' ' 106' ' ' GLU . 2.7 p30 -49.01 -9.28 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.866 ' CE1' HD12 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -47.04 -14.85 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.684 ' C ' ' O ' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -4.32 99.85 0.03 OUTLIER Pre-proline 0 N--CA 1.45 -0.452 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.917 ' HG2' HG11 ' A' ' 130' ' ' VAL . 84.1 Cg_endo -72.4 151.64 53.99 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 124.287 3.325 . . . . 0.0 109.602 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 110' ' ' GLY . 2.9 mt-10 -132.67 156.59 46.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.555 ' HB2' HG12 ' A' ' 125' ' ' VAL . 1.1 tt0 -65.81 66.98 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.8 10.02 0.08 OUTLIER Glycine 0 C--N 1.335 0.509 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.828 ' CB ' HD13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -69.97 170.67 10.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.508 HG13 ' HB2' ' A' ' 119' ' ' PRO . 60.9 t -156.23 73.94 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.866 HD12 ' CE1' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -105.46 135.48 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.626 HD23 ' CD ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -105.04 161.55 14.12 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -108.51 5.23 24.99 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.44 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 0.9 OUTLIER 166.29 -11.09 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.72 -43.04 0.21 Allowed Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.451 ' HA ' ' HD2' ' A' ' 119' ' ' PRO . 3.6 mt -82.51 112.46 36.99 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.626 ' CD ' HD23 ' A' ' 114' ' ' LEU . 83.5 Cg_endo -72.31 165.59 32.21 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 124.322 3.348 . . . . 0.0 109.588 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.863 ' HB1' ' HB3' ' A' ' 132' ' ' LEU . . . -126.91 90.87 3.23 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 6.0 m -62.55 95.54 0.07 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.828 HD13 ' CB ' ' A' ' 111' ' ' MET . 2.6 mp -68.98 89.98 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 121' ' ' THR . 30.7 p -80.1 -17.74 51.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.712 ' HB3' ' H ' ' A' ' 131' ' ' THR . 0.8 OUTLIER -119.99 130.85 54.94 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.707 ' HA ' HG12 ' A' ' 130' ' ' VAL . 7.9 p -124.26 52.92 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.68 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.2 OUTLIER -79.07 126.49 30.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.539 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.3 OUTLIER -52.12 0.06 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.68 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -111.7 -21.14 11.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.6 OUTLIER -178.84 167.02 1.69 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.917 HG11 ' HG2' ' A' ' 107' ' ' PRO . 19.7 m -132.62 141.16 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.912 HG23 ' HD2' ' A' ' 94' ' ' LYS . 23.5 m -96.49 83.91 3.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 1.007 HD11 HG12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -78.93 97.08 5.89 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.848 ' CG ' HD21 ' A' ' 135' ' ' ASN . 25.5 t0 -71.17 97.52 1.53 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.789 ' HB2' HE22 ' A' ' 93' ' ' GLN . 2.1 m-30 -42.89 -56.91 3.05 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.87 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 13.1 m120 55.98 -118.04 1.18 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.631 ' ND1' ' N ' ' A' ' 138' ' ' LEU . 24.1 t-80 -175.19 174.16 2.46 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.603 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 4.8 tp10 -65.84 -43.9 87.12 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.823 HD22 ' HE2' ' A' ' 141' ' ' LYS . 25.4 mt -97.46 10.79 38.82 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.596 ' HB2' ' HB3' ' A' ' 136' ' ' HIS . . . -62.52 133.76 55.41 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 86' ' ' ASN . . . 41.73 36.56 1.73 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 110.234 -1.147 . . . . 0.0 110.234 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.823 ' HE2' HD22 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -146.6 144.04 29.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.505 ' C ' ' HD2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -95.71 143.12 27.24 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.838 HD11 ' CZ ' ' A' ' 145' ' ' PHE . 0.4 OUTLIER -130.67 154.06 48.31 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.601 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 0.5 OUTLIER -73.71 168.46 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.838 ' CZ ' HD11 ' A' ' 143' ' ' LEU . 26.8 m-85 -154.97 90.24 1.28 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.626 HG23 ' OG1' ' A' ' 75' ' ' THR . 96.0 m -81.6 58.8 3.87 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.663 HG23 ' HE2' ' A' ' 61' ' ' PHE . 3.2 mt -53.31 175.09 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.584 ' H ' HG22 ' A' ' 147' ' ' ILE . 3.2 tmtt? -177.59 96.64 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.963 HD11 ' HE2' ' A' ' 68' ' ' MET . 1.4 mm -62.21 134.22 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.408 HG13 ' HA ' ' A' ' 13' ' ' VAL . 8.9 mt -122.12 -26.51 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.591 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 2.1 tt0 -162.74 -175.41 4.42 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.853 HG22 HG22 ' A' ' 11' ' ' ILE . 73.8 t -140.27 137.45 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.69 HG12 ' H ' ' A' ' 154' ' ' GLU . 2.3 t -142.28 -143.95 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.69 ' H ' HG12 ' A' ' 153' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.786 ' N ' ' HA ' ' A' ' 69' ' ' GLU . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.902 ' CG2' HD13 ' A' ' 11' ' ' ILE . 9.2 t -119.67 167.71 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.767 -0.456 . . . . 0.0 109.767 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 8' ' ' GLY . 19.4 m-20 -146.78 164.75 31.78 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.524 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 17.3 ptmt -63.44 70.18 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.664 ' N ' ' HA3' ' A' ' 53' ' ' GLY . . . 155.19 16.63 0.05 OUTLIER Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.536 ' HB ' HG13 ' A' ' 5' ' ' VAL . 2.5 t -126.65 136.33 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.842 ' CA ' HG22 ' A' ' 51' ' ' VAL . 2.7 tttt -88.27 158.27 18.52 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.902 HD13 ' CG2' ' A' ' 5' ' ' VAL . 1.8 pt -166.23 133.49 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.744 ' HE2' HG22 ' A' ' 153' ' ' VAL . 18.3 mtmt -87.18 85.12 7.18 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.719 HG11 HD12 ' A' ' 149' ' ' ILE . 0.9 OUTLIER -122.8 158.75 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.449 ' O ' ' CG2' ' A' ' 147' ' ' ILE . 10.9 m-20 -114.55 -160.18 0.72 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.5 p90 -179.44 155.87 0.7 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.991 HG21 HG11 ' A' ' 32' ' ' VAL . 1.3 mt -127.39 73.21 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -54.68 134.02 47.01 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.579 ' HG2' ' N ' ' A' ' 24' ' ' VAL . 8.1 mttt -123.92 -162.75 1.08 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.63 ' C ' ' H ' ' A' ' 21' ' ' SER . 39.9 mt -118.28 165.65 13.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -55.02 0.97 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.63 ' H ' ' C ' ' A' ' 19' ' ' LEU . 53.5 p -114.85 1.38 14.06 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.9 28.53 50.12 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.221 -1.151 . . . . 0.0 110.221 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.453 ' C ' ' HG2' ' A' ' 18' ' ' LYS . 98.1 m-20 -99.85 121.97 42.11 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.579 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 76.0 t -66.18 134.71 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.532 ' CE1' ' HB2' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -128.07 -28.87 2.59 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.532 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 11.3 t0 -145.68 132.17 19.75 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.966 ' HB ' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -152.26 126.67 9.34 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 73.0 m -86.49 14.13 7.28 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.9 mt -113.11 116.85 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 1.1 tt0 -54.01 -41.6 68.15 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -52.54 -70.78 0.08 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.991 HG11 HG21 ' A' ' 16' ' ' ILE . 67.5 t -48.48 -41.44 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.734 ' HB1' ' HA ' ' A' ' 39' ' ' TYR . . . -50.05 -38.34 37.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.522 ' CG ' ' HB2' ' A' ' 39' ' ' TYR . 22.0 mtpt -79.54 -21.4 45.22 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -87.21 -10.88 51.43 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.4 -10.66 12.61 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.68 43.57 10.05 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.548 HG13 ' HA ' ' A' ' 33' ' ' ALA . 0.4 OUTLIER -141.85 16.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.734 ' HA ' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -47.62 -13.25 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.911 ' HB1' ' HB3' ' A' ' 43' ' ' ARG . . . 71.27 151.55 0.14 Allowed Pre-proline 0 N--CA 1.448 -0.555 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.623 ' HG2' ' H ' ' A' ' 42' ' ' ASP . 82.0 Cg_endo -72.5 -82.6 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 124.343 3.362 . . . . 0.0 109.577 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.623 ' H ' ' HG2' ' A' ' 41' ' ' PRO . 4.9 p-10 -93.7 -14.12 26.7 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.911 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -76.29 145.71 39.42 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.583 ' N ' ' HG3' ' A' ' 43' ' ' ARG . 0.4 OUTLIER -117.76 -174.74 2.69 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.519 ' CD2' ' HB2' ' A' ' 33' ' ' ALA . 2.2 m-85 -139.27 131.78 28.68 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.717 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -135.61 -180.0 1.22 Allowed Pre-proline 0 N--CA 1.448 -0.546 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.717 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 82.3 Cg_endo -72.45 127.83 12.96 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 124.293 3.329 . . . . 0.0 109.573 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.8 HD23 ' HD2' ' A' ' 50' ' ' PHE . 2.6 tp -82.68 94.71 7.63 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.711 ' CD ' HG21 ' A' ' 153' ' ' VAL . 43.1 tt0 -76.58 97.95 4.53 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.8 ' HD2' HD23 ' A' ' 48' ' ' LEU . 6.4 p90 -118.92 173.86 6.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.905 ' H ' ' NE2' ' A' ' 56' ' ' GLN . 57.8 t -130.7 109.69 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.961 HG11 ' HG ' ' A' ' 66' ' ' LEU . 16.3 t -49.08 -10.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.766 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -108.07 25.74 19.41 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 51' ' ' VAL . 4.0 mt-10 -123.25 -43.16 2.21 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.85 7.59 50.24 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.905 ' NE2' ' H ' ' A' ' 51' ' ' VAL . 1.2 mt-30 -46.0 -50.07 15.36 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.518 HD22 ' N ' ' A' ' 57' ' ' LEU . 1.2 mm? -96.48 175.24 6.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.89 HD13 ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -75.99 150.88 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.472 ' O ' ' C ' ' A' ' 60' ' ' GLY . 10.6 mt-30 -40.11 -65.72 0.37 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.673 ' H ' ' HB3' ' A' ' 82' ' ' LYS . . . -33.46 -82.78 0.01 OUTLIER Glycine 0 C--N 1.335 0.506 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.693 ' CE1' HG11 ' A' ' 65' ' ' VAL . 2.3 t80 -40.88 -53.57 2.88 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.504 ' O ' HG22 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -45.28 -34.04 2.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.634 ' HA ' HD12 ' A' ' 66' ' ' LEU . 5.9 mt-10 -80.73 -31.11 36.13 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 61' ' ' PHE . . . -64.43 -29.84 70.88 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.728 HG21 ' CE1' ' A' ' 50' ' ' PHE . 2.5 m -92.36 -21.46 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.961 ' HG ' HG11 ' A' ' 52' ' ' VAL . 1.1 mt -50.14 -55.67 14.09 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -98.74 55.58 1.06 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.733 ' HE3' ' HA ' ' A' ' 73' ' ' GLU . 9.4 mtp -134.12 123.8 25.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.786 ' HA ' ' N ' ' A' ' 4' ' ' MET . 1.1 mp0 -77.92 167.49 21.41 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.594 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 0.2 OUTLIER -68.62 96.63 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.837 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 118.87 17.76 4.95 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -95.99 -172.08 2.49 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.733 ' HA ' ' HE3' ' A' ' 68' ' ' MET . 2.2 tt0 -162.54 123.11 2.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.512 ' HB2' ' SD ' ' A' ' 68' ' ' MET . 5.2 ttmt -125.82 99.69 6.07 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.531 ' OG1' HG23 ' A' ' 146' ' ' THR . 84.8 m -93.82 76.32 4.23 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.45 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 3.9 t -106.04 156.83 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.616 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 5.4 ttpm? -95.1 113.12 24.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 1.107 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -79.19 130.83 67.95 Favored Pre-proline 0 N--CA 1.45 -0.438 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.504 ' CG ' ' HD3' ' A' ' 82' ' ' LYS . 84.0 Cg_endo -72.35 144.54 41.33 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 124.33 3.354 . . . . 0.0 109.595 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.643 ' O ' ' N ' ' A' ' 85' ' ' GLY . . . -50.99 -11.68 0.1 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.54 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 15.7 tt0 -86.1 -34.65 20.59 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.673 ' HB3' ' H ' ' A' ' 60' ' ' GLY . 1.0 OUTLIER -105.67 41.45 1.38 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.107 ' HB2' ' CG2' ' A' ' 78' ' ' ILE . . . -159.57 -34.27 0.06 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.681 ' CD2' ' CB ' ' A' ' 138' ' ' LEU . 74.2 m-85 -158.89 8.6 0.12 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.643 ' N ' ' O ' ' A' ' 80' ' ' ALA . . . 72.49 143.5 0.49 Allowed Glycine 0 C--N 1.336 0.557 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.903 ' ND2' ' H ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -47.82 167.38 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.554 ' HG2' ' HA3' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -41.4 139.96 0.97 Allowed 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.951 ' CB ' HD12 ' A' ' 91' ' ' LEU . 1.9 t30 -93.13 153.23 18.78 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.508 ' C ' ' H ' ' A' ' 91' ' ' LEU . 48.7 mt-10 -86.49 -39.18 16.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.48 11.86 0.22 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.951 HD12 ' CB ' ' A' ' 88' ' ' ASN . 54.5 mt -118.57 5.73 11.67 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 51.1 mt -84.75 114.05 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.758 HE22 ' HB2' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -106.22 166.3 10.62 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.793 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -146.39 96.81 2.83 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.657 HD11 ' CD1' ' A' ' 100' ' ' PHE . 3.7 pt -96.06 157.69 35.34 Favored Pre-proline 0 N--CA 1.449 -0.505 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.555 ' O ' ' N ' ' A' ' 99' ' ' ALA . 83.4 Cg_endo -72.45 139.96 32.48 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 124.296 3.331 . . . . 0.0 109.576 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.841 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -43.81 -20.65 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.572 ' C ' ' H ' ' A' ' 100' ' ' PHE . 3.3 m-20 -78.17 -35.46 48.76 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.555 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -50.56 -6.99 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.657 ' CD1' HD11 ' A' ' 95' ' ' ILE . 2.3 m-85 -131.46 -26.54 2.05 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.498 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 0.9 OUTLIER -63.39 -15.15 56.7 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.29 6.14 49.59 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.552 ' HB1' ' CZ ' ' A' ' 105' ' ' PHE . . . -100.61 -137.51 0.32 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.72 18.15 1.47 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.552 ' CZ ' ' HB1' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -133.13 -144.07 0.23 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.506 ' H ' ' HB2' ' A' ' 105' ' ' PHE . 0.4 OUTLIER -171.21 126.65 0.63 Allowed Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.892 ' CG ' HG11 ' A' ' 130' ' ' VAL . 82.3 Cg_endo -72.33 131.83 18.34 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 124.321 3.348 . . . . 0.0 109.579 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 110' ' ' GLY . 2.1 mm-40 -118.83 157.62 27.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -67.19 66.1 0.07 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.89 12.25 0.07 OUTLIER Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.797 ' CB ' HD13 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -68.55 171.34 7.67 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.543 ' O ' HG12 ' A' ' 112' ' ' VAL . 96.4 t -155.57 65.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.34 136.76 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.863 HD23 ' CD ' ' A' ' 119' ' ' PRO . 0.1 OUTLIER -104.58 172.81 6.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -119.71 -1.62 10.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 172.46 3.17 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 152.65 -32.34 0.83 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 18.2 mm -94.4 116.03 65.94 Favored Pre-proline 0 N--CA 1.449 -0.485 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.863 ' CD ' HD23 ' A' ' 114' ' ' LEU . 81.9 Cg_endo -72.42 171.8 16.3 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 124.333 3.356 . . . . 0.0 109.582 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.862 ' HB1' ' HB3' ' A' ' 132' ' ' LEU . . . -132.13 75.5 1.64 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 3.7 m -49.13 97.83 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.797 HD13 ' CB ' ' A' ' 111' ' ' MET . 1.8 mp -71.14 95.6 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.498 HG22 HG22 ' A' ' 121' ' ' THR . 0.9 OUTLIER -82.06 -18.94 41.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.726 ' HB3' ' H ' ' A' ' 131' ' ' THR . 1.7 tp10 -121.9 130.88 53.7 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 125' ' ' VAL . 15.0 p -122.02 50.89 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.657 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -78.62 126.03 30.18 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.537 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.9 OUTLIER -53.17 0.18 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.657 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -111.28 -20.21 12.38 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -177.86 164.64 1.94 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.892 HG11 ' CG ' ' A' ' 107' ' ' PRO . 17.4 m -129.57 135.95 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.793 HG23 ' HD2' ' A' ' 94' ' ' LYS . 24.2 m -95.45 87.24 4.71 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.862 ' HB3' ' HB1' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -85.68 122.2 29.44 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.589 ' HA ' ' HA ' ' A' ' 92' ' ' ILE . 15.4 t0 -90.17 94.28 9.7 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.758 ' HB2' HE22 ' A' ' 93' ' ' GLN . 2.4 m-85 -38.33 -42.29 0.7 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.675 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 0.7 OUTLIER 42.04 -112.12 0.18 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.908 ' CG ' ' H ' ' A' ' 137' ' ' GLU . 15.8 t-80 -177.76 -170.4 0.26 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.908 ' H ' ' CG ' ' A' ' 136' ' ' HIS . 1.5 tp10 -73.55 -42.03 62.2 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 1.013 HD12 HD22 ' A' ' 143' ' ' LEU . 2.6 mm? -98.97 -15.64 19.03 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.777 ' HB2' ' HB3' ' A' ' 136' ' ' HIS . . . -58.7 115.69 3.23 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.554 ' HA3' ' HG2' ' A' ' 87' ' ' ARG . . . 71.17 15.57 74.63 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.692 ' HE2' ' CD1' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -134.7 131.94 38.26 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.553 ' C ' ' HD3' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -100.47 130.02 46.5 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 1.026 HD23 ' H ' ' A' ' 143' ' ' LEU . 1.4 pt? -115.98 144.94 43.39 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.616 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 0.2 OUTLIER -68.02 173.96 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.635 ' CD2' HD13 ' A' ' 78' ' ' ILE . 25.5 m-85 -157.44 90.28 1.09 Allowed 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 146' ' ' THR . 85.4 m -81.88 64.35 6.53 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.9 mt -60.3 178.51 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.554 ' H ' HG22 ' A' ' 147' ' ' ILE . 13.7 tttp -178.03 110.59 0.06 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.837 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 4.4 mm -70.84 139.0 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.598 HD12 ' HB3' ' A' ' 47' ' ' PRO . 3.6 mt -118.39 -41.15 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.594 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 2.4 tt0 -158.86 -165.69 1.69 Allowed 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.894 HG22 HG22 ' A' ' 11' ' ' ILE . 97.0 t -136.95 151.7 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.744 HG22 ' HE2' ' A' ' 12' ' ' LYS . 1.8 t -133.5 -133.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.748 ' HB2' ' H ' ' A' ' 10' ' ' LYS . 11.4 tp10 . . . . . 0 N--CA 1.45 -0.461 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.691 ' N ' ' HA ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.644 ' CG1' ' N ' ' A' ' 6' ' ' ASP . 1.5 t -164.11 169.67 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.644 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 0.5 OUTLIER -138.04 175.83 9.23 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.542 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 16.1 ptmt -67.35 65.65 0.07 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 6' ' ' ASP . . . 165.35 15.32 0.02 OUTLIER Glycine 0 C--N 1.336 0.557 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.588 ' HB ' HG22 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -129.14 132.64 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.8 ' O ' HG23 ' A' ' 11' ' ' ILE . 4.2 ttpm? -87.55 165.03 15.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.033 HG22 HG22 ' A' ' 152' ' ' VAL . 1.1 pt -169.19 134.42 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.664 ' HE2' ' CG2' ' A' ' 153' ' ' VAL . 7.5 mtmt -94.3 91.98 6.98 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.575 HG12 ' HA ' ' A' ' 149' ' ' ILE . 0.8 OUTLIER -116.02 153.95 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.607 ' OD2' HD11 ' A' ' 150' ' ' ILE . 3.6 m-20 -111.41 106.12 14.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.597 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.9 p90 -101.99 159.46 15.35 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 1.107 HG21 HG11 ' A' ' 32' ' ' VAL . 3.5 mt -133.55 73.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -56.9 129.17 48.86 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.596 ' HE3' ' O ' ' A' ' 16' ' ' ILE . 5.9 mttt -116.98 -164.03 0.95 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.623 ' C ' ' H ' ' A' ' 21' ' ' SER . 85.3 mt -118.02 165.87 13.21 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -54.66 0.07 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.623 ' H ' ' C ' ' A' ' 19' ' ' LEU . 84.5 p -112.05 -3.88 14.63 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.62 25.11 43.61 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.458 ' C ' ' HG2' ' A' ' 18' ' ' LYS . 1.6 m-20 -96.6 122.13 39.18 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.528 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 55.8 t -68.49 113.66 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.595 ' CE1' ' HB2' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -104.41 -31.56 9.45 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.595 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 14.4 t0 -140.07 138.94 35.76 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.995 ' HB ' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -158.24 161.24 37.74 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.442 ' HB3' ' OD1' ' A' ' 14' ' ' ASP . 12.9 m -115.73 -11.92 11.58 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.62 HG22 ' H ' ' A' ' 32' ' ' VAL . 3.0 mt -92.77 116.23 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.505 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 2.5 tt0 -51.51 -38.98 56.69 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -48.72 -67.86 0.23 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.107 HG11 HG21 ' A' ' 16' ' ' ILE . 34.7 t -53.93 -38.32 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.743 ' HB1' ' HA ' ' A' ' 39' ' ' TYR . . . -53.16 -43.05 66.74 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.55 ' HG2' ' CB ' ' A' ' 39' ' ' TYR . 3.9 mtmt -68.13 -30.91 70.16 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -80.99 -20.08 42.6 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.41 -11.42 17.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.01 45.75 19.22 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.526 HG13 ' HA ' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -143.12 16.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.743 ' HA ' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -57.97 -14.6 6.69 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.993 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . 72.13 174.53 0.08 OUTLIER Pre-proline 0 N--CA 1.449 -0.477 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.993 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 82.9 Cg_endo -72.36 -90.45 0.01 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 124.341 3.361 . . . . 0.0 109.639 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.494 ' H ' ' HG2' ' A' ' 41' ' ' PRO . 11.0 p-10 -100.15 -8.56 23.5 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.538 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -41.52 153.63 0.05 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.436 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -115.92 100.12 7.76 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.873 ' HE2' HG23 ' A' ' 27' ' ' THR . 1.9 m-85 -67.48 76.19 0.17 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.663 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -82.58 177.48 3.0 Favored Pre-proline 0 N--CA 1.449 -0.502 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.663 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 84.4 Cg_endo -72.43 128.81 14.03 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 124.292 3.328 . . . . 0.0 109.598 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.0 tp -69.41 104.63 2.33 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.514 ' CD ' ' CE ' ' A' ' 10' ' ' LYS . 13.3 tt0 -91.15 100.87 13.63 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.884 ' CZ ' HG21 ' A' ' 65' ' ' VAL . 32.1 p90 -119.78 170.61 9.07 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.841 HG12 ' H ' ' A' ' 53' ' ' GLY . 69.5 t -131.31 113.07 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.928 HG11 ' CG ' ' A' ' 66' ' ' LEU . 4.6 t -50.53 -8.7 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.841 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -117.33 35.35 4.16 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 2.7 mm-40 -124.27 -31.97 3.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.11 5.65 59.4 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.769 HE22 ' HA ' ' A' ' 50' ' ' PHE . 7.9 mt-30 -57.95 -97.36 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.793 HD22 ' H ' ' A' ' 57' ' ' LEU . 1.5 mm? -54.32 157.8 2.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.952 HD13 ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -60.96 149.18 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.459 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 2.1 mt-30 -44.6 -55.24 5.35 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.484 ' O ' ' N ' ' A' ' 63' ' ' GLU . . . -39.65 -79.79 0.04 OUTLIER Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.658 ' HE2' HG23 ' A' ' 147' ' ' ILE . 0.3 OUTLIER -43.45 -44.69 5.98 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.413 ' CD ' ' HA ' ' A' ' 52' ' ' VAL . 6.5 mt-10 -55.85 -32.81 63.95 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.778 ' HA ' HD12 ' A' ' 66' ' ' LEU . 7.3 mt-10 -77.86 -29.77 50.57 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.59 ' HB1' ' HD2' ' A' ' 74' ' ' LYS . . . -63.36 -42.37 98.88 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.884 HG21 ' CZ ' ' A' ' 50' ' ' PHE . 4.6 m -84.06 -15.29 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.928 ' CG ' HG11 ' A' ' 52' ' ' VAL . 3.8 mt -63.05 -48.4 78.87 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -102.85 54.83 0.77 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.593 ' C ' ' N ' ' A' ' 4' ' ' MET . 6.1 mtp -131.57 -144.8 0.25 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.691 ' HA ' ' N ' ' A' ' 4' ' ' MET . 0.0 OUTLIER -155.96 -178.56 7.39 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.606 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 0.5 OUTLIER -90.09 80.12 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.671 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 138.4 11.07 0.9 Allowed Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.479 ' CG ' ' HB2' ' A' ' 69' ' ' GLU . 2.8 m-20 -95.48 -178.39 4.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -153.72 130.47 10.83 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.59 ' HD2' ' HB1' ' A' ' 64' ' ' ALA . 9.6 ttmt -131.69 96.68 4.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.676 ' OG1' HG23 ' A' ' 146' ' ' THR . 80.3 m -95.5 78.77 3.39 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.668 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 4.0 t -111.38 171.25 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.668 ' N ' ' CG1' ' A' ' 76' ' ' VAL . 1.8 ttpt -103.35 114.79 29.36 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.754 HD13 ' CD2' ' A' ' 145' ' ' PHE . 0.3 OUTLIER -79.4 129.33 72.37 Favored Pre-proline 0 N--CA 1.448 -0.554 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.486 ' HG2' ' HG2' ' A' ' 81' ' ' GLU . 83.0 Cg_endo -72.29 141.9 36.44 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 124.346 3.364 . . . . 0.0 109.582 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.579 ' HB2' ' N ' ' A' ' 141' ' ' LYS . . . -54.36 -8.39 0.21 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.622 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 8.3 pt-20 -81.38 -37.4 28.25 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.48 ' HD3' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -87.52 -30.0 20.91 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.639 ' HA ' ' CB ' ' A' ' 58' ' ' ILE . . . -71.52 -94.74 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.593 ' CD1' ' N ' ' A' ' 84' ' ' TYR . 0.3 OUTLIER -106.71 21.64 17.17 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.622 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 46.58 87.67 0.01 OUTLIER Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.645 ' N ' ' ND2' ' A' ' 86' ' ' ASN . 0.0 OUTLIER 39.9 -144.5 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.567 ' HD2' ' HA3' ' A' ' 140' ' ' GLY . 0.1 OUTLIER -91.3 145.1 24.93 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.969 ' CB ' HD12 ' A' ' 91' ' ' LEU . 7.0 t30 -83.79 132.47 34.82 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -66.63 -25.97 66.84 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.62 8.17 15.13 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.983 HD13 ' HA ' ' A' ' 135' ' ' ASN . 34.5 mt -110.19 5.23 21.72 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.606 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 24.6 mt -84.88 108.28 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.703 HE22 ' HB2' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -101.84 152.14 21.24 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.822 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -135.81 91.4 2.7 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.569 HG12 HG23 ' A' ' 130' ' ' VAL . 3.3 pt -86.23 159.04 54.48 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.61 ' HA ' ' HG3' ' A' ' 129' ' ' GLU . 80.7 Cg_endo -72.46 136.18 25.7 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 124.35 3.367 . . . . 0.0 109.551 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.848 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -42.24 -29.53 0.25 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.546 ' HA ' ' CB ' ' A' ' 101' ' ' LYS . 8.4 t70 -70.29 -36.08 74.14 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -51.01 -12.82 0.12 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.569 ' HB3' ' HD3' ' A' ' 107' ' ' PRO . 4.5 m-85 -133.63 -21.03 2.0 Allowed 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.546 ' CB ' ' HA ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -49.84 -9.9 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.512 ' H ' ' C ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -143.32 40.45 1.46 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.651 ' HB1' ' CE1' ' A' ' 105' ' ' PHE . . . -103.25 21.52 15.73 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 71.16 -14.84 0.44 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.651 ' CE1' ' HB1' ' A' ' 103' ' ' ALA . 0.9 OUTLIER -135.87 -148.76 0.31 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.516 ' HG2' ' HD2' ' A' ' 107' ' ' PRO . 1.4 tt0 -160.78 138.04 6.77 Favored Pre-proline 0 N--CA 1.448 -0.552 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.923 ' CG ' HG11 ' A' ' 130' ' ' VAL . 82.9 Cg_endo -72.41 141.02 34.38 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 124.311 3.341 . . . . 0.0 109.61 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 110' ' ' GLY . 20.9 mt-10 -130.06 153.57 48.32 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -63.64 70.06 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.21 5.23 0.12 Allowed Glycine 0 C--N 1.336 0.571 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.859 ' HB3' HD12 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -65.34 165.89 11.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.513 HG23 ' C ' ' A' ' 111' ' ' MET . 52.4 t -156.27 70.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.66 134.93 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.637 HD23 ' CD ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -104.47 170.57 7.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.415 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -116.07 5.23 13.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.415 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 0.5 OUTLIER 167.01 -10.88 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.419 ' O ' HD22 ' A' ' 114' ' ' LEU . . . 169.81 -45.15 0.21 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.446 ' HA ' ' HD2' ' A' ' 119' ' ' PRO . 4.3 mt -80.46 110.97 18.93 Favored Pre-proline 0 N--CA 1.45 -0.465 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.637 ' CD ' HD23 ' A' ' 114' ' ' LEU . 82.7 Cg_endo -72.37 163.94 37.12 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 124.255 3.303 . . . . 0.0 109.628 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.857 ' HB1' ' HB3' ' A' ' 132' ' ' LEU . . . -124.73 94.3 4.15 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 21.3 m -66.4 97.02 0.39 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.859 HD12 ' HB3' ' A' ' 111' ' ' MET . 5.9 mt -71.75 84.41 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 123' ' ' THR . 0.0 OUTLIER -74.82 -16.94 60.68 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.837 ' HB3' ' H ' ' A' ' 131' ' ' THR . 0.3 OUTLIER -119.23 127.95 53.74 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.606 HG13 ' O ' ' A' ' 125' ' ' VAL . 8.1 p -122.56 49.15 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.689 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -78.05 125.48 29.41 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.678 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.4 OUTLIER -52.82 1.7 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.689 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.1 OUTLIER -112.95 -20.94 11.37 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.61 ' HG3' ' HA ' ' A' ' 96' ' ' PRO . 2.3 mt-10 -174.75 165.67 3.68 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.923 HG11 ' CG ' ' A' ' 107' ' ' PRO . 16.7 m -135.23 130.76 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.837 ' H ' ' HB3' ' A' ' 124' ' ' GLU . 66.1 m -93.79 94.89 8.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.857 ' HB3' ' HB1' ' A' ' 120' ' ' ALA . 0.3 OUTLIER -92.35 103.37 15.82 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.809 ' CG ' HD21 ' A' ' 135' ' ' ASN . 18.9 t0 -74.8 96.87 3.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.703 ' HB2' HE22 ' A' ' 93' ' ' GLN . 2.0 m-30 -41.32 -82.59 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.983 ' HA ' HD13 ' A' ' 91' ' ' LEU . 0.3 OUTLIER 77.74 -127.67 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.689 ' ND1' ' N ' ' A' ' 138' ' ' LEU . 14.1 t-80 -171.49 178.34 3.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.678 ' N ' ' CG ' ' A' ' 136' ' ' HIS . 10.2 tp10 -67.88 -16.47 64.1 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.875 HD23 ' HE2' ' A' ' 141' ' ' LYS . 16.2 mt -118.14 -16.83 9.72 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.646 ' HB3' ' H ' ' A' ' 136' ' ' HIS . . . -57.57 110.17 0.83 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' A' ' 86' ' ' ASN . . . 79.97 31.99 37.59 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.875 ' HE2' HD23 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -155.26 146.15 22.44 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.549 ' C ' ' HD2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -95.31 135.44 36.91 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.777 HD23 ' N ' ' A' ' 143' ' ' LEU . 0.4 OUTLIER -124.15 149.16 46.59 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.589 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 1.7 t -73.56 166.87 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.754 ' CD2' HD13 ' A' ' 78' ' ' ILE . 25.3 m-85 -151.21 91.64 1.71 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.676 HG23 ' OG1' ' A' ' 75' ' ' THR . 83.9 m -84.48 61.92 6.94 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.658 HG23 ' HE2' ' A' ' 61' ' ' PHE . 1.7 mt -56.21 -179.47 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.6 ' H ' HG22 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -178.33 90.61 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.671 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 1.1 mm -60.51 130.7 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.607 HD11 ' OD2' ' A' ' 14' ' ' ASP . 4.8 mt -113.64 -45.37 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.606 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -153.98 -165.64 2.16 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 1.033 HG22 HG22 ' A' ' 11' ' ' ILE . 88.7 t -138.65 153.3 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.664 ' CG2' ' HE2' ' A' ' 12' ' ' LYS . 1.9 t -129.99 -133.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.618 ' HB2' ' H ' ' A' ' 10' ' ' LYS . 2.7 tm-20 . . . . . 0 N--CA 1.45 -0.441 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.412 ' N ' ' HG3' ' A' ' 69' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.508 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.667 HG21 HD13 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -111.9 179.31 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.525 ' H ' HG12 ' A' ' 5' ' ' VAL . 8.5 m-20 -154.87 165.77 35.61 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.599 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 4.9 ptpt -69.94 63.68 0.21 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.43 ' H ' ' H ' ' A' ' 9' ' ' VAL . . . 175.05 3.19 0.03 OUTLIER Glycine 0 C--N 1.335 0.508 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.43 ' H ' ' H ' ' A' ' 8' ' ' GLY . 2.5 t -119.98 140.3 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.719 ' H ' ' HB3' ' A' ' 154' ' ' GLU . 10.8 tttt -96.68 149.38 21.86 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.682 ' HA ' ' HA ' ' A' ' 152' ' ' VAL . 10.8 pt -158.05 140.49 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.61 ' O ' HD12 ' A' ' 150' ' ' ILE . 7.0 ttmt -94.11 99.07 11.42 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.575 ' CG1' ' HA ' ' A' ' 149' ' ' ILE . 1.1 m -124.13 152.37 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 147' ' ' ILE . 16.4 m-20 -95.07 -167.35 1.61 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 0.3 OUTLIER 177.52 148.75 0.15 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.97 HG23 ' HB ' ' A' ' 27' ' ' THR . 4.5 mt -132.25 74.27 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -58.21 134.14 52.49 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.587 ' HG2' ' N ' ' A' ' 24' ' ' VAL . 7.8 mtmt -118.98 -152.99 0.52 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.592 ' C ' ' H ' ' A' ' 21' ' ' SER . 1.5 mt -128.49 166.08 19.47 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -52.67 -3.71 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.592 ' H ' ' C ' ' A' ' 19' ' ' LEU . 52.0 p -113.89 14.25 18.51 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 19' ' ' LEU . . . 65.33 32.03 82.35 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 18' ' ' LYS . 2.3 m-20 -101.6 123.98 46.5 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.587 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 76.7 t -68.98 130.22 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.577 ' CE1' ' HB2' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -124.59 -29.55 3.45 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.577 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 9.3 t0 -145.08 135.78 24.47 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.97 ' HB ' HG23 ' A' ' 16' ' ' ILE . 1.7 t -153.47 144.87 23.16 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 2.5 m -96.96 -4.95 38.99 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.44 ' CG2' HG23 ' A' ' 32' ' ' VAL . 20.6 mt -100.87 103.62 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.594 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 5.5 tt0 -46.72 -38.72 10.33 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -50.03 -66.12 0.45 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.89 HG11 HD13 ' A' ' 16' ' ' ILE . 3.0 t -47.86 -42.41 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.604 ' HA ' HG13 ' A' ' 38' ' ' ILE . . . -49.17 -41.8 37.78 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.601 ' HG2' ' CG ' ' A' ' 39' ' ' TYR . 8.8 mtpt -74.31 -24.86 59.28 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -86.84 -23.76 25.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . -93.83 -27.48 16.41 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.3 16.17 19.2 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.604 HG13 ' HA ' ' A' ' 33' ' ' ALA . 3.5 pt -118.17 31.01 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.601 ' CG ' ' HG2' ' A' ' 34' ' ' LYS . 13.0 t80 -64.69 68.84 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.814 ' HB1' ' HB2' ' A' ' 43' ' ' ARG . . . -48.36 136.16 12.25 Favored Pre-proline 0 N--CA 1.45 -0.475 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.42 ' HG2' ' H ' ' A' ' 42' ' ' ASP . 80.9 Cg_endo -72.4 -94.99 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 124.374 3.383 . . . . 0.0 109.564 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.497 ' CG ' ' N ' ' A' ' 43' ' ' ARG . 0.3 OUTLIER -42.7 -50.19 5.54 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.814 ' HB2' ' HB1' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -41.27 149.94 0.1 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -126.71 98.44 5.38 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -82.26 99.95 9.61 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.703 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -123.85 179.83 0.98 Allowed Pre-proline 0 N--CA 1.449 -0.495 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.703 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 80.7 Cg_endo -72.44 129.84 15.34 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 124.273 3.316 . . . . 0.0 109.556 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.855 HD12 ' N ' ' A' ' 49' ' ' GLU . 5.3 tp -97.26 135.14 39.61 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.964 ' HB3' HG21 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -105.08 107.77 18.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.926 ' HA ' HE22 ' A' ' 56' ' ' GLN . 8.1 p90 -125.49 162.21 25.38 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.937 HG12 ' H ' ' A' ' 53' ' ' GLY . 41.1 t -105.79 123.52 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.692 HG11 ' HG ' ' A' ' 66' ' ' LEU . 8.3 t -58.53 8.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.937 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -147.31 48.74 0.64 Allowed Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.735 ' OE1' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -126.61 -32.76 2.6 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.58 -12.57 54.08 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.926 HE22 ' HA ' ' A' ' 50' ' ' PHE . 27.8 mt-30 -42.06 -78.53 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.676 HD22 ' H ' ' A' ' 57' ' ' LEU . 1.2 mm? -71.5 164.92 24.92 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.814 HD13 ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -65.09 157.71 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.531 HE21 ' HA ' ' A' ' 82' ' ' LYS . 22.1 mt-30 -49.84 -59.29 3.99 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.629 ' H ' ' HB3' ' A' ' 82' ' ' LYS . . . -39.05 -78.31 0.06 OUTLIER Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.81 ' CE1' HD13 ' A' ' 147' ' ' ILE . 0.9 OUTLIER -41.08 -55.18 2.65 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.541 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.0 mt-10 -45.94 -37.05 6.0 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 60' ' ' GLY . 4.8 mt-10 -77.63 -25.45 49.73 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.655 ' HA ' ' HE2' ' A' ' 74' ' ' LYS . . . -67.32 -40.04 85.94 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.642 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 2.1 m -73.5 -32.77 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.692 ' HG ' HG11 ' A' ' 52' ' ' VAL . 2.5 mt -41.31 -51.66 3.59 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.36 52.29 0.84 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.597 ' HE3' HD11 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -140.62 114.05 8.67 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 4' ' ' MET . 1.3 mt-10 -77.58 168.89 19.24 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.662 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 1.5 t -61.93 113.04 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.842 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 100.52 9.0 48.22 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.95 -176.54 5.22 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.558 ' CA ' ' SD ' ' A' ' 68' ' ' MET . 0.6 OUTLIER -157.44 141.81 16.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.655 ' HE2' ' HA ' ' A' ' 64' ' ' ALA . 12.1 tttp -138.95 95.8 3.01 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.903 ' CG2' HG23 ' A' ' 146' ' ' THR . 0.0 OUTLIER -92.4 93.23 8.49 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.55 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 16.2 t -131.63 164.64 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.598 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 5.6 ttpt -99.48 114.8 27.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.731 HD13 ' CD2' ' A' ' 145' ' ' PHE . 0.3 OUTLIER -78.68 129.95 72.34 Favored Pre-proline 0 N--CA 1.449 -0.492 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.501 ' HG2' ' HG2' ' A' ' 81' ' ' GLU . 84.8 Cg_endo -72.39 138.22 29.61 Favored 'Trans proline' 0 N--CA 1.447 -1.218 0 C-N-CA 124.28 3.32 . . . . 0.0 109.664 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.681 ' HB2' ' C ' ' A' ' 141' ' ' LYS . . . -51.56 -10.62 0.1 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.594 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 20.6 pt-20 -79.0 -38.2 37.27 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.629 ' HB3' ' H ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -84.88 -33.1 22.87 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.649 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . . . -74.12 -100.07 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.616 ' CE1' ' HB2' ' A' ' 138' ' ' LEU . 38.9 m-85 -90.22 17.81 6.68 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.594 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 42.35 85.71 0.01 OUTLIER Glycine 0 C--N 1.335 0.508 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.658 ' N ' ' ND2' ' A' ' 86' ' ' ASN . 0.0 OUTLIER 47.26 -164.85 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.591 ' HD2' ' HA3' ' A' ' 140' ' ' GLY . 0.4 OUTLIER -81.17 146.42 30.52 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.693 ' CB ' HD12 ' A' ' 91' ' ' LEU . 9.7 t30 -89.2 149.98 22.87 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -85.35 -35.02 21.67 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.3 -9.08 37.42 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.866 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 75.1 mt -94.03 6.04 49.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.61 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 69.1 mt -85.56 113.75 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.749 HE22 ' HB2' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -106.99 150.3 26.63 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.698 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -130.17 97.08 4.34 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.999 HG12 HD11 ' A' ' 132' ' ' LEU . 18.5 pt -93.11 156.7 40.03 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.534 ' O ' ' N ' ' A' ' 99' ' ' ALA . 82.0 Cg_endo -72.43 140.37 33.21 Favored 'Trans proline' 0 N--CA 1.447 -1.219 0 C-N-CA 124.33 3.354 . . . . 0.0 109.609 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.818 HH21 ' CD ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -42.72 -32.93 0.65 Allowed 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.473 ' HA ' ' CB ' ' A' ' 101' ' ' LYS . 6.7 t70 -66.81 -36.71 83.0 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -43.92 -21.61 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.493 ' CD2' ' HD3' ' A' ' 107' ' ' PRO . 3.3 m-85 -122.94 -28.82 4.03 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.473 ' CB ' ' HA ' ' A' ' 98' ' ' ASP . 0.8 OUTLIER -56.45 -24.15 43.57 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -104.18 1.91 31.2 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -102.05 19.69 18.02 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 41.63 36.78 0.62 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.3 -150.2 0.44 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.441 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -179.96 102.2 0.18 Allowed Pre-proline 0 N--CA 1.45 -0.475 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.918 ' CG ' HG11 ' A' ' 130' ' ' VAL . 83.6 Cg_endo -72.32 138.52 30.36 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 124.313 3.342 . . . . 0.0 109.592 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 110' ' ' GLY . 16.8 mt-10 -128.9 156.53 43.56 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.71 68.97 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 151.8 10.23 0.09 OUTLIER Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.545 ' HB3' ' CD1' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -68.17 167.7 13.66 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.507 HG23 ' C ' ' A' ' 111' ' ' MET . 62.0 t -156.41 82.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.35 137.13 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.91 HD23 ' N ' ' A' ' 119' ' ' PRO . 0.2 OUTLIER -101.36 156.72 17.28 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -109.65 0.49 19.04 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 176.47 -12.37 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.646 ' O ' HD22 ' A' ' 114' ' ' LEU . . . 166.93 -34.42 0.22 Allowed Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 3.3 mt -94.04 122.41 61.89 Favored Pre-proline 0 N--CA 1.449 -0.483 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.91 ' N ' HD23 ' A' ' 114' ' ' LEU . 84.9 Cg_endo -72.31 170.22 19.71 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 124.311 3.341 . . . . 0.0 109.662 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.883 ' HB1' ' HB3' ' A' ' 132' ' ' LEU . . . -128.58 73.61 1.51 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 28.8 m -50.2 95.36 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.625 ' HA ' ' HA ' ' A' ' 132' ' ' LEU . 1.8 mp -69.74 100.1 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 131' ' ' THR . 0.6 OUTLIER -85.19 -19.11 32.21 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.554 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 0.4 OUTLIER -121.77 131.77 54.25 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.654 HG22 ' O ' ' A' ' 125' ' ' VAL . 7.9 p -122.33 52.99 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.647 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -79.21 126.83 31.27 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.686 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.3 OUTLIER -53.16 0.21 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.647 ' H ' ' C ' ' A' ' 126' ' ' THR . 1.1 p30 -111.58 -21.22 11.85 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -177.85 168.5 2.08 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.918 HG11 ' CG ' ' A' ' 107' ' ' PRO . 29.0 m -132.09 145.42 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.698 HG23 ' HD2' ' A' ' 94' ' ' LYS . 21.4 m -102.47 84.71 2.48 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.999 HD11 HG12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -82.36 119.76 24.56 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.831 ' CG ' HD21 ' A' ' 135' ' ' ASN . 13.8 t0 -90.21 97.89 11.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.749 ' HB2' HE22 ' A' ' 93' ' ' GLN . 2.0 m-30 -41.25 -52.97 3.31 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.866 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 9.3 m120 48.44 -122.39 1.58 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.74 ' ND1' ' N ' ' A' ' 137' ' ' GLU . 24.3 t-80 179.71 174.93 0.8 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.74 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 0.5 OUTLIER -76.05 -8.62 57.4 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.959 HD22 HD22 ' A' ' 143' ' ' LEU . 52.5 mt -119.35 -1.48 10.77 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.497 ' CB ' ' HB3' ' A' ' 135' ' ' ASN . . . -67.71 141.66 56.56 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.591 ' HA3' ' HD2' ' A' ' 87' ' ' ARG . . . 41.95 27.16 0.36 Allowed Glycine 0 C--N 1.336 0.536 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.858 ' HE2' ' CD2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -138.49 146.11 41.62 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.494 ' C ' ' HD2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -99.19 137.39 37.78 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.959 HD22 HD22 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -124.7 152.07 44.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.598 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 2.1 t -73.86 165.72 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.731 ' CD2' HD13 ' A' ' 78' ' ' ILE . 30.9 m-85 -148.6 98.05 2.82 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.903 HG23 ' CG2' ' A' ' 75' ' ' THR . 24.0 m -89.8 57.78 4.0 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.81 HD13 ' CE1' ' A' ' 61' ' ' PHE . 2.3 mt -57.54 -179.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.749 ' H ' HG22 ' A' ' 147' ' ' ILE . 12.4 tttt -179.39 110.68 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.842 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 4.8 mm -67.14 145.29 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.649 HD13 ' HB3' ' A' ' 47' ' ' PRO . 4.1 mt -126.6 -45.86 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.662 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -161.66 -159.89 0.66 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.682 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 42.4 t -128.44 135.59 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.964 HG21 ' HB3' ' A' ' 49' ' ' GLU . 61.9 t -111.47 40.53 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.719 ' HB3' ' H ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.453 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.647 ' O ' HG23 ' A' ' 5' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 4' ' ' MET . 23.2 t -159.09 145.87 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -132.2 168.06 18.7 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.575 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 10.2 ptpt -72.93 70.32 1.01 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 174.13 -2.9 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.12 122.64 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.832 ' CA ' HG22 ' A' ' 51' ' ' VAL . 1.7 tttt -76.52 166.88 22.79 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.917 HG22 HG22 ' A' ' 152' ' ' VAL . 1.0 OUTLIER -168.65 132.07 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.714 ' HE2' ' CG2' ' A' ' 153' ' ' VAL . 17.4 mtmt -89.82 92.89 9.22 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.675 HG21 ' CG2' ' A' ' 147' ' ' ILE . 0.8 OUTLIER -112.66 152.99 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.606 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 4.4 m-20 -110.55 95.49 5.6 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.1 p90 -92.7 154.4 18.35 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 1.018 HG23 ' HB ' ' A' ' 27' ' ' THR . 6.5 mt -129.36 75.08 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -60.22 132.06 50.23 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.608 ' HE3' ' O ' ' A' ' 16' ' ' ILE . 4.5 mtmt -121.03 -160.77 0.86 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.88 HD12 ' HB2' ' A' ' 23' ' ' ASP . 30.5 mt -119.38 166.15 13.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.426 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 9.8 mt-10 -56.32 2.6 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.627 ' H ' ' C ' ' A' ' 19' ' ' LEU . 52.8 p -117.24 0.3 12.24 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.24 28.0 42.26 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.88 ' HB2' HD12 ' A' ' 19' ' ' LEU . 18.8 m-20 -96.15 119.2 34.21 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.555 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 63.9 t -69.06 114.26 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.556 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 1.6 p90 -103.08 -32.69 9.56 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.556 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 11.6 t0 -146.23 136.55 23.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 1.018 ' HB ' HG23 ' A' ' 16' ' ' ILE . 3.8 t -154.11 149.9 27.6 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.606 ' HB2' ' HA ' ' A' ' 14' ' ' ASP . 27.1 m -97.8 -17.41 19.37 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.821 HG22 ' H ' ' A' ' 32' ' ' VAL . 2.1 mt -85.01 95.15 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.49 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 4.9 tt0 -42.03 -29.59 0.23 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -59.62 -63.52 1.27 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.822 HG11 HG21 ' A' ' 16' ' ' ILE . 59.8 t -51.28 -38.97 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.714 ' HB1' ' HA ' ' A' ' 39' ' ' TYR . . . -48.03 -44.76 31.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.538 ' HG2' ' CB ' ' A' ' 39' ' ' TYR . 11.1 mtmt -71.52 -32.29 68.01 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -74.54 -15.53 60.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -110.23 -6.15 15.12 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.3 46.44 34.04 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.538 HG13 ' HA ' ' A' ' 33' ' ' ALA . 1.3 pt -143.3 11.98 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.714 ' HA ' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -45.39 -18.25 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.785 ' HB1' ' HB3' ' A' ' 43' ' ' ARG . . . 75.28 159.4 0.16 Allowed Pre-proline 0 N--CA 1.45 -0.433 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.597 ' HG2' ' H ' ' A' ' 42' ' ' ASP . 82.3 Cg_endo -72.43 -83.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 124.34 3.36 . . . . 0.0 109.604 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.597 ' H ' ' HG2' ' A' ' 41' ' ' PRO . 11.9 p-10 -99.88 -9.9 22.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.785 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -73.72 137.93 44.33 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.454 ' N ' ' HG3' ' A' ' 43' ' ' ARG . 54.5 mt-10 -104.38 -175.81 2.9 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -138.53 90.49 2.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.686 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.4 OUTLIER -83.44 178.49 2.39 Favored Pre-proline 0 N--CA 1.45 -0.449 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.686 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 83.2 Cg_endo -72.36 125.38 10.69 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 124.337 3.358 . . . . 0.0 109.586 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.0 83.12 0.11 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.58 ' OE2' HG21 ' A' ' 153' ' ' VAL . 40.6 tt0 -77.41 97.19 4.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.869 ' CD2' HD23 ' A' ' 57' ' ' LEU . 5.6 p90 -118.64 167.83 11.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.969 ' H ' ' NE2' ' A' ' 56' ' ' GLN . 21.4 t -128.36 114.44 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.914 HG11 ' HG ' ' A' ' 66' ' ' LEU . 9.1 t -46.99 -14.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.816 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -115.88 39.76 2.63 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.428 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -131.58 -19.7 2.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.23 18.13 79.74 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.969 ' NE2' ' H ' ' A' ' 51' ' ' VAL . 4.9 mt-30 -60.81 -63.12 1.41 Allowed 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.869 HD23 ' CD2' ' A' ' 50' ' ' PHE . 2.0 mm? -87.41 171.23 10.72 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.057 HD13 ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -66.21 155.09 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.522 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 2.3 mt-30 -49.72 -57.09 7.94 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.446 ' H ' ' HB3' ' A' ' 82' ' ' LYS . . . -39.58 -79.68 0.04 OUTLIER Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.667 ' CD1' ' CB ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -41.4 -52.21 3.6 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.727 ' O ' HG22 ' A' ' 65' ' ' VAL . 1.7 mt-10 -46.47 -42.19 15.07 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.875 ' HA ' HD12 ' A' ' 66' ' ' LEU . 4.8 mt-10 -70.17 -32.92 71.09 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.55 -24.85 67.98 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.753 HG21 ' CE2' ' A' ' 50' ' ' PHE . 8.6 m -100.25 -8.58 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.914 ' HG ' HG11 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -66.65 37.29 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.593 ' HA ' ' HG3' ' A' ' 4' ' ' MET . 0.3 OUTLIER 166.94 27.77 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.895 ' HE1' HD11 ' A' ' 149' ' ' ILE . 44.0 mtp -109.56 96.02 6.0 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.468 ' N ' ' OD2' ' A' ' 72' ' ' ASP . 0.5 OUTLIER -55.95 -177.09 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.618 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 1.5 t -75.18 108.42 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.842 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 116.07 -12.22 17.2 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 1.0 OUTLIER -65.53 166.37 10.59 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.42 ' HB2' ' HD2' ' A' ' 148' ' ' LYS . 0.0 OUTLIER -151.16 135.85 17.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.51 ' HB2' ' SD ' ' A' ' 68' ' ' MET . 1.4 tttm -142.33 102.33 4.07 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.588 ' OG1' HG23 ' A' ' 146' ' ' THR . 52.1 m -101.9 79.81 1.94 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.661 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 3.5 t -112.49 171.12 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.661 ' N ' ' CG1' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -105.18 114.11 28.1 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.722 HD13 ' CD2' ' A' ' 145' ' ' PHE . 0.5 OUTLIER -79.0 129.8 71.98 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.476 ' HG2' ' HG2' ' A' ' 81' ' ' GLU . 83.4 Cg_endo -72.39 144.37 40.81 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 124.304 3.336 . . . . 0.0 109.607 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.64 ' HB2' ' N ' ' A' ' 141' ' ' LYS . . . -55.85 -9.39 0.56 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.618 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 14.8 pt-20 -81.41 -38.21 26.88 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.446 ' HB3' ' H ' ' A' ' 60' ' ' GLY . 9.3 mtmt -86.94 -31.62 20.57 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.652 ' HA ' ' CB ' ' A' ' 58' ' ' ILE . . . -71.88 -95.88 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.732 ' CE2' ' CE1' ' A' ' 136' ' ' HIS . 2.0 m-85 -98.41 16.91 20.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.618 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 42.36 84.82 0.01 OUTLIER Glycine 0 C--N 1.335 0.509 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.698 ' N ' ' ND2' ' A' ' 86' ' ' ASN . 0.0 OUTLIER 49.01 -171.99 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.932 ' HG3' ' HB1' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -89.26 152.5 21.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.57 ' CB ' ' CD1' ' A' ' 91' ' ' LEU . 2.2 t30 -90.24 100.77 13.53 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.458 ' C ' ' H ' ' A' ' 91' ' ' LEU . 29.9 mt-10 -44.31 -25.36 0.23 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.19 16.68 0.3 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.734 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 17.5 mt -114.11 -4.08 13.18 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 20.6 mt -78.47 114.21 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.557 ' NE2' ' CD1' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -110.33 167.7 10.0 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.641 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -140.2 90.51 2.37 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.915 HG12 HD11 ' A' ' 132' ' ' LEU . 35.8 pt -85.41 154.66 59.71 Favored Pre-proline 0 N--CA 1.449 -0.478 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.56 ' HD2' ' HB2' ' A' ' 99' ' ' ALA . 82.6 Cg_endo -72.36 140.83 34.24 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 124.309 3.34 . . . . 0.0 109.636 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.927 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -41.8 -33.89 0.57 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.471 ' HA ' ' HB2' ' A' ' 101' ' ' LYS . 8.4 m-20 -66.53 -37.03 84.14 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.56 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . . . -43.52 -21.58 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.55 ' C ' ' H ' ' A' ' 102' ' ' GLU . 2.8 m-85 -122.2 -23.24 5.37 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.471 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -70.96 21.9 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.55 ' H ' ' C ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -143.59 -13.09 0.68 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.98 22.31 3.26 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 43.4 33.86 0.67 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.475 ' HD1' ' H ' ' A' ' 106' ' ' GLU . 0.3 OUTLIER -123.74 -149.46 0.42 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.475 ' H ' ' HD1' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -173.6 113.03 0.33 Allowed Pre-proline 0 N--CA 1.448 -0.525 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.927 ' CG ' HH21 ' A' ' 97' ' ' ARG . 83.5 Cg_endo -72.38 147.26 46.61 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 124.275 3.316 . . . . 0.0 109.632 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 110' ' ' GLY . 1.3 mm-40 -138.37 151.94 47.96 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.543 ' HB2' HG12 ' A' ' 125' ' ' VAL . 2.5 tm-20 -66.4 66.33 0.05 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.76 9.27 0.08 OUTLIER Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.509 ' CB ' HD12 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -62.87 170.09 2.86 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.678 HG13 ' HB2' ' A' ' 119' ' ' PRO . 61.1 t -155.63 65.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.92 137.31 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.61 HD23 ' CD ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -109.3 146.09 34.88 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.432 ' O ' ' CB ' ' A' ' 116' ' ' GLU . . . -95.04 4.19 54.02 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.432 ' CB ' ' O ' ' A' ' 115' ' ' ALA . 0.9 OUTLIER 166.64 -12.15 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.48 -37.73 0.2 Allowed Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 134' ' ' PHE . 1.2 mt -85.93 111.72 40.06 Favored Pre-proline 0 N--CA 1.449 -0.484 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.678 ' HB2' HG13 ' A' ' 112' ' ' VAL . 82.7 Cg_endo -72.37 159.56 49.07 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 124.352 3.368 . . . . 0.0 109.579 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.763 ' HB1' ' HB3' ' A' ' 132' ' ' LEU . . . -121.51 84.05 2.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.577 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 3.5 m -53.34 97.52 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.715 ' CG1' HD23 ' A' ' 132' ' ' LEU . 72.3 mt -76.58 91.1 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 131' ' ' THR . 0.2 OUTLIER -77.53 -27.24 51.62 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.861 ' HB3' ' H ' ' A' ' 131' ' ' THR . 0.5 OUTLIER -111.12 132.42 54.29 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.688 HG22 ' O ' ' A' ' 125' ' ' VAL . 7.1 p -129.67 53.55 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.697 ' C ' ' H ' ' A' ' 128' ' ' ASN . 81.4 p -80.1 133.11 36.06 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.583 ' HA ' ' HD3' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -54.58 4.36 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.697 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -112.21 -24.73 9.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -177.22 -178.45 0.79 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.537 HG11 ' CG ' ' A' ' 107' ' ' PRO . 4.2 m -144.57 134.14 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.861 ' H ' ' HB3' ' A' ' 124' ' ' GLU . 17.4 m -95.82 95.26 8.16 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.915 HD11 HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -87.66 166.62 14.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.663 ' CG ' HD21 ' A' ' 135' ' ' ASN . 15.4 t0 -137.39 97.95 3.59 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.557 ' CD1' ' NE2' ' A' ' 93' ' ' GLN . 3.3 m-30 -41.57 -41.48 2.17 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.734 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 7.1 m120 41.47 -121.94 0.51 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.922 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 8.9 t-80 177.01 169.49 0.54 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.576 ' CG ' HD22 ' A' ' 138' ' ' LEU . 3.0 tp10 -58.55 -53.88 53.38 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.92 ' CG ' HD22 ' A' ' 143' ' ' LEU . 2.2 mm? -97.83 20.02 12.78 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.932 ' HB1' ' HG3' ' A' ' 87' ' ' ARG . . . -66.57 134.45 52.37 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.621 ' HA2' ' HA ' ' A' ' 86' ' ' ASN . . . 38.85 30.54 0.11 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.805 ' HE2' ' CD1' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -138.42 144.42 40.16 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.515 ' N ' ' HD3' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -94.04 138.84 31.67 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.92 HD22 ' CG ' ' A' ' 138' ' ' LEU . 0.5 OUTLIER -129.13 140.47 51.53 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.607 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 7.8 t -66.45 168.25 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.722 ' CD2' HD13 ' A' ' 78' ' ' ILE . 23.2 m-85 -152.79 93.92 1.81 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.656 HG22 ' O ' ' A' ' 146' ' ' THR . 54.9 m -87.97 62.66 6.97 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.675 ' CG2' HG21 ' A' ' 13' ' ' VAL . 1.4 mt -57.58 179.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.529 ' H ' HG22 ' A' ' 147' ' ' ILE . 6.5 tptt 179.3 100.42 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.895 HD11 ' HE1' ' A' ' 68' ' ' MET . 1.0 OUTLIER -63.23 139.24 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.531 HD11 ' OD1' ' A' ' 14' ' ' ASP . 12.6 mt -126.47 -31.5 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.618 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 1.5 mt-10 -166.8 -170.91 1.69 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.917 HG22 HG22 ' A' ' 11' ' ' ILE . 47.2 t -136.95 144.6 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.714 ' CG2' ' HE2' ' A' ' 12' ' ' LYS . 38.8 t -145.05 47.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.763 ' HA ' ' H ' ' A' ' 10' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.795 ' N ' ' HA ' ' A' ' 69' ' ' GLU . 1.5 ttm . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.105 HG21 HG21 ' A' ' 11' ' ' ILE . 58.7 t -131.27 148.6 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.593 ' HA ' ' CD2' ' A' ' 66' ' ' LEU . 1.1 m-20 -119.67 173.79 6.8 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.519 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 9.4 ptpt -68.83 68.46 0.16 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.403 ' H ' ' H ' ' A' ' 9' ' ' VAL . . . 168.93 7.03 0.03 OUTLIER Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.021 ' HB ' HG13 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -126.78 134.47 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.895 ' H ' ' HB3' ' A' ' 154' ' ' GLU . 9.1 tttt -87.73 158.48 18.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.105 HG21 HG21 ' A' ' 5' ' ' VAL . 3.3 pt -162.09 139.46 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.938 ' HE2' HG22 ' A' ' 153' ' ' VAL . 20.0 mtmt -89.91 78.48 6.78 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.625 HG22 ' CE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -116.83 145.71 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.707 ' OD2' HD11 ' A' ' 150' ' ' ILE . 0.0 OUTLIER -98.29 -160.67 0.82 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 0.3 OUTLIER 178.4 156.72 0.44 Allowed 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.985 HG23 ' HB ' ' A' ' 27' ' ' THR . 4.5 mt -136.68 77.7 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -61.73 133.22 47.08 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.588 ' HE3' ' O ' ' A' ' 16' ' ' ILE . 4.9 mttt -120.42 -157.89 0.73 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.593 ' C ' ' H ' ' A' ' 21' ' ' SER . 1.8 mt -123.05 165.62 16.48 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -53.79 -2.05 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.593 ' H ' ' C ' ' A' ' 19' ' ' LEU . 59.6 p -113.6 9.03 17.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 19' ' ' LEU . . . 70.91 29.73 68.84 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.46 ' C ' ' HG2' ' A' ' 18' ' ' LYS . 4.2 m-20 -98.43 122.75 42.01 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.557 HG13 HG22 ' A' ' 16' ' ' ILE . 35.5 t -67.89 118.34 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -110.87 -27.51 8.8 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.734 ' HA ' HH22 ' A' ' 43' ' ' ARG . 14.7 t0 -151.95 141.24 21.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.985 ' HB ' HG23 ' A' ' 16' ' ' ILE . 2.5 t -152.89 153.76 33.69 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.586 ' HA ' ' HA ' ' A' ' 45' ' ' TYR . 0.6 OUTLIER -104.35 14.76 29.6 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.518 HG22 ' H ' ' A' ' 32' ' ' VAL . 6.4 mt -124.97 99.17 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.678 ' CG ' ' CE2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -43.12 -35.8 1.46 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -53.71 -65.03 0.64 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.732 HG11 HG21 ' A' ' 16' ' ' ILE . 87.9 t -47.83 -43.66 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.708 ' HB2' ' CE1' ' A' ' 45' ' ' TYR . . . -44.35 -51.75 8.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.527 ' CG ' ' HB2' ' A' ' 39' ' ' TYR . 13.9 mtpt -65.42 -28.07 68.98 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 32' ' ' VAL . 45.8 tt0 -86.08 -13.62 46.76 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.536 ' HB1' ' HB ' ' A' ' 24' ' ' VAL . . . -106.59 -23.38 12.48 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 33' ' ' ALA . . . 99.32 14.87 34.3 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.606 ' CG1' ' HA ' ' A' ' 33' ' ' ALA . 1.6 pt -114.87 31.55 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.582 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 3.6 t80 -64.49 70.02 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.918 ' HB3' ' HB2' ' A' ' 43' ' ' ARG . . . -57.19 146.66 60.59 Favored Pre-proline 0 N--CA 1.449 -0.494 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.35 -37.77 4.13 Favored 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 124.329 3.353 . . . . 0.0 109.62 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -134.67 57.19 1.82 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.918 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -78.85 -150.5 0.05 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.885 ' H ' ' HD2' ' A' ' 43' ' ' ARG . 0.2 OUTLIER -145.96 50.13 1.18 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.708 ' CE1' ' HB2' ' A' ' 33' ' ' ALA . 25.9 m-85 -66.72 -133.05 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.668 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER 61.52 178.0 0.04 OUTLIER Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.881 ' HB3' HD12 ' A' ' 150' ' ' ILE . 83.5 Cg_endo -72.37 116.9 4.89 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 124.3 3.333 . . . . 0.0 109.585 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.1 tp -82.49 103.81 12.31 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.734 ' OE1' HG11 ' A' ' 153' ' ' VAL . 36.7 tt0 -83.61 100.52 10.87 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.69 ' CD2' HD21 ' A' ' 57' ' ' LEU . 2.1 p90 -122.9 170.76 9.78 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.974 ' H ' ' NE2' ' A' ' 56' ' ' GLN . 48.9 t -124.82 113.56 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.854 HG11 ' CG ' ' A' ' 66' ' ' LEU . 3.5 t -49.67 -8.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.838 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -121.08 38.2 2.76 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.424 ' HG3' ' HB ' ' A' ' 51' ' ' VAL . 2.1 mt-10 -123.29 -19.65 5.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.36 18.19 62.92 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.974 ' NE2' ' H ' ' A' ' 51' ' ' VAL . 6.2 mt-30 -72.86 -76.83 0.11 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.69 HD21 ' CD2' ' A' ' 50' ' ' PHE . 1.3 mm? -73.17 149.58 42.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.886 HD13 ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -55.68 163.27 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.64 HE21 ' HA ' ' A' ' 82' ' ' LYS . 16.1 mt-30 -53.53 -59.08 5.05 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.826 ' H ' ' HB3' ' A' ' 82' ' ' LYS . . . -41.54 -78.78 0.06 OUTLIER Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.279 -1.129 . . . . 0.0 110.279 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.651 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 1.0 OUTLIER -38.34 -52.37 1.52 Allowed 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -48.59 -51.77 26.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.806 ' HA ' HD12 ' A' ' 66' ' ' LEU . 6.8 mt-10 -58.33 -27.67 64.36 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.651 ' HB3' ' O ' ' A' ' 61' ' ' PHE . . . -63.9 -55.28 23.88 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.554 HG13 HD13 ' A' ' 147' ' ' ILE . 33.9 m -78.84 4.08 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.854 ' CG ' HG11 ' A' ' 52' ' ' VAL . 5.3 mt -84.77 -38.08 20.05 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.07 26.01 11.13 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.988 ' CE ' HD11 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -104.2 -155.11 0.52 Allowed 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.795 ' HA ' ' N ' ' A' ' 4' ' ' MET . 0.5 OUTLIER -144.35 -177.38 5.44 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.618 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 1.1 t -90.71 84.36 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.771 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 131.07 12.54 2.09 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.484 ' CG ' ' HB2' ' A' ' 69' ' ' GLU . 1.3 m-20 -100.54 -170.56 1.88 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.2 126.4 6.58 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.469 ' CB ' ' HE2' ' A' ' 68' ' ' MET . 2.3 ttmm -119.63 96.3 5.14 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.537 ' OG1' HG23 ' A' ' 146' ' ' THR . 62.8 m -96.87 83.05 3.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.452 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 3.8 t -119.69 157.75 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 13.7 ttmt -89.87 114.48 26.25 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.692 HD13 ' CD2' ' A' ' 145' ' ' PHE . 0.3 OUTLIER -79.11 130.18 70.36 Favored Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.479 ' O ' ' N ' ' A' ' 81' ' ' GLU . 84.6 Cg_endo -72.34 134.3 22.49 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 124.286 3.324 . . . . 0.0 109.634 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.727 ' HB2' ' N ' ' A' ' 141' ' ' LYS . . . -46.81 -14.56 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.601 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 3.2 tp10 -76.64 -39.3 52.74 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.826 ' HB3' ' H ' ' A' ' 60' ' ' GLY . 14.6 mttt -81.97 -34.13 29.89 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.627 ' HA ' ' CG2' ' A' ' 58' ' ' ILE . . . -73.31 -102.05 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.561 ' CE1' ' HB2' ' A' ' 138' ' ' LEU . 2.8 m-85 -90.7 20.29 4.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 47.38 89.24 0.01 OUTLIER Glycine 0 C--N 1.336 0.535 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.584 ' HA ' ' HA2' ' A' ' 140' ' ' GLY . 0.0 OUTLIER 40.99 -133.94 0.28 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.495 ' H ' ' HB2' ' A' ' 86' ' ' ASN . 0.3 OUTLIER -90.85 149.17 22.06 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.899 ' CB ' HD12 ' A' ' 91' ' ' LEU . 1.7 m120 -87.52 135.18 33.45 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -81.46 -26.55 35.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.96 -4.99 59.13 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.899 HD12 ' CB ' ' A' ' 88' ' ' ASN . 28.2 mt -102.83 13.31 34.7 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.617 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 26.5 mt -82.5 124.09 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.773 HE22 ' HB2' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -115.53 156.2 26.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.724 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -133.32 90.16 2.7 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.65 HG23 HD11 ' A' ' 132' ' ' LEU . 34.4 pt -88.25 154.25 51.62 Favored Pre-proline 0 N--CA 1.449 -0.501 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.512 ' O ' ' N ' ' A' ' 99' ' ' ALA . 81.5 Cg_endo -72.44 141.49 35.14 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 124.275 3.316 . . . . 0.0 109.591 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.924 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -44.11 -30.59 0.78 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.522 ' HA ' ' HB2' ' A' ' 101' ' ' LYS . 5.1 t70 -68.93 -36.18 77.67 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -47.9 -27.76 2.31 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.623 ' CE2' ' HB3' ' A' ' 107' ' ' PRO . 0.6 OUTLIER -99.41 -33.03 10.86 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 1.1 tttm -58.22 -0.35 0.09 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.531 ' H ' ' C ' ' A' ' 100' ' ' PHE . 7.8 mm-40 -117.12 4.65 12.71 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.14 -133.94 0.07 Allowed 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.71 -8.96 1.87 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.422 ' HB2' ' H ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -137.76 -157.73 0.8 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.471 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 1.6 pm0 -125.88 137.78 30.75 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.924 ' CG ' HH21 ' A' ' 97' ' ' ARG . 83.5 Cg_endo -72.3 129.31 14.78 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 124.38 3.387 . . . . 0.0 109.584 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 110' ' ' GLY . 1.7 mm-40 -125.65 150.84 47.25 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.454 ' HA ' HG22 ' A' ' 122' ' ' ILE . 2.5 tm-20 -62.68 71.07 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 151.86 14.72 0.07 OUTLIER Glycine 0 C--N 1.335 0.513 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.907 ' CB ' HD13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -74.41 173.53 10.16 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.531 HG13 ' HB2' ' A' ' 119' ' ' PRO . 61.1 t -156.84 82.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.453 ' C ' ' HA ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -115.31 127.67 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.989 HD23 ' HD3' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -102.32 163.25 12.34 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -112.61 6.97 18.62 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 169.93 -6.33 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 156.34 -21.91 0.49 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.494 ' C ' ' HB3' ' A' ' 114' ' ' LEU . 3.0 mt -102.7 103.15 30.82 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.989 ' HD3' HD23 ' A' ' 114' ' ' LEU . 82.7 Cg_endo -72.4 158.72 50.85 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 124.264 3.309 . . . . 0.0 109.572 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.75 ' HB1' ' HB2' ' A' ' 132' ' ' LEU . . . -115.83 87.05 2.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 32.5 m -55.57 97.98 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.907 HD13 ' CB ' ' A' ' 111' ' ' MET . 1.8 mp -63.45 99.96 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.3 p -86.09 -21.19 27.8 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.779 ' HB3' ' H ' ' A' ' 131' ' ' THR . 1.6 tp10 -128.66 136.1 50.18 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.732 ' HA ' HG12 ' A' ' 130' ' ' VAL . 10.7 p -119.3 56.71 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.915 HG22 HD21 ' A' ' 128' ' ' ASN . 0.1 OUTLIER -78.44 123.97 27.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.512 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.2 OUTLIER -52.01 -2.54 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.915 HD21 HG22 ' A' ' 126' ' ' THR . 0.0 OUTLIER -111.69 -17.87 12.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 126' ' ' THR . 0.3 OUTLIER -179.33 163.33 1.25 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.916 HG11 ' HB2' ' A' ' 107' ' ' PRO . 0.6 OUTLIER -127.48 118.9 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.779 ' H ' ' HB3' ' A' ' 124' ' ' GLU . 20.7 m -82.03 84.95 6.82 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.75 ' HB2' ' HB1' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -79.7 169.66 17.65 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.617 ' HA ' ' HA ' ' A' ' 92' ' ' ILE . 11.6 t0 -132.29 95.3 3.62 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.773 ' HB2' HE22 ' A' ' 93' ' ' GLN . 2.1 m-30 -37.7 -38.96 0.31 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.752 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 0.8 OUTLIER 38.89 -118.32 0.23 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.759 ' ND1' ' N ' ' A' ' 137' ' ' GLU . 14.1 t-80 177.93 176.88 0.41 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.759 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -73.36 -8.39 55.68 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.931 HD22 HD22 ' A' ' 143' ' ' LEU . 72.0 mt -122.08 -5.63 8.96 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.752 ' HB3' ' HB3' ' A' ' 135' ' ' ASN . . . -68.1 133.66 49.32 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 86' ' ' ASN . . . 55.25 24.45 36.88 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.867 ' HE2' ' CD2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -142.07 145.94 34.89 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.503 ' C ' ' HD2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -98.91 137.61 37.23 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.931 HD22 HD22 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -127.15 152.76 46.92 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 2.0 t -74.36 165.69 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.692 ' CD2' HD13 ' A' ' 78' ' ' ILE . 28.0 m-85 -153.27 94.65 1.85 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.653 HG22 ' O ' ' A' ' 146' ' ' THR . 42.0 m -88.54 67.37 8.49 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.627 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -60.72 -177.81 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.496 ' H ' HG22 ' A' ' 147' ' ' ILE . 10.6 tttt -175.45 108.34 0.1 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 1.03 HD12 ' H ' ' A' ' 149' ' ' ILE . 1.5 mp -75.4 134.11 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.881 HD12 ' HB3' ' A' ' 47' ' ' PRO . 6.9 mt -113.47 -41.61 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.618 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -166.02 -156.31 0.25 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.634 ' HA ' ' HA ' ' A' ' 11' ' ' ILE . 18.6 t -131.63 155.1 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.938 HG22 ' HE2' ' A' ' 12' ' ' LYS . 2.6 t -138.03 39.73 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.895 ' HB3' ' H ' ' A' ' 10' ' ' LYS . 9.8 tp10 . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.63 HG22 HG21 ' A' ' 11' ' ' ILE . 48.8 t 65.88 117.47 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 8' ' ' GLY . 0.5 OUTLIER -154.49 177.48 11.13 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.547 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 15.7 ptmt -66.32 65.45 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 6' ' ' ASP . . . 156.05 23.78 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.17 125.63 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.6 ' HB3' ' N ' ' A' ' 154' ' ' GLU . 2.8 ttpm? -85.22 150.21 24.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.866 HG22 HG22 ' A' ' 152' ' ' VAL . 1.2 pt -154.17 126.9 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.655 ' HE2' HG21 ' A' ' 153' ' ' VAL . 21.0 mtmt -86.77 86.14 7.31 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.596 ' CG1' ' HA ' ' A' ' 149' ' ' ILE . 0.7 OUTLIER -114.93 152.48 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.806 ' CG ' HD11 ' A' ' 150' ' ' ILE . 0.8 OUTLIER -117.49 108.32 15.37 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.631 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.2 p90 -94.32 160.94 14.45 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 1.037 HG23 ' HB ' ' A' ' 27' ' ' THR . 5.1 mt -129.98 75.49 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -59.14 136.64 50.93 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.602 ' HE3' ' O ' ' A' ' 16' ' ' ILE . 6.6 mttt -122.87 -159.6 0.85 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.589 ' C ' ' H ' ' A' ' 21' ' ' SER . 57.8 mt -117.68 165.93 13.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -55.33 0.05 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.589 ' H ' ' C ' ' A' ' 19' ' ' LEU . 56.8 p -114.16 2.11 14.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.32 28.6 52.49 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.456 ' C ' ' HG2' ' A' ' 18' ' ' LYS . 4.1 m-20 -97.81 123.55 41.82 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.577 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 47.4 t -67.87 126.02 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.579 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 1.9 p90 -119.62 -38.85 2.93 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.579 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 8.3 t0 -138.13 135.7 35.99 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 1.037 ' HB ' HG23 ' A' ' 16' ' ' ILE . 3.9 t -152.58 148.75 27.72 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.46 ' HB3' ' HB3' ' A' ' 14' ' ' ASP . 0.6 OUTLIER -91.79 -18.78 23.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.744 HD11 ' CG ' ' A' ' 14' ' ' ASP . 4.6 mt -93.81 121.1 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.596 ' HG3' ' CD1' ' A' ' 45' ' ' TYR . 3.5 tt0 -63.62 -32.02 73.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -51.67 -63.41 1.14 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.913 HG11 HG21 ' A' ' 16' ' ' ILE . 52.0 t -50.58 -42.18 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.67 ' HB1' ' HA ' ' A' ' 39' ' ' TYR . . . -46.11 -42.79 14.16 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.534 ' HG2' ' CB ' ' A' ' 39' ' ' TYR . 11.6 mtmt -71.62 -32.41 67.95 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -74.46 -17.61 60.75 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.5 -7.57 16.52 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.0 43.73 32.67 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.54 HG13 ' HA ' ' A' ' 33' ' ' ALA . 1.8 pt -139.65 11.16 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.67 ' HA ' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -46.95 -21.39 0.21 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 1.001 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . 67.99 175.55 0.07 OUTLIER Pre-proline 0 N--CA 1.45 -0.474 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 1.001 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 83.2 Cg_endo -72.33 -69.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 124.299 3.333 . . . . 0.0 109.623 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.695 ' CG ' ' H ' ' A' ' 43' ' ' ARG . 9.0 p-10 -109.92 -68.21 0.94 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.695 ' H ' ' CG ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 41.73 -153.71 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.48 ' H ' ' HD2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER 179.15 81.13 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.596 ' CD1' ' HG3' ' A' ' 30' ' ' GLU . 2.9 m-85 -76.45 101.37 5.57 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.738 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -114.53 -179.15 0.58 Allowed Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.738 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 82.4 Cg_endo -72.38 122.53 8.4 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 124.283 3.322 . . . . 0.0 109.607 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.9 HD21 HD21 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -75.43 96.0 3.36 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.549 ' HG2' ' CG ' ' A' ' 10' ' ' LYS . 48.0 tt0 -79.31 97.49 6.31 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.831 ' CE2' HG21 ' A' ' 65' ' ' VAL . 39.7 p90 -110.81 170.39 8.13 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.02 ' H ' ' NE2' ' A' ' 56' ' ' GLN . 89.6 t -134.48 104.4 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.558 HG21 HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -44.54 -17.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.628 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -101.24 37.59 3.54 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 51' ' ' VAL . 5.5 mt-10 -141.78 -30.08 0.6 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.1 7.37 77.35 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 1.02 ' NE2' ' H ' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -42.3 -68.89 0.16 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.9 HD21 HD21 ' A' ' 48' ' ' LEU . 2.3 mm? -79.74 160.37 26.25 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.693 HG13 HG21 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -60.48 160.35 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.837 HE21 ' HA ' ' A' ' 82' ' ' LYS . 6.1 mt-30 -48.85 -67.01 0.3 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.952 ' HA3' HD12 ' A' ' 78' ' ' ILE . . . -29.86 -74.37 0.04 OUTLIER Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.61 ' CE2' HG23 ' A' ' 147' ' ' ILE . 1.0 OUTLIER -45.98 -51.72 12.95 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 59' ' ' GLN . 2.9 mt-10 -50.49 -38.63 45.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.602 ' HA ' HD12 ' A' ' 66' ' ' LEU . 18.9 mt-10 -74.63 -25.09 58.99 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.763 ' HB1' ' HB3' ' A' ' 74' ' ' LYS . . . -68.88 -51.7 37.49 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.831 HG21 ' CE2' ' A' ' 50' ' ' PHE . 27.2 m -74.0 -12.71 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.602 HD12 ' HA ' ' A' ' 63' ' ' GLU . 2.5 mt -60.51 106.31 0.53 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 66' ' ' LEU . 1.8 m-20 84.34 33.06 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.511 ' HG2' ' HB3' ' A' ' 72' ' ' ASP . 4.8 mtp -123.43 106.29 10.52 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -70.53 -179.63 2.18 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.887 HG22 HG23 ' A' ' 152' ' ' VAL . 7.1 t -60.05 127.4 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 107.43 -32.3 7.29 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.511 ' HB3' ' HG2' ' A' ' 68' ' ' MET . 0.9 OUTLIER -54.07 160.47 1.52 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.52 145.83 21.82 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.763 ' HB3' ' HB1' ' A' ' 64' ' ' ALA . 2.2 tttt -143.78 98.72 3.28 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.745 ' OG1' HG23 ' A' ' 146' ' ' THR . 83.1 m -100.01 83.17 2.66 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 2.9 t -121.62 156.13 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 19.8 ttpt -79.16 114.71 18.32 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.952 HD12 ' HA3' ' A' ' 60' ' ' GLY . 24.5 mm -78.51 123.24 85.65 Favored Pre-proline 0 N--CA 1.449 -0.489 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.656 ' HG3' ' HE3' ' A' ' 82' ' ' LYS . 85.0 Cg_endo -72.29 145.03 42.61 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 124.361 3.374 . . . . 0.0 109.587 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.538 ' O ' ' CA ' ' A' ' 85' ' ' GLY . . . -54.33 -23.74 16.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.527 ' CG ' ' HB2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -69.87 -41.07 75.29 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.837 ' HA ' HE21 ' A' ' 59' ' ' GLN . 17.8 mttt -82.24 -28.79 31.67 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.771 ' HB2' HG21 ' A' ' 78' ' ' ILE . . . -112.75 110.97 21.42 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.639 ' CD2' ' HB3' ' A' ' 138' ' ' LEU . 32.6 m-85 70.91 -9.78 0.81 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 80' ' ' ALA . . . 64.02 156.41 0.15 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.702 ' ND2' ' H ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -41.36 155.4 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.435 ' HD2' ' OD1' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -39.41 131.1 1.68 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.566 ' CB ' HD12 ' A' ' 91' ' ' LEU . 7.7 t30 -81.08 147.73 29.98 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -85.12 -27.49 26.2 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.88 -0.56 18.9 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.766 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 71.7 mt -98.95 3.46 47.07 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.609 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 42.1 mt -85.77 113.32 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.641 HE22 ' HB2' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -108.2 145.73 33.82 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.618 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -128.3 97.2 4.67 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.019 HG12 HD11 ' A' ' 132' ' ' LEU . 25.2 pt -92.63 153.63 42.4 Favored Pre-proline 0 N--CA 1.45 -0.454 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.559 ' HG2' ' HB2' ' A' ' 99' ' ' ALA . 83.6 Cg_endo -72.44 139.65 31.98 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 124.272 3.314 . . . . 0.0 109.562 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.782 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -44.73 -26.89 0.43 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.548 ' HA ' ' HB2' ' A' ' 101' ' ' LYS . 10.0 t70 -73.73 -34.01 64.58 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.559 ' HB2' ' HG2' ' A' ' 96' ' ' PRO . . . -58.5 -22.28 54.56 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.675 ' CD1' ' CD1' ' A' ' 95' ' ' ILE . 1.8 m-85 -121.42 2.88 10.26 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.548 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 0.2 OUTLIER -53.06 -41.44 64.85 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -118.74 34.68 5.1 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.672 ' HB2' ' HA ' ' A' ' 100' ' ' PHE . . . -81.15 20.06 0.86 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 59.34 -6.75 0.06 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.621 ' H ' ' C ' ' A' ' 103' ' ' ALA . 0.5 OUTLIER -150.63 147.52 27.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.496 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 0.6 OUTLIER -94.83 129.67 35.33 Favored Pre-proline 0 N--CA 1.449 -0.496 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.846 ' CG ' HG11 ' A' ' 130' ' ' VAL . 82.6 Cg_endo -72.36 135.02 23.77 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 124.367 3.378 . . . . 0.0 109.544 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 110' ' ' GLY . 1.2 mt-10 -124.19 156.81 36.12 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.481 ' HB2' HG12 ' A' ' 125' ' ' VAL . 2.8 tm-20 -65.7 67.55 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.65 14.04 0.06 OUTLIER Glycine 0 C--N 1.336 0.537 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.808 ' HB3' HD12 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -69.97 171.27 9.72 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.66 HG13 ' HB2' ' A' ' 119' ' ' PRO . 64.0 t -156.7 70.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.19 135.49 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.882 HD23 ' N ' ' A' ' 119' ' ' PRO . 0.3 OUTLIER -99.2 149.2 23.33 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -103.37 3.48 35.22 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 171.41 -11.09 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.652 ' O ' HD22 ' A' ' 114' ' ' LEU . . . 166.06 -34.88 0.24 Allowed Glycine 0 C--N 1.335 0.492 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 3.0 mt -93.3 121.32 65.51 Favored Pre-proline 0 N--CA 1.448 -0.53 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.882 ' N ' HD23 ' A' ' 114' ' ' LEU . 83.9 Cg_endo -72.39 164.13 36.55 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 124.282 3.321 . . . . 0.0 109.631 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.866 ' HB1' ' HB3' ' A' ' 132' ' ' LEU . . . -123.55 82.94 2.07 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 2.4 m -54.13 94.82 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.808 HD12 ' HB3' ' A' ' 111' ' ' MET . 12.8 mt -70.49 97.3 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.482 HG22 HG22 ' A' ' 121' ' ' THR . 1.3 p -82.68 -24.73 33.56 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.769 ' HG2' HG23 ' A' ' 126' ' ' THR . 1.2 tt0 -111.54 132.38 54.56 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.705 HG22 ' O ' ' A' ' 125' ' ' VAL . 8.1 p -126.22 48.03 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.769 HG23 ' HG2' ' A' ' 124' ' ' GLU . 2.1 p -79.85 129.28 34.35 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.552 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.4 OUTLIER -53.87 2.41 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.682 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -110.79 -22.74 11.41 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -177.88 168.66 2.06 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.846 HG11 ' CG ' ' A' ' 107' ' ' PRO . 22.0 m -132.15 143.56 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.618 HG23 ' HD2' ' A' ' 94' ' ' LYS . 16.3 m -99.75 85.37 3.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 1.019 HD11 HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -82.5 107.72 15.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.609 ' HA ' ' HA ' ' A' ' 92' ' ' ILE . 18.8 t0 -83.86 97.04 8.98 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.641 ' HB2' HE22 ' A' ' 93' ' ' GLN . 2.3 m-85 -42.53 -45.55 4.55 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.766 ' H ' ' HB3' ' A' ' 91' ' ' LEU . 6.7 m120 42.17 -121.76 0.58 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.695 ' ND1' ' N ' ' A' ' 137' ' ' GLU . 21.6 t-80 -179.21 166.87 1.54 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.695 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 0.9 OUTLIER -70.99 -16.07 62.61 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 1.04 HD12 HD22 ' A' ' 143' ' ' LEU . 3.4 mm? -111.26 -23.2 10.97 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.528 ' HB2' ' HB3' ' A' ' 136' ' ' HIS . . . -48.66 144.66 4.18 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 42.45 22.12 0.12 Allowed Glycine 0 C--N 1.336 0.531 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.81 ' HD2' HD13 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -133.09 133.03 42.42 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.566 ' C ' ' HD3' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -99.11 131.56 45.06 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 1.04 HD22 HD12 ' A' ' 138' ' ' LEU . 2.4 pt? -122.57 146.43 47.44 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.578 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 4.0 t -67.71 163.04 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.737 ' CD1' ' CG1' ' A' ' 78' ' ' ILE . 16.4 m-85 -146.43 85.87 1.66 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.745 HG23 ' OG1' ' A' ' 75' ' ' THR . 95.0 m -83.82 70.81 10.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.631 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 2.1 mt -64.4 179.54 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.631 ' H ' HG22 ' A' ' 147' ' ' ILE . 3.1 tmtt? -177.65 96.49 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.596 ' HA ' ' CG1' ' A' ' 13' ' ' VAL . 2.4 mm -60.06 135.01 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.806 HD11 ' CG ' ' A' ' 14' ' ' ASP . 2.3 mt -122.51 -24.62 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -163.11 176.39 10.09 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.887 HG23 HG22 ' A' ' 70' ' ' VAL . 85.7 t -137.69 136.84 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.655 HG21 ' HE2' ' A' ' 12' ' ' LYS . 0.9 OUTLIER -142.99 -142.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.6 ' N ' ' HB3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.498 ' N ' ' OE1' ' A' ' 69' ' ' GLU . 22.7 ttt . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.906 HG21 HD13 ' A' ' 11' ' ' ILE . 16.6 t -81.07 162.62 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.464 ' N ' HG12 ' A' ' 5' ' ' VAL . 7.8 m-20 -143.4 168.83 18.89 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.527 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 11.7 ptmt -66.05 69.59 0.06 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 6' ' ' ASP . . . 162.59 11.3 0.03 OUTLIER Glycine 0 C--N 1.336 0.561 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.827 ' HB ' HG13 ' A' ' 5' ' ' VAL . 1.4 t -119.05 133.96 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.909 ' H ' ' HB3' ' A' ' 154' ' ' GLU . 3.6 tttt -86.64 133.39 33.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.999 ' CG2' HG22 ' A' ' 152' ' ' VAL . 9.6 pt -147.03 136.38 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.615 ' CG ' HG23 ' A' ' 153' ' ' VAL . 9.5 mtpt -95.03 91.94 6.6 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.633 HG22 ' CE1' ' A' ' 50' ' ' PHE . 1.1 m -118.35 145.79 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 147' ' ' ILE . 41.3 m-20 -92.19 -166.69 1.6 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.0 OUTLIER -179.81 151.79 0.45 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 1.077 HD13 HG21 ' A' ' 32' ' ' VAL . 3.5 mt -133.22 81.65 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -65.74 138.62 37.91 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.643 ' HE2' HG22 ' A' ' 24' ' ' VAL . 10.4 mttt -125.44 -165.81 1.46 Allowed 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.636 ' C ' ' H ' ' A' ' 21' ' ' SER . 34.1 mt -112.98 166.52 11.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -54.84 0.77 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.636 ' H ' ' C ' ' A' ' 19' ' ' LEU . 54.2 p -112.4 2.54 16.47 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.04 30.51 57.26 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 18' ' ' LYS . 87.3 m-20 -100.87 124.29 46.33 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.643 HG22 ' HE2' ' A' ' 18' ' ' LYS . 82.2 t -71.06 122.83 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.484 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -115.48 -30.13 6.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.484 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 16.7 t0 -143.56 140.23 30.13 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 1.015 ' HB ' HG23 ' A' ' 16' ' ' ILE . 6.1 t -158.72 148.66 19.48 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.4 m -101.78 16.68 25.12 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 29.0 mt -127.91 108.47 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.583 ' HG3' ' CD1' ' A' ' 45' ' ' TYR . 2.8 tt0 -48.81 -35.42 14.45 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -47.4 -64.66 0.72 Allowed 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.077 HG21 HD13 ' A' ' 16' ' ' ILE . 49.5 t -53.81 -40.39 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.596 ' HA ' ' CG1' ' A' ' 38' ' ' ILE . . . -54.68 -38.09 66.55 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.522 ' CG ' ' HB2' ' A' ' 39' ' ' TYR . 7.7 mtpt -78.51 -17.93 55.51 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -96.01 -23.62 16.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 32' ' ' VAL . . . -95.14 -23.71 17.17 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.81 37.58 4.93 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.596 ' CG1' ' HA ' ' A' ' 33' ' ' ALA . 2.1 pt -135.38 17.17 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.522 ' HB2' ' CG ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -43.44 -20.47 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.983 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . 57.27 174.93 0.04 OUTLIER Pre-proline 0 N--CA 1.449 -0.492 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.983 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 82.6 Cg_endo -72.5 -74.2 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 124.296 3.33 . . . . 0.0 109.57 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.671 ' H ' ' HG2' ' A' ' 41' ' ' PRO . 4.6 p-10 -104.29 -53.36 2.74 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.653 ' NE ' ' CZ ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER 46.1 -162.42 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -171.36 74.89 0.06 Allowed 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.658 ' HE2' HG23 ' A' ' 27' ' ' THR . 80.3 m-85 -79.65 102.99 9.26 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.618 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -131.23 174.92 4.13 Favored Pre-proline 0 N--CA 1.449 -0.523 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.618 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 83.8 Cg_endo -72.41 130.84 16.71 Favored 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 124.319 3.346 . . . . 0.0 109.643 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.806 HD21 HD21 ' A' ' 57' ' ' LEU . 1.4 tp -88.63 96.66 10.74 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.611 ' CD ' HG11 ' A' ' 153' ' ' VAL . 23.4 tt0 -79.08 89.73 4.82 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.757 ' CE2' ' CE1' ' A' ' 61' ' ' PHE . 0.7 OUTLIER -108.32 172.8 6.63 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.676 HG12 ' H ' ' A' ' 53' ' ' GLY . 59.1 t -123.6 107.28 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.85 HG11 ' HG ' ' A' ' 66' ' ' LEU . 2.8 t -50.93 -8.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.676 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -96.98 -25.27 11.53 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.296 -1.121 . . . . 0.0 110.296 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 51' ' ' VAL . 14.6 mt-10 -74.28 -65.32 0.86 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.82 13.84 8.36 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.53 HE21 ' HB2' ' A' ' 56' ' ' GLN . 0.5 OUTLIER -43.47 -67.09 0.31 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.806 HD21 HD21 ' A' ' 48' ' ' LEU . 1.5 mm? -70.67 -171.97 0.57 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.067 HD13 ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -81.68 146.38 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.543 HE21 ' HA ' ' A' ' 82' ' ' LYS . 14.0 mt-30 -43.15 -54.69 4.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.581 ' HA3' HD12 ' A' ' 78' ' ' ILE . . . -39.45 -81.51 0.02 OUTLIER Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.757 ' CE1' ' CE2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -42.53 -49.56 5.37 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.67 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 1.9 mt-10 -49.88 -35.08 22.17 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 60' ' ' GLY . 4.9 mt-10 -78.09 -32.0 50.4 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.473 ' HB1' ' HB3' ' A' ' 74' ' ' LYS . . . -64.47 -25.42 67.99 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.678 HG21 ' CE2' ' A' ' 50' ' ' PHE . 33.5 m -95.02 -20.4 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.85 ' HG ' HG11 ' A' ' 52' ' ' VAL . 1.2 mt -51.07 -60.44 3.1 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -96.33 55.59 1.5 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.471 ' CE ' HD11 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -144.37 127.38 16.47 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' A' ' 4' ' ' MET . 0.8 OUTLIER -75.31 -161.77 0.16 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.686 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 0.2 OUTLIER -90.0 115.56 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.868 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 107.0 -6.57 37.26 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 72' ' ' ASP . 0.9 OUTLIER -68.64 177.81 2.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -154.8 142.59 19.96 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.473 ' HB3' ' HB1' ' A' ' 64' ' ' ALA . 2.4 tttm -139.38 101.98 4.37 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 1.066 ' CG2' HG23 ' A' ' 146' ' ' THR . 0.2 OUTLIER -99.19 93.6 6.04 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.413 ' CG1' ' N ' ' A' ' 77' ' ' LYS . 18.3 t -136.09 156.04 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.673 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 2.5 ttpm? -85.35 116.44 23.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.689 ' CG1' ' CD1' ' A' ' 145' ' ' PHE . 22.2 mm -78.37 126.65 82.82 Favored Pre-proline 0 N--CA 1.448 -0.568 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.502 ' HG2' ' HG2' ' A' ' 81' ' ' GLU . 84.4 Cg_endo -72.32 144.1 40.57 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 124.264 3.31 . . . . 0.0 109.656 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.709 ' HB1' ' O ' ' A' ' 139' ' ' ALA . . . -56.62 -8.57 0.58 Allowed 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.582 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 9.3 pt-20 -81.55 -39.25 24.9 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.574 ' HB3' ' H ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -86.85 -34.73 19.38 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.639 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . . . -67.75 -96.44 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.604 ' CE1' ' HB3' ' A' ' 138' ' ' LEU . 3.1 m-85 -99.29 17.56 19.76 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 42.53 84.56 0.01 OUTLIER Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.666 ' N ' ' ND2' ' A' ' 86' ' ' ASN . 0.0 OUTLIER 47.65 -166.22 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 1.042 ' HE ' ' HB3' ' A' ' 139' ' ' ALA . 3.4 mmt85 -70.47 145.91 50.64 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.64 ' HB2' HD12 ' A' ' 91' ' ' LEU . 0.9 OUTLIER -83.27 143.83 30.15 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.09 -26.79 20.06 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -74.66 -23.3 58.64 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.64 HD12 ' HB2' ' A' ' 88' ' ' ASN . 85.4 mt -85.34 26.67 0.88 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.601 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 86.5 mt -93.16 116.41 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.825 HE22 ' HB2' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -109.19 154.23 22.67 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.664 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -134.96 99.09 4.19 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.038 HG12 HD11 ' A' ' 132' ' ' LEU . 21.4 pt -95.5 156.02 38.0 Favored Pre-proline 0 N--CA 1.449 -0.483 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 99' ' ' ALA . 83.0 Cg_endo -72.36 139.53 32.01 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 124.283 3.322 . . . . 0.0 109.577 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.82 HH21 ' HG2' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -42.16 -33.94 0.67 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.522 ' HA ' ' HB2' ' A' ' 101' ' ' LYS . 0.9 OUTLIER -65.85 -36.37 83.25 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -43.65 -19.85 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.488 ' N ' ' O ' ' A' ' 98' ' ' ASP . 0.6 OUTLIER -126.49 -30.61 2.83 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 1.2 tmtt? -53.42 -17.46 1.95 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.03 28.36 8.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.469 ' HB1' ' CE1' ' A' ' 105' ' ' PHE . . . -113.03 -139.16 0.38 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.99 -3.31 3.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.469 ' CE1' ' HB1' ' A' ' 103' ' ' ALA . 0.1 OUTLIER -128.13 -148.43 0.38 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.436 ' CD ' HH22 ' A' ' 97' ' ' ARG . 0.0 OUTLIER -162.44 132.93 3.5 Favored Pre-proline 0 N--CA 1.45 -0.448 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.82 ' HG2' HH21 ' A' ' 97' ' ' ARG . 82.3 Cg_endo -72.38 137.39 28.14 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 124.27 3.313 . . . . 0.0 109.591 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.479 ' O ' ' N ' ' A' ' 110' ' ' GLY . 4.0 mt-10 -126.05 154.61 42.77 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.528 ' N ' ' HB ' ' A' ' 125' ' ' VAL . 1.2 tt0 -65.51 67.03 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 153.91 9.86 0.08 OUTLIER Glycine 0 C--N 1.336 0.539 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.917 ' CB ' HD13 ' A' ' 122' ' ' ILE . 1.4 mmt -66.64 171.38 5.19 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.508 HG23 ' C ' ' A' ' 111' ' ' MET . 60.7 t -156.11 73.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.473 HD13 ' HZ ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -110.29 136.95 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.767 HD23 ' CD ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -106.49 171.07 7.56 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -114.79 -4.29 12.7 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.417 ' H ' ' H ' ' A' ' 117' ' ' GLY . 1.0 OUTLIER 172.33 5.63 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.418 ' O ' HD22 ' A' ' 114' ' ' LEU . . . 153.87 -38.86 0.69 Allowed Glycine 0 C--N 1.335 0.483 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 48.8 mm -87.47 114.65 59.74 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.767 ' CD ' HD23 ' A' ' 114' ' ' LEU . 84.9 Cg_endo -72.38 173.5 13.03 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 124.305 3.337 . . . . 0.0 109.604 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.875 ' HB1' ' HB3' ' A' ' 132' ' ' LEU . . . -134.64 73.14 1.47 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 77.3 m -49.85 96.86 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.917 HD13 ' CB ' ' A' ' 111' ' ' MET . 2.9 mp -69.1 98.73 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.426 HG23 ' H ' ' A' ' 123' ' ' THR . 1.0 OUTLIER -83.76 -21.14 32.32 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.561 ' HB3' ' H ' ' A' ' 131' ' ' THR . 0.3 OUTLIER -120.16 133.41 55.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.796 ' HA ' HG12 ' A' ' 130' ' ' VAL . 7.2 p -124.76 52.6 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.639 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -79.67 127.81 32.63 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 97' ' ' ARG . 0.5 OUTLIER -53.25 0.63 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.639 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -111.62 -21.67 11.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -177.83 168.43 2.09 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.796 HG12 ' HA ' ' A' ' 125' ' ' VAL . 4.2 m -133.66 141.69 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.664 HG23 ' HD2' ' A' ' 94' ' ' LYS . 17.3 m -98.18 86.27 3.64 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 1.038 HD11 HG12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -82.65 113.32 20.26 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.833 ' CG ' HD21 ' A' ' 135' ' ' ASN . 10.0 t0 -81.96 95.12 7.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.825 ' HB2' HE22 ' A' ' 93' ' ' GLN . 1.6 m-85 -39.88 -50.61 2.46 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.833 HD21 ' CG ' ' A' ' 133' ' ' ASP . 8.6 m120 45.97 -132.89 0.99 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.779 ' ND1' ' N ' ' A' ' 137' ' ' GLU . 23.2 t-80 -167.84 174.21 7.7 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.779 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 8.7 pt-20 -86.06 10.11 15.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.844 ' CD2' ' HE2' ' A' ' 141' ' ' LYS . 63.5 mt -135.01 5.32 3.31 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.042 ' HB3' ' HE ' ' A' ' 87' ' ' ARG . . . -60.58 -111.23 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.858 ' H ' ' NE ' ' A' ' 87' ' ' ARG . . . -65.59 38.65 0.13 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.844 ' HE2' ' CD2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -136.47 143.18 43.71 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.495 ' HB3' ' HA ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -101.0 129.9 46.91 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.788 HD22 HD22 ' A' ' 138' ' ' LEU . 1.1 pt? -121.07 145.69 47.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.673 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 1.6 t -62.14 163.88 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.689 ' CD1' ' CG1' ' A' ' 78' ' ' ILE . 12.3 m-85 -148.28 102.58 3.36 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 1.066 HG23 ' CG2' ' A' ' 75' ' ' THR . 24.3 m -97.17 60.81 1.7 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.691 HD13 ' CD2' ' A' ' 61' ' ' PHE . 1.1 mt -59.67 177.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.473 ' H ' HG22 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -177.25 113.86 0.09 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.868 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 2.8 mm -69.49 139.98 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.524 HG13 ' HA ' ' A' ' 13' ' ' VAL . 6.7 mt -118.78 -48.12 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.686 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -158.11 -165.39 1.71 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.999 HG22 ' CG2' ' A' ' 11' ' ' ILE . 10.7 t -134.16 137.83 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.629 ' O ' HG12 ' A' ' 153' ' ' VAL . 45.8 t -117.78 43.6 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.909 ' HB3' ' H ' ' A' ' 10' ' ' LYS . 14.0 tp10 . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.71 ' N ' ' HA ' ' A' ' 69' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.079 HG21 HD13 ' A' ' 11' ' ' ILE . 23.0 t -123.64 155.07 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' A' ' 8' ' ' GLY . 0.8 OUTLIER -137.76 171.08 14.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.539 ' HA ' ' C ' ' A' ' 52' ' ' VAL . 16.9 ptmt -64.76 70.64 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 6' ' ' ASP . . . 161.61 11.24 0.03 OUTLIER Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.838 ' HB ' HG13 ' A' ' 5' ' ' VAL . 1.7 t -125.17 132.97 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.839 ' H ' ' HB2' ' A' ' 154' ' ' GLU . 11.6 tttt -88.2 152.94 21.62 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.079 HD13 HG21 ' A' ' 5' ' ' VAL . 6.2 pt -160.72 137.96 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 7.7 ttmt -96.12 99.94 11.63 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.607 HG12 ' HA ' ' A' ' 149' ' ' ILE . 1.2 m -119.65 152.62 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.621 ' CG ' HD11 ' A' ' 150' ' ' ILE . 0.5 OUTLIER -115.42 103.01 10.35 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.605 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 9.3 p90 -96.63 151.63 19.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.941 HG21 HG11 ' A' ' 32' ' ' VAL . 1.1 mt -119.81 77.94 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -62.65 130.45 43.07 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.603 ' HE2' HG22 ' A' ' 24' ' ' VAL . 6.9 mtmt -125.56 144.43 50.57 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 21' ' ' SER . 80.2 mt -64.07 170.09 3.88 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.61 50.86 0.07 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 19' ' ' LEU . 94.1 p -161.82 -1.01 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.29 22.34 48.43 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 18' ' ' LYS . 2.2 m-20 -96.71 116.34 28.96 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.603 HG22 ' HE2' ' A' ' 18' ' ' LYS . 54.6 t -68.44 115.07 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.513 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 3.3 p90 -103.84 -37.75 7.31 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.513 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 9.3 t0 -136.04 133.46 37.43 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.9 ' HB ' HG23 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -153.91 131.59 11.49 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.605 ' HB2' ' HA ' ' A' ' 14' ' ' ASP . 3.0 m -79.68 -23.2 42.62 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.487 HG22 ' H ' ' A' ' 32' ' ' VAL . 5.0 mt -84.67 114.93 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.594 ' O ' ' HE3' ' A' ' 34' ' ' LYS . 6.4 tt0 -60.89 -22.02 63.89 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -60.51 -62.46 1.84 Allowed 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.941 HG11 HG21 ' A' ' 16' ' ' ILE . 89.3 t -54.54 -41.0 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.596 ' HA ' HG13 ' A' ' 38' ' ' ILE . . . -48.22 -39.18 20.37 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.594 ' HE3' ' O ' ' A' ' 30' ' ' GLU . 18.0 mttt -77.56 -24.32 49.84 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 32' ' ' VAL . 35.7 tt0 -84.37 -12.98 53.52 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.82 -10.49 14.76 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.83 44.0 10.74 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.596 HG13 ' HA ' ' A' ' 33' ' ' ALA . 1.6 pt -140.06 16.28 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.54 ' HB2' ' CG ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -45.07 -17.51 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.774 ' HB1' ' HB3' ' A' ' 43' ' ' ARG . . . 70.44 155.55 0.15 Allowed Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.597 ' HG2' ' H ' ' A' ' 42' ' ' ASP . 82.5 Cg_endo -72.41 -84.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 124.326 3.351 . . . . 0.0 109.618 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.597 ' H ' ' HG2' ' A' ' 41' ' ' PRO . 4.3 p-10 -93.16 -14.41 27.22 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.774 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -77.53 140.53 39.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.494 ' N ' ' HG3' ' A' ' 43' ' ' ARG . 4.3 mt-10 -115.15 179.01 4.08 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.56 ' CD2' ' HB2' ' A' ' 33' ' ' ALA . 9.8 m-85 -133.93 109.91 9.35 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.607 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -117.42 174.78 2.33 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.607 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 81.7 Cg_endo -72.36 124.07 9.63 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 124.312 3.341 . . . . 0.0 109.578 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.581 HD21 HD21 ' A' ' 57' ' ' LEU . 2.8 tp -86.66 125.15 33.66 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.581 ' O ' ' HE2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -91.95 98.69 11.73 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.795 ' CZ ' HG21 ' A' ' 65' ' ' VAL . 10.5 p90 -99.76 170.96 8.19 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.672 HG12 ' H ' ' A' ' 53' ' ' GLY . 57.6 t -135.01 106.13 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.539 ' C ' ' HA ' ' A' ' 7' ' ' LYS . 93.3 t -48.88 -10.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.672 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -117.27 62.3 0.41 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.43 ' H ' ' H ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -167.22 -20.05 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.43 ' H ' ' H ' ' A' ' 54' ' ' GLU . . . 82.38 6.57 88.57 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.701 HE21 ' HB2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -42.05 -78.61 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.673 HD23 ' CB ' ' A' ' 50' ' ' PHE . 3.0 mm? -75.02 -174.2 2.18 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.069 HD13 ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -82.19 144.02 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.895 HE21 ' HA ' ' A' ' 82' ' ' LYS . 3.7 mt-30 -41.83 -51.91 4.14 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.647 ' HA3' HD12 ' A' ' 78' ' ' ILE . . . -42.23 -78.48 0.07 OUTLIER Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.817 ' HB3' HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -47.68 -37.94 13.98 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.555 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 18.3 mt-10 -62.51 -22.78 66.55 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.763 ' HA ' HD12 ' A' ' 66' ' ' LEU . 4.7 mt-10 -88.54 -34.8 17.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.54 -30.39 71.42 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.795 HG21 ' CZ ' ' A' ' 50' ' ' PHE . 29.9 m -86.14 -32.8 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.763 HD12 ' HA ' ' A' ' 63' ' ' GLU . 2.9 mt -41.87 -43.25 2.97 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.36 50.4 0.81 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 1.072 ' HE3' HD11 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -145.07 119.3 9.51 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.71 ' HA ' ' N ' ' A' ' 4' ' ' MET . 3.2 mp0 -73.74 -168.77 0.62 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.679 HG22 HG23 ' A' ' 152' ' ' VAL . 34.5 t -79.29 113.93 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.774 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 108.99 -3.45 31.72 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.514 ' HB3' ' HG2' ' A' ' 68' ' ' MET . 0.7 OUTLIER -73.13 169.9 16.05 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.515 ' N ' ' SD ' ' A' ' 68' ' ' MET . 1.5 tt0 -150.15 139.16 21.05 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.5 ttmm -147.22 97.99 2.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.631 HG23 ' OG1' ' A' ' 146' ' ' THR . 28.6 m -93.71 90.63 6.66 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.9 t -126.41 145.69 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.625 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 5.6 ttpm? -76.44 115.08 15.85 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.68 ' CG1' ' CD2' ' A' ' 145' ' ' PHE . 37.5 mm -78.31 131.46 68.84 Favored Pre-proline 0 N--CA 1.45 -0.449 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.505 ' HA ' ' HB3' ' A' ' 142' ' ' ASP . 84.2 Cg_endo -72.41 139.44 31.73 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 124.35 3.367 . . . . 0.0 109.567 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.736 ' HB2' ' N ' ' A' ' 141' ' ' LYS . . . -52.01 -14.52 0.41 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.558 ' HA ' ' HA2' ' A' ' 85' ' ' GLY . 7.5 tt0 -78.85 -37.22 40.98 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.895 ' HA ' HE21 ' A' ' 59' ' ' GLN . 14.1 mttm -85.04 -36.27 21.34 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.656 ' HA ' ' CG2' ' A' ' 58' ' ' ILE . . . -67.55 -92.43 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 1.004 ' CE1' HD12 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -103.72 17.1 24.82 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 81' ' ' GLU . . . 65.09 144.09 0.03 OUTLIER Glycine 0 C--N 1.335 0.523 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.7 ' ND2' ' H ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -39.75 150.84 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.484 ' HG3' ' HA3' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -39.37 120.99 1.11 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.662 ' CB ' HD12 ' A' ' 91' ' ' LEU . 7.7 t30 -80.11 147.23 31.48 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.413 ' HA ' ' CD1' ' A' ' 92' ' ' ILE . 1.8 tt0 -73.87 -33.72 64.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -17.51 62.42 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.711 ' HB3' ' H ' ' A' ' 135' ' ' ASN . 13.0 mt -79.11 0.06 29.62 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.608 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 11.6 mt -94.31 118.94 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.615 HE22 ' C ' ' A' ' 91' ' ' LEU . 2.9 mp0 -109.08 171.61 7.33 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.463 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.0 OUTLIER -143.2 81.76 1.73 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.78 HG23 ' CD1' ' A' ' 132' ' ' LEU . 26.4 pt -79.8 155.87 75.35 Favored Pre-proline 0 N--CA 1.449 -0.485 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.625 ' HA ' ' HG3' ' A' ' 129' ' ' GLU . 83.1 Cg_endo -72.37 137.08 27.6 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 124.316 3.344 . . . . 0.0 109.624 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.823 HH21 ' CG ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -42.61 -33.45 0.71 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 100' ' ' PHE . 2.5 m-20 -66.07 -36.88 84.4 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -44.3 -19.68 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.77 ' HZ ' HD13 ' A' ' 113' ' ' ILE . 3.1 m-85 -124.47 -30.32 3.39 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 4.3 tttt -60.63 -19.8 59.02 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.59 18.08 22.91 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -103.85 -137.61 0.35 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.45 -0.57 4.46 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.413 ' HB2' ' H ' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -134.89 -149.81 0.36 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.505 ' HG2' ' HD2' ' A' ' 107' ' ' PRO . 1.8 tt0 -161.78 136.31 5.23 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.943 ' CG ' HG11 ' A' ' 130' ' ' VAL . 83.1 Cg_endo -72.41 141.48 35.24 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 124.279 3.319 . . . . 0.0 109.624 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 110' ' ' GLY . 1.0 OUTLIER -130.81 157.58 42.46 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -65.74 66.16 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 152.27 11.64 0.08 OUTLIER Glycine 0 C--N 1.335 0.477 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.905 ' CB ' HD13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -66.24 171.15 4.99 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.743 HG13 ' HB2' ' A' ' 119' ' ' PRO . 60.7 t -156.49 70.87 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.77 HD13 ' HZ ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -99.41 134.99 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.626 HD23 ' CD ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -103.29 144.75 30.94 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -96.02 0.49 51.7 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 170.82 -7.16 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 164.69 -38.82 0.3 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 5.3 mt -87.42 114.71 59.99 Favored Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.743 ' HB2' HG13 ' A' ' 112' ' ' VAL . 82.8 Cg_endo -72.44 156.18 54.63 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 124.246 3.297 . . . . 0.0 109.575 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.766 ' O ' HD12 ' A' ' 122' ' ' ILE . . . -116.37 94.06 4.48 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.56 HG22 ' O ' ' A' ' 121' ' ' THR . 1.3 m -64.84 98.4 0.27 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.905 HD13 ' CB ' ' A' ' 111' ' ' MET . 2.9 mp -70.41 100.13 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.5 p -83.28 -21.89 33.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.839 ' HB3' ' H ' ' A' ' 131' ' ' THR . 0.4 OUTLIER -121.84 131.52 54.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 125' ' ' VAL . 11.3 p -122.29 51.59 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.69 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -78.72 126.26 30.49 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.676 ' HA ' HH11 ' A' ' 97' ' ' ARG . 0.3 OUTLIER -53.36 2.84 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.69 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.3 OUTLIER -113.51 -21.96 10.57 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.625 ' HG3' ' HA ' ' A' ' 96' ' ' PRO . 1.4 mt-10 -173.96 168.43 4.19 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.943 HG11 ' CG ' ' A' ' 107' ' ' PRO . 18.1 m -135.07 122.55 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.839 ' H ' ' HB3' ' A' ' 124' ' ' GLU . 9.4 m -88.12 88.28 7.59 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.78 ' CD1' HG23 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -76.66 163.18 27.1 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.748 ' CG ' HD21 ' A' ' 135' ' ' ASN . 31.8 t0 -139.69 95.96 3.0 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.597 ' N ' ' O ' ' A' ' 91' ' ' LEU . 4.5 m-30 -37.5 -81.08 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.748 HD21 ' CG ' ' A' ' 133' ' ' ASP . 0.6 OUTLIER 58.04 100.87 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.693 ' CE1' ' HG2' ' A' ' 137' ' ' GLU . 14.3 t-80 -43.11 158.47 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.693 ' HG2' ' CE1' ' A' ' 136' ' ' HIS . 0.7 OUTLIER -54.78 -13.9 1.21 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 1.004 HD12 ' CE1' ' A' ' 84' ' ' TYR . 11.3 mt -114.09 -5.34 13.09 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.54 ' HB2' ' N ' ' A' ' 136' ' ' HIS . . . -55.25 133.26 49.25 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.484 ' HA3' ' HG3' ' A' ' 87' ' ' ARG . . . 48.5 17.94 0.85 Allowed Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.736 ' N ' ' HB2' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -124.95 129.57 50.61 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.548 ' C ' ' HD3' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -96.43 131.22 43.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.87 ' CD2' HD13 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -123.31 152.21 41.65 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.625 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 2.2 t -65.78 160.36 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.68 ' CD2' ' CG1' ' A' ' 78' ' ' ILE . 14.3 m-85 -146.85 92.15 2.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.631 ' OG1' HG23 ' A' ' 75' ' ' THR . 89.8 m -86.18 63.35 7.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.7 mt -60.94 174.24 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.508 ' H ' HG22 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -178.65 103.29 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 1.072 HD11 ' HE3' ' A' ' 68' ' ' MET . 0.8 OUTLIER -60.57 140.97 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.621 HD11 ' CG ' ' A' ' 14' ' ' ASP . 2.8 mt -122.75 -47.12 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.605 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 5.1 tt0 -151.52 -164.05 1.9 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.941 HG22 HG22 ' A' ' 11' ' ' ILE . 95.8 t -141.42 141.03 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 1.0 HG12 ' H ' ' A' ' 154' ' ' GLU . 24.1 t -120.96 -135.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.0 ' H ' HG12 ' A' ' 153' ' ' VAL . 1.8 tm-20 . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.627 ' CB ' ' HA ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.859 HG12 ' H ' ' A' ' 6' ' ' ASP . 3.4 t -103.12 -176.69 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.859 ' H ' HG12 ' A' ' 5' ' ' VAL . 52.5 m-20 -152.21 159.8 43.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.515 ' HA ' ' HB ' ' A' ' 52' ' ' VAL . 50.9 mtpt -66.93 79.63 0.12 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.55 ' HA2' ' HA3' ' A' ' 53' ' ' GLY . . . 157.78 -1.93 0.12 Allowed Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.478 ' HB ' ' CG1' ' A' ' 5' ' ' VAL . 1.3 t -106.33 130.25 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.835 ' H ' ' HB2' ' A' ' 154' ' ' GLU . 8.7 tttp -84.33 148.88 26.41 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.898 HG22 HG22 ' A' ' 152' ' ' VAL . 4.2 pt -160.27 136.28 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 11.3 ttmt -96.35 105.69 17.79 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.558 HG21 HG22 ' A' ' 147' ' ' ILE . 0.8 OUTLIER -122.44 160.62 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.544 ' HA ' ' HB2' ' A' ' 28' ' ' SER . 0.5 OUTLIER -114.72 98.55 6.92 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.652 ' HA ' ' HA ' ' A' ' 147' ' ' ILE . 1.2 p90 -94.8 161.33 14.21 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 1.058 HD13 HG21 ' A' ' 32' ' ' VAL . 7.0 mt -138.91 80.04 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 144' ' ' VAL . . . -67.87 131.03 28.24 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 110.314 -1.115 . . . . 0.0 110.314 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.624 ' HE2' HG22 ' A' ' 24' ' ' VAL . 4.8 mtmt -119.5 -171.67 2.17 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.689 ' C ' ' H ' ' A' ' 21' ' ' SER . 50.2 mt -108.25 168.76 9.08 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -60.07 13.36 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.689 ' H ' ' C ' ' A' ' 19' ' ' LEU . 98.7 p -124.58 -6.63 7.49 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.31 23.97 32.81 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.44 ' HB2' HD12 ' A' ' 19' ' ' LEU . 4.0 m-20 -94.34 117.71 30.52 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.624 HG22 ' HE2' ' A' ' 18' ' ' LYS . 76.1 t -70.81 112.93 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.573 ' CE2' ' HB2' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -100.02 -40.43 7.64 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.573 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 21.3 t0 -134.4 127.53 31.77 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 1.056 ' HB ' HG23 ' A' ' 16' ' ' ILE . 3.7 t -148.13 155.92 42.0 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.544 ' HB2' ' HA ' ' A' ' 14' ' ' ASP . 5.4 m -103.78 -21.39 13.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.674 HG22 ' H ' ' A' ' 32' ' ' VAL . 3.9 mt -83.78 96.71 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.443 ' CA ' ' HB2' ' A' ' 45' ' ' TYR . 3.2 tt0 -43.31 -24.17 0.08 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.458 ' HB3' ' CG2' ' A' ' 29' ' ' ILE . 20.3 tt0 -60.54 -61.39 2.63 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.058 HG21 HD13 ' A' ' 16' ' ' ILE . 95.2 t -53.75 -41.09 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.567 ' HA ' HG13 ' A' ' 38' ' ' ILE . . . -48.29 -40.5 25.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.524 ' CG ' ' HB2' ' A' ' 39' ' ' TYR . 15.7 mtpt -76.54 -25.2 53.86 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -84.45 -13.38 52.23 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.97 -10.41 15.05 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.56 44.22 11.11 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.567 HG13 ' HA ' ' A' ' 33' ' ' ALA . 0.3 OUTLIER -141.46 14.12 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.565 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -44.31 -19.15 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.824 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . 73.71 169.33 0.12 Allowed Pre-proline 0 N--CA 1.45 -0.473 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.824 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 82.2 Cg_endo -72.47 -82.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 124.274 3.316 . . . . 0.0 109.623 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.638 ' H ' ' HG2' ' A' ' 41' ' ' PRO . 10.4 p-10 -103.48 -15.1 15.97 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.501 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -42.91 151.68 0.12 Allowed 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.436 ' O ' ' CG ' ' A' ' 46' ' ' GLU . 50.5 mt-10 -130.8 100.72 5.37 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.495 ' CD2' ' HB2' ' A' ' 33' ' ' ALA . 16.9 m-85 -68.37 91.91 0.41 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.652 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -101.27 177.3 1.55 Allowed Pre-proline 0 N--CA 1.45 -0.452 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.652 ' HD2' ' CB ' ' A' ' 46' ' ' GLU . 82.3 Cg_endo -72.4 130.77 16.63 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 124.27 3.313 . . . . 0.0 109.546 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 tp -97.96 118.74 35.22 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.669 ' HB2' ' HE3' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -89.5 98.29 11.69 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.806 ' HB2' HE21 ' A' ' 56' ' ' GLN . 7.9 p90 -96.63 169.81 9.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.573 HG12 ' H ' ' A' ' 53' ' ' GLY . 54.4 t -131.62 102.92 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.678 HG11 ' HG ' ' A' ' 66' ' ' LEU . 2.9 t -44.54 -17.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.573 ' H ' HG12 ' A' ' 51' ' ' VAL . . . -108.55 40.87 2.39 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . 2.0 mt-10 -138.26 -23.72 1.0 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.33 8.46 85.15 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.806 HE21 ' HB2' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -42.43 -83.64 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.69 HD22 ' CZ ' ' A' ' 61' ' ' PHE . 3.8 mp -76.46 165.52 24.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.705 HG13 HG21 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -56.84 145.25 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.476 ' H ' ' HG3' ' A' ' 59' ' ' GLN . 1.5 mt-30 -43.14 -42.76 4.24 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.518 ' HA3' HD12 ' A' ' 78' ' ' ILE . . . -41.63 -83.85 0.01 OUTLIER Glycine 0 C--N 1.336 0.552 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.712 ' O ' HG22 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -43.93 -46.37 8.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.649 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 3.4 mt-10 -51.22 -29.69 15.0 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.69 ' HA ' HD12 ' A' ' 66' ' ' LEU . 2.8 mt-10 -85.32 -33.88 21.99 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.715 ' HB1' ' HD2' ' A' ' 74' ' ' LYS . . . -67.45 -25.87 66.12 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.723 HG21 ' CE2' ' A' ' 50' ' ' PHE . 5.8 m -88.63 -28.61 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.69 HD12 ' HA ' ' A' ' 63' ' ' GLU . 4.1 mt -48.42 -25.89 1.84 Allowed 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.627 ' HA ' ' CB ' ' A' ' 4' ' ' MET . 0.7 OUTLIER -125.5 47.9 2.13 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.773 ' HE3' HD11 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -140.01 102.41 4.39 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.507 ' N ' ' CG ' ' A' ' 72' ' ' ASP . 1.7 mp0 -61.47 -178.38 0.13 Allowed 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.643 ' CG1' ' HA ' ' A' ' 151' ' ' GLU . 1.9 t -71.34 109.36 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.853 ' H ' ' HB ' ' A' ' 149' ' ' ILE . . . 110.35 -5.04 29.88 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.507 ' CG ' ' N ' ' A' ' 69' ' ' GLU . 0.9 OUTLIER -70.97 173.21 7.76 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.605 ' N ' ' SD ' ' A' ' 68' ' ' MET . 0.2 OUTLIER -150.29 143.04 24.66 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.715 ' HD2' ' HB1' ' A' ' 64' ' ' ALA . 7.0 ttmt -146.05 103.93 3.78 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 1.071 ' CG2' HG23 ' A' ' 146' ' ' THR . 0.2 OUTLIER -103.62 114.33 28.51 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 75' ' ' THR . 54.8 t -157.91 159.25 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.591 ' HA ' ' HA ' ' A' ' 144' ' ' VAL . 4.6 ttpm? -86.14 116.73 24.52 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.707 ' CG1' ' CD2' ' A' ' 145' ' ' PHE . 34.9 mm -79.26 118.87 74.86 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.504 ' HA ' ' CG ' ' A' ' 142' ' ' ASP . 84.6 Cg_endo -72.33 138.43 30.17 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 124.381 3.387 . . . . 0.0 109.573 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.915 ' HB1' ' H ' ' A' ' 85' ' ' GLY . . . -44.32 -34.19 1.87 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.43 ' HG2' ' HG2' ' A' ' 79' ' ' PRO . 3.7 pt-20 -55.62 -32.28 62.99 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.413 ' N ' ' HG2' ' A' ' 81' ' ' GLU . 14.7 mtmt -106.48 -0.34 24.1 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.668 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . . . -121.44 -82.31 0.65 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.674 ' CZ ' HD12 ' A' ' 138' ' ' LEU . 3.9 m-85 -107.9 -48.07 3.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.915 ' H ' ' HB1' ' A' ' 80' ' ' ALA . . . 101.35 154.88 26.56 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.81 ' ND2' ' H ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -36.61 137.03 0.32 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.613 ' HD3' ' H ' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -39.84 143.77 0.23 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.552 ' H ' HD12 ' A' ' 91' ' ' LEU . 22.6 t30 -79.57 140.05 37.31 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.432 ' HG2' HD12 ' A' ' 92' ' ' ILE . 2.3 tt0 -65.74 -27.46 68.33 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -14.65 61.63 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.046 HD13 ' HA ' ' A' ' 135' ' ' ASN . 52.6 mt -85.15 7.62 21.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.581 ' HA ' ' HA ' ' A' ' 133' ' ' ASP . 62.1 mt -87.93 120.25 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.811 ' O ' HD12 ' A' ' 132' ' ' LEU . 0.0 OUTLIER -116.57 146.65 42.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.39 118.73 31.93 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.989 HG12 HD11 ' A' ' 132' ' ' LEU . 36.3 pt -114.45 152.29 45.97 Favored Pre-proline 0 N--CA 1.449 -0.48 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.599 ' HA ' ' HG3' ' A' ' 129' ' ' GLU . 84.7 Cg_endo -72.34 129.97 15.63 Favored 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 124.292 3.328 . . . . 0.0 109.654 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.881 HH21 ' HG3' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -41.98 -28.98 0.19 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.515 ' HA ' ' HB2' ' A' ' 101' ' ' LYS . 28.7 t70 -65.08 -38.14 89.78 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 96' ' ' PRO . . . -50.09 -28.41 7.15 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.54 ' CD2' HD11 ' A' ' 95' ' ' ILE . 1.2 m-85 -107.96 -26.82 10.52 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -60.45 -0.85 0.29 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.497 ' H ' ' C ' ' A' ' 100' ' ' PHE . 5.1 pt-20 -120.14 22.27 11.48 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.415 ' HB1' ' CE1' ' A' ' 105' ' ' PHE . . . -104.47 -137.93 0.36 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -140.85 -3.11 1.28 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.421 ' HB2' ' H ' ' A' ' 106' ' ' GLU . 0.2 OUTLIER -123.02 -149.48 0.43 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.421 ' H ' ' HB2' ' A' ' 105' ' ' PHE . 1.0 OUTLIER -158.77 125.0 2.43 Favored Pre-proline 0 N--CA 1.449 -0.511 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.881 ' HG3' HH21 ' A' ' 97' ' ' ARG . 83.7 Cg_endo -72.4 141.97 36.15 Favored 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 124.408 3.405 . . . . 0.0 109.559 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 110' ' ' GLY . 0.7 OUTLIER -133.16 159.45 40.1 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.622 ' HB2' HG12 ' A' ' 125' ' ' VAL . 0.9 OUTLIER -64.73 67.71 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 108' ' ' GLU . . . 156.44 8.07 0.06 OUTLIER Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 1.036 ' CB ' HD13 ' A' ' 122' ' ' ILE . 0.5 OUTLIER -63.43 172.62 1.92 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.561 HG13 ' HB2' ' A' ' 119' ' ' PRO . 76.3 t -156.86 65.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.479 HD13 ' CZ ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -96.68 136.87 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.904 HD23 ' N ' ' A' ' 119' ' ' PRO . 0.3 OUTLIER -103.38 153.03 20.91 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -105.9 2.72 27.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 173.28 -13.65 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.654 ' O ' HD22 ' A' ' 114' ' ' LEU . . . 168.25 -33.65 0.19 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 114' ' ' LEU . 3.0 mt -94.51 122.19 61.58 Favored Pre-proline 0 N--CA 1.448 -0.535 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.904 ' N ' HD23 ' A' ' 114' ' ' LEU . 81.7 Cg_endo -72.36 169.71 20.99 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 124.313 3.342 . . . . 0.0 109.549 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.682 ' HB1' ' HB3' ' A' ' 132' ' ' LEU . . . -126.79 67.98 1.25 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.54 ' HB ' ' HB3' ' A' ' 133' ' ' ASP . 6.2 m -41.77 100.26 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 1.036 HD13 ' CB ' ' A' ' 111' ' ' MET . 2.6 mp -71.42 94.8 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 131' ' ' THR . 1.3 p -77.08 -25.43 52.33 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.526 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 0.6 OUTLIER -122.46 129.28 51.86 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 125' ' ' VAL . 7.7 p -115.82 59.56 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.658 ' C ' ' H ' ' A' ' 128' ' ' ASN . 0.2 OUTLIER -79.71 119.84 23.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.407 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 0.3 OUTLIER -48.9 -3.66 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.658 ' H ' ' C ' ' A' ' 126' ' ' THR . 0.2 OUTLIER -113.73 -25.07 8.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.849 ' HA ' HH11 ' A' ' 97' ' ' ARG . 1.4 mt-10 -167.76 167.16 13.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.876 HG13 ' CZ ' ' A' ' 97' ' ' ARG . 16.6 m -132.56 146.57 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 131' ' ' THR . 65.9 m -102.71 64.16 0.87 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.989 HD11 HG12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -58.91 151.06 22.6 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.828 ' CG ' HD21 ' A' ' 135' ' ' ASN . 12.5 t0 -124.38 97.15 5.19 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.546 ' N ' ' O ' ' A' ' 91' ' ' LEU . 1.6 m-30 -39.47 -78.84 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 1.046 ' HA ' HD13 ' A' ' 91' ' ' LEU . 0.5 OUTLIER 68.0 -131.93 0.11 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.747 ' ND1' ' N ' ' A' ' 138' ' ' LEU . 8.2 t-80 -172.12 176.51 3.45 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.749 -0.464 . . . . 0.0 109.749 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.742 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -70.56 -6.61 37.71 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.955 HD23 ' HE2' ' A' ' 141' ' ' LYS . 56.9 mt -126.78 -12.02 6.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.538 ' CB ' ' HB3' ' A' ' 135' ' ' ASN . . . -57.21 133.41 55.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.674 ' HA2' ' HA ' ' A' ' 86' ' ' ASN . . . 39.94 39.75 1.5 Allowed Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.955 ' HE2' HD23 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -145.48 145.32 31.03 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.504 ' CG ' ' HA ' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -103.57 124.3 48.53 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 1.091 HD23 ' H ' ' A' ' 143' ' ' LEU . 1.6 pt? -107.61 143.64 35.79 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 77' ' ' LYS . 2.1 t -60.69 164.9 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.707 ' CD2' ' CG1' ' A' ' 78' ' ' ILE . 9.9 m-85 -153.03 97.03 2.15 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 1.071 HG23 ' CG2' ' A' ' 75' ' ' THR . 30.7 m -94.71 70.28 3.49 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.652 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -69.0 172.07 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -175.1 103.38 0.09 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.853 ' HB ' ' H ' ' A' ' 71' ' ' GLY . 3.7 mm -58.68 146.93 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.499 HD11 ' OD1' ' A' ' 14' ' ' ASP . 15.6 mt -131.4 -42.33 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.643 ' HA ' ' CG1' ' A' ' 70' ' ' VAL . 2.0 mt-10 -153.44 -163.89 1.78 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.898 HG22 HG22 ' A' ' 11' ' ' ILE . 61.4 t -143.87 140.19 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 1.015 HG12 ' H ' ' A' ' 154' ' ' GLU . 32.9 t -119.83 -133.95 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.015 ' H ' HG12 ' A' ' 153' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.96 . . . . . . . . 2 2 . 1 stop_ save_